<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:61.8pt;left:44.4pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Systematic Review</span></p>
<p style="top:104.6pt;left:102.5pt;line-height:17.9pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Biological Augmentation and Tissue Engineering</span></p>
<p style="top:125.5pt;left:165.8pt;line-height:17.9pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Approaches in Meniscus Surgery</span></p>
<p style="top:154.2pt;left:59.1pt;line-height:12.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:12.0pt">Cathal J. Moran, M.D., F.R.C.S.(Orth), Alberto Busilacchi, M.D., Cassandra A. Lee, M.D.,</span></p>
<p style="top:167.1pt;left:120.1pt;line-height:12.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:12.0pt">Kyriacos A. Athanasiou, Ph.D., and Peter C. Verdonk, M.D., Ph.D.</span></p>
<p style="top:229.9pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt">Purpose:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> The purpose of this review was to evaluate the role of biological augmentation and tissue engineering strategies</span></p>
<p style="top:240.8pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">in meniscus surgery. Although clinical (human), preclinical (animal), and in vitro tissue engineering studies are included</span></p>
<p style="top:251.7pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">here, we have placed additional focus on addressing preclinical and clinical studies reported during the 5-year period used</span></p>
<p style="top:262.7pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">in this review in a systematic fashion while also providing a summary review of some important in vitro tissue engineering</span></p>
<p style="top:273.7pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">ndings in the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">eld over the past decade.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Methods:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> A search was performed on PubMed for original works published</span></p>
<p style="top:284.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">from 2009 to March 31, 2014 using the term</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">meniscus</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> with all the following terms:</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">scaffolds,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">constructs,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">cells,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span></p>
<p style="top:295.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">growth factors,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">implant,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">tissue engineering,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> and</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">regenerative medicine.</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> Inclusion criteria were the following:</span></p>
<p style="top:306.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">English-language articles and original clinical, preclinical (in vivo), and in vitro studies of tissue engineering and regen-</span></p>
<p style="top:317.5pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">erative medicine application in knee meniscus lesions published from 2009 to March 31, 2014.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Results:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> Three clinical</span></p>
<p style="top:328.5pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">studies and 18 preclinical studies were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">ed along with 68 tissue engineering in vitro studies. These reports show the</span></p>
<p style="top:339.4pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">increasing promise of biological augmentation and tissue engineering strategies in meniscus surgery. The role of stem cell</span></p>
<p style="top:350.4pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">and growth factor therapy appears to be particularly useful. A review of in vitro tissue engineering studies found a large</span></p>
<p style="top:361.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">number of scaffold types to be of promise for meniscus replacement. Limitations include a relatively low number of clinical</span></p>
<p style="top:372.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">or preclinical in vivo studies, in addition to the fact there is as yet no report in the literature of a tissue-engineered</span></p>
<p style="top:383.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">meniscus construct used clinically. Neither does the literature provide clarity on the optimal meniscus scaffold type or</span></p>
<p style="top:394.2pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">biological augmentation with which meniscus repair or replacement would be best addressed in the future. There is</span></p>
<p style="top:405.2pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">increasing focus on the role of mechanobiology and biomechanical and biochemical cues in this process, however, and it is</span></p>
<p style="top:416.2pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">hoped that this may lead to improvements in this strategy.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Conclusions:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> There appears to be signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">cant potential for</span></p>
<p style="top:427.1pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">biological augmentation and tissue engineering strategies in meniscus surgery to enhance options for repair and</span></p>
<p style="top:438.0pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">replacement. However, there are still relatively few clinical studies being reported in this regard. There is a strong need for</span></p>
<p style="top:449.0pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">improved translational activities and infrastructure to link the large amounts of in vitro and preclinical biological and tissue</span></p>
<p style="top:460.0pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">engineering data to clinical application.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Level of Evidence:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> Level IV, systematic review of Level I-IV studies.</span></p>
<p style="top:490.0pt;left:227.4pt;line-height:12.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:12.0pt">See commentary on page 956</span></p>
<p style="top:517.5pt;left:44.4pt;line-height:28.9pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:28.9pt">T</span></p>
<p style="top:521.0pt;left:64.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">he meniscus plays a key role in joint congruency,</span></p>
<p style="top:532.9pt;left:64.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">load distribution, enhanced stability, and assistance</span></p>
<p style="top:544.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in lubrication and nutrition at the level of the knee.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">1</span></sup></p>
<p style="top:521.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Surgical</span></p>
<p style="top:521.0pt;left:349.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intervention</span></p>
<p style="top:521.0pt;left:411.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">for</span></p>
<p style="top:521.0pt;left:432.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:521.0pt;left:454.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">injured</span></p>
<p style="top:521.0pt;left:494.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:532.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">driven by mechanical symptoms or pain (or both), with</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is</span></sup></p>
<p style="top:544.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">symptomatic relief being the primary concern of the</span></p>
<p style="top:556.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patient. More than 1.5 million meniscus procedures are</span></p>
<p style="top:568.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">performed across the United States and Europe annu-</span></p>
<p style="top:580.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ally, most often partial meniscectomy for an irreparable</span></p>
<p style="top:592.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lesion.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">However, once the normal functions of the</span></p>
<p style="top:604.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus are impaired, chondroprotection is disrupted,</span></p>
<p style="top:616.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and the risk of degenerative change and related</span></p>
<p style="top:628.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">morbidity is increased.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">3</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">It follows that restoring normal</span></p>
<p style="top:640.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:640.5pt;left:356.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">form</span></p>
<p style="top:640.5pt;left:387.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:640.5pt;left:413.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">function</span></p>
<p style="top:640.5pt;left:459.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">through</span></p>
<p style="top:640.5pt;left:504.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair</span></p>
<p style="top:640.5pt;left:540.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">or</span></p>
<p style="top:652.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">replacement may be in the interest of the long-term</span></p>
<p style="top:664.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">health of the knee.</span></p>
<p style="top:676.4pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although it is now known that meniscus repair is the</span></p>
<p style="top:688.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">preferred option for patients with a meniscus lesion,</span></p>
<p style="top:700.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">there</span></p>
<p style="top:700.3pt;left:337.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">are</span></p>
<p style="top:700.3pt;left:359.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">many</span></p>
<p style="top:700.3pt;left:392.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">situations</span></p>
<p style="top:700.3pt;left:443.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:700.3pt;left:460.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">which</span></p>
<p style="top:700.3pt;left:495.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this</span></p>
<p style="top:700.3pt;left:519.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is</span></p>
<p style="top:700.3pt;left:534.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">not</span></p>
<p style="top:712.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">possible</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">d</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">e.g., lesions affecting the inner third of the</span></p>
<p style="top:584.5pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">From Sports Surgery Clinic and Trinity College Dublin (C.J.M.), Dublin,</span></p>
<p style="top:594.5pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ireland; Antwerp Knee Centre, AC Monica Hospitals (P.C.V.), Antwerp,</span></p>
<p style="top:604.4pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Belgium; Clinical Orthopaedics, Universit&#xe0; Politecnica delle Marche (A.B.),</span></p>
<p style="top:614.4pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ancona, Italy; Departments of Orthopaedic Surgery &amp; Biomedical Engineer-</span></p>
<p style="top:624.3pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">ing, University of California (C.A.L., K.A.A.), Davis, California, U.S.A.</span></p>
<p style="top:634.3pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">The authors report the following potential con</span><span style="font-family:AdvOTc548c603.I+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">ict of interest or source of</span></p>
<p style="top:644.3pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">funding: P.V. receives support from Orteq Sport Medicine.</span></p>
<p style="top:654.3pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Received July 18, 2014; accepted November 19, 2014.</span></p>
<p style="top:664.2pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Address correspondence to Cathal J. Moran, M.D., F.R.C.S.(Orth), Sports</span></p>
<p style="top:674.2pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Surgery Clinic, Santry Demesne, Santry, Dublin 9, Ireland. E-mail:</span></p>
<p style="top:684.1pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt;color:#0a7fac">cathaljmoran@gmail.com</span></p>
<p style="top:694.1pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> 2015 by the Arthroscopy Association of North America</span></p>
<p style="top:704.0pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">0749-8063/14626/$36.00</span></p>
<p style="top:714.0pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt;color:#0a7fac">http://dx.doi.org/10.1016/j.arthro.2014.11.044</span></p>
<p style="top:747.3pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">944</span></p>
<p style="top:749.7pt;left:127.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Arthroscopy: The Journal of Arthroscopic and Related Surgery, Vol 31, No 5 (May), 2015: pp 944-955</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus, an area known to have a limited vascular</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">supply and healing potential.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">4</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Degenerative tears of the</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus are also unlikely to heal if repaired because of</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the pattern of the tear, the quality of the tissue, and the</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">typically older patient pro</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">le with which they are most</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">often associated. The preceding tear types are therefore</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">usually an indication for meniscectomy. Furthermore,</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">even when tears seem to have the ideal physical and</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biological characteristics for repair, we know that there</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">remains a failure rate of up to 30%.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">5</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although there are</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">now increased data to support the use of synthetic and</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">allograft meniscus replacement material in advanced</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cases of meniscus loss, even under appropriate in-</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dications these options are impaired by a lack of uni-</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">versal ef</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cacy and limited availability.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">6,7</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">For this reason,</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the consideration of biological augmentation and tissue</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">engineering approaches to meniscus repair and replace-</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment is important for surgeons and scientists alike.</span></p>
<p style="top:270.3pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Biological augmentation strategies attempt to over-</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">come the inherent limitations in healing related to</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">poor vascularity and heterogeneous cellularity by</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">promoting</span></p>
<p style="top:306.2pt;left:100.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chemotaxis,</span></p>
<p style="top:306.2pt;left:162.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cellular</span></p>
<p style="top:306.2pt;left:204.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">proliferation,</span></p>
<p style="top:306.2pt;left:271.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">matrix production at the repair site. Mechanical</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">techniques traditionally used to stimulate healing by</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">creating vascular access and stimulating cells, cyto-</span></p>
<p style="top:354.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">kines, and bone marrow cells in the vicinity of the</span></p>
<p style="top:366.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair are representative of early augmentation stra-</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tegies. These techniques have been applied clinically</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">over the years with varying clinical outcomes.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">5,8</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">provision of exogenous</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin clot, growth factors, and</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cells from various sources to the meniscus repair site</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have also been previously noted in the literature.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">9-12</span></sup></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although the term</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue engineering</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> has been</span></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">applied to a multitude of biological strategies in pre-</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">vious literature, it correctly refers to the addition of</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cells or growth factors to a scaffold with the aim of</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">host target tissue regeneration. This strategy may</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">involve varying levels of focus on both ex vivo and</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in vivo meniscus tissue generation before and after</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">implantation</span></p>
<p style="top:521.4pt;left:110.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">into</span></p>
<p style="top:521.4pt;left:136.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:521.4pt;left:159.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">host.</span></p>
<p style="top:521.4pt;left:189.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">However,</span></p>
<p style="top:521.4pt;left:241.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:521.4pt;left:258.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">critical</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">importance is the understanding that current models</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of meniscus tissue engineering must also provide for</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the impact of mechanobiology (the effects of implant</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and tissue loading in the knee on cellular function and</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue formation).</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">This concept has grown in focus in</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">recent years in the overall world of tissue engineering</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and regenerative medicine; it is of particular impor-</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tance when considering musculoskeletal tissues. It</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may be of particular bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t to consider this in areas in</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">which we have struggled in our efforts to make</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">further</span></p>
<p style="top:652.9pt;left:84.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">advances</span></p>
<p style="top:652.9pt;left:133.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">toward</span></p>
<p style="top:652.9pt;left:173.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:652.9pt;left:195.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">satisfactory</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">management of cartilage and meniscus lesions.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">surgical</span></sup></p>
<p style="top:676.8pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The aim of this article is to provide a review of the</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">literature as it relates to original reports of biological</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation and tissue engineering approaches in</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus surgery. Because it is impossible to provide a</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">comprehensive systematic overview of the entire litera-</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ture in this</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld, which would cover all published reports</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of clinical (human), preclinical (animal), and in vitro</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies, we have focused this review on studies reported</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the past 5 years. The preceding period has also pre-</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">viously been addressed in this journal.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">14</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">We place</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">particular focus on addressing preclinical and clinical</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies reported during this 5-year period in a systematic</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">fashion while also providing a summary of some</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">important in vitro tissue engineering</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ndings in the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">over this period. This approach serves to highlight the</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">trends in the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld, reveal the limited progress from</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in vitro investigations to clinical trials, and promote an</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">understanding of the need for greater translational</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">interaction to drive the process forward from here. The</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">role of synthetic scaffolds used in isolation is not</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">addressed in this article because it is dealt with in a</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">separate focused review in this issue of</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt"> Arthroscopy</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">.</span></p>
<p style="top:282.7pt;left:403.0pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Methods</span></p>
<p style="top:296.2pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">A search was performed on PubMed for original</span></p>
<p style="top:308.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">works published from 2009 to March 31, 2014 using</span></p>
<p style="top:320.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the term</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> with all the following terms:</span></p>
<p style="top:332.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffolds,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:332.1pt;left:363.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">constructs,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:332.1pt;left:428.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cells,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:332.1pt;left:468.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growth</span></p>
<p style="top:332.1pt;left:513.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factors,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:344.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">implant,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:344.0pt;left:359.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue</span></p>
<p style="top:344.0pt;left:397.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">engineering,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:344.0pt;left:465.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:344.0pt;left:490.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regenerative</span></p>
<p style="top:356.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">medicine</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 1</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). Inclusion criteria for the clinical</span></p>
<p style="top:368.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and preclinical sections were the following: English-</span></p>
<p style="top:379.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">language articles and original clinical and preclinical</span></p>
<p style="top:391.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(in vivo) studies of Tissue Engineering and Regenera-</span></p>
<p style="top:403.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tive Medicine (TERM) application in knee meniscus</span></p>
<p style="top:415.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lesions published from 2009 to March 31, 2014. To</span></p>
<p style="top:427.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">provide</span></p>
<p style="top:427.8pt;left:347.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">an</span></p>
<p style="top:427.8pt;left:366.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">up-to-date</span></p>
<p style="top:427.8pt;left:421.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">summary</span></p>
<p style="top:427.8pt;left:470.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:427.8pt;left:487.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">some</span></p>
<p style="top:427.8pt;left:518.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:427.8pt;left:535.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:439.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">important in vitro data over time, the 5 years leading up</span></p>
<p style="top:451.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to March 31, 2014 were also considered for the in vitro</span></p>
<p style="top:463.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue engineering section, and some of the most</span></p>
<p style="top:475.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">important articles were chosen. All abstracts were</span></p>
<p style="top:487.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">evaluated. Only Level I to IV clinical studies were</span></p>
<p style="top:499.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">considered for the clinical section. When an article was</span></p>
<p style="top:511.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">included, the full-text article was reviewed, and refer-</span></p>
<p style="top:523.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ence lists and related electronic libraries were checked.</span></p>
<p style="top:535.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">All articles identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed by these search terms were</span></p>
<p style="top:547.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">manually reviewed and discussed among us, and a</span></p>
<p style="top:559.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">decision was made regarding inclusion or exclusion.</span></p>
<p style="top:583.6pt;left:406.7pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Results</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Clinical Studies 2009 to 2014</span></p>
<p style="top:617.0pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">We identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed 3 clinical articles relating to biological</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation and tissue engineering approaches to</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus repair or regeneration in the past 5 years</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 2</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). Jang et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">15</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">described a standardized</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">arthroscopic technique to deliver additional autolo-</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">gous</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin clot to inside-out sutures. This was reported</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to have a success rate of 95% (39 of 41 patients). This</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">series included 41 meniscus tears (19 radial tears, 12</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">longitudinal tears in the red-white zone, 7 transverse</span></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">945</span></p>


<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tears, and 3 oblique tears). Ra et al. also investigated</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the ef</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cacy of inside-out meniscus sutures in associa-</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion with</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin clot placed inside radial meniscus tears.</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">At a mean of 30</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 4 months postoperatively, the</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Lysholm score was noted to have improved from</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">65</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 6 to 94</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 3 and the International Knee Docu-</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mentation Committee subjective knee score improved</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">from 57</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 7 to 92</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 3. Second-look arthroscopy</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed complete healing of the meniscus lesion in 6 of</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">7 cases. These data support previous studies that</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed a bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t to using</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin clot in meniscus sur-</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">gery.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">9,16,17</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The delivery mechanism described by Jang</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al. may provide a user-friendly technique for</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">applying this strategy more frequently in the clinical</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">setting.</span></p>
<p style="top:354.0pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In 2014, Vangsness et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">18</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reported on a randomized</span></p>
<p style="top:366.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">double-blind controlled study investigating the safety of</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intra-articular injection of human mesenchymal stem</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cells (MSCs) into the knee, the ability of MSCs to pro-</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mote meniscus regeneration after partial meniscec-</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tomy, and the effects of MSCs on osteoarthritic changes</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the knee. A total of 55 patients at 7 institutions un-</span></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">derwent</span></p>
<p style="top:437.7pt;left:91.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">partial</span></p>
<p style="top:437.7pt;left:129.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">medial</span></p>
<p style="top:437.7pt;left:169.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscectomy.</span></p>
<p style="top:437.7pt;left:245.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">A</span></p>
<p style="top:437.7pt;left:262.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">single</span></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">superolateral knee injection was given within 7 to</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">10 days after meniscectomy. Patients were randomized</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to 1 of 3 treatment groups: group A, in which patients</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">received an injection of 50</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 10</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">6</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">allogeneic MSCs;</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">group B, in which patients received 150</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 10</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">6</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">alloge-</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">neic MSCs; and the control group, which received a</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sodium</span></p>
<p style="top:521.4pt;left:86.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">hyaluronate</span></p>
<p style="top:521.4pt;left:150.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(hyaluronic</span></p>
<p style="top:521.4pt;left:211.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">acid/hyaluronan)</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">vehicle control. Patients were followed to evaluate</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">safety, meniscus regeneration, overall condition of the</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">knee joint, and clinical outcomes at intervals over</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">2 years. Evaluations included sequential magnetic</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">resonance imaging (MRI). No ectopic tissue formation</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">or clinically important safety issues were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed.</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There was signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly increased meniscus volume</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ned a priori as a 15% threshold) determined by</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">quantitative MRI in 24% of patients in group A and in</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">6% of patients in group B at 12 months after menis-</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cectomy (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .022). No patients in the control group</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">met the 15% threshold for increased meniscus volume.</span></p>
<p style="top:676.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Based on visual analog scale assessments, patients with</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">osteoarthritic changes who received MSCs experienced</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant reduction in pain compared with those</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">who received the control vehicle.</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Preclinical In Vivo Studies 2009 to 2014</span></p>
<p style="top:67.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">We identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed 18 preclinical in vivo studies relating to</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the biological augmentation and tissue engineering</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">approaches to meniscus repair or regeneration pub-</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lished in the past 5 years (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 3</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). These reports</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">included both large animal models, such as goats,</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sheep, and swine, as well as smaller animal models,</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">including rats, rabbits, and mice. The heterogeneity of</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">experimental models testing the different treatments is</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also evident in</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac"> Table 3</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">. However, these reports do</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">appear to provide promising data as to the potential</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t of biological treatments.</span></p>
<p style="top:198.6pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Regarding</span></p>
<p style="top:198.6pt;left:367.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:198.6pt;left:389.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">potential</span></p>
<p style="top:198.6pt;left:436.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ts</span></p>
<p style="top:198.6pt;left:479.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:198.6pt;left:496.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmenting</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus repair with stem cells alone, in a</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sandwich</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">model in nude mice Scotti et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">27</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed that</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus layers containing</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrocytes in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">glue improved bonding and integration compared with</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">acellular</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin. Furthermore, the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin gel appeared to</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">be a valid vehicle for cell migration and viability to</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">promote</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brocartilaginous differentiation. In a rat</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">model of meniscus defects, Horie et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">28</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">not only re-</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ported the regenerative effects of synovial stem cells</span></p>
<p style="top:318.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">injected into the joint but also their differentiation to a</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus lineage. This was shown through histologic</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">data, immunostaining, and molecular analysis based on</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">LacZ</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> gene expression in transgenic mice. In a rabbit</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">model, Horie et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">29</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">injected synovial MSCs to stimu-</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">late the healing of a 1.5-mm</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">diameter defect in</span></p>
<p style="top:389.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus and noted a signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly improved regener-</span></p>
<p style="top:401.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ative response compared with their control of phos-</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">phate buffered saline alone. Ferris et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">30</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reported on a</span></p>
<p style="top:425.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">construct of meniscus layers and</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin glue loaded with</span></p>
<p style="top:437.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">equine bone marrow stromal cells (BMSCs). They</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed increased vascularization, thinner repair tissue,</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and better bonding with surrounding tissue when the</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">construct with MSCs was compared with constructs</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">without cells. Desando et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">31</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">investigated the potential</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of adipose tissue</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">derived stem cells for meniscus</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair, showing that these cells were able to improve</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing of cartilage and meniscus defects in a rabbit</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">osteoarthritis model. Finally, although all the studies</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mentioned point to the potential bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ts of stem cell</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation, in a meniscus pullout suture enhanced</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with human BMSCs versus simple sutures alone in a</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rabbit model, Hong et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">32</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">did not show signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased healing in the group treated with suture and</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cells versus cells alone.</span></p>
<p style="top:617.0pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The role of growth factors has also been addressed in</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal preclinical studies, both with and without</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cellular therapy or scaffold use. Zhang et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that full-thickness meniscus tears in the avascular zone</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in a goat model showed enhanced repair when treated</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with human insulin-like growth factor 1 (hIGF-1)</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meshed BMSCs in an injectable solution. Their study</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">histologically</span></p>
<p style="top:700.7pt;left:372.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:700.7pt;left:397.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biochemically</span></p>
<p style="top:700.7pt;left:466.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed</span></p>
<p style="top:700.7pt;left:509.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that</span></p>
<p style="top:700.7pt;left:535.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus defect was completely</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lled at 16 weeks after</span></p>
<p style="top:55.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Summary of the Data and Main Variables That Were</span></p>
<p style="top:66.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">Assessed During This Systematic Review</span></p>
<p style="top:80.7pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Search Terms:</span></p>
<p style="top:90.7pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Meniscus + one of the following terms:</span></p>
<p style="top:100.6pt;left:60.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Scaffolds, constructs, cells, growth factors, implant, tissue</span></p>
<p style="top:110.6pt;left:68.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">engineering, regenerative medicine</span></p>
<p style="top:120.6pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Criteria: English language original study</span></p>
<p style="top:130.5pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Type: Clinical or preclinical (Evidence Level I-IV for clinical articles)</span></p>
<p style="top:140.5pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Dates: 2009-March 31, 2014</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">946</span></p>
<p style="top:31.6pt;left:257.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">C. J. MORAN ET AL.</span></p>


<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment. He et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">34</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">performed a study in rabbits using</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growth factors in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin glue. Their study found that</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">connective tissue growth factor enhanced healing in</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">defects of the avascular zone of the meniscus by stim-</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ulating the neosynthesis of both collagen types 1 and 2.</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Ionescu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">35</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">published a bovine study that evaluated</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the in vivo effect of basic</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">broblast growth factor</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(bFGF) as a promitotic agent and transforming growth</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">3 (TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">3) as a pro-matrix forming agent on</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:162.7pt;left:357.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair</span></p>
<p style="top:162.7pt;left:393.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:162.7pt;left:420.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">integration</span></p>
<p style="top:162.7pt;left:479.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with</span></p>
<p style="top:162.7pt;left:509.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">synthetic</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus scaffolding. In the short term, delivery of</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bFGF or sustained delivery of TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">3 increased both</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">juvenile and adult tissue formation. In addition TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">3</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">stimulated an increase in proteoglycans in the longer</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">term. Zellner et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">36</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">carried out a study comparing</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">different strategies to</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">x meniscus defects in the white</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">zone in a rabbit model, comparing suture,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brin matrix</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">seeded and not seeded with BMSCs, platelet-rich</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">plasma, and an untreated defect. They reported a sig-</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ni</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant healing rate when MSCs were used. Moriguchi</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">37</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">developed an experimental tissue-engineered</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">construct of synovial MSCs and ascorbic acid, showing</span></p>
<p style="top:318.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly improved healing of 4-mm defects in the</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">avascular zone of the meniscus after 6 months. Finally,</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Esparza et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">38</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">assessed in vivo collagen gene expres-</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sion by synovial meniscus cells after stimulation to</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">vascular endothelial growth factor (VEGF), TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">,</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bFGF, and IGF. Data were reported for different areas of</span></p>
<p style="top:389.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus in vivo and showed that growth factors may</span></p>
<p style="top:401.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">exert different effects in different regions of the</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus.</span></p>
<p style="top:435.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Biological Augmentation and Tissue Engineering</span></p>
<p style="top:447.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Approaches In Vitro</span></p>
<p style="top:459.6pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although there has been limited progression of scaf-</span></p>
<p style="top:471.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">folds combined with cells or growth factors into pre-</span></p>
<p style="top:483.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clinical studies, the in vitro tissue engineering literature</span></p>
<p style="top:495.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is too vast to review all individual studies in a systematic</span></p>
<p style="top:507.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">manner here. However, some important</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ndings and</span></p>
<p style="top:519.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">trends were noted. It has now been shown that various</span></p>
<p style="top:531.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffolds (e.g., synthetic, extracellular matrix [ECM]</span></p>
<p style="top:543.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">constituent, tissue derived, and hydrogels) for meniscus</span></p>
<p style="top:555.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue regeneration each have their own inherent ad-</span></p>
<p style="top:567.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">vantages. Regarding their incorporation into meniscus</span></p>
<p style="top:579.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">substitutes,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">nite element models have shown that</span></p>
<p style="top:591.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">circumferential and axial/radial moduli are important</span></p>
<p style="top:603.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">determinants of the contact pressure distribution by the</span></p>
<p style="top:615.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">native meniscus and thus should ideally be matched in</span></p>
<p style="top:627.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">any replacement technology.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">39</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">A signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant advantage</span></p>
<p style="top:639.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of synthetic scaffolds is the relative ease of manipula-</span></p>
<p style="top:650.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion of their biomechanical properties, whereas natural</span></p>
<p style="top:662.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffolds may possess inherent advantages for cellular</span></p>
<p style="top:674.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">interaction. It has now also been shown that electro-</span></p>
<p style="top:686.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">spun</span></p>
<p style="top:686.7pt;left:336.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">synthetic</span></p>
<p style="top:686.7pt;left:384.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffolds</span></p>
<p style="top:686.7pt;left:430.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(e.g.,</span></p>
<p style="top:686.7pt;left:460.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">poly-E-caprolactone</span></p>
<p style="top:698.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">[PCL]) may provide an appropriate microarchitectural</span></p>
<p style="top:710.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">environment for meniscus cells. The nano</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers created</span></p>
<p style="top:713.1pt;left:42.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Clinical Studies of Meniscal Repair With Biological Augmentation 2009-2014</span></p>
<p style="top:700.3pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reference</span></p>
<p style="top:602.8pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Defect</span></p>
<p style="top:499.2pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Strategy</span></p>
<p style="top:382.8pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cells</span></p>
<p style="top:275.8pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:158.4pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Measure</span></p>
<p style="top:713.9pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Jang et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">15</span></p>
<p style="top:706.0pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2011)</span></p>
<p style="top:639.7pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">41 meniscus tears</span></p>
<p style="top:639.7pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(19 radial, 12 longitudinal</span></p>
<p style="top:639.7pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in the red-white zone, 7</span></p>
<p style="top:639.7pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">transverse, 3 oblique tears)</span></p>
<p style="top:531.8pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Inside-out sutures and</span></p>
<p style="top:531.8pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin clot</span></p>
<p style="top:380.2pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:268.2pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:202.0pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MRI and arthroscopic second look</span></p>
<p style="top:202.0pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Average follow-up 8.3 mo</span></p>
<p style="top:713.9pt;left:109.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Ra et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">19</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> (2013)</span></p>
<p style="top:639.7pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">12 meniscal tears: 9 in</span></p>
<p style="top:639.7pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the lateral meniscus and</span></p>
<p style="top:639.7pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3 in the medial meniscus</span></p>
<p style="top:531.8pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Inside-out sutures and</span></p>
<p style="top:531.8pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin clot</span></p>
<p style="top:380.2pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:268.2pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:202.0pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lysholm and IKDC subjective scores</span></p>
<p style="top:194.0pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">at 2-yr follow-up: both signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cantly</span></p>
<p style="top:194.0pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">improved from 65</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 6 and 57</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 7 to</span></p>
<p style="top:194.0pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">94</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 3 and 92</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 3, respectively</span></p>
<p style="top:713.9pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Vangsness</span></p>
<p style="top:706.0pt;left:159.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">18</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> (2014)</span></p>
<p style="top:639.7pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">55 medial subtotal</span></p>
<p style="top:639.7pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscectomies (</span><span style="font-family:AdvP4C4E51,serif;font-size:8.0pt">&gt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 50%)</span></p>
<p style="top:531.8pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Administration of A-MSCs</span></p>
<p style="top:531.8pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">injected in the knee 1 wk</span></p>
<p style="top:531.8pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">postoperatively</span></p>
<p style="top:425.8pt;left:152.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Group A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">: dose of 50</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 10</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">6</span></p>
<p style="top:425.8pt;left:161.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">A-MSCs;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> Group B</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">, 150</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 10</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">6</span></p>
<p style="top:425.8pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">A-MSCs</span></p>
<p style="top:311.0pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Administration of one</span></p>
<p style="top:311.0pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">injection of hyaluronic acid</span></p>
<p style="top:202.0pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2-yr follow-up: MRI showed signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant</span></p>
<p style="top:194.0pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus regeneration (15% threshold)</span></p>
<p style="top:194.0pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in 24% of patients in group A and 6%</span></p>
<p style="top:194.0pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in group B at 12 mo after meniscectomy</span></p>
<p style="top:194.0pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No improvement in control group</span></p>
<p style="top:708.0pt;left:206.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">A-MSCs, allogeneic mesenchymal stem cells; GF, growth factor; IKDC, International Knee Documentation Committee; MRI, magnetic resonance imaging; NA, not applicable.</span></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">947</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may provide an increased biomechanical advantage of</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the temporizing structure and of the regenerated</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus by helping to organize and optimize the</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">3-dimensional (3D) orientation of ECM deposition in</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the circumferential direction while facilitating cellular</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ltration through the scaffold</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">s</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">40-42</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">At the</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">same time, 3D woven PCL scaffolds have conferred</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased biomechanical properties in a composite</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">preparation with cartilage-derived matrix, obviating the</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">need</span></p>
<p style="top:162.7pt;left:74.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">for</span></p>
<p style="top:162.7pt;left:96.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growth</span></p>
<p style="top:162.7pt;left:136.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor</span></p>
<p style="top:162.7pt;left:170.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation,</span></p>
<p style="top:162.7pt;left:243.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:162.7pt;left:268.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">certainly be applied to meniscus restoration.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43,44</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Gunja</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">45-48</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have conducted work using nonwoven poly-</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">L-lactic acid scaffolds exploring the positive synergistic</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects of bFGF and hypoxia, hydrostatic pressure, and</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">TGF-&#xdf; and coculture (chondrocytes and meniscus cells)</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">using in vitro models.</span></p>
<p style="top:246.4pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Ultimately, it is hoped that cellular in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ltration and</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">matrix deposition may restore some of the viscoelastic</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">properties of meniscus tissue in which the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">uid phase</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">carries</span></p>
<p style="top:282.3pt;left:81.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a</span></p>
<p style="top:282.3pt;left:95.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant</span></p>
<p style="top:282.3pt;left:149.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">amount</span></p>
<p style="top:282.3pt;left:192.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:282.3pt;left:210.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:282.3pt;left:233.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">load.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">49</span></sup></p>
<p style="top:282.3pt;left:271.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biocompatibility and biomimetic properties of ECM</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">constituent scaffolds have therefore led to their use in</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this situation despite their inferior biomechanical pro-</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">les. Balint et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">50</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reported the use of a collagen</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffold reinforced by a network of degradable tyrosine-</span></p>
<p style="top:354.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">derived polymer</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers that showed circumferential</span></p>
<p style="top:366.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tensile strength stiffness and hoop stress behavior under</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compressive loading that mimics the normal meniscus.</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Hydrogels (natural or synthetic) are biochemically</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">versatile and can be used as cell and growth factor</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">delivery</span></p>
<p style="top:413.8pt;left:89.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">systems.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup></p>
<p style="top:413.8pt;left:143.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although</span></p>
<p style="top:413.8pt;left:194.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">their</span></p>
<p style="top:413.8pt;left:224.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biomechanical</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">properties can be tailored somewhat by substrate con-</span></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">centration and composition, they often fall short of</span></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">native meniscus properties. To overcome this problem,</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Holloway et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">51</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">proposed a</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ber-reinforced composite</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">containing ultra-high-molecular-weight polyethylene</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers in a polyvinyl alcohol hydrogel and varied the</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">composition and orientation of the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers to mimic</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">native meniscus properties for total meniscus replace-</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment. On implantation in a dynamic cadaveric model,</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this construct was seen to restore contact mechanics to</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a level comparable to that of meniscus allograft trans-</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">plantation.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">52</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Anatomically shaped alginate hydrogels</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have been fabricated using extracted geometries from</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">MRI</span></p>
<p style="top:581.2pt;left:72.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:581.2pt;left:98.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">microcomputed</span></p>
<p style="top:581.2pt;left:176.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tomography</span></p>
<p style="top:581.2pt;left:239.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:581.2pt;left:264.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">show</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improved biochemical and mechanical properties after</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">seeding with</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrocytes and supplementation</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with IGF-1.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">53</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Tissue-derived scaffolds under current</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">investigation</span></p>
<p style="top:629.0pt;left:112.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">include</span></p>
<p style="top:629.0pt;left:155.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">small</span></p>
<p style="top:629.0pt;left:190.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intestine</span></p>
<p style="top:629.0pt;left:239.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">submucosa</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(porcine) and silk scaffolds. The use of xenogeneic</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus tissue is currently being investigated in ani-</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mal models and may provide a solution for partial</span></p>
<p style="top:676.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus replacement. Indeed, processing of ovine</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:688.8pt;left:94.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue</span></p>
<p style="top:688.8pt;left:128.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to</span></p>
<p style="top:688.8pt;left:146.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improve</span></p>
<p style="top:688.8pt;left:192.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">porosity</span></p>
<p style="top:688.8pt;left:237.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:688.8pt;left:263.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">inter-</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">connectivity as a xenogeneic meniscus scaffold has</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">potential.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">54</span></sup></p>
<p style="top:55.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There are growing data to show that the use of dy-</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">namic culture or</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">uid mixing can be optimized to</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">modulate</span></p>
<p style="top:79.1pt;left:356.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:79.1pt;left:378.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">spatial</span></p>
<p style="top:79.1pt;left:414.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">heterogeneity</span></p>
<p style="top:79.1pt;left:483.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:79.1pt;left:500.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">engineered</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">menisci as well as the correlated mechanical proper-</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ties.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">55-57</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Compressive deformation or hydrostatic pres-</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sure has been shown to enhance the structure and</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">function of engineered meniscus tissues.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">58-60</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Dynamic</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compression of constructs based on microchanneled</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scaffolds resulted in aligned cell layers and collagen</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">58</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">whereas hydrostatic pressure combined with</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1</span></p>
<p style="top:174.7pt;left:347.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased</span></p>
<p style="top:174.7pt;left:396.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen</span></p>
<p style="top:174.7pt;left:441.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:174.7pt;left:466.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">glycosaminoglycan</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">deposition by meniscus cells, ultimately leading to</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">enhanced</span></p>
<p style="top:198.6pt;left:357.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compressive</span></p>
<p style="top:198.6pt;left:419.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">properties.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">45</span></sup></p>
<p style="top:198.6pt;left:482.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Cyclic</span></p>
<p style="top:198.6pt;left:517.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tension</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">speci</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cally stimulated collagen type I mRNA expression</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and protein synthesis but had no effect on collagen type</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">II, aggrecan, or osteocalcin mRNA levels, resulting in</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">enhanced</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrocyte-like differentiation of bone</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">marrow</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">derived MSCs.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">59</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Combinatorial modes of</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical stimulation, including tension-compression</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">loading</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">60</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">or perfusion and cyclic compression,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">61</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also reported to additively increase matrix production</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and tissue mechanical properties.</span></p>
<p style="top:318.2pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Another area of focus in tissue engineering of carti-</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lage and the meniscus is the concept of scaffold-free</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">self-assembly (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Fig 1</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">).</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">62</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">With this strategy, cells are</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">seeded densely in nonadherent molds and manipulated</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to enhance cell-cell interactions, which initiates a pro-</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cess akin to a developmental one, allowing the forma-</span></p>
<p style="top:389.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion of a matrix with adequate mechanical properties.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">63</span></sup></p>
<p style="top:401.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Cells naturally form a bioactive microenvironment that</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may increase the likelihood of integration with host</span></p>
<p style="top:425.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue because of its biocompatibility. Growth factors</span></p>
<p style="top:437.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">such</span></p>
<p style="top:437.7pt;left:334.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">as</span></p>
<p style="top:437.7pt;left:351.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bFGF,</span></p>
<p style="top:437.7pt;left:386.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">platelet-derived</span></p>
<p style="top:437.7pt;left:464.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growth</span></p>
<p style="top:437.7pt;left:504.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor-AB,</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">endothelial</span></p>
<p style="top:449.7pt;left:363.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growth</span></p>
<p style="top:449.7pt;left:403.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor,</span></p>
<p style="top:449.7pt;left:438.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:449.7pt;left:463.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span></p>
<p style="top:449.7pt;left:498.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have</span></p>
<p style="top:449.7pt;left:528.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">been</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">shown to promote matrix synthesis as well as cellular</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">proliferation</span></p>
<p style="top:473.6pt;left:370.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:473.6pt;left:396.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">migration.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">64-67</span></sup></p>
<p style="top:473.6pt;left:470.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">With</span></p>
<p style="top:473.6pt;left:502.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">exogenous</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">agents such as chondroitinase ABC, self-assembled</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus constructs have been shown to increase</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen content 196% per wet weight, 136% in</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compressive instantaneous modulus, 68% in compres-</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sive relaxation modulus, 600% in circumferential</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tensile modulus, and 500% in radial tensile modulus.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">60</span></sup></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">By increasing the circumferential and radial tensile</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">modulus, anisotropy can be achieved. In addition,</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical stimulation (hydrostatic pressure) has also</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">been shown to improve mechanical properties.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">68,69</span></sup></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Because</span></p>
<p style="top:605.1pt;left:351.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:605.1pt;left:376.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:605.1pt;left:426.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">undergoes</span></p>
<p style="top:605.1pt;left:482.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">direct</span></p>
<p style="top:605.1pt;left:517.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">loading</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in vivo, these self-assembled constructs may provide a</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">more physiological and biological implant in meniscus</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">replacement.</span></p>
<p style="top:663.3pt;left:396.8pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Discussion</span></p>
<p style="top:676.8pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Meniscus repair and replacement is an area of</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">growing investigation. Recent data from clinical, pre-</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clinical, and in vitro investigations have provided much</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">support for the ongoing research in this</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld. However,</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">948</span></p>
<p style="top:31.6pt;left:257.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">C. J. MORAN ET AL.</span></p>


<p style="top:713.5pt;left:42.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Preclinical Studies of Biological Augmentation and Tissue Engineering in Meniscus Surgery 2009-2014</span></p>
<p style="top:714.2pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reference</span></p>
<p style="top:643.2pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal</span></p>
<p style="top:586.6pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Defect/Model</span></p>
<p style="top:493.6pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Strategy</span></p>
<p style="top:399.4pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cells</span></p>
<p style="top:327.7pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">GF</span></p>
<p style="top:276.3pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:204.3pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:130.1pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Measure</span></p>
<p style="top:714.2pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Zhang</span></p>
<p style="top:706.3pt;left:82.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">33</span></p>
<p style="top:706.3pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2009)</span></p>
<p style="top:657.3pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Goats</span></p>
<p style="top:599.6pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Full-thickness</span></p>
<p style="top:591.6pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">experimental</span></p>
<p style="top:591.6pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect anterior</span></p>
<p style="top:591.6pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">horn tear in</span></p>
<p style="top:591.6pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white area</span></p>
<p style="top:522.5pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Injection of cell- loaded</span></p>
<p style="top:514.6pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">gel into the defect</span></p>
<p style="top:432.4pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Bone marrow</span></p>
<p style="top:424.4pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mesenchymal stem</span></p>
<p style="top:424.4pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cells transfected</span></p>
<p style="top:424.4pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> HIGF1</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> gene</span></p>
<p style="top:328.4pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3 control groups:</span></p>
<p style="top:225.1pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cells without</span></p>
<p style="top:225.1pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">transfection, gel</span></p>
<p style="top:225.1pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">without cells,</span></p>
<p style="top:225.1pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and defect left</span></p>
<p style="top:225.1pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">untreated</span></p>
<p style="top:145.4pt;left:73.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology, electron</span></p>
<p style="top:137.4pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">microscopy proteoglycan</span></p>
<p style="top:137.4pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">determination, MRI.</span></p>
<p style="top:714.2pt;left:132.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Scotti et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">27</span></p>
<p style="top:706.3pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2009)</span></p>
<p style="top:657.3pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Swine</span></p>
<p style="top:599.6pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Meniscal construct</span></p>
<p style="top:591.6pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">implanted in nude</span></p>
<p style="top:591.6pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mice</span></p>
<p style="top:522.5pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Construct with cells</span></p>
<p style="top:514.6pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin glue</span></p>
<p style="top:432.4pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Swine chondrocytes</span></p>
<p style="top:424.4pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">seeded on</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin glue</span></p>
<p style="top:328.4pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Construct with</span></p>
<p style="top:225.1pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">acellular</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin glue</span></p>
<p style="top:145.4pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology and</span></p>
<p style="top:137.4pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Electron Microscopy</span></p>
<p style="top:714.2pt;left:161.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Horie et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">28</span></p>
<p style="top:706.3pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2009)</span></p>
<p style="top:657.3pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lewis rat</span></p>
<p style="top:649.4pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">transgenic</span></p>
<p style="top:649.4pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(Luc/LacZ)</span></p>
<p style="top:599.6pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Massive meniscal</span></p>
<p style="top:591.6pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect</span></p>
<p style="top:522.5pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Intra-articular cell</span></p>
<p style="top:514.6pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">injection</span></p>
<p style="top:432.4pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Rat synovium MSCs</span></p>
<p style="top:328.4pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:196.7pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:145.4pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Electron microscopy,</span></p>
<p style="top:137.4pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology, Real</span></p>
<p style="top:137.4pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Time PCR</span></p>
<p style="top:714.2pt;left:191.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Zellner et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">36</span></p>
<p style="top:706.3pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2010)</span></p>
<p style="top:657.3pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbit</span></p>
<p style="top:599.6pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2-mm defect</span></p>
<p style="top:591.6pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">anterior lateral</span></p>
<p style="top:591.6pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus</span></p>
<p style="top:522.5pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Hyaluronan-collagen</span></p>
<p style="top:514.6pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">matrix with bone</span></p>
<p style="top:514.6pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">marrow or MSC</span></p>
<p style="top:432.4pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Autologous MSC</span></p>
<p style="top:424.4pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(bone marrow)</span></p>
<p style="top:328.4pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Contralateral knee,</span></p>
<p style="top:225.1pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">scaffold alone</span></p>
<p style="top:145.4pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross, histology</span></p>
<p style="top:137.4pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(integration,</span></p>
<p style="top:137.4pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">immunohistochemistry)</span></p>
<p style="top:714.2pt;left:221.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Hong et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">32</span></p>
<p style="top:706.3pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2011)</span></p>
<p style="top:657.3pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbits</span></p>
<p style="top:599.6pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Anterior horn</span></p>
<p style="top:591.6pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect</span></p>
<p style="top:522.5pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Transosseous pullout</span></p>
<p style="top:514.6pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">suture</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> cells</span></p>
<p style="top:432.4pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Human bone marrow</span></p>
<p style="top:424.4pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mesenchymal stem</span></p>
<p style="top:424.4pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cells</span></p>
<p style="top:328.4pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:295.7pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Submeniscal</span></p>
<p style="top:287.7pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cartilage</span></p>
<p style="top:287.7pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect</span></p>
<p style="top:233.1pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Simple pullout suture</span></p>
<p style="top:145.4pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross examination</span></p>
<p style="top:137.4pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and histology</span></p>
<p style="top:714.2pt;left:251.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Riera et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">20</span></p>
<p style="top:706.3pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2011)</span></p>
<p style="top:657.3pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Swine</span></p>
<p style="top:568.5pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:522.5pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cell isolation and</span></p>
<p style="top:514.6pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cultivation</span></p>
<p style="top:432.4pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Meniscal cells</span></p>
<p style="top:346.1pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">IL-1 alpha,</span></p>
<p style="top:338.2pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TNF-alpha,</span></p>
<p style="top:338.2pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1</span></p>
<p style="top:271.9pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cells in 10%</span></p>
<p style="top:225.1pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">serum without GF</span></p>
<p style="top:225.1pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">stimulation</span></p>
<p style="top:145.4pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Micro wound assay.</span></p>
<p style="top:714.2pt;left:281.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Horie et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">29</span></p>
<p style="top:706.3pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbit</span></p>
<p style="top:599.6pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cylindrical</span></p>
<p style="top:591.6pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus defect</span></p>
<p style="top:522.5pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Intra-articular</span></p>
<p style="top:514.6pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cell injection</span></p>
<p style="top:432.4pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allogenic synovium</span></p>
<p style="top:424.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MSCs in right knees</span></p>
<p style="top:328.4pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PBS</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> saline alone</span></p>
<p style="top:225.1pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in left knees</span></p>
<p style="top:145.4pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">uorescence</span></p>
<p style="top:137.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">microscopy</span></p>
<p style="top:137.4pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Immunohistochemistry</span></p>
<p style="top:714.2pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Ionescu</span></p>
<p style="top:706.3pt;left:321.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">35</span></p>
<p style="top:706.3pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Bovine</span></p>
<p style="top:649.4pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(juvenile</span></p>
<p style="top:649.4pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and adult)</span></p>
<p style="top:599.6pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cylindrical</span></p>
<p style="top:591.6pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus defect</span></p>
<p style="top:522.5pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Meniscus-to-meniscus</span></p>
<p style="top:514.6pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">construct</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> GFs</span></p>
<p style="top:396.8pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:346.1pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Delivery</span></p>
<p style="top:338.2pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of bFGF,</span></p>
<p style="top:338.2pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3 for</span></p>
<p style="top:338.2pt;left:342.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">4 or 8 wk</span></p>
<p style="top:295.7pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Meniscus-to-</span></p>
<p style="top:287.7pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">scaffold</span></p>
<p style="top:287.7pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">construct</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span></p>
<p style="top:287.7pt;left:342.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">GFs</span></p>
<p style="top:196.7pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:145.4pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology,</span></p>
<p style="top:137.4pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Biochemical contents,</span></p>
<p style="top:137.4pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Biomechanical tests.</span></p>
<p style="top:714.2pt;left:351.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Esparza et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">38</span></p>
<p style="top:706.3pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Merino sheep</span></p>
<p style="top:599.6pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Synovial</span></p>
<p style="top:591.6pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">vascularized</span></p>
<p style="top:591.6pt;left:372.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">area of meniscus</span></p>
<p style="top:522.5pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cell incubation of GFs</span></p>
<p style="top:396.8pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:346.1pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">VEGF</span></p>
<p style="top:338.2pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">IGF</span></p>
<p style="top:338.2pt;left:372.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF</span></p>
<p style="top:271.9pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Avascular area</span></p>
<p style="top:225.1pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of the meniscus</span></p>
<p style="top:145.4pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Col1, Col 2A, MMP-2</span></p>
<p style="top:137.4pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">e MMP-13</span></p>
<p style="top:137.4pt;left:372.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">expression</span></p>
<p style="top:714.2pt;left:381.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">He et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">26</span></p>
<p style="top:706.3pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbits</span></p>
<p style="top:599.6pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3-mm defect in</span></p>
<p style="top:591.6pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus</span></p>
<p style="top:522.5pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Delivery of GF</span></p>
<p style="top:514.6pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">incorporated in</span></p>
<p style="top:514.6pt;left:402.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin glue</span></p>
<p style="top:432.4pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Fibrochondrocytes</span></p>
<p style="top:346.1pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Connective</span></p>
<p style="top:338.2pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tissue</span></p>
<p style="top:338.2pt;left:402.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">growth</span></p>
<p style="top:338.2pt;left:412.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">factor</span></p>
<p style="top:271.9pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:196.7pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:145.4pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Immuno</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">uorescence</span></p>
<p style="top:137.4pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Col1, Col2, VEGF</span></p>
<p style="top:137.4pt;left:402.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">expression</span></p>
<p style="top:714.2pt;left:420.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Ferris et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">30</span></p>
<p style="top:706.3pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Horses</span></p>
<p style="top:599.6pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Placement of</span></p>
<p style="top:591.6pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscal</span></p>
<p style="top:591.6pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">construct in</span></p>
<p style="top:591.6pt;left:452.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">nude mice</span></p>
<p style="top:522.5pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Construct</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin</span></p>
<p style="top:514.6pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">glue</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> cells</span></p>
<p style="top:432.4pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Bone marrow</span></p>
<p style="top:424.4pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mesenchymal stem</span></p>
<p style="top:424.4pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cells</span></p>
<p style="top:328.4pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Construct</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span></p>
<p style="top:225.1pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brin without cells</span></p>
<p style="top:145.4pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross evaluation,</span></p>
<p style="top:137.4pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">H&amp;E stain,</span></p>
<p style="top:137.4pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">SOFG stain</span></p>
<p style="top:714.2pt;left:460.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Kon et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">21</span></p>
<p style="top:706.3pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Bergamasca-</span></p>
<p style="top:649.4pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Massese</span></p>
<p style="top:649.4pt;left:482.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">sheep</span></p>
<p style="top:599.6pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Subtotal medial</span></p>
<p style="top:591.6pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscectomy</span></p>
<p style="top:522.5pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cell-scaffold (hyaluronic</span></p>
<p style="top:514.6pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">acid HYAFF</span></p>
<p style="top:514.6pt;left:482.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">polycaprolactone)</span></p>
<p style="top:432.4pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Autologous articular</span></p>
<p style="top:424.4pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">chondrocytes</span></p>
<p style="top:233.1pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Acellular scaffold</span></p>
<p style="top:225.1pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and empty defect/</span></p>
<p style="top:225.1pt;left:482.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscectomy</span></p>
<p style="top:145.4pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross, histology,</span></p>
<p style="top:137.4pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">OARSI cartilage</span></p>
<p style="top:137.4pt;left:482.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">OA grading system</span></p>
<p style="top:714.2pt;left:490.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gu et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">22</span></p>
<p style="top:706.3pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span></p>
<p style="top:657.3pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Beagle dogs</span></p>
<p style="top:599.6pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Anterior horn</span></p>
<p style="top:591.6pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">medial meniscus</span></p>
<p style="top:522.5pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PLGA scaffold with</span></p>
<p style="top:514.6pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">autologous cells</span></p>
<p style="top:432.4pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Myoblasts cultured in</span></p>
<p style="top:424.4pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">chondrogenic media</span></p>
<p style="top:328.4pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Acellular PLGA</span></p>
<p style="top:225.1pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">scaffold and</span></p>
<p style="top:225.1pt;left:511.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">empty defect</span></p>
<p style="top:145.4pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross, histology</span></p>
<p style="top:137.4pt;left:501.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">quality,</span></p>
<p style="top:137.4pt;left:511.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">immunohistochemistry</span></p>
<p style="top:87.0pt;left:528.5pt;line-height:7.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">(continued)</span></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">949</span></p>


<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the reduction in the number of reports available in the</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">literature as one moves from a search of in vitro to</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clinical studies re</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ects the immense dif</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">culties that exist</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the translational arena from laboratory investigation</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to clinical application. Safely taking advantage of the</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">potential of such new treatment options that may be on</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the horizon is closely linked to the concept of trans-</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lational research, the mechanisms by which we link</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">science and surgery, the laboratory, and the patient.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">70</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">As</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">surgeons, our goal is ultimately to restore our patients to</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a state of natural form and function through our surgical</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">interventions. In translational research, the relevant</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">questions are raised at the bedside by clinicians and</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">investigated in the laboratory and clinical research units</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">before bringing a suitable form of intervention back to</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the bedside. It is critical that this process be applied in the</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">context of meniscus surgery if we are to make progress</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld. This challenge is highlighted by the fact that</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the National Institutes of Health funded nearly $15</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">billion of basic science research in 2009.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">71</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Unfortunately,</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">current statistics indicate that less than 25% of highly</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">promising biomedical discoveries result in a published</span></p>
<p style="top:318.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">randomized clinical trial, and less than 10% are estab-</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lished in clinical practice within 20 years.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">71</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The trend in</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the data available for the techniques considered in this</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">article suggests that approaches in biological augmenta-</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion and tissue engineering for meniscus repair are also</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">being affected in this manner.</span></p>
<p style="top:389.9pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although we have highlighted a large number of</span></p>
<p style="top:401.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">preclinical studies in this review, it is readily apparent</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that there is signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant heterogeneity present in the</span></p>
<p style="top:425.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies reported. The need to identify appropriate</span></p>
<p style="top:437.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">translational models in regenerative repair is therefore</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of critical importance and worthy of particular consid-</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eration here. Arnoczky et al.,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">72</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Chu et al.,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">73</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and Sah</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and Ratcliffe</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">74</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have previously addressed this issue</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">separately regarding articular cartilage, the meniscus,</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and regenerative medicine in general, and readers are</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">referred to these texts for comprehensive coverage of</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this important issue. Ultimately, there are many animal</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models that are used in meniscus and articular cartilage</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">defect research. One can appreciate that various models</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">offer distinct advantages and disadvantages for studying</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regenerative repair strategies. It is readily apparent that</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">no one animal model reproduces all the features of the</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">human injury condition regardless of the clinical con-</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dition being evaluated. All animals differ from humans</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regarding the biomechanical use of their joints. Large</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal models such as the goat or the horse may more</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">closely resemble the human than smaller animal</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models such as rodents or rabbits. However, it is usually</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">not</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scally feasible or practical to conduct initial</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">experiments in larger species. Also, because no animal</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is immunologically identical to the human, a possible</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">adverse immunologic response to a regenerative med-</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">icine therapy in human patients may not be predicted</span></p>
<p style="top:713.5pt;left:39.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Continued</span></p>
<p style="top:714.3pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reference</span></p>
<p style="top:643.2pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal</span></p>
<p style="top:586.6pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Defect/Model</span></p>
<p style="top:493.6pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Strategy</span></p>
<p style="top:399.4pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cells</span></p>
<p style="top:327.7pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">GF</span></p>
<p style="top:276.4pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:204.4pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:130.1pt;left:59.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Measure</span></p>
<p style="top:714.3pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Desando</span></p>
<p style="top:706.3pt;left:79.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">31</span></p>
<p style="top:706.3pt;left:90.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span></p>
<p style="top:657.4pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:80.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbit</span></p>
<p style="top:599.6pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">OA induced after</span></p>
<p style="top:591.7pt;left:80.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ACL transection</span></p>
<p style="top:522.5pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Intra-articular</span></p>
<p style="top:514.6pt;left:80.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cell injection</span></p>
<p style="top:432.4pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ASCs</span></p>
<p style="top:328.4pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:295.7pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Role in Meniscal</span></p>
<p style="top:287.7pt;left:80.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">healing</span></p>
<p style="top:287.7pt;left:90.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and anti-</span></p>
<p style="top:287.7pt;left:100.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ammatory</span></p>
<p style="top:287.7pt;left:110.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">role of cell</span></p>
<p style="top:287.7pt;left:120.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">administration</span></p>
<p style="top:196.7pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:145.4pt;left:70.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Laverty</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:8.0pt">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">s Score,</span></p>
<p style="top:137.5pt;left:80.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Col1, Col2, MMP-1,</span></p>
<p style="top:137.5pt;left:90.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MMP-3, TNF-alpha</span></p>
<p style="top:137.5pt;left:100.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">expression in cartilage,</span></p>
<p style="top:137.5pt;left:110.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">synovium and menisci.</span></p>
<p style="top:714.3pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Zellner</span></p>
<p style="top:706.3pt;left:139.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">36</span></p>
<p style="top:706.3pt;left:150.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span></p>
<p style="top:657.4pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbit</span></p>
<p style="top:599.6pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">4-mm meniscus</span></p>
<p style="top:591.7pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect</span></p>
<p style="top:522.5pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">HA-Col matrix</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span></p>
<p style="top:514.6pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PRP or cells</span></p>
<p style="top:432.4pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Bone marrow</span></p>
<p style="top:424.5pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mesenchymal stem</span></p>
<p style="top:424.5pt;left:150.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cells</span></p>
<p style="top:346.2pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PRP</span></p>
<p style="top:271.9pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Suture with No. 5-0</span></p>
<p style="top:225.2pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">thread</span></p>
<p style="top:145.4pt;left:130.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross examination,</span></p>
<p style="top:137.5pt;left:140.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology,</span></p>
<p style="top:137.5pt;left:150.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Biomechanical tests</span></p>
<p style="top:714.3pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Moriguchi</span></p>
<p style="top:706.3pt;left:168.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">23</span></p>
<p style="top:706.3pt;left:180.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span></p>
<p style="top:657.4pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Swine</span></p>
<p style="top:599.6pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">4-mm cylindrical</span></p>
<p style="top:591.7pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect</span></p>
<p style="top:522.5pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Construct of cells</span></p>
<p style="top:514.6pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and ascorbic acid</span></p>
<p style="top:432.4pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allogenic synovium</span></p>
<p style="top:424.5pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MSCs</span></p>
<p style="top:328.4pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2 control groups:</span></p>
<p style="top:225.2pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">defect untreated</span></p>
<p style="top:225.2pt;left:180.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and normal meniscus</span></p>
<p style="top:145.4pt;left:160.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histology,</span></p>
<p style="top:137.5pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histomorphometry</span></p>
<p style="top:714.3pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Esposito</span></p>
<p style="top:706.3pt;left:198.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">24</span></p>
<p style="top:706.3pt;left:210.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span></p>
<p style="top:657.4pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:649.4pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">white rabbit</span></p>
<p style="top:599.6pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Medial meniscus</span></p>
<p style="top:591.7pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">resection</span></p>
<p style="top:522.5pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PLDLA/PCL-T scaffold</span></p>
<p style="top:514.6pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with allogeneic cells</span></p>
<p style="top:432.4pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allogeneic</span></p>
<p style="top:424.5pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brochondrocytes</span></p>
<p style="top:328.4pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cell-free scaffolds</span></p>
<p style="top:225.2pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">v</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> no implant</span></p>
<p style="top:145.4pt;left:190.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Gross, histology,</span></p>
<p style="top:137.5pt;left:200.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">histomorphometry</span></p>
<p style="top:714.3pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Hatsushika</span></p>
<p style="top:706.3pt;left:228.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">25</span></p>
<p style="top:706.3pt;left:240.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span></p>
<p style="top:657.4pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Japanese white</span></p>
<p style="top:649.4pt;left:230.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:599.6pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Anterior horn</span></p>
<p style="top:591.7pt;left:230.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Medial</span></p>
<p style="top:591.7pt;left:240.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">meniscus excision</span></p>
<p style="top:522.5pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Cell injection</span></p>
<p style="top:432.4pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allogeneic Synovial</span></p>
<p style="top:424.5pt;left:230.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MSCs</span></p>
<p style="top:328.4pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:271.9pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">NA</span></p>
<p style="top:233.1pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">PBS</span></p>
<p style="top:145.4pt;left:220.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Histologic quanti</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cation,</span></p>
<p style="top:137.5pt;left:230.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">OARSI cartilage OA</span></p>
<p style="top:137.5pt;left:240.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">grading</span></p>
<p style="top:708.3pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ACL, anterior cruciate ligament; ASCs, adipose stem cells; bFGF, basic</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">broblast growth factor; GF, growth factor; H&amp;E, haematoxylin and eosin; HA-Col, hyaluronic acid-collagen; HYAFF,</span></p>
<p style="top:714.3pt;left:262.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">hyaluronic acid scaffold; IGF, insulin-like growth factor; MMP, matrix metalloproteinase; MRI, magnetic resonance imaging; MSC, mesenchymal stem cell; OA, osteoarthritis; OARSI, Osteo-</span></p>
<p style="top:714.3pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">arthritis Research Society International; NA, not applicable; PBS, phosphate-buffered saline; PCL-T, polycaprolactonetriol; PCR, polymerase chain reaction; PLDLA, poly-L/D-lactide; PLGA, poly</span></p>
<p style="top:714.3pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(lactic-co-glycolic acid); PRP, platelet-rich plasma; SOFG, Safranin O-Fast Green; TGF, transforming growth factor; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">950</span></p>
<p style="top:31.6pt;left:257.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">C. J. MORAN ET AL.</span></p>


<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">from animal studies. Although a nonhuman primate</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">shoulder, e.g., may offer more anatomic, biomechan-</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ical, and immunologic similarities to humans than do</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">other animals, cost and management issues make use of</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this model impractical. Therefore, it is generally well</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">accepted that a small animal model will be chosen for</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">initial lines of investigation. However,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">nal preclinical</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">evaluation of a clinical strategy for a repair or recon-</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">struction technique may require con</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rmation in a large</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal model before trials in humans. Although sci-</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">entists may play the leading role in selecting animal</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models for preclinical testing, it does not make sense for</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this process to be ignored by surgeons.</span></p>
<p style="top:605.1pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Ultimately, the design of a successful meniscus scaf-</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">fold, while providing a degree of biomechanical stability</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the short term, should incorporate features amenable</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to cellular in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ltration at the meniscus tissue interface.</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">These include consideration of pore size and inter-</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">connectivity while maintaining a near-native meniscus</span></p>
<p style="top:676.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compression modulus to exert a pro</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrogenic</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effect.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">75</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Mesenchymal stem cells,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrocytes,</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and chondrocytes have now all been successfully</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">incorporated into cell-scaffold complexes and show</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">promising results in both in vitro and in vivo studies.</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The overwhelming issue with the latter 2 cell types is</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">availability. The use of autologous</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brochondrocytes/</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chondrocytes requires a 2-step operative process. Given</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the relative scarcity of these cells in the tissue, mono-</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">layer expansion is also required, which can result in</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">downregulation of genes involved in matrix produc-</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">76</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Allogenic and xenogeneic cell sources have</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">shown promise in animal models, and although they</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may overcome the discrepancy in supply and demand,</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">they are fraught with translational issues.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">77,78</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">MSCs, in</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">contrast, have been successfully isolated from adipose</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue, muscle, and bone marrow and subsequently</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used in soft tissue engineering.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">79</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">It is important to be</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">aware that bone marrow aspirate, concentrated (bone</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">marrow aspirate concentrate [BMAC]) or otherwise,</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">does not equate to using a puri</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed or cultured collec-</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion of MSCs. Although MSCs are present within the</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">aspirate and concentrate, they are present in very low</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">numbers and are only one of a number of cell types</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">present. The possible advantage of BMAC, however, is</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that it may be of bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t for MSCs to remain among the</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">other biological factors present in BMAC. Although</span></p>
<img style="position:absolute;transform:matrix(.32010953,0,-0,.32010973,-638.9813,-432.8833)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZIAAAAAB/9sAhAACAgIDAgMEAgIEBQQDBAUGBQUFBQYIBwcH
BwcICwkJCQkJCQsLCwsLCwsLDAwMDAwMDAwMDAwMDAwMDAwMDAwMAQMDAwcFBw0H
Bw0PDQ0NDw8ODg4ODw8MDAwMDA8PDAwMDAwMDwwMDAwMDAwMDAwMDAwMDAwMDAwM
DAwMDAwMDAz/wAARCAXXCBYDAREAAhEBAxEB/8QBogAAAAcBAQEBAQAAAAAAAAAA
BAUDAgYBAAcICQoLAQACAgMBAQEBAQAAAAAAAAABAAIDBAUGBwgJCgsQAAIBAwMC
BAIGBwMEAgYCcwECAxEEAAUhEjFBUQYTYSJxgRQykaEHFbFCI8FS0eEzFmLwJHKC
8SVDNFOSorJjc8I1RCeTo7M2F1RkdMPS4ggmgwkKGBmElEVGpLRW01UoGvLj88TU
5PRldYWVpbXF1eX1ZnaGlqa2xtbm9jdHV2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4
KTlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+hEAAgIBAgMFBQQFBgQIAwNtAQAC
EQMEIRIxQQVRE2EiBnGBkTKhsfAUwdHhI0IVUmJy8TMkNEOCFpJTJaJjssIHc9I1
4kSDF1STCAkKGBkmNkUaJ2R0VTfyo7PDKCnT4/OElKS0xNTk9GV1hZWltcXV5fVG
VmZ2hpamtsbW5vZHV2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4OUlZaXmJmam5ydnp
+So6SlpqeoqaqrrK2ur6/9oADAMBAAIRAxEAPwD7+Yq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FUg1TXotNlS2I5OxFfauVynTIRtXTWYHl9AHemVHPTLw9kwjuUkbgp
3xx5+IsFTn8RWnTMqtlpxfjuRtlU50hsPUVGQjltJCFs9Qt7/mLVw5jbi1Oxy9CN
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KrHkWMVdgo9zTFWhNGTxDqSe1RiqpirsVdiqFnulgYK1KHqSQA
MVXRXcE6mSCRHVdiVYGn3YqqGaNftOo77kYq1HPHNUQurU68SD+rFVXFXYq7FXYq
7FXYq7FWqitO+Kt4q7FXYq7FXYq7FXYq7FXYqsaVENHYAnxOKr8Vdiq1mVftED54
quxVTMlHEdDuK1xVUxVomgqe2KrIpBKocAgHxxVUxV2KuxV2KuxV2KuxVpmCgs3Q
YqpGUkpwUsrdT4YqqFjyC028cVXYqorOjuYlPxDqMVVsVdirsVdiqnLJ6SlyCaeG
KqVrcG4UuVK0NBXFUTiqk08SmjOoPuRiqrirsVdiqBa/jWT0KgEHfkQPuxVFNKqr
zJ2PSmKqmKuxV2KoG6vfqpClC1e9cVRcbiRQ69Diqm1xGkggZqO3QYqr4q7FXYq7
FXYqgIb71Z2tShBXviqNZgm7Gm9MVXYqo/WYgeJkUN4VFcVVsVdirsVdirsVdirs
VdirsVdirsVdiqhPP6ArxJ+WKqcN4koJaiU8SMVaF9AX9MSx/wDBiv3YqvN7bgkG
WMEf5QxVeLmI9JF3/wAoYq19ahoT6iUHX4hirX1uAjmJU4jvyFMVXxTRzjlC6uPF
SD+rFVXFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqpTye
lG8n8qk/dgJpXzs2rnWdYeNnrwPj4ZiTmG6AZGQFuGkD7geOY2SYpyaVdP1uSO4P
NtsowZRbV4ZZ3putpcSFCc2scopgcZTO9v4kItififplWWbARS7TdWEqXDOdoKjI
QmLYkPL/AMlWu5ZdZnvSSjXZ4V8KnNgDsh7zgQ7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqk2vaxD5d0271u8P
7q1ieVq/5IrTFX8zP/OQv/OVH5r/APOVfn2T8svybmntIbWZo0W2lMXKhoKsMVeL
+e5P+cjv+cRdY0nzP+ZGpagImlDoj3LSxvT9k1GKv6Pv+cU/+chE/PjydZ+YtQUR
akYwZlXpWnXbFX0mmu6ezGM3MSsOzsFP44qsj8xaVNMLOG9tnnP7CyoW+4HFXyN/
zndrup+X/wAsNQvvLVy9pfhTwljNCNj3xV+fv/Pr38xdZ1fy9rmsfmNrNxP6ErGP
15Kio7VxV8Xf85j/APORv5lfmP8AmYfLvkfVLixt4yYIIrSfgrb0BYjFX6Xf8+7v
yU/N7ylKfOf5t6vLdWdwn7uB7j1QAR+vFX674qoXDiOMlm4jpXFUkvfNejaWUi1D
ULeJ22HOVQT+OKqum+ZtJ1eVrbS72CeVOqxyKx/A4qnBnjBKlgCvWu2KpQfM+jqz
RNqFoHTZgZ0BH44qjrHVLPU1MmnTxTqpoTG4YD7sVWalqFrpUf17UJVijXbk7BRv
88VSlfOugO4iXU7Qu3Qeslf14qyKKeO4USQOroehUgj7xiqDn1aztEM15PHCgNCZ
GCj8cVQNt5q0a8PG11C1dj2WZK/dXFU4luYoY/rErqIv5idvvxVAjXdNKmQXlvxH
U+qm344qo2vmXSL5/Rs762lk/lWVCfuriqMutVsrH/e25hhruPUkVf1nFUNpOv6d
rqvLo9zFcrGxVjG4ahHyxV/O1/z9H/Nnzj5V/ODStJ8qa3eWNn6Uf7qCQovLko3A
69cVfth+QHnaz/5V/otz5m1aJrxraMyPcTKHJIHWprir3ux1iw1P/jnXMM/f926t
+o4q/n2/5+bfmp538o+drCx8n61d2MHr0McL8Qd8VfsD/wA4vecv0n+W2iah5o1B
Hv5YgHaeVQxNB4nFX0tHIkwEkTBlPQqajFUJLqtlBIIJ7mFJT0VpFB+4nFUbXkOS
b7bYq5egqKHFUqu9f0ywb0728t4n/leVVP3E1xVvT9d07VTTTbqGcjqI3DfqxVUl
1K0tnb6zcRx9qSOqj8cVQtx5n0i1/wB6L+2SvjKn9cVRNnrWn6iK2F1BP/xjkVv1
HFUReX9tp0fr380cMf8ANIwUfecVQX+IdLCpJ9dt+Mn2T6q0P01xVTTzLpMs62EV
7bvcNsEWRWP3A4qiNV1K00mIXmpTrBCp+0zBR9NcVQ0XmjSJrf6+l9bfV/5/VSn3
1xVMbbULW8AazmjlUioMbBh94xVAX3mHSdLY/pC8toH8HlRT+Jriqtp2u6dq9f0X
dwXBHURSKx/A4qjbkOYz6R4kb16bYqk0/mvR7I+lfahaxyKPiDTKP44qj7DWLDVV
56Zcw3C/8VSK36jiqYswUfEQB74qxubzjoVtP9Qn1G1SfpwaZAf14qj31W2ubSa6
0+aOdUVt42DCtPbFX8yH/ObH5rec9F/OSysPLnmK+trV5owYY5SEB5Cu1aHbFX9A
X5JedoE8jaZfeaNRh+sfV0LPLKoZiR3qcVe36VrFprMIutPmjmQ943DD8MVTTFX5
s/8APxD8t/zK/Mny7Y6d+R901pfwzFrgpP6BZfDlir2r/nEDyr5m/Ln8rtNsPzev
zda5DUzyyS+pTbu2KvqS18waZep61rdwOnisimnz3xVDr5s0VpDbrqNqZFNCvrJX
9eKp5HIJRzQhkO6spqCMVSTVOKypVjVux6CmKqw1zTYHWye7gE1PsGRa/dXFUHee
ZNJgmSA3lqLo7KrSoD+vFUw1HW7LSLcX2pTxxQsQAzMApJ8CcVX2msWF+AbK5hlq
K/BIrfqOKplWm5xVJJfMukwu8E19bLIn2laZAR8xXFUdY6jbaknr2EqSx1pyRgw/
DFWPz65ZwagsJuIUZtiHcKfxxVHXnmfSLF0hvb23jZ+nKRR/HFUfFqlncxma2njl
TxjcN+onFX5G/wDOd/5J/nN5+806bq/5Laq1ppSlPVjW59Hfap9/lir9HPyR0bWv
LPlKw0XzrcfWNQht09aYvy+Km9TirP4/NOh2ylG1K1FGIPKdAQfDriqZ2Gt6fqjF
NNuoZ2XqI5Fb9RxVETX0NvIIZmCk+PTFUrm82aLbSGC41C1SQdVaZAf14qm9re29
6nrWcscqfzRsGH3jFULJrWnxHhNdQI3g8iqfuJxVHpKkierGyslK8gQRT54qlya7
p0s/1KO7ga4/32JFLfdXFVsuvafbo0t1cRwopoWkYKPxxVAt5y0FAC2p2e/T9+n9
cVT21u4L2MXFnIssR6MhBH3jFUR164q/Mn/nNj8jvze/MKN5fyW1Ca2cj7EUhSu/
tir8Mfze/L7/AJyS/IqBNQ/MHVNStYn6Mt67f0xVGflD+XP/ADkv+eNs2pfl9qmp
XUC/aZrx1/gcVT78+9K/Pn/nHvS7a2/MLzHqFveTgAKsx7/5WKof8pvyZ/5yf/Ov
S/8AEPkXU9Tnsm35Peutf14q9S/6E4/5zJjQwrc35Q9QNQf+mKv2d/59/fld+ZP5
V+RLjRfzzmlm1mS5MkfqymRlQ125Hrir7zxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KoLUmCWk7EgUjfc/LIT5JD4d8r6jM+t3jcvhBejdvv
zW5JOVCLIxr1z67OxPEd/HMTLkNORGKb6VrRvbgjpmFhyEFsON6hokbrNyrtm5xz
sNcoUm2uM0bLqAO0ODJNpIQem8vSkVTvd1bBjNlolFFflw8UYvLaKlVl+Knjm3A2
ayHqOBi7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYqwz8wtKl17y9qGiWtPWu4HiSvSrCmKv5LPzJ0D8wv8AnDn8
zdQ1uytJFlaR5VnCN6dGbb4gCMVfaNr/AM5kflX/AM5X+UtM/LX/AJyUae11VXCC
5UGinsQ3zxV+t/5Cflv5F/IP8vJr78tLw6hpcVu0qzO3I0p0OKvwP/Pj/nJf8xf+
cjvPkv5eeSr79FW9vM0aPHN6XKhpuRTxxV5vqVh+bn/OL2s2fmzV/MBu0V1ZlW9M
oYE13DE4q/WL83Pz/T89/wDnHq51gkLfRwgSEHcnjir5M/5wj8lap53/ACY8y6H5
TkKa48rsjVoaCuKvzK1j8rPN1v55fyZPM5115yiyc25cidt+uKv6Z/8An37+TX5j
fkv5Xa1/N/UWuI7kB4FlmL8FbdR8RPbFX6OchWld8VeE/wDORvni78g+Sb/XNLia
W6WNuAQVNQMVfzZW3kn8+v8AnKTUdV8waPfXFjYWZdyJ5mhWgNdjtirAvyI/OXz/
AP8AOP35nWuia3qk10rTiOZTcGVDvStTXFX7N/8AOdn/ADlVe+Rfy5sdV0EvBear
CtHiNCCw8cVfiB5P/Lf82vzU02bz/p/mSVVlrLwe+dWb/Yhh+rFX6E/8+3fzN/Mv
yl5vf8uvN/1q8sLh6GSUs4G/Zjir0X/n7T/zkR5k8kXlh+WPlad7Vb2IO0sbcTuB
3+nFX5gt+SX5zW+jw+e7TX3lSSMTKqX7F6Ur9mp/Vir9l/8An2P+aXnDXNNu/Ln5
jtcu9rFUS3AO/H3OKvir/nOf/nL3zr5u88zfkx5FuBZxrKY/VR+PU+P0Yq+Sdf8A
y4/OL8nY7f8AMDU/MZaBSs1Evmeo60K1pir9jvyb/wCcprj87/yU1WynnMWrWNmQ
Zlb46qvjir8M/K/nb82vMHmi78oeStav7m4uJXTi0rMB8X4Yqzvz15f/ADy/5xS1
Ww89ebdRukmmYOqvcOytXsVO2KvatZsv+cjP+cuPLx/NLT557bSNPiPNYZnj5ADr
8NDir1D/AJ9b/nxrvlrz3dfk/wCZrm4nkupG2nkaSjKaMKsSeuKsB/5+1XLt+b9l
Nbj/AElIhwHaoZafjirGdB/5xp/5yM/P7y5F+YekTy22mW0ISKBJ3iJVB1CqRXbF
U9/5w1/5yQ87/kH+aKflz+ZNzcXCSyi3eOeQtTtsTvirOP8An6Jq1vrPn/RtXjNL
d3iYge9Diqv/AM5P+SfNflX8pfLv5peTdWvLazYIxjicgDbwGKv1G/598fnK3nj8
sba6167M93AhMjyNVvhHfFX5Nfm/+ZHnD82P+cjIfKPlDVrxLGG7CusDnhTl7Yq/
pB/LvQLny3oVrpuoTPPcKg5s5qa0xV5B/wA5X/mfrP5SeQL/AM2+WIDPdRoUAUVY
Eg0oMVfzfQ/lh+fX/OQEd9+aE+rXNhZ82dUnuXhAB7AVGKp//wA4p/8AORPnz/nH
z8xYfJvmO+fUbe4mSJhJMZVHI02Jrir7Q/5+pedNb0rRtK1rQdSubCW69OUrbyFA
eVNqjFXwL+Tn5Sf85B/85K6Ktz5O1S7ks0/3ZJMy8h2+LFWvKfn783f+cPfzJsfL
Xnm+uXLTKskM0zOhBNK1bFX6Uf8APzD82tS1j8pfL/mPRL2bT7i74vILaQryJAqK
jFX5gf8AOP8A5Q/P7/nJq0fy35A1a7NhYDeaSZl+jlXFVXU9W/Of/nBvz7YX3nW7
ubiVXD8J5nkjkFd/tE4q/Zf/AJy7/N25/ML/AJxpPn3TpnsdUu7dZh6DU4krvuMV
fiT+Qnl785v+ciom8g+R9ZvTGzg83mYKAD3ao/Xir9aJvNfmr/nAr8ormx8/X8mo
eY5QUhZ5OZqenEknFX5n+Q/y2/5yE/5zNur3zx5avbwWPqMQTO6IKnooFK4qnfkP
8z/zf/5wX87W8fn+a4ns55BDJHPIzrStCRyrir9yPz0/5yXvLX8k4fzO8hRtc32p
QqoSIcmRiN9hir8HLf8AJv8AP/8AOK0uPzGutUnsrKZ3YLPctDRa1oBtirI/+cKv
+chPPH5JfmzB+XWs38mowalcrayrLO0qqx7qST4Yq/Xf/n4//wA5VXv5A+XbHTfL
7FdS1VKKVNCta7jFX40eT/8AnGX/AJyI/PXS5PzX0e8vDaz1mVmuZEJHX4QDir7a
/wCcB/zZ/NLyHr13+T35hW11cQyM6tPcKzcabbMcVfEH/PwgpYfmolzojFrwPUDw
bamKsg0r/nHr/nI/83fKB89afdzQ6JaRVEKztGSqiu1N8Vew/wDPuT/nIPzX5U86
y/lx52vbieNJfSMc0hYgg0I3xV/SxbzLcxJcR/ZdQw+RFcVfjn/z93826/5Z8n6b
L5Wv7iwZrikjW0hRmWo2JFDiqafkV5k1Of8A5xL1HWb7ULi51FrJz9YlclwePYnf
FX4i/kN53/ODzhqdz+Xv5dape3FzqZMfKSVmCEnqCTtirOvzz/Iz8+v+cZPR80ed
9UuwkrBvVjuncda7itPnir96/wDn3R/zkHffnj5DjXWCXudORYndjVmINN8Vfc3m
6cW1nJPJtGIpKsOo2xV/Jn/zkn+ZHnrQfzYurbyhrd8zzTlYIhI1KsaUpirf5u/l
F+f/AJJ0m2/NzznqV6lk6rNHItxItO/QGh+nFWe+Q/zQ/wCchP8AnLLy8Py08nzO
9tZKC1yHIYhf8rxxVjf5Gfmr+Y//ADjB+bVr5Z87X13PJPOsE0E07yJuaVo1aYq/
Zr/nPT/nMDVvyS8hafqPk3h+ktWjRTUiqcx1GKvxe8u/k5+dX516A/51Wfmf04Lx
ncxNetGwHWnEMP1Yq+qf+fdX/OV/mfyd56f8lfzEvGvY5pDEJJJOdCKdD3xVjn/P
0Tzz5m8refbdvLOq3dpFI1Y1gkKjpUdMVeS6L+SH/OS352eWIfNdje3R0uGLkGMz
I7ADrUb4qr/84ef85G+f/wAkvzIj/LrzTeXF6skvovFcys4U13+1U4q96/5+c/mN
5j0jzNoNx5Z1i9sEvTG7wwSsigkeAOKvtjz1+enmD8jv+ccrXzXbO97qN1aCMzSm
rjkvWpxV+HHkTyN+bP572935x0TzDJHE88jmOW+aMgk12AIxV9l/8+//ADt+Yn5e
fmpN5I84T3l9bOAhdmaWKu4qGOKv0I/5+M/85S6l+RWjQ2Xl4qL+/jVUIPxKSMVf
j95P/wCceP8AnIr/AJyA01/zK0u+vDazEyL+/dBTrtxIxV9of84H/mt+b35e+aZ/
ym8/W93c2/NozNcBmAp3DHFXzL/zm5598xWn5y22l6Rrd9bI1wgMUcrKn2h2Bp7Y
q/oE/LC+1K5/KOKfVJW+tDT2pKD8R+HrXxxV/Pb+QvnXzRqX/OSMuiXet3r2gvJB
6ZlYqQCKCnTvir6g/wCfnf8AzkV5h8uXVl+VPlmeS0adQWmjbid6Dc4q/Pq+/I78
4bDR4vOVv5ieaOSMSqi3z89xWnHkd8VftT/z7I/NXzt5g0R/I/5hQzn6opK3E6nk
1B4nrir9asVdir8U/wDn7M7T+XUJcgxr0rtirI/+fRxuH8m3Ty/YP9cVeDf8/kpZ
LltMhp8MfEg+wxViH/OFP/PxLyJ+RnlCLyd5zS59RAASik7j6MVfalz/AM/ePyfq
kdmt2zswHxIQBX6MVfoV+UH5t6N+dHl6Hzn5VLfU5ezDeuKvU8VdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirxr879aOkeXpDE5SSQlBxNDvmN
nk2Yw+aPKVk0mjek9RPzLlv2iDmpy5A52OKbGUXMAt+hjNSe5zAyTcoRZDoMP1hg
8Qp8srxDdBL1a0u/qqBD1zcYjswkVS4uzdRtH1rjkLRJdaT/AKNKs+9FNK/LHEWm
QSf8itTOqfpmZtyt2R+vNviOzjzFPoHJsHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXnf5q+a/8E+Wb/zPx5fU
4mloP8kVxV+Z35Q/85Rfln/zm3NqH5T/AJgadDFexB1WeVQrMASNmI9sVfGv/Oc/
/PvfyT+UnlQed/yju6XUDGW4iklFCla/DQmntiqYf84D/mn5p1r8qfNXlvnJdRWt
rIqGQlqADtXFX5j/AJcflLrf5zfmHeeWNJuxYak9w59Rm4EEt4gjFX2b57/59n+e
/L6JN5q8z208dRQTXJb7uTHFX1N5r/JSb8oPyEvlnnS5Qx9YG5Dp7Yqmn/PqOMX/
AJM167hPEL6ux698VfC3mH99/wA5IRWtwTx+ujcH/KxV+2X/ADnF5789+Q/y20yX
8o4JLi/9OFiUUs3wqKDFX5rfkb/zlT/zkzrnnnTLPzPp9z+jppo4pucBVVTp74q/
YH/nMP8AOJPyh/LqfzBdwRzXEsWySAFeVBXr7nFX4cflT51/N7/nMaz1Hyl5Je10
XTYQ3rSW59JivXcimKviuH8q9V8g/mraeS9duVubqK5Aably5b+JJxV/QF/zkN+U
flXz3+VuleX/ADbdwQ3YgUQs7Ab8dsVfhr+YH/OMXnz8qXiufKupteWUnxwi0mYg
DruFNPwxV9Jf84cf85kecvLfnPT/ACDq9hbSTlhCZGjAlG4rX7/HFX3t/wA/JPyS
8ufnDHpWuG/t7XzG9uvBZJAKbDbrir8UvNv5Wfmb+St/BdWlxc3trColVopHeHiN
6FakUxV+mX/OC3/OaGueer/UPI/mKwgjMdiVV7VKOaAip2rir81fzZ8o6h+Yf5zX
ug2Uptru7uDweQ8WXc09++KvqfzJ/wA+0/zF0rS4tZ81eaIG0qRAyrJcsdj7MxH4
Yq+tPya/5xtuPyr/AC21nUNKvI7mCW3b1DE3Ltir41/5wI9E/m5ferGsipO1CwqR
8WKvqH/n8XE0cGhSCvBgu3bFX3d/ziPpMNh/zj4sqpw9WwckLsD8HfFX4zf84Olf
+hoWikAAa6ufoo4xVmH/AD9VaK0/OjTGn/uUMbuf8kOpP4Yq/eX/AJxn88eVdb/L
LTbvy/PBHZQ2apKOaijcN64q/nX/AOciL7Trv/nJW3l8sgSobxATFvUlsVZ5/wA/
CbKRNY8vzzKVmYwcVYd6DFX6rXP5YD8yv+cZbfTtRj53cFl6kagVFQo7Yq/G/wD5
xu/5yJf8gNN81+R9bkaGVkkSFS3GhJI2GKvq/wD59e/lnP8AmF5t1v8ANHzBFyHq
l4JZBU9a9cVf0MKvEBfAUxV8Cf8AOfv5/Rfkn5Ke5+rx3M01eMcoBUmm2xxV+QPk
O0/OX/nNnylqD6Jc2ui6NasxIgf0gQvUbUxV8Z/l3+Xt75X/ADZs/Kus3Aurm3u4
w8gYtUq2+5JxV+mP/P1BYl8oaEsVSqxwrU+NBir7D/59d+dfLN1+XNtoOlyxx38S
gyqzAE7Yq/PH/n6JrGjax+Z+n2OnMkt+k4JaIgn7Xtiqa/8AObEUw/Irysl2sgZV
Q/GPADFX01/z6S89eVm8tT+XoJI4NUgBDliFLdOuKvG/+fz2raTeXvly0tHilvRX
kYyGYDfrT2xVlP5hR3Nv/wA4nRC6RhGbReJYf5PbFWU/8+atItR5Z1TU+Ctcesw5
kfEBU7Yqkn/P4e1v7jTbW4twxso3Tn4AgDFX0p/z618y6J/yquKwt57eGdCnJS6q
3Q4q+EP+ftuq6fe63ZW9pJBNd+qOPpMGNa+2Ks50X/nIGf8A5x4/Iiz1XVLVLvUr
hFSG3uVBQEigoDir538m6D+dX/Ob+gT39rfW+jaHZlnCW7+kGA3pQEYq+UvyK8kX
nlX8/NE8rX84nurPUl5y1ryI264q/Qz/AJ/O2c0N95VmfkUMVK9qhDir9Z/+cNNf
0i9/JzyzBaXVsjpZoJU5qDUdaiuKvQ9b/MT8utDvX02CTT21aVWFYRGXqR3I3xV/
Nj/zm6IbX85bB5RWCeaN6nwLAfxxV/Q5+XmkxaZ+S/pacAqvppf4fdcVfz1f84zz
Bv8AnI64ilA3u2FB0+1ir+r6yUJbxKvQRqB92KvxY/5/IUh8maaw/bnA+9hiqc/k
FbC4/wCcOrx+h+oufuXFXwz/AM+lxaf48v8A63Gryqf3bEbg+2Kv0L/5+zojfl/6
ripjSor06nFWF/8APm6MN5L1OZdqSUP/AAWKv2C81IsmnzpIKqYpK/8AA4q/lA/M
WIxf85GRRyKHiN4tFbp9rFX7Cf8APwWGBf8AnH+2jjFGMC0r/q4q+fv+fRmmBPLd
7eRoPUd2qw60NcVfDP8AzmBH9W/5yRtQB8X12L8XxV6h/wA/NJ9RbSvLcV6ri24I
VJHw/YxVg35B/wDOAX5ifnN5ItvN/lDzMbLTbgcvq5uWRF2r9kMMVel/840f84V3
/lX80rdZtYtrnVtNmJbjKDU/firHv+fnUM1n+YGhWWoUaeOSMP4H4hir9yf+cdhD
Zfk9ZyKoVDZNUL/q4q/nJ1tK/wDOSKPCAAbwMB/ssVfQH/P0GcXWv+U248JFSEAU
pXYYq/TKfydon5nf8472Og+dbiG2UWqcDIwG/Hbrir8KPzJ/5xf81/l1ZSeY/IOq
S3WnNOwWKymaoFdvsHFXqH/OKH/OXvnH8qPNGk/l75i0+CVZrpIpJbiP/SAD4k7n
FXu//P2m4Ot3Oja/CsiRSqhIfYVK9sVfrb/zgrrmk3X5L6Hbw3Vurxw0lHMA9B1x
V7ZafmZ+XTau2h2k2njVN1JQR86/63XFX803/Odr/Uvzqt9TZaWq3KfGeh+Id8Vf
0Oflt5l0jTfybg1TULyH6s2nHfmO69MVfzwf8446hBc/85PPqGmsHtnvJSGrUUJG
Kv0d/wCc9fyC8s/mzf21dRt7fzEU/dM8gXr074q/G7z9+Un5l/ktrUVvHd3N/Hag
To8MskkPFd6EVIpir9gv+fb/APzmT5g/N7zK35feZrG0tltrcASQIFZuII32rXbF
X7i9d8Vdir8T/wDn7PayN5dMkfRVr+OKsp/59JS8vJkqn+X+mKvAf+fyHKF9NdP2
ioPyOKpb/wA4T/8AOAv5WfnL5Ji83ee5We+cAlFkC0r8zir7Mb/n1d+RgdLm1LIy
MG3kUrt4iuKv0B/Kr8udB/K3QovKfk7j9Rh6cSDv9GKvSsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVWSSLEplkNFUVJxJV8XfnD5qj8xaomixP
WCN6nfwzXZpFycYSP9Jw21yLezI9MxgbeOajNJzcYVY0MPNh+2MwDKy5JGz0HyVa
UFXGZmHG4vGWe3dsK7ZtYQoIMnRwAFaZDKGs7rJ1FxJwPQAj8Mhj5sCxb8pbmHyp
qN5oEw/e3k5kUd+ubXDLo1zhb6Zy9xnYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUg80eW7PzdpV15d1ZeVrdxt
G49mFMVfzef85M/84Reff+cffNcnnL8glne2unZv3I+IcjX+OKvCdQ/LL/nJX84j
D5S81rdiynIjb1KgU98Vfu5/zhh/ziLD+Qnkq48va4qSXmpQlZ9hX4hvXFX5U/8A
OVf/ADgx5/8Ayv8AN8v5j/k6X/0iQyKINiKkntirxbyp+QH/ADkJ+e2s21j56uNR
gs0dQSzsAQCMVfsn+bn/ADjvqXlX8iZ/IPllpLvVmhCv6nxnlxxV4x/z7T/IfzT+
W/l7WF86xNAZvU4oRxqTXtir4082/wDONXn2X/nICPzVptlK2mi7D+pw248vHFX9
HGk6dHc6TZ2mrQpKyQRqyyIGFQoHQ4qjotD06Fg8Nnbow3BWJAR9wxV8xf8AOYn5
Mn86/Id15ZtlJuyrelQV3OKv51PJn5H/APOQv5F6zc+VvIFvNFHeOY5JEU0K1pWv
bbFU51X/AJwu/OW08y2PnXW4pJ7syrI7gEnrXFX7B/nl/wA4oXf55flBp9taT3Fr
5msrUGisVqwHhir8ULD8vf8AnIb8qLmXQNLsrm8gjJjDSoZBQ+FTir7H/wCcIP8A
nCbzxf8An+3/ADg/MyBYUVjI8ZSlCT4Yq+n/APn4r/zhhr/5rPbeffy5upYriyjo
YFc0JA7AUxV+W1no3/OSuiWDeT201rqxZfq/OWHmeJ2ryOKv1C/59y/84T3v5VTz
/ml56QfpK+jK+i69OVSRT6cVeK/852f84P8AmO783H81fygR01J35FYxQddqYq+I
m/Kb/nI/81NRt/IHmyTUI7MMI+XJgoGKv3F/LP8A5xo1j8ofyevvJU873mrXVrwY
M3IglcVfmz/zhf8A84x+fPJP5pahq+uWckdmZmIcpsatXFX0j/z9O/I/zZ+aNtop
8p2r3C24UOEWvscVfZv/ADjr5G1ny7+RMXlPVYimpCxdAhFDXj4Yq/IH/nEv/nHb
z75a/wCcjT5p1PT5YdNS4mczMp4sHYH+GKs5/wCfmP8Azjj5z/NL8zLTU/KNlJcQ
ND6bMqkgE03xV8nXv5T/APORP5R2EXkTyoLw6XMgYiOvU9sVfVX/ADhN/wA4K+ct
T84Rfmd+a6kPEyyn1lqajfvirPf+fjH/ADjz51/MnzppVx5OtjLZ2jxn4F7LTwxV
+rv5DaA/lr8ttN0PzyUiZoQkiyHiOgFN/lir+X7/AJzp8k6bafnPeaN5NKyQXswV
RFQipb2+eKv6Qv8AnB38q4fyz/LbTYfREVzcRKz7UJ2HXFX2Xir87f8An4f/AM4/
3353eSjbaEOV9DUoAK7gbYq/DXyB+U//ADkh5CgfyN5PgntNMmfg7KCAQx33GKst
j/5w2/Nv8uPPmkeap4JLp7iaKWeQKWpUitTir6R/5+nFrLynomn3Xw3Xpw+op6g7
VxV8L/kz+Xf5z+WvL/8Aiv8AKV5WhnH2Yie+Kvpf/nGr/nCv8zfzi86235h/m+kg
SCYO31gdQN++KvrP/n7dpMflv8u9F0TTlRLaEKlAKdNsVflB+R35Y/mhpmgjz3+U
byetcgsVjr/DFXvP5V/84ifnD/zkp5pg1T83ROtrZuCfXHUA9q9sVfsD/wA5l/lL
c2/5CD8sPKEHqXEMKxKEXrQU7Yq82/59Zfkz5m/Kbyvex+bYGgNzIXVWFKVOKvsX
/nKr/nHS0/5yH8qT+WJeCXJVijMO9NsVfzq63/zjv+fX/OPGr3Hl78vhdtZFmCmK
vGn0Yq9h/wCcc/8AnCT8yPz281w+YPzwMy2ls6zf6RU1pv3xV+lX/OZf/OG6eefy
5j0DyglbjT4hwVV6lRtQYq/HT8rvym/5yP8AJ5TyV5VhntNLklMbEAgca07Yqyry
P/ziL+afk385NF8yalbSSn68k88/Eke9Tir9s/8AnNf/AJxVT/nJLyhbW6gDV7CI
NGSN60r+vFX4B6d+XP8Azkb+V8l35a8spffU7NjGoXlxI6DiBir9Bf8AnCr/AJwi
/MDUNT/5Wj+cd9MPVq4gkclq9aUOKvIP+czP+caPOvnj82dNn8vWEsmmwPGBIEqA
FYHr9GKv3F8j+Vr/AEn8rl8tTqfrq6eYuJG9eOKvwm/JX/nGjz95e/PybzNNZyJY
m6aT1Cm3EnFX9KdkGFvEH+0I1r86Yq/Jb/n65+WHmP8AM/ynpem+TrV7qeK45siC
uwIxVmP5GflL5g0P/nFu6/L3VoGTV5LGRFjIoakeGKviP/n2r/zjt50/Lvzzfap5
rsZLa3VioLKRyoev04q+7P8An5D+WOu/mf5Jl0zyzC0sgSnFRU4qxX/n1n+UnmP8
qPKV/Y+bYGge4fmFYUO5rir9PvMQJspVUVYxuB9IxV/N3+Yn/OLv5ga5+ekPmzT7
OT9Hi6WQycNgoOKv1D/5zj/LXWPPv5Q2vkzy7Ez6ktuoKqKmoQA/jirzT/n15+UH
mX8rPLd5a+cLZ4Wd2Kqy0xV8O/8AOV3/ADjZ5780/n7bebtDsJZdON5E5kCmihXr
+OKv08/5yy/5xV/6GC/K+y0eOJY9b0+1RkbiAxZVHTFX4a6T5B/5yX/LSzk/Lvyi
LxNLQsiiKo2rT6MVfpH/AM++P+cL/OHlHW5PzZ/Nm7uDeyEssbuaknxqcVeOf8/B
/wDnH7zp+aH5l2Wo+XbSSW1SZaMFrQBsVfsF+SXk7UfLX5YWvlvW0IuktCnEjevG
mKvwq8y/84wefZfz6i812NlJ+jxcq/q8NgAcVe7f8/D/APnHfzj+Y2qeWtX8uWbz
raJEJfTSvSlemKvsrzR/zjLN+bn5G2nlOCS4sdbgtFFAxSrKvTFX4oWH5Sf85C/k
1fXPl3ytbzXtpFKxUTKZQaHrQ4q95/5xW/5w7/MP85fzKi/Mz837b6j9RkSbiY+C
sV3G2Kv1r/5zV/5xEs/+cjPKtvptsPSv9OQei0YoSVGKvwa078q/+cjfyhubvyF5
JF2bCMlRxrx49NsVfc3/ADg7/wA4X+edT1u4/MH837q6inR+SrI53JxVln/Pw7/n
C/XfOqW/mLyUglNuKnitWNB374q/PLyj5A/5yO1ayX8t3jvY9ECFPirSnTFXpH/O
Jv8AziJ+Y/kz84dOvtbspVs42YyTlTuGIrX3xV95f8/Av+cJte8+/V/PP5ZXVwt7
bJV4lc1LDwoRir8vovLH/OSejWL6C2ntcwOpty00XN+PTqcVfqf/AM+2P+cMtX/K
Z5PzV88j0tUvFP7oihHLfp4VOKv2PxV2Kvyt/wCfk35WeYPzK8vPYeVYHml9MCir
U4qu/wCfY35WeZfyw8rXGnecIGhdh8IZaHrirzP/AJ+k/kj5k/NkWP8Ag+1e4eEA
kKtegxV+V3kLyj/zkx+XFqdI8n215BartwoSP4Yqzi+1z/nLSaEpIl6FHXgprir9
m/8An3VN+Yk/k2d/zhEy6j6nwievLjU4q/RrFXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXlv5r+brfyvo0slw3FnUgHpvTGUdrbceMl+cT6xcST
z6nOWYyFgh+fTNJqdUImnMhgLMPIaXUsXLUKs/KvL2zVTzDJsHKhCnrUZWQqoYbd
skOzpH1W2yO1PTvL88UKhieOZeOdBwvCLJXv4bg8UkAOZg1ApBxlUt2Kn1a80Xwy
EpcSCKbjjMwknjYAncDGOIsCXlVxaTxeedP83GUQ6bapwljOxZj3GZuOfCwmbFPr
y3nS6jW4i+w4qPlmXGVi3FIpWySHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVKWCKcUnRXA/mAP68VUfqFrUN6
MdR0PAbfhiqLxVRmtobiguI0kA6clB/Xiq2O0ghNYYkQ/wCSoH6sVXTQiagcAqDu
CKg4q6O3ihUpCiop6hQAPwxVSjsYUPqGOMyfzcAD9+KovFXYq0VDCjCo98VQv6Pt
S/rGCP1P5uC1++mKqj20Mn240anioOKqwUKOKgAeAxVCNp1o55NBESe5Rf6YqrxQ
RwDjAioPBQB+rFWp7eO5X051DL4HpiqgumWaDitvEB4cF/piqKjjSJeEShVHYCgx
VbJDHN/eorf6wBxVRGn2of1RBFzH7XBa/fTFUWRXY4qox28URLxRqrHqQoBxVuWC
OccZ0V18GAI/HFV6oqr6agBRtQDbFVCOyt4X9aGKNXP7SqAfvGKtyWkErerLEjOP
2mUE/fiqySwtZSDLDGxHSqA/wxVWigjgFIUVB4KAP1YqpvZwSP60kSNJ/MVBOKvh
j/nOnyr5+80+VVtPyskeK4QE/uyQa/Rir8i/+cWf+cGfzG80fmDa+dfzeikeG2m5
sZfi5UNa1OKv6VLLTYdPtYtNsxwhhUKgXagGKphiqXXtibxkJI4DqpFa4qrCwtQK
CGOn+oP6YqqtbxPQuikjpUA0xV+Qn/Py3/nGjzL+cVjb6h5UiaaZZQFRRXaoxV7n
/wA4Cfk75i/KnyZF5b88QKZEUGsiCvT3xV+hMUEUA4wIqDwUAfqxV+YP/Py/8gPM
f52+WbO38oAvJA1WUCvQ1xVH/wDPvz8jNc/LHygNG8124SVBQGVK4q/Si1sobVR6
UcaPShKKFr92KqOpabHqSiK4CsgNaMtRiqMgt47ZBDAiog2AUAD8MVVsVQk9lBOS
8kUbv4ugOKqkFvHAtI0RD34KAMVVWVXBRwCp6g7jFUMlhbJukMYI8EA/hiq82kBY
SmJC46NxFfvxVEEV2OKpeml2qli0EJLGpPprv88VRqRrEOEahVHYCgxVTe1hkb1J
I0ZvEqCcVVgABQdMVQ4srdZPrCxRiX+cKOX39cVRBFQQNj44qgBp6SD/AExVmINR
yUH9eKowRIF9IKOHTjTb7sVU47SGEloI0Rj3VQD+GKrfqcTr6dwqyA9eQB/XiqrF
BHbjhAiovgoAH4Yq6WL1aAnYGuKrPqkAbmIk5ePEVxVSnsUuJFlkCkKKUZQRiqJj
hSEcIVVF8FAA/DFVjWsLt6rxoX/mKgn78VViARQ9MVQY020U8xBEGPfgtf1Yqi1U
IOKAAeAxVASaZBLP9bljRmHSqAn78VTCgpxpt4YqhWsLZiWaGOp78RXFVzWyOQro
jRgdCtTiquqKg4oAB4DFUEdKsjIbg28XqHq3Ba/qxVExW8UFTDGqV68VA/Viqqa0
NOuKpbFpNqpM0kEJmb7T+mtT9NMVTBI1jHGNQo8AKYqpz20V0pS4RXU9mAOKqUWn
2sO0MES0/lQD+GKqqWsMbeokaK/8wUA/fiqo8aybOob5iuKoQ6ZZsebW8JbxMa1/
ViqNVQgCoAAOgGKt4q7FUHLZpPIJJVV1pSjKD+vFURHDHCKRKqjwUAYqtkt4pjWV
FY/5Sg/rxVSFhbDpDGP9gP6Yq76hbdPRj/4Af0xVWihjhFIUVB/kgD9WKquKuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVTllWFGlkNFUEk/LBavgv8
/ddm/MeZdA0AsIYpAHI70yGXIBHZzcMdnn955FufShit2A4ooYe4GcvrJWXOiz3y
1p36Otvq1wKvTMDEd2dppaWsNs7PcqVY/ZJ7Zv8AFL0UxkUOfMUWnzeldXKkZVwN
XEoX3nK2V1WyrIxP7JOSjFiZM/0Y65rUSnSkeJCPjr3y8RajLvTv9Fa3ozi5u+Uk
XVqZbANJKX+aNU03VLcRmPhOlGPbpllIt6P+Wv5nWHmeD9HL+7ktwI9+9NsvxTrY
tMovZFYMOSmoPcZkAsG8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirTKGHFgCD2OKrUjWMcY1CjwA
piq/FXYq7FXYq7FVpUN9oA08cVXYq7FVrosg4yAMPAiuKuVQg4oAAOwxVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVU5ZPSRpD0UE/dleWfCLU
Pk78zvzc/S3qeXPKj8pg3CTj1HjmBLUcXNujjYjYWsGlaZ9YQcr5yC/jXvmLl1G1
U5mOKi+p2tuPrV7MsRP7JzUZdy5QS2/8yWlpH9egYOo32yGOG7EypisfmK/88MbD
RoGJO3IdvfNriPRqlJmPl/8A5x01PUJRc6vdGnXc5k8LSZgPa9L/ACg0nQCs0wEz
JvkuFHHb02x1q0tE+qWyCGnQU65aNmki+aaJq9tc/wCiXlPi2oe+WAsTHuePfmV5
USzjOoadASp6keGTUG3iUelCxA1Hyw1KEGXieh75VbIh9Rflr5xt9btFsnkBuk2K
98ysc+jVIPVMuYOxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV4H/zkR5ivtE8r
TroMpivXKgMvWnfKc49LKAsvmmCxtNP0i38zQKI71ogZ27s5G5zn8mSnPjB5Zf8A
mq8N0b1JisHTj75hTy31b4RSW/1GS7H+mOXZjt9OOMW2M98mflvqPmACZZT9VO5T
fpmVHH5NMy+tvIXl2x8qoEgiCyAfEfHbLI/U4xk9IvPMNBxgNBmyY8LHG1GSQklq
4qhp0WcrKNmXvhVyOOQd92HQ5IFjSvfXdzeRNbySExFSKfRkuJFPlZYr3yprMttI
5FpOxPDsa5Rxbtpjs9H/AC4vLfQNeE0uyzdB88yYFpmH2SjB1Dr0IqMywbaF2FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXzP+YH/OSOneW71/L3lO2bWNXhNJreM7p86YqknlD/AJyn0/Ur9NE8
6WTaPdymirIT1+nFXvXmLz5YaCLb4hKbqhj49wfDFWZW0wuYkuACA6hqH3xVhP5g
efrP8v7FdU1Ecg7hAoPjirK9I1KPWLKDVLf+7nQOPpxVMsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir53/5yJurXQPL
8vmPUN7eMqGB8Tleb6W3B9T458z6rLPYWstmaWVxGsgHahGcxn6u04d3n00I1WRb
K26KOR+jNRx0WwBNvLGl/wCJNQS0HRCFza6WFok+5vKulN5XtEth3AzaeFTjZCyh
4lUGXlu2Y0hUnD4t0MkY6k5m8TfS8qq74OJeFTMxAIQVwca8KjGpY8j1w8a8KrLO
YqbY8a8DBvzA8urqkS6nEKFBU/RlIlu20+bZdfkm8zWljbN9h0Bp88y4Fxph+m1g
a20JP++0/UMz48nGKLySHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq0SBuTTElUvvtWtNNjM93KiKOtWA/WciZBlGNvIdZ/5yG8k6BIYdU1
BI2Bodwf44OJt8DzUdM/5yP8h6y4h0vVEmc7UFB/HEyQMJeu6Vr1lrEYnsZVZT0+
JT+o4RIFrlGk4wgsXYVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdiqA1SGa4tZIbNuMrCgOKvy98g+ctO/Jj80vMFx+aNn9Wj
u2IhuyhatTir6S84fl15H/5yQSHXfKV/EL21IPqRbHbcVGKpJY/m5ZaRqtr+Xmra
elz+iR6Ul01KgjFUFqf59+avN+ozaP8Al9ppkt7ZivJe4Hvir5l8z/m75p87/mLZ
fl/52sjb2caepJy6fBir3mx/P7zT5su/8G/lrpCy6LZD0nvw1KMn7NK4q9B/KP8A
5yI1fzD52m/KLzjp4tb2CAyrPX7VB0698Veij81fMr/mNJ+XEegk6NHEJP0hU71/
DFX0FirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVfMf/OUVpD5i8rTeVJTxa4o4/2OV5jUW3Aak+BRqU9zYQ6DZjmLRBFXwAzn
NVjJ5O18UKljIbb4rEF5/ssP15p/y07bPEi9w/Lry8tiV1cbEsCfnm10vp5sZSBf
U0Wo2+owKiMTKAM3BnE8nFyC1eBBx43TFSPs5jzwkm3E4Da1GWR/SVhz8K4ONy+F
d8AkELt8WJLGmRWGleqrEAHAASt0l97YS2pq60GHgKRIIAokg+LBwSTxBi/njVBp
ukzP/usI2/0ZEQKTJ8HeSdVE+sS+ZLqv1VJuIf3rmbjiXHkX6m/lxrD63o0V1Jvs
AD7Zm43Gmz7LGLsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVa
JCip2AxV5D+bX50+Xfyh0mTXfMtyqKo+FQQWrTwyByANscEpcn5pedv+cyvOHn2Z
tO/KyzM+lyg1uiKMtRlMzxGwzGMx5vn+58g+dvPN0bnzX5tvtP8AUNTEj7Cvbrke
KnKx4SeTI7f8hILFaT6xLqZI+JpTU5E5g5sdKe5Vk/Jm3SPhp949qG2EibEHB44U
6WXcxif8oPNflmUar5f866jJIDVbfkeJ9sPigtZ7Lyy5B6z5O/5yy/Mv8sWFv55s
mm0qHrcNuxHSuW45AblxtR2ZmhuQ/SX8lf8AnJnyh+dFqH0G7UXaj95G5CkH6Tln
ihwzp5jch9GKwYclII8RlgLS3irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirFfN+qalpVi0/l+2F1dnZVPTFXwV56/
5yu/MP8ALnVLfRfMfl+NXvGpbin2sVeqfl9+cX5m+Zr+JdX8vxwWMu4Y7bfPFX2F
aXH1mMOaB/2lBrQ+GKonFVnqLy9PkOfhXf7sVX4q7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq8t/Nzz/L+XOhTeYLeD1jGpPjSntirDfJNz5R/O/y7Z+aPM1jZ3Nz
IDzWcLyUj6cVfF+q2cf5c/mMmo/lzetHaLIfXtIT+7p4bbYqkvmXQL7zE+ueatPL
rJLJycqD8OKvqX/nFSHSvLnla81GSdGulJeVnYBqAEkb4q+MPPOqXH5z+eLzVfI0
Z+s2nqRO6D9nodxirI/yD/I4HS9Q1LS/M9xaSLcMbiEPxo4O+xxV65+VP5UaDbfm
HL5+n16e51K3ho9TUUXxOKvv/RdT07XYRq+kPHOjVT1VoSePYkYqnWKuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV87fnPaC9u
re38YnP3A5RqfoZ4hcn5ueT5/VOsTruYLpo/xzSzls54hu9j8q6JzQXBjqWYHpmJ
KZbo43uthoMyyRlBwgoKr0GQGRn4Yer2ElppsIagLgZmY8xa5QYtq/moqxEaio6Z
neOeFhwvLNT852Npcetq92YHPZWAGYAmWwxZPo3ndJiLjTpEmi8SwJyYmxMXpOl+
dRcuvomh/aGSE6YGAZXqGpfXYxxNT88tGYsfDCVQIVFZPxyXilBxhjnmm3hvdLuL
WcChVuvywxNpI2fK3lX8v/rOlzxW61Aui1APfMmBceb71/KyJLTRIrIEc4wAR3zL
x8nHk9KyaHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FUDd6la2KNLdTRxqvXkwH6zgJWniHmX/nJTyR5U
5rq18gkT9lGVv45HjbRit80eYP8An4Z5L0mdoIfWkU/YISuR8RyI6eLz2/8A+fg9
tdt/uGglbwqn9mVyyFEtJE96Bj/5zo8wP8UFgGX/AClH9Mr4y1HQR8050/8A5+D6
bpriLzTBLEzUB9NM2PHs5Phin01+XX/OXPkrzxxRLsxu9KerxXr92VGTjTxjo+ot
P1K11WJbvT5kljYVBRgR+GAStopH5JXYq7FXYq0TTc9MVfJH/OS//OT2nfkjYrbW
nC51e4FIYgQeo2qMrmW/Fjvcvyz0ryx5m/MzV2/MT8xLmWWzmPqR2MhrFxPtmHN2
2DG9L0m1ij1BfK/le3jt4pTuUHGlcMDQY6jEDJ7TJ/zj1YxWx1PXdVdJ2XkFEn9u
RlJycOGnkUdtF5Vv2toLh7iIniKmuYsi5o2ZJqupCyt4+QpU1yqJa/GISj/EUUks
a9CTl0C5mHWFPryGy1BHXUolnjYbI4qMyBK2zW5zkG7wvzP+VOoaCx84/lXM9pfR
/G1vB8Kk9egyYDos0Nn2h/zjB/zl82sovkv81aWmrRfAjNQcjWm+XwNOozQfpBb3
Ed3GtzbMHjcVVgagjMgFxlbFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX51/85NPD5o/Mzyjp1ivriwl/0kLvT4q7
4qz382vzo1RtVsPys/KmBJb25AWRx/uv226Yq82/MDzz+ZP5F6Kuq+YUVrR5UWWZ
WrSp8cVZR+fP/OQuraHpegab5PUyapq9tFNQd+QGKpTdj819HsIfOGuUS3WJZX4t
uBSu4xV735N/NTWPPfkNvNPlSFZ9RRmhIY916nFWeflHe+Y7zSi/nKL05+ZK+OKv
V8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVSbX9As/MtlLpGrRiS3lFCCMVfJGt/8
4cadeTifQtdv9OirUwwsQn0AHFWdeUf+cYfLvldXaW4uLu4k+1LKfir95xV6F5W/
KvTvL1pf6S4Etvesa1G9DiryDVf+cTdIummOmareWcU5JeOM0Xf6cVZl+Uf/ADjp
5b/KJZ30gvcT3NfUkk6mvXvirEtW/wCcU9IudUuNb0fUbqyW6LGSCM0Qlup2PXFX
oPkH8i9F8g6JeeW7OSS4e+SRJLmX+8AcEbH2riqa/k9+U1n+Tuiv5X0u8uL2F53n
53BqwLnoNztir1jFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq8J/M+IzapaxDqYZP1HKswuLZhPqfnL+UHlqW91PXtLILF713
p16HNTkxGnYiQt9VeXDDpf8AokqAmM77eGa/LjLfGQZbe+YVul52o4qNsx/DLLiC
VxayUBaY9MthAtcph5F5x88ukhsbQUeT4VPvmYIlqMxbw/z55CvdWsFub2dxO244
HAMZZmQY55T8p+dvKkC6jGXksRua+GS4GPE+nvK35l2eqQx28fwXUe0ldt8HhleM
PbtH17nxZ2+E5YIFHGGdvdreRAQ9fbBwFPEGNeZmW6jNvbH4ghqB8slGTAhg/wCV
91HbLdadcAVBZt8zIScaQeh/lRq895rdzbH/AHnUNTMnG4xD6QzIQ7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
qtZlQF3ICjqTja0+T/z3/wCcntL/ACrhe009459RoeKBgd65j5J2NnIjg735seaP
zA/Mz8/bgukrWFmSaiNuHw1rmEJU2xwFI0/KjQPL9H82ahc3N6ftAtyFceMuXjwl
mmj6H5bcqtjZwSKO8qCv44kufjgGcvoenQKrQafaAeyDBRcuMB3JdqkljZxVa2gT
6AMNFu4B3JLHFpsNH1PTbZlfcF4x3+eZQybOjmPUWNeYPyk0rzMp1TSZZLKVfiUQ
DiK/RkTNfAJTH8sfz481fkXq8djrcklzoJYR8pDX274gsJ6YkP2G/Lr8w9N/MPS4
dY0mVW5qCVDAmpFemZMJW67PgMHoOWOO7FXYq8M/Pr869M/JTy9N5g1RgZ+J9KOo
qx37fPIyk3Ysdvxx8leXtX/N/wAxT/md+YjFrKd/VsY5NwFrttmNKbtcGEl9CMYe
Tac59OVTSADZOOYxLtsOJIbzS7u2m/S+icfUQUNOtcAkxzY6KBt4tY80SFdaupow
vYMaZAlshBH6fodlYTsbt2fgOVW9sqkjJFKfMetwakEhgoaNTKwKddMFK/0Y8csU
tDSoPTLAWeOBZlqWsx6SILYgerckKlfHL8TmCJHNC2vmb9E3q6dICLqU0AbZMtac
kGEfmv5AhmVdU0thHrT0ZDB0qN9yMnGTrc2EvsH/AJw4/wCcgH1mybyF52mK6pan
04gx3YA0y6E6dfPGX6Iggio6ZkAuO3irsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirRIUFm2A3OKvz3/ACbt5/MH5x+Y9Q1i
L1LSKV/qzOKgdemKpH+W4t/y2/NDzHq35iBka4ui2nsw2C17Yqnn/OWfnO0/NjQV
/KXybW5vL6SOUyKK8Qhr2xV893mvnSfza8m6L5tVTpGlabHBM3YOg74q+x/zm/OC
w1/QJPK3kgme9uiIgtP2TttiqI/I26tvyX8u2/lPzefRu7qb1VAHeTFX13GwdQ6f
ZIBHyOKr8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsbVommC1aV
eIoK/TjatIQRRa098bVfhV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KvFPPxQ63a+qCQI2FB13GAi0xNG3xTpWpWv5a+dpkskZ
lu3LupG+/XMfJiDkxym3uF3dWN4x1bRiI4nqZBJtueua7LhDaMpSiFopZOEMilOp
ocx/BCfFK+4ijuXFpYuvqnbrk4YQwOUsz0/8mtEubVtT83SBXC8lIIFMyoYRbUch
t4G1jDdeYDowmV9FjaimtTSuW+AGXil7N+YmvaB5a8sS2OitGXWP4OR74PAC+KXl
fkPyH5f84eW5/M+j3CJrdupZ15ChOHwAg5SnPkfXrG/D6Jq9wi6kh4p8QpXB4QDL
jL2/TLC40iMtd3MDFvsDkOmDwwvGUp1iSHy/FJqErerI6sfh37ZreL1ORezxryHr
P6T1SeW3BSpYEH3zMxlpm+i/yqSCDU5oYQfU4kk5n4y40w+hMyWt2KrWYICzkADq
TiqmlxFIKxurD2IOKqwNdxirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdir5A/wCcovz4tvy70KXTtImH6WmqiLWhB6ZTOTl4
cRG5fmF5M8pX/nm6bzL59eSSYOZFDGoodxlEi7HFhBO71rUJ3MkOm6Jxh5kIePw9
Mp8MOYdOHr/lr8pdHjtZ9V84XCvxXko5VPTJDGEeGA8V8z2+jXWpQx+T+aRRH98T
sD8smMQYHJTWr6vNpcJgjrJK392V3AHvkxiC/miHjfmfzFL5i1S00jSyyRcQbmv8
48Mn4IU62SZ3Hm/Ur+9g0bXAiwQ0RCnUgeOYxFNI3NvadQ1lNBsY1jI9JlHzyILm
YwEruNI0vz7pj2k6D4QXDUqa5IFnKApKPyJ/MjVfyf8ANi6beTN+gpHEa8228MyY
F1eoi/avRNZttes4tTsHDwyqGBHuK5eDbqJRpNsLFomm56Yq/Eb/AJyX843/AOcf
5lw+UI29TStJm4SqpqpAPcZjSm7TDiZuNOWVYdG04enZWw4tx2pTMUzdvhxhjHnm
4uFsClgQJomCq3emVcTnxCh5e1g2uo21rKWeBogZD1HLIyk0aiVFna3EN/dH0poo
wK0FQMDOEks1SzlWOR7hg6MCAU3wiNolu8qn0ia0WKayDNN6lXrvth4HF8MF6rKs
k8FtJEoBBHqV8MjwOdg08Ul866WL57O8jYGOBgw45diFNmsxCAFJ7o0GledFksdb
Iikj2ikGx+/JE04RFpFqmkXXkiX1DMlxZ9ix5GhyPG4+TEHkXms3PkTWrH8xfKJZ
LjkjMOimp3rlsJW6/PiAftv+VHnaDz35bsdbgkDzPCnrUNaP3zMxmw6qcaek5Ywd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VWSRiVWif7LAg/TirFtF8k6R5fuZdR0yAJcTGrv3OKsd8+flLoP5hywXeuxt69v9
l0oD9OKsf8vfkpoHkL6xrOiQtNfiNyjS0NNugxV8xfll+RVt+aVxq+u+f0dLlL0i
JlFCBU7D2xV9R6J+Q/lbQ76HWLaF2uIFAXkajbuRirJ/NP5aaN5vu4NT1dGM0FOH
E0G3TFWewxLBGkEf2UUKK+AFMVVMVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVYV+YHm6PyTotzr0wr6SMw+YGEBBfnin/Oe
dw8UhS15yJIy/CtRQH5ZCRpkGov+c6tRkjEv1I9d/h/syo5GwRUrz/nPK+tkFwLF
/THX4P7MY5EGLA7D/n4jrvmC6ntvL+nNKsB+KiVp+GXx3aynq/8AOdHnBv8ApUv/
AMiv7MJQF/8A0PN5w/6tL/8AIr+zAl3/AEPN5w/6tL/8iv7MVd/0PN5w/wCrS/8A
yK/sxV3/AEPN5w/6tL/8iv7MVUp/+c5vOKxST/otlWNSxJjoKD6MIVvyv/z8Kvdf
tv8AeOtyCVYKvh9GRma5MWV2n/Oc945lhms35KKj4f7MxZZCGVKaf85034Whsmr4
8f7Mh4pSA03/ADnTfsCn1Jh7hd/1ZMTJZcK1f+c579RwFm59yu/6smZ0FMVQf851
agNvqLf8D/ZkPFLGlrf850ag44/UmHuF/sx8QrS1f+c5tQQ1+pufmv8AZj4hWl3/
AEPRqHLn9Tb5cdv1YPEWmz/znTfnc2TADrRf7MIyFaYVef8APxHU2v20zT7Asw2A
4b/qzLQjn/5zp84BSU0lyQNv3X9mKui/5zq84SIC2kSBu/7r+zFVT/oebzh/1aX/
AORX9mKtf9DzecP+rS//ACK/sxVqb/nObzl6qxwaS5Ujf91/ZgRanJ/znT5yKFYd
Jf1AenpdvuwpQ+m/8/Eb/wDTg8qapYsl2Y+ZXhQ/dTI2yAZjH/znTqLFibFuIrT4
f7MBky4W1/5zvuYY2nu7Ngqgn7P9mDjSIvqr/nHz89P+VzW816qhFQVC9xkwba5D
d9L4UOxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvFvzGmbSb+DWuNVRCPwwSlW
6QLL4Vv9XtW8+Ra/rRDW3Tj88xcmoBbhjL6Hv9K0HzRaC20q4WDl8VC1MwMucNsc
ZQWnflutSNOuVMdKVrXfKPGDLwir6b+UWp2+oDUVnBjBr1zJxzDWcZUPzX0XzFqF
p+j9JmIBXieJOZkS1nEXz/D5A1nyzZLc3jM0z13rvkvEDHgKIuPIVz5sWysb2Yos
xo3JsByBPhlmnl78i7n8v7wi31BRYTH94vPahyJyhl4ZTSX8idHl1NfMFlqCIQan
46ZA5wz8Mss/wQi3KXE2pK8CClBJkPHCxxG2XafDpulW0reYJ1lj4txFa7ZqJS3c
vo8W0K+srzV5V8v/AApyPTM7EWiYfWf5ZW8ERLn/AHoK7nNhhO7jTD2XMxqdirxT
/nIDWtY0LyTquoeWFZrxLclOPWuKvwcsP+csvzw8u+nI9tctEpPUHxxVmNr/AM/N
PzQ0tvq+paXKwXYsY/7MVehaJ/z9J12oOtae6r3+Gn8MVey6B/z9M8r1X9OwOh77
0xV6rpn/AD87/Km9AWeSSOQ9uQ/pir03Rf8AnPD8stbp9XvONf5mH9MVesaR/wA5
KeRNYCmDU4F5Upycd8Vek2n5ieWr0A2+qWjVFf70fxxVN4/M2kzbRXtu3ykU/wAc
VTGK+t5zSCVHJ/lNcVReKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ksb
81+YYfLOmz6rdGixRu//AAIyMjTPHGy/Djzfq0n/ADkD+YlxqiSN+ibZmpvVaqcx
pl22CNvaLe7s1po1qVEkSgNTwGY1u3w4+qR6noszSC5sTupqDlgyByZlYuieYtSB
kuLulueq8j0wxyB1+UsK8/eZtJ8h6XJ3vCB33JJzIhMF12UvadNj0Hyz5Cg8z+YC
sl9qUPqQV6rUZdEuLLd81eVvJeueetTbzB5fgZLWJt2K7HfLaaeG30A35DXV6Uvb
gUnAqdh1zCljNu0xjZ5X540DVdIl+q36t6Cd+1BkDCm4TphOj/mEmmXL6VamjBDX
IgJOcKl3bv580+RbL4bqy5TkjrtvlsZbuFlnb9Hv+cLvzZj80aCvle8krd21VPIk
n4R/ZlsZOvnAl915Y0vK/wA7PNX+CvJOseZw3BrS3Z1Nab5CfJsxDd+H/wCTt5cm
18wfmhqI5XGoMZIGbfv2OYGUu708XtWm6xf6XJZR3vXVk9QfTmMZOzhsyOfRYJpz
FfH4WqchxNwkEhmtrbQbOaWNSyciOXgPngu3F1BspZH5PstY05tatLrjKDXjzy6A
YjYImy1GTTtL9GR+bcuIJNcyOBjPMArW1zcWEBvrniyvsABhlBoGpCZ2HmCKeE2t
yvEybA4OF2Wl10U0FpZafaFbp+RcbCuIDZr9QJgUk15oNtqtqp8vycLlB8VDTKpG
nExm0jj8tahcUs9Zl5r865TxOR4dpj510CG70oaPGKuq/D47DLscnD1OOnvf/OAf
nV007UPJ+qyEzx3BEYJ7AkZn4nQ6jG/SvL3DdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirunXFUul1ezgPGaZFPuaZWco
TwoF/NGkISsl7AvzcDB48U8JS2w1vy9p3NLS9tV9RuRAkUVP0YBlHeik4XzDpj7p
dwt8nBw+NFaRsWoW8+0MitXwOSGQFeEozJodirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir58/5yXIXyVeE/yN+rIylTGT8y
/wAh/L2j6lps89/b839V9yK5h5J03QevDyjp9xWOztQF90GYviOQAoa35Rsk0qe3
aGPmq/yDDHJuiQSj/nALyppera15wh1a0il9B+K8kBpU02zOxSHNxZv0xi/LHyy6
A/UIP+Ra/wBMyBK2EVT/AJVb5Z/5YIP+AX+mFk7/AJVb5Z/5YIP+AX+mKu/5Vb5Z
/wCWCD/gF/pirv8AlVvln/lgg/4Bf6Yqxfzx+WPlqPy5qpSxhRhZzENwXaik+GAq
/IH/AJxu8s2N3eahJcohjWeYCoHYnMbLNlT6Zj8maWZ5rgRR8afyjNdlyMxBdH5P
0p05elH/AMCMxvHDaA0fJ+ldPSj/AOBGXwzBmINf4P0r/fUf/AjLpZNkmDv8H6V/
vqP/AIEZV4oYcBd/g/Sv99R/8CMfFC8Bd/g/Sv8AfUf/AAIx8ULwF3+D9K/31H/w
Ix8ULwFx8naWVIEUdf8AVGGOXcKYvBPy/wDL1lP+af6JuYUaH1AKFRTN24j9h0/L
DyxCFUafBWgH92v9MVd/yrPyxIxT9Hw1H/Fa/wBMVb/5Vb5Z/wCWCD/gF/pirv8A
lVvln/lgg/4Bf6YqsX8svLMUoIsIeVP99rk7NILUX5VeWopDOLCGprt6a5AlX4//
AJt+XNOsv+coYtDtYES0awLFQoArTMacqbIh77L5Q0qOMkRR1qf2RmHPMA2hinnP
ypplvok1xFFGG4H9kZTLUAMqZz/zgUpGoasFP7sL8I7dc2unlxRtx5836d5cxdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVeW/m9Yy3Xl+4lslLXCD4QPkco1Mqgab
MQuT8ndQ0u+m8zRwXNwJVK8mRTuD4HNGc0qdhwC08u2v0l+uWdwYVjPDgWIJzHlk
LbHGHoGkectU02AJFOU70YmpysTNsuAJ+Pzv1y2H1bkSOld8zMeXzYHGE/0n83bu
QhrxwwPUHM0ZhXNgcT2CPzPpvmO1gSdVJruAMqOY97AYwgNS8vx6mCdKHptBuhx8
UrwBims+UNclgWKWct6o3ofs5EzkyEYvLdS8j68imyspZKn9oMcqOQshAJDP5e17
RIDDczvKx3oGOVnMWfhhjY1DVJI3j1C65KAQF5Gvyysc2BDJfyeuxbai/q1Uk/td
8zIENE33x+XDoblnZhyZdhmwwc3GyB7Xmc0uxVDXlnDqED2V2geGRSrKehBxVgcv
5UeVp4xby6bAUXp8C/0xViV9/wA44+QNQV1uNJh+PqQq/wBMVebaz/zhZ+XOqqVF
gqA9gq/0xV5DrX/Ptz8ttWqwt2Vj4cRiry3Vv+fVvka4JmsldXHQcxiryjXf+fX0
9tUeXLmSKlePxjFXlWp/8+5fzOsuQ0jVpFp9n950/HFWC3f/ADhh+fvlmskWrzSA
dOMh/riqTv5G/wCcgPJ/x+vdTFPBmOKr7b88/wDnIfyiT6VrePT2Y4qn9j/zn5+f
+iMINU0m7ZB3KMcVelaZ/wA/LfPsCAazp8qP35K2KvVdB/5+raRp3BfMFhJy/wB2
VLUrir1rSP8An61+WmokRywyRuevxbfqxV6zo/8Az8K/LTVqf6UsVf5n/sxV695e
/wCcs/y418gR6xbxV/mfFXp1r+cPkm9Aa112xcHwmGKp7b+e/L13Q22p2z16cZAc
VT+21G1vN7WVJP8AVNcVRuKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV8Sf85x/mMPI3kr0rdqT3jm
32JrR6Dtlc5BtxHd+fXkHy4fJXlsTg0url/WLnuH3pXMaUgXd6eBHNk3+Hruwih8
2h6rdPwI8MolydtExA57stOotbwzQL2SvLsMwhOTWTJ59JrOoI8At71GiY7qDl0Z
Fwslpb538mWPmLVNJi1dT6Ep/eOfs7b5k45lwpjvVbSxufzI1+H8tbQOdMtGEccw
PwIoPftmTGbVwAmn6IeTvLlt5Y0n/DWhenE8A4SSFR8RHcHMiOQtw0/kyBo5Ayyk
A8BRqDrkjwtvLYMV83eWNO88WklsY1WZUbegrlUwGMuJ+Rf5leXJfKHm02FjG0sj
uV4r1pXKeFxJZHsflDT7nyrcO93C0f16IRsrdgw64KLHcp/+QWozflt+ZsmnK5Wy
uGHFq/CS2WghHB3v3BtpRPEkymoZQfvGXW4UhRfGn/Ocmqm2/Lu/0lH4m7j40r13
yrIXI0787fI9tYn8v9O0Sa5itZBFQs5AzX5Cbd3g5Msisr7WZdPvZpAbbTE4JIPs
sPEZiStzgziaaGX/AEi7B4j9rI0VlJLJdR03Vo28vQuohkqWY+OWY4HuaiQebA77
Rl8vobay5zRs1fhO2ZcInuYSnEdUh8z30VvpSx2cypPy+yTuMyYxddqM3cWA6R50
vY5W0/U7lHhjHIGvXEh1hyzZXbee7XUI3EETSTQitF65WW/FqMgZNLrT3r6K81vI
kVxLScmtEHicrLsIZpz5sj8uT/V9f1W0tlYWwP7hz9lvllU7Lm4jRTXWNfOmTJIq
/WHH2kTqMx5AuwjOPemdreprY+vwnlwRuSDqu3Q5biBacxiQlH/OJOovB+bR0qE0
hk5uwHStc2WN57V+T9pcyHWOxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxVZJIsSmSQhVG5JxtXnXmD83PKPllWOq6taxyD9gyCuR4wr5
T83/APOeHlfQLiXTNOtZb2VOkkRJQ79tsByw726GInd4Frf/ADm75p1oMPK9nJbk
/Z5qcgc8e8Nng+Tya6/5yK/PPU5+MV8sds53FCNsplnh3r4R7lKfzf8Amnq55Xmo
9etCcplmh3r4Z7kJe6Z5vvFEl5eSMx68XbKjnj3o8Moabyp5jPGeK9lVgOhkb+uQ
8ePenwyrWg8+WJpaXzgDoS5ywZ496+GUfL+Y/wCbOiilhqFSv2dz1y6OaHeF8M9y
O0f/AJya/O3S5Q2s3Szwg9Ap6ZdHUR70eEe57Nof/Od2q6OyR+adOmmA+0VBy3x4
d4XwfJ9H+Q/+c1PJ3nGUwXoOm8erXDUB27bZPxYHkWqeMxfTegfmB5d80AHQNStr
ontG4J+7HjDWzDJK7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXzz/wA5M1/wXd+HBq/dlOa2JfnT/wA4+ykaVOq7AyuAT45r88i3QD2u
H9IwtWKZQhO49swTOnKASbX2lW2uJi1QF3yUJFjNb/z74f1Nf85Gn2pB/wASGbPD
biyfqLCQaoBQDMvGNmAVqDLEuoMVdQYq6gxVhv5iCvljVx/y5T/8QORlyTF+Lf8A
zjpIA96iqd7mb9ZzBzW2gB9TNwiIjAJD7HNRmm2AKhhjiPpruBmNZbRFSMcdehzI
gSGwU704/A5dKeyTVN+lH4ZTxFhQd6UfhjxFaDvSj8MeIrQd6UfhjxFaDjHGqswB
qBUZKEjxBBAp4B+XHJ/zYE7Hf1BnS8Qde/ahmHFXYV6YVVFAPx0oTiq+gxV1BgtU
NIBJU0+IdMtiaY7ogdKd6ZVJIfjH+cYST/nKqFHG/wCjT/xEZg5jQbIvc/RjYMs1
VFT1zV5ZFvESxDz9GqaJKApMfA79sxZGRZMn/wCcDwBf6sYt4+Ox+nOj0N+GLcbJ
zfpnmUwdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVQ15CLiCSFhUMpFPmMpzw4
okMoGi/Knz55IufKH5oxvCh+p3EbyMe1aVzTyjQdjGTDZ7mG/NzK320mYD78wsjf
DdasvrR+rcbONh8sxpTcgQRVjaS6g4iiGxyslXq+keQYxF6tzsxG1cRG0cTLtO0c
aUtf45lwDXLZ6l5avS9EzOxuJMs9KKVKtT4syWpB3FpHbRM5A+7MXK24y8i1REnn
bp3zCmHMiXmU3lC1a8LW9uZwas3HCeTTJ53rHmLRvLusx6exW2mqBRtt8ljBa5Pq
j8t9fS51GJY5g8bItKZutK48n2KrcwGHQiubBw12KuxV2KuxV2KuxV2KuxV2KrGj
VxR1BHuK4qgJtHsrjeWCM/7Af0xVLJ/KGkXH99aRGn+Qv9MVSLUPyu8t6kpS5sYS
D/xWn9MVeR65/wA4neRtbYyTWaAn/JX+mKvOtX/59/8A5WauhE+njmepFP6Yq8m1
n/n17+Wt2GbTYPRc9DX+zFXjms/8+rdNZiNNuTGvY88VeXaz/wA+nvM1ySPL/mD6
uO37w4q861D/AJ9j/mv5VrNZ+ZZJVHhK2KsVn/5x6/PXyUTBp17czrF0YOxBxVBf
41/5yd8lnjp8N7Kq9KBjiqY2/wDzmH/zlJorBdS06+Nsn26o3TFWb6Z/z8e/NfRi
G8w6XcmMeKtir07R/wDn7vbaNT/E+izMf2vtDFXo+kf8/i/IGpHjNpNxCa0PJj/T
FXsvl7/n5v8AlvrnH1CbflT7bdPwxV7x5d/5zR/K7XFVpNctoC1NmbxxV6ja/wDO
QH5c3tPqvmTT3r0Al3xVk9n+ZvlXUKfUtWtZa9OL1xVlVlqtpqNfqMyS068TXFUw
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtE03O
KvyJ/wCc7tYHmLXrLyPueMqyU+7Nbm5stGPUxHzRaGHSLOyi6JGlfoGY0Bu9gBsG
fX1tGfItq6uPVVq075lAuszR/ehhnll4rq0nh1IV9VSu+U274limoeTba24fo0EP
XxyQLhZ3nN35vljuZNJ1xuQhNIq9snwulzS3fQX/ADiaVvZdXueIKCQ7nc9fHLBG
2vHLd9qywoHFvDsX3y+EXd4Z7K0zTxUSA1QChzHA3cLEbyKMJjRZLhP7wIa5lxFO
Zl5Pz61aXTm/NKO51oqIzIBVqUrXG3mpR3L178+msbfUrVtKK8HVAONBgJdjpR6X
zV5vkfy35h0a9k+EPcLv45jZDsnUx2fuD5Evf0holpd9eUan8BmTh+kOl6l8cf8A
Od1uJ/Ldtt3PL5VOOQOTgD4M/JLR9C812Mlj5yFLaAER1NK5iZA7rTsx8oXj6le3
3l6FvT0m2k4Q16FfnlJc0STTzpcfoSD6tI3KI7A+xyTTkk8uhsxBcpaW7H98PU5V
6ZlYy0lkSanPbv8Aoa1HqTv8II98tu3WaiNvT/I3/OOs2qynVvNQPpyioDHxwOJ4
LNfMf/OL+hJZmTTlBnI2oRgLmY8T5VufJEn5a311cXilVIPGuY8ot1Unlz5jXQtK
h1jzHT6jebRkjb6MjjbtLk4bZ/oM9pc6fHrdq6/V0FY8ZFvnK2cfkx5ag1FdZ17X
YixYs0PLw9q5HhRDG8o8vXS6fd60bUUQytt4ZbHknhTX/nFTTpf+VvQ6hbisDI3M
jxJzIg6zVF+1GXOudirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdiqW6rq9nolu1/q0yW9sm7SOaKPniAr40/Nz/AJzd8peQOdp5Zprt3uoS1JPE
++QOQBsEHxFr3/OQ/wCaH5sztFoN0+ladJX4HqKA5jZtUO5uGJg4/J681O4+v+ab
x9SuGNWVJDvX6c1WTVDuZfl7eh6P+WOmaWwl+rNH/kNuRmrmbNuywx4Y0ze28sRy
MDaoEA9hkKbCU6MENmRDJB6snYADIGCDJWW0Mp2gMJ9xkaYFEjTXUVqG9gMjwIUJ
rU8gGiIPjTHgW1T9HgipYfKmIitoZoo4T8VoZKdSBk6ZArLjT49SH+ixhPoGSEKZ
cSQXvle3dfSu4w5PsMNJBYFrP5Q6JqMZN4hTl0o1P1ZfgnwlxtVj4gwOw/LvzN5L
ma+/LbVjZSg1ALk/xza4tSB0cP8ALl6h5X/5zB/Mj8p5K/mTBca/ApoPRBrTNpi1
II5NcsVP0C/Kn/nLPyT+ZNmlzdXkOlXslKWd09JP7cvjK2kxp9O21xHdxLc27co3
FVI7jJFgr4KV2FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+e
v+cm/wDlCL3/AFG/VimL85PyG/5R8/8AMQ/681mob4vcx9s5qsnNvSLXP94Lz/Uy
/C1zUv8An3f/AMdnzh/xkH/Ehm7w8nFL9So++ZEmEVXIsnYq7FXYqw/8wf8AlGdW
/wCYKf8A4gcMeaQ/F/8A5x0/vb7/AJiZv+JHMLVsovqZupzn8nNyAo5bhbWx1y/J
yQV3bMSPNCzLmTsVdirsVc32W+WGPNEuTwL8tf8AybA/4yDNxFwX7T9l+QzJihVH
U5NW8BVa2VSVQ/by2HJkqn7WS6NJ5vxm/OaN5f8AnK2BYftDTK/8KM1+q5N2Lm9v
t63Ucn17YqWpmqlzdgOTEfNwuX0O4Mv+8YRq/LMrEWjIyP8A5wMuIZdQ1ZLRgYQv
wj3rm3hycUv05yaHYq7FXYq7FXYq7FX5G/8APxX/AJzJ8wfkOINI/Le+WLUCQHA6
jxrTFU4/59+f85ga9+fAbSvPt4sl+FqARQk0xV+rWKoM6haiUWpmT1j0TkK/diqJ
MiKwRmAY9ATucVXk03OKpbZaxZai7xWM8crxmjhTUg4qmJIAqdhiqhJdQwxmeSRR
GOrV2xVfDPHcoJrdg6HoVNRiqDl1iyglFtLcRrKxoFLCtcVTHFULd31vYr6t3Isa
9uRpXFV1vdQ3aiS2dXU+BxVXJCjkxoB3OKpeNVtWnWzSQNIwqKGuKpjirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdir5q/wCclLex0ny7J5qeMfXYisaN
3o22YOoxDo34p7vhHVtEGmWkV6PtXAWUj575oNRs7XAlcxF+gmg2oKEZrzLdzhFH
+U9dXSrxYrod++XQFuPl2fTkN1+lIY5rX7IodszY49nDOTdWuWMgApjENsyzLyta
0+LrmVBxZM6ZS0iqNhl1lqQvmRvStyoPbKcjbB4vKCrl2OYsg5USnmmQy6haS3ti
v1LgrAsf2vfDIbMJPmeDyXpPmLzM8/mBRcyBjR698F1yai9Ih8p3nkjzBD5j0255
6X8KiAdqZudJJom/QDyzrUWuWMV3AQTxAYfRmyIcWQZBgYuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxVxxV2KtMoYUYVHviqj9WhpxMa08KDFVJtPtW2aGM/7AYq
keoeTtK1JWjurdCjdV4rQ/hirz3U/wDnHzyNq4432mRsPCg/pirAdQ/5wu/KLVa/
XvL0Lk+P+1irzbX/APn3X+TuqHnYaLHbNT9k/wBmKvCvMv8Az638o6kWGkUtlNaU
b+zFXhGu/wDPouZ2J0vVyit0pIdsVea6r/z6d85+Waz6N5ikmbqAJGxVhlz/AM4f
/n15Nr/h65uZ+HQqzGtMVSNvLv8Azl95OYvolvfyBtjxDHbFVSH83/8AnMTyw1dS
tL8Rr15K2Kstsf8AnO788/Li+l5lsblpB15K2KvQ9J/5+2azoQWHXtDkklTZyVbf
FXqOif8AP4/y7essWo6FJE3cjkP44q9p0L/n6N5F1ZlFzAbZW6s5NBir3Dyz/wA5
7flNrdFvdct7Vj/PX+uKvWLT/nKf8qL4BrXzVp7VFaczX9WKsl0/89/IOqAGw16z
kqaCjn+mKs+07zNpWrANp13FKD04tiqeVB3HTFW616Yq7FXYq7FXYq7FXYq7FXYq
tZgoqxAHvirSSLKOUbBh0qDiq/FXYq7FVkm6N8jiiXJ+Ln/OU8yj83IhLv8Au9vw
zX5g26L6k9vbRr+zVDs5QUGYoezhGwwlrXWWjj0Zmb0Y35Ee2X3s67PD94zy1sor
eNeY+zucoDsOJCavPGlpPfWv+6hXLohoy8ny7rvly6dX8x6gD6c3xR175cA6PO9t
/wCcWPP9l5euLvSr6ifWW2r88vjFxoSIL9F7ye0uzBfaY4ai70zKjB2uLJstdJLJ
PUlNUfc+2YojujTn1sD/ADI83af5U0Wa+tZA05VvhHXplpc2fIvyM8067f8AnbzA
l9ZApKlxyqK9K5US8+Y7l9OeYJLi7t9NurpizK0YNfbIGTtNJH0ME/5yMvOFx5ak
h2LXSA/hmPI7J1Y2ftn+UZJ8qacT1MK/qGZmD6Q6GQovG/8AnMbQRqH5a6zqkS8r
m1t+UY9wcnIN2A9H5e/lHaWvmfytprQn07lIz9ZHete+Y0w7XDJnseiPdatB5f0F
vTaQEsR3plJDliTHIpZPM+p3HlrU32tWZCx8RkQ1SlaHstFmGn3SxtW7ikKRt/k5
YJIHJ6z+QnlJZb/615hHOYEFS2WRlbjyhb7ZeSYv9Wk+G3VfhGZAZwwA9FJGjt2S
aQ1UNWmSpyfBro8d/PXyRb+eNKuLvT1CyRR8jTKZxcLOOF8i+UfIr/n7pLflpX05
tH5UbpWmUHZw4ZCgNE8r3+hR3/kIOS2mDiffA5uGdvb/ACj+cOleW9Ansb6EevbK
UII6k407SEdnkAuobHRNW8yS/CLxy8a+AOTiGrKKD6Z/5wD8pSXdlfecNTQib1iI
ifAnMmIdJqZP0yyxwXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
YqseRYlLyEBQKkn2xtXyh+dH/OWflL8sLSVdPvYb/Vo6qLSOpYtTbESjW6CD0fmZ
5i/Mn8zv+ci7tm1eaXQvLbN/cvUBlOYWbUiPIt0IFlHlT8o9A8tET2Np69yR8c9a
8j475p8+tPQuVjxvWbPTYrZeH1b00zXz1Uj1c7HjCLgsI45PXsXCSV6ZSZyLlxxR
TOWO5DfWbscye+XQiacfJsaTOHSGvY/WimEI+jJGLG0tudW0rRgV1G5VHH+7jT4c
eAliZMfuPzT8i2O+reY4B4k4fBPcx40nl/Pj8sIjS38x27N8jj4Eu5hxoR/z9/L6
v77XYAvjTHwD3Lxq8H56/lZP8J8x24f5Y+BLuSJhkVr+ZPku9odM1+GRT2Hf2weE
e5lxspt2stdAOlXCx/Km/vg4CyEmrmw+o/DK3qt44RBlxJVPppuKPcp8A+yPHK8o
I5NuICXNLJ7cqQsVqUH8+QjlkGZhFA32lQ3MdJHErfy0GXw1ch1cPJjDxDzH+SOj
6hIdRsk+rapXkk4YjiR06e+bTBre8uFPGyHyB/zkp+ZP5EX0Wl+eRNrugIQiSCtI
1J8fYZt8WeMurizgX6mflh+f/lD80beFtF1CH6/IoJtSfjWvbMgyHRrAPV7cCCKj
cYpbxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV89f8AOTX/AChF
7/qN+rFMX5yfkN/yj5/5iH/Xms1DdF7mPtHNVk5uQkWuf7wXn+pl+Frmpf8APu//
AI7XnD/jIP8AiQzd4XFL9So++ZEmEVXIsnYq7FXYqw/8wf8AlGdW/wCYKf8A4gcM
eaQ/F/8A5x0/vb7/AJiZv+JHMLVsovqZ+uc/k5uQFHLcLa2OuX5OSCu7ZiR5oWZc
ydirsVdirm+y3ywx5olyeBflr/5Ngf8AGQZuIuC/afsvyGZMUKo6nJq3gKrWyqSq
P7eWw5MlQ9cl0aTzfjH+dXP/AKGttxDJ6bfoz7X+xGa/Vcm7Hzev6/dPpOmzXKL6
8q8moO+aqXN2A5Pz6/MD/nOh/KsVz5K1TQWdW5R8iD8szsOO3HyFf/zjb/zn95d/
J+a7nv8ARmAuAdl2Ir9ObSHJxi+vk/5+3eWCFkOjSFW6UJr+vJIfWX5A/wDOXSfn
xdejo+jSwW4Pxykmg+/FX2nirsVdirsVSTzJrcPlzTLrWrw0it42c19hir+Yf8wt
Nb/nLD88r2xV6aXCzAVPw1B98VRX5avJ/wA4u/nrBo6sf0dK6JUHbwxV+wv/ADmh
/wA5RSflL5Dh8weU5eN3fICrDqOQ6Yq/KP8AK/Sf+cifzdgb83ND164hs4i0qqC1
KdemKqn/ADjt/wA5Hfm35g/OmDyl521mW4hgn4srVoaGmKvtj/nNv8xfz+1LWbHy
x+T2nXOm6O1FuLxa8XB6nFXw/wDnNov5sf8AOOegW/5h2vn9pr2XhJcWgYkgncg7
4q+zPLP/ADlZ5n8//wDONl956W4ZddtBwNxvUkDFX52/lh/zkP8An5+c1pJ5R8rX
FxOfrABdeWwrir7Y/NX/AJyM89/841/llbeUNQvXk833bhADUuOWKvDbH8rv+ckP
M3lT/ldT63cxgA3H1erbL1GKvqX/AJw5/wCc3Ne1/Sde8s/mFI02q6Rbs0bNWvJR
TFXxPZf85E+f/wDnI/z/AHnk2782NoFjDKyxyOSoUA9cVfRX5Ear+eHkv8zovJ8V
9N5p8t+qA18hJUr44q95/wCfgn/OYWrfltFafl95CdodXvKLMR1Unt9GKvzw1XVv
zr8teVx+aB85SEpxkNvyNR3p1xV+tP8Az7//AOcpLr89PLZ0zzVcetrNsKcz1anX
FX6NYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXjP55+Rf8feW5dJM
vpBD6tfHjvTKswsJjzfCVy667bH6yPSudPX6stv/ADhRTlnN6rG7fTzee2zGy5XE
q8W5cfTzVSju7ISQOqWTX063MI4DrtmXgDiZpPqH8oeWoxnTjvxXc/RmxB2deRu9
UuPKqmT0RJ9OR4W+RZdpegrpCchJzrlsWophxQyK7nivc5PiQxrzEXuCQm9uvV8h
IJD5x8x+dI7a6/ReiJ9bnJoQO2Q4LbBJN7zW5vLGhO13cF7ibf0D2r2yM47MywTy
rbpqQa+jPGZmrQe+UHZqL6J0mwS60q4s7n42iiZw58QOmbPSSaZsh/5x/wBSmuop
UnY8Q7KF+WbwbxcaT6dytrdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdiqEu7G3vk9K7jWRfBhXFWB6l+UflDVzz1HS
baRvErirB73/AJxb/KzUam78s2LM3U8DU/jirzjzB/zgr+UWsoVt9At7eQ/tIP7M
VeA+Yf8An155E1gMtpMbdW7KDtirxXXf+fNvljVSXtNfmtz2opOKvMNV/wCfO1x5
f/f6N5mklXt9pf4DFWBaj/z7o/NDy6xbypqU88a/ZKs3XFWGXf8Azjl/zlf5ZYjy
9Ne+mnTizYqpw3//ADmH5R+HUHv3t4/tqeRBGKpraf8AOU/59+Uj6+rafcyoOoKt
irONL/5+vedfKZEWveV5JWXqSjYq9E0n/n8q9yeGoeVWiPjR/wCuKvXdB/5+x+W9
Q4/pPT/q9eteW344q9v8v/8APyb8rtSUNqd+lsT1B/28VesaZ/znR+TWqlVt/MUP
M02P+3ir0PS/+clfy+1ohdL1aKbl0oR/XFXpul+eNF1gqun3UchboAw/rirJGu4E
PFpEB8OQr92KvDvz/wBP1a88pX2reWLxra5toS6BduVO2Kvyh/KD/n5lL5R1IeQ/
zIsvSMDlJLlhu29AeuKv2K/Lf83PLX5p2Kar5TvI51ZalQwqPorir03FXYq0RUEY
oIfjV/zmDpf6K/Mu28xTGtoQF5Hpy22zEzxps0X1JjeXUUqQXfqekqRq3EdxTMGq
e6w8gkF3+YGnrP69qwd3+Blp098nbgan60ZL5nsbSB5ZHD8x08MqZCeyX2urWWu6
ZdaTE4jM6lefhmRFZCwlGp6lZX+j2/lC8AWSyXiklP7zLoup1EHkjeSOc63umzG3
u4T8EY/bzIiXX09v8ufmd50/K63Fxqukte2xFQzGtO+ZEcjlYzQTJ/8AnMK4vbeT
RbrTOFzcH4Nt1r0yglu00vWxwaRqGsRNrHma6MdrL8QiY7UOAzdlIWlP+EtO06Ft
X0ijybgKO5ygzdMQitHg1TXYYbTVrY20UclVc98gS7LSj0sM/PuBdQvfLuk2w5Sw
3Sn575A8mGsPpftp+U0Elt5XsIbgUcRLUeHwjM3APS6DJzZN5q8uW3mzSrny9qAr
b3SFH+RywhYS4Tb8MfJESflz+YXmPyDqo9C3E5Szr0cV7VymQdhjmyjUdVgt9dGu
aZd+j9RJSQL3JyiQckTQdl5ImvLK+1PT7wtfXsvqqw60OUkMwLR8Ua+SdPNnq1zz
uH+IyHqD4YE8n0P/AM4+X9trTs4YSUH28tggF9DtMTetEH5xqK08MzIOXArBGLx+
cW8QO+WuQTtuhtTCrZahFDsvomuVTdVqg+Dfyy84N+W2va3r+nLycBmYDvvmNMW6
WZpLfy681zectd1zzawos5LSL4ZGnZ6IWypPLWnz3LapcQBrZjV17NknfQFPHfzV
vpNeurbyB5VjrcXTp6cK/wAtd+mTiXB1eTo/aL8kvI8XkTylp2konC4+roZh/l03
zIiHn80+IvXMk0uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KoDU9
UtdGtpNS1OVYbaJSzuxoABkZSpX5Jfn7/wA5eav5/wBWk/L78oYnNmrenNqEdfhr
sd8xpZmfA8X8r/kzZ6Zcrrnmz/cjfykOzuTUN9OavL2h0p2kdJtzfQ6xJPAtqg5W
6igj8M1OfVX0ZjT11TK1tRAgVz6KE0X3Oa+U+JIjSerp10ihtQHGE9GJ6jLcWMFl
x0w7zL558ueTUMmrzLFTvsc2uHSWOaRqa6PEdR/5yOvNQla08iaWdWjOyEKdzl3g
8OzRPNZtJh5O/NT80XH6SE3lm1b9pa9MlwgMTK2f6J/zhnqa0n1bzZJqUJ/vEYmh
w82L0fT/APnEDyfyrq9vHdL4MTh4Sgsxg/5xR/K6Bf8AlHbct41w0e9Gyof+cXfy
0b4ZNAgI8K48J71tA3X/ADiR+V06/udAt43/AJq4kHvViF3/AM4eeWByGj8bUkfB
xJ2PbBwsg8x1n/nDvzFp4a70zznNbyCpWFSfoGR2TbFLR/zU/K5jHc6VLrlmn/Hw
1TUDauJgCniIZPp3/OSOnPJ9V88RfouZto0Knc5H8vxtmPUcL3Ly9rkWuQC9jcPZ
sKhqjpmJm01dW06i+iLn0+CRjc2NDGOrDNdkhSOO0nvLN7n/AHlj9RR1ORx5eFiY
WlOr2NlfWjadekTlhQxHNng1ldEflb6vm/VvyxvvJVz/AIz8jzNY3sbchFGT8QG9
M22n1vHtTRn0vDG7fcn/ADjf/wA5ex6v6fkv8zo/0dqK0RJZNuZ/tzYxzOu4X6JQ
zJcRpcRGsbqGU+IPTMgSvdiq4VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdir56/5ya/5Qi9/wBRv1Ypi/OT8hv+UfP/ADEP+vNZqG6L3MfaOarJzchItc/3
gvP9TL8LXNS/593/APHa84f8ZB/xIZu8Lil+pUffMiTCKrkWTsVdirsVYf8AmD/y
jOrf8wU//EDhjzSH4v8A/OOn97ff8xM3/EjmFq2UX1M/XOfyc3ICjluFtbHXL8nJ
BXdsxI80LMuZOxV2KuxVzfZb5YY80S5PAvy1/wDJsD/jIM3EXBftP2X5DMmKFUdT
k1bwFVrZVJVH9vLYcmSoeuS6NJ5vxh/OxC//ADlbbhRU/o3/AI1Ga/Vcm7Hze4LF
zuT9YWsVd08c1Uubnh8d/wDOVH/OPml+d9Pl8xaPGtrcxqW+HqTXMzBKmjIH4p6z
pMml3c+nXylpYiwNa9jTNtHk4xZL+Wcul6ZrNtqPmZQ+nRPydWBIIySH9OX/ADih
+fX5P3emW+ieSpLey1GYAGNaAsaDFX6DxypMOUTBh4g1xVUxV2KuxV8N/wDOfP5w
QflR+W15O5/fXiPEo77ilcVfzz/848fkd+cPn+W585/ljHPxnlZ/XSvRjXFVD87P
ym/Nb8u9ZsfN35mxzA28wczPXehxV9S/n75ouPzd/KTStY0wNcNZIDJGKn7IxV9Y
f84j/wDOaX5beRfylPlvzPdpZ6zFCyi0K7u3GlMVfAf5C+cYPPH/ADkQmu6cnoW1
xcsykClQDXFX0J/zlX/zld5981/mRH+TPl3UZdKsFlEJnVaCnStcVeX/APOYP5I2
P5e+QYNZ1Pzq2u6rcosjW5atDTpirOPyQuUP/OJGuqyelMJvhH8wxV77/wA+jdEt
pLPUNaYD1wWABH44q82/5+X+W7zSPNtr52vozPbpcAgUNAAeuKvtv8s/+co/JVn+
Sxk8xahHHOtk0QiNKklKUpir8sP+cPLNtR/MvzB+YM0Bk8tStIzrQ8WSpPyxV7l5
i/KD8of+cjPNl7Y+TNZi8rahD3jIUuwxV8yeSfzJ88f843/nJZfll5a8wzatZm4E
TU+IEE064qmv/Pwjy5rlt510TzZ5hZ7Zb9kZpCDtXvir2GH/AJxx8o6x5Di8zar+
ZZ+pSxhp7QsKKT2pir7P/wCffv5EeUPJ8knmj8vNf/SkK1EiitN8VfrFirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVUZ4EuY2glFVYEHARavhXz/5KXy55
zGtolNMKHmKGnLNRnwk9HLw5KYpr3lvTteU3tlRW3+HNbLTkdHPGYHq8bmDaZePZ
3a0UDY5Xw0spW9J/KbzQukay1vX4JfhGWDJvTWYHm+xzEspEq9wDmYItVr5JSQEw
qpMquAr/AGe+Klgn5jPPZ6eV08/Aw3pih4toPlexsIX19WDXYBYg/fjS28W1jzN/
jC/kvYT/AKPbMY3HaowTjs3vRPyzVBKZ2/uun05gTay+kTPFpGkPcTbesCg+nM/S
Fpmzf8mNBXT7JrxejkkfTm+idnFk9yxYOxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuAp0xV
2KoS6sYL1THdRh1PUHFWJ3f5b+Wb/a80y3kHgy4qxi6/IL8u77/evy5YSV/mi/tx
VgfmP/nEP8rNfUf867ZQMB1jSn9cVeD+Yf8An3B+XGuluEC24P8AIDirxXW/+fQv
kDVWLw6lPCT0AU/1xV5nqf8Az6J0/TlZ9B1FmcfZ3avtiry3V/8An25+Zmik/wCF
L6cUrx4s30YqwK9/5wv/AOcodHZZfL2pXoZDX4XbpiqSP+Vn/OV/lm8a71O9v5Uj
61LHpiq+8/Or/nIDy1DNY+ZLe5lsgKNzDUIxV+ef5g6yfMuqT6hPAPrshrIp/ZNc
VT78uPzw84flPcR3PlfV7mMKQTbpXid+mKv2/wD+cYP+fkM/m02vk/zpZt+kZQFS
Uqd6mlTTIZDQQTT9iNE1WLWrOLUIDVXUHI4snEERNptlrJ+X/wDz8R8oNc6NZazp
5Kyx3SM/EHoCK5TnTpdp08p8t6tHqmmwT2cC3CegkRr4gb5ri91pTYYnOt7olywX
RIpEnPEP4V75G3D1P1Jdq+i3zRemlqN9/vwxa8aL8nafeae5+sWilT45NyxHZl+t
zWlmUu3tEN6P7mP+Y5ZGTiZ8PklWqW2v6nHFrmu6Sml2UQ/v06/PJeIHXHCe5Kk0
e6vLaS+m1aW5suoRugGTGVsjiLz2XSfLE90NSjuibiI04kd8eNr04qbPke41eNZ9
UkMelRinLtQZEzdoRsgLHzVYaZqgl0Um7s1FGUqeII75TxOjkd058wm488GO+0S6
a3iiYM0amg2y2Ac3BL0vP/LdtN5x8/2miis31SVW5fLJmDia3Ls/ePy7ZGw0+C2b
qI1r9wzJxig6wm06yaH5f/8AOdn5G30/1T83fI1vW803451QGr9dzTIkN+Ob448m
+YNMt9P5wAX17qA53qP1gc9qZjzDn4zb0jUheeXtM+raZUyXRDIw6oD2GY8nNhF5
x+ZmgahbaUiCVrl5VDs5NSpp0wYxbDMOFT/IT8xH8iXK2uoyMiMyg7ZeIuJ4lP1C
0TWLTWLCPVNEZZnlADbjocyAW3HqB1Ka3MVxCiQ2iAITuQRkjJzhlB5PKfzd8+WH
kvRbqH1R9ZliINKHKZScbNu/OBfXtrGTzAkhcahyBX6cr5usyYnov5OaedKjuZo/
7q4r6o8MkA7LRY3p3mDzBb6Lptxe3RCQxj4R41GB2k5UEd/zhX+VNx5980S/m/r4
Kw6fIVtlYGjAnbDF53V5/N+w49synXuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KpB5l8y6f5TsJda1uZYbaEVZiRkJz4UgPxr/O787fM/8AzknrL+S/
IEkljoED8J549hKBtUnNbmzVuS5EMdpv5I8j6Z5IsxpmmIrXaik8vdm8Tmqy6q+r
mwwHuegWtqZN7wUHbNRKUiXZ8UaTu0sgD+6+z44xxyLXKQS3zH5p0vypbNfa1IPS
FQNwaHxpmTj0sj0cWcg+ddR/MLzt5+nbRfyztn1CxckNOwI4A9x8s2mHABzDjTkS
9S/L/wD5xPhvCNc886lJfXjfE9lLXiK7kZnwlENJt9X+W/y18s+X40XRNNitrhey
Cn05RkHEbDIF6YkFwyCG6j5xjoDkRFlxIuDSlpxt4wiHqBlnhoMkyi0MHou2Xxxs
OJGDQh4ZMYvJHE3/AIf5b0w+H5I4lOTQOI+zkfCTaVTaGwNQN8hLGyEkHNpiA87m
IO46VygwZcSFu4Li4iNvIn+j9OPtkDBPG8Z83/kt5N82xi2vtMha6bYSkbqfEZbh
IjzYS8nyR51/5xa8z/l/L+nvy71ifUafF+jqngPbJZDGSgFIvLf57XmkzjRvzEsj
pl5GePpBdmOa7Npr5BuhJ9LWOoW2tW6XmgSBhKOTKCNs1mTTSHRyoSCWXOnQK5Zf
96fD3ygxkHJjIJNcxyOfRuUq/YZZhyGJ5rlqUaDxr8zfyti8zqvmHS5Pq+q23xoq
9SV6ZuMWqHe62eDyexf84z/85S6lpN/F5D/NRmi9IiOGV9ugoNzm0w5PNwZwp+rt
jewajAl5ZuJIZFDKymooc2MZW0ovCrsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdir56/wCcmv8AlCL3/Ub9WKYvzk/Ib/lHz/zEP+vNZqG6L3MfaOarJzchItc/
3gvP9TL8LXNS/wCfd/8Ax2vOH/GQf8SGbvC4pfqVH3zIkwiq5Fk7FXYq7FWH/mD/
AMozq3/MFP8A8QOGPNIfi/8A846f3t9/zEzf8SOYWrZRfUz9c5/JzcgKOW4W1sdc
vyckFd2zEjzQsy5k7FXYq7FXN9lvlhjzRLk8C/LX/wAmwP8AjIM3EXBftP2X5DMm
KFUdTk1bwFVrZVJVH9vLYcmSoeuS6NJ5vxh/Owsv/OVtuY+v6N/41Ga/Vcm7Hze7
lXlZz0bfNTLm7AcmNeZjw0W6E68gI265l4mib84L7/nFmT807PVvNHlxPUvIY3do
xXbevbNxDk4smf8A/OGP/OOfl38wEv8AyV+ZlotvcqGRHZSDUfPJIZd+c3/PtLzN
+X036d/I28ladfij9MsCvfFXkfkz/nK784/+cYrxdJ/M2G5vVBo5lUt39/bFX6sf
kd/z8H8h/mfDFba1crY6i4+w1AK1p44q+69I8xadryCbSbhJ0ZeQKMDUfRiqd17Y
q+Pv+cnf+cRtM/5yZso9L8wanPbQo/PioqPlir1j8h/yU0n8hvK1v5F8usZIYd2k
YULbUxVLP+chPyC0f/nIHy83lTX3MPUpKo3FcVfDHmn8h9G/5xF8gT28MZ1uC5DR
lZFJCV8MVfA/kvSvyT12G68xebo47S/i5MkBSlT4YqlX/OIX5f3HnP8AOf8AxL5T
siuhWc5KsFIHGuKv1r/P/wD59/8Alf8AOnUR5isLt9J1ImrTRA8q+Ipirx2L/n1v
5fvtNbQfOHma71GZ943k3IA8KnFXuvkv/nBLy95S/Lm+/Jr9ITTWd45f1iN19sVe
g/8AOM//ADippH/ONttPZ6JdyXImJPxCnXFXov52fkV5f/PHSG0HzNGAf2ZQNxir
847z/n05pU90Hj8xTnTuZb6q3LjTFX6A/lH/AM41+Ufym8vHynp1pHKsqcJZGXdh
SmKvk78wf+faPlfzHq03mfyhqk+j3spLViBAqTXscVTj8pv+fcvlXyBrkHnfzBfS
arrEDcxLICTX5nFX1D+en/OOXlX8+tMj0fzZAvOAUhlAqV22xV+fVn/z6Y0W2vS7
+Zrp9KLhjZnlxIB6Yq/TH8pvye8t/k3o8flzybaJbxqoEjqKFyO5xV6nirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirGvM/li18z2jWN4o3NeVN8hOFp
t8k/md+Xs/kYprlixNjyCkDMHNhpux5Hj/nXTItbs01WzHx0AJGabN6XOxG3luhl
9I1S3lkPxGQZhRn6g5ko+l+gvlq9N7CrMd+I/Vm9LrAbTgirkZAsnDirj1TRe+Rt
XkXmuW91i/WxsQWtgfiyYQWL/mBptdNGk+WmJv3HEqOu4pkxsxJfOI8mS/l7Mvlb
Ua/WtQImb2JyEzs5XR9G+SPLsNmY9PP2m4vmtyHdgWZ+faasLXyzYH41dSaZnaMu
PN9N+T9HOiabFaP9ripP3ZvocnFkWUZJi7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FVCe1iuRxnQOPA4q+Av+czPO9p5T0CbQdH0dLi9uV4B
ljqRv7DFX4i+WP8AnB/8x/zYvTrSacbe3uWJBCsDStcVfen5X/8APp+0lCN5+maE
jrwqTir7/wDy2/5wj8g/lmUfS7ZbiaP7M0y/GN67dchkjYpBFvr3TrCHTYFtLUBU
UUoMhhiANkRjSOy5k8X/AD28hRef/Kl7pjoGkWJ3QnrUDtlWYbM8A9QL8Z/yi1K6
0S/vfJF4zLLDLIV5bbA7dc1sy9no5bPoGO5/0fnfuaqajKwbLTqfqYle+bkW4EXx
EVpUCoy4Ra8J3ZXBdLcxB4j18DjTtIRBDHdd0u5u5Ibq2+KaL7IORJa82NWv9a8z
+arP/BupoEikoF37DK+N18obo39FRjTR5Pi+CdRxLDvTAcjKOPZjMfkOO9spLO+t
44JEagderU75aJuuwx/eUut/JYXTH0xrhmQGtCdqYJTdoRsmuleZdK0TQH8kW2nQ
vfOx/f8AH4qH3yHN5+bDrvyvbeUtFudWuLx4ppFYrGDTc5nYt2/EfS9J/wCcIPy5
uNV1iXzreKXjdjxdgfDMsRddrpbP2GUcQFHYUyTjhvFKFvbOG/ge0u41likUqyOK
qQexxSC/Fr8/v+ce7/8A5x58zyfmX5Gga+8vajJ62oxspIgJ3oo8MqnF2GCV7oHy
p5utfPMPqWZAgcVYv8JQnsBmFkdxh3dcabNpkUlhU3Vo78jI+5UeAyzBu0azZ6X5
X/K7yP520mUG4EOpopYA7fFl9Omy5KfMl/8AmT5m/JXV5NH08tcWQYhd6igyQaY5
WWH/AJyg8y6tGLK1iYMe4wF2GLKV2k6j/jx7m284ysrlNg2Y8pOWDa6+8lpobaZd
qxk0m3k5TDrRfljhNtcoMl8q2Ri1XUPMNpRdBkNV5GgA+WWuw0sKDzy5srv/AJyO
85WnlDycHGlWsgS6ZVPHY+IyJXWSoP3A/L3yVY/l9oVp5c0yJI0gjCOVH2iOpOXY
Y0Hls097Z0DXcZaxBbxSt5r4j78VbBr0xVvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYqlmsalHpFnNqEzKqxKW+I0H44q/Hj/nIX87dQ/OLUj5I0WV47KBuFwY+hAP
tmLmLKAtV8i+VIvLWl/osqLbktFnj2Z/c5oNVldnhgzuztWghK3qhZB/dsOrjxOa
LJl3drixWGR2umtelWfZAKk9szsOESFurlqDZDyz80fzVs/J0X6JszzuWqo9OjGv
0ZssOlDE5ywDyD+S+s/m1cjX/OsssHl0kOla/Ex7EZsI4AOqLt96+Qvy/wBJ8q2y
2tmgswgAVogQWp4/PIZBSeF6VBayTOBFEAo6P3Oa/LqTHonwgyNLKS4UW88KxqP9
2L1zLwnijbjzFFPLDR4LPeJ2mY9my4Bim40yWdgzxhEHhmRGLDiTSHTVB9syIxpB
mixYJloixM14s0XYDDwI4lpslO2RMWXGgZtNU123yqULSJoIae8QKtEGU9zmNMMh
IMev/LtvK3qiVlb+XtlJDK2PX+nyyp6BgVFXpIOpzF1WQ4wKbcUbYvHpvoMVuZHW
M/tCtchjzmXRt8IPHPzK/KjQvPiGyvbSNIz1vKfvB71zOhC0GL4N8w+UPN35B35u
o2ln0UsPRbc1TrjPTiXVHFT6T8h+etK8/aestowXUKbq1Aa5q82lA6svHLIbmyk4
mOVf9KBqB7DNbqIeGLDdpcpnLhLHbqFb1vrFsSJk2K9tsqwZDbl5sYDxr8yfIkXm
mFtYtlEGpQglCnUkdM6DS5HVZoPoH/nEX/nIO8twn5Z+bXrewtxDSkDYCg3ObzEX
XS5v0+RxIodDVSKgjLlXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXz1/z
k1/yhF7/AKjfqxTF+cn5Df8AKPn/AJiH/Xms1DdF7mPtHNVk5uQkWuf7wXn+pl+F
rmpf8+7/APjtecP+Mg/4kM3eFxS/UqPvmRJhFVyLJ2KuxV2KsP8AzB/5RnVv+YKf
/iBwx5pD8X/+cdP72+/5iZv+JHMLVsovqZ+uc/k5uQFHLcLa2OuX5OSCu7ZiR5oW
ZcydirsVdirm+y3ywx5olyeBflr/AOTYH/GQZuIuC/afsvyGZMUKo6nJq3gKrWyq
SqP7eWw5MlQ9cl0aTzfjP+csgj/5yut2Ir/uM/41Ga/Vcm7Hze2rHNNPI8ew3zUy
5uwDF/NEzJpN3HKK/umzLxNE06/5wSSFr/V4ZDyEykFDuKZuIcnFlzfbWm/lDo+n
a1caxaWsduHowaMUJrkkPYUUIoRegFB9GKvH/wAwPyI8nfmTE8XmXToZZH6yFat0
xV+U353f8+t4reaTzP8AlRdSRXIPNYkqKUFe3virN/8AnBb8vvzW8h62+mefmmks
Ym4gy1pQH3xV+wmKuxV2KuxVJtd8vad5mtH0rXbeO5tXFCkigj6MVfG/mT/nAf8A
LfzDfDU/QMHxVaNFFDvXxxV9Efld+S/lj8orZ7PyhaJCZPtPxAY4q9E1rW7Hy7aS
atrMyW9pF9qRzQDFUo0rzpoWuWZ1rTbyGW0QVMwYEAfPFVby95x0bzWJD5fvIrr0
W4v6bA0OKsmxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxVhP5gaAPMWjXFkQCQjMAflko11ZRfCmho9qt15elXkwLgV
7Zq9bEdznYi8ul09tHvkW5FWMhIr23zmMg9ezmE7Pt/8t4vrdqD7D9WbjGdnCDMb
i29FyczQBTYEiulMoaQkhV65hZuaJMK8vvJc6o1yy0WKtPA5CPNpKW/lpat54833
HmHj/otg7RuvYmubjBDZpkWGfnHYfWvNyOEBK14nuB7ZiZRTbAst8kw+lKTNuwSg
J65hyi5IZT5Y0garqx4/E6mte4zYaWLi5n09BF6MaxA14gCvjmzcVVxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVIdT8r6TrLepqtnDc
N4yIG/XiqYWWmWmmxiCwhSGNeiooAGKo7FXYq7FXYqskjWVGikFVYEEexwEWr8j/
APnLv8jr3yhrA/MjybEywsxaQRqfprmPKNOfhzGubAPLnmi284aFIkZC38UdHUne
oHhkDEOeMlh6H+T+m6NrFlLpeohP0hLVU9XY1+nBKYaoWxnzP5VvvyzvXGrNW3nP
wcTUb5AzDl4zLvV9Q1M22kPexV+JfhPfKjIOXESefQa3c/pPTkDtWUVrXKjINvCX
qqT/AFkSzAUljJHLvlUphlwFKH8x6WI2aWWTmp4t4Vxolh6Qld/eX0jjRtK4lZl5
Bid6HL4xScgCUaEF03U30LUVT6xGvrNI3gPfMqADi5Jw7mCeYLm8/NnzHB5Z0FXe
xWQJIUFRTv0zKjs6jUTs7P2X/Jj8trD8udAttN05SGKKzEim5G+WAusPN7BirsVW
u4QF26DriqUa5oVj5mspNJ1iFZ7WZaMjioNR4ZGUbW+5+YH55/8AOG9/o1zJ5p/K
x2jiQ83t1qF2FaAVyvgb8WQja3zFZ/mTquiA+XfPVm8M8Z4VCEAjxwSFO+0eqhGN
T3ZzZtpWtW5n8v3pguWHQMF3yslhmy45cg8o17RtXtpXkuY0uV3+JviNMjRcCWPd
OvI/lyW6X6wLdQ3uMibb8MKep2nlX1n9S4CRU6kbYQ7rT58cfqCN1jzFpWg2/wBT
uJFlhIpICQaDLcQcjNqsJFAPGW1bWvzcv4/y/wDy7glS0kPBnVSFpXxGTLzmtzj+
F+tH/OOP5BWP5MaOIGijOpzCs0oHxE/PJxDphKR5l7d5m85aT5SgN3rVwkSgdCwB
yVs4QMnx5+YP/Oaeg6E7ReXW+sOu3YitMPGHKGGIG7591D/nOPzHqitBZWfFCdmV
f7MgJ7px4eM8MebHY/8AnLnzUWrJFLT5YDMJnoMgT/Tf+c3dc0d/9LtmceDL/ZlP
igOP+VkOb6E8hf8AObnl3WVSPzPW2mc0oAAMnHOGY0+z7J8u+bdK802qalo1zHLF
IKijqT91csGQFx5x4ebI69smxbxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+cP/OZn50H
TgvkTR52juJjwb02Fdzmu1Uz0cnDF8ufll5POgql1fIJJbipd2G5r45zeoyyJ5l2
mKA7ntEQazmawp6i3B+Gu/H5Zi2S3kgJ4bFrYrBD+9YjvvTLo47a5T2eWfm3+bUX
5d2f+EdKPrane9OJBK8s3UIinXy5qf5D/kHPfyDzl54rPcTkSxxTAkUPzwTn3Moh
942GnLZwrpTxLDxpxiQUWnY0yHEUksxsdJ5gclqMyIbtE5MusdJYUAG2ZUcQPRxJ
yPeyK0t4o3Mb1Mg6g9M2EMYA5M4yNJoLWMMHAAyXCO5HEVS4oEJJ+DvTEUGogtQg
cAYunvg4wwIPRtnVerqD8xg8QL4ZUVlavxOnH55HxQvBJXVg392ysfY5LjC8BUbo
qoBlJBrtTCJhIiVZObACUCmEgM42pS20cgoQK4BENgkkzWkMrNFFUuvUHpkcmOPU
IyyPRjV/pYJIKgjMWcB0CYSLDNR0/gCoX4fDNfktyoSYdrvlq3161ZL2FblEBHGQ
VA2zEJLfb85vzM/LbUPy81f/ABroXOG2icExRAhfHJRN7FgQ9z8i/mNbfmHp66ue
KX8C+l6dRU/RiYA7LjO+ydCxWOJ7WX4JXJavffNZr4VycuJLGpbc2SGyccjWtTmn
hKd822nzx+ZXlKbTbyLzpoztbyW7eqzRbFqdic6rs3KepaMsB3P0/wD+cXPzlh/M
7y/FBLJzvrdQsgJFdhnTxoxt1maL6pwNDsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVfPX/OTX/KEXv8AqN+rFMX5yfkN/wAo+f8AmIf9eazUN0XuY+0c1WTm5CRa
5/vBef6mX4Wual/z7v8A+O15w/4yD/iQzd4XFL9So++ZEmEVXIsnYq7FXYqw/wDM
H/lGdW/5gp/+IHDHmkPxf/5x0/vb7/mJm/4kcwtWyi+pn65z+Tm5AUctwtrY65fk
5IK7tmJHmhZlzJ2KuxV2Kub7LfLDHmiXJ4F+Wv8A5Ngf8ZBm4i4L9p+y/IZkxQqj
qcmreAqtbKpKo/t5bDkyVD1yXRpPN+MH52f+tWW3/bO/41Ga3V8m7Fze+3RKSnge
PyzSyO7njkw/zn/xyLn/AIxNmViaJp5/zgWoOo6uSNwu335vcXJxi/TrLEOxV2Ku
xVDR2cMTmeNFVz1IGKonFXk35sfnHoP5P2Cat5olCJIwVQSB9OKph5e/NXQPMnln
/lYNjcL+iQhYvUbUxViXkH/nIryb+Y99Jo3ly8SS4jJVhyHUYq15w/5yL8m+StWj
8r6rdg38hChFI6nFU28/fnl5U/LrQx5q8wXsaQMgZI+Q5tX2xV4t5L/5zm/LPzlN
FZwXpgllNB6hFK/hirA/+fjWtyp+SOo6toF0yCQBklhbqCNiCMVfAP8AziH5h1i+
/wCcavM1/cX0z3KFgkjMSyj2OKsj/wCfVOu6vqeu6smqX89xGJH+GRqjvir94cVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVULlecMieKMPwxSHx/F5dhs/MdxLPQBq7H55ga2OznYnj/nvRDPrlIl+BTXb
OZyRqTkk7Po38uZ/qNrxPh/DNniOzREMpmvWuZSBmcOTJSktjco1rH9p8xMosokw
vzprVv5P0OfVYAPXt6IQOprtkIDdpnszn8lfLUfl7Sfr5P73V/8ASvv3/jm9wjZx
pG3kP5kzRN5pRKbgUzX5Q5EOSZ6Jbs87ekNuBzDkHJHJm35Y27w6xM71oVIzYaVx
cz6GzYuK7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYqkXmPy9Z+Z7CbSNTjWSGVCtGFaVyMo2zhPhfjr+dn5C67
+Sury+c/KUby6dzaRo1UkUr0plEhTmY8pLA9E862fnKSDXObaffRtuhPp7j2zBJL
mQL0TX9Q1jzpNbwXjCa2hIo4PLb55DiczGnc2nLLaPp0v2FFBlZkXNxpGvl+JHhv
gPithRcgSXIEQyG6b6lxVB/fKWOQLOnlT3FtfaRdxWaE3QuQK0982EMezqcmWine
t6bFpUMHmGa5VJY4R8HOhqB4ZYIU4uTOXi8Nz5i/NbWV0rytBJ67H03lCn7B98ti
KcHJqZF+rv8AzjV/zjpafllaLqupRrJfyqCS67gkb5fFxJ5SX2GAAKDYDLGlCzX9
tbkrPNGhHXk4H68UWkV/500PTlL3GoWoI7esn9ckItsMRk82v/8AnIDypp0npS3U
be6uDkjAd7adMUNB/wA5C+Vp2FLqL0z/AJYr92DhapY6Z3pP5j+WvMKFYL62Ibbi
8iiv35GkCJ6MF8+/kn5R/M5GnligMvEqJIgvceIynLG1nmnHZ8Mecv8AnBTVNOmf
U/Jty3GpITl/CuQEKbMWYnm8R1b8qvzE8tMbaa3aYKaV4k9MPCC7GBtiss/5paZI
LPT9MIB2qIjj4YTKfCNmR2HkP82PMZVJ7cxB/wDJIyBgA4eTWSi9j8qf84QeZPMM
sd35xuONs5+JeW9PlXJwDXDXzPN+in5X/kv5c/KqzFpoVsnrU+KZlHL78tEWvJlM
nnH5+/8AOS+j/lHZPFZyx3Orkfu4lYNv7jK5z7muIsvy21bzf52/PC4kv9dlktrK
Q8goPEAZAzc/DiXaR+X9jayfU7YPc3I61HLfI+I2ShT0K0EugEWV1p6Ih/beOg+/
KpZC39li8u7KIJoZV5tawUP+SMolmLvsuOPeoz6RYX/xSwQD/YjKTmLrpYIlhXmD
8rtI1BfX/u5X2UxjYHDHMQwOlixDTovPn5Gzr5o0O9e605Dy9Evy2+WXRykuu1Gl
979Ev+cf/wDnLvS/zR46Zr9LLUm24vRQSPCuX49RK6LrZYuHvfbCurjkhBHiDXM9
iuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KvMfzR8+v+X2mNrZjDQRjk5/hirwz8uP8AnMjyV52mbTbq7S3vAacWYDet
MVfV2m61Y6xGJ9MuI5kO4KMDiqZ4q7FXYq7FWEfmH5pg8oaFeazcyBGiiYpU0qcj
M0GURb8PdOjvPzm843XmXUizQQSMyltxsc0+qyudhg+nYXjZWtUAAj2U5z+Td2MO
Sc6SquwluR8SfZOMMdoJQXmnzRB+W/l7UPM+pMDPUiFSd/iG1MzseIFxZZHhn5Af
lVN+ZWqyfmL59DGr+rbK42412zJlkrZpiLL9F9NiF68aQr6QthwRRsCB0yAZs8t7
N7+ZdRvBxuFHAL7DLIC2BL0DTbEcRUbZnYoOPMskgiCdt8zoRceS2eaOI/Z+M9CB
mQAkKUkayoJLp+C+JNMEjSbeM+ePz+8pfl7DKNQulkli6orAk5jzysowt8YecP8A
nPG8lJi8l2ZdG6ErUj8MxZZyGfhh5HN/zkb+YOuk3SJIjHenTKTnLIYUGv56fmcW
4yK4TxyPjFfBTSz/AOcpfP3lZxK8LygdQRXJjOUHE958k/8AOeFpcGOHznbGJ2IU
0Wn8MvjmJR4YfaXkz82PLvn6MDR7qPkyg8S4ruMyY5LDWY0z9FFsC1S0fYjfMiO6
LVoJI5atGtD4kYJhiUPc2wkqQMxJpgw7VLClTTMHJFyYMHa3fSxJDKKrPuMxZRci
JeeeZPLNrr1nNpGpoGSUEior2yukvzV8yaJf/kl5rXU7cMNHeQBgNly+G+zCOxfW
C3CebbeDXdNYcTGpIB8cwtbjcqJQE1J5mWQbhaZo/DpvDFrvSBrUM2j3A+Dia18M
2+inTCYeU/8AOPvniX8j/wAxbnSLpiunak3pRVNFqfDOoxZjTrMoft7Y3aX0CXMR
BDAHbpuK5kRNuIUXhV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV89f85Nf8oRe
/wCo36sUxfnJ+Q3/ACj5/wCYh/15rNQ3Re5j7RzVZObkJFrn+8F5/qZfha5qX/Pu
/wD47XnD/jIP+JDN3hcUv1Kj75kSYRVciydirsVdirD/AMwf+UZ1b/mCn/4gcMea
Q/F//nHT+9vv+Ymb/iRzC1bKL6mfrnP5ObkBRy3C2tjrl+Tkgru2YkeaFmXMnYq7
FXYq5vst8sMeaJcngX5a/wDk2B/xkGbiLgv2n7L8hmTFCqOpyat4Cq1sqkqj+3ls
OTJUPXJdGk834wfnZ/61Zbf9s7/jUZrNXybsXN75d/3pzTS5ueOTEPOf/HIuf+MR
zKxNE09/5wK/46Gr/wCr/HN7i5OMX6c5Yh2KuxV2KuxV2Kvzf/5+RflfdeePIL6n
prustorMQp/lFcVfl3+VP/ORl1p35KXf5ax3LG9VpIt2+LbbFXh3/OKHm/W/yw8x
XXmDVbiRY5JGYc2oNzir2bypqOpfnt+cs+uxTPJa2ThyK1XbFWA/85G/mLqHmf8A
MUeS9Vupjo1q6q0attQe2KsN/Oaz0nS9Ptbz8vLe+S4t+JZkQjf5jFX2352/M/U/
Ov8AzjRPp2v+oXt4FX9516d8VSj/AJw5kD/842eaYUHwgt+rFWTf8+n6/wCIdXC9
PUf9ZxV++uKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV8a/m9qx0bzRDb24I9UqNvfMXUiw5WKSj5hs445w8y1kK
A1p45zuWHqcwHZmPlWEi3qvTMnCwpl9qUqdt8zxyZNxLKzSTQGjJ0zGyRRJ4r54u
LTWPNGleRp1YpqNGl8CQccUd3Em+wNM0qPTLaCzSnG2j9OOn8ubvGCBTjvkT8x4k
k83xwofiIrmvzi3Kg9H8p2BVmZqbRnMMuRdJ7+Xt3HPq88cYpxDZsNMHFzvcMznG
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirRAOxxVvFUt1XSLTWoGstShSaJhQh1B/XkZRtINPz4/Oj/nC+28yTz6
t5VrbympRYwFFSa9BmKMJDlRzB8YX3lf8z/yiElpewm4s1+yVWrUwnAS5OPUAJcn
5928EItNW0u9W86M3AgE5X+XLmw1QZJbfnDpV0kZFtMigfGG74Py5bxrIhD6j+eu
h2zgy2F1KFHEcATg/LFP5yLEIfNWr+ZL4WP5e6XcxR3BqzTRmlTmWIbOqy5rL2ny
n/zib548+alDdedZWWyPFiq7CnfvjThZJv09/K/8kPLv5YWscWkWyG5CANIyitRk
ow73HZb53/MDR/y/sTqeuTxxxp+yWANB4DJGTOMbfnn+af8AznTc3cv1D8pYGkdS
Q0ki1Gx7bYONyceB87ar54/Mv8xhLf3F00DOKsA5H3ZRPMAU/lyZWwWD8r/M17/p
2s6hdFTuaStTCM4dtp9MU/8A+VXz2gjnFzNIG7lyafPD44cuWmNK0/5RR2RXUJby
ZWfevM8RkfHDg5dOUkvfyx1FpVu9J1WYzjdFjmO/0VweOHHGAs68qfnh+ZH5Q8YN
TZp9GVhzqSXoDvk4ni3cbUaOUjb9I/yS/wCcnPLX5sRx6dbyehfhByWVqVPhvlkO
4uNLCY830u1nbTfE8UbV7lQcmGviKl+i7InkbaGvj6a/0wrxFV+o2w6Qxj5KMFMS
L5okAKKKKDCmnyB/zlf/AM5G2v5M6Oumaewl1vUAUgVGBKHpVgNxkJSbMePifmH5
L8i6l5pu3/MH8wJnnupT6kcbtyUb+BzFlJ3On0ZO72jWreWe2DaSqxQIPjVRQn5Z
SZuy/LGk+/Lzz75Q8txvLJazSaom3xCorkSWmWEpf56/MDU/zAU2FnFFb24aoPEK
1MgY24vhGJtS0m0kNkRMfiRd/oyqUGMpsShE+rmb6kxjEQJbkaVpkDjLZjkm3le/
a9tzDdEvCCRtudskMZdxpzafx2tishMcgde8Uhr+BzIjiLkyiO55N5y8g3+o3H+I
vKB+p39qecXH4ATl8YVzdZrsYMDs+x/+cS/+cm/8SSyfl/57kMetwHhykbZyNtq5
kQm8oYbP0TVg45KajxGXA21rsKuxV5/+Zf5jab+VuiTebPMAc2kP2gg3wE0r4Xk/
5+f/AJWRO8bM9UYqfjHUfRhVQ/6Kj/lV4yf8GP6YquP/AD9F/KoCpaT/AIMf0xVr
/oqP+VX80n/Bj+mKu/6Kj/lV/NJ/wY/pirv+io/5VfzSf8GP6Yq7/oqP+VX80n/B
j+mKu/6Kj/lV/NJ/wY/pirv+io/5VfzSf8GP6Yq7/oqP+VX80n/Bj+mKu/6Kj/lV
/NJ/wY/pirv+io/5VfzSf8GP6Yq7/oqP+VX80n/Bj+mKu/6Kj/lV/NJ/wY/pirv+
io/5VfzSf8GP6Yq7/oqP+VX80n/Bj+mKu/6Kj/lV/NJ/wY/pirv+io/5VfzSf8GP
6Yq7/oqP+VX80n/Bj+mKu/6Kj/lV/NJ/wY/pirv+io/5VfzSf8GP6Yq7/oqP+VX8
0n/Bj+mKu/6Kj/lV/NJ/wY/pirS/8/SPypPJWeQN+z8Q/pirGfNH/Px38nfOGlXO
geYlkaOdSoCGvb5Yq/CD83vOVlB5nm1v8srqWCzeTki+oRtir2T8oP8AnO7z1+W0
kUEty8sCkVLyEilcVfrf+Sv/AD838qeaFh0nzYf9yEnEVjbuT8sVfpt5N832XnfT
o9d0kMLeT7PMUOKsrxV2Kvz0/wCc6/Pf1DR7XyxpshW7uZODUNOpzBzZRbk48ez5
h/LLRG8uaQlqgAvZq82p1rmk1OR2GEU9Pt4OETxf8fI6nxzWyNuUyyytRcxRrHtK
o+L6MycIcfIXyR+ZGo3H5u+dLDyDpTEWELBbkV2JU+GbfDj2cHIbL9EvKfl630Sy
tNNRQjWkYiHAUBp45rp820cnp1tZrJxnhFJh08MvhFBLPtLt3kpLeget0FOlMzcc
GiRZ1bxCBAPHNjii0SNqsriOle5pmTFilt7qcWlxT3upMsdtCvLk2368jIgIfmJ+
fX/OWl3r13J5P/L4NyU8TIhNOtOuYuTI2wi8D0L8ndT8wzRav52uJJXm3C8qj6c1
+XMHLjjL6C8v/lxpehHhHBG1P5kBzAllcmONnaaDaD4o4Ix8kGUGdsxFFtpUbLwa
GOn+qMWVJfL5fst/Ut4mr4oDhjOtmJg8z8w/lHpWvszNEqVruqgUzIhma54nguqe
SvNP5X3h1jyfcyG0hPMjkaEDtmxxZQXFnCn3b/zjr/zlZZ+cY4fLPmesOoAiMNIa
VIHvmfjm4s4vu0OoBdR8NK1HfLju1tRuJRyXKzFUBe24nU0HTMbJjPNtiaYNqtr6
orMBVfs5iSg3xYFfW/UzDcdKZjyDdb5p/PLyKvm/QZrVFX1lJcNTfYYcJqSl82/k
Z5muILyTyPcMfVi7sdqDJ6qNssZe96lCsilLbaYEknNLkxudAsUvpZYIla32lc0Y
+2V458J3RMPAvzy0DlY2nmbS/gu9Kb6xMw2JA983GmzguvzRfqt/zi75+g/MPyDp
uuwk+qycXDbmoAGbnBLdwZh9FZlMHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
z1/zk1/yhF7/AKjfqxTF+cn5Df8AKPn/AJiH/Xms1DdF7mPtHNVk5uQkWuf7wXn+
pl+Frmpf8+7/APjtecP+Mg/4kM3eFxS/UqPvmRJhFVyLJ2KuxV2KsP8AzB/5RnVv
+YKf/iBwx5pD8X/+cdP72+/5iZv+JHMLVsovqZ+uc/k5uQFHLcLa2OuX5OSCu7Zi
R5oWZcydirsVdirm+y3ywx5olyeBflr/AOTYH/GQZuIuC/afsvyGZMUKo6nJq3gK
rWyqSqP7eWw5MlQ/ayXRpPN+MH52f+tWW3/bO/41GazV8m7Fze+Xf96c00ubnjkx
Dzn/AMci5/4xHMrE0TT3/nAr/joav/q/xze4uTjF+nOWIdirsVdirsVdirA/zL8p
w+dPLeoaBcry9a3kC/Pjir+THUfyo81eUfzafyXaafdPpkl8eXFDx4sx38MVfXP/
ADmR+Q+r+QvKdjrfkeymMkqIZREh5CvXpir3f/n11+S95eWt35r80WssMtwpEhlS
h6e+Kvnv/nLj8gtZ/Lf81pPOtnaS3OjySh2CLUkVxVPtZ/P6x8yWdn5P8h+WJlvz
xSZ5beoJ6HqMVfWf/OTH5ZyeXf8AnHWQwWLnV7+BXeOJPsmngMVeF/8AOGmh6jY/
842ea9NvbC4W9cv6alCCRQ9sVTn/AJ9PaLqtjrmtS6rYz2yiZwGkQgd8VfvRirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVfIn5vaYLvzVaykVAZMpzx2bsZTvznYrGVlUf7rX9WaHNDdzIlf5Ul/ccDg
xFsplEJ4Mc2EeSqRvPq1wtv/AL9yrIGEyw6+8tG/89aPqyLtANzk8MXEmX1O4Jqe
1Dm3Djvhzz1Ny89RID2zX5x3OXje2aCxgWRj09I5h05NWEB+VVz62s3Q9mzY6cOJ
nfRWZbjOxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KqMtxFBT13VORoORAqfpxVWxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpNqXl7TtWXhf28cg/yl
BxZxmQ881b8j/J+sj/S9OhqOhCL/AExADMZy8v1L/nFDypdSc4IFVfAKBkqiz/Ml
kGjf84x+TdPUfWbNJSPFRgICDqZPVtK/Lvy/oyiOwsYU49CEWo/DA1nKSzGOGOEB
YlCgbAAUwUwu3kf50fm7pf5Q6HJrusSKHYMsSVoS1NsrySpsx4+J+NGta75u/wCc
hPMck2ozyRaMXJX4iF4k1GUcdOZjweTOPqWkfl+6aTplsbufbkVAbfvkfEc+GEMy
0jyR5q8zzC60tPqdrJ9kSLTMeRsshiFsb0fWdasNbv8AybrsiSLCeIZemHdzsdBl
Oo38PluP17h1uoB9q2j3kb5DBZZTy0ObyHXvO0erhrKcm1tJTVYJDSRR4YLLrp5r
6phoMlhqGqWs3leb0DAnBxK1QxxssoAF6nezwzSfojzGqSCUEcgNt8y9OdnNjhiR
u8N86+Rr/wAjXsWs+Rp2UI4nYRtT4RvTbLrdVq8IHJ+oP/OMv/OQVn+aelRaXeOB
qluio4J3JUe+GEujpJWC+tctV2KsQ8+ebrbyHoN95t1GnoWURlYHvTtkZmgyiLfh
R5elufzy866r+Y/mGRn0eWQvao7VCgHsDmNKbtdHhBfQzRIm9oONnBtt0pmNOb0u
HFEBi995qg+uRyWyk2UfwykdMx+NMyAn1/Y2Kyxah5ei5mReTUFdzl0d2gxClMkU
QBvoG9ckHiBQ0y2ER1Zx08Z82GedfMlxYTpBo7iFCByDYygGnLooDkFfy/dHUFZS
wkLL8Qj98qIAccYAOTJjDFo1gx8vxsLvcup3OGIDkQkYjZjnlvRX8zzu0Uwh1UdA
x2r8svFNOXVTCYXmo655PufqnnO2kuYz9h41oo+eTlydZPWTmeEvNPzG02OGa1/M
TySrQXliQ8gQ8SxrXtlOOTRPCA/WH/nGb847b82/LEM8W95aIEud6nn75nY+ThZY
0+ksm0uxV53+Z/kKD8x9Em8s3tPRmBVq+BFDkJhX5/T/APPrP8sp3edo5fUlYu24
6nrk1Qf/AESs/LT/AH3L/wAEMVXN/wA+rvy0Ip6cv3jFVv8A0Ss/LT/fcv8AwQxV
3/RKz8tP99y/8EMVd/0Ss/LT/fcv/BDFXf8ARKz8tP8Afcv/AAQxV3/RKz8tP99y
/wDBDFXf9ErPy0/33L/wQxV3/RKz8tP99y/8EMVd/wBErPy0/wB9y/8ABDFXf9Er
Py0/33L/AMEMVd/0Ss/LT/fcv/BDFXf9ErPy0/33L/wQxV3/AESs/LT/AH3L/wAE
MVd/0Ss/LT/fcv8AwQxV3/RKz8tP99y/8EMVd/0Ss/LT/fcv/BDFXf8ARKz8tP8A
fcv/AAQxV3/RKz8tP99y/wDBDFXf9ErPy0/33L/wQxV3/RKz8tP99y/8EMVd/wBE
rPy0/wB9y/8ABDFVaD/n1f8AlhRxPBLy/ZPJf64qkeu/8+0vys8paTd65qxZIoFL
VZgKbeOKvwd/OLyno1v5nn0P8ubaW9SOTiqRHkT8sVewflD/AM4QfmL+bjxCOJtO
tXIqLhADStO+Kv1r/JL/AJ9Z+XvIslvrfmiX6zqMZViUIpUGuKv1f8s+XLTyrp8O
jaavGGJQo+jFU/xVpmCgs3QYCaV+Kf8Azl1r03mj8xbfRbYloIJgaD/WzTzLnwGz
OxCLT6tbw9RSv3ZqM5c3GGURIBOCenfMAFyaTLUNRXRrWbV2NIYwan5jM/Thxcof
Pv8Azi75ePmLWtd84XwqyXJMJPhXtm8hycCT9FNNt+RBPffNZKO7fWzP9NtqkCmZ
OODVIvQ9PtNhtmwxxceck8QivonqMy4hptewVzRh0ywGlfmn/wA5jfnddGT/AJV1
5Xcpck8ZGUkV3zCzZSDTZGLxj8n/AMsV0+2F5rK+reS1NWAJqd8wM2ZyscH0bo9h
DCssV4OMif3YzXZchLm44JnHbV3I3ykEltTOOzYjplscdtRmrvZkCoGS8Nh4iFks
zTfIShTZGVoB7UNWL+fb78hdNlJNqukQLbjQuPqEHm7UrtmTjyloyQfJf5seS7jQ
5R5t8p1h+on1nCfD0+WbLFmcGcH6If8AOKv51r+anlyGO9at5EOLVJJ2GZ2CZk40
hT6wqI6J45eQxc6gqQO+VyikFimpWwINcw8kab4SeeanB1zDnFvju8+1PT1vUlt5
R8JRh+GVQNFnPYPzX15h5B8//uhxWVqeHXMg+oMcZfUs21vFdf78UH781uohTsMa
UXUKSH0/5d81MpUWZDzXznpf6Z0nU7OlS0BGZ+kyG3DyC3tX/OAPmhjY3Pkgt/vD
yqvhnTacdXByR2fpbma4zsVdirsVdirsVdirsVdirsVdirsVdirsVdir56/5ya/5
Qi9/1G/VimL85PyG/wCUfP8AzEP+vNZqG6L3MfaOarJzchItc/3gvP8AUy/C1zUv
+fd//Ha84f8AGQf8SGbvC4pfqVH3zIkwiq5Fk7FXYq7FWH/mD/yjOrf8wU//ABA4
Y80h+L//ADjp/e33/MTN/wASOYWrZRfUz9c5/JzcgKOW4W1sdcvyckFd2zEjzQsy
5k7FXYq7FXN9lvlhjzRLk8C/LX/ybA/4yDNxFwX7T9l+QzJihVHU5NW8BVa2VSVR
/by2HJkqHrkujSeb8YPzs/8AWrLb/tnf8ajNZq+Tdi5vfLv+9OaaXNzxyYh5z/45
Fz/xiOZWJomnv/OBX/HQ1f8A1f45vcXJxi/TnLEOxV2KuxV2KuxV2KsNf8vfLkl+
ddk022a+O/qGMVr44qm2q+WtL1yD6jq1pDPBSnF0BFMVdoPlrTPLEH1HQraO2h/l
jUD9WKoHzF5K0XzXx/T1pHcFOhdQcVYzp35M+TdKul1Gy0m2SdTUH01/pirONZ8v
6f5gs20nV7eOe0YU9NlBH0DFUv0byZovl+xfRdJsoYbKT7cSqOLV8Riq7y95O0by
qJB5fs4rX1W5P6agVOKsmxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvnv8AMWxD6vFcHqGGQyx2bIFQ80qZrUOe
yjNNnDlw5sd8qvVeGYmLm5QZnIfTIGbOPJBDHNevkstU09JD9s5CbTN6Z5SWDVbq
W+ABaBqA5LCN3DmXo84bcp/Kc3Eardxy+BfNwmb8wIw9aZrsnNzcXJ9K2cYggZ5P
99H9WYJcoMc/KGWOTV7n0+vxZstONnEzvpLMpxXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUNeXkVhBJe3bBIYlLOx7AYq8Z
/wChhvI/qU/ScP1cN6Zm5fCHHbFXpU3nDR4dMXzKbuNtMYAidTVSD74quTzbpEml
HzPHdRnTApb1gfhoMVYre/nB5TsLO31a41GIW9yaI1cVSdPz88ktdJYHU4Q8hopJ
64q9B1jzbpWh2H6b1C5jS0K8lfkPi+WKvPl/PryaZIoG1GMSTU4ivjirMda/MLy/
5e9I6xfRQLMnqIzHYjFWCWP/ADkF5MuOX1jUoY6y+km/Uk0GKs+80efdE8n2aarr
l3HFBKAYyT9qvSmKsd8tfnF5X8zTDT7S/hF4ekRbcjtirGfzXuI9RvtJ0+2uljaO
4V5AG6iuKp5rn52+UPLl1LpF5qEX1i3UGRQ32RirL/L/AJ50TzLYjWdKvIntiKlu
Q2xViOp/nl5N0mc2d1qUQdTQ74qyHyl+ZPl/zsXXy5dpcFNjxxVneKuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpJ5i1y38uafPq98wSKFGck9N
hXAS2YsfEafh9+aHm7UP+clfPE1m9zx8uWjMFoSFLL2zHyF3en0+1B6r5fsV0TT/
ANDQx8Aq8edOtPfMOcqdjHCWJ2Otp5R1I301k94A1agVyiUmQjT07zF/zkBqPmi2
ttH8oadJaywkeo3GmZ+HETG3EyyqTzC5u4NFln1DVUNxq170C9a5Z4RaZZqTi+/K
TV30Y+dBdDTNQ487Zp+g+jInG63Pqg+aYJo9XmmtdchbVdfDUWWDoT4gYPDcUagM
g8u+X9T0bXbeTUtNnhtStWZtgD75MYi7TS5LZpfeYlub1oZ5g8SkhWB+z4DK8npN
OTk1AiaZjoeu6dptjJHrUyvNKCihtzxOAG2oy4nlmia1N+TXmu38z6ZIU024mFdz
x3+WWRcXJpyX7neQvNlv5z0a21yyNUkjUn50zIidnAy4+A0zI7b5JrJfl/8A8/Bf
zNvbePRvy40B2CarN6V5SoohNN8pzml0mcTlQeJ+TtI0XyLpcXlZ5kSUike+7E5r
pzen0saLJxzWJtIXpN0OYmSe7teOnn36Ml0+wvdA9FmnnkBVvbICVuuzZgNmRy63
L5Uht9J0aBp9QaMEqu52zOw7sMWYLvL3myXzSzSamn1TUUbgBIKZk5fTG3aYc3Bu
t8xWGjWlyLfzFSSaQbb065hHMuXViXRHeXNEs9Dkd9PHpeovwFvfplZzBxxK01WW
WzLpT1bw/bYdKYRkDkwwksdm8uvK7atpk4tdQG4JNN8ujkaMvZ0j1T7R/wA4ZNOt
Z9A8/WDalK44xTouyHxrlspbOu/k+UZWSwvyzI2oNqFtc2biGavoKw+0PbIY2zLj
b/5xu873v5S/mXD5EiLR6VrcnK5qTRDy/DNlidTni/bVHVwHQgqehGWOsIXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXlX5r
eR2/MLTH8sTBvqlwvF2U0p1xV4H+Vn/OD35eflxctraWCT6qTVZpAG4716EYq+ub
Hy/p2ncfqdtEhXcEIo3+gYqnGKuxV2KoDVXMdnO69RGx/DIy5JD8PvNFwmp/mXqD
3R5NGxIr880+RzoF7KkZ5C+f7ApTNNqHOxsltB9YHIdZemYRclh/54XbaJ+XGsXC
GkqBaH55n6XcuNmGyff84x2EcXlSwvrYUNzCHlPia5usZcIvsXTFGwyjh3bej0HT
ANszMcXGyM/tGCIDmZGDiyKJA/fV9sstglnmS+GmaXeagNvSiZ/uyNpfiF9aP5kf
mBeX8lW9KRiSd+je+afVTqTnYRb7E0xPqXBrYBuFNhmtyTcyEGSz2y3TLezHhIdw
OmY1uRScafaGUgHMjGLLVMvRdM8vesBQdc2eHG4OSaeS+VKCtMv8JoE2I6poPoE7
ZiZsdOTimwa7tipKr16DNbMUXOgUquh6UYtrcepfk/GB1C5UJMiGD+ZdKhurSXSp
af6QvBwffMzHNxskHgv/ADifrc3kX8ydW8moxFlGT6Yqab5uuz5XbgZw/Zov6gjk
8aHNi4pVpHCsq+ONKk+pCla9MxsobYF5xqY6jNfMOXjLA7urMVXqdswpmmeUbPzf
/wCcmNMax802l+Nv3i/wy7CbDVB9F2sgvtMtgu/GJD+GV6gel2WNI7zlDSX+Y8c5
3N9TkFJ7qIQM0MnSei/fmVopWXEyJB/zgPfcfzW856KCeEANB4Z2mmHpcDNyL9ic
yHCdirsVdirsVdirsVdirsVdirsVdirsVdirsVfPX/OTX/KEXv8AqN+rFMX5yfkN
/wAo+f8AmIf9eazUN0Xuf7WarJzchItd/wB4Lz/Uy7C1zUv+fd//AB2fOH/GQf8A
Ehm8wuKX6lR9TmRJhFVyLJ2KuxV2KsP/ADB/5RnVv+YKf/iBwx5pD8X/APnHT+9v
v+Ymb/iRzC1bKL6mbcmmc9k5uQFHLsLa2OuX5OSCu7ZiR5oWZcydirsVdirTfZb5
YY80S5PA/wAtf/Jsf89Bm4i4L9p+y/IZkxQqjqcmreAqtbKpKoft5bDkyVT9rJdG
k834wfnZ/wCtWW3/AGzv+NRms1fJuxc3vl5tKQc00ubnjkxDzn/xyLn/AIxHMrE0
TT3/AJwK/wCOhrH+r/HN7i5OMX6c5Yh2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV4/+bKrBZC8iFJwdmzFzTINN2MMP0GY6rowN98cjVAOYExfNyYc1
HSdGezNQab5UIxDcSyOQKo/eCpzJgxMi8f8AzAs73U9f0WSwJEER/eAZdGIPNx5y
L2r8qpgW1GIdVkzJx4wHGlb2F2P0cTlwYU+KdVMc35ip9ZHJApzXyNlzRsNnuCKZ
bOZ23AVgPlkRAFPGWEfk5EY9fuiv2eLbZlY9mjIbfUuZDS7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+Cv8AnNf80dW8v6LF
5V8pLIt9PKvqsP2oj1UU8cVeAWsGi2fkWZIfId1eXM9uSiqTUTsPt/fir278h/L2
sa3+Rt95Y8/WUunTKJmiWUkFVP2dz4Yq+av+cevNOrfmxqTf847Q3jR6VoUzyXMl
T++Sv2a98VZf/wA5AeT9PHnzy1+WOhI0OnrcKsiBjuCRXFX0z+bP5AeR/LHl061a
WJF7aAcGDGpIGKvDLDznZ+dNFi0m8kNwbYcRaAnkfbFXkn5k3tlZ6ppegW3lO4tL
qTgUuCT0r1xVlf5neX9Q/MTz55Y8rLI40wWqCehIodtjirN/+csvyf8AKv5V/l3Z
ahpNqf0kl/bKJAxqSW3+7FU8/On8vtdvvL+heeY4pdZ02G1ty+nxk1Hwg1xVO/y9
0PyF+Zc9teaGn6A80WvD1rZ2o9F67Yq8X/NTzpfx+cdb0TSZjMdOtS6OpOxUdcVf
QH/OPf5MeWvzE8nwed/OlqbnVdQDCaRmIqBirwjzFqkPknXdX8keV5TFpsVViHI0
GKsr/wCcY/yR0vzxLq2q+e4Gugr0h5Mab4qnX/OO+nWui/mPrfl7y+pj063uCpSp
I2OKv0ixV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+f/8A
znd+Z7+VvLA0Cxk4zXTcCBWpDU8MgTbsuz4xO5fDPkjTV8ieXknis2ubm6YS+mN2
q29cqyVTu84GOFxegWHme+aNLfWbVoOR25eBzFlEMNLmJNFPr+a2gjieKdUqfirl
Moh3OeMQNkPpXmXTIryW30+6jFxTdabt7ZZjySAoOkzDd89avpXmXzF54tW092it
Y5KyP2Ue+XjIXVZibeq+evNfmb8ytVtfy3sJGuLW0IjkmTYCm2+WbuNwcR3fWX5Y
fkbonka1XUZ4lbU0H94aHfJU5ePSR7nqMml2muxyRalEsgNR9kDKjIhyBDh5PkH8
6PyOtrbTrjVvK4+qopLMlepA65fiiJi5MJRvcvh/y3rKDUZLLzApnliBCmp2pgMQ
HXjLIF61HpkPnzRbi3mccbRWljXuCOmCqdlp/VGy+4P+cEfzLl1LRz5U1GTlJA5V
Qa1oBthBpx9ZEcL9IcudW/DT819Xl89fnfrelXD87XSXDxReND2rleeIdhodPAG6
bsLTS7uDzLc+c6Wl+i/7iXkNPTPtmKYRd3iiLZd5bvZLjSLL1G9WeJKPc9ifHMee
KJdlHhIT62mknukV+4P77sMr8KIa54cZYhZ65deRfMv+LZbRtTWMNGIlFa175dGN
cnByCMeSFt5YdW1ebXNdH6PM3KSOJ9qE9Ms3IouNPUHoWNr5nsLDVDb+b7Q3tTSG
fso7HHwYuHPPMdU61N2tbhL23vluY3p6cC9RXoMHgR7msaqfeyPTfMCIZWuD6d9A
nOWM9eIx8CPc7TT6ufexy783SwSwa3cWTvZXr8IiOlRkJQA5OzhnJG5ehyLDfCOq
CFW+0CMqJTMghEWUjwXHNJAVt/7oU6YYOLEXzfPP5l3cmieYbXzFbnhKZFJf5nMy
Ei4uoxRfuF+WWoHVPK2lX7tyaW2RifE5lxNvO5RUmdYWt2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpbrArY
3AHX02/VglySH4Yaoqwfmdqout+RYD781eUCnNg95i5iJYZP7ojYZpdQA5+Jk+nD
0VWX9mP7Oa5yXnX/ADkiGvfy11e4h+zReVMzNITbj5uT0b/nF9UtvIGnI+8jwAqf
DNtGRcIvqzSqjjXrgB3bOj0PTRuKe2ZuIuLkZ1CtYwPcZscdOLNHcv3hHcLk6YsU
87RvdeWtTiX7bW0gH3Y8ItL8Qvyjjm0zzfqNlPVXMj8ifnnPdoA8Zp2enAp9zWnG
MBbLeQAcqZqpW5sKZNdNHqSQun7uW3+2PHKwzKe6VOoYE5mYebi5bewaJfRoFJIz
b4CHW5bZdJqUPDtXLpkANG7z3X7yNgeNO+YOaQcrDbye+l5SfDtU7Zq8rs8aRSzf
o6/LQjndMAGkHhlADdbFdZRJLmS5kP2QCcyscWqdPlb8mLuTUPzhvIdPtmmRpKM6
/se5zddnghwNRT9sLdPqfGG4k5VoEr8s2YcE7ohVHqVkYFv2R4ZJCHvYVnBIahHX
KcgZRLzPVp4+Rt0X4vHNdlDmQYBer9XbmWHKvTMDUDZtkdn5/f8AOVl5Emu2UL/a
MifwyGnJpEAHsOmxtBYW0kWyGFP1ZPJKxu7KACC1D4k4Hou4+earJCJLYUnmlS5S
JpN5Awocnp4AHZwMpYV/zgJbOfzn8+XD9hufpGdNppyNB1+Uv2ZzYuM7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq+e/wDnJn/lCb2vTg36sWuZI5Pzi/Ic/wDOvmn/
AC0P+vNNqiXO04vm9wqQxJNB4+GYHMudwCkq1+KOHTLi59YOrLuBmzw44uHlQn/P
u8Mdb85ONkMi8f8AghmziAOThbv1LSqAKevj44Qe9A25t/EDUnbJWGS13kQVVOWK
tiRiwQilRXHZBbYmla4GBJYn59LL5a1YhfUP1Kf4R3+A4CaZQvq/Fz/nHkTSXN6F
Qxr9ZmqD8zmHmN822I3fUV1eq8wsUX02NBzOajNAOTFVkhNuTCW5kftZjiRHJvoL
OmZEDfNFNcuwy7w4hQA0a5E0zoNivfIGmJAbyDEr6ZElrJWyHhG70rQVpjAmwpL5
+/LKOXUPzUE0IMQEozoxEU4sq6P2kkJiRQ53AArk+TRMS6LFlZ6cDX5ZK2ojIFer
jdumCRZx4lxrItFND45AUW4eanX015TUBHc5OJpEr6ODszAoKrTrXLBTQRK343fn
aoP/ADlXbbUP6Lr9PEZhaiIIcjFdvaUmkEcktwhdqkA5p5wFuyjyYz5nPPy/dXE2
x9NuuXQiiQin3/OBcxkvdUKRkKQav45uMXJwJ836dZYxdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVeafmhEJdL3G9cxs8d7bMbBvLUaRaTHTryzDyuV
Dmj2nYdsxgHILlkD/b75dAtcgvNtAZFmYDktaZkxLRIO/KVeMmrSnoZTmTAtEub2
R5hwLnYBD+rJgsSHxTeQtfeaZNUi6RuVrmGRu5Ae9aeDJYyRDc8CaYYilJYn+UED
x6zdM4/my+DTJ9LZe1uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2Kvlv8A5yQ/LO4802cPmPRozNfWjA+mP2gMVeJ6h5+/MjWd
Os/J3lny9JZzBlikuQv2V6csVZP5j8n/AJl+ZUs/yx9eRLKIrLdaiNg6ncpiqUeb
PyFvPyr1PSPMX5TWpS5EytqV0nV171xV856svmvzb+bM3nHQbN9UTSHWRo1r264q
+htcufzF/Pm/i0O80qbQdL6PI1aU74q85vvyd8z/AJK+aLPUPK+jvrtsprNItaGu
9cVRPn3TfzP8+ectN80to0kNhbxkCCmwxV69+Sf5Ya02vy6754Rra4Vi0UTdSoPb
FWaf85AeT9Y/MK9s/LsWmtc6UjKxfsGr1+jFXlGqN+aP5Q+dILmwil1jyk1osQtF
3VTSmKsY8sfll5p86fmNe/mA+jPosEkFQakBj4YqyPRvyC1XX9S1+8vYGs7me2aN
JT/uwnt9OKpR5L83/mP5M8vv+Utn5ZmRrUOkd9vRgT2xVQX/AJx98yajZDWr61c6
nL8UlevXFX195N8s3/k/yc1lp1rx1V4zVR1qRSuKsC/I/wDK298r6re+Y9ZhMdzd
sXcnqScVfVOKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVZI3B
WbwBOAmkE0H4t/8AOV2qL56/NW18hytWNF9an+rmLGbm9lG1W/eSx1exeJuFlGI4
ie222Vzm77WH0Mm/Nk2899bG0mBQqlaZj8bi6aW4SW9tYFtubW3rfCKHK5Tdzqcl
BgI1jTwK3WifUHtjyF6f92ZkYo2LcCW4QkmvR6NDNqGn3wnk1IUoP915eIutzB79
/wA4xeQJ9Hj1DXtWn5y3RLRE98vpqhHd9VrHNM/CV/hyYDtIR2U7mY2RCQ7nK5Y2
ZxbJV5nt1vtInivNgyMafRksewcfJGg+B/y9/LHTvMHmm9SVBQK5yBLpa3TPS/K1
toOp3WlxkLG/JKfPBbt9IPSgP+cftabyR+bEnluDaGQg0+eFxdbyftrd3H1e1a5/
lUHL4upL8HdRuGs/zc8267bR+pcsCVXvWuV6k0Haac0n11cDXbqzt/Ptj9WW7NIm
fvmAS7GM3qV3ZNYPb6XoVvy02MUkYdMhxOZHJTDPNfmy9ivIdI0+xKW1PilHthAt
hkzIePzjJ5kt2XR4fTurY+mQO9O+Xxg67NmYp5r1W206SO91SUX2okBVte4Jywwc
WE7LHLv8tvO3m2H9KnT5ILMjkny7YBsynFgUen3ui3q6dqNyYbwNRK12PbJtIg9T
0bQLq3nmn1O69fUbyP0ye9CNsgQ5OKVMqn0/Vb2307yjCpYabJ6jH2yibsceXozD
zFqHoGHSBte3FFjHeuYxLkeJaVzadqnll44NV5B5vHLYlF082/Pxom0y3aP++5R/
rGZUA4mpns/Z78jAw8h6Dz+0bNDmVDk6DMbk9YyTU7FXYq7FUo1XXbHRYzNqM6Rg
CtCdz9GKrdG1+x16EXOmyq4PUA7j6MVVNU1ux0VVk1OZIVY0HI9cVVrDVLTVE9bT
5klXxU1xV8I/ml+f2s6Nq19YaeCI7WXgtOlMVfSP5FeeL7z5oJ1bVa+orhRXFXs1
xcxWkZnuXVI16sxoMVY5L510SGRYHvIubkAUPc4qyZpFRTKzAIBUknamKsfsvN2j
ajObCyvYpLgGhQNviqdXV5BYxme8kWOMbksaYqlWn+aNK1VxDp93FK56Krb4qmd3
fW9gnq3sqxJ4saYq8083fmZpFjot/qGn3iGWBSBQ9/bFXifkb8z9b83aDdyLITKG
pG3fjXFX0J5X1u3sNLiGs3ievTk/JtxirJdJ8xabroZtJuY5+JoeB3H0Yqr6trFp
odu1/qkqxQr1ZjiqT6N520TXohc6beROhbiKsAa4qyoGu4xV2KuxV2KuxV2KuxV2
KuxVD3cfrQyRfzKRglySH4g/nrpbeV/zGa7I4rPLT/hs1WVz4vYpHV4oPT6tT9Wa
fO5uNkcDghbUdW65rqchKfP2j/pvydqvls7tMNvoGZmncbKWN/8AOI/mIahpF7oF
yaSaW3oqp9jm4jDZwTJ9xadKKimVDm3Dk9E0uYbHMzHJomHoNi4YcfbM6EnGmEVE
hLGQ/LMglrIU7izFzBLavusilfvwWr8Vvzz0O4/KTz4+tSRlLG6k2btu2arV47kX
MxzoPoHyhq8d3HBrlg3qxS7kD5Zq54acrHkZ5X6xK95GeIPVcxTByRK0fa3XA1GT
gaYzFsntNbaKmZuPM4s8Vpl/iN2HXJTztXhJLeau0tQcxsmS26GNjc9wWrmLLm5Q
FKLOLKB74/vJWWgOThjtZSeE/mV5tg8q6DNqd7IBczKwVc2GLA4uTInn/OCnkK9n
vL/8xb9CkN6G4Oc2mkjTh5p2+8fzS/MvSPyr0s+Z/MkoaGMclrmbTj2+Rf8AopB+
WEtu93Hdxi4T9g9f14aRaUXX/PyL8vDGGSeLkw+IU/tyqYZxLDZ/+fhfkK6lEds8
bSOaDbx+nMLJG3IjN7f5N/Mmw/MaD9Lacw4U5UG2YmTFbMyfEv8AzkHIfNHnW2tb
Y8vTdage2COGgzhJ9QFPQ0e1j/aVEB+gZr9Qa2dhCbH5D6hkB/lzUTy7ttsU1SUa
dZtfOfhi+I/RmdpBZcTIEy/5wD01n88ebPNFP3V8PhPyIzqNNjrdwMw2frNma4js
VdirsVdirsVdirsVdirsVdirsVdirsVdir56/wCcmv8AlCL3/Ub9WSAteG35w/kP
voB/5iH/AF5pNY5uHZ7oQCSGFVpuPHNZe7eZpVryKNNm9O2rGFzZ4cjiSNviP8of
zO83+R9Y80DyVbPwkJ58PnmbxrDHbPbz/nPvzbo6xaRc2TyXifCdtwfvyMsjOeh4
+r2Dy/8A85E/mp5201r/AEnS5qAVqPbBxpHZHmxqy/5yo/NaO7OiT6bN6wbiP865
YJMh2Ue9PtV/5yI/NjRT9d1LS5o4yhoT/t5MNn8kebDNP/5y0/MbVV/RtnZSvMZK
gD/bydr/ACR5vRNd/M387NZ0K/KaZcRWzWj833+zTBLYW06jQ+CLt4t/zi2moz6f
Nc6m5S6M0hZT1r3zEylx4vrhmhaOky/v+xzWZg5EQh1BAo25zHLcuy2BVqlNsyZy
2RbeYhmlunfBxItrDbElcDXEFrK8UOx6HDEeoIPJ8QeY9S806Z+Y7/4Htnmk5CgT
xrnQW4GM2X0trn5x/nH5ciEmr6HO0YUUJr4ZIO50+nMnm0f/ADl9+YQlNp+iZYnO
y/51xunY/wAncXVlsf59/m2LY6jPpkwgpWvt9+VGbRl7P4eqXaB/zkl+afmW7On6
Pp0zyg0oP9vKzOnXTw0lvnf/AJyl/MP8tZwPO9rKitvxYHb8cjHNZc06Oo3aT6F/
zmb5+86usfk2CQx1FQo/tzMjk2dfk0/m8mi86eYda/PhfMfm62ZbxNPNeXXYb5jZ
pbMIQosl8wf85naR5VvZNG1OAAq7DceBzC8O23xKSLzF/wA5ieXNX0uSyjCAOpFK
eP05kYsTRPKnX/OLX/OaPlT8qb3UJfMEgFnOp4AdjmxiNmm7fql+T/8AzlZoH5zT
pH5Zo0bGhNDklfWGKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVg3n
+1e70704hU1yrKGcC870239DT0tztKrbrmLOLkR5olQekgoMxBAuSZO9NT0OWCLW
ZIuzthKxj6ua0Hjl0Q1yK78tYXiOqwkUf1emXholzeia5I1tpcsi7MEP6smOTDmX
zJ+XdodRF7cTL8YnNPvyvh3bbe8eXtOfk8jL+54EV98kIsTKlLyhof1C/nukWiGu
/wA8nEMZF6XlrB2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2Ktd8VbxVoKBuABireKoS+tRfW8tmxKiVGSo7VGKvHvyw/KKL8uNS1
HU4JvWF/uSeo3rir2zFXYq7FVhjUsJCo5gUBpvTFV+KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KsF8+efbDyDYtq+rnjCgJY02AGKvkRv8An4P+WMEr
2c+pKJkYqQQBuPpxVef+fg35YAlP0knICp6f1xVSH/Pwv8rmFV1NKHau39cVfSv5
V/nToX5tQG98ryetBSvMCgxV7FirsVdirsVS/Vbn6paTTkV4o36srymggvw588Bd
R/O5tbdv3gjZAMw+jteyMW70HzDcizt+EsfOjFxmPkLvtdiPByYXNq0WvBPVPGdT
TjTtlVuFp8Zt6TbyNBZxKBzO3Ie2CQdrqoelgP5o11N9IsY/ht2lAkUdCMzcPJ1W
SWzxrzTaLZNqmkW0QjXiBA4/Z+WXxIdXmm/QL/nHHULTWPKdtZWlx9Yu7GOlwSd1
OXBGOYe1FGd6RPU5ZbtMUwiDbrGQ0+7eGQkW45Aw78yNWXT9FnupgFKo1BX2yu2q
ZEg/OPyD+bkui+YrudIaxnmvLISLpa3eleX9a/T1+2o3i+nyaoPzORBdrpR6WG6e
36J/Ni31UijSOir7nLI8nG142fuTZCS/0yNbleLyRLUH5DMiJdO/BrzHbXFp+c/m
vT3YxTW+/Hx3zH1vIU7XSC3oGq3ms+ZxaTazYBbXTd45j3zAp2AiyW11eFIjBa3z
F5wT6fYYabg8zWW61Cx1Frq4ZJ4ZKRjxGWwDTMEpfLr8lkkFnpkHo6hIAtFG7175
lwi4OWJL60/Kf8k9NsYk8x+dUE+oSgSIH6iu+SyRoNWKBB3fSKQs0QBf0baPZYB0
IHbKohzuG3m/5iflxoPnXTJL/wDR0drqcYJSQdWI6ZZTVLHs+CvLdhPp3mG9sfNM
xhuIwfqoP7TDoMqk4hlRSHTvNOtaD5omXVWeN5zxCkHp2zHm3Ysu72qa3EvmbQdQ
vf7z1QVB75TTs4bvTP8AnIXUvrXmDRbG0jAZyOYHyyyDZlNPmD80rQa1q1p5esz6
lwXQemPYjMiDqtRlft5+WVk2neVdJsZBxaK1jUjwIzKjydVI2WdZJi7FXYql2r6j
FpFjcapcnjFbxPKx8Aorir88/JVrrP8Azkh5jvdTa6lg8q2zsIbhP92EHpirLtd/
KzzV+WOtw+aPL9/LLokDB51r0UdajFXzpYfmY/52eddWsvM2qy6fpVkaW7AGjUxV
fpXn/U/JfmhLHQ9RluNHQkPJvSmKpBqurr5h1e7uQ3O3lmHJz7nFX6efkz5YXyx5
dgiQ1WcCQfI4qwL/AJyqi1yXyZJ/hNmW4EgL8OvHFXyD5P0G38y6NYxWOtPJ5lS4
j9S3YkEb79cVZd/zlF+cOq6LPpn5Q6RcvbagFie5mjrUpQV6e2KvOfMJsdL09tX8
s63Kuq20ImJANXelaYqwCH/nJvV/zdsNM8mX1xJZ3lrNxu5gDVkB74qzzzLd2v5d
3NprvlfXJbmWoZoqHrirL4fzD138/Nb0ry5FcSWsKtxmZajFVD/nJr8objyToq2v
l/U5XluiKqxoTvvirGNLudT/AC/OhaTazsYbm0LXB8Gp3xVJfyX0fzZ+cPmu9gvN
Qmi0qGZl5b0pXFXrumaTd/lV+elr5a03UZZ9Ok083Elqa0NBUn54qjLa41r/AJyM
/Mi5hivJbTypZRtG0adGZNiPniry3/nJ7yhq/wCRuoeX9T8m6hI8V7fRwtaqT0Jp
WmKv1Z8uer+irI3f98beIv8AMqCcVTnFXYq7FXYq7FXYq7FXYq7FX5Kf85xeXbiw
12w1+OKlt6wLP7VzW5IubCWyT6DqMeoQ211E3KDb4vozSaiLnYjbLIp6SzXK/ZT7
Oa+nJJZrAI7mOIv0kU1+7MrA42V8gflxfSflv+ZU/l2/PoRarMZEHZhXN3j5OBN+
mVhdIJFhDVZt1HjmMebd0Z/b3aWbLHdNxdqUGX4yxIeg2dzx4gdSNvlmVCbRIMiV
m9IcNycy4StokETFXiOfXLAWLwf89/ye0384dEm0uZR9fgUmEjry8MqyY+JIk/Jr
TdV8xfkZqUvlnzjbvFZxsRG5BIIrtmDkw30ciE31R5U84ad5mgS8sLgEU+IVGa/J
iPc5kMjORcxE/AwplBgQ5AIKJS5T+bI7rQVTdIO+RkSjhCk86kVrkQCWWwQj3UKq
VdwCRk44ySxMgHkPnj8ztO8n2xtriflLUkDrmfiw+TjTyPEvJnkLzJ/zkZ5gijlt
3GgRycmkIIHHrmzxYnCnN+yXkjynYeRtIh8n6OtLe2QAnx23zMhCmkytb55/L3Q/
zB0eTy15mt0ntZUKgsK8flkrRb+bj/nNj/nAm8/Ka/PmnyZbGXRnPJ2XkQo3PbIk
hIfmM9hHG5hZP3vgajKzJkA+m/8AnHnSfJNtrVvJ+Zc62kPJSOQJH2somWwP3k8u
/mh+XGgeWxpvk2SH6r6RAuVK1r2GURG+7O3zT5Bil84ed5dWkHqWIqVkrhyUAyhb
6nuydrf9len0ZodWC50JJFPGx5tEK0GaSQNtvE8W/MzWRD5a1O0ib/TDAwjXxbN1
2fAtE5PsL/nAryudO8hWutXy8NQn5GUHrnYQiBFw852feOLiOxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2Kvnb/nJ408kXlP5H/VlmNsxh+c/wCQw/518/8AMQ/680Wt
cmD3eNA78DtXvmpKJlLdeil/R93bpIeATrmZhLQC+Uf+catH1K/13zTHaoZoFLc2
8MzidnYaeNh8o+dPyn81nz9NfXMUkemtNVXoaUrkZToO/wBDhifqD9F/Jcmv+UPL
jSaVKxtxG3JgRttlPHu7Ixxjo/OyT8wPN2refSljdzU+sDoD49MvE3Xzy4wX2x+f
DfmFdeV7ULDKjmEUYA7inXJRy+bXk1OIDm+OPyp0nz9Y+Z01C7aUWa0LMajcfPLP
FHe0DV4geb9VH/5ye03yd5LutJ1eb6xqdxbPAkJ7MVI7fPJyzWKDgdpzx5AJRO75
i/5x68u6hJBPrOqStb+tNJIsfsxqMxck+51UQ+mDXmCF5gd8wp7t8QqPKHbfYntl
VNq9o2RebDbJhiS0imQcl3w5CeFhxKUkqxEJIaMemYgtPEipImhUPMKKemSCLU3Q
pSopXcZMKtHXCEKgX1P3RNOW1fDJx5hafKZ8yXH5X/mUNb1GraZ6gJlIrtXNwZtE
MFcw+j/+cgvzuT8zNEEP5e3ZaXgKhaDfvicve7PTyjAU/KLTdI/MqDXkkuHmmQv0
3NN8Esgdhj1Ue99++dNS856Z5G5uJFYRb7Hwyjjco5YyD5p/5w8/MXzBJ52MGo3M
gHJtmFO/vgkXGhg4jye2f85beWdV85TTSXchkap9MVr29sxsc6Lt8unHByeL/wDO
JH5Z+a9H1hor9ZLe3Y/AaHcV+WbAT2dDmxU9N1G1vND/AOcik0rWY/VEtgRxb+Uj
rlcz6XVyFF59/wA5Rf8AOLFr5jim8yeU4hJc/E7Itdt8phkpom/IfWvL9zoF7JpG
pKYpUYggg9jTNljcSRZp+Xel6FLqcQ83uF09Wq7EEimZATHk/pi/5xS85/kro2gW
Fj+X8ls17QCRxQEGgr1OFk/Qi2u4bxBNayLIh3BUg4qiMVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVU5YknQxSiqMKEYCLVIh5atQZCK/F9n/J/rlZxW2eI
kk3lJqfC1coOEht8YJc3lKYdP14RiQcqZ6N5fe0mEs/bpkhBiZozy5pJ064vJSKe
rJUZOMWuRT3U7QXlrJbfzA5LhQGF+S/KcWjwzh1+J5CcPAniZxa26wRtGnQ1wiKC
VS2hEK0Hc4aQicKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV3Tc4q8i/NHzD5Oh0uex89TQi1KMCHZfDfvir+Y7/AJzX
0ryBbazJeflZKsnKRiwjFQD9GKvhlohyDo5aVhTjTfFX21/zih/ziTr354a1bSm2
K6bA6ySsysAVpXFX9Pn5Q/lBo/5S6VHpOhxKh4KG4im4Arir17FXYq7FXYql+qwi
e0mjPeNv1HITFhIfhh5pIX83prMiko5kfLMQinoOxo7vYZbaO+Yi63VRvmJkL0Gu
j6Ergi0eKUoir6njlLrsOxRrTfVm9Rv7rLuF2OrNRSDzM0ST6brUY9SCKQNIvWgy
6MqdBljbAPzc0cTBvMWnH4L0D01GWRk6rPDdj/5Ved9T/LmZdRhVkta1uUA2b55k
RlbVHYvvfy3+d2h+ZYBcs4gZhXsMlxU7HHPZNtV/MbRbS3a4iuhJIAaCoOQlNnKW
z5K/MXzZqv5hrK+nSMlqlUKjYHbK+Jsw7h4r5Q8k/o/1bm93PInfKyXX8NF6/wCW
UWRRHAg2bbJRLtdKPSxOWP1vzAs7RzW5ilVgMui4WvGz9xPLMkkumWz3H2/TSv8A
wIy+LpYl+NX/ADlPob/lp+acXne6QiPX5wjGh/m75HVx2DttHKk482wXnmXSbptI
lMcEKg0U9cweB2gLCddvLS+0zSbXy6gN7bx0uXXrX3wCNMuJBaPeh+VjPF8bH4iR
lkQxJZZqGj2txdWuqW4HqRMg269cyYFx5xffulyRXVjZiYVcQrucsyHZqlGt1S7R
p6JF0GVxb8PqV7WZF4291vuOuTIbMkNnwj/zkB5WbQPN9r5xpWyklFPvyqQdNmFF
OPza1LyzrVnouoaLHG2ph19elKgDxpmGVwGyxfXbC5vp7TW7Wo+qEMlMhVO+xQoW
1C97rt4df1piPq+6FsnGLHUHZJfyK0Cf8zvzYtdUjQvp9hJSZqbbN7ZkwDz+fJu/
b+GFIEWGIURRQDMkCnGVMKuxV2Ksc836YdZ0TUNKXrcW0sf3qcVfAf5M+erz8kbS
byRdWJaFZndRQjcnxxV7J5c81+Y/zhudU0WaFrXTvT4gGoFDir538oWGl/lnrmsa
HrWkpO9SEdkr1xVNbfTpNRt767stIRYmrwohxVgHlX8utavNRFrNZmKCeQN0Pjir
9WNCsjpunWtgesUSIfoGKvmb8+vPmveTtRtjp1mbzTGUeolCR74q+WfOi6j518wa
brv5bab+j5FkjM5hUjvvWmKs4/NLyFfeWPONt+b2t2Yv7d7WOBw4LUam+2KqPmjz
Hpnm1dM0vy1occdxcTLHPxTopO9cVY9/yq21/I3zlc+Y77SkubG+RQg41AJ64qyy
5Sx896jDbafoscaV7JTFVKSxv/yk8xwanYaaPT5VPFTirC/zu87+YfzX1vS7XR7B
4be3Px0BPfFV3mryp5gkjtbg2rF4UCdD3xV9Wf8AONnkabylp891dQenJcfGT3qT
irziz8s33nf81LnzHrcH1X0raS2jmAP2KU64q8/8seYbj/nHvzHeeXdJtxqFtdSv
I0nWlT4jFXkuo32rfn3+cNrpd6zGzsXS4EP7K0NcVfr/ABRiJFiXoqhR9AxVUxV2
KuxV2KuxV2KuxV2KuxV8sf8AOV35dt538pTyWy8p7ZCwAr/DMfLj6tsJ9H5k/kxr
Bgtrny3q543EPIIrbb1zSaqDsMM3vlnT00iP+zzUTFOYCySymeVwseyR9MuwmmuU
beJ/nx5Ll1vTj590AE6ppjKFIryoOubXDk2pw5xt77+QP5mWn5kaNb2krhNVtIxH
JUgHkMEtisS+k9FnKyMus7uhopPtjxUkhn+m6j6h5jcdB8suhLZrMWe6ddclocy8
cnHnFN0bkdszocmotBVDFlHxdzkmt5N+Zn5Q+X/zRtJLPV4ENyBQSU3GUyjbbGVP
zI89f84sedPy8u2v/J7PJYg14rypTMTLBujN5/D+aPmzyQ/oa5p7sBsSUJzFlgDk
RykM30//AJyBgnUT30JiPcccoOnDd4yPf/nIrSp29JVIPT7OVy0y+MlWpf8AOQ5s
1K6dbGZj0+CuSGmARLMwiTzP54/MJ+OjWMkQkPEEKR1zJhgDTLJb3f8AKn/nDjW/
MN1HrX5juxiJDcXr37Zmwx7OPKb9MvJ3k3R/JFomj6BCsIRQDxG5oMy4xpokbZUV
UBmA+Km5yxrAU3cC3L/yiuQlJmAwDzVoukef9Lm0HzIim3dSCG+WY05tgD+eH/nM
z/nCi8/L7Um80+VIeWnyOHHAMaDrlQytpgzb/nGL/nGPy3+fvkq8m1dVh1WzqoLA
g1GVTyUtPlj81vya80/lhqcugeX7uWWFHIWJakEDJ+Jta8LI/wAtfz083/k08a69
Ys1uaVZlPT6crlPibYin255V/wCcrPK/nBUF7c/V7lqArsNzmvz4CQ3Rk9ng1W08
wxB9HuwV2LEMOhzUy04tmZvnfz+D568z6L5J8ru0kyXQF4U3+CvembjQ4+FplN+4
v5eeULbyXoltotmAFjRdx8hXOkB2AcTLOyznA1OxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2Kvnj/nJxeXki9/1G/Vk4FnA0/OT8hj/uAI/5eH/Xmj1rlYzb3eM1k4+O
amt0zikXmRZYbK84mo4Zn4YuOIpd/wA+/IobvVvOEd0oILUNfCormwjAHm28ZHJ6
7/zk1e6P5O0xvqtqjyzLUNTcbHMfLAF6TsyRkDb8btF/P3X5fMDeXFllNjJIFMdP
hoTTIHEG3LPd+uH5I/kL5Z1Ozh826hBClywEpYmh2Na5WQ6vUSro9G/NL/nJH8vP
INm2jz+nqFxCpiCNxYAgdMFdzqMhN2X53a5r+r/m7fNceS7T6laOx/uwVFDhumgm
3oPlj8jbW1ZL/wA2t682xo+9DgOTuWG5e4iC00u2W109AFGwpkeO3JAV7eM+nVjT
IEN0Vk0qFVRBVx1ORASUUsDzx0cnJVTWVCG3o3ocyAe+Em9mBVjGLclJVDeDHIeE
i3fV0kHLUJwg/ZUsMfDW0PGjqCJTX+U+2RMWVr6U3wcktcu/hhB3THmx/WfLOnea
YjaajbpIW25NmccrlZI0Hgmu/kJL5fc6poF46KPi9Ja0weI6zJkpP/yu/OC3/LzU
Gt/P2mJJAxpHK61P44CWoak9z9ArXzD+Xv51acunabcxqzLQxVApt0yWxdlpdTKO
/N8Bf85EeRbL8lueo+VbdIpeoli3PSuSEXo8Gaxb4u/Lb/nIW/1bzNBp/mVnukMi
rSQeLZX4O7lHVmqf0E/lro2k3Wk2mqRWMaM8StyA3zOhGg8zrpkS5vzP/N70B/zl
bBM7UUaZxp2rxGY+YelweN7ctvzuJbebaCSo+/MO2JFvz8/5yh/5xntLm3uvNGio
GnKM21etc2GDK404MN/5wL/5xy0P86JdW8pecUVbiCNgCwNembKJtAD0z8zP+fe3
nr8tp5b/APKm4lSCP4l9Ll44UsI/Lz/nMX82P+cebw+X/PdjPd2qHi7yoTQdO/yx
V+on5Mf8/BvJX5hottrcy2d42wU0G9adzir7z0TX7HzDbLqGlTLLCwqCrA/qJxVO
cVdirsVdirsVdiq1nVSFYgE9AT1xVdirsVdirsVdirsVaDAmgO4xVvFXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7GldirQFOmKuAxVpVC9MVbApireKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KqE1zDbgvcSJGo6lmAH44q+Z/zS/wCcsfIn
5ZQzC+v45buOo9NGU70r44q/Lv8AMz/n5jrGvXEmkfl7ayOz1VCiV6ig6Yq+d9G/
LL8+/wDnJfUxc6j9Yh0yZqmvIAK2xxV7r51/5wI0f8mvJlz5x853Dz33pOeJqfjA
xV8Vf84j/wDOJF/+d3m2TV72GRNGjuDQsjAFRir+nX8qPyk0T8qNJh0fy/AsbKiq
7gUJIFMVerYq7FXYq7FXYqpTp6kToOrKR94xQX4i/wDOQGlN5G/O+HW5xxtZYSK9
qkZjTi7fsbJuzm6lb0PXh/3YOX0HMDI9Brso4Hm8kJiuDOG+KvTIRdZjy7ofUfMN
zwMBU8QOuZcRs5OuzjhDJ/KtHtZY9R+OO4XjGD2OUzO7dp8Jnj4llxpJ/dR6g37m
0NY0Pf6MILr9RgKS3T2EkjNNEBA/2lp/DMiJpxBhKSX2n28qEaUzQp2oKYSXKjiY
pYWl1ZXYa6neSGoqOuVym1ygXqk97DPw/Q/wQBaSdt8iJN+GOya6NaW1zayc3Bff
auQJdeeaW2WuL5dcMqVUPUmnbJ43Y6c+liH5cLN50/OtdTthys14dNxmTBwdedn7
yW6CKJI02VVAH0DMl04fHH/OaP5Nr+ZflJtet15X+iqbiAAEkkHtTIZBYcnBk4X5
h+RvO99rtjZ+WXJiut1ulOxFNt8oMXMjnekaXYweS9Q/RLgStenYntlZbo5gmk2o
WFr9YkiQerGSDt3wMzlDxfQvzFkj1v6hfbRGUEV8K5bGTETfqT5P1mx8waRBeWjg
siKuxGWcYKJmwnssrWvxAVBycQ5Ok3QqKs7CWU0FctMXPyR2fHv/ADkD5jh1vU7f
ytyBjgkDVr75RN5zUj1Plry1qT2PnHVtPv6ta+mPq4I25e2Yswx0vN9L6RPJLbwR
3AoB9oZAh6rFA8Lzj80fOhsNPudD0paXc9FiA6mu2GIdbrDT72/5wo/KWb8v/Kx1
rVYwL3VKSsWHxDf3zKw7vO5DZfbWXsHYq7FXYq7FWPX/AJU0jUpVub2zieVTUMVF
fpxVNrWwtrKos4Y4q9eCgV+7FUru/K2kX0zXl5ZwyTt1dl3OKphFpdnBH9XhgjWP
+UKKYqvTT7aJlkjhRWXoQoFMVRmKoS7sLa+X072FJV8HUH9eKpbp/lrTNKkM+n20
cTn+UYqmV5Y2+oxm3vokmiP7LqCPxxVJbLyfo2nXBvrOzijm7EKNvliqa6hpNnqq
iPUoI51HQOoNMVULLQdO048rK1ijYd1UVxVWvdJstSKm/gSUr0LCuKoSDyzpVrJ6
8FnCsniFGKphLp9tNtLCjfNRiqKRFjASMBVHQDYYqk2q6NFfWlzbwKsc00bgSKAG
DEbGvzxV8F6H5G8yeSv0hHr9t9dnnlk9KSQEkKTtir0j/nHr8j5vKus3f5jayON7
eKUVD2BxV9j4q7FXYq7FXYq7FXYq7FXYq7FULfWceoQSWVyOUcg4sPbAQr8Tvz//
AC/vfyy8/fp6zQx6XJLUkAhaE5p9TFy8Mme6TrUWssLuyNYpOtM0GUUXa4+TLmvD
bTRNb7xL9sjIwlTMxZWhtorSWGgkguQeQO43FMy8cmmUXxV5p0XWfyN8yx695X5G
xu5BLIFBoKmpzYcw4PV+jHkv8zNM8/6PbSQyKL8IvNQRWvfKjs2jd61pl36CiInf
JwKCGfabqgAG+ZuJxZBllnqKMd82ONxppks0dySiGhHXElAaEkdWgQkP3NMKWmjD
L6FwBIp7HHgtHExDW/IXlrWEMOqWEDFu5TfAcV8gnjeMav8A84n+TNWczLH6YO9F
G368h4LIZEm/6E08kjdVbl40/tyMsBKfEZZoP/OMnkzy+RM1us3Eg/GtemIwoOR7
LpflPQ9MjUaXYwxhenFadMsGOujHjT4hnoynii9hlnCi3LJFcsUSvMdTTDySse6j
RhbLu3Q1yMitJRrNylovGJqk9RXMfJKmyAeearqkUsfoD4XPhmvyzcmMXnXmrTE8
0Wn6I8wIstqVIBbegplBm3EPjDzJqHl/8h9I1DSvJk3C/u5CQiHffJA21yFPNvyy
8j3HmnUh+YPmzlIu37uStDXKNdk4caMcd3qn5g/lfofnm2Ns9lCkVCOQG+YGlz31
bzB8Oeff+cQrBGa68ozOtzUkBQdjm7xkkMDF89aneeevyLkf63JLJE/wqNz7ZLwA
ejVI09i/5xU/5ylsfy1813Hmfz3aFpbv4Q0qU4mnUE5dDHTQZP35/LL/AJyR8m/m
ZBG+lX0KTuB8DOo3p882IGzSXvkc8cwrC6uP8kg/qxVVxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2Kvnr/nJr/lCL3/Ub9WFhI0/OL8iB/zr5/5iH/Xml1Zc/Tm3uin4
9uua4DdzDHZJNdZ1sbyu/wAGbbDBwcgpb/z7ydZNY83im/qCv/BDM+MHHMn2r+b/
AOUdj+YlkYbsonFerGnbInGHadn9oDFtLkX5Heb/AMjPLH5T6tJrayJPcI1QoPLf
rlJDm5e0MXej7b80vO/npB5f8mxvbQAcKgcfhOxzHnEBwsuvxlNdA/5x5iFyNT83
zNcTMecgff4u+USk0+NAvoOw0+20G3Wz8uW6Iq0FV2OUkuRGUD0RokWcBLliZgak
HKpljqAOHZFSTQBeKipyMS40EKjNN8A2GTDYFwVYa13IySkq1u7Tk1NExLVJLNa1
vRtMiYXd0qSD/KAw4RcmsvlT83/+cvtF8qRLpujussyChIIO9M2ZwsbfCeq/85Ve
ZvPXmC1ttFdxF6iAqvhX2yBw0m37C+T72fUdFsrm+BExgTlXxzDnFsDI+uYk2bRp
0yFpC4LNGOUQHHxy3jQcwlsEI0lrX/SZHL/y9skDbUcRklmt+WNJ802/p6zbxIkY
+BgNzmRAFiNLLufPOpflhqnlm6OueQ7mVOBrwWoGZMYt0QY80t1v82tU81Qjyx+Y
Ftsvweow38MmItkdWAeb0T8lf+cT/JmuavBrwuY/VJWRVLU6HLYYyS7CeccNv130
DS20S3h0i2RTaRRhAw9syeCtnS5snEbfj5+edkB/zlbaRIftacHP0qMwtSNmmMrL
6E1ajERQfaHhmnJ3cvGLYj50jUeX7pLr4/3TbHMjFJtOJjH/ADgT5JjTzDqet2h9
Ity5cds3uI3Fwcoov15ZQ4KOKg9RljB4r+Yv5B+UfzGtntNY023LS7PJw+KmKvyr
/Of/AJ9kz2876x+V8zxyIeSKlR03xV8nW3mz8/P+cZL5YdYW6n0uEgHYsKdcVfqb
/wA4h/8AOZ9x+fV1HoNxaNE8Y4ysyUPKtMVfpJir5O/5zC/MvUvyw8j3Ou6AxW6V
HIIPgMVfHX/Ptz/nJLzT+dt1qkHnCVnjh5FeR8MVfrAde00Eg3cAIND+8X+uKqNr
5m0m9mNnaXsEk4/YWRScVfFn/Oanmjzr5U0y21DyHxBqAKNQ1riqeaf+bus+QPyP
l/MrzrKn6YitWlRSwry7DFXln/OCX/OZNz/zkyupJr5SCe0JEaMwBbfw+WKsO87/
AJifmfqP5srpGkOI9Iin4hQ9Ay18MVfqDa3n1Wxhn1iRIpfTUyFmAFab7nFUttfO
ug3rGK21G2dw3GgkWtcVfN//ADmX+ZGtflj5AuPNPlVqSpyqVO/TbFXz9/z7v/Pv
Xfzp0u7vPNTs9wrMPiNemKv05xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuwFWhXvgiTW6qUUvqFlp9k0zHwZMkieON
DoyICqa9svlI3sEN5NDsVdgJPRXYhXYVWu3EFvDK8siBcRZSFsTiRQ46HBhlKUbk
KKlUy1DsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVYt5j8
66J5Tt2vddvYLdFFSHkUH7q4q+APzi/5+PeSPJUcln5TlF7qCbcdiK/jir8z/Ov/
ADlP+cX5+3RtfJ8FxbwSGg9IECnTtirNPyw/59++ePzJvIvMP5mXNz6R+J1aprvi
r9Rfyf8A+cIPI/5cotxPZx3M4NQZIxXrir7I0nQNP0KIW2kW8cEYFKItMVed/mz+
WFv+aunr5d1c1sCasB1riqO/K/8AKvRPyq0lPL/lyCOONTyLBQGJ9zir03FXYq7F
XYq7FXYq7FX5bf8APwHyFc3q2vm7Ro2a8gZa8RX4RSuUzDnaH0cnl/k3WYPMOjQT
2zBpkjSOQE9CBvmBlg9EIjNGpLJPL9sLn1nY1ruO2ViNKNBALr+w0+5YWicanbbr
lwmWvUacTFFHQWdroHpRirhTWlK0yJje7kYsxxx4BySDzuJf0ppeq3BI0vmDME60
9xiBTjZJGXNQ8632hajrOmH8vVkeOo+srKuwyfEWmQRHnu2cWfHTI1WcjcKO+Imm
y8s0Ow8xWw9W5hR4z1qKnIliQSyTVLeYWouIF4QswR6CnxHBdM4DhDp/Ll15SSN/
WLy3ADKK1HxdMIFuHLEA1rl7e6PYz2urRIJGhZlaniMuhFj+YMBQeu/84LeRH1S/
k8y3yH1OZIYjtQ5dEOFm1BmKL9fFHEBR0G2ZDhqNzbRXkTW1yoeJxRlPQjwOAi0g
vxP/AOcofyK1b8ovMd1+ZHlCJv0XePynVV/uxXemRlAObixiSX+RL6y892MXmOCQ
Ga1X41c/FX2GY84uyx6OB6qrWq2Us0t8p9KYk1plBLKemiBbznUPyq1HzjqSXvlR
BVfbETdblmY8nrvk/wA56t+TMyaN5qDC0NCzeBGW4pcWzi/m5Ho+nNO/PvyjrVsC
twBJTcFhmQZVycvT62UejGPNH55aKtu1noMnK6NabilchLUydlHVylzfGnmSXVtU
1ObzDqCnnuwoNvHMc6glqlpRM2UPFpk9zcad5jKKS8o5gfaIHjlJylENJGBsPofV
tVs9OgfWdUZY7GNQXCmhApjCZJAc3JrpY4bMF/JD8vLr89/PUHmO9iYeXNPkrbsF
2dQe+bE4A6HJ2hOfN+2VjZQ6dBHZWahIYlCqo7AZOMBHk4hNorJIdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqm8SSf3ihqeIriq8AKKKKAYq
3irsVdirsVdirsVdirsVdirsVdirwX8//wApLD81PL01jegrNGpKMo+LKMmnjPmz
jMx5PyQ8rXeoflXqsvkjzKhS3ZilnI4oTv3rmr1HZ0Du5mLVSD3+x1FIUfSxR2uv
2uoH05ps2nEOTsMeUy5p9pzPpNNOlPMSdCd6ZhS1UonZzI4ARumeoadaa3p82h6w
iyPKDwY7keFM32CXFGy6yWIWXyQ1t5i/5x91g6xbB5dNd+VDuAMzI4IzazGn3R+V
v50aP+Y9uj28oTUQoLIzAfPLPykQr3PTNY+uN6dnWo6lun35XklwcmmcWXW2twRs
LXkTc+3SuYU+1ckOQaDiBZNFqssIEc5UMP5Tmx0+plkjxS5r4YT6DUfrKcU4j/KP
XMkZig4wj4aRrxZqsffLPHLUcaLFCPiAPzwjKSjgDdKmvTJeKUcC806HI+IV4VEF
U67jD4hT4bTSLSi0GDxSnwkDMebeoGAp2rkfHLIYggrzVFQcdgfFcj4xZjEGNXOq
MRV/sL3HXMDXa+eMCgy8MMbbXLa6lKaezNOP9+dMxMevnPmEiNMR1HVDJdC3n4pc
9idk+/MyOIT5t8Xy9+b3/OQNj+Xiyabpj/WtRf4WCEMASO2Wfk497YS+YfJX5Za1
+aOrDz95lJS1DBxG+w65VKEY8lELfWE9zFaqljYRqkEScCF6GmantGX7um/T4QZb
setbqT45Im/dCtQTmq00zFycmAR5Me1DXLSyt5b+EgLGCX57dOtM6HS5idnX5Nng
flfyJN/zkP5qhjvLfl5dgmqknEmrA1ofbNxjxg83BnlJfbH5gf8APvfyX5qsgLGF
IbrgoqqU3p88ujhAaibfmx+YX/OCf5m/lRey6v8Alnd3LIh5KoJp1y6qCoDyN/zm
T+a35CXK6d5+tri4ING5qSPDuMih+l/5N/8APxPyP57jS28zTpY3z9FLKN/ltir7
t8teeNF81wC80a7hljPSkikn6K4qy3ruMVdirsVdirsVdirsVdirsVdirsVdir57
/wCcmf8AlCb3/Ub9WRnKkGFvzj/Iffy+f+Yh/wBearUQtysJ4Xtz1Xk6/aptmuls
XNGQ0gNeRo9GmuQRzZfjBzMw6guPkFvC/wDnEb8+fLf5W6r5tXWWIuJWrGo7kGv8
M2+OfE4Mo0n/AJ+/5yX87fnDctp3kuN7bTYTR3X4SR0yjWZTjqmWIXzSDyn+TEtx
ONa8y3c9xMTyKSkkVzBOrkWw4QXvdtZWWlxiCxgSEgU5RihyuWclj+WCMgYwg7l6
/wA2VGbIYQFgXi3NdvbBbdGVLhQMZKDkcrnyZSyE7LVUA1pldsQV7qJNunyy2Mk8
ZdAUkLW8h+IfZPjlwjbHxCketG7sLWURj98R+7A75IYwWMpvy2/PHTPzMuJLm+cm
GwB2atDSmZWnxRu2uRfnZdy3kc8w1SRpbjltyNc2Mg12+rf+cOPIcXmbzNHfXsRM
aMCfh2qDmPkZxL9yYh6cUcCqFWJeChfAZgTi3Bvp0zCyBsG7VcqplWzt/E08Mt8M
Bx4wAVC6kcSi/OmSiKbo5CEEbRWcSFjt+z2y2OUhn45TBpuQC8QAOwyf5gtcp8TE
/MHk7SvMqenfQpGafaRd8I1JaDhBeDat+V/mXyLcjXvKF7OwjPJEDGlBvTM6GcgN
/iGqfQH5V/8AOaupaFImjfmrA0cUdEEgG/zrTDLVSaJQBeAecfPmjfmR/wA5M22u
+WZDJB+jgOR8eOUZMhkLYjCAX1DIKXJHXMCWMN8ZcLFfPEf+4q5cn/dZ2wDZt8Yp
3/zgUK6lrD+K9PpzfaY3AOFkNm36d5ewdirRFdjirDfM/wCX+g+b7d7LXbKGdHBB
LICcVedflz/zjv5R/K7UJNY8p2qwSSElgqgbnFXvGKvhb/nP+Kv5bXcwFeKSVHtT
FX5J/wDOAF1eadpHmHXNElMTRxTE0NOgOKvO/IH5kfmj+cHnC68n+VryZk+sOleZ
/mxVFeY/Nf5l/wDONP5oadpnmS9uJFuZ1DqzmgBOKvtT/nPD87tR0fydoXmDTZXe
e5RCVJ23AxVgPnT8vvNf5i/84+t+YNzfSiFLbm0HM8enhir5p/59kfkn5l/MLV7v
zL5evWtLHTmIuAjceR7DFXqv5gfmv5j0P8+rLypbTEQQzBJCWoSa4q+pv+ct5vzn
85alo+meSbmKy0WS3X1pGk4bEb4q+BvzpTzH+Qdjba1pGvTXWql1aVBNyWvfFX2H
5j/N7Uvze/5xuOq67Iz6gqlWBNRSmKsp/wCfTC00e/KgU5tXFX7Q4q7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FVOWaOBTLO6og6sxAA+k4qldt5i0q8m+pWd9bSz/wC+
45kZvuBxVN2YIC7kBRuSegxVJrXzHpd7M1naXkEk6faRZFJH44qvOv6YJ/qBvLf6
z/vv1F5fdXFU3xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVLb/AFmw0sqNTuoLYv8A
ZE0qpX5ciK4qj45UmUSwsHRhUMpqCPYjFV+KuxV2KpXca5p1pKLS6u4I52NAjyKG
+4muKpmCGAZTUHocVbxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVaq0J
Pjiq7FUkfzJpUVwunTXlul2xoIWkUOT4ca1xVO8VQ9xKIlBJpUgYqiMVdirRIAqe
mKpZFrenSzfUobu3a4/32sqFv+BBriqaYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYqpyypApkmZUQdSxoPxxV4R+Z//ADkj5G/Kq1N7r+pwO429OKVS
22Kvy3/OP/n6hdi4l0X8oLA3czVVW4hyN+22Kvkm28ofnt/zk/etq+qS3drHKaiM
lgKdemKvuH8n/wDn2Bpsfoa1+Y0rS3Tbyqd/44q/TLyD+Qvk38uoVttB06EcRQMy
CuKvYo4khHCFQq+CigxVUxV2KuxV2KuxV2KuxV2KuxV2KuxVgH5h+TLTzhpN1ZXa
B3aCRVBFdyu2VZI7N+HJwl+Hfl2y1H8rPNF75U8w8obZ7iR4y/wildsxMgt2uHUA
PctdY/URdWJ5Bx9oZWIufHUAhA6X5G1OfTX8yWpMkiAsFG5wiLbdt+V/McV0r218
hGpPVSrjpTImVOXi1ERGiitSgOmAzapR6bqvUfdkeMJ/MQ7ks0HVrZ7kpJCqSSn9
2eNMeMMfzEO5ltnGt9PJBcDcE7nHjCDqIdyGt9Ne2uWEpUwA9MfECPzEO5Jtd1rR
4g2nzKxY1oF8e2Sju4WqyiR2Svy7pLa9MRqkmyfHHyPQDpllOBKTz38xdXufN2pW
vkHQ19W79YK7pv8ABlsA4WQv17/IP8s4fy68uW1rwC3DxqzbU6jMiEXEmXu+WNbs
VYt5v8oad5206TQtdiWW2lFGBAORItnCfC/HD85f+ccfM/5K6y/mLyUHfy8zcnRB
2670zGnzc7FqAEr8n/mPo/5ksNHvaWVxD8L+ueFT7Vyoxc0ZxJm9rd6p5Pvgvlbj
JEOr9Vp88eFhKBkxb84vzA0vzBpp0nWoHOrnf1Ix8I+nLccaajpiHyzYeW/rE4fT
53UH9nlTLCVhhL2fRPKNtbKLm5d2mAHU5jz3c2EHsPl66t7m3l03VYT6RXjE/Hav
ucqMXIBSu28qP5dlTWpJo0t425t6holPbCINUpU8ov31D86fMzeSfy1SVra8YR6j
IwrGFB34Hpl2PEbcTUZLiaftR+Sv5Taf+UPlu08saei+rElJJANyczXRh6/il2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KtMoYFWFQexxV8V/85Uf845RfmRpq6/5eVYtUsV5xhBux
GUZIs4l+cXkj8wJ/K91J5Q88RvFfIeCPJt3981GpwE8nNxZQH0XBc87YyowkZt0Y
GtPpzTZNMQ7GGYJ9ZXLAK9yf3oG2URziOzWUzvbex8w27WXm2NXhIIU0rmRDWDzY
kPmDzb+VGseUbk+bPy0lKRqxPCtKgds2OLXROzXKD0j8vP8AnLB7Ap5W/MK1lgYU
QzceIqO9aZkg8XJhRfZ3lrXrDVYF1Hy7eQTROAacwz7jLRpTJeC2YwaiLf8A0qYs
xPbD9HpLVKO6dwa4l8OKEx08dsIyBjScW+uxWhEXMs56b1wiYRwpuPMJ8cnxMTFX
HmDbrk+MMaX/AKdLbk4OMLwrG1xfHHiZUhzrigF69NzvkTNICSXOrxajVoHKU7E5
DjTSTT69HafupAze/XInIF4UoudamgUy2VDG/wDeBuw9sfD8XYNkIEvL/N/5g6N5
Stm1XXLuBbZRUxI4Ep+jrkTgIbeB8S+d/wDnIzW/zLL6H+W9vLBYj4TNKCGp02OV
SyCHNQFb8vvyUGkSJr/nl2u55vjo/wAW+YebXxZiD6FklrGLS1At7FRQBfh2zAlq
w2Bj1/dyW6ejZ0aAn4m6n78p4+M0GUTRY7rl/Bp0X6TuJBFAi1ZSaVpmVh0smOXM
C+eXutV/O3Xk8reS45BYs3CVwNqHrm80+Eh12TJb9gPyQ/JLS/yo0C20iKNXulAd
3p+0Rvm0hGnEL3jLFUZoIp1KzorqeoIrirw/z7/zj15P/MGNl1KwtwzjdvSBOKvz
Y/OT/n1hot36nmD8vLmaDUB8Sqmwr17HxxV8TX2i/wDOQH/ON96npm5uLOAjjxqR
Qb74q+rPyh/5+h31nNFon5uWjW/AqrSEBT18aYq/UH8uP+covIH5mxxyaBqkIdwP
hdwDU9sVfQkM8dwgmgYOh6MpqDiqrirsVdirsVdirsVdirsVdir56/5ya/5Qi9/1
G/VleQq/OP8AIb/lHz/zEPmu1DfjL3RN34nvmrmd3KilV/p0eoJc2V45WJloKHGE
6KZB876J/wA43aTZalca5Cxb1zVh1rvm0xZnGlB9C6PothpcK22k26xmMUc8aVyn
XTukY4UnT3MqDiAAPbMG2dKcLRuazdcbWlxYV26Y2mncsbWncsB3SA1yyNK7oKZZ
EMaU3ZfheL+8Tc5fALTd00UUZ1zW3VLaAVPI0y0FjT8vv+cl/wDnIKfzxenyJ5Gj
V43YIWTf2zIxit2Enzl+Yf8Azj7qflHRbXzPqUZ9SVVJHHepyzxwSwp94/8AOF3k
CLyzop1bUIuE89GQstOpynLlDMB9weg9sSs2/I8h8sxpTbYhblBbQHZAhkv5Y200
7lja07lja07lja07lja0tkaSOIyxUkWu4O+ZAyhDFfNvknQvOFoIruAJcnuq74jK
h5H5P/ISz8lecl/MK0k5OIvSAPXJSyWKXhfRMjcrjl4iuQC0xfzwf9xNz/xibI0l
Ov8AnAn/AI6Gr/6v8c3ml+gONPm/TrMhi7FXYq7FXYq7FXwj/wA/Crh7b8rruVAS
KScqeFBir8gP+cDbuK48ueZmhfhD9XnqCe9DirPf+fddjbXH5n3T2pXkt05Ysf8A
KxVGf8/PLn6r+aGkmAJ6ryxgE061xVJP+c4TJp/5XeVLjUXSVpETZCDTpir7Q8kl
dQ/5xE1N1DNxsGIUbnZRir5K/wCfQX5teXPI58weVfMdyLe/vZOUSOwFeNNqYq8Y
/O29sZf+cjYr5JPiaYulDsaHFWSf85E/nx5p86+dtH/LXUbk6dpRRE9YP6fw9Ou2
KpF/zl7+XnlPyT5Rsb3TdX/SN7IqF6S896fPFXo/ki6t5f8AnHSZrNhsrEivtir6
T/59JXPraXqKoP3fJt/fFX7VYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXwl/z8
D/N6L8sPywv1tZmi1S5FIOBIboemKv56P+cYv+civNH5f/mbp2tedry9e0vZUX05
ZGIo7bEe2Kv6wvMl+mq+TbjVraTis2n+ujg/zR1G+KvwK/5xq8/eYtR/ODWdFur2
Z7ZXkC1kJA3OKpNeeffNNl/zklFoCahMbNpVBT1DShPhir+ifUPM+leVdOgvvMd5
FaQ+mg9SZqAniMVeR2P/ADlH+W99qb6HHrloJVNAxlFCcVe9WN/banAl9p8qTW7i
qyRsGUj5jFXlHnH8+vI/kacWGv6xaRXFaMjSqCvzxVZ/0MD5AMUdwNcteMtOPxje
uKvUYtasZbFdbWdBYsnqCVmAXj41OKvHLv8A5yW/Lqzv/wBDza7aCYHif3goDir1
fSvNej65Z/pfSL2G4s6V9WNwRirDNW/OvyRobNHqet2kUi9VMgriqRad/wA5G/l7
ql3FplrrdqbiZuEa+oNycVe2xypKOUTBgd6g1xV5J5z/ADz8meRpfqOuavaRXYND
E0oDD54qn3kn80fLH5hKx8p6lb3kifbSJwWH0Yq/Oz/nPb8vpPzM1jRxonmJNJls
HUToZ/T5fFWlKjFX6CflO0Gl+S9LhmuBJHaWqpJO7bMVG7cj2xVjuq/85G/l9pN3
+jLjXbL1geLD1hscVeo+XvNej+a4BfeXL2C9gpXlC4anzpiqfncb9MVfzm/85i+e
/Mflz8/rWzs9Rkg0j115D1SFArir9jvLH/OTPkDTNM07TdU1u2+tGGNXJkB3p1OK
voiHzPpVzpn+JLa7ik0zhz9dWqnHxriqUeVfzD8ued2lj8q6jBfNB/eCFw3H54qg
/Nn5oeWvJFzDYeZr+G0mnpwWRgCa+GKqevfmv5U8tRQXOs6nBAlyoaLk1OQPcYqw
7Wv+cj/y/wBHEYOuWbySEUUSiu+Ksjvvzr8kabYrrN5rdklsyggmUd+2Kpl5Q/NH
yv56H/Os6nbXT/yRyAnFU+17zbovleNrjzDf29miryPrSKm30nFXj+m/85Rfltql
0bC216z5BitTKtKjFXtSeYNNk08+YIrqJ9OCep66sCnHxqMVeb2f5+eQb9LiS112
zYWoJk/eDtiqF8n/APOQPkfzteNpOiavayXQNAglBJxV7UDXcYq4mm5xVhGqfmV5
U0SQ2+sa1YWso2KzXEaH7icVTXQvN2ieZ1Mnl3UbW+UdTbyrJ/xEnFWtV84aHocn
1fWdRtbWWleM0qoafInFXmnnf/nILyP5O0i71yTW7CZ7eNnEUdwjMaewJOKvlH/n
F7/nOjSPz68zapodzd2tpbQVW2WR1QuwPQVpXFXz15o/Irzr5t/5yDt/P0Pm21g0
i3uVkFgZ6Myg9Ate+Kv2P1LV7LRYDd6xcRW0KirSSsEUfScVYUv5n+TNVkSztNe0
+WZj8KR3CMT9AOKsu1HzDpejRJcareQW0Tj4WlkVQflU4qqx63p8tt+k4rqFrQCv
qh1KU+daYqkNz5m0jXNNvjo19b3PpwS8jDKrFSFPgcVfz3/849eedV1z/nJi90HU
L26ktI534x+qxUUbwxV/RRq3mDTPLtst9r15BZ22w9S4kVFr82IxVi1r+bXkq+nW
wstf02W4c0WNLqNmJ9gDirOLq+trGE3t5KkVuoqZHYBafM4qwt/zV8mxkI+vaaGJ
oAbqOv68VZtaXkF/Et3YyJNA4qrowZSPYjFUTirsVdirsVdirsVdirsVdirsVdir
sVSnVde03Q4zPrF3DbIoLEzSKgoPmRir4R/Ob/n4h+XX5WLNaQTi+u05KPRcEch8
hir8ufzD/wCc9PzY/Ou6bRPyrsLoWE7FFaMMaBumKpj+XP8Az7w/NL83p183fmFq
UsVvOeTwzSb0bc7E4q/Uv8l/+cC/IP5XwRXUtotxqa0LvKqsK0xV9naV5V0rRQBp
1pDEQKVRAP1YqyDFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7rscVfC/wDzlr/z
jZJ+Z9k3mTy1xi1O2UyHiACwUZi5MdNscpD88PIfnmW0lm8iealNtNBWMNOaVK7d
8qpz8WcvdPIv5iz+Tbo2V3GbjTW6soqtDhAdpiysb8wa3pfmXzG115OhaCeoLOwo
h+WYeWwUylInYJvrttNdWs3q1a9jAow6E5WCWXq7mIaFpepXbRXeqlfUh+wFFDhs
oqXcz7WLyLTrb1YWHrN1I7H3wWUS4u5iUseo2yC+vJOKuOSoTQsPbFpJl3JLB5q0
TTdWS48yafcyp6ZAZVPGvjmTgFhoyTI5sG8y/mLDA72HlxGe5uGKRqh3Abptl9ON
Kb7c/wCcSP8AnHSaytk8++cYz+kZWDqJVqaHfvl0BZcSc36RooRQi7ACg+jMhx12
KuxV2KpZq+j2uu2smm6nGssEgoysAf15GUQUg0+C/wA7P+cHtE85D6/5ODWeoDdT
HRRUDvT3zHOOm+GY9Xwz5o8s/mn+QDix81W76roi7f6MnJ+PXqMPCHYQypTD+bvl
XX0EOpaTc2UbCjtcrQhj7nJEU3nICEVp+k+VI5hq8Wr2kMRNeDyqD+vKySxBAeht
r/kqKESDVbR3UdFlGQIbBkrqxLX/AM+NJ8u24gis5NSs22jFoOTV+jDGNsZ6ilnl
T8svzB/5yUljtraKbTfKnL7Ew4ycevU5dCAcSeoL9YvyM/5x90L8l9NSx0yFXuaf
FKygtUjffLuEBxMmoJFB9CYXGaZuILUJp2HXFW8VdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
RAYUYVB7HGlfFn/OR3/OJ+m/mnbvq/l1FtdZX4gygCpAPyzFyYR0bIzIfm7pPm/V
/wAqb9vIHni3mh4twW6mFI/nXMKemBb45yH0PpWqw6vEtxZyrNtVTGajOcy6aiaD
sAbDILPUEnf6rqSkqPDMMwMTyTaeK0St6D72fUKetclDKQU0GF+b/IVn52hNprKw
pEfsmNQrffm20+oIRwvAZfyu83flpMdR/Ly8kMFSQsjkj7s3eDUWOaOBmXl//nLH
WPKzrp3njT7ie7jNJJEU8SBttmPmlcubRPm+nPKX/OQ/lbz2qobqLT5PCd+J/HKe
IhFB65a+cdAiK2ttfQ3U7/ZaN+QwiZY8KeLq5Y0RuR9q5PxSEGIRa6jKBurU+RyX
iMeBd+kZH6V+44+IvC015N1Ib7jg8VPCg5dVWGrTSAKN2rXpj4tshBjl95x8sshu
f0pb2vDqssnHcZV4hTwvBfOv/OWPlryoGsLL/chMNgYG5fqwgkrT5y1L/nIfzt59
kNp+XVrLZvX42nU8SPauZOmnwnm2YwgNM/IjVfNV0PMP5lXkkt0TyCo/wV67iuOf
UVyLcMb6H0PQNO0OJbKSOJol2HpqOX00zQ6jOSnhCb/W1PIIDwT7APYZrpSJQx65
v2v3Nvd14DpxyUMZPRbYn5h16Dy/bsXuokgWrcHajEjtmx0eluW4a8s6FvGNH0Pz
J/zktrCaDoEE9rp0bAPKwojL33zfQ04DgSykv1u/I/8AIPRPyg0yK3tYUfUOI9SU
gVrTfM7HhAaDK30Bl7F2KuxV2KuxVJNW8uabrcD2mpWsMqOCDzjU/rGKvi/83P8A
nAn8vfzLt5nNqIL1wSrRqq70xV+cWo/8+1fzA8g6zDqH5a6lJHaJcI5Uv+wDXxxV
+2/5UeXtU8u6Ja2Wuy850gjR67ksBucVeo4q7FXYq7FXYq7FXYq7FXYq+e/+cmRX
yRe/6jfqyrKgvzl/IVS3l8lRX/SH6fPNfqGyBe3uD8XD7VNs1eQOZAtXEVuIY0vQ
zPIaNxyoNjcUdvYA/o8NUfzZlY5liQ4PdOPUmK/F0Aw5SZMKpwDn7eU8KFzQqMPC
rVMHCrqY8Ku4+AOERSFo3+zv8slwJdWpoNz4ZbGDAry0Nkj3VwQqgVYnoPnkxFD8
1v8AnJv/AJyLvNRlbyH5Rl9YyEI3oMa+GXY4d7AlO/8AnGb/AJx1e1RPOHmdOdy/
xqJACete+DLOgin2v+Yv5e2/n6zh0u5VBDGAQAo7ZiRyFaTLy/oNtDpsel6cno/V
QE6UrxwmRLIBlEkrT8Q/VBxwUzClTDwswXUx4E23TKeFg6mPCrqY8Kupjwq6mPCr
fphP3VrUM25r0yNlC6V3stQjgugHjZKkqNsItCGnhj9T6zFUCvQ5bCym1RqiYHtQ
ZeIqWNeeQV0i5ZtgYzucPChO/wDnAn/joav/AKv8c2+nFRcafN+nWXMXYq7FXYq7
FXYq8v8Azc/LGy/NnQJvKWrkCCYEGorsRQ4q+dfyp/5wV8hflZp15pGmI7LeqwkI
2+11xVOPyc/5wx8l/k3rU3mnQFY3Ujlx23PjiqK/PL/nDbyP+e2p2vmPzPG631q4
ZWXcGmKpX+ZH/OE3kj8xtEsfLGphzDYgCPkajbFXtHk/8kfL/lHyY35W28fPSZIj
FIp7gimKvkDy7/z7T/Lvyz5tHnnTTNGwYtxjPEVPtirObv8A5wB/LrVPNsP5iaqk
k17bn92On3nFUB+d/wDz7+8h/nDPBqU6Pb3NuAqGPY0HvirArf8A59g/l3c2a2Gv
T3NyFHw83LU+/FXtPl3/AJwk8jeXPKU/5fWyO1rKGFewB9sVZr/zjv8A8406H/zj
zZz6Z5aNYpmLdN98VfTGKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV/Nv/z87/NX
/lZH5g6Z5E0XUI49Ps5kiuFLUFQd64qxD/nMX8v/ACF5e8meW/NvkbUrR/MlrBAX
WIjlVQK9MVfq7/ziB+cX/K1/yOkXWped9a2TwspPxEcNvxxV+WX/ADjNFJH+dut2
tuCEDyN+OKpTqEiD/nJuKc1AWZOZPhXFXrP/ADnf+cPmH8wfPGm/lLoV1Imlj0kI
jYjbbwxVl/5if8+9NP8ALX5ZP+Y2lXFyNXhthcORKa9K1xVR/wCcMf8AnLLX7T8s
fNVpq07ySeXYXWEsxJ2FMVfM/wDziV+SWo/85yedtc83+dLm5/RcExZwJW4ivT9e
KvOv+c2fyO1//nG7zppnl621KdtKu5Y2tFWVvs8hTocVfpf/AM5i/wDOQ035c/kr
5Z8o6HJJFeX2nQ+pIGIO6juMVfnR+WnkLyTr/lS680+cdXca7IjSIDOQeRG3fFXu
H/ODn556xpN5rH5caldvNpSRyGEs5bbem5xV8+ad5V1j88PzquPKM1zcpYyTECkj
Abn54qz7/nKf/nG2/wD+cZfMWk6vpt1cusUiSikrUJ+/FX622P8AzkdLof5Gnzna
sY9be1ADOT1C0rir8Tvyxu9H/OPXtS84/nTqkhkZ3ZB6xA67bVxVOfyt/M+6/IP8
3LKX8tb+SfQryb96plLqATir1X/n5R5wGuapofmDRrmVZrtonkEUhArUdhir7A/5
yG/PbVfy8/5x60DRdBmMd7fWMSNICee48fpxV4h/zjD/AM4B/wDK7vJk35gea9Tu
P0pdgvF+9b7RG2KvqD/nDv8A5xu/Nb8ifMtxYXl/JN5e9U0WViw4198VfryK0o3X
vir+XX/n4jpV3qv51waFZS0E84TY77tirO/+cgf+cHL7yV+W1t+YdvqEqXTwq5Hq
naor44q+l/8AnD38xNV1z/nHLzZ5W1O4a5uNMsJRHJyJZdvH6MVeaf8APma9u73W
/N4ubiSTgausjlupG4r74qxL/n63rl+PzJ8t28Ms0ESyoAquVr8XtirzX/nPe61m
Sy/LyLTb2VPUs4lKpIQakAb064qzn80P+cNP0R+UFt+aou7n9KGBZR+9PWlfHFXl
3/OHX5Aax/zk1FeeX/NOpT/o+1jZlHqtWqjbviqh+QqeY/yI/Po+Qbe9nOlxT+mo
kkYigagxV+h3/Oav5Da5+b2rWOv6n5xttJ0WONHmt2m9MuncDcYq/PX/AJyt8mfl
H5O8i20n5TXU58yw7XEyTk8iOp2PfFX6A/8AOIfnzV/MX/OLeswatM1z9R0+UcuR
MgUrvv8ARir8vP8AnCb8l9Z/5yH806poum3tzDpqyOZ+UrbKTXFWV/nV+VV3/wA4
afmrpQ0q9nkguJ1qfVYjdsVf05/ljrLeYfKmka3Iatc2kchPzGKtfmVb3935dvbb
Qr+PTb142CXMpoqbHrir+fXzX+W/lTyjr2o6x+emsy+dbmQyNHb6VcNyU022U4q8
j/5w5/O/UPKf5wp5Z8kpd6d5fuJwFs7yRmcIW7g4q9n/AOfpl1q11+aOh2mg301v
FfJDFIscjKPjoD0OKvprXf8AnAvyT5c/KC6883cl3N5gbTfWaVp2K1Za9K4q+Of+
fWf5EeWPzD8z6jf+aklll0mZpLZo5CoLIaCtOvTFUH+YWp3Wlf8AOX9lp/1i4Wza
+jjjjEjBaV226dsVfT3/AD8K/OPXvNHnbRfyK0C6a2sb144rkxsVNGpXcYqzjzD/
AM+x5E0fQ9c/JzW59O8wQRo88s8zFWJ3rirzT/nOS083eRvJWk+VPOuqtc6tEsa+
vA7LUj5Yq9w8qatfJ/zjhMDPKLv6ttIXPL7Pj1xV4h/z7c1q4isPMcerSXFyzevu
7lh38cVeC/8AOMaiT/nKW/ewQoTM9SfDlir7a/5zm/L/AFb8ydfh0jzD5xtdL8o2
SC4fTvV9OaXjuVG464q/Jn/nInzB5M8orpevfk1omtaRqFnMobUbiV/RmZOpXxri
r9l4vzM1T8zP+cUpfN2pXLLqrWRUSBiDUL44q/Pj/n27/wA426V+fU2oat+Z11e3
H1R2MSi4bqD8/HFX9G3lLy5p/lDS4PLeiBhaWi8FDEsdvE4qWTYq7FXYq7FXYq7F
XYq7FXYqsllWFTJKeKjqTiryvz3+dnk78vLKTUfMWq20XBSRGZBybauwxV+Wf5x/
8/XdEg9bQvyttJZ9SBKo9eQJI26DxxV8P3uqf85Gf85iXYtr9rqz02RgqFSyAKdv
bFX2Z+TX/PqNNLuINS/Nm/8A0op4O6cqkHuDXFX6pfl1+QXkj8rYUtvKGlQwcVA5
Misdu9SMVexoixiiAKPYUxVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
iq10EilHFVIoQcSr4y/5yG/5xG0j817Vr/y4EsNbBLCVQACfoykwpnCVPzM1Cfzr
+Q19J5P886XcahpKkr9ajWq8a065UQ7CGYBn2geevKWoKg066ht3b/dbMOQPeuUy
hZd/ptZER5PRfTe6QS2N1HLH/k74PDcwawHoqwzR2f7y4Q+oOjU2x8NsGrHclGsa
EtxayxGZVluvjRj2x8NhPVCuTzW4822OjSpd+etSgm+pj04olah9tsHhuJLWDuY1
PrPm/wDNC7Xyl5EsmEdyf3d2Eqio225y3FCnSdoZxOWz70/5x4/5wsh8i8PMP5lS
x6nqx4yCg2U9aZkCLrDkfoPBEkEawwKEjUAKoFKAZaGkquFXYq7FXYq7FXYqgrzT
bTUFMd7BHKrCh5oG/WMBjaQaeB+bf+cYvJPnZ2Gu2SNA9SVjUIan5DIcDcMzxDVf
+fcv5R6q5kltLlR4LLtkTjLLx/JC2H/Ptn8oLGQSLaXLDwMuAYyxOV7J5M/5xM8h
eRrgS6NZAwpuqSgPv9IxGM2wlkt9IWWmWmmosNhBHCiigCKF/VlwDC0dhQ7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq8O/OX8hfLn50WB07zJCOQU8XVQGrTbfrkT
FX5J+fvyZ/ML/nGe7e60v1NU0PlWKOH4isfWhyjJpTLdzoZNmTeRvzRsfNMIuL64
j06+FA1tOaOT8s1Go0JbI5Q9WWV72MXdtOqtX7J6keIzT5NIR1bYzTY6hZxxhbiC
R5f5h0rlAgYtokj7O89VaVCx+Db5fHUCLO1LUNI0q9iP1yKJ+XWiCuXxy3uwIt5H
rH/OOflHzUTcossEx7q/EfhkxnpicdsGm/IXzT5eb6v5F1MwSH+7kkckL88mM4PN
iYUhj5W/PrQPiHmO3mI60Ncn4sWBgUXD5p/PG2pHdagkgHcA5LiijhKMPnH84qfB
c0bxoceILwlL5tf/AD21H93b6okQO3xDAZxC8JUR5C/PbWv3tx5lt0Q/aWu5HhgO
WKeAo6z/AOcbNQ8xP6vny+kdf2gkhWp798r8cDk2CFvR9D/JLyV5RZf0fA8kw/ak
PLf6cic1pEKepQWNrYRgQLEitsKKAcqlmEebOIpDyX62fw3Q9RD2XKJ5hJJklTXE
Eretp0bwt4v0yrwTJrM0svNQbTRyuplCvuZP2V+eZWLRktZyPCfPH5wxaHJ+jPK0
LaxfSniDa/FxJ8aZu9Poi1nKzv8AKH/nE/zP+cV7F5y/MGV7fSiVf6q5o3XwzZw0
5g4+adin6w/l7+XWlfl3pyaRo0MahAByCgE098uAcWnoOFXYq7FXYq7FXYq7FXYq
0QD1xVvFXYq7FXYqtDVJWh279sVXYq7FXYq7FXYq+f8A/nJSp8l3q0qPSf8AVlcx
aC/I/wDKH84tI8maXJpepkK31h/tH3zFyYyWUS9eH56eWXYzLcxCvblmFPCS3Cak
fz38uE19eL/gspGAtoyO/wCV8eWx/wAfEX/BZdDAQnjd/wAr58t/8tEf/BZPwSiU
nf8AK+PLf/LRF/wWHwSx4nf8r48t/wDLRH/wWPglbd/yvjy3/wAtEX/BY+CV4nf8
r48t/wDLRF/wWPgleJSl/P3y9CA0c8ZFfi+LtiMBTxK7/nl5bkAurC5iWIbv8WSG
Eo4mk/PjytcsJLOeNSp+Jy22PgljxPk//nJD/nLewgsm8u+T29S5mHGWSNjQ/LLI
4WJk8W/5x48r6It3/jXzXcx+u5L8ZmBPWvfJSiWJL9FLf88PK1gotYJIgo2BUgDK
Z4iQvEiP+V8+XP8Aloj/AOCzGGEsuJ3/ACvjy2ek8Q+TZIYiom1/yvby5/y0Rf8A
BZPw08bv+V7eXP8Aloi/4LJDEV43f8r38u/8tEX/AAWHwynjCz/lfHlv/loi/wCC
weCWXE7/AJXx5b/5aIv+Cx8ErxO/5Xx5b/5aIv8AgsfBK8Tv+V8eW/8Aloi/4LHw
SvE7/lfHlv8A5aIv+Cx8ErxKg/Pfy5T/AHoj/wCCyk4CwM3f8r48ud7iI/NsRgKO
N3/K8vLkvwm4joN/tZZ4KeNQufz48uOwRJ46j/KyccJXiY/54/PDQdS0t7JJ4/sn
9rLPDKeJ9B/84Fq89xf6nbCtnMp4sNx45nYhs0yNl+m+WMXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYqseRYlLyEKo6kmgxVCW2p2l43C0njkYdkYE/hiqOxV2Ku
xV2KuxV2KuxVK5Nb0+GcWMlzELg/7r5Dl92KppirsVdirsVdirzP84fzGtfyo8o6
l571JS8NjCz8R3NNsVfy1flJ+Q+o/wDOb35p6tr1rdmysrm7eYO1TQV6Yq+5vzA/
59H6sLObVrPXjcfU4HdYyx+LgtdgcVfP3/OAn5o6h5D8z+YPy38ySFbC2hnhAatO
S1GKsi/5xZmkuvzp1vVq8LZ2l4selCTirHtSQz/85NC1RTJHNIq8h2qeuKvR/wDn
Oj8rNc/J3zppP5k6ZE1xZO0buRuKbYq9S/Mz/n5BoGq/lkPy40m0d9cvbUWrDcgb
U6fPFWMf84Xf84na/rH5debLu6JSTXI3MaHrvvTFXgv/ADjl+bPm/wD5wK8y6xoe
uaRNdaPcTESAKd99txiryD/nN/8APXX/AM+fNmi+aNc06TT7FZIvqZdSAELCnX78
Vfoz/wA5t/kVe+b/AMkfLHnDQka9mtNPgMgjHbiDir5I/I38yvyG8r+SW0n81PL0
lz5njooXkQaj2xV9kf8AONOm+R/Py6nrflHyfcadarbycLph8PTbfFXyv/zjvBJ/
0MJJY2U6lI7o7d6BumKvqr/n6/dyp+jIoB8ahDWnXfFWaflv+U835vf84+yW1o9d
SitiREOpPGtMVflt/wA49XvkD8ovMWo+W/8AnIjQZrlVdglSR3xV9ifld5l/Jr81
PzFtNC/KzyTP9Rjeksw3A+nFXiH/AD820a18r+ZdJ0/R7Rre3WSMBW7b9MVfWf8A
zkr+R+qecf8AnHrQPNegK11c2tjFIY06gAf2Yq83/wCcXv8AnP7SPyd/LiXyR5ig
ZdftqpGprs1KdMVfQn/OI3/OR35qfnb5vea8R18uF6glTTjXxOKv2GJ4gsewxV/M
7/zmjH9a/wCcgbC9gQtxu1P/AA2Kv1O/5zBibUPyFt5m+Ei0jJH+wAxV8M/8+9bG
61P8tPPWhaXG0lxe2kscYHjQ4q+R/wDnEX/nIFP+cM/O2vad5ltWkubuRlljNa05
bdMVY5/zmZ+ed7+fPn3QvM0dk8UCyRmFKHcchir1r/nOqYqfy0uLVCWFvB6q+BqM
Vfq1+fpr/wA486XJaR8kOnqWUf6mKvl3/n1L8MWtSmMrIfUAPh1xV8peehdWv/OS
UyXR6zMU278tsVST/nLrV9f/AOVhaba+fxPB5ZQRs1WZVZcVVP8AnKnWfyduPy9t
Jvyk08tqZjUXDhid6bk4q+xf+cJAq/8AONHmm+sCKvYSBoupHwnFXlX/AD5n5DzN
5sborFvhpuN8VSX/AJ+xyFvP/l+1sYjLMZkqy/62Kv3S/IBHj/Lry2kwIcafFUH6
cVeX/wDOYVlrVx+XGrJoDO87KxVY6hgOJ8MVfh1/zhR+YX5WflVc6zqH5xx+v5lL
yLEs7FjyNabNirAPy0822Xmv/nJCHzDa2foafJcD0mC0XiW2xV7v/wA/J7uP/lcn
laK3Qm3JtiW7dRir9pvMlimrfkrdWKL6ok0XiAPHgMVfi7/z7B/MDQfyn88a55U8
530VpJcTSrAJNviJIGKvN/zPb67/AM5haddxN61mdQjaKRelKnFX0T/z8L8hah5H
/MvQvzhtrV59Jt5Ipbpl6Bdq1xV9aax/z8q8g+VvLejzeWIzq+oXESKbO3JLqelN
sVeCf85rS6v+e3kSz/M+20W5063hVJGWUb064q810X/nJPyte/kjcfl3b3Ef6eSE
oE71AxVFf8+vtUk1HT/MOm3QpOfWIJHzxV5D/wA42m7P/OUWqadEpimV5CrEdaHF
WK/85f3h0z/nImy1H84UmPlwyIgq7BBuNzirM/8An4r+c/kDzx5P0P8ALL8mlhuo
dPEc8zW6iqgAVqRir6z8pz2lx/zh96tjGYClq3wnxC4qkv8Az6Ddm0nVJjEQzM9W
/wBlir9tISjAyIKEn4vniqvirsVdirsVdirsVdiqUavrllocD3mpSrHGgqSTir4v
/NX/AJz2/L38sYZGnuFuJ16Ip74q/LP8zf8An4z+YP5yXD+XfygsZ44JTxBjDfLF
WMeRv+cG/wA5/wDnIi4XzB+ZeoT2dvGaiOVyOQr7+2Kv1H/Jb/n3P+Xf5cRw32uW
q3+pIASzUIqDXuMVfemheV9L8tQLZaJaxW8SigCKBiqf4q7FVoNSVodu+KrsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVY95i8q6X5rtG0rXrZLi2cU
KsB0yEoAshIh8U+e/wDnAjyPrDS33lK3+oXkm4YNsCTkDjU6jIORfNN5/wA+/wD8
0bSVm8t+b47eD9lDX+mPht0dblHVKLn/AJw3/OO1P1S78ypMh2LDHw/Ju/O5e9Nd
M/5wH/Ni9mS81TznGtuv2YqE7fQMTBhLW5O979+Xv/OAXlmyLXP5oEaxc8uQblQV
riMbjHU5Cdzs+1fJX5beX/y/thp3lizSCFdl2BIHzpXJxxgKckjzNs8ybF2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KoO+0+21KJra+iWSNgVIYA7H54pEiHwp+eH/OC/l38wy+teTX/AEVrdSyzA7V7
bAZXLGCzGQvhDzH5I/Mr8hrn6lrllceYIU2F1DUqFHyzEy6OJ6N8Zp55b/PHSbil
prtxHY3XeGT7VfDNVn0g6Bujkeo6d5it9VYParzhP+7B0zW5MNdG3jZCGghb1fUD
jwGVcRGzlRFhV+utPtboUA74ifekhNLe79JSs86sT/uvuckJMaRC6rHGN7c/TkuM
sab/AExz2ijC/RkxMopr67OvxHiR4cRjxopv9NKNpIg3yGCUymlranG+6wMD2Phk
eNNIW6u5Zfie4V18B+rIcbKkF+k7RB6ZjPP+bBxlkAhGAas0slVG6rg3kwybMT1L
ztY6Wf8Acmwto1/bfpmTDBfRxzN5P5j/ADyhnb6n5Pj/AEvN04W+5zaYNGD0aZZE
08mfkL+Z/wCfjcrlpfLmkkgyRzg1cV7d+mbLHpYjo0TyP0i/Jf8A5xQ8oflLbxyx
2q3GqD+8nejcj1qARmXGIDVxl9SRQxwLwhVUUdlFBkrYE2qYodirsVdirsVdirsV
eT+evzw8kflu4g84axbWcx6Ru/xYqwPT/wDnLv8AKbVHWCy8yWjysQAobepxV9B6
Vq1nrdsmpaVMs9tIKq6GoOKpjirsVeW+dvzm8ofl1cJY+cdSisppKemJDTkT2GKq
PmT87vJnlDRYPN3mTVILXTrgVid2+18sVZn5R83aV550uDzL5YuFutPuBWORDUHF
WS4q7FXYq7FXYqk2vaBZeZLOTS9WjEtvIpUg++AhXztJ/wA4d/lhcA/XNJEjMxcn
lTc/RgMAVUj/AM4Y/lMd/wBCL/wZyHghNt/9CZflR/1ZR/wf9mAYIrbR/wCcMfyo
P/SlH/B/2YRhCeMtf9CYflR/1ZR/wf8AZh8MLxl3/QmH5T/9WUf8H/Zj4QXiLv8A
oTD8p/8Aqyj/AIP+zHwgvEXf9CYflP8A9WUf8H/Zj4QXiLv+hMPyn/6so/4P+zHw
gvEVy/8AOGX5ULUfoRSDsav/AGY+GF4iot/zhh+VCRmJNHEcf7QD7fqw+GF4i/MD
/nNzV/yV/J/T5PInkTSPV8wOChMLE0NadciYItgv/OCn/OBz/mC5/MP8y42OjzMX
itpTU0O4G4ODgRb9fv8AoTD8peIjGhIFHSjU/VkvDCbcP+cMvypUcV0ai+HP+zAc
QQ7/AKEy/Kj/AKsw/wCD/sx8EJt3/QmX5Uf9WUf8H/Zj4IW3f9CZflR/1ZR/wf8A
Zj4IW3f9CZflR/1ZR/wf9mPghbd/0Jl+VH/VlH/B/wBmPghba/6Ew/Kf/qyj/g/7
MPhBPEXf9CYflP8A9WUf8H/Zj4QXiLv+hMPyn/6so/4P+zHwgvEXf9CYflP/ANWU
f8H/AGY+EF4i7/oTD8p/+rKP+D/sx8ILxFv/AKEy/Kj/AKso/wCD/sx8IIt3/QmX
5Uf9WUf8H/Zj4QW1yf8AOGn5UoajRR/wf9mPhBbU1/5ww/KhW5/oYE+7/wBmPhBb
VX/5w0/KiSofRFIPYv8A2Y+GFt675A/K3Qvy0iaw8pW4trMiixDt9OTApD0fCrsV
dirsVdirsVQt7fW+mwPe38ixQRjk7saADFXxh53/AOc8vyy8l6t+gZ9QjnZTxd0b
YEdcVe0flv8A85FeQ/zUIg8p6tBNckA+lyHLfFUx/Nb88fKn5PWR1DzhexwEiqoW
3OKvm/yd/wA/Cfyv803h0x9QjhetAS2xxV9Wa7+aPl3QfLr+e7m9i/RSpzEnIUIx
V853X/OdX5ZWlg2pvqUTUFQFbFU//JX/AJzB8i/nXfNofl+8j+u1PBOXXFXqf5of
nj5Q/KKD6z5z1CK3ciqxlqMcVfN2if8APwT8tNf1ePQbS8RPUYKJHbbfFUw/5y4/
P/RfKH5fXOqaBqkLXUyExmNqmlNumKvym/5wl/5zGvrfza8fnTUfXtbicoAzE0BP
vir9n9c/5yw/L/QL5NPv9UhQMqkkt0rirG4P+c0vy91G5urXSb6OZbNeUjBuo9sV
Zh+Tf/OT3k387b260fylcBrq1JDKSDWmKq/50f8AOSvlL8jLqx07znN6ct+QIxWn
U0xV6lL5/wBFtvL0fnq9uUh0mSETCVztxIrir5B1P/n4V+V9jqX6Jjv0cBwhflti
r3Sb/nI3yVf6DN5i8varBcsIGkVEarA074q/nt17/nMbXJvzsXVLfUyNEjueLx8m
pQHfFX9Iv5WfmXpH5naJb65oEwlBiQuPAkb/AI4q9LxV2KuxV2Kse80+VdL86aZP
5b8zW6XWnXK8ZYn6MMVYL+Xf5F+R/wAqWeXyHpEGnu/2mjG+KvWJI1lRopByRgVI
PcHrirwS0/5xg/LSx1GfX7XQbdL25LNK4H2i3WuKplon/OO/5f8Al29fV9H0aGG5
f7RUdcVVI/8AnHvyBFrP+L49FtxqwNRPT4gcVZp5y/Lzy/5/sho/myxivLZdlDip
HyOKvAdP/wCcIvye0+8OrJ5ehkua8gz70Pttir3XUdAXyt5butM8jW6W8qQt6CRj
9rFX4pPpH5l2fnO5vfzF8oz6/pUkpIXhsd9u2KvPvzb/AOccPzF/5yN88aOE8uTa
L5YtJIyIitAqqRt0xV+9/lbyRZ6X5UsPI2pRJPa21pHbvG4qDxG+KvD9R/5wp/KD
VNU/xDd+XYDc1qQNlJ8aYq9w8veT9B8i2Q8seX7GO2011IMaDah2ocVYdoP/ADjv
+XvlvWW85aJotvBqztzM6jck71xVkvnv8o/KX5lGM+ddMhvzF9gyCtKYqn3lXyTo
vkq1Om+WbRLW2P7CdMVeQeef+cVPyy/MW9OseadEhmumNS4otT92Ksp/Lf8AIbyN
+UrPN5D0iCxlk+06D4j9OKrPzG/IPyN+a7pceedJhvZ0IKyMPiBHTFXoNh5U0rTd
Ij8p21sg0qKL0VgIqvDwxV866j/zhR+T+q6mfMF35ctzcseTAbKT40xV7v5L/Lvy
9+Xtr+jPKFjFZweCAfrxVmuKvHNe/IHyH5m1ZfNWtaPBPqaNyErDevjirN/MPkfR
PNWl/wCGNds47jTOIX0WHw0G1MVSTyD+UvlP8sIZbXyPpkNhHN9sRjriryfzZ/zh
3+VXnTVT5n13QoX1F25SSgAFz77Yqnc3/OLH5X3DW0k3l+1Z7QAQsV3WmKp15j/5
x4/L7za1s/mDRLe5azAEJcfZp0pirPbnyNod7o48o3dnHJpKpwEDCqgeGKpF5F/K
Hyn+WplPkvTorH1q8xGNjXFUhv8A/nHvyDqevDzvfaNBJrCtyE5G9cVV/wAxvyE8
jfmuiReedIgvVjUKvIAUAxV55pv/ADhj+UOlQvZWvly3MEgoUfcUxV6r5T/Jryf5
H0e48peWNLhtdKukKTQIPhZT2OKoP8ufyL8j/lPPcXvkDSINOnuiTM8QoWr1xVZ5
1/IjyP8AmFdRar5s0mG6u4TyjlYfEp9sVeoaZp1vpFrDplggjt4ECRqOwGKr76xg
1KB7K+QSQyAqyt0IOKvlnWv+cIfya1++bW9S8tW7XrvzaQbEnFWY6R/zi7+WehXM
WpaXoNvFcwU4SAbinTFU684f84/eQ/Pl9b615p0eG6vLanpSON149MVemxaBYw6e
dBiiAsTH6fp9uNKUxV86S/8AOGf5SS6r/ig6BENSDlxKpoeRNa7YqyW2/wCcYvy7
t9Yi82tpET6rCwaOZuqkdMVek+dfy80H8wrFtE822iXdk68WjcChGKvC/L3/ADhT
+Tvla+TWdF8t28V1Gaq25oeuwOKvobV/KOk67pLeVtVtkm0x04GFh8PHwxV8723/
ADhP+TtnctqFr5bgSZ/tEE719sVekeS/yE8k/l2so8l6ZHYPNXm0fU164qs0T/nH
7yL5e19vPemaVEmut9q5p8RxVBfmN/zjf+X/AObU/wBd/MPSIdSmHRpB0+7FXnmk
f84O/k5oU8l5pfl2GJ5l4PvUEeG+KvY1/JfylF5cH5fQWCR6EAR9XX7JB64qify6
/KHyr+VEEll5F0+Oxhl+2E74q9HSNYySo+0anFVTFXYq7FXYqskkWJechCqO5xV5
d5z/ADo8oeQ4HufMepwwFATxJ32xV+bn52f8/ONF0BZdO/LqIajcbqpjBJqD7Yq/
PzU/zL/5yC/5yQvSdDjurHTpyQwHIDjWv6sVfTv5Rf8APry882SR+YvzY1N5BXkY
WJNe+Kv1Y/LT/nGD8vvytgij8t6TCk8Y3lKgkn7sVfQaIsYCIAFHQDFV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
tEBhQ9MUEW3il2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2ACldhVC3llDqELWl4gkicUZWAII+nEJBfLH5hf
84bfl1569S9/RsdtqT1InTYgnvSmV5IcTZHJT4z84/8AOFnnzyezT+Ttce5sKnjb
rXYdh08Mw5aC+rMZ3isujfml5RuGtdS8u3MtrF/x8GtGzX5Ox7PNyI6+hVOl/Ot9
IP1fW4TauOoYHKD2P5s/5Q8mT6X+cXlq/Tms6C7/AGDvscrl2YR1ZDW30ZLa/mXY
TbT3aHKjo66r+ZtOU886U4qlytch4FMhnaHnawr8VytMfCT4yyXz7pMY3uUBwjT2
g50kufzOsIyQLxOA6/LLBob6sfzVdGJ6j+c/lu2qba5TkOo365YOyyeqDrh3JD/y
tS+179z5X09ryU7LwB3yyPY570fnwOiaaP5E/Nvzq7250e506I/3czVpmTg7Ire2
rJreLo998g/84G69q7LqH5n64bq2bc2xr08OmZ8NHw9Wr8w+2fIH/OMf5fflw6Xf
lzSo47pesh3JP0jMyApqlkt9AKoUBVFAOgGSa28Vd74K6q7CrsVdirsVdirsVeH/
APORX5mL+UnkPVfOZ+3BEwT5kHFX82f5Qflr5o/5z38+XN35j1OWPTfVJRuTUVQe
mKvqr87f+fVdz5G0f/EX5d38kt5ajl8LtVioqNsVfYn/AD7l1z8wrXSLjyr+ZNtL
FZ2YISWatPhrvU4q9+/OD/nNryL+Vd62jTXcc90hIdQa7jqNsVd+TH/Obfkf839U
Pl60uI7W6IHAO1ORPbfFX5b/APP0uf6/540iMysYlmT01ViKmo8MVQf/ADnjAY/+
cfvKH1tGSQ8KEk79MVfoZ/zgX5p07yJ+Qumaz5luBDZW8Zcu57U98VWa3/z8g8ha
de/U7BluLflQyAnbenbFX1T+UP5/+Vvzkg9XytdJLKBVkB6Yq9yxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2Kvzq/wCc2v8AnMbTPyT0a58r6Mwn126jMahdyhJp2xV+
bv8Azh1/zij5g/PrzM35tfmmHlspJWlT1CaEH4gN64bV/Q75f8v2Plexi0bRYlht
YVCqqgDoKdsSUAJ1gS7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FX5/f8/EfzLv8A8ufy6luNJYh7kPFRa13Htir87f8AnA3/AJxC8s/n
do195t/MdTc3c5ZlVmJILd8VfQ3kL/nBt/yV843vnLQdSMFrBWRLb1K7Dpir4O/N
jVNW/wCcivzjXyR5iunOmW0wRoixAoDir6z/AOcwP+cGPI/kL8s7fzf5Dh+o6tax
K7zK/wBs8QcVfOvkH80r/wA5fkNrPlrX5HkNjAUQknegpiqVf8+1f+cV9I/Pm21f
UvPTO9naErHEWJrU0H44qwKz8tQf84x/85Gw6borNbac1zwReRpQtir3n/n5d+X/
AJw80eZdA87WVvNe+XWt0llVGIU9Centirymzu/yk886dp3lw6cvlfW4vTV7qQkE
sO+Kv0p86/kn5G/5UhLIlymuXKW5ZbhWrTbFX59/8+5PyV8rec/OOo23mO1Dx28j
tGCelOmKvL/+c5fKEUf5s2/kry6WghuplhWjHappir9F/IP/ADgTo/5Z/ljrPmrV
rpp9SuLAzA1Jp8Pjir5h/wCfSFuq/mN5mgJP7qWTgxJ7E4qmP/P4q4S784+WLdG3
iaMNQ9KnFWR/85vfmxq/k/8AJ3yP5J0mRlg1GxiV6E71AHXFXrn/ADjJ/wA+9/JH
nH8ro9b8yJ9Y1zU4vVjn5V4MRtirMf8AnH//AJwXl/K3VtSk8yagbjRyknGJnqAP
DFX5Vea/yv8ALUf/ADkTH5U0+3B0yW6BdK7GrYq/qJ/LjyBoX5f6RbaZ5VtEtYfR
jrx6n4R1xV6DirsVdirsVdirsVaBB3GKqcUyy149QaUOKqte2KtEgbnpirgQRUGo
xV5Z5j/OXyv5Z1S38t397Gb+4fgIwwqD74q+XP8AnM3/AJyN8wf84+WNl5g8n2La
mt1Tmi70BPtiqbeYP+chtaX8lU/OifTjbXwtxKYSK70r0OKsV/5wI/5yy1T/AJyg
0nU7/WrX0DYS8AaAd/bFX6FVFaV3xVvFUuuImluE+GsYG5xVMQKbDFXYq7FXYq7F
ULe3S2VvLePusSM5H+qK4q/Ffz//AM/HvMurea77yT+XmiNO2nTNGxXwXqcVfUv/
ADiH/wA5nQfnfeTeSdejMWuwFuS9wR2OKv0NxV2KrVdXFVII9jirSSpJX02DU60N
cVa9aPl6XJef8tRX7sVVMVUpp47dec7qi+LEAfjiropo519SBldfFTUYquaVFPFm
APgTirmlRCFdgCegJxVgP5oeZr7yj5cvNd0WD6xdwoSiD5Yq+SP+cY/+cgPOP5ma
1c6b5ysXgtlZlRj+GKvvKa4itxyndUHX4iB+vFV0UyTqJYWDoehU1GKr2YKCzGgH
UnFVGC6hua/V5EenXiwNMVVmYICzEADqTirSurjkhBB7jfFVrypGQJGVSelSBiqp
iqEh1C2uHaCCVHkXqqsCRiqLxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kp
fqOqWukxG61GVYol3LMaYq+Sfza/5zQ8i/llHJyvo7i4QN+7WhqQPnir8sPzU/5+
OeavzMuX0L8utOkRSSquitv4dMVeX+Xv+cavzj/5yOu11fzTLcQ6fOaHkWAAbfFX
6Qfkr/z7P8o/l96OpeYZPr13szq1SK0364q/Rby15E0PyjAtnoVnHCigAUUV6UxV
lwAGw2GKt4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUPdWkV5GYLlQ8
bdQcBCvL9X/IzyJrzmbVtDtJ3PUsp/rkeAK8r8wf84ffl/qYZtK02KzkPRk7ZXLD
bMSeU6j/AM4H6PdgrbX7RHxAOUS0x7mQyMFuv+fdaTMWg8xzRjwAOQ/KeSfFQI/5
9xSA1PmmenyOD8me4MvGTex/594QWzBrjX5ZaeIOS/KHuY+Kz7Tf+cF9CteP1u7M
wBFQa7jLI6fyQcj1zR/+cSvy302jXOjQXDgDd69cujipgZW9S0P8o/KHlpg+haTb
WzL0KLv+OWcIRb0VEEYCIKKOgySF2KuxV2KuxV2KuxV2KuxV2KuxV2Kvg3/n5Bpl
1qn5Ia5Dp1TKFrQfI4q+Cf8Anznruix2N/o8/EasWfjWlftYq/bnz15x0nyJo1x5
k8zuqWEC1flSh9t8VfEfmX/nLXyj5z8lavN+W7rFcRpKpMYA3AP8uKvwX/LbzBZ+
dfNuoav53tTqBFw4CvXffFU180R6j5f8/wCleYfy80xrOE3MYKpUVFcVe8/85tax
ea7P5a1PVoCl6jwmSvXamKvTv+c/ZZbr/nH7yZf09SJuAA8NsVet+UPI+q+d/wDn
F2z0rRpmhkmtiFRTTtir87fycn038mY7ny5+aXlsXoJZfrLgmlT1xV+mX/OBkfke
TzPPq/lDV0iaZywsQffpir9nMVdirsVdirsVdirsVdirsVdirsVdirsVfCn/ADmN
/wA5a6V+Q2gTW9pIsmrTKyIi0JB+g4q/Iv8A5xx/5x681f8AOYvnc/mV+YEkkejx
zGZefIBlPxUocVf0beTfKOn+R9Jt/LmhxCK1t0VQAOpAArirKcVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfH3/OZ/5Mz/nF5HuN
OsByuLdHdFHc9sVfjN/zjv8A85A+cv8AnFH6/wCXNa0uSaQs8cQKk9Nhir6A/Ibz
D+cX5/8Anm41vWFntNCnOwYELxO+KvKv+cmvyR80fkH+YMf5maDbPd28jq8hUE13
36DFUH+fX/OYvmr8+vK1p+WGg6LLFKVWORwrb02xV6XH/wA4vaz+XH5D3mozRs+o
31vyMVDWpFcVet/8+j/L+q6Nomtfp22a2blQKwIr8Q8cVfIP/OTHl/WdW/5yKtXu
9Md7UXIKycTQ0b5Yq+sf+cuPPXnPybJ5fmh0t7vy5FaossXEleg9sVfBn/OQl9oH
5vaZaR+S9D+p60SvIopBqflir9MP+cbvyQ8w6f8AkVd2WvO5u5Ld/Tiatenvir82
/wDnGrzx5o/Ij8w7zRr7SpCZblxyKndS3yxVlX5/aXrfnn83dE81Raa6xm5jY/Cf
EHwxV+/mo6HP5q/Lmby8EMU1zp3ohf8AYjFX82P5feavNv8AziD+al8mnafJLHLO
3IhWoat8sVY9/wA5g+cfOf56+YrDX7rSpUQyIyfCfHFX6Yf85S/8426r+aX5G+Ut
d0tCdT0iwiLRitRQV/hir59/JX/nNXzp+VPk6T8rp9IlfUokMMUvFqqaUGKvqT/n
BG2/Nzz5q+peafzWlnGhTCQxRy1A3rQb4q/PX/nJjy75j/Ln87l84abpztAlzyVg
pNQG27Yq/oL/AOcePzQuPzN8s22oahbmC4jhjDVFK0FMVe/4q7FXYq7FUHf3sWnW
8l7cmkcalifkK4q/FP8ANf8A5zB8+fm357m/Lf8AIu3d3s2aJhGdiR3JxVnv/OOv
54/m15Q84j8tPzd02QzXHxq7AkU+eKsr/wCcoPz/APPfl7XI/Lvki1KtIK8lNOuK
vhnzF/znF5+/K3zNY6V52d0WWROQrUUOKv0+/Of/AJyLvLD8mIPzV8rjnLJEGeny
xV+dX5Ef85AfnX/zkNby3PkiOaSKJmDEEigGKviH8ytW/NHVPzdg8u3Mkw1qGcDh
U9a4q/Rn/nI781/NP5JeS9Ij8/6YNTu7pIwVm34Vp44q+jPzO83f4t/5xkTVjALQ
XFnUQr0Hw9MVeBf8+dmey8q+aZAKOs7uq+NKnFVT85v+ck/zP1rzhcaT5Tha1srN
mQuppUDFXm/5Nf8APwfzT5d/MCDyP54VrmKZ1hJc9CTTFX6D/wDOZP8AzlUn5NeV
7S50Vq6nforIg6jmNsVfnfr3/OQ357+VvJrfmxJazNpEoJRzXpir7K/5wZ/5yu1T
80/KWoea/PbkLYxtI/I/yjFXz5q3/OV35k/85Bedrny3+RKl4LRyvFWAHwn54qyb
8mf+cx/OX5cfmM/5TfnpFwluZBGrMwPE+INcVfs7b3Ed3ElzbsHikUMrDoQcVYt5
81Kx0nQb671icW9sIHBcmnVTir+Ru+/NH/lT/wCZuva/oJN3FeXUgVqVFHPjir9Q
/wDn3f8Al9YaPqd5+fOszJDHeOxYFhsznwxV+4tjfQalAl7ZOJIXFVYd8VeTfn15
wufJHkzUdd04VuI4zxp8sVfg55B/5y2/NX8w9V1HyV5bMz3XKRU418dumKsRsP8A
nMr82PyO8xzeSfPpmN7OeKB+u/Triqc/mr/zkB+dfkqwj/MZ/rCadPR0JrSh3xV+
rf5Bf85bQ+afyWl/NDzKwXUNNti0oanxEDbFX5can/zlb+af/OROq3Vx+XjONOhc
1o1BQHFXtf8AzjP/AM5oeZPK/nGL8tPPxMjPVWDnvXxxVJP+czv+cyvNvljz1ZaH
5OLxwzEcVTFXmH5i/nn+d2mwWf5kytcx6THGvPY0xV92fk1/zk9qX5k/lDfa3fMZ
r6GJ6g9dhirx3/nCb8/7vzdqmvi8i9N9OWaVaDqUrtir588w/wDOZfnv86PPmoeS
9DeS0aBnjRQeIPE0GKva/wAl/wA8vzc8secrDyNrsT3No0wDMTy2OKvff+c6P+cz
Ln8rra18l+UK/pi84rKq0LKW/HFXxGvnP/nIDyXoCfmUy3P6NmAkBHI7Hfpir7Ms
v+csfNGr/lFdeZb6B0vYod3K0bpirIf+fd358eYPzai1KDzLI8qIWKcu1Dir5+/P
f/nKvzR5d/OiDydBK4shOE4DpSuKpt/zmn/zmr5i/LyfSNA8stJFNeQx8ig7sB3x
V4Ev5sfnJ5fNj5x0jnPFclGYc6/a+nFX7d/849+d9c8+eU7bWPN9v6F8VUN77Yq9
0xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV5t5y/Njy15Gikm129jjaMbryFenzxV+
b350f8/K9A0JZdJ8nfvrg/CGUcjWnz8cVfn9rf5v/nh/zkHO2leU0uRb3DbEKwAU
7Yq95/KP/n2tr/nySPXPzZv5Y5KhmjYtv44q/Uv8q/8AnETyB+WECR2mmw3FwgA9
V1qajvir6bsNOttLhFpp8Swwr0VRQDFUZirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVWs6r9ogfM4q2CG3U1GKt4q7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYqsaRV+0wHzOKrgQwqpqMVbxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvOfzX8ixfmP5ZvvKU4BW5jK0P
jQjFX83ur/kz+Zv/ADhv56uPMPk6zllsZZSwKBiBXfFVL8xvzw/O78+4R5K1GzuU
s7pwCOLUo22Kv0t/5xN/5wmbyf8Al7dWPmhKajfxMyhq1qwPjir85dQ/LDzH/wA4
z+eru4vdC+vWUk7uoKkgivyxV9BflrqvmP8AOLz3YfVfKq2thDJGx+AgbfRiqt/z
8W/K3zNq/mHRzoOnkWxaNZPTBIUbb7Yqiv8AnNb8sfMmp/kB5P8ALvlq2ku57cqZ
lAJIHfFXt35Z+Q/Odl/zjrYwaPHIusWkBJgoQa08MVfGek/mdq9nol75S/MDykt3
qtyGVJJIySD08MVZp/z7z/5xl8z6F+Y0n5g65A9lprSGRIaELStab4q/oSxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KvnD/nKL83j+TPkq68zRKWlZXRKCpBpir8IPyV/J7z
V/zmd5+k80+c2lPl1Ji6mQMB40xV/Rb+Wn5c6T+WGiW/ljy/CscMKKpIHUgUxV6D
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
aIDAqwqDsQcVeY65+TPkvzHcC/1jR7aacGvIr3xVmujeXdM8uxC00S1itogKcY1p
irWueW9L8ywGy160iuoT+zKtcVYZpv5L+R9IkFxp2hWcUoNQwj3rirO73RrHUbb9
GX0EctrQD02Hw0HtiqD0LytpPllHi0CzitEkNWES0qcVQGoeQvL2q3y63qOm2818
m6zOlWGKphrXlfSfMcAstcs4bqACgSRQQBirA7D8ivIemXP6Qs9DtEmrUHh0OKvU
YbOC2hFnBGqQAUCADjT5Yqwi7/KvyjfXf6WutHtHvAa+rw+Kv0Yqi7j8uvLV1NHe
TabbmaEgo3HcUxVmaqEARBRQKADFXm+s/k95N8wXjavrGkW092xqZGXeuKrrr8of
J16kcU+j2pEVOHwdKYqzldLtEtBpQiX6oE4CKnw8fDFXnr/kr5HknN8+h2hnJqX4
b1+/FWf6Vo9noluLHS4lhgXoqjbFWPeYfy88t+an9bzBptvcyjo7pv8Afiqb6F5a
03y1D9T0S3S3h/lQYqnmKuxV2KuxV5x+bMV7N5W1FNIXlc+i/Ef7E4q/CT/n3bf2
2i/mx5i03XysOtS3shUyniacj0rir9n/ADL+ZHkHRNbWHXGtpfMCoxjZaO/yqMVf
i1+cn516t+Yf56w+QXUWVnNREmB4/CTQHFXiX/PwT8lNH/LL9FM2rNf6jM6SM5bk
QG7Yq+3vM0Cx/wDOI1oyy8o2hpUnc/DirKv+fSf1aPyldQQKFm5ty998VfG/5sR3
Wnf85UwXl3+7i+uDk5NP2sVfR/8Az9cFvq/l3RryK4HBFiIKMDXpir07UXe//wCc
T7d2UenFZfa7/ZxV4V/z6t8xSeX/AMvPOmv2qeq9s8hAPyJxV49+Q2s6t/zlJ+YO
uaPqNwNJt4bqQFg4Q0BIxV88/nr5A8v+Qvz50jy7oOotdMtxEHkrUFw3jir61/5z
/wBN1Oy1PytqeuJXTVitvcUAG+Kvsb87vM+hzf8AONsE+jPDLbC2AMYYGh477Yq+
H/8AnDe2Gsflf5nu/Lzychbzc40BpSh6Yq+cf+cKPKnnTVvOOqxfl5dvZag8sgPJ
/TPU+NMVfSPmr/nGS/1v81NKufP2svJryTqZCsnMk19jir+hXynpH6B0ez0gO0no
QqnJup2xV+bH/P0f8yda8ofl3JouhI6pd09SZAaqDUYq/Ov8pvyO/Kjzl+U0vmXX
dVB80GH1OLsOXMDFXxx+Xn5wa/5d19fy+N/NBoQv40ABopXlTFX9cP5Vw2cPlXSz
pc/1iF7WJvU5VqSoJxV5b/zld63/ACr3U/QXkPSct7bYq/IH/n2fpdtqH5h390qL
LNHI7MW7AVxV5H/z8BsoJP8AnJnRoQinndRBo+xHMYq/SL/nPzR7SH8lLKOxtYkc
W0dEAoB8AxV+f/5G6Rq9z/zjp5riKkj6s3FU3/AYq8B/5wj8m3nmnT7+zsdRfTbi
EsGXlwLb++Kvd7T/AJxzsL78xLG5i1WSTUkYF2VqkmvtirDv+cxtJGj/AJw+U9IU
B+IhVif2jUdcVfrp/wA5RaFZW/5CxQPaxRoLFS1ANiUr+OKvzY/5wwu5oPyx8x2c
IDxUnAJ7ChxVEf8APu57fTtb8wvcAPC7Ti4J6hKmuKovVfyF8m/mX5+1G8/KPVza
X6lmZg3A867jFXjXlX84fN//ADj7+btl5R1xBqsn1hV9VzzNK0xVKv8AnKXVL2b8
69L8/wDnOBk0q6njbgVPACoPyxV+3Wv/APORP5Z+Wfyxiu7ua3urX6soW0bi29PD
FXyb5z/MLSPzX/KDWZfJGnpbpwJVY1oKAYq8V/59i/mrofkq61PS/NlytpMocUYg
b/I4q+X/AM5fPOm+bv8AnImObTJPWtjdD4x0pyxV9yf85ReSPJnnJdI07UZUS9a3
QLMaAqSPHFXxj+cvlbzP/wA47aJa+ZdJ1Z9TsealImk5AAdNsVfs/wD84CfnVcfn
F+Xdvfalb/V7mCgIpSu2KvuvFXYq7FXYq7FXYq7FXYq7FXYqhp7yC1RpriRURBVi
SBTFXy1+av8Azl/5B/LSCVZ9RimvU6Roynf78Vfln+av/PynzT51Z9D/AC50+SNa
0EsSkk9sVeJ+XPyV/On/AJyLu1k16S6htZzUswYbVxV+g35R/wDPsXyz5aWLUfN0
xu7wULK4J3Brir9G/JH5WeXPINsln5fsYYSgoHVd/vxV6L0xV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVBajex6bay385AjiQuST
QbYq/ma/5yG/5+Gee9G/MLU9B8t3TDS7e6CVVtuPLtTFX77f841/mlF+bXkPS/Mw
kEl0YEWc1BPKnfFWD/8AOWP/ADk1pv8Azjv5Ym1aR1bU3UiKMkVFRsaHFX4h2H/O
RH58fm3c3HmfycLp7FuTKFDcQD8sVZ3+RX/Odn5l/lp5kTyp+bsEwtZJQvOVT49N
8Vf0CeRvONr530O280WXwwXCBt9qbYqmH+LNFE/1L6/b+v04+otf14qn0cqSjnEw
ZfFTUYqvxV+YX/PwT/nKvWPyJ/Rvljy5WO41OgWQGhqdsVfCU3/OXv5n/kddaNqf
mWaS6tdZKOodq0DH+3FX7++Q/MR82+XdM8zOvFr22jmI8Cw3xVluKvxF/wCfjH/O
Vvmv8m9fXRvKtzJCCtAENBirLf8An25/zmFq/wCc9xP5S86XBku1UlS7Akn2xV9G
/wDPwL/nIS8/IryWl75fl9PUJmJ+E706DFX5f/8AOG3/ADm35+/MLz1FomuXUs0E
0gopaoAOKv1G/wCczf8AnMnT/wDnHHy9GLUrLrl4gCICCVLDwxV+Rdl+dP8Azkd+
adm/mXy5BcrZXNWjYBhQddsVewf841f854edPIPmu38g/nakqwu/pu7jfc074q/f
vTdYtNWsYdZs5AbS4jEiO21VIqMVS9fN+iPP9RS/tzPWnESLWuKshVg4DIQQehGK
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqT6v5e0
3X09DWbWK5TwkUHFUksfy78taa4lstLtY3XoRGKj78VZkqhQFUUA2AGKsb1zydov
mUq+u2MN0y9DItT9+Kq+leVtI0M89IsoLZqUrGgBxVFaloen6vx/SltFPx+z6ig0
xV1xolhdQLYXNtE9un2Y2QFR8hiqJtrG2s4RZ2sSRwDbgqgL92KsUuvy38r3twL+
70q1kuAahzGK4qyiy02005fTsIY4V8EUD9WKo7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYqwL8wvy90z8xtO/QuvwpPb1rwkFRiqC/Lv8rdE/LW2Nl5cto7dD+zGKDFXpWKu
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxVZJIsSmSQ0UCpxV+fn5l/8526R+XPm9PIV7bq0zyemN9+tMVQ3m/8A5zcn8vax
p+k2ul+rBeuqlqHYHFX3voGrLrmn2+rIvETxh+J7VxVOMVdirsVdirsVdirsVdir
sVdirzb82/PUn5beV77zhDD9Ya0Tl6fjirw3/nFP/nKO2/5yQsb+5jtTa3FjJwZS
CAd6Yq+u8VdirsVdirsVdirsVdiqHmt0uKCXdaEFexBxV+WP58f8+7o/N3m3/lYn
5aX8ulXspLS+i5Q8j8jiqef84/8A/OCd9+XnmkedPPWqzatIEK8Z3L/rxVjf/OR3
/Pu9PzF81p+Yfke6a01BRUENx4n2NcVeW3f/AD7K1bz9Gr/mVqs1zcQj92Xct06d
8VfW91/zhtDd/lLD+Tk13JSCtKE0pirOP+cT/wDnGK0/5x40mSxt3ZpZCag++KvA
/wDnJ3/nAtvzb8ynz/5Yu2t9QZg1Q1CDWuKsY/Mj/nA3VvzT8tab5W8yX8rzWIUM
zMSDT3xV9Pan/wA45Wdr+U0P5ICZuDweiWB9qYqxL/nEz/nDaz/5x38u615WaYzx
asW5BjWgYUxV8qeZP+fY9/o3mi787flvq81k13I0jpFIV3b2riqX2f8Az7AutR1S
283+Yb1pdWguEl9Rmq1FNetcVex/85t6B+W1p5XsPK35g3sqXsMSQpJ4EADrir4S
86f848R6N+Uc3mfy75m+taVIr+navcA9tvhrir6X/wCfT3l6SPyzqFpqlmPqsvJC
XT4XHf51xV6R+bH/AD78u7jzLP59/KfUH0m7uGLNHbOYxWtcVTr8h/8AnBnV/Knm
lfzD/MXV5729jfmqvIXqfvxV+n4FNh0xV49+eH5PaT+dfli68na7GjespEbsN1Pz
xV+Qx/59X63ot6f0FqjiwLf3Yfanyrir03U/+fVWh3mkpIlyV1gMr8ge498VfoT/
AM46/lJf/lB5eXy7q1490yBVTm3KgGKvRPzP8kJ+Yfly98qSuUF1GVDD3FMVfHH/
ADiz/wA4SW3/ADjzr935riumkkuWY8eVftYqwv8AP/8A5wFi/Nz80bD84EumVoZk
kdOR2oa4q+m/+cif+ceofzs8lQ+QDO0QhRYw4NCQFA/hirDP+cY/+cR9O/I3yvfe
StWk/SFtfAo6SHkOJxV8dfmJ/wA+0b2LXrvzF+V+oyWEdw/IRROUFCfAHFXvv/OO
n/ODy/lzer5p8630t3qa9AW5b/fiqT/nf/zgBafmz+Ymn/mO12Uhs2VuJbccTWmK
vrz81PyStPzK8iH8srmdkjWBYlkr14rTfFXyt+S//OCsH5Y+WtS8pi6JF56gBqf2
sVRn/ONn/OC2nfkzfalqt7cNIL8uGjr1DYq8s/Mj/n3ZcTeYp/NP5banLYeuSzCN
+B3NexxVA/lx/wA+2V03zVZ+fvOt897d28okb1WLE0+nFX1r/wA5Jf8AOJPlv889
EWw9BIL+2UCB1FDUdN8Vfn75e/59h6+8g0/zHqjSaaDtGXqKV8K4q/TDyX/zjN5Y
8m+UW8g2UY9OSIo706kimKvzP1j/AJ9aX1v5ruNb8u6i8FndSFzwcgAH6cVZp5a/
59e6f5f8zWvma4unnlQqzvUncHxxV9IfnZ/zg9o/5j2MEdpe3ENzAgVWStagbUpi
r5O/6Jna9r80Wn+aNYmuNJjYEJLITsPauKv1P/JP8m9G/JLy5B5Q8uIAkYHNwKVI
GKvYMVdirsVdirsVdirsVdirC/NX5heX/Jds9/5gvoII0BJBkWu3tXFX52fnJ/z8
08k+TvW0rykTe3wqq8aEVBp2xV+dHmf/AJyF/O7/AJyWuW0jyRFc2dqSfiRSoIrX
t7Yq9X/K7/n2z5z84zR6/wDmjeSkSHkVck9d8VfqH+Vn/OF/kT8uY0b6lFcTjqXT
FX1fpuiWGjoIdLt44EGwCLTFU1xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV8U/851/m7F+WP5bahb283panqERjg+IA/Ri
r8J/yQ/5xv0z8y/yp84fmN5suozr6FpIObjkSN9sVfaP/Pof832to9U/KPX5+dys
pNuC38p7Yq8I/wCfsOt3us/mxo/kRpWWxl9IstfhNSo/jir9q/8AnE78q9F8ifl5
pdnY28DmeBHd+IYnb3xVKPzl/wCcQvJP5p6jb63qSQ2c0ThyQAvIjFXyr/zmz+a2
qf8AOPPk638n/l+ZRbBAhlhHQdOoxV+bfkh/Mf5haSfMWl+Y549ZkJIjkm40J38c
Vfs3/wA4bXXnxdBh0zzlKly0P95KX5Ejtvir7yJAFTsBir+e3/n7T538secdU0bT
fLE7XXmHTG3jjFdwSe2KvjH8ldV/6GH806H5X/NSVrS00kKv7w8dkPvir+mj8oPz
P8m6xaQeR/Jd36502NbcACo+HbqMVe84q/nD/wCfqOmC589wwkB/UWlPnTFXzB/z
ize3f5JfmHY6peMbW0maKp+yKHFX0D/znz+Zc350ecYvKHl+U3VnHCjEKeQqflir
xT/nCHQJPLP5w2+jTRheMy12xVPP+c0tRvfPf/ORkXkW+f1bCO4hRI3Pwiv+1ir+
kn8nvIWmeVvJ2l6FHaQKsduteKjckda4q8D/ADQ/5wy8h+d/Mdr5rvBFaTK/NwxA
JINdq4q+PP8An4t+devflNp2leSvIss8GnQxLEZYPClOoxV8W+Q9O82ectHi80+R
vMUkmrnizRTz0NfkTir9t/8AnEK+84z+WDbfmU4kvo6cWDctvnir66xV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV8yf85U/nvJ/zj/5OuPO0
ESytF05b/hiqA/5xK/5yQg/5yU8pDzdDEIpkYLIB0rir6qxV2KuxV83/APOUf54/
8qB8lz+eFjWR0JUBvYYqxL/nEH/nJaP/AJyP8r/4ilj9O5ViDQbEfRir69xV8Xf8
5g/85G6z/wA4+6fYaj5csxdyXLfEpWvelMVe/fkv59uPzM8oab5y1CD6tc3cfKSK
lKHFXqeKrVdX3Qg022xVdirsVdirsVdirsVdir4O/wCcrv8AnL5/+cfbm2sLO2SV
5iAxf3xV5V+Y/wDz8Dfyb5TsfNUNpGZ7pUJrSnxfPFX25+Qf5q/8rh8pWnnF4xG8
ygsF6bjFXtWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV5N+cn5sab+UHl648z6uyjgjGNWNASBir8aP+h+/zJ/M
rVZ/8I2BfS4ZGAKLUUB9sVfDnmD8wdT/ADI/OWzvvMlssc8c6llYeBxV96/mR+f2
m6F5w0Xy7Lp0DOzxqpKitaDFX0F/zkP/AM5vaj+TNjo8el28amUKOApvtir5t8z/
APPwb8z307/GFjppWwgoxYLRaYqyfT/+flfmP8xtIgsvJliJNR9P/SDGtSCPliqf
/wDOMf8Az8V1PzF54X8qvzHh9F5HKh3oCprTFX2F/wA5Yf8AOZGl/kBZxWel+nda
zdLWFCdtxttir87LX/nPP81NDkj8165agaRLIGNegU4q/RCH/nL6w8zfllJ+Y3lw
odShj5vECCKqKnFXwV5U/wCfnPnD8wI76w0HT1a9ty6gIg/Z+QxVO/yC/wCfiXm3
VfOEHkT8wLVYkuJ/THqUBFT74q+s/wDnKv8A5zYT8hzFZabHFLcXaqISxB3bFXxl
B/zm7+bHk2EeedYs1utNvjyRF+OgJ8MVfeWqfn4PzA/I/VPzOv7H0lgt+c0Uq0Bo
K9Dirw7/AJ9tfnXpf5j6P5gv7DT4LCK0dmcxqF5Ab74q87/O7/n4RreoebJvyu/K
a3E13C5RjH8RqPlirHfIX/PwTzt5O1638rfmnZelHK6oTKOPU06nFX0j/wA5W/8A
Obc35SaJY+YvKqJJFOEdjUHr2xV8k+Z/+fh35hecNCj1fyvp3CEAM7RrsfpGKvrH
/nDX/nNWf84YZ9C83IkV3YoWlevxAAb4q8n/ADw/5+D62PNs/wCXP5SRwylDwMjk
A1rTriqT+SP+c8PzE8reYdN8mef9JWa0uZAjTovKgPuMVfsJ/iW1/Q3+KaN9V9D1
6U+KlOmKsixVo1pt1xQfJ1N+XelOu2KXEVyMo2kFvJIdirsUOxS7FULNbCZg7UJH
SvbMPWYJ5K4DVMxIBEFeS8ST8xmUBtTBbHH6Y41J9ya4xFJJt3FufKvw+GQETxXe
zF8vf85If84waD/zkJo36D1ocJeZYTUBYV8Cd8xNThySmJRO3UJfDyf8+pdHgjhs
08w6k1kknJrdpW9OnhxrTNqZRplMgjZ+mf5Q/lRpH5O+X4PKHlxAIIQAWpQsad8h
KVtcRT0mO0Ecz3QdyXAHEsSo+QyLO0SRWh8MUN4q7FXYq6nfFXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXHfbFXdMVdirsVdirsVdirsVdirsVdirsVdirsVdiqhNcw2w5
XEiRjrVmA/Xir5u/Nf8A5yy/Lz8oEc+ZtSjMignjE6sagVp1xV+Wf5t/8/TdZ1e4
k0z8mLF7qGXlErhORHLYHYYq+btK/JH8/wD/AJydvRe3txc29hO3qOHYgBX3xV+h
X5N/8+x/Lvl9IdT88t9Z1FaM/NQwJpv38cVfo/5S/KLyv5MtYrLRtOgjMYA5qgUm
gpvTFXpSIsahIwAo2AGKrsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVfzl/wDP0f8ANBfzM84aZ+Vfly4P6QtpBGyI
2xJPhirAfy7/AOcF/wA9p/LjR6HO0OnXSFmj5EBhTwrvirwX8k59e/5w9/PDT287
Ew8pQkhJ4qSzDxxV9zf8/QPyj1PzdPov58+WomltfRSYtEOW1AeoxV7N/wA4f/8A
PwvyFoXkSHy9+YF49vqdgoUrIRU0HTfFXyt/zkv/AM5raj+fXmy08sfkfd3ax/WF
WsLmhFadsVfZv5nedNN8n/lhp/l388LNp7ydEDTOnJtx1qcVfAX5l/k5+XNp5RHn
78tNekt9Q3kMAm4079K4q+yP+fWX5p+Z/Mk1/wCXtd9SexQFUlck14964q/Y3zhJ
cQ6LfSaeCbgQPwC9a0xV/L75J1/y1pP/ADkBd3v5/c1tvrLeks32aV71xVIP+c5d
V8had5tg1z/nHqVx6p5TfVug2/ycVfop/wA+lPO/l/VNF1G21W7U+ZXlPwzuOZ33
pXvir9scVfzn/wDPySVG/MfT3ZxT6wgIY70qMVYb/wA5cfldJpv5f6Z+ZWhIYo1i
jJdRQ1AHfFXnf/ODfkS//MS+1PzvrAa6jigIVmHKhUYqyP8AIa5S2/P10nKilxxA
U77HFWS/8/GvyS1v8uvP1l+d+kwyyQzPHKGjUkinicVfoH/zjv8A8/J/y11DyhaW
HnW+a01WwhCTB6VJUe9MVfnv+bv/ADlx5v8A+ck/zQg8r/kvcXI0pZ1AeNjQqG9s
Vfdn/OVnnHyj5N8reXPKP5rWjS3klsiXE7JUhiNzXFX52fnT+UHkjyb5dh/Mn8m/
MM6TuFkNsk9N+tOIOKv0i/59o/mr5o876W+n+ZEke3jjoJX3rT3xV+tGKuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV4N/zkl+ccX5E+RNQ/MOdQ31RdgfEg4q/G7yL/AM5a
/n1+d9pe+b/y/e2GlQuW9J3HqUHYDFX2d/zhz/zll5o/MLUbjyZ+ZNhNBNbhuVyy
EJyX/Kp0xV5d/wA5Rf8AOe2t+XfMsn5ZflYqyanyZFINR7VxV4Z5W/5zc/Nb8p9X
tpfzn4Gxu3UKENdm8cVfpd+Y/wDzmFoHk38voPzIiZWkuoxwUGtGIxV+W+qf85gf
nr53aXzd5IEZ0GIljvvxH9mKvvr/AJwq/wCczYPzvju/K/miRY9Z08fvizdwN8Vf
Mf8Azkf/AM5/eZp/Pcn5Qfksgl1KKT0j3BOKvkr/AJyk/O383pvKb+SPzptBGt4F
EbcdqYq+sv8AnAr839I/JD8ldV1zUwqvbtyQHYE0NMVeWat/zmh+c35nXc2u/lyE
/REDVrXbiMVfY3/OIf8AznHL+YuoSeRPzIeOLVYFNXJHVcVeW/8AOWX/ADnx5i8v
+Zh+Wn5PIs9+zcVaM1qe1aYq+Lv+crPzn/OnUfy8j0n84rQR2k45KePZsVfoD/z6
YkX/AJV1wjjC1NWNMVfrdir8o/8An5/+bsv5VaRod5Bbw3BeWpWUA/tU74qgvOP/
ADlfrHkH8kdF896LAkElzbB2CDiBt2xV8j+W/wDnPf8APD8yNHa68lWglhjU8nAq
aD3xV9Ef84N/85r+ZfzA80Tfl1+ZSpHdM5BLHcNWmKv2XJJUmPc02xV+Mv53/wDO
ZvnP8p/zTt/Jl5QabNcKg37E0xV6D/zmz/zmzf8A5Q+V9O1DySR+k7mNHZSafaAx
V6N/zjv/AM5dTefvyVufzR8yuq6zbQSMFr1YLt9xxV5F/wA4Q/8AOXnm788fMOuS
+bqLomneoweuwVScVeU/nl/znj5u8x+drryD+RpWYwNwDcqrUGhxVJ/yt/5zu/MH
8tfNEPlb89VjEd4/FSTsK4qlP/Px/wAyW3nV9D1nTQrRXXBlZdxT54q+av8AnIBI
LnyBolm+xWOMH8MVftn/AM4GqY/yzsI46eiI0A8a0xV9sYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX5V/8/XpL
+P8ALSP9Ec+Zc8ivhirGv+fYWneT7v8ALaVNQS1fWD/e+rxrShr1xV+d/wCdFppd
r/zkAln5fMYIuhy4EcacsVW/nwwT83fLycfhWeKppt2xVnH/ADnRbrdan5c9ajQs
0dAu/hir9CNW8jaJaf8AOMGqagLKE3H1BnV+A5AgCm+Kvj3/AJ81eTdL8wReZtY1
m2jne3YKokUGnKlcVeB/85DaNb+V/wDnICK58vokMz3QIEQA/axVj/8Azn9d6rc/
mJ5UtJ2blJZxFef2SxoBXFXvvmH8gfze83eQILa4fS4tJeEOjFlDUI2xVX/Kn8mP
M35Z/ltrFz5guUns/RlFEaq1ocVTb/n1H5C0XzBrOtarqtskzc5aK61HfFXlv/OY
Wh2nlT899Jh0OIWqPeqP3Y4j7WKvqn/nLH/nHvy3+aek6OE1FRr5SP0w7inKgxV8
c+bbL82v+cbtLgHnG3tL7y7AAYi1HHH/AGsVfe1r+fGlfn7/AM4zeZBpdvHZraWp
SdYQFHTwGKvk7/n2rc30H5Z+dYtD/wB6lL+mR1Ip3xVJ/wDn3Xpmi6n+d2qX/mlk
fWEnkok1DvU9jir3n/n6zpWgafBZ6/5fNvHrEcyArDxDE7dhir40/PC+vtX/ACn0
eXXQ3NmhUc+u9MVfq3/zi5+Unl9/yGlur2zikvHs3b1GUbHhUYq/Nz/nCyP0vze8
xeX7h/Ss2MqScTSi1OKvRPzb/wCcQm8w+cbzW/yT1GI6knxsryAEmtfHFXl1t/zk
D5x/IjzFpnln85dOtZkhlCmZkBaladTir+gofmfpR/LI/meIx+ihp31gpTbj0p9+
KvbsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirRrQ8evbFWO
a75u0fyzCbnXb2C2Cip9SQL+BOKvgD86f+fkn5c/l3FcaXpU7Xmqj4YxEwI5U2xV
+XfnX/nM786v+chb39FeS7C4trZzwikhQqvFttyAMVemflX/AM+3fzF/M+ePzB+d
2oM1lMVdoy/xUJ32J8MVfqZ+Uf8Azg1+XP5QpG2i2aTTADk08atuPnir640nQrDQ
4hb6XbxwIOyKB+rFU3xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVa6CRTG3RgQae+Kvg3Wv8An3t+XPmLzyPz
X1j15dRWUSqhO1a13NcVfdGn2EGl20Wn2SBIIVCIo7AYq+MPz4/5wS/L38/tetfN
fmuKWK4gIZmgPEkg1H34q+kz+Vmh3PlWH8udUhF1pVvALdBIKkKBQde9MVfn15t/
59OflT5ovpNUDz2xlcsVi+Eb/I4q9d/Jf/n3p+V/5K30euaHbvcXsZBDzAHcffir
6R/Nz8kfLX5z6SPLvm63DW6/ZZVFQPAYq+G73/n1h+W95OeV3eCyYkmIOQN/atMV
fa/5L/kD5S/IjTBoXka29NAKGRqcj9OKvbMVfBX57f8APvX8tfzy1R/NWswyW+pO
eRaGgqfntirE/In/AD7K/K/yZcJdsst2OJDJN8XX3JOKs38g/wDPvv8ALb8tfMje
efKf1q2u2k9T00eiVrXoMVfdCII1Ea9FAAr7Yq+Pvzt/5wm/L/8APXWIPNfmpJl1
CBw6sh+Go9tsVZ752/5xo8oefPJUX5U63Ex0mJAgI+1QCmKpZ+Rn/OKXkn8gNMuv
LvkmF/qd2rLIJd2+Lrvirz7y7/zgZ+XPljzo35p6akw1NpPVKk/DWtcVfTf5g/lp
oH5m6a2g+a7VLi3IoOSgkfLFX5yeaf8An0p+VWuXz6nZvcW/qNVo0NB+vFX0d+Rv
/ODH5afkPcpq3lazL36b+rJQmuKvVfzt/wCcdfKH592aad56tvU9MEI605CuKvja
D/n1j+W0dyDLdXj2akERFyRt2pWmKvuz8qPye8u/k3pQ8u+ToBFbilSQORpir1TF
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+aP+ctfKXlzzp+XGp6N55lWHT2X7TMFHKl
O+Kvw18u/wDOMH5ieRdKufPv/OP2uWjaDb1aSFpQagbmorir0r/nGX/nMHzRrd3q
H5X+Y7C2+viORXmt4wHLUPcDFXxc1l5jvvzhuPqE0Ud/NMyxtckbEnbrir6a/Nn/
AJxN/NHV0stS8667pTRSspjRZFqAenfFWGf85JeRPNv5ceQbHQPME31nTqjjIhqn
34qnn/OPf5P/AJp+YfJTXHkPVtOj0edCJUmdeQUjFWWfkF/zin538n6vrfmDyvq1
rcXpVmuI7ZwWPjQDFXlv/OKzaRH/AM5EzwefqRa4t0QjT7AMD3rir9D/APn6fd+V
NY8iODcWzara04cCpbfpQjrir8vtLOtTf8476gIgfRotGX+OKvQP+cRvyh/M3zl5
Fnl/L/VdOtrUr+8W4ccqHr1xVmP5X/8AOKPmvT/Nl5qdtrFo+ppG7zejIN6daUOK
vLvyflsdI/P1IPMp3jmCM9zuCwPUVxV+mn/P0u68v3P5QRXNtJavcqQY/TZS3HiP
DFVH/n0w01x+XQuUoIeRBHfb+3FX634q/Cz/AJ/VcF0LyySDzaZgSOlAScVYF+cw
M/8Azi/oMcgHFLRQtOvTFX0f/wA+xPK2lx/lTqOrX9rG7+m9WdAduJOKvgjyYBpn
/OQcs+j/ALsPeVATbYtir+mjSQRZW/L7RiQn5kYq/Eb/AJ+kflW2jXth+bWjxEGG
VHkam1VpXfFXwt5f14/85ceZ5vLeqgywWWmURV3HJV8MVeZ3X5q69+S/ly//ACgt
n9KORpYxExoxB26Yq/W//nDT8ro/Kv8AzjlrnnCGB01nUrGdiQKMdq7ffir8jP8A
nFLyl5y8y+d9Ss/J97a2esGeQD68w5E8j44q+rvzj/5w/wDzJ8465ZHz7rul/Xom
Ur6UihjvXbfFUZ/zlvot75N8reXfLl0we5s0RDIdw3yOKsF/5yB0wW35ZaJfzSL6
jxxGlflir9qv+cCN/wAq9OPiqfqOKvtjFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq8a/Pb8pbP85fKl35Qv1UvI
jekWHRiMVfiPp3/OBP59flfeT2f5eagqWM8rU4tQBSduhxVH+X/+fav5qv5rg88+
Zb6GS85h2bkDv7muKvY/zC/5wC/MnzV5r0jzNHe2ZtbKVHl3XkQvhviqef8AOSH/
ADg557/M+70eTyXPDF9SKeq09KbUrSuKvtDVfyO8wz/kld/lFHNE2vS2jRBx9gtQ
DFXzn/z7h/5xM87f84z2+vwfmI8JTUnBjWLvSm/00xV5D+cP/OB/nbzr+b8P5h+W
5Y49OScSMZaUpWvfFXvf/OW//ODKfndoGnanoBRPOOlwKkcuwUlR2+nFXw/of/OH
n/OSnmdIvKWrauttpFuVQ1k4/CNvHFX6Iyf84n6no35QzfltpV16/mGaMq0rtVas
KHrirAP+cCf+cQPOf/ONtzqN358ureeO5LmMQkVHLxocVea/85Rf84TfmD+bn5t2
H5gaDPbr5bguFldDTmADU4q9G/5yP/5wg13zxpljefllqRttYtFQsJHoCyjtir48
82f84gf85LfmXpkPkTzXeWr6RDRGdqFivzPtir7l8tf84Vr5A/I/VPyk8qUGv6nb
lZZDTiXIpirFP+fe3/OGfmP/AJx20jXLD8zWhmbUWKxxxnYKRQnv2xV87fnN/wA+
9fPnkfzvcfm//wA49XaRXFxI0jx1oQW9q4qkPkv/AJwE/Nb80vM9r5o/5yKvPrGn
RyJIYUau4NelcVfSf/OYv/OCevfmxpOmeXfyjlt7OysfT5JKQK8MVfXP5KflDrPk
D8qR+W/mN0l1MWrxEx9KlaD8cVfn/wD84+/84DedfJf5j6v578xXMaaPfF+C1o9G
P34qu/OD/nCP82dA8yz+fvyR1ZQW+L0nfrT2rirynTv+cAfzg/OrzDp/mT8+Li1+
owyBpESgcgH54q/akflRow8kH8pQp/Q5s/qZHfj1/Xir0/FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYqskkWJTJKQqjqTirxf8wf+cgvI/wCW9tJc6/q1
ssqCvpCQcsVflD+cH/P1CeC4n0X8rrU3F2/wwMoLCvTFXyDFpP8AzkN/zlvqKpqX
1uxilPxOSyJ1+jscVfe35K/8+qdE0OSLVvzYnbUr0UYgMDQ1rvXFX6feQ/yZ8pfl
zajTvLWmwRovRmjUt99MVeoqqoAqAADoBtiq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq8P/AD9/Jax/PHytc+T9QleFpVPB1Yihp3xV+S1v/wA4
Afnb+X8c/lT8uPMEY0S6J5CWStFP04q+mP8AnEv/AJwFm/JXWJfOXn65g1DU51bn
wAIq2KsP/wCcmP8An3Vd+eddfz5+VN2ljqJYuFJ40J39sVeUeSv+feX5t67qdrqP
5qeYxJY2zqRCsprxX2rir9J/zM/5xg8u/mF+X4/LK7jDGGELFK1C3MDuTir8rtO/
591/nX5CaXRvI/mCOLRLl2UxiTdVJ9j4Yq+/v+cPv+cQbr/nHqS+1rzPqDahql6N
zzLKK9cVfLn/ADlL/wA+4da86+b3/N38o75LPWZX9ScKeJJr2xV5Frv/AD7J/Nb8
yNLr588xRTXNAY4y/T/Wrir7a/Ij/nB8eT/yy1L8o/zHlivDeghJI6EJttir4vj/
AOfZn5veS9Qurb8svNMFnoM8hIiL8SFPamKvtv8A5xb/AOcKJPyheXWvP982patK
DyYSEqa9cVeR/wDOU3/Pue7/ADO15POX5TXsOlXv2m5UU8vnir5813/n2X+b3nKx
bRfOHmeG6tVTiimSu9PAnFX6Hf8AOE//ADjNrH/ONnlk+WNfu0n3JUJ4nvtir7gx
V+cf/Of3/OIvmX/nKuw0rTPKl5BbLYvyPq0G5O/WmKpF+Y//ADhH5h81/lBo/wCU
OlajBFqdjAI5pW+yxA7Yq9o/5xN/5xw1n8h/Id15C80XcV5NOjKDF03UjFXy3pP/
ADgD5msPzOT81ba/hjsVl5mBqciK1xV+tVhC9vbRQTkNIiBSR7DFXgH/ADk5+Sb/
AJ8+TbjyTbyxwzScijuK0JGKvhL/AJwy/wCfdur/APOO3mi781eaLyG7jnUoAvE/
Ce22KsB/5yK/59f6/wDmp+Zi/mH5a1K1g0VpUeSBwA1A1SB88VfrX5A/Lq08m+Ub
TyCVVreG3EMgUChqKHbFX5Yfnx/z7T1HUPNQ/MD8jb4aZqMsnN25cFBJruBiq38s
v+fef5inzbZ+b/zk8yDUIbdwxSGU9vbFXuf/ADln/wA4U6x+eJ0238p3sNtaWIUc
ZKBjT3OKvHPzK/592+aPOXlex8tR6pCZLRUHGo34/hir9D/+ccPyovPyc8nWvk7V
JlmmhVQSnQUGKvfMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVaoK174q3irsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdiqS6v5i03QY2udYuY7eNRUlzQYq+H/zn/wCfgv5fflUkkNrcJqF2lRwiavQ+
2Kvy+/MX/nP/APNH867iTRfyitpobeYlEVA1ev8ATFUF+Xn/AD75/NL895xr/wCa
2pT2gc8mSWQjY79CcVfqb+S3/Pvv8u/yyhjl1WzTUNQi3WV6EA/SMVfc+maLY6NC
tpplvFDEgoAiBf1DFU0xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxVKdW1yz0SMTajKsasaCuKo+2uY7yJLm3blG45KfEYqr4q7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqozzx2yGWdgiDqSdsVeN+e/z+
8meQYHn1fU4fVQE8A1TsK4q/NH84v+fnFtY+rpvkKEy3XxIhSp+RxV8PXfmv/nIL
/nJW+9GxS7h0q4ahI5ABWxV9ffk3/wA+tY7povMn5nXrXEz0d4nYk1I3xV+nv5b/
APONXkP8sY4m8u6VDHdR0/elQWqBTFXv3TFVjBiVKmgB3FOuKr8VdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir8Z/wDn5l/zkxL+XU2l+X/L
kxWfkPV417t7HFX6B/8AOKP5kx/mT+Xekarz53KW6rKffFX0rirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVeRfmx+cOiflNaJe+YrhYfV+zywWmmvyq/Ofy9+bFs1x5bukmki+2F7Y2h6
9hV2KuxV2KuxV2KuxV2KuxVIdc8zaZ5bi+s63cJbx/zOaYq+Lfzg/wCc6/I/5eK0
dpfRyuvUjfenscVfmf8AmP8A859+e/zheTQvy40yXg54JLGrDkDtXFWFeTP+cN/z
Z/Oy5TVPOlzPaxSsGKuzDYmhxV+ln5N/8+5/KHkaSHVPNAF/dKFJB33HzGKv0D8s
+T9I8n2w0/y9bJbwqAAFArtirJsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVSHzPr9v5X0u517UG4W9shd2PRQO5xV/H/8A85cf
mRJ+bf5h6pdmX1rGOb/R37EAnpir9H/+fVX56yR6i/5ZarPxaUlYIj+0OXbfFX7/
AOKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KsL1L8xPLmkainl7UtRhi1FyAsLH4
iT7YqzTFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FWNeZ/NumeUbU6jrk6wwjuxAyrJk4WcYW/Or80f+fg+jaNLcaR5diErRmiy
Dev45jyyk826OIB8Xa5/znh5zvZS+mtIsVew/tyPiJ8MMx8m/wDPwLzFobLea9G0
8SdVYZZDIg43095G/wCfjOjeYplh1O1EIJ69O/zyfjeTA4w+s/LP/OTfkvzDxU3q
RO1NiR3+nCMqDje2aP5l03XovrOl3CSxGlGDChywTBayE9yaHYq7FXYq7FXYq7FX
Yq7FXYq7FXYq/GP/AJ+kXs8kug2ZNLf1hyHiK5jSnRb4w2fEP/OPf52X/wDzj75p
XVZ+R0W5erp2INPfCMiDB/Rj+V/5oaP+a2jxeYvLkgaJwCy1BKn6MtjK2uQp6Tk2
LsVdirsVdiriabnFXlnnn85PKn5fW8tz5j1GGFoxXgWFT+OKvzF/Nz/n6Dplh62k
+SbUzTrsjqCamtPE4q+F5vPv55f85P3xtLaC5gsZDRTRgAP8zir6j/Kb/n2ZqOoz
x6h+Z8zXEbHkySFvHFX6gflv/wA4teR/y2WL9D2EYkiFAae9cVfRsMEdsgigUIg6
ADbFVXFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FX54f8/DfzxX8tPI03li0HqXerxmIqNyAa4q/l11DQtVsof0rqsTRCbe
OoIrU++KvbPyX13W/wAivNui/mLJbP6ZKFX4nozD6MVf16flt5uh89eWtO80Wzh/
rkCStTsx6jFWc4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqh7suIXMRo/E0OKv5v/wA7
fPHmKH/nJe0sJpXaL64oUVP82Kv6NdGMrWUD3RrI0SE/SoxVM8VdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeQfnN+a9h+U2hya7qTAN
Q8ASNzlOWdbM4Rt+An5zf85I+avzg1KaG0uZI9O5EBRSlAcwJzAc2EHz5JYQueMo
DzD7THvmNLN5uRDGmEEZgXisYplfi+bZ4R7l5CNtcxAx9wcPjV1QcXkgItPgWQyW
qiP5YRqPNgcXkqI+q2c4mtbl0UHtlkM472JwHueh2n53edvLoWx0jU7hY1oaDLI5
R3sDhPc9f8nf85ief9DdXv7madFpsxG+WjKK5sfBPc+jNJ/5+W6npgjttQ01ZegY
mlcnDN5sJ4duT2/y/wD8/FtH1JlGo2qwKepB/ty/xnE8MvbNH/5zj/La7UfpK/ED
H5f1yYzBfDLM7b/nL38rLsFoNcjNOop/bh8UL4ZR0P8AzlX+Ws54xawhP0f1w+KF
8MsktP8AnIDyNegG31SM12FSP64+KF8MvTtN1+x1WJbi0mjKuKr8a7/cclxBhSbe
ov8AMPvw8QWkDf6ra6ZE11eSoiKCSSwH6zkTkA6shEl87eZP+cuPy38qztYaxqap
OpIoKHcfTgOWLPwi8C89f85+eW/L6teeW2F+nZTQd/Y4jLFPhF+V3/OUf58Xn/OS
95YX9vF9WjsJObRjpQHNVmy1M7ufjxel4fJHFqcfp6qB6CfZrkY5vNTh8n11/wA4
ef8AORdz+S+unyxq0pOjag/wlqUQVHjmRHL5tEsb97PJ/nrSfO9t9d0KZZU9iD+r
M3Hl4nFnjpmWXNbsVcTTc4q+U/zz/wCcr/K/5JpIurvynQE8fcYq/JT80P8An4x5
2/NC4fRPylspQjkorIh8fHFXn/lv/nEj86/z7uU1nzrcXMdpKeRViwFDvir9Hfye
/wCfcXlLymsN75qQXN1HuQQTU+9cVfoX5d8h6D5UgSz0Gxht0QUBRaH78VZfirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVfH/5vf84x2n5t6/a6n5hPrWkDhgrVpTFX5R/8/bvIWh/ltZ+ULLypapax
v8MnD9rixG/3Yq/Qf8t/+cZPJv5v/k/5We9tY1vGsI39Wm/L/MYq+rPya/Li4/Lb
Tf0E0nK2hHCNfbFXtOKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KqFzX0np14nFX8zn56
tcf9DQ2ZbcC9Wn/BYq/pb0olrK2ZuphjJ/4EYqj8VdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVfih/z8L8/3Y1tvKTyH6stAFr/lZh5X
IxPzW02CO3jeNGK+BGazNKnZYo2joFCCo3PicwJZHNhBHRxeudyR8shxMzFOItKW
QUNTkZTpBjaNXQww4gUysZkeGiRoJC8aE5OOZBghD5W39ShJ+WXjOxONCXPl1z0B
p8sujmR4STP5fYEq8IavcjJjOxOEUony+YhxVPwyQ1ZcX8sEnufLPqtyYkfRkhqi
j8uFkejPZgiFjv12w/myv5cNx2dyrVWd1+Qyf5opGnDIbbWNU08ARXUu3TDHVFfy
4ZFa/m75304r9V1e7VF+yA3bL/zJcU4A9S0X/nLD8wdIh9A3c021Ku2+QOpLKOAM
I82/nz5482gxXeqXMKMTUK/jkPzBbBhDyS6tJNVf63qc7Tyncs+5yB1JbRpw0tuv
H0iAV+WR/Mll+XCusSw8VgASnXj+188xJ5LLkjHQVZaTMrkABf2exxE2MooHULBd
THAsYm6q69Vp4ZlY8jj5IP0Z/wCffv5z6inmOH8tryQyRPVVZiKkBsz8Ut3ByB+4
mbFw3Yq7FXxx/wA5C/8AOIWgfn7dw3euSGEIwLcB9r54qyj8rv8AnEvyF+VyqNL0
6GSRQBzZN6gUrir6Ts7C30+P0LOMRoOwxVGYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/Bb/n9UKxe
Ufm3/E2xV+s3/OKdP+VSeUgBSmmx/rOKvoPFXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYqhL5PUt5ErSq9Rir+aH87yV/5yftLckkfXV3/2WKv6WdJT07K3UGv7mP8A4iMV
TDFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX88v
/PxWWX/lZRhFeBZf+JZiZnJxPky8jWAKE7gdM0+Yu0xL4+gpmAXOCdWS7gYgKSy+
0AWjYckDTVxbshtWVj0zDMSz4mQwwo46DFbCawWSOv2Rg4qSiTpEb9VH3YjLSVFv
LsTfsjJHMqHk8rRPsFGV+ImglFz5OU9F/DJDIVoJRP5OFKhfwyQyFFBKJfKfHou/
yywZF2Sa78tsvQfhkxkXZKp9DZR9nLRlaDBLH010H2cfEXhSia2eu4x4mXCGhVRT
EWzC0VU1OJBTYcTU1yQYktYUWqQkBwX6ZZjaZvWf+cU/Ndp+X/5rad5p1h/TsI24
sSaDdvHNpiLrsot/S9outWnmCzi1bS5Fltpl5KykHb6M2cZW4BFJrkkOxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV+C//P6n+68o/wCs3/E2xV+sn/OKX/kpfKf/AGzo/wBZ
xV9CYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVC6/uX+RxV/M7+eP/rUlp/zGr/xL
FX9Lmmf7x2//ABij/wCIjFUbirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdir8Bf8An4x6MHnZ7sj41IP/AA2Y2YN+IvhTSNbj1Z2Db8M0
2eNO0wyT+orVPs5gkObaZ2jlTUZZCIYZJFkttN0y3LEcLTGRtkdlKKgtmvlFttl1
pItOuVyCgp9bTACmVSZCRTmCZaZWWXEjQ4I2GV2bXiVYKd8tMUcRRMipTJCK8SXN
Gr12yYikSKAe0UmtMIC8SU3eno3UZMBHEWPXljHSlMISxu6sEAPw5MAItjdxpyOS
CKe+WgBFsaudPCtt0ywRDHiKAmtQgrkhELxFLe9Bh4QtluhG52yJCQpSH4Cw3+WS
gWElDUbGS+SOHTm9OY0fkNqU3zZYC4GaL9T/APnBr/nLNTPD+VXmyUKUoiSyt3Bp
1za4qp1077n7EQzJOizQsGRhUEdCMmxVMVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfgv
/wA/qf7ryj/rN/xNsVfrJ/zil/5KXyn/ANs6P9ZxV9CYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FVC6/uX+RxV/M7+eP/AK1Jaf8AMav/ABLFX9Lmmf7x2/8Axij/AOIj
FUbirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir+e
v/n5BcNJ57ms13LUA/4LKqS+APLunXOhzS+spAl6VzD1AcrCXokJKqA3bNFnG7u8
BTKCWmYsQXIkQnMNwBTMiIpx7ZDZ3O2EsmSWd1uKHKyVZLBdig3yosaTy2uumVlF
Jst2OmCwmlVJ6HJllwq/rbVwFeFZ64HXIsgh5bgdBgSlU0xrgpUnmdTXLm0yFJJd
SDIENE90iu3Vlo34YgNJixPUC3+6KbZkwDKOzHZ5Vf4bn8MyYBuEwlEoirxsdpPf
JHGWEswVZIbj0/8ATJEp7dcRjYHOENE8MKkj4l75aIFrOoCvDF9ZUvE4Vfxy0QLU
cwS9p20bUbe90aQpdI6GsbUNQfbJcB72HjR7n9G3/OIXnTWPO3kO3v8AzNU3EVI1
J6lQDmw0QqLg6yYlKw+qMzHEdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfgv8A8/qf7ryj
/rN/xNsVfrJ/zil/5KXyn/2zo/1nFX0JirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
ULr+5f5HFX8zv54/+tSWn/Mav/EsVf0uaZ/vHb/8Yo/+IjFUbirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVWuwRS56AVwFX88P/OdVxHqf
5oW6saiWcKf+CyMRspY5+d35YL5T0HS/McUXFZwprQeGY2aLfiL5tik9dBMvQ5pN
RB3GCaIRqZiCLkmSMSfj1y/hagd05tb4Cm+RptT21vwCDXKpBWRwX4I65RJKeW2o
bDfKyoimseoAkVOQSAmSX69a5OyzpEfXx0rgssSpPeg98Kod7sHvkqYoGS7B74aW
0pmvAK5KmvxCx+6veu+HhbY7pFc6isYJlO2WRx2yMAxszySsZENEzJhBx57JDeal
F6npMvI+2XjG4xy11Uo/U1JvqeiWcs130om5zKjhtw56g29m8i/841+efPEix3Gm
XVvG/R3WgyQxDuYeOX0rD/z7V89TRC+i1WCOOhJhYDkdstjh2ums5i+WL7/nGf8A
MPRfML+XH026mh9QJ6yL8NCeuTGPyY+MX3L+Wv8Az7p1KR7TzB5juo1Q8XaFqctj
0yfg30Y+KX62eSvJ2n+R9Kg0HRohFDEgBA7kDc5kY8YiKDGUiebLcsYuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KvwX/5/U/3XlH/Wb/ibYq/WT/nFL/yUvlP/ALZ0f6zir6Ex
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KqF1/cv8jir+Z388f/AFqS0/5jV/4lir+l
zTP947f/AIxR/wDERiqNxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KoDU5RDayyMaAL18MhM0EgW/m3/5yy1NNZ/N2z0uzYSFLrdx/rYwK
CH6Df85NeRBq/wCUOjS26Ukt4lZ2oP5chmGzLGd3472TBIha9SlRXx3zTaiDtcBR
HKjccwxFyrVJfiXivXLoi2u90EuoRWky2t64iLDYth8Nl4ieRXZij+s9Yq0DdjlU
oMxNPIb4IgcGtcoONsE06g1A8eQ3ygwZiSZWuqCb7Xw08cgcbISTNNSU9GrjwLxo
tb0N3w8KDJqW+9IBq1GGMWJKmuoCRSfDJcKLQY1BZWMdaZICmIKXz3oFVyVNI5pF
dXQIyQjblYykjyx3PKOU0Cio9z4ZfCDYZMVvdUnQC3t1KzOeKp3OZuODgZ5vvP8A
5xu/5wj1X8xraPzf5iuhb27/ABCJwCTUVy+OMnYOpyZH6qfl7/zi15G8irFdw6fH
JqK7tKwBqflTM/HjoUXHL6Oit4oEEUKKqL0AAAGWgKrYVWeknXiK/LFFLgKbDFLe
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+C/8Az+p/uvKP+s3/ABNsVfrJ/wA4pf8A
kpfKf/bOj/WcVfQmKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVQuv7l/kcVfzO/nj/
AOtSWn/Mav8AxLFX9Lmmf7x2/wDxij/4iMVRuKuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV88f85HfmtY/lt5VvJbiULdTRMsY71ynOaDZ
jFl/PJ5FE/n38wodZ1Qlma6Ygn51GRxyRkD+gD8z9ChvPyb1C0lUFoNP5p7EAf1y
zJyYw5v5vNP5KTG/2gWr95zUah2eEpl+1XMJzFs7NSifaPTL9OLNNOY0LfWP5D/8
4gah+fHlq98x6iTFJblvSqaVp0pmacVcg4ccvm+a/OnkfX/yw1ebyx5ogdbKJyEd
uhAyvwr6Noy+aWxXUN0A1s4CDamY0sXk3DIi47ySBuHLbKZYvJvjNFz3hoGVvmMr
8LyZcavDqIXcjjkvB8msZEwGqqRtKBkfC8mYyNfpNgDST1Pl2yJgy4m7fVyvwvkT
FIKyW7JbkpwUhAXF8w6HLKZcCXNdFxlkIsgaS26VpF9QGnp/GfemZGOLTPL5vpj/
AJxW/I+9/O3zXD5guIiNMtmVjXoeIzOhDo67Llt/Q/5f0Gz8uWUWmaZEsUUaKtAB
2FMz4QAcCRtO8mh2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+C//P6n
+68o/wCs3/E2xV+sn/OKX/kpfKf/AGzo/wBZxV9CYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FVC6/uX+RxV/M7+eP/rUlp/zGr/xLFX9Lmmf7x2//ABij/wCIjFUbirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfh//AM/KtR1R
dSttPSRvq5kGwrSnLMfUnZuwDd8b/kSyHzjaWw6xygn7spxy2ZzD+g3z9Ki/lZqc
rfY/Rxr9wy6R9LTEbv5nTIr30zR/Z5NT7zms1DscKNPXNfI05wSXWb79HxJc/wDF
sa/e2Zeh3yAOLrNoP6Tv+cS/LE3lz8v9Pa6j9M3cSTgeIIO+dAYcJdLE2nn5zf8A
OPnl783rKWLU4VS7KMEkA3qRt2yiWHubozp+Dv5x/wDOMXnH8qtWnt9PsJLjTwzs
kgqRQdO2Y0ouTCVvFrPTPMMisj6a/Nduh/pmPOIb4yQZ0jzO7kxaY5K9BRv6ZDhF
tp5K8emebZv96NHdR8j/AEyZiA44mvksdRthyvrNo6eIP9MqMWyJS59ajtZFiZeB
bxByowb4ptPLzUSx5jSFNwKis8hGQIZhr1i+2XAbOZwbNluIrk4uFlFJn5N8uXfn
3XIPLGlVMryKHA/lOZENnWZZv6Pv+cdfynsvyo8p2mj20SrcsitI/ckjNppx1cGc
re+5ksHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/BL/n9bMkUflA
OaVLnp4MxxV+tH/OKDB/yk8pOvQ6bGR95xV9C4q7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FVC53if5Yq/mV/PS7iT/AJyns4mJ5fXV7H+bFX9Mmm/7x2//ABiT/iIxVG4q
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXxF/znL5R0
zVvIlxq9zbI95AGZJePxbUzE1fJyNPzfmJ/z77/K+bz95luNcvoyYraRiSwI2GX6
WIqy1agm9n7K/wDORqPpn5aazb6etES1K0HhlsgCC0xsEP5mNIUz+o5+1Vv1nOc1
d27/AEoHVN/SLKSp3XrmLhFndycxFbMy/KHyk35q+f8ASvIscIeKVlZh2PFhm+0u
MDd0momTs/qB8qaKPLuj2WhDpaQpEPkopmc4rIMVSrVNDsNajMGqwJOh2o4rkTEF
IkQwRvyb8okll02FSetBg8OPcnjPerwflF5St900yGviRg8KPcnxZd664/KbyrcD
i2nRD5DEYohTkJYZqX/OOnk3UqiewjIPtkzCPc1Ey735S/8APxP8j9F8j3Hlu+8n
2wt43NJwvehIzX6iAjycrDOV83wLGAI6dlzT5A7fEW40r+8r8IysBvsIKa7WIE3q
+kB0I75di5tWTIa5t6bFc+Z5E0nRonkd2Chgp7/Rm2wYx1Dqs2SXe/aT/nCX/nGJ
fJMa+ePMdur3kqLx51qNuu+ZhxR7nE4i/TRVCAKuwAoMsApDeFXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq8B/OH/nHvy1+dEkEvnW0jvltiDEk37G9d
tsVeq+TfKtt5L0qDy7pvw2lsoSJB9lFHYYqynFXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FWsB8lU6nlxzEHicXky2VczGLsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVaPTbIZLrbmoWFPUQpJ32xx3Xq5qXzRq3/OMnlPUvMg89XW
mQ3OqB+YnenJTXrmdgyQG8kai5D0830dbQPbxpDWoQAA/LNRmjkOS48kwFCijczF
dirsBVYCxJBFB2NeuSKSF+RHmh2ABVprXbpkJGXFtySuy1DsVdiq3evtlNS4vJK7
LkOPtipWDlQV698KI8t1kjN8Sxn4qbdMjD6t+TKPPdq3aRkBuF4vk5gXsymBeyvk
WDsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVYl518n2XnjS5tA1ZQ0EylTX3yjPj4hs2Y58JthP5TfkroX5R
W0lr5ciCNKSWIHWuSxQ4RuxnKzbIfzU8oyeevK2peVoG4yXcLIprTc5aw6v5jfPf
kq9/KzzTc+TdUUrJE5WpB3qT45o9VjdxpZpEUa3aQn7JOY2GO7kZZvvT/n3j5UtN
U84DzSwBuLUlVPf7WbrT7OpzP3dzLcZ2KuxV2KuxV2KuxV+V3/Py68itrDRI5P7x
y3H7zmBqhu34Tu/HmyRpIH5dTmomLdriOyKCFLYgHfIxg28S2wgTVNRtbfVRxgLo
p+ROSgN2rIbD9/v+cdvyC8j6foFnrdrZxTzuiNzI3Bzb6Td1eY7vsu3t47WNbe3U
JGooFHQZnuOrYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq8h/NP88PKP
5NWq6t5/vRZ2x2DEVxV833P/AD8j/Ii2jE769IyHuluzfqOKvV/yo/5y3/Lb86bn
6h5B1GS5lrT44igxV9LE0xVvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FVORmWnEAjuSaUGKvln80v+c0fym/J27bSvO2trFdqaGOJPUIP0HFU//Jr/
AJyp/Lr89y0f5e6otxKP91yAIx+Qrir6JZ1TdyB8zirBfzD/ADJ0D8rdJfzR50uh
a6fHXlIfbFUt/Kr83/K/5z6R/ir8v7wXmn8inMbbj6Tir0JrsCcWoFTSp9sVRmKu
xV2KuxVa7BFLtsAKn6MVfOdt/wA5U/l1ceZG8gDUguuB/T9GgqTWnjiqt+a3/OUn
5ffk1f2mheeNSFve3rKsMdOvLp1pir3jStUttbtIdV01xJbToskbDurCoxVMMVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVWgUJNeuG2Ijvb8Rv+fln5fRaBrOlebdOT95fP+8YDuCeuYGox
25mGb86I5jKoimHxONswhGnLMrfoZ/z7UlH6dvIg1KSEUP8ArZl4Z+qnGzQNW/cb
Ng4bsVdirsVdirsVdir8Yf8An67qbWl95Os1J/fOwP8AwTZhakbt2I7vzMCyovCM
CnfNWYuxjKksTWIvriaOzVmcVAG4y6OPZTMJw90LBUubmgaKZTt4A5TCPqWZ2f0O
f84cec7fzt+X9rqNj/dxcYjXxA3zb6YU63Kd31hmU1OxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV+OX/P2KYQ+V7DiofnIQa9OuKsw/5wZ/J/8AKzVPy2tt
R81WGj3N7Ov70XBjLLt7nbFX3b5G/K/8uPy/E2seRrKwhCgszWxRqU8OOKvL9J/5
zk/KrV/Oi/lHDqEsfmB5PTWOWLipatPtE4qyj86/+ctvy5/IK8tNH/MHUGivb0gQ
xQp6jGvTYHFXsGm/mLoOp6DF52W6WHSpovWWSekZ40ruDir4z8w/8/MfyT8uahLo
tzf3kssMhjeSG2Lxgj/KBpir6x/Kb85fK/51aKvm3yHdi5sSaGtAy/MV2xV5Z+c3
/OYv5afkXOLDzvqLfWTt6duokYH5A4q8ntf+flX5KXMltbnU54pbpwkaSRcWJPsT
ir7I/wCVh6Gnl5vPk9yItGWL1jLJRfhpXvir4guf+foX5I216+mG8vm9NirTLakx
Chp9qtMVfcHkX8wtB/MfRYPN3lK7S6024TmrqRUD3AJpir5c1/8A5+A/k95b1q98
oahqkv6TsHMc0aRVNR4b74qqflz/AM5+flF+Z+tDyh5e1KZNRLcQlzF6VTWm1Tir
6t17zjo/lrT5Nd1m7igs41Ll2YCoArtXrir4a1f/AJ+c/klo2otol1fXrSrJ6RkS
2LR8v9atKYq+xvJf5q+XPP2gf428tXaz6aIzKzAgsqgV3AxV5P8Al1/zl5+XH5o+
Zp/y88p6g02s27FXjKgCo964q3+Yn/OXf5cflf5rs/y08237w65eyLFFGqVBZjQC
tcVTv86f+cm/Iv5C21vqH5g3voJdAGJUAZjXptXFXj/5df8APwz8nPzN1yDyb5d1
OUalcvwiWaLgGPzJxV9tRw8ZGmDkq3bt9GKvKvzz1O40fyZqWpae8iTxRMVMf2vs
nFX4Cf8AOI2l+U/zh/Ni/T842juJ/VdY4r6gBqaftYq/Ufyl/wA++PI3k/zW35i+
S9TuLGH1DL6FowEexrTY0pir5N/5zR/5+JX/AOVPm21/L7yZDI9hbFVuZnFHPGgJ
HicVevebvzt/Kr/nJn8nY4fPt9e2OmenWeZkKtyp8VDir1z/AJw6i/Kn8oPyuufM
H5X6rPfeW7cvNLLNuwI67Yqj0/5+N/k5cWcms2N7PcLEWWURRcmXiaHYYqm3lX/n
4f8Ak15vs7rUtK1SUC0UtJHJHxk28FJriqUeVP8An5J+TXm7WrfynY311De3T8Iv
rEPpqTWnUnFX09+aX53+Vfyf0VfN/nO69LTHAZZEHIEH6cVS/wAif85A+TvzG8tT
/mF5XuzNo9upd5CKEAfTirEPy2/5yq8hfnPc3/l/yNeNPeWiyJIpFKECmKvw4tYH
/wChqlu+jLcH4Ox+LFX3l/znJ5G/JDzN5g0HWvzr1a407XFMIgih6MailcVfpr+W
Vtp1p5Y0238vyNNYLbxiF26leIp+GKs8xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvjX/nNv8u7X
zf8Al9f67Moa50uIyxbV+778qyxbMcqfz16Zf8raKSRf3gXfbNfkDmwL6+/5wa85
/ob83NL8swHjDfKWfegrXI6c3NlnjUX9EGbd1jsVdirsVdirsVdir8vv+fln5XN5
t8v6f51Qf8cWrVp4knMHUnem7E/GOyvFu9MFwDRivj45hcO7mWmOlfk7q+leVb/8
0NVRwkMo9JmB+yfA5mRjbVKZCSBDrV5YafGa/WWjr3+0cw4D1N0js/pQ/wCcUfy7
/wCVb+Q7PSSvEzKs1KU+0M2uAbOvyc30vlzB2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuJpu
emKoYXkDI8qSIyxglypBpTfemKvlb8u/z/m85f4jNvFz/RF0YIyRsQDTfFWWeb/z
nfyR5aPmjWliV2YKik03PTFXll//AM5KX3lXRk1zW0jYXZHoVO/x9MVfQf5V+Yda
8waSNb8zBI4ZgHiNaGh8fbFXqMM8dwvqwMHQ9wa4qqEgbnYYq0WUDkSAPHFXK6v9
gg/I1xVssAaEgHFUPBeQXLMlvIrshowU1ocVebfmD+bug/lygOuS8ZWZVVOlS2Ko
fzn+YF1o1rYalokInt71UblStA2KvT7e6DwxTTlUZ0ViCabkVOKq6SpIC0bKwHUg
g4q8qH5v6K/mU+SY5Fa4Xq3Lviqyw85X0nnG58vSxs1gEX02A2BxV6w80cVBI6qT
0qQMVVAa7jFVGS4ihBaV1UDqSQKYqvjlSZRJEwZT3BqMVX4q7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYqtdealelRTFX47f8/Y0Sz8jWEFt8ckkxBPUjfFXiX/OJ3/PvXQvza8i2fmr
U/M+sWbTf3kNtMygV9qjFX6f/wDOPv8AziLon/OPz3J0nV9R1SG4BBS+lLgV+ZOK
vzt/5+WfkDb+RprT/nIP8vDBY6tp37xlSiu53+/FXyl/zhLol/8A85cfmPaedfzc
vYb6TR2HpW8xB9ShHRTir7a/5+iebZdD8ow+S9Flk0uHnHEgtzwHE7U2ptir13/n
Ef8A5xw8o235KGHW9Os7+a/tGna7niV5eRQn7RFcVfmh+TH5k63/AM47fmnr3l/y
/NK+isk/G1U/AvWlFxVP/wDnFTQ0/Pz87rzW/Og+vW3qMxt7scwBXspxVKf+fiP5
SaJ5M/NTRL3yfbx2ievFWCNAqGjA9B8sVeif8/Cvzc1W4/Kfyr5ZtJp7BQI1uBbs
UEi0AoaUriqV/lf/AM5NfkvH+Th/KvWvKN1caq9sYpLxLAM7MR9oPxrX6cVTz/n2
b518y6TruveSLaHUB5aujILIXaMPTU18emKvDPInky080/8AOUepafLEk7W96wkj
kUFW33rir0z/AJzy8r6F5F8/6Hrvk+GPTb6F4xItooTka96YqnH/ADmt+aureYPL
nlXynJc3NrHdwQc2jJHKtBvir7//ACo/5xp8mJ+TPo+YtKsrkzWJm+uGJWmDca15
da4q/Pv/AJxD8+aj+X/mrzV5B0u5ln0AQXIVJGqF2OwGKsW/5wIjt7r889W1DSgR
em4kJ5Cg+0cVTv8A5zb4zf8AOQ3lq5vgpvBfRbAf5QxVNP8An5n+XnmeHUdC8/W8
U+oWiLCwtkUyKAAP2RXFWPfll54/5xx1m58sXXnSyv8AQfO0ci8isJhXmKd6Dvir
+izyvPaXOk2dxpMpms3hUxSMall7EnFUVq1rbahAdN1BBJDOCrKwqKEd8VfkZ/zl
N/z7KtfODTeevyUvJdM8ycjKFRyikjelQR1xV8uf84+f85R/mx/zjr5ytfyd/Nxv
rWnBlieSVuTHelQTiqVf8/B7nSfNP5l+X9Z8v2cAhuWhaUMo+IsRWvzxV9c/85je
XtC0b/nHewFrYwWQa2QsYEC1JX2xV5V/ziOwsv8AnGXXZ0H+jPbzgCnscVeTf8+m
vy60PW9a8w6n5ntYb6GUyIsMyB1ABPY4q8Vu/IGkn/nLOTy1p8CW+jSXg5W0a8UK
1pQr0pir3b/n6N5Z8ueUNc8tWP5e6dBpt5bvFylt4xGTuO4xV73/AM5ZS3l7/wA4
yaHNft6sptE9Rn3J2xVv/nC5bUf84465LbFuawNyFNq0xV4N/wA+yoRB518x3M3Q
yzGi9e+KsS0YC/8A+cshNc1SJJjQf7LFWQf8/WpfrnnvyxLAv7pJ7cGo9xir93vy
U4HyTojRdDZQf8QGKvVMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirzL849KXW/Jur6XIKrNbspGC
SQ/mS8wWEOj6vd6UoosDlc1moc/C3+X3moflt5rsvPHLg8EqKrVpszDvmJo5XkDl
aqP7t/UV5B1s+ZPLum685qbu2SWv+tnQF0gZfgS7FXYq7FXYq7FX50/8/EPP6eXv
KEflByA+rgqv0VGa/Ux9TdiL8IZ9Ne2srbTbM/vWaMUH+sMqG5bydn7Vfn/5BtLL
/nHKys7CFUmls4nlYChLFa5sMUdnGlJ+NvkyFbHWNOubg/DBJCDX2IzWj6nMJ2f1
I/lH5itvMnlbTryyIKrbxoaeIGbPFycGXN6XljF2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kv
jf8APX85NVXWLT8rfy64vqV63pzS/wAlTTr2xV4T+blh+Z/5CeU7rzv9eS5s4gPr
aq1T8W22KsV8p6xq35dflFeeYNNWP9O+aZUuoQRvxc1/jiqQf85AeV/N35gzeVvI
NpcL6t7axXE6qf2gATirGvzF/LfzTrfmDSvy3uZAqWNukpFf99jFXo1l+a/mvzdq
EX5TaNew2iWKBWdnCghNsVZRp354eaPy718eXLi5hu7RKeoQwYe+Ko7zF+aP5jfm
x5gj0b8uZUjsUI9QqdgO9cVY95n/ADd863+sx/lDZX0MV/aECacvQH6cVTaX8zfO
n5X+bfL/AJY1HUILy2vZAspjkDbHFXfml+e/nTzf57i/L78rP2XEczjcJ418MVTf
Vrj8wfye81aOmo3sc1tqC1uFDVq1cVeRfnd5f83fml+amjeSLqZUhvEFwhB+EKu+
+KvpK783+YtI1Kz/ACptjFNNaIE33PwYqhvPWu+cda1MWLXkNnHDCQQW4dBirzn8
vfzE862l5qeiWF7FdtFA7bPypQdcVee/k1+X/nLzR5gvvzJu7pA1o7yyAt0C74q9
2g/5yG1PSpr3V5BCySIY4HoN2XbrirWg6L+av5oW7eZVukghNTEC1K/LFW/yf/5y
D1uxtvN+k+bis155aB713Hjirzb8qNX/ADU/PibU9dtrhbbS3cmMuaCngMVe7/8A
ON3n7Xb3WtQ8ma+xlNlIYy1agkHqMVfbmKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtGlN+mKv
yX/5+e+UNZ8weVrE+VraS8aOUlkjXkaVxV4P/wA42/8AOXNz+R/lS38v6p5b1V54
v70CBqH5bYq+8vyW/wCc2bH85r6TRbfy/qenuARzuIWVa08SMVfnF+ZWk/mH/wA5
O/nzbfl15ktLyLyRYzmORirCN1r37HFWN/nd/wA4nebf+cO/zC0v83PyIhnudHgl
QzQQg7gnf4Rir7k/5yf/ACQ1L/nMn8rNP80+XoWs/MUduszxTLxPNRWgBxV8k/lJ
/wA5Reb/AMk/Id5+SvmfQdSudchBtoZ44mMdAKdaYq9H/wCcMv8AnFTV/Puo6l+c
n5nwGGW7WRYIZlo1WrSoOKvCr7yf51/5xL/OK58+JYy3mnTORHFaRk7E7VAxV84f
85X/AJq+ZPza/MjRvM2u2ktjYrcR8IplKsSCOxxV+nf/ADkl/wA40aj/AM5Dfkxo
+t+SljTVdNgWYxuu78VBoMVeC/lf/wA5QP8AlH+Xkf5faj5Aa6852qtHFMbAMhcb
Ak8cVfen/OGOlfmTqthd+dPzU02wsF1NWe3jhhVHQEbVA6Yq/OH8o/yu836P/wA5
S6rq0thOmnT3rsLpkIjIr/NirMv+c/fys1fzJ5+0q/8AJthc3KRSxm5dULJUHtir
3b/nI3/nFrXvzp/LjRdZ8mRJBrWl2qVSRaNVAMVeAeV/+cs/O35YeR5fyX1jQNSu
NfINok6wsYxUUrWnTFXvH/OIX/OIetQ6bqHnnzynpalqiO0akUIEm9Dir5AtNB80
f84l/nFeeZpNIuruwmdiHtoiR18RirB/zas/OX5xfnR5c/M+y0e9Gky3kXMNEfgA
IqTtir9Af+cwPMX5v/llqOjeZ/KGn2+q+WIhCZLZ4hK4AAqKb4q+IvzGsL7/AJzP
84eWY9A8rzaHdW0y/W5RbekvwnfegxV/RT+X/lg+TPLmm+V3f1GsrdIi3iRiqXfm
cuvtoVx/goqNSCsU5eIG2Kvxz8vf85o/nF+TvmDUNI/NnQ7q/wBIDuEkghLEeFDT
FXivkzyh5s/5zA/NiHzjcaVcado0UocNcRFDxB7k4q9b/wCc/wD/AJx71O01fRtf
8p2s91DpscbuIVJJ9MA9sVUvza/MXWvz8/I6Lyxb6NewXNjH6XpSREOSgp0xV6B/
ziZ+X2vr/wA4363omsWU1tcLbz+nBIhDsaGlBirD/wDn0z5H8weWNU1+bzPYXFnG
7y+n6yFQdz0riryXVPyy80ad/wA5dSeY59NuH003QYTpGfTpy8cVey/8/UPyy8ye
cNb8u6j5RsZbhUaIymJCxFKdaYq99/Oj8ntb/MD/AJx00zRbOJhf2lmvqQcfiNF8
MVfn/wDkX+aXnP8ALb8uta/KA6DeiacNGrei1PDFXof/AD7P/Lzzl5Z856prXm2w
ngs7j1WHqRkda4qlWnflj5u1H/nKceZE06dNHW4P730yFpy8cVZl/wA/Pfy080eb
PPXlr/CmnzXFpFJbtI8cZIFCK1pir9o/yjsZdN8oaPZXSlJo7SFWU7EEKMVej4q7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FWE/mFKyaHdqg+0hH4Zj55kcm3FEE7v5g/PkizebtZZhyji
nPMD5nNZmmS7HFAMG8wRwazbJGY3CxujADr8JrmPo7GQN2r/ALsv3v8A+cJ/+cgb
Hzn5TtfK+u3McN9YosEKu1CVXYDfOit0QffJPNaxkb0oeuFK/FXYq7FXYq1v2xV+
FX/PzTzxH5q81eX/AC5or/8AHMelyK9ySc12WZJcvFAU+AbHil9HKVJlWWPjXp9o
ZUDu2mL97fzst2v/AMirOMRmRjYxmij/ACM2eL6XXzNF/P5cOaSta1WeKZfopmsq
pOwq4v36/wCcAvMk2ueQQl/Osk0bqoWtSAK5nYpdHEyxAfeGZDU7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FX53aRFB5I/N3UL/zftb3MxNvJJ0XftiqC/wCcxPzgtPN+gy/lP5SI
nudQZFaTqKA9sVY/e6PLB5s/Lj8tdRiZ7FdNX6xT7PJQOoxVmcGnPP8AnvZzW8b/
AKHsLZ4xXcAqNsVX6Xp9951/N6+vp4yLeO3mjjIG3Q0xV435S8k+U9B84ajH5/Sa
K6aSQq4bjUVxVk0/ljyTJcX1xottcTkxMFepbfFXqP8AziV5aa0Gs8I3hM0bJGz9
RXYHFXh9r+X/AJd0fz5qUfn1pDM7H98rUrU+OKsuj8o+Q5vNNjqOkR3F39SflUtz
pirNP+cTvLsf+N/OfmCW2ZUe4H1dpRUgV7E4qi/z0jm8w/nD5U0ZgzaZEh9anSta
4qx2PWrbSPzmt7zVkJjtY3igbwXtirG9Y1HUf+VkXPnXS0YhFk4Md1xVW8l6novn
+DVtS/MqZl1BBKsXB+PjTFXlX5C29n5Zvtb1bTVklkkWZAXNRx3pir3v8o/MOnaV
5U14VK3t7FNGN+7VxV4Pf/llqknkzSJhUxxXbyS+JUmu+Kvtjy3+e3lvyd5WhtlD
PNaRcTGvjTvir4astG1XRbLzz51ngfj5w3tRTxPbFX6Jfkz5fTyr+V2n2sEXpXL2
JeWgoS5r1xV43/ziDaXU+oeZtR1mL9+l4Vicj9kk4q+6cVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVaIDAg9DiqXy6TZXChLmCORRuA6hh+NcVQ7eXdJenOwtTTpWFP6YqiLfSLCzP
O0tYIm8UjVT+AxVVTT7WOQ3McESynq4RQ330riqpcWkF2vC6iSVfB1DD8cVVIoY4
FEUKKiDoqgAfcMVS1tA0x2Mj2VsXJqSYUJJ+dMVVLu1eKzlg0hUhm4N6fFQAGpts
MVfhr+dX5i/85Aflt+YP6U/RJ1bRUmqVEHqfAD8sVeX6j5b84f8AOWP5n2Ou+Z/L
txp2i27RlE9HgA46k4q/oA8l+XE8saJa6CACsMSqRTboBTFU1Pl/S2b1WsrYv/MY
Ur99MVTNYkRPRRQqUpxAoKYqgm0iyYEehGCerBQG+/riq79F2ZAV4I2p05ICfxxV
FLDGq+kqKE/lAFPuxVLpNB0yZvVlsrZn68mhQn76YqmiIsaiOMBVGwAFAMVQVxpV
ldnldW0Mp8XjVv1jFVkejafFT0rSBeO44xKKfLbFVS70y0vqfXYI5uPQSKGH3HFV
O30bT7NvVtLSCJx0ZIlU/eBiqZYq4iux6YqllzomnXlRd2lvLXrziRv1jFVSz0qy
04U0+2hgH/FUap+oDFVaezt7ne5ijk7fGoP68VQA8v6YDyWztwfaJafdTFUcllbx
xm2jijWI9UCgL9w2xVq20+1s6/U4I4q9fTRV/UMVaOnWhl+tGCIz/wC/OC8vvpXF
W7iwtrshrqGOUjoXQNT7xiqt6ERT0Ci+n040FPuxVLv0DplS31K2qep9FP6Yqi7f
T7W0/wB5YIov9RFX9QxVy6fapJ9ZSCIS/wA4ReX30rirc9jbXRD3MMcjDoXQMR94
xVEgBRxUUA6AYq3irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVQOpWEWp272VwKo4IP0jIzjYplGVP
5tv+cqfye138o/Ol/fx20kljqk3NCBtTNdlxObjyB4C2sxxIjvAQwX4l98pwYiJ2
26jLcKetf841flr5+896uPNnlP17awt7lOVCQCA2+bZ1b+l3yv636Js0vQROkCK9
e7KKE5IKn2FXYq7FXYqgNTvDYW7XCqWYdB/XAVfzB/nvr8vmr8y/MVxPJR7afYE1
7npmvyhzMbCNBt5LzVrOGQ8VZ0qT/rDKRzbJF/SSnlz9N/lja6Kq+qTp4AFK1+A5
tcOwdfk5v5xvP/liXyH5vv8AQ9YQxrNK7qGzXVZLnA7PpH/nDz/nII/lf5hTy1ez
gWU8igAk03JzKxxaJyf0G6NqsOtWcOpWjBo5UVwR7iuZLQmmKuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KvOPPP5W6F59SusQD6yo+CZdmBxVi2nf8AOPXkyyaC6lshLdwAUlY1JOKv
R5PJejS39trj2iG9tE4QyU3UYqqW/lDSrW7fVY7dfrMhJLnrviqtYeV9M0y6fVLK
3WO5cEM4674qwrzX+Tnlrzje/pbWLatxShK7VxVNNA/LDy75ciNvp9mpBFCX3OKs
p0vQrDReX6MgSHn9riOuKsH8yfk/5X81TfXdVtKzE1LKaE4qu8r/AJReWfKEslxp
FoA8nXmeWKsx0jy5p+hPNNpcKxPcNykKjqcVQl15O0e91GPzBc2qNfRfYkPUYqkN
9+VPlrUdRGv3dmGvB+1XFU1h8g6FArxx2cdHqDUb74qwaT8gPJkkjzLZFDISWCtQ
Gv0Yqm2hfkz5T8uRSW+l2KqsoKvU1JBxVbZfkv5UsIzbwWdFZix37nFWWHyXoxsf
0L9VT6pSnHFXno/IDygDNS1PGb7Qr/ZirOpPIWiTafa6HPao9paACJSOmKskXT4E
tf0bEgWAJwCjoBiqUeXfKun+V0lTSYwhnfnIQOpxVkmKuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxVSkgjl/vUVv9YA4qpRW8MTn0olRv5goH4jFUVirs
VdirsVdirsVdirsVUp5fQjeY78VJ+7FX5Ueef+c8pvLf5qw/ldGpEck4iI38aYq/
VGwuhfW8d2oKiRFah9wDiqLxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KsA88/lroP5iQrb+Z7VZ/TBEbMBUV8MrnjEmUZkP
kK8/5wT8s3l3JdgKkReoTbp92UjDRumyeSxT6z/LP8r9F/K/ShoPl2BY4mIZ6Abn
7syAGl6RTag2ySt4q7FXYq7FVkiLIpjcVVhQjFX4Pf8AOVf/ADiHr9j5vvPOXlO3
kktr6TnJwpTucwszkYi+H5/J/nRNUg0/T9NmMscqCoH+UMqiN2yRf08/k/a3dp5M
0a21VuVwtnGHB7Gm4zPx8nElzfLH/OSH/OHen/m5eHzPYlYr1AdhQctvlmMcRBtv
GTZ8t+VP+fdd011DrtxP6UsEyniSKkKcui1zL9bvJvl7/C2k22i8+ZgjVOXyGXNQ
ZRil2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxVD3bBYXJHIcTtir+Zn87re2m/wCcpbE+mUAvlqK/
5WKv6Y7Dj9Wh4Ci+mlPlTFUXirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqHurWK8jMFyodG6g
5CcBLmkGmGQflt5dtrj69FYxCateXEZUMIvmyMyzaGBLdBFCoVB0Ay8CmCrhV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KqF1/dP8sVfzO/nl/wCtSWn/ADGr/wASxV/S5pn+
8dv/AMYo/wDiIxVG4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYKV2FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq6uKqbyohCuwUnoCQK4qqYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqoXX9y/wAjir+Z388f/WpLT/mNX/iWKv6X
NM/3jt/+MUf/ABEYqjcVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVST
zHfXmm6bc3+kQC5u4o2eOImnIgVpir8lfJP/AD8/upvzLk/Kj8ydATSLZZ/Q+sEk
GtaDqcVfb/8Azkv/AM5RaD/zj15RHnW6aO6uJ0D20HL7akVr1xV5J/zh3/zl15n/
AOcnJp7++8ujTtBRSUugW3amw3PfFX6A4q7FXYq0WA6mlcVbxVomm56Yq0jrIOSE
MPEGuKrsVdirsVdiq0OpJQEch1Fd8VXYq7FXYq7FWiQoqxoPfFVkrmNGkUcioJA8
aYq/PD8xf+cx/NPkz8xrb8tLHy0LiwmZQbqrbVPzxV+gumXT31pBeTJ6byxq5TwL
CtMVR2KuxVDXlx9UgkuacvTUtT5Yq/LzyL/z8Tl83/nNN+QraKkcMc5hFyGNdjSv
XFX6mYq7FXYq7FXYq1UV4138MVbxV2KuxV2KuxV2KuxV2KuxVTjlEtSoNAaYqofX
E9b6oKl6VOKqs83oLzIJ+WKoaTU7eCB726cRQxirM5oAMVYPZ/mfomuWGpal5XuF
vn01WMiJ4gdNsVfC/wCQv/Oe19+cX5k3f5UXOgNZwW0zRfWSHA2NK77Yq/S/FXYq
7FXYqxHz55kk8oeXtR8z28Qnksbd5hGTTlx7Yq+Ev+cN/wDnOmX/AJyf8ya15Nvt
JXT5tL50ZSTyCmnifDFX6N4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX4v/wDP
1783PNP5Sny7ceStQmtDen4wh6cWI/GmKv0m/wCcY7++1j8s/L2t61cvdXl5ZpNI
79anFXvWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVQuv7l/kcVfzO/nj/AOtSWn/M
av8AxLFX9Lmmf7x2/wDxij/4iMVRuKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV+EX/Pz3/nFGPTCv8AzkH5QVbdbN1kuQvXmNwfppir80tI87+b/wDn
MfzPoP5YalKz20Aijox/YWlfwxV/UZ+VP5caD/zjf5Cj0TSlEcFlbCWYnbk6pU4q
/Jr80f8An4T5/wDzL8wXfkH8kLGMizdw0gIqSpp1xVkn/OPv/PwfzzYeZLf8tPzx
sIrUtIESeo5MT2rirLv+c1f+c9vM/wCSmr2Fl5Jt0lgnKldxvXFXzl5w/wCc+fz7
k0iPzZYaEoswoblx2p49MVfot/zg9/zl7d/85DeWrzUfOkcdpf6atZyCNqda4q+S
Pz5/5+Led9S84XH5RfkHpMeoXPqGL1dietMVeeW3/Oe35x/84+a7p3lr879EWCx1
Bk5ylfs8j4nFX6wfmJ/zk7oXkv8ALdfzgtmSe2ktxIq8tgxWtD9OKvx68v8A/Oen
55fm3rFz5j8haQZvL9qzEFVqtF+WKp9+Xf8Az8w/NDzh+YNn5E1bS4rUGdIJY6Be
9CSMVfen/OY//Oa5/wCcfNPtNM8uwpc+YbyJGCEg8S48MVfnev8Azm7+ffk9I/zC
1LSYpNInbk/Ig0Q74q/Rvyz/AM5i/wDKyfyov/P/AJeRI9atbYvJGGGzAb0xV+dv
kf8A5+Ufm7+acF15L8l6IlxqdvyX1QKtsSOoxVNPyN/5+HfmhoH5kWP5W/nNYrDD
dzenIX6rU9d8Vfsx+eH536N+THk24/MLVJUaFY+cK1HxkioxV+KsP/OfH59fnDd3
HmX8t9Dh/wAOWTEgkgckHfFX2T/ziZ/z8Al/Nq5ufKn5g2sdpq1orKeJAqy9sVfM
Pnv/AJzD1u3/ADpg8vWWi2tzA1ysYmcCoUtSuKvuX/nLL/nNW0/5x78v2V9o6Jd+
Y7yFOFkSOILAfxxV+ekv/Oa3/OTFlpq/mnf+XR/h9zyXipPw9tsVfqD/AM4d/wDO
Vh/5yS0M3urWTWOqxD95GVKgkDfFX2BrRK2FyU3PpPT7sVfyY33njV/y6/5yQ1LV
vKtqtxqhvGEa0qeVcVfV/nL/AJ+Ffnp+WnmaOTzdo4isZ5FC81oOJIHceGKv0g/P
H/nLS88vfknD+bXlVQdYkhSRohSgYjfFWVf84Lf85G69/wA5CeQ5vN3nWBYb2BqD
h+0oB/pir5G8zf8AOfPnmD84ZPyy06wRdPh5qvTcDucVeY/mZ/z8m/Mbyl5xHkfQ
NLjmllGy7Hc4qwPzf/z8S/On8rL631vzZooWzmYFua7cT8xiqf8Amb/n4t+c35h2
X6W/LXy+F0yBBI8yLsaCp3xV9cf84C/853at/wA5G3+oeR/zAtIrPVNPSqyA/aI6
g4q8v/5yH/5z4/Mqz/MW9/IX8nPL31mZpBBHeujDqeoNKbYq8R13/nN788f+cWdX
stB/NzT4bhL9l6sGpyOKv0O/Pn/nLHVvKX5RW35q+TLVG1G6gWUoTspIrQYq/Ovy
n/z8g/O/8y9AnuPLOgxvJbgh5Y1rWn0Yq9Z/5xA/5z/88ed/OC/l7+aFosLu/E8i
AQa02xV+3yOJFDr0YAj6cVeI/n3+dNh+SPlqfzTfxvNMFb0YkUsWYDYUGKvytT/n
On/nI/XdGvfP/l3ybp8flu25usly3CQovQ8WxV9bf84Of85q/wDQ0Wn3Ft5itorL
zBakiWKI7bdcVfIf53f8/MfzB8gfmjf/AJPeS9At9RlimEECv9pmJ26DFXmP/OUv
/OQH/OT/APgyW788aBDoOl3MYIltz8VDiqe/84Afmr+ceheWrzWL3QYdQ8slWeW7
f+8YUrVqYq9z/wCcbP8AnLey/Mr80L3ybaeVNP0yNZm9a+jRVk2PWtMVZ5/zkd/z
njr/AJT80p+WX5B6TDr+uV4uH3HL6MVea+QP+c9vzf0DztY+Rv8AnIbyemk297x4
y2yM1OR8cVZV/wA5a/8APwLzD+Q/nvRvJvljS4rvR9TWIvLLs6+oQCR7itcVfQP/
ADkt/wA5Mal+Q/5SWf5teV7VNQubpEkKTHYc1BP0AnFWK/kv/wA5B6z/AM5LfkLr
v5g+ZbSOyuGtJ0CwnY8QcVfnd/z6DLD8wPN98VBBMwdu4AYnFX17+ev/ADnj550r
zuPys/Iny8mp6h6npl7pSqVrT7R2xV5r5e/5+K/mh5N8+Wn5bfnz5esNPNzIE520
gYCp8QcVfU//ADmV/wA5i6n/AM4+eW7Hzb5LsItQjvED/vDsK9MVfPn/ADjx/wA5
nf8AOQP59yQalo3k2zGisR6k5JHw13I+jFX6/aXJdS2kEuposd20amVFNQGpuBiq
PxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV+DH/AD+o/uvKP+s3/E2xV+sv/OKv/kpvKf8A2zY/
1nFX0FirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVULr+5f5HFX8zv54/8ArUlp/wAx
q/8AEsVf0uaZ/vHb/wDGKP8A4iMVRuKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KrWYIC7kBQKknoAMVfgZ/wA/Ov8AnKWbzVMn/OP3kRhcw3brHcGMhiXO
3b54q/N5vIvnv/nC7zPoXnO/tSrXSQzCTiQoQ0Jqexpir+hDzJ+dUX53/kJdeb/J
8ytqLWfGaNDVg3GjdPHFX4Of84e+S/O/nHzhq2n+QTBHqwmlaQ3LBNqnxxV9Jeaf
+cS/zE1/zvpl/wCarqzS7t7pXb0ZQSaH54qxP/nODQZtN82+XtF1r4jFLEpJ6GlM
Vfrtr/kjQ5P+cdZ7m3tYhLHpvqCSm/IDxxV+WH/Pva7vT5b8/wAWglmu+Mvwj6em
Ku/597XWjab+cuoyee2SPVTct6frUFDy98VfT3/P2q/0K50uzjJgm1IlPSZGDP8A
hirwvzpo3mJP+cQri61pZCvJPTqDXhir6V/59becPKejflDeabq8lpFfgtJIsxUM
60O2++Kvzr866z5c1j/nJOPVPKriOM3IXjF9nly9sVZH/wA53W+uj8xNNEgMnKGL
0jL9mu1N8Ves3/5Afm7568jwyTzafHpMsQCKZlG1PCuKsu/LH8itf/K/8sfMMOqz
qf8ARXr6TVQ7djirX/PobQdLn8w+YbuWFJblGk+JlrTfFXk//OfOlWHlv89dMn8v
gLcz3KepT9n4u2Kvpv8A5+LLqifk95djgMkkU1qhk2qK074q+W/+cXfy1/Njzf5G
dfILWMGlCLjLylCua+2Ksw/JL/nFXzn5S83XHmK/mt2FGaX0HDGvfpir5/8APtmV
/O6zhtXYTpOvIV3ryxV6f/zmgkredfL935mDG0pAoLD4e2Kv2q8qea/y80L8q7D/
ABlNZnSFtlLxMVJPw+GKrP8AnG/8wfyx83XdzZflBbJFHFyLNGoAP3Yq+rtdeRNO
ungALiJ6V+WKv5ffyw0uHWv+cuS2pqrhb4kodwTyxV96/wDP2rQLFtA0u6t4I4pk
I5OigH7Rp0xV89eZbm917/nGN7bjyjhhQBh1pTFX0l/z6786ab5Z/LO+0/U7mFeA
L0dwGqAdqHFX5/a35lsdf/5yKuNS0WQNEGkBKmu+Kq1naR3X/OQtgkyLMS0Z4tv3
xV9wf8/UdJttN8kaXLHZQRF0ReSgDFXsf/OGPl7Tp/8AnHK8ils4BIbOYmTgOTfu
6jf2xV+cf/Pty803QPzb813WuOUit2mZePejHbFXt35g/wDOY/mL8wfzWm/LL8nP
L2mrfxy+ml7IirLWtKluuKvj3/nOfyf588p61pN9+btxHc6nO6FFWTmqknFX3P8A
nrcep/zjFZtdnjcm1T0+PTpir0T/AJ9VeT9FuPy8vpbuBJ55EPNnFevXFXwjcQJo
H/OUMdhp1IoWuvsr0+1ir+nLS97O3PX9zH/xEYq/Pv8A5+A/n0v5CeV7bWbKwg1T
VLicJFBdKGjqTtWuKviq/wDyn83f85J/l7qP5pfm3qC+WdLis2mt7PSpeETnjUAq
pAxV5L/z5xsvqv5geZFtn5xRxvEK9wtaN8yMVYH5iAuv+c1XZ41PK/UlW6dcVfqh
/wA/MvT/AOVbz8wxEcdaKNuuKvKP+fdck+k/k1q1zqEglgngcxRlq0HE9sVfD3/O
N0co/NXzE9uPTnkmlMfp9uvhirO/+cVLk2357ahL5sCC4W6YRvLsacvHFX7p6g/k
7UtWifzImnS6kKeg03Bm9qVxV+DP/P0j04/zl8tpKgS2D29GUUWm2Kvr7/n4JNav
/wA446U9rIn1f6tEAoI3+AYqlv8AzgaGh/5xh1OdjW3a3uBT5Lir5Z/59Uaxb6D5
987asxP1aITNx7Hc4qzLUfzo81f85Hfmjq35aeT9OsdMs4nKHUIqJOBXqGG9cVfF
P/OS35GN+Tvn/SLB9cn1bVLqdPUkuJS5Qk+JOKvvP/nPy0vf+VL+V21niBDbRcWX
q2w64q+5P+fcy2r/AJXWFxaKFb0lVgMVfoJirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfgx/
z+o/uvKP+s3/ABNsVfrL/wA4q/8AkpvKf/bNj/WcVfQWKuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxVD3X9y9fA4q/me/PEV/5yktD2+urv2+1ir+lzTP8AeO3/AOMUf/ER
iqNxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVhH5i6RqmveXr7SPLM
oh1CeJkjdjQCo8cVfkX+Rv8Az7f8xab+ZUv5nfm9cQ3lusxlRCQxJBqO+Kvvb/nK
7/nGPT/+chvJbeTII4YbyJeNvKwFVAFAAfDFXyx/zht/zhr54/JD675X8+3UdxoM
yMiIjBlodugPXFXlP5kf8+8POHl7zXdecfyVvfqn1kux9JuB+I+xxVnX5F/84J+c
7DzBb+dfzW1m4lkikDiMTE9PEVxVP/8AnLn/AJwh8yfnh5p0rW/L0sK6faSIWLEB
6L474q+1NX/J64uvyrf8p7aRRcmyFvz7FqYq+Rv+cJv+cKtc/wCcdtR1q480yQT2
Opl/gQgkhvEYq8v/AD6/59xanf8Am5/zO/Ji6W0vpH9Rk5cdzv44q800D/n3V+YX
nzzNZav+dl8bnTYHVmTny6Hwrir9Lvzx8n+UPK35Vy+SNcg/3BQwCJVVf5R1OKvx
B8if848eXvOE19f+T9dfT9MiZi0Qm4fCO1K4q8W/LzyFpf8AyvOx0XyiJr2KC4j9
SahYcgdzXFX7u/8AOUP/ADhvY/nzotrNpZW31q3hQK52JIA74q+D9N/5wI/O+5SP
yre668OiRvQ0nI+D23xV+iNr/wA4tTaN+WEv5X6feGe9lg4PLM1SSRvUnFXl3/OF
H/OHuu/842anqOo6tLC8N6WqEIJ3+WKsJ/5ym/5wV1r85PzD0/8AMTy3NGiQSLJL
6hA6Gvc4q+0fO/5B6f8AmX+XcP5Y+bwjyRWwjWUCvFgKbHFX5Pw/8+9Pzg/Lq/ms
fyw1gx6TK9AnrUUKfauKvtj/AJxo/wCcO9Z/K+eXWfPGqyXl3cI3NDIXHJvpxV4R
5w/597+Z9Z/NeL80dOubddOSYSFCwBoDXxxV9Q/85Nf84baZ+e3l22sYykOs2cah
JKUBZR4/PFX54af/AM+9Pzh1hz5W8zaoR5eU8VAk/Z+/FX6m/wDOL/8Azi/o3/OO
Wjmw0xjLezKPVc/jir6e1C2a8tpbVDxaRCtT74q/JDyN/wA4Ca35b/PM/nVcTKbE
XBmpXrU18cVfR3/OZ3/OMmsf85EaamnaHLGjIFC8yBSnXriqX/l9/wA4hS6f+WEv
5X+Z3ja6aIxgjda02xV+dPl7/n27+a3lHzDdRaLfmPRLiQ0WN6LxP04q9E8hf8+y
vMvlHzqnm761HJE68pGZgfi798VepWP/ADgN5itPzatvzN9aI2cCqa1FKj6cVfQ3
/OZH/OMGu/8AORvlqz8tWU0SPbcdyQOn3Yq9C/If8htS/LH8rZ/yo1KVDcyQSRK6
mo+NKdsVfIf/ADjV/wA+99S/KbzpqnmzzFPHJa3ruw4kHZiT44q8p/Nj/n3f580/
8x5/zS/KK4hjS5k5kAgMN/nXFUo/Mn/n3b+af5zTWepectRjeW3Kn97ICRT5nFX1
957/AOcRPMXmb8pE/KFJ4WuI4ljDEjsO2KvS/wDnDH/nHLUf+cefJ0/lDWXRp5ej
L8jir5muP+cBdYm/OBfzb9aM2wl9SpPvXxxV+sdhA1rbRW0h5NGiqSPYUxV8nf8A
OYP/ADjXaf8AORvlT9Ayil5CS0LAbhu2Kvzi0j/nCz/nIK20Jfyw/ScI8repRg0o
5+n4Ur4Yq92/5w1/5wW8yf8AOMvnzUfNTXMcuk3kXELyqanr398VSjW/+cCvM+s/
n+Pz59eFNNW4WYqCATQ18cVff3/ORf5P/wDK6fKN15Pj9MSzKQrSYq/Pb8jP+cRv
zm/J2C88q2t3aSaDc8lClxUKfAVxVlX5G/8AOEfmT8r/ADreee9RlglhupGd1qCa
HrTFW/zv/wCcINV8w66fzA/JqZLTVSS0nNuIL+2KvMvy7/5wk/ODX/O1n5p/ODWm
TT7QqQtvL14n2OKvfv8AnMz/AJwluPz+g0+fyzIqajp6r6cspHIlOlSTir5p89/8
4R/nR+ZvkmH8v/M99B6FqAsaiQdF2G1cVfZf/OOP/ONetflF+T9x+TuoyI15cRSI
DUUq4pirxv8A5w2/5wX1n8i9e8xar5tkiez1gSKojIqAxPv74q8d/Mn/AJ97/mJ5
d8+P+YX5F30MEckvNw7hSamu++Ksa8z/APPtz8xfzM1yDzt54v421OJ1baQEAg9t
8VfWH/OQP/OIPmT83PIek+QpJ42k02JI/tA1p9OKvpn/AJxZ/JSf8i/JsHlG9cPM
oFePamKvpbFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/Bf8A5/U/3XlH/Wb/AIm2Kv1k/wCc
Uv8AyUvlP/tnR/rOKvoTFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FULfTm2t5bldzGjP
9wrir5C0P/nLLyzqOsXXk3zRMlrKrFASwWtDir8Tfzs1WCT/AJyYsrzTZFfShdo5
lrX4S3jir9sfPv8Azln5U8j3Wj+WtGuo7q7vWjjKKwJWoAxV9baRffpKzhviOJkU
NT54qmWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxVRuLiK1Qz3LrHGOrMaDFW45o5oxPEwaMioYHanzxVStr23vOX1SVJeBo3BgaH
3piqQecvJ+m+etKn8ua/H6lpOpUjuKilRir8xdY/59rwW2rT33lLU3t7G4Zi0Ycr
sfbFX0f/AM49f84Y+VvyRuTr0cYuNUY1MkgDGvjXFX2pirsVdirsVdirsVQlxf21
ptdzRxf67hf1nFURHKkyiSJgynoVNRiq/FXYq7FXYq7FXYq7FXYq7FXYqskkWJTJ
KQqjck9MVULa+t7yptZUkp14sDiqKxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kr
JFLqUBpXvirUUSwrwQbYqu4ANz7nbFV2KuxVRMCFxMR8Q98VVsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVfgv8A8/qf7ryj/rN/xNsVfrJ/zil/5KXyn/2zo/1n
FX0JirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdiqnLGsyNDJurgqfkdsVfz2f8/Kfymuvy
61VfPnlFpYVlcseB47lh4Yq/JWX8w9Yub861cuzXaD7ZJJ298VfoP/z7z/LDV/z7
/MB/NXm6WWS10xhLH6jFl2Fdq4q/p1hhS3jWCEcUQBQB4DFVXFXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYqoXFwtshlkrT2xVJdY82aP5e4DXb2C0aQVVZnCk
/QcVVdI8zaVrw5aLeQ3I/wCKnDYqiNU1uw0WP6xq1xHbxD9qQ0GKpHZ/mD5a1GQW
1jqtpNKdgqSqT9wxVkV7qVrpsX1q+lSKH+ZjQYqxqT8xfLEQ5y6taKD4yqMVfGv5
i/8AOd3k/wAtecLP8v8AS7uJ3kmCSz8qpuf1Yqxv/nOjzF5p1/yhZSfk7q0UEk4U
vIrbMDvtiqbXvmnzh+W//ONr+Y9VuxNr1vZVMorXcePzxV4P/wA+ovzO80fmVpHm
TW/O921wRcfuwxJI3364q/VvVfOuh6EAdbv4LMnoJ3CE/fiqpo/nDRPMD+lol/b3
T0rSKQMafRiqdXl7b6fGbm9kWKIdWc0GKsTX8yPKzMYl1ezLjqBKpOKsk07WbHV1
9XTLiOdfGNgcVS7VvN+i6E/o6zf29q/hLIF/XiqJ0nzFpeugto13DcgdfScN+rFU
6xVJ/MGoPpenXN/EKvFE7D5gE4q/m+17/nIP8wfzw/MnVfK+lat9RstNmkBVnIrw
xV9jf84Cf85O+ZfOXmq9/KrzTcfW2tHdBLUkUU4q/ZPFVC6uorKJrq6cRxIKszGg
AxVgr/mr5Sjga8k1a2WNSQauK1HtiqloP5teUvMrvFpGq20jR9fjA/Xiqw/m/wCT
VvG0l9ZtFuk6qZB+GKvQLa8gvIVu7WRZIWFQ6moI+eKsE8xfmx5S8qMsWv6tbWzt
0DuK4qnPlfzvofnOM3Hlm9iu416mM1xVR1X8wPL2iXH1DVtQggnBpxdqHFWM6z+d
vkvRGjhu9XtfUkICqJBXfFWvzPv31XybeX3lq6QGSEtHMrVFKeIxV8Uf84eHzYuu
Xlx5n1eO7tC7gRh6kDFX3Z5m/NXyt5R+HW9Tt4pK/Y9QVxVHeWfzF8t+cAD5e1GC
5Y/so45fdirI9W1iz0O3fUNWmSC3QVLuaDFXn+k/nV5J1qb6nY6zametAjOATirP
pdasYLVtUmuI1tE+1KT8I+nFUJo3mnSfMNTol5FdcevptWmKoO988aDp16NGvr+C
K9bYRs1DXFUy1bzDpuhQfXtXuoreDjy5uwAI9sVeeaJ+enknXpjZ2Wr2wmDcArOB
U+2KvWY5EmUSxMGRhUEGoIxVfirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdir8F/+f1P915R/1m/4m2Kv1k/5xS/8lL5T/wC2dH+s
4q+hMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdir49/5zQ/J1PzV8iXccCKbqzRpQaC
pAptvir+S3zJpd3p+tz+X1QrM8skSqetQaYq/qC/592fkxF+X35eWWv3sYXUrxau
aCpBUeGKv0SxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVjfmzWo/Lu
mT63cLzht42dlHegqMVfgFoOveav+c5PzXv4kv3stM0mZ7eOLmy7A0GKvrT8p/8A
nGn81/yN/MKG6tdZa88qyDk8fIkDf3xVJf8AnM2DzT5q8ww6bY+aYdO0dE5TWxcq
x8R1xV+U/wCZ35q6n+UfmOwvPJd1N6YlVZLj1GKMR174q/XX85Pza1vzH/zjda+d
NPnK6iYQWmBO9Bir5D/5wi/J3zD/AM5F+W73V/NGpSr6bOUYu3XFXxn5q/IW7/5X
Un5fTX7FjchFkLn+bFX33/znZb6/+Qfkvy7omiXhmKJGHIJNa0xV9O+YvMF/r/8A
zic2oao37+WyB36n4cVeL/8APn+V38n+Z+HwTCSQqT2O9Diry785dO1zzd5q1HzH
5881RTaXYyvHHYxyFW26CgOKvk78qv8AnJLzB+VH5uWVnpU0sWkTSpCI5HY8gxp3
xV+mv/PwT/nJjVtH0TR/J/lQvb6hqiRlqEg0kA32xV8z+ff+cc/N/kL8pv8Alb1p
qcz6lPF6rJ6jVFRXFXtP/PvL849atPy81rzZ5yumkubSGQxeoSd1BpscVfL3kzz5
qP8Azl1+YV/B5580xaPp8ErhGkkKKQp274qnnkj867v/AJxm/Oq18jWvmFNZ8u3d
wsYkjcstCada4q/oz0rU4NZtIdTsW5QTIHUjwOKvOfzq/MLS/wAsfJ+p+avMLKLa
KB14sftFlO2Kv5DPM/mnWG816v8AmL5Fspksbu5LGVa04sd+mKv1b/5wd86fl/8A
lLpzee9XZG8wXbgSLUc+TnfFX7k+UvM9t5w0yHXrBWWGcclDdcVeP/8AOTt7d6f5
D1K70+QxusL1INO22Kv53fyB8vecfzz803nkqC/lCtO615ttU/PFWE/m9pfnX/nH
D8zY/wAr7bUZZJbt1Sokb9o07H3xV7b/AM5If843ec/y08oWH5uz6tKl1MqylPUY
HffxxV9vf846f85V36/kFq2u65PW+0y1b03YmvTxxV+Zn5a+Ybv/AJyZ1LUNW8+a
wbO1jZjGXkZRQdO+KvQ/yS/5yI138hPzFj8maVqButGlk4K/JmBBOKpl/wA5y/mF
5ivfzF0OHQLyRU1JEcqjEbt8sVTf85f+cYPPGieQ7X83by/mQRosnEu3Trir6R/5
xv8Azu1fzL+Teo2dzM0s1tC6ciSegOKvPv8An3/5z1jXtX80fXZWJt4p3jBJ+0K0
pir47vfP2reYPzSv0/NOWe30UzOkbSOwWgbFX1j+S3kbXB+ZunXv5Z+Y1OhSzLyj
EhIp4dcVZv8A8/EP+cj9f1LzLYfkN5IuCNRDpHO0RILE7HpiqQap/wA4E/mHp3k2
z87eX9QnbXmjWQxLIeVTvir1q91j8yPLv5Kapp35gNNDfW8fFXckHp44qmf/AD6t
8z6rr1vqn6ZmecJyoWYnv74q+Vf+cjPP+vS/n7FptjcyJClyBwDEDriqbf8AOe35
nefrOTRdL08zpozQR+s6lgOgruMVeS2Xl3T/ADJo2nar5M10W2uB4zInqmvL78Vf
0Af84y22uW/keyHmy8F7ccQFcb0AHjir6FxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+C//P6n+68o/wCs3/E2xV+sn/OKX/kp
fKf/AGzo/wBZxV9CYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUFqVhHqlrNp1yKxT
IUYHwOKv51/zU/5xNvLz/nISG3sLVjpCXQkcgDjQtU4q/oX8s+X7TyvplvoemIEt
4I1UAewAxVPsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVYb5/8vS+a
dBvdEtpPSkmicK3vxNMVfz3f84hfmLp//OMX5ya/5P8Azdj/AEeLu9keC6lGzLyJ
qMVfqTH/AM56+VPMvnZfyx/L+BtYMkTN9ZhrxBxV+Pn5++c5T/zkHb2X5lyNYeXJ
WHP1CQoBO+KoH/n4F5m/K1dO0byr+TSxXtGSSW4h33pU74q+wfNU1mf+cR7Rbe7C
lIqmPv8AZxV6d/z6cuPrn5f3IToWcA064q+FPzjW28h/85I2/mjzXcC10wXYZpH+
zTlir3T/AJ+fee/Lnmnyto+ueUtSiu4GSLj6e/SmKvoCaQX3/OI8N2z7rY1p/scV
fPf/AD6z1e8i/LTzxeaNEZL6FpOCr1NVJxV82/8AOKvmHyZ5g/NHzBF/zkNfpZ2q
XUr+lcMVBIJoN8VeT/n35q8mea/z20ub8v4Fj8t213FEkyA8SQ2xqMVfaH/Pxbyf
faGPKv5pRuZ9OihtgXAqAABir2b80v8AnK7yTr3/ADj0ml6XexS6wLQRtbgfECFx
V4p/zgl5SvvzL/KjzHZ2wK3MkE3pKNiSQaYq+Uf+caPyw8q6R5y1Xyd+edwNJKSy
fvZiV25Hvir6xi8r/kxqf5jaP5X/ACzsl1+eznX1LmI17+OKv390Kwh0ywt7G0i9
CKONQI/5dumKvzG/5+l+WvMerfl3Ld6C7tYpT1Y0r269MVfnZ+SP/OQv5TaX+UVz
+XvmPTo18xNEUEjr8XOmKvgHylqV3oXnOPW9UEieXfrqtvXhw5bU+jFX9e35DfmB
5b8/eU9Pu/JMitaxW8Ssqjo3Gh/HFWKf85YStF+XeqMp29F6/dir8iP+fXxsx551
Ca4cfWnlkCgjeu+KvGf+c+XC/wDOUOlNKfiFzDxFPFhTFX6Y/wDPwRreP8jbS41J
P3q20dBT/IGKvhT/AJxh8ov+aX/OPPmnRtDs2e/a2cRhepIxV8rf84r23lDygdR8
p/nKVsryJ2HpyVBJrir7A8jeXfy3/NLz5YaL+X+nLMYOsid6HrXFXiX/ADmXDb6b
+dflrRLT90bV4o2UjpQjFX7E/wDOVFslz+QqwBwYvqEZJp1pHir8sf8AnDDUIU/K
/wAxCM8+BnXv74qmP/PvDUeGv+Y7u3HPgJyUp9rrtiqb6n+Yf5YfmL5wuPI35o6U
ulKsrL9YkHHv1rir5Xm1K58gfnlp/ln8itSa80FLpCDDUrxJ3qcVeof85h+Q/Mv5
afmJpX553lrJ6bSRyySEEg9Dir9AfM//AD8m8s2P5aWuoeVbhJfMzQKvoAVPICnT
FWMaR5v89f8AORX5M67qXm+zkt5ZYy8JK0qAO2KvjL/nBf8A5yq0n/nHPVNV8r+b
RUhnQ7Gta7Yq8T84fmknn/8APaHzLpikwz3AaMUPQttir9Gf+civzK0zQ49K0L8w
9N9SyngQc2XoCOuKvhf/AJyQ0v8AL7yn5ctvMv5Makn6ZlYMbeIkspPsMVfsv/z7
W1nzVr35U2+o+fTIZ2ekRk2JWmKv0OxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+C//P6n+68o/wCs3/E2xV+sn/OKX/kpfKf/
AGzo/wBZxV9CYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqxpvKOlvqLa88CteOA
C5ArtirJRirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir5f/Nr/
AJxH/L384r5df816ekuop9mWgqPuxVX/ACk/5xO/L78nbr9MeVdNjj1Dp63U0xVZ
+an/ADib+X/5w3h1TzlpkdxcdnI3xV55p/8AzgD+VGnlRHpaFFNaHf8AXir2XVP+
ccfJWo+XV8i/UUXSlFPS7EYqyr8r/wAoPLX5Q6f+g/JNotpa9Sqjvirz780f+cVP
y+/NyU3nm3TUmuDvzp3xVj+o/wDOGP5aappdp5cvNMR7O0ACq2/TFXqt9+TPl2by
un5c2tsqaKqen6PbjTFVD8qfyJ8ofkzZXOleRLBLSG7qZwo+2T1xV4Z5z/5wK/Kr
zrqM2u6jpUYu53LyOuxJPyxVF+Wv+cFPyq8vFCmkxyCJg6AgbMOhxV4z/wA52fm9
pX5K+WrXRfM/lEa35XIEauy1WP8A2sbV+bX5h+af+cc/Mv5VnzH5OmhsvNNzyX9H
KDyUntSmKvuv/n1l+XureX/KMnmTUI2jsLssIQajb5Yq+w/zN/5w8/Ln80b2TW9d
01Pr0v8AeSDav3Yqivyk/wCcRvy6/Jm8/TPk/TViviamTvXFX09irH/NPlfTvOWm
z+XvMEKz2VwvF0bvir4nuv8An3Z+VNzqB1T9GxrV+VAPfFXp2pf84aflfqVlHpM2
jxfV4wBSg3p36Yq9h/Lb8qfL/wCVNidG8n24trY0+EdMVZX5l8tWHm3T5dD1uIS2
kwoynFXkX5df843eSPyv1F9d8q2CQ3bsW5AU3PfFUt88f84s+QPzD8zQ/mH5o05L
jWbdg8cpAqpHTFXo/n/8q/L35l6OvlXzZbC4sEAUIfACn8MVS78sPyY8sflFZSaP
5MtVt7WUUZABQjFXhn5jf84Ofln+YmpN5hv9NjS9kbk7Dap+gYq9E/KT/nGPyN+T
ko1Hypp8cV+AR6w674qoecP+cWfIHnnzAvnfzDp6zaojc1kYCoOKvU/Mv5daL5q0
MeTdUh5aaE9MR9uNKUxV5r5S/wCcYvIXknTZ9A8v6csNpc8vVUAfFy64qi/y9/5x
v8j/AJZXM+oeVdPSGS4qXoBvXrirB/zG/wCcNfy4/Ma6Oq6npka3jGrOO/3Yq1+X
f/OGP5bflxeLrWkaahvkNRIQNjir2f8AMr8pfLn5r6avl/zfarPaJ9lSBsPDfFXy
9o//AD75/KvSr9dQXS42jQ1Vfprir7GsPJ+kaZpQ8r2VsiacE9P0gNqdMVfIOuf8
4BflfrOsSeYZNNjEkz85NtyfoGKsv0z/AJwo/K3SL+DWrHSUS6t6FGoK1HTFXpf5
kfkB5M/NOzj0/wA12CTeknpxvTdRir5+0L/n3z+VmkX66pLYLOFbkqMNvxxV9o+X
vL2n+VbCLQ9BgW3soBRI0FAMVTrFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FX4L/wDP6n+68o/6zf8AE2xV+sn/ADil/wCSl8p/
9s6P9ZxV9CYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqtHU5Rj+opK7L0NHpkZ8lbwhXYS
gB2KVrNxyjNk4N0gLsuBQ7CrsVYJ5z8haF5+gOj+crSPULBgawTCq7981+ojeQN2
OZESHiUH/OFP5LW0v1qHylYLKG5A8Tsc2EzYppjsbfRflzy3p3lOxi0PQIEtrKEU
SJBQD5YIihSnc2nuFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FX4L/APP6n+68o/6zf8TbFX6yf84pf+Sl8p/9s6P9ZxV9
CYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+NtA/wCcnZ9Z/OzWPyAe0EcemW4n
E/8ANUYq+ycVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
aA3rlUIEElLeWIaapG2QyxJFBIbGSiKG6Gh74wBHNXb19sFG/JVORS1OOYmtwzmB
wsomlUZmRFBi7JK7FVjLUg5i5sJlIEMgV+ZTFqnfFFN4pdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqWarrFnotu9/qUqRQxgsxZgNh8
zir8z/8AnI3/AJ+TeUvyqEln5LkTU9Xi5L9WqOJI71BxV81/kZ/z9b1vzx5qt9C8
96ZFY6fdSpFGy8Ruxpir9zbK7S+t4r2EgxzIsikbijCuKorFXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX4M/wDP6ZTJH5RVeoY/
i5xV+sP/ADikQfyl8qAdtOjB+84q+hcVdirsVdirsVdirsVdirsVdirsVdirsVdi
qlLNHAOczBV8SaYCaSIk8krufMOm2al7i6iUDxdf64DMBuhppy2Aef6t+d3k7RuQ
vNSiDL2DKf45Dxoufj7D1EzUY7sYt/8AnJnyFcyC3TUk9Q7Uqv8AXB+Yg5s/ZLWx
FmD0XTPzK8u6vx+pX0Lcunxr/XB+Yj3uuy9k5sf1BmsNxHcAPC6uDvVSDlkZg8i6
4xI5q2TQ7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXVxRam0qJXmyinWpAwErxBiGu/m
BoPlxS2p3sKkCtA6k/ryByAM4wJ5PnTzV/zm9+WHk92h1e/YOtfsLyweNFn4Mnim
r/8APxjyTekx+VpZZD0FY+px8aKRp5nowG+/5+Aa/EWj0nShcbEoSvXww+NFt/I5
e5JR/wA52fmxLBHPZeVYJecgXfbauPjRX8hk7nw1o/8Azkf550f8/ta/MRNFiOv3
dsscttTZFptj4sWP5LJyp9yn/nPH8y7OOM3flqILtU0x8aLL8hl7mVad/wA/BtTi
AbXtJWI9wBj4sU/ydl7noul/8/HPy1j4xa/dSw3B+3GI9lPzx8WLUdLMbEPdfKX/
ADl5+W3nPiNH1LdunMBf1nHxQjwJPftO80aVqsQubG7hdD/xYv8AXCMgYHGQniSJ
IOUbBh4g1yQLBfhV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2Koe4uobRTLdSLGgFaswH68VfFn5+f85t+SPydtZ7eS8SXUACFVHU7
028cVfgh/wA5Bf8AOcfnT817iaLSLyW20xiQPScbgjwGKvhe4nl1OX9I37PcTs27
MKsScVe5+QfyQ86+arlfOHl+yl+o2CC55+m23AVxV/R1/wA4B/na35o+T49P1aaU
6rZfuZEk8EFMVfoLirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVWM6r9o0+e2KLbV1f7B
B+RxSRS7FXYq7FXYq7FXYq7FXYq7FXYq7FX4K/8AP6pQYvKNGoxLDb/WbFX6z/8A
OKcSRflJ5SWI8v8AcbGSfepxV9B4q7FXYq7FXYq7FXYq7FXYq7FXYqoXNwlrE1xK
QFUV3NMWcIcRoPkv85P+cq9A/LO2kWeZPrShqKrqdxkZZAOTvdL2H4h/eEgPzm17
/n5VrzTumhWqyRgkKTTplEsxd7pvZPBL+IsH1n/n4n+YesWpshYRRxnYSCnLKJZX
dYvY7ABdl8t+aPz187+cJmefUriDkfsxvt1yk5S5A9nMUORS6xttd1NDc3upXUh7
8iTkDktvhoBgPHEmwl+o6PrEINzb3U6nsRkXIn2jky7FKNL84eaPL9wLn9MXYCH7
PPF12bs+OX6iX6F/84y/85w3Xl2ZfLnmad7hZWADzEVFT75dCLpdT7OYauzb9qfJ
fnWx85WEeqWMsbK6g/C4PXNnGVh4rW6KWGVMzrknAJbxS7FXYq7FVhanbDTAzrov
wM3Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYqt5gsUH2gK4aVzOqbuQK7bnBavPfOn5peXPIcDXHmG8jj4ivEMOR+iuV+J
vTIQ4jT4b/MD/n4B5d0wGy8mJJd3vRVZaiv3ZYZFyf5Kjysvl3Xvzo/Pb81am1tI
7DSX/wB2RtxanTKJBvx9jx82HwfkpqmtP9d1vX797j9uMsSK5TIudHsyMepegaN+
Smkw0Go2yXxH7U6VJyiTkDQxD0Gz/LLRLNf9E0WzU07RgZUzGmATGw8q6XAWiuLG
NWoaUTJ8Tdxoiz8swu8aMpjiSQNsCO+PExMnwTZWscn/ADkLrqWatIi243INMnez
jCZ4n3FcWULQRi4t1Ow6jIW5kZFJLzQ9GuAFns4yf9XJcTaMlJRqfkPyo8aPNo9o
xPVvTFcgS42TEJG2Kal+SmiaxAZNHlbT37eiOOSjOnHnpgwux/LDzV5WuPrnlfXr
64uk/u4Hc8DTxy6M3BnpQ9I8t/8AOS35xflpOIfMtks2nKRyc/Ead8yIycWelD7G
/Ln/AJzl8peZDHp+rzPDqDUDI4CqGPvlnE1flw+zPL3nPSvMkCT2FzC7OAeKyKev
048bTKFFlQNdxk2DeKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
gHmT8zPL/la6h0zVr2CO4mbiEaQA1xVm8V3DNEt1FIphYVD1FKfPFXzz+b//ADkt
5U/Ki0kmv7yGS4UbIJFxV+Gn/OSn/Px3zF5zd9K8mSejAPhBicDYgjsMVfl/r3mX
WPM0z3uq3MlzLMeTiVuVD7YqyDyJ+V3mHzpeRWPluznleRlH92Su5pir9mP+caP+
fZsN5Jb+a/zLjK1Cn0QpA99icVfsZ5N/Jryx5G0OTyjodnElpNE0TkoKlWBH8cVS
D8q/+cffLH5PzTXPlGNojO7O47Vbrir3TFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWjsKnFUBPqVtaC
s8yj6RiSmGKRSi5846RaDlPdRKPdhi5ENHOXIMO1j86fK2jRNPcX8HwgmnqCu2RM
gHPwdiZchoPkbzt/znX5e0KZ7exk9UgkfCwPTI/mAHb4/ZbIe54bqn/PwW3lJSBX
BOwp/tZE6kU5sPZjJHcgIGx/5+CnTjW7ViPc/wBmYsdSxzdigvZfJP8Az8C8t61M
sOoyenU71YD+GE6l1mXsI9H175Y/5yB8n+alB0++j5dwXGWR1Pe63J2Rki9gsNSt
tSQTWcgdT4HMiExJ12TEYGij8m1uxV2KuxV2KuxV2KuxV+aP/Of/APziTqf/ADkw
dEOik8rI/F1NByNfwOKvtX8jfI035beSNH8l3jcprG3WNvoxV6zirsVWs6pu5A+Z
xtVFruBdmkT/AIIYOIJAWNf2y9Zk/wCCGDiCiJK6K8gm/upFb5HHjCmJCJySHYq7
FVKSeOLeV1X5nAZAJESWMa1520fQoXuL+6iRUBJqwHQY8QcvBoZ5TQfmJ/zkr/zm
3+jbefQfJkivMSyVVhWlMxNZkHBT1HZXYs8c+I0X5U63dax+ZuoHVNfmkZXNSpNR
vmpGanqxg3ssv038vWdVh0u3DHb4mTKzm83ZYdXihsUDr35cajaA/WUVaD9kYPEc
z+VcJYdpfl6GC4CXFeVclxMRq8cuT6a8qeW2uUSKJE9BvtHIWbZ5o8cCIpt5ysLH
TbNrOJV5UoDloLrcGinD6nyVeeVZLm4aUMCpPSuS4nbYTGPNZ/g+VHF3boUdNwQK
dMsjNsz5MZHJ9B/lb/zkz5s/Ka4itpJJJLJSoNTtSuZcMjyXaem8UEAB+xH5If8A
OW3lz8xbKKO9nVL1uKkFh1OZMMht4rV+z2WIMhyfYsMyXCLNEaowBB+eZANvNWq4
UuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxVhPmzz9pHk+2kvNVuI09MVKswByqWUBlGNvzX/Nf/AJzjur26
k8ufljE896SUDkDiCD4gZjZJ25+HCej5ouPIvm78wrlde/M+9kWZjyiijclSeo5D
KxkFuy0+lIkCQ9S8u/l5peiOJry0hkk/mKA5acod7xw7npEekNeEfUi0cI/ZQ0H3
ZA5Qk5odzKrPRUlKi2RqrsxIO5ykza55oPQLHytPOgEaqP15UZuJPURTyDyZBF8V
+xDDcAZXxhxTqoot/LkEhF3IqCMbVw23nfZZqWkafGqPGo41FSBjxMDEvFo/yC0O
y803H5kaWAbq9Xg5I/jjxsBj3tmOqeXo4ysChT0x4m6MWK6loAt2DcBT5ZLibREs
WvtMMH71lqp6CmVmbnxjslH6Lub7/eUiMeHTCJ0px2ozQ39sv1P4eR/bB3+/JjIG
o4PJC3dzH6f1XUYxNXY8t8tGUNEtOe5gut/lb5T8ywtIwazuWB+KFeJ3+WEZg0S0
vk8+03QPOX5Sub3yHqFxdWSNzpO5J27b5YMocPNoz0D66/Jr/nORZZ4/Lf5kI0N3
UJzNAKgeNMuhlp1ubTP0i0DzHYeZLSPUdMnjljkAI4OG679syY5AXAnDhNJ9k2Ds
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVSzVdRtdOgaW+njgWn2ncLir+V
/wD5zk/NXWY/zbupdI1GVtPsn5w+jKaV5e2KvcNT/wCfm9/bfl7Y+UtI5jWIYwjy
VNSQKbmmKvzR88fmf5o/MaVtY8y30pRjVl9Q4qxnyt5U1LzNcLb6BbyzyuaKePLv
ir9OP+cdf+fd2uecLu31Lz5C8dpJR6cKbV+eKv3V/KD/AJxo8oflHaxwaRZQvMgA
5vGpNQfpxV9EIixgJGAqjoAKDFV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVgHnX8xtI8j25vdXm
RVXc1YDDsObmafRSycn58/mt/wA5/wCk6UzWvldg4GzHl3p22ynNlobPS9k9jY55
BHLb4X84/wDOb3nLXpSNHciM9PiOYZzl66XszpQfTbxnWP8AnIT8w9X2muWVT4Oc
rOoKB2Hhjyeaal5x17WrgDU724Lt1CyGm+VnUlujoIR5Mo0PQxdlWLvJMf5zXKTq
S5WOHDye8eWvyyF+gm1KNQAKj4RlR1RcrjNUhvNn5cWkEDMqAED+XJCZcIaUSO75
fv8Ay4Ybsx2zsm/7O2SOUs/5KhLvemeWLfzBoCm80S5m9Qb0LmmTGVpz9gY6vd9k
/lF/zmtrnkiWPRvOLVjqFqW8TmTCZeS7Q7Lxx6F+xH5Z/mZpX5laXFq+jSq5ZQWU
NU5m48t7PG6jTmB8npWXuM7FXYq7FXYq7FXYq7FXYqk+vXk9jZSXNkvKVRsKVxV8
Xec/+cgfN/li4ezWxMvXiyJUfqyqcqL0vYnZuHUYzLIaL528y/8AOV35guWS3sZQ
N+in+mVcbuY9h6XveEa5/wA5U/mghb0rS4C7/snAZt8ewNL3vJ73/nLr8zLOb95H
Mkdd+VRkTNyIezmkPVm3l3/nP/zLojoL9qkdQWyPE5sfZfQ9S+nfK3/Pxi3vVX9L
BBTqQf7Ms8Whs6btf2Z0+Ojjs33PRZP+fgnl8JWGhb/W/sweKXWY+wIHpJhes/8A
PxmwtFJtUUt8/wCzK5ZS5cewMXUF8+ec/wDn4pqOso8OjfBKdh8RA6fLKjkLlYux
sI5AvkXzl/zkd5184syaldOsD/yOehx8Yh3Ol7JxvL9OVry6/SF7I0hJ35GuY+bK
ZCi7/Tdl4477vdfLCWJ4tLQDbMPhcjLosb3q28z6fptoI4QnTr3weG6jPpY9A8l8
1efbZy8SHk2/fLBiDhnAAeTw2PX1ubysmy1yzww5unxRt7xo/nVdMteFs3bxx8MO
+hCADAfM3nC61asUJqT74KcfOQORSjy3Zq1wr6kxBJ6V98iXVTzSHJ9Kab5esNTt
hFIF4kbEdciJm2H5mZ6ME8++T7XTrR0t0Ugg7kb9MyITbo4uPm+bdA8x6h5C1KPU
NEmdDFKrkcqD4TXMmOQ22HQY+E33F+73/OLH/OV9n+aFpDp2sTxx3kcaRnk3WgzN
jOnyLP2UBKRgDzL7xTUraQB1lQqdwa5fxOsOGQ6Fe9/bxgFpVofeuDxAxOOQ6Fr9
IWwFTKn/AAQwiQLHhPcfkV8d5BKeMUisfY4RK2P45InCl2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku6bnFXy3+fP/ADknof5U
QmwWUS6od1RCDQ+9K5Tkn3M4wt+YfmrX/Ov556s+raxM0WjSEhVjamx3zDnNzsOn
ei+XvJmk+T7cRWkSSTEfE7qC1fnmNPISXc6fThP4GRW41Yh/E9PlkOLq7GWIRjYZ
dZCPj6Lbr4nrkfFLrhmkznRYLe1IZO/jkhMsxMs1h1e3tf8ARzGOT/tAdMbtSSei
a28xiPr+qtPAHA484HuVZfMCSAoWAA61ORMHHOLfkxu+8wJKptLd6Ww3JJ75dwO0
AHNDWnmiGWI2cJDRg/FU1NMfDQafNFh/zklDefmHe/lZbBvq1mvPqa1w+Fs1iYun
ukusLdzCW3fj0I5HB4bbGlKTWnlZkvHQqvShw+G5ApK7qb0l+sM6PG3RQakZjSG7
IZyNmNSrHektFyj/AAxbhmtKborACgasnjXAzE7ShPgb1COR98laSulAkYSMAD7Z
DjLSVruDJycVFKU7ZfjmTzXwxIbsM81fl5pPmiMzSxiKYCoaIUNfnlvGQ6zU4Awr
y15788fkpexS+XJ5ZtKhflMsrE/ANtsyITdFnwv1j/JH/nIfy9+cVkv6PnWPUkWk
kLkA1A3pmXjyXzcEin0KK0365chvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqpTzx
2yGa4cIg3JY0GKvkv87v+cv/ACb+UUE0U91HPeIpIVG7jt0xV+En/ORP/PwTzP8A
mXcy2fl+dre0DMFCOy7V2xV+eer6/f61dvquqO000p+JmPI/jiqCZjWkQq7dqdMV
fcH/ADj7/wA4QeavziaG8mRhp8+/LiKU2xV+9X5H/wDOD/k38qILS4kt45r6FfiJ
RSCcVfbVtZwWaCK1iSNFFAFUCn3YqicVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVebfmd58tPIu
kT6neScCq1Fdq4mXCLdhoNIcsvJ/PL+fH/OSOt/mDq9zp9vcOLMNReLnpvmvy5Xu
9Ho5bAU+UvSa4kKMzvIx7muYU8tu8x6Q4Bxyep+VdA9crG0ZqfbMclycevgXukf5
XQTWn1m4Xjt4ZC2/xoyeEeY9GttAvyse6jDRajROzI/KmrQRzLcOQFFMqljJZwxk
veY/zOtYoRFC6gqPHIxwm3IOA0w3zD+ZEeoQMqsKkZlmDj4pUXzxd60xuzL2rlcg
7LDqgHtn5e+Yre6k9K6KgDxyu6dh+ciRVKn5saFolzB9ftWC3A3FDTMrFN53tLAM
m4Zj/wA4d/8AOQ9/5E8wRaPrM7jTS4SjOaULZmRlu8fm7JllBiaf0R6BrNvr1hBq
li4kilQMCDXrm1p4HUYvDmY9xTnFodirsVdirsVdirsVdirRAYFWFQeoxVJJ/Lem
XFfVtom5eKg/ryrJiEt2UZmPJI5/y80Of7VpD/yLXKPyvm2DPIdT80ivfyh8v3QI
+pwb/wDFS4Dpi3w1kh1LznX/APnFryf5ghaK6tIwzV+yijJeA5WPtSQPV8W/ml/z
7x0maOW88trSShIFB45A4i7jD2tjI6vzc8+/844+Zfy8mdbuzuJYWNE4L74nCS9L
7PdpY7N7+94bJpWp6e5S6tbiMD+bbKziL1Q18P5v2IBwJX4TMVP+UcrOMtc9dDu+
xSYW8h42kDl12LDocqMC4UtXDuVoZjIfRnHE++VGDk4NVHuRJu2tiIo/s5GMXL1W
qHAzDR9UnACqT9+TLgY9UHq2m6fe6tEBGW3Hji5kdQD0RzflfdTobmUEk48SnJHu
eW+YvKkmjyE0IIwiYcTLkARvl62mu3SN68e+PE0SzAh7Lpv5avcn60ikj5YJBrx5
BJjnmbyfdacTdR/CE3ykuSMBKU+XvzGl04mCR68DTrgIcmGIovzf+Y51C2Mda1By
UQznsHztczNeys56Hr8suBcU5b2T3yl5mv8AyTeLf+XJ3jKkE0Yjp8syBlDSdIeY
p9aWn/ObvmrT7RLIyuWUAV5N2ywZ9nXZuywTdBY3/OcHnKNQ/wBZPE9ixyUcriS7
LPkhpv8AnNrzRMKS3ZB/4yHLOMMR2TM93yTnRP8AnO/zRo55pOXp4uTk4ZKTLsCe
TY18n0l5P/5+P+p6Sa2Kt+2eRwSlZt57N7MZOIgEPqzy7/znp5F1GJfrsnCSm/xf
1GSjMuPP2XyjqGdRf85leQJhyjuKnw5D+mWiTiz7Ayx6hkGg/wDOT/ljzJOtppay
OzEAGtRvkw4s+yMo7n0HpupRanCLmHYEAkH3yUo04GTEYGij1YMOQ6HARTAil2BD
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirRNNz0xV8m/85Mf85C2
n5U6TJYabIr6tcKURVO61HtlUsgbsULL8sNA0K/846i/mj8wHkmW4csgY1py3HXM
Oc3dabSkvfrSBdEgXTNPAEIAI2zEnJ3OPREK0cBc+rM2UkuT4RiF7yJsE7Y0xMr2
R0F4V75CmA05DIbXVfTA+L8cti2DEU0PmF0XaRQncE7/AEZbEMjGkpn8zRqa24kL
eNTTL4xtpnIMa1H8wLKzr+lbuOKnQM9DhEGiWQB5jrP5+afpk31cQyXMZ2/dGtcy
fCLqTqwkLfns0dykGgaPehpWALFSRucHhNZ1YfIWl+aNTs/zt1XVYYWFxLCOcZHx
AHJeGWoakXb64ufzv/RUgTVtLvH6VKA0wDEW+OqCdab+c2h6lzPoTWx/4tNMIxFv
jqg9F0LzNoephTpV2huT1Beu/wAswcmI20+OLT/ULy7hH+kUaM9Cgys43MxTtKQi
TKbha18CcgcZdjjKnlRi20uG+VSDAha6VFe+XYhsyhKgut2aM/ENskxyR4m7uCyv
I3hvYw0Tij7dstjJwcumJeAa15X1j8q9QXz/APltK6QK3Nogx8e4GZMJupzaUh+n
n/OM3/OTFl+b1h9R1iRYdZiFHVjQsRTpmbCbrcmKn2BlrjuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVTllSFTJKwVR1JwE0kC2K3fn3y7YMUvNT
tYmHUNIBg4gngKlbfmJ5ZvDS11W0kJ/llByPix72NMptb2C9X1LSRZF8VNckJA8l
RWSV2KuxV2KuxV2KuxV2KuxV2KuxV2KtEhRU9Birxn80Pz08q/ldZS3euX8C3SKz
LAW+I0FemKvw0/5yS/5+R655me48u+Rp/q9tV1qvIVxV+VnmjzvrXm64e+8y3Mkz
uSftt3+eKsPZQaE7AncnFU103TtQ1q4GmeXrZ7uZjQCPfFXs/nT/AJxj8/8AkDRL
Hzhd2cx+v0KRUHIYq/oJ/wCfa2v6xqHkp9K8zWb2s1sAE5rQnpir9MMVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdiqElv7eD++lVfmcBkA2xwylyCHTWbGQ0S4jJ9jg4wyOln3FFR3kMu0Tq3yxM
wGEsUhzClcala2o5XMqIPFjTB4ke9McE5cgXmPnL86fK3k+3M93qNuZOyhqnHxB3
uVi7OyyP0l+L3/OWP/OV83n15PL2hSn6uu1VJ33OU5coPV6bQaMw/hIfnXDE6/vZ
iS79Sc1WeZPJ7bs/BEc080x4be5SgrIe+YkCSd3oc+PEYU998i6iiXKmenEH+OZB
iHXY9Fj7nqfnL8xdPtLT6nCQXpSgx4A2TwRjyD5a1S4Ov3JZUZVPjkhEOMYeSXNp
V1a/ubcNv4YREMOIxQsui6jb/vZHYA9iclwBh455WqWNpLO4iZ+vauCVMzGuT0vT
/wAtZr5BNwNPHMTIWmWWUeRRzeQLzS1NzbVUr28cpssBqp97AvM1veNEXuiw49ic
yMZLlQJmN3ncMjIBJakxSowbl06GuZUZbuVj0UJA2Oj9fP8AnDf/AJy5tYraLyx5
uuREsIEYaQnx983kcsK3L5NrtBOeSQETzfo/e/8AOQXku1iFwup27Drs9cHiQ73W
nsnMP4SkkP8Azkx5MnPw6jAorT4jgOSPe0y7OzD+Es50f85fJ2tUFnq1sXP7PPB4
ke9r/JZesSz601mxvwGsp45Qf5TXETHewlp5x5gplk2l2KuxV2KuxV2KuxV2KuxV
aVBHEgEeGNLbHNZ8o6VryhNSto5APFAf4YQacnDrMmL6DTw3zX/zi75O8y1MlnGp
P8qr/TKJYy7CHtHrI7cTxe//AOcAPIV6TI9r8Xtxys4i5EfaPOfqLoP+cGfJ2mKI
bWz6jwXMeWEuTi9oZ9S+NP8AnJr/AJw3TyjZya95dhPBASQoHhXIywU9D2d2t4/W
n5eyQyWcr2l2pWRGpQ5Rkjwh6bRZBm9MzbLdIdKqq7tttlHE5mbTY48n0h5K1eHT
1VbyiHb7WVmR6Ory5JQ5PZf8UWJhEYZcjxFhDUTJeB/mLqFnIrPGVJ9sRIuzxYxP
6nkWjeaorKTidqHJRkbc3JpMXhmhu950P84rezh+rsyjbMucXT4sddGLea/zF/TM
bW9tRuXhlJi5oJeL2mjSxyM8teUhqBkCzgD1ZK3lO5mhMrwvwpWvbCzML5vOtVhX
TpDGo36EZJxZwiCli0XeIFQe5w25EoEC6Rmm6Tf69cpp+kxNPI5p8GWRBdLqdRXV
9v8A5af84NeafM8SalrcbpbyAFVIG1RXJji7nTZu0eH+IPrHRf8An3LoxhWTVYyz
9/s5dwTdTL2hkDQKZ3X/AD7v0Tjxso+B9+OS4ZL/AKJMo5Fgl9/z7u4s3oV9iKZZ
wSpuHbQkLJ3S6w/595XImHqtIFr/ADDBUrasvae2xe7+VP8AnADS7F459SkdlFKj
mMtAk6fN2seQL698lf8AOPXlPyZEosrYmYftE+GXRBdfPtHIer2yzsobCMQWy8VG
WE24c5mRsovAwdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirzD
83PzI0/8r/Lt15j1ZwoVGWME7liNsrySoMowMuQfixo0epfnH5nuvMvmiRnsvUZ4
eRNKHp1zEM9nY6bTyvcPdtLtbdQ9reKDHEp4UFOnTMWcnqdHij1Uvjlg9YbNUgKe
tMxzbuBGFc1SC3eVKu9Di4maui6JVjrHSrHDIbOvBPE037vZtjlILlGRXCRiOSgk
DqcvhEtcspCU67r2l6Fbm815+MgHwKTQnMiMS4WbVEdXi9v5m84fmTd/or8urSVY
S3H1KVG+2ZEYkOsya2Xe+lPJf/ODWr+Zkj1H8zLozMxDcFahGMbtw56yXe+tfLf/
ADiL5M0eKP1bbnLHT7VD0zPADgHNJ7FYflN5WsJVEOnxHgBSqLTb6MaDHxTb8qfL
HkXy/f8A/OYHmfSLqJGt0skcQrT4SRXph4Qw8ST9ULj8lvKF5GEfT46UFDxX+mRp
tGaTx7zT/wA4heT9f5+lb+mW/loMkAGwagvkXzz/AM4Qan5W56p5DmZZBuByrmHO
O7k45g9Xz9/iXzj+W8/1P8wLOaS1U09Qg0yHhuxwZQOr13QPMWn+bbf6/ojig6xj
rlOSDtsOSJ6puQV2YUOY8ouaKcpr0zHkGBitBDNyBqMtxjZplYKszUHviQ3wA6od
GXmDMP3f7Q9sbpsMIlcISJWAo+nzbemRWgy+EnW6jEOjwbzHpN9+UvmGDzt5QZvS
Zw7xoem/gMy4zDodRhN7B+xn5F/m5p/5raBDfWkoe+hQC5QdVb3zJhMF1mSBid3t
2WNbsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVY5rnm7R/LS+pr15FaL1rK
1MpOcXSaeB+ef+cr/IvlOIyadqVvqMyg/uYG5MTlctT3JECXzLrv/Oc2qeYg1j5P
8v3UVahZ2BPyOVy1LbCDzm7/ADE/M/zIjPfak1rbv/utqigOUHUByY7PL7/8utW8
yO0+oXjzE7sQ5H8cqnqQRyZndg+oflP5g05i/lrUHhp0+Nj/ABzExkW45xJDb/nT
+c/5NXaXJuJr7T0NWVeRqM2WKYa5Rp9+f849f8/EfLf5o3aeV/Nts2j6kvwGS4JC
uelRXM6OVqMafpDaXcN9Et1ZyLLC4qrqagj2OWA2xRGFXYq7FXYq7FXYq7FXYq7F
WKebfO2i+R7J9W8zXcdrbopNZDStBXFX4+/85N/8/NbHSln8t/luhmfdfrCciOnX
bFX4pfmV+d3mH80r99Y168eR2qAebACvalcVeTrGy1uHq4O/OuKtxCTUpBb6f++l
JoEXrXFX2b+Qn/OEHnj857iKV4pLSwJBblSlCK4q/er/AJx3/wCcEvJ/5QW0N3qN
slxqagEuQp3p8sVfW3m/8stF85W9vZ6nAhjtv7scFoKfRiqc+VfJ+n+UoPq2mRql
epUAfqxVleKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2Koe5uEtYzPKaKv45KMbNMowMjQfLH5q/85ML5AWSCx0qa8mF
eJStOntglGnbYuyJSF2/Przv/wA5f/m1rkjjyloV5DEa0oGykxLssXZFc3zxrH58
fnbIGk1S2ukXcmvLbMbJjPV3mm7PkPpYBJ/zlD+YOjuVu5pIW78i2UnG5/5KZ5pl
p/8Azmj58smL22pksdiKtkDjvmxPYEtV6YmkPq//ADmH521hDFe6gxB92GDwqc7S
+ymXF/E8J8xfmFqvmVzLeXTsx/y2/rg4Hdw7OyQDDWu4beks84Z26gmuQONjLTyH
NFiMSr66TqV/lyvhQNCZdVaGNgPXj2K4I826PZhj6rZPpWp3Nr8Sk75YS2xuLV3F
dahL9ZbkfpyolhPVeTJ/LVZr1LWfpsMgXHl2gOVPrLRvIWn3EC3TsvLiDvTBxuJl
yibAPPWh2NpHIUYVUE5cJOB4FzG75z0+eM3quppRshbvcmnfYflTWbaO0RZnU7fw
yBLg5dN5p9rGv6YkS7LywguJ4fC+TPzHuXvZGazO3tlgLk483C8XDNH8N2MLssWv
A2IVVrCwkgDJ4EEj9WU8LP8Ak+R9Q6phNq2osnCO6cDw5t/XJDG2HRzHVDLqN/x4
y3D/AD5t/XLYwcfJopI3TvNOt6K4ubC4lqNx8bf1y4Y3V5tFPvfQHkH/AJy284+V
3WJrl+K7CpY9vnhGKjs6rN2aZ7Sfol+Vn/PxLTLiG30bzREfrK7STGtDtmdiJDzO
o9k5SnxRmAO59z+XP+ck/InmCISpqsEbEfZZt8yg6bV9kzwmubPYPzQ8r3K+pDqU
BT+bltkDMB18sJjzTGHz35fuN4NQgb5NgGQNdIk+b9H/AOWuM/TkuMMxiJTTT9Ut
dUQzWEgkQGhIyTGceE0UwxYuxV2KuxV2KuxV2KuxViXnPyzB5p02bTroAhkYbgHq
D45GQty9HqPClb+dT/nLD8k778utfm1WNCLF3ZuW1PwzX6qNxfROw9UMktg8F8sR
x6q6R2CUn23Gavheu8LjOz1PWfJOppZ/pGW4+JRULiIon2VKQu3k6+YdTjkMMjNs
adT2yXC4n5OUTzRTSzakKTVP04eTYJ8HNUh8uJIeRjJPhgBZjtOMeiy+8vmFSwhZ
fpyzxEHtiJ/hSrTInScIDx3748aB2oD0fQ/kjy9baoQ9+wZwdj4ZCWRvjqhLo9L8
7RWui6YYIp0Hwnag8Mjx2s5inwvrk6tds1PUqx3GTBcKQ3tKpLkNLHo0S+pPKQBT
3y/Fjc/V9pA4+Gn7K/8AODX/ADjTb6fFH5r81W/JpAGjVwDvxr3zZ4YdXzXt3V1y
5v1vtrWO0jW3t1CxqAAAKdMyHjJSvcojFi7FXYq6mKuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KrWbgpY9hXEq/IT/nMn8xF8+eYovyzt
CeA3IBPUZr8/K3c9lD1sf8laN+htMS1O3FQPuzCL0wTwDiS2KG+fP4sUOxVVhrzX
j1rgLOHNZaOlxNcLd7FOlchEN2Q0k+va/D5WsptVvSBaIPir+GZ2N1eoy7PPvyj/
ACj8wf8AORWsHXdWV10SFx6VdlKVzNgHRZsr9g/y5/K7QvyxsEsNBt0WUKAzUFSc
tdbklb0vgR+8br1xAccx3UopXlZpCOMYB2OFtW28/OFpV+LjU7e3bFXiGkfkd5aX
ztd/nPZ2Zg8w3qelPMafEo/HFXuTzCJlgTp0xVWdQGBGKuLDkVf8cgWNPP8A8wfy
z0X8w9Pk0nW4UYODQ8RXpTwwANsZU/IP81/yP8wfkHqb+YvLSudEVvjpuKdchN2W
DJ1DI/KHmSLzVpR1AMPrHcfPMLKHdafNbIkHC2Mw+0TTMGYdxhkpJF6I4+O+ShyT
M7r8m0lxXmOHji1ltW+pr6a9MWqQQesacuoWTigLEd98DUQxP/nGTzy/5R+fU8uX
DFLXWJPjJJp1zJwOj7WHJ+2UMyXCCaE8kbcHxzZxlYt06rkldirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdiqVatrdjoURu9XnS3hHV3NBlc8ojzSBb5T/MX/nMHy15Qf0PL6/p
eToVhPfMc6lPAXyh5t/5yE/Mj8x0ceTjNoiufhah2GY2bOa5t2DFctw89P5c+dfO
Ser581978ftRkkVzBOoLsDph3J9oP5G+WtNkBuNK4S1FZyxP075VLUHvUYB3PYLD
yfb6VSDR7lXjABoANvbKjnkvgdwTe4tWUenf2/qjxyo5Zd7IYT3JXNo0pH+4xPTD
fsePtkY5SSzhgN8kkubKWL/RbqL0G/mOZ8tnMlpfJItQ0uBoWtbqVbhXFKUGUnPX
Vwcunro+SPzk/wCcbotcg/TvlJvqepxfFHxNCxG/bMjFrN+bg5MbJv8AnEv/AJza
1r8ptTX8rPzhZ5Ii4jimkr8NWoNyc2uLLe4LjGL949B1yz8yWMOs6VIJbadQ6Mpr
sczgwIpN8UOxV2KuxV2KtFgu7ED54qh7y8g0+F7y9kWKCMcndjQAe+KvzX/5yM/5
+NeUfyoiudM8sFdS1JAVHpmoBIPvir8GPzt/5yv88/nTdPd6rqMi6dIai1+IUFKU
64q+aWZ7r44axD9qpJr9+KoaWW3SkASiHqfE4q9//J7/AJxr89/nTcxWflSxlfTn
ZQ0q1oAfoxV+6n/ONn/PtHy3+X0FtrfnOl3qA4u0bCtDTcE0xV+omgeVtM8sQi00
O3S3iChQqAAUGKsgxVqoO3cYq3irsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVUZ4EuUMUw5KcINJBI5MVu/Ieh3ze
pd2kbn3GAlvjq8g5SKJg8naRar6dtaxoPZR/TA2HtDKeZQF/+Xfl/UlKXllE4PX4
R/TImFt2PtbPDlJ5Zr//ADi1+XXmAN9b0iIu1d9u/wBGVywtw7dz9ZPn3zR/zgj5
Nut9GsEgatSwI/pjjw2d3P0ftBlxmzJjVv8A84AeXXNZYVP3f0yUsAcuftVmPKbM
LD/nAfyXEKXMC1/z9soOA9HBye1Gp6TZlp//ADg9+WSQyQ32jxySdFc03/DIDTks
P9Eeo58VvzX/AOcpP+cNpfILSa/5ThI09TXgvQDf2yPg+T0/ZvbE8gszfnGwmqYO
XB0NCnjkJ4qHJ6oa8yFCT03yhox1JkikPWmYciwllmer6g0/8rY5LDmCORXMaUi4
kzleVa35Qk8uTNOPtipByPE0COS92NxfmRqNo31RWPEbZIO008R1CX6jqmo60wZq
lT165ZbtRp8VXW7F9Q0WZH9S2HHvkRJwZZr6ptpV3qdvRC7EDCw5vS9GS51tHSYH
knTCF/L30V7jyDdurXEleIxtH5Yjo8S812UVk7RMKkZYA0ziQxLSrS/1x/q+jxm5
krQKoOZgxCuTjS7ZA24+T27yj/zjT+YfnCRUh0ieKJyPj37/AEZIYx3OPPtofz30
35f/AOfbXm7Wgr6hqLWwIB4sen4ZbDEC63UdvCPLJb1TTf8An2bq0C8Z9Y5fT/Zl
4wB18vaQ/wA5B6z/AM+x9UdS1vq9D8/7Mn4ADWO3ePq8A8z/APOB3nLy7I9vpiyX
vDpIpO+US2LvtLrMEoeuYt55af8AOLn5s2s3C20q6UA/a5NkbbTqNIfqkHsmh/8A
ONX5ycViaS4jjPWMlt8mHHyfyeecg9s8sf8AOHn5ramR6mvS2C+BZtssjAF0etOj
j9BBfTfkf/nEfzj5cdZ9c8zPfAdUJbxyZg89PVQJ2fa3kPy0/ljT/qUxq5NanqcY
A9XX55cUrZxk2p2KuxV2KuxV2KuxV2KuwUrwT89fyY0v81tDm0u8hUylW4tt1I2z
F1OOw7jsvtOWnlz2fg1+a3/OP/m38kNYk1KztJG04MSGFSOI+jMLgBe90/bEbBE1
HTvzc0m9082Wr8UugOJVhvXIeH5PY6LtPFMeqTwnV9Riub957UUiYmmRMKcjJkxS
5PV/ImnW+ouqz0ocrlF1WpA6Ppqx8i6UIhKvEyAbDbKZAumhGRmAeTy/z9b2umxN
VQD9GVgSdrk0wHR8kX+txxXJZPHLhEuLKMQzfy3+aEWgRn1k5V775LwyyjqIR5pL
5v8AzQ/xSwt7NTyO1ADk44is9dj70b5S/Jvzf514Po9nJIsjAVFe/wBGSEGB1OOr
4n6d/wDOOP8AzgU9hcQeY/Pic5l4uEc9Pwza4sO27xev7YMCeGVv1z0PQbTQLSPT
rCNUjjUKAB4DMkCnkdRqZZZcUinWLjuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ksc816n+idMuLytOMbn/hTkZNuIWX4WaM
/wDjnz/f+cXPOO2neL8cwtRyd52bD1293kmIJRNhXMF3rl3FDihaq8RTFW8VbEnp
H1f5cWUeaktsbwvcJtXrkoxZZ5bPCfO0c/5jedtB/JeybhDqpAlcdqHMzGHm9Xn6
W/bn8uPJFh+Xeg2nlLSEVRaRCNmA+0fE5mQDo8mSyzZVjVqsQWy0hqErdIxQ8iaj
wyQFtwjaHvhIYwYTxFd/llbFavFVRLKm7DlT8cVfMej/APOTFtrH5uan+QaWvp3G
mQiZpv5gfpxV9U+msvGbodjiq6RSSpHTFUJKguJVaNt0yVMq2VpGQuqMatkeFrka
Y3508rWfnXSrjy7qyB7eZGrXxpQZCcbZ48lcn4grplz+VPne78tX4KWUkzekD049
sw8gdxpc3m9sJoQn+63+IZg5IvS6WdriSTvkYjZyZNZJqLRNNxi1lYAZRV+uLEhc
sjAel+ycDWYvGPzb0Q2EMXm7Tjxu7MqVI69cydO6jtOF0/X78gPOkXnTyXpd8rcr
hIFWb/WGbDGejoZinteWsHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXyX/AM5C/wDOUWl/
k3belpvC/wBVH/Hsu58KZi5svckC35+v5q88/nYza7rt1LZabcbpZmoVB4ZrcmVv
x47Z75a8gaTpaFZLRXlHWUnfMc5Lc6Gmvq9M06ygt04oeMfgMjOVinJhp+He08vL
WHR7U6vdScLNRVpPCmUcDdxMK0P85PJPmDUToltqyzIoozbbN4ZE4SsSCw78xPz/
APLH5cyLAnH1nfiBTt44Y4LciEQ9I8oee9P82af+nBOPR4hqfPIHA5mPT3yL4h/O
r/nKq80LV5vLvlSMuY6gSKOhr88tx6bq3y01Hmw3yR/zl/fQTR2HnK29YO1GlcdB
mVkhYbJx23ffGj6npOv6XFrmhKtwZhUKO2afMaLr8+JDPZclN6ZP3yf7q/lyiE6L
ps0Hyl/zkT+QFl+aOn/pby3GIdahHLkuxqor2ze6PUU4MoJD/wA4R/8AOX2rflJ5
kj/Jr83Ll/qXIRJPIPs/FsKk50MMuzAxvZ/QXpeqWutWsWp6ZIsttMvJHXoQcm4p
TDFXYq7FXYqsYrsr0qTsDir+cj/n4V/zkj+ZOiebNR8kaZezaboiOFTiaiQEnuDi
r8i5JZL6T69rTl7iXcOa/FiqlShJA2HfFWbeQ/IHmL8yb9NH8p2b3LOQNg3c08MV
fsv/AM4u/wDPsUXNvF5q/M9ik6ujfUnrQivyxV+1HkP8tPL35b2MeleUrKO0hRAp
EY6074qz7FXYq7FWqAb9zireKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtVFad8VpxNNz0xWm8VdirsVdiq1k
DdcILCUAebYUDpjaRGkj8w+XLLzPaPpmrRiWBwQynocQ5ODOcZsPxn/5ys/5wmm0
55/OPkWM8kPIWyV+IU+WVZoXF7HsftcZJiNV5vzgsLzU/JV8tprsLQTAiqkHY5qZ
Y3vo4Tb6N0j84FhhSCU0UgZiTxudDRcXVKPNPn7TtRYwu4Zita5XwIyaIR6vIrS0
h1W9CQDZm64eGnXZMvh+b6d8s+Q7W3gR7gg8gK1yNtX8r36eHm8y/MyK30iQ21iB
8xhjFmcAG7BPKkiCdXu25LXcHLOFycGOn1HpmoaDa24kXik1Nl2+LJxg7HjoMN88
fmfp9jZvbIQkxFFUb1yYx7uDm1/AKef/AJSfkb5g/PXVF+tRPaWDSKfWoRtX5ZbH
FZ2dLm7U4ATIP3G/K3/nE/yV5Es7RorKOW6jQB5TuWYd+mbYYqfMtZrRKRodX09p
2lWulRiCxjWNB0AGSEQ6yUyeaY5KmLsVdiqz01G4GRMAU2uoMHhhba4itab4REMa
XZJLsVdirsVdirsVdirsVdirsVdirsVaPviRasb8x+UtK8225sddt1ngIoVYeOVS
wgm2ePKY7h8F/nN/z768o+embUNAZdLckklKjqfllM8ZD0Wh7bEKBi/Pjz//AM4K
ebvKlxJF5XV9StE+xICd/wAMqOMl6bH7SR5cLzbRPyn/ADE8szeneaNIAp67/wBM
plip2OPtaUxtF6RLpn5gGL6tp2jyNMRRaA9ch4NsjrpQ9dckqtP+cdPzQ8+zCHXb
KW1RjuTXJDTOPl9qiecX1D5G/wCfZMN5Et9r2qurnqm/X7ssjpSXU6j2rjH+G3uO
lf8APuXypaLwvLn1hXuD/TLRpT3uuye04l/AHsvlb/nCr8ufLoUyabFPIKfE3+1l
0MFc3Wanto5PpiA968u/ldoHlbiuiWywIpFFQeGTjiAcCWvmRT0QCgoOgy1wm8Vd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
Vdiryv8AOe8ay8p6hMgqfScf8KchJvwc34qf848Rela69Izeo0l+zcvDfpmHqeTv
+zeb33jvXMF3C7vXFDZ3xVrFVyDkwWla9sUhfby/WLj6pF8AWvLLgjU8nl/5Mpbj
87dNtpT6l0ZT6UndN+2ZUHk9Zzft8xR3ZYz8QPxZnRdLkG69UUnkRU+OSJXGEG6c
GJdq+AywHbZzo8ldDL6RaRanpx9soam4jHAqkpwZ2pT3OKvyN8pQ8f8AnMvzRt8T
WKfF7EdMVfrtJyRUjT2FcVVTsAldziqDCcGKrsT3y0cmzorCJU+I7t44LtxsiElj
Yqy+oVqeuVZA0Rfkr/zn/b/UfN2kXFhEELIvN1/jmJl2Ozt9Kd1kpDWNjNbfGTDH
y+7MKT1ujOyLuEVWHpGo4ivzysuZJQocWJcNuoxYU40JqNhixVDIpFOOKKYP+YFq
H0O51CQ8lhArH/NmTpnXdox2D6q/59/6nJf+XdRWQ1QS1Ufy79Mz8bzmeNbv0Jy1
x3Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq8H/wCcgfzk0/8AJvy1ca3fuFuGQiEVFSflleSV
BID8OvIWmav+eXm27/MbzA7/AFAOzorVoQDXNVnyVs344W+6dJsIoYpJEf07aMbD
t0zWZJ27jT4L6Pn7zz/zklpflCd9MhZZHU07YwiS7rBg8kb5F/5yz0a6P1S9iQu4
2Bp1y4QLk6rS+i6TvSvzW1Hzl5gbyhq0Aj0C8icCQ04gsKDfDVB04xS7nytbf84r
ea/Jfno6toambRprn1ywJI41rk/EBDWMBiXs3/OVGleRr/T7WbUZlttbgiUNEB3A
3xg5YA6vDfys/P8A0zy7C3lJTzRxwUkZMw6ux02eI2eQ/mb5fvU1WXzHawE2s25e
h2BNclGnLuJOzzzQfL1z5jvFtbJGl9Q8VLAjfISkzyYrfpH5Im86eQINH0bTtMSW
KtHowO2a7LDiddqI0+yp7S6EUesXFoqMwrKlcwvDNujzxYVrcb20i6vpA+H9tB75
mYpU4Ji+AP8AnLf8kYLi2T8xtBQLqUbLKyrWtRv2zZ4dWAaJYSg+2/8An3P/AM5O
SeeNPi/LjW3rfW6hFDUqKHN9HcOtlzfrfhQ7FWiabnpirA/M/wCZvlvyeK69fxQ+
3Na/rxV+QP8Azmr/AM/CdPtYJfJ/5S3ZbUotmljoSprSoIOKvw91jWvN/wCal2Lj
X7i51K+mP+7FY039sVSweV9QkvovLk0EjX9QqIEY0PTwxV+l3/ONv/PtPzP+Ys0G
t+fQ+naW1HB+IcgD4fLFX7w/lB/zjb5M/J6xistB0+A3UYobgr8Zp3xV9AgU2GKu
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KsB86/mPo3kNFk16YRc+lemAlhMnojdA896J5ktV
v9MvIZImpuHXv7VwojM9WXqwYBlIIO4pizXYq7FLsVdirsVdiqFvLWC7jMV4oaPu
Gxq9mUcpx+oGnyv+cH/OLXlH82rSWKG1itbwqaTKKNWm2Y0sFu20XtFk5cRL8N/z
/wD+ccPM35Gai8Jie404klZaMfhGYs8T3eh7ZgQPXb5rW6HLluzd6g7HwzGOIvUY
u0MUxzt6N5K1P6tcLIy7Ajrj4aZ5IS5PpC8/NK3s9PeDiA/DYjtg8JxJRiDdPkzz
H5mudblLRu71J7HxyXhssmuxHqhtO03V56NAkv0I39Msji8nGnrsfQvRNO8iebPM
S+npMczTJ0HFhl0cXk6nVdpR6SfZv/OPf/OCmvecLyPW/wAxw0Vuh5ANy33yyOLy
eX1vaRG/EbftF5G/LXRPIenx6To9siLGvHkBuctx4KNl5/NrsmTmS9AAAFBsBmQ4
beKuxV2KuxVDm5j9X6tzHqUrTJ8Bq14Tz6IjIK7FUvv9UtdMjaa9lSNV68mA/XgJ
ptx4ZTNRFvMr/wDPPyZpzNDc6nCrr25D+uQ8aLnx7D1Uh6YPO/MH/OV/kLQkZbnV
YxJQkUAP8cplnpytJ7N6o/3kafL/AJw/5+F+XdHLR6HMLplqBWmV+PbsP9Dsx0eB
6r/z8r8xGQnStKEqA7bDfAcobY9g5B/AlJ/5+d+bxKBPoSonc7Y+KGP8gZB/C9b8
m/8APyKHWJo7fX4FteR3IpthOZh/oemf4X6G/lb+ePlr8zoeOhXqTXEYq61AI2+e
X4svFs6rtDsbLp/VIbF7UGBoQdj0y901N4q7FXYq7FXYq0QGBVhUHqMVU1hRV9JV
ATwwUniPNLLrQNPvK/WLdGr4jK5YgXIhrMkeRKHg8raXbsHitowy9DTAMQDOWvyy
2MinItYl3CAZbwhxjkkeqsABsNhhYN4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXmX5wWhvPKmowqKn0X
p/wJyE23FKi/E7/nHo/VLXXrGfaX9IPQHwrmFqOTvOzJXKnv2YTvXYodirsVdzMY
5r1GLKPNah9KOS5h3lbr7ZKMmeeNh4Dr1zN+VXnvQvzOgBaOFg03tUjMzGXm9VhN
8n7neSPNNn5z0a08y6eyFbuISEKQaE9jmbAuiy4qLKnkEZFemWNQjS1kWUVHfDGT
aJ01FbtGvEuW375BC4ESPwkXddxir8mPKGnak3/OYfmfUZICtn9SQJJQ0NB49MVf
rUtZApYU2BxVZG3KRge2Ktq/NipHTDa2uIAx4mqUbQ1zPDaxPNclVRVLEtsNhlcp
Dqzhivo/Ez89/Pp/Nj8wf0HD8cVs5QN8vlmHMu40+E9z0nTrcaSiafLvSOgzAySe
k00aCFiqvIHfc4x5OQVXlhY21XFWsVp2K0xbz0f+dfvEPcZlaZ13aI2e/wD/AD7j
Mn6A1gS1oLj4flXM+DzWofpVljiuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Koe6uUs4XupdkjUs
fkMSr+fv/nM781Lr83vPMfkXT5Wawgm4sq7igb2zGzHZlEPoHyJ5Yh8uaNZ6PpCh
FQD1j0qCM0Wee7sMEXpGpaJDe6Xc2+nzgSlegb2zB4t3odHjt+On5peQLzTNdnur
4s68606nM3HJ3+DTPOVDQzLJACnDeoG+X3Qc3VaccHN9ZeXdR1fzl+Wt7NoAddWt
pgscgB5UB7ZSZUXRnT3HYvt3/nFPzD5h1LybJZebxI93EQpeWoNB165VOVHZxjj2
eW/m95A8kfmBrog1DUCmpFuJjB8clHMQ4sqt4Z+YX5R+TPyburLUJHMjvIp+yTlk
cpkmOTh6Ppjz7Lo195J0y+0azWUXBVD8NT0yIyHk7HBqSZAPlH8x/Nel+VdPh07T
LVbTUYzWqrQ1xiLd/qqiNmK/kr+bvmSPzhp1vrtzLLbXMtEVjUDLJYQQ83nmbfqB
53uPNMGu6bcaMEk0aUg3PNgKDMfwg6jUXbKb2GG8b1rNlMS/bCmo/DMPIacTheee
ZNJOpWVwXiWa3COpVvcZjHOQUxD8y/yb1mX8hPzshvIyY4LudfhHQcm9873F9APk
6SfMv6htHvDqFhbX5NfWhST/AIJQcmhHSypCpkmYKoFSSaDFXwr/AM5U/wDOXHl/
8q9FubLTLxX1IqwAjZSQQaeOKv5tPzE/PPz9+cWr3Bsrq89FnbiFUnate2Kvvb/n
F/8A59w6r+aNlbecvzC5w2d3uZSCJGFK9DTFX7G/lP8A84Zfl5+VED2lhYx3xcU9
S5Srio7b4qmXkv8A5xH8h+TNdvfNUWnw3c94/qfv05ema9F3xV9O21tFZxrbWqCO
JRRVUUAxVXxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxVbzUdSPvxVb6qDqw+/FVKS9t4hWSWNR7sBiqS
3Hm3SbX++uohT/ixf64qkd5+Zvl2y2lvoanoPUX+uSAtnCHE+b/+chbjyD+aXlu4
sNR1iO2uUjYoySLUEKad8aT4b+bnWvza87/k35puNO8t6zc3OmRTVjBcFSF3GQtg
Yvrr8tP+fo3mzTJYYPOCcbePipaqmoGRKOB+kH5V/wDPyLyX53eHTpZ2+tvxFKDq
cFt8cYL9GfK/mKHzRYR6tZgiKQAqfEHJg2wyQ4SyLC1uxVby7YaYmTga9saWMrU5
oFnXi3zriJUjJDjBieq2C2WAUXr44ZStqw6aOPkwjz9+Xul+f7F9M1q3jmVwVJcb
gEU2ymcLdnpNT4Urfnz5z/59z+WbieS40WaRfUJbjQ7E+GYc4GJp6DTe0Jj0Dw+6
/wCfcmpQTFrCZ+FdvtdMgAXPHtXIdAyDTP8An3ZLcuker3MixE0c/F0w0WUvayRF
U+hfKf8Az7s8j+XpFuJZpZyN6MDSv0nJQhKTqP8ARHMfwh9P+X/+cevJWgRiKLTI
JKd3WuZmOJjzcDU9rzy+TNLT8svLVi4ls9OgiI/kSmWOEdVIs3gt47VBDAoVB0Ax
ccyJ5q2KHYq7FXYq7FXYql72MBn+tMpL0+ivj88uGU8NMvzEgOFGqiruNsqJRxW8
Y/NT86tH/LLT5tUvpYz6Aqw5rX7q5jzzVydhpND4n1XT8Q/z8/5zA8y/mVdtaeTZ
HitHOxSg2pTMQ5SHsND2VDanyfP/AIluf9I1a+nEjb7b5jyzkPYaPQcI+pIb+y1F
lpdTyTA/tON8h4t83IzYDE1alofly2upgJ92r4YmTGGC+r3HTPIsjoi2UQYNQdMH
G5scDXmjyBPotuZ7yMDauPGxng2fPMml/WrhjAKFT4YeNwjis83r/wCUn5v67+T2
ri9sZH9F2/eAeGZGnlu6jtjAJxAlu/eH8i/+csPLn5g2MFpc3KJfUoysyjfbM+M3
z3X9niO8b+T7HtruK7QS27q6ncEEH9WWRlbpCKRGSQ7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FUi8y2Q1DTbm0YVDxuP+FOQyckg0/DCG0PlD8y7rypGCkdxI
8pBFB+OYWfk7jsmV5HtzijEDxPTMJ6UhbirsVdihsSLD+9k+yu5wFlHm1ZL9Q9bU
LneGbdBlcS35OTGvNPliPzHpVxZagAxuN4K9qZnYy6vUYtlH/nH38+NR/Im6PkTz
a7yRXDgW/Loq18TmbAujz4h1frx5S84WHm6xjv7WWNi4B4hgTl1usyQplhPHp0w2
48ilz2QuJfriyuAP2e2LaixcepT6uOVNiTiqQJ5R0WHVpPMsdvGuqSji8o+2R74q
ydZVYlF6jFVICnORe+KqcZIFfHIHZoMt1011FZxtc3TqiKCSWIHT54LbYC35zf8A
OS//ADlFbCyufIXlmT/cnM3FWjodqe2VzNuyw4Q+Uvyy8ofUa+adT+K9fclutcxM
pdzp8T1nmbhzdyfIZr8hdxiih2YW54P1O+TxnZM+bX1lMmxb+sKdhTFkGztikOxT
TzL81tR+paPJEDu9NvnmVpnV9p7AP0D/AOcM/J48seVFu1Ur9dUSmoI75nQeZz8n
2VlriuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KvD/8AnIXz1F5D8lanqkrcXaB0Q1pQkZXkOyQ/
n7/5x6s5PO/m698x3YMwaWQhm37k5p9XMgOw08bL7w/M3zGvk/RXmi+ElBuuacEk
vR6cRA5PztT/AJyQ80adqAFo3K0JO5YdK98zseMO3w5AOj1C0uIfNtrN+ZWtUaKw
BMidVPzyRFbOYMg5vGNI1zylrerPNqx9KzmkB+HtU9sgQWjJnBHN9Fa5+Zmnfkot
pY+WrT1bG64t8SbMD3yuMeIukz5SOT9BPy11uLzz5R/T1hbJavNHw4oKbttXCI04
AMj1fGPmD8ktO8mecR5l806k6vJJ6nDn0BOZceVOZgx1uX0Lr+g/lb+YENta3936
s0YWlSDuMjIUNm6cieY2em2Vh5a8v6M1locQu47FPVVHWo2HYZinm66eSjs+NvzO
/Iq8/PZR5m0W3W2mJNVK8RscujPhb8cpT6l4h+WH5OweUfN8MfnKYCWzkqgU1yZn
butLEXul356/85E6vceYLny1oU0sdtauFUq1NsHhuXlyRPQPbP8AnE/8ztQ8zR3O
japIZSzUqxqeuYubHW7q8xj3PsLV7eVZf0fa7KwPIHYZhyg8/qJdz8xv+ckdDtdB
876d5hsq845ogxI2qCM6bSSPCHW5gH7j6D+ddh5U/LGz85azNGxhtE+FXBPwjNlj
3DrpyIflH+cP/OeHnP8ANu6m8sfk5byGQs0TcBUU8dhgnyYxJvdS/JT/AJwG8zfn
JeDzT+b91cLFKebJJX9rfKbPRyY8n6Tfl9/zgX+Xv5f3Md7ZQLMyUJEiddvnmVA1
zQS+1dO0220m3j0/TYlht4xREQUAHsMBLFHYFdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdiqDgv4LiRreFwzp1AOKozFXYq7FXYq7FWGe
c/P+h+QLX9I+aLpLaGhILED9eKvmXUP+c4vy4hcxWV+kvHqea4qwDWf+fhHkjSwW
WZXUeDA4q8w1n/n5/wCVLEE2sZf5UOKvNdQ/5+x6SCY7Wzf5hAf4YqwXU/8An5/r
epMf0BZSNAehKb1+7FWA6j/znx+Zmq1/RVjNv0oh/pirCrz/AJyt/PfViRp1lccm
+z8B/piqXD81P+ck9d/dS2lwtf8AJbFVRfJ//OQvmY8pjdJX/WGKplbf84q/n35u
UytdXKFNtywxW0+t/wDn3B+bnmSJrjzBrFzbxorO1ZCK8RXxxTb8zfza8rXXlDzF
L5Sjka6uLVzC7faJIxQzX8qP+cXfOf5uXcdrpthJ6chWpeJgKHFX7V/841/8+09K
8lGHW/Og43ihX4ovcfTitv1m8vaDbeWrGLSNPBEMQAWvtiqd4q7FXYq7FXYq7FXY
q7FXY0rsaV2KoW7vYbFPWuWCr74s4QMjQYRffmZoWnnjPcoPGrDIm+jmw7Myz5Bi
t7/zkB5L0+v1rUIlI/yl/rkTIudj9nNRPkGF6n/zln5Cs9otQjc/6y5VKczybv8A
QjrDyAY0v/OZfknnwe7QD2dcjxyaj7KawdAz7Rv+cnfIutALb6gnM02JH9csjlPV
T7M6oDcB6jpP5g6FrO9leRNUV+2MtBddm7Oy4/qCfrruntuLmKn+uv8AXAZ04xwy
7km1Lz3oelCt3eRD/Zj+uVnUANsdJM7vMdf/AOckPJWhq4lv4zIvbkuRlmJ5OVh7
Jyz5DZ8U/mx/zndpulxywaDNyZuhDDKznIeq7O9nog3N+VH5j/m7rn5nX7XdxdTN
ak1ZC1VPzzBnK3tBixiIAiNk28oeVl1KMekgU+IGY8pFExHoKe8aR+XUEcPO7o23
7WVmTGMJd7BvOflbT7dGNVVhWgGSiWwRIG5eT6JbQwXXFKH4smxi+pvKM8NvCJZS
oCgHrkHJjIvOfzL81QairRI9QKila4Q15J+bxXSdLW+lPpKKk9slbTG2YS/lrd3a
+rFDyXuaZEypvx5YY98m7DdS0HU/KDjUtHuJYJE3pHtl2OZLTqMWPKLgA+6/+cX/
APnNO80qVPL/AJyuGaIHjzdhXqBmXjmQ8v2j2HLLyAD9pfLHm7T/ADVZw6jpsquk
y8loQc2EZbbvA6rSSwyILKcm4jsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirT
AMCp6HbFX5Of85p/lvceVtRj/M3SIiCjUZkHbauVZRs5GllU2A+VNcTW9Kh1yxIk
mVVDp1377ZrZRelxZk9nlN2V1NBSp4suYs4l2mKYKIl4lgY91pldFzNltd65KJcP
LAr2oQQRUZZbiQBErKkfiHBt1HQdsmCHaHNFdUmgY1A6e2WcTVOUSxnzP5RtfNFu
WeNfra/Ykp8Q+Ry6MnXZ8QPR575V1/zz+TV59c06aW4tlYEI5qKDfLeJ0Oo05fbP
5e/85xaPdItt+YoNnNstVA6/hjZdZPTyt9U+Xvzx8n+ZEWSwvYwGoQGYDY/TmQJi
l8IvSbDVtOvwJ7K4iYGlArr+rLQWuWMgvzz8qfnfq1//AM5J6/8Alpq9wqaLZ24a
GjjjXLBIMPDkX6LfXINmjmhAI68xkLCeEsX1v8w9A8ug/pS8hWnWjg/xyBkG6OI0
+dPPn/OZHkjyrCy6VcG4uh+yKUr+OVmYZxxPhX8xv+cjfPn5zV07yohtrQ7VX4du
mQMrdhgw+THfJf5cRaWRq/mpvX1ftz33ymc3c4MIHR6WzLFsPhX+UdMxJufGKGfV
FiHEUpmMQvJK7rWQzdjmbpyBFkClT6nzNAaYZELSsl3z+EmgPU5RIrwlPtOuZZq2
kI5Rj9o4IhCcwwxojiRjVRmSAviAc3gM9hc/mp5xsvI9hVkZwrU3Gx75mYBs8927
l4jHhfuf5I0EeWNCsdAChfqsIjNPbMh0NsqxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+aX/P
xzzkNK8nHR434vKpFK9anK8vJlB8L/8AOJHl9dJ8vDVHX97Mzb033zSat2OnFPpX
8wvKX+LfL8/rdI03zT8dF3unL8w7j8lNXvJLoaaysK/ux1PXNlim7CFvsXyf+Vdr
5C/LfUNJ8/SiKfUkqgJoemSmbLk8ZAp8+eXv+cZz52lju/JkgZIGUmu4+E5X4lGn
GnuNnvP5q6DqeratofkiO1hkkt4Y0cqgPTDCIG7gZTb7c8hTXHlf0fITQ8P9E9Wi
rT4gMnHGC1xgH5wf85F+WfO/nDWLjWbf1xHE7qqCvQe2ZUQA38JLBP8AnHry15p1
TzNDY6xHcrBzVSWU0yOQCmqUi/ZHUbTRPyk0uTU9Q+OeaACNW6FqdMw5RddOXqeQ
Dzw+p+W7zVfgtZ0RikcZ418NhkHYYeT8u9B863mufmRYWWr+sizzkMz1p18cyQNn
Y6fKbes/m5/zjhfr5im1TTDFNbXTBqx/ERt3xEnLzXb0X/nFbyrofle9voZp1/SK
OQE5b1r4ZDJG3V5p832brskHpS3+qSrDwqVJNKjMY4g6LUS3fmH/AM5WectM1y19
DS1P1uOQBX8SO9c22lNCnFy7h9O/84j/AJPeZPzu8qLa+brlzofFUpyqKZtsfJ1u
Qbv0H/Jj/nDryb+Tt42q6XbxzTtuTIgO+GQtjGJt9cQW8Vsojt0VEHZQAPwwCIDa
rYVdirsVdirsVdirsVdirsVdirsVdirsVdirBPOf5iaR5HRTrEn71xVY16nFXmPl
7/nInR9b1RdHkieFX+yzA4q9G1D8ztE07UItFnmHrSgEGtBQ4q1q35m6NptwunxT
LNcMKgIdhirBNZ/5yH8t6Jdfoa8f/T2HwIprUnpiqK8q/nro2sXy+XdULW+oE0HI
UVq9MVT3zv8Am9o3k1jaSMZ7ym0ab9cVSTyh+emj+YbqLSb+trdzmkStty+/FVbz
d+fflnyhqH6BvJed5WhVSOuKqHlH889J80350xaRdaEnFXa/+eekaffnQtLPr3a1
5U3FB16YqyXyP+aelefluF0vkDbKfVJPQjrirzvyl5t0i0F95ulvF+pQTPGQX/aB
6Yq3H/zkZpSv6txERa8qBx4eOKvUbz8y9DstAHnN7hTYEVB5Dc+GKvIn/wCcoPL8
9ul7pyl4+RDknYAYq988reZrPzbp0WtaWwaGQdjWhxVkWKvjv/nLX/nHa9/P3S4d
L026kt2jBB4NTx/rir89NH/59RXVpCRc6lI0p8X/ALcVemaH/wA+s9Gt7ctql5JJ
c12BNR+vFXpWhf8APs7yNbgHVCX8Rxr/ABxV6XYf8+8vypsgOVl6jDuVGKs30z/n
Cv8ALTSlEdtpycR0qgxVn2nf843+RtMoLfTYNvGMYqzzT/yx8saaB9X0y1qvQ+mM
VZEnlrSUNUsbcH2iX+mKopNIsY/7u2iHyQYqi47eKH+6RV+QAxV53+bi6hJ5Xvod
DLLdyJwUrsfiBGKvzM/Kf/n3Jpmp6xN55/Mhmkmnm9cKwqSa18cVfqD5R/LXy95I
hjtvL9lDD6SBAyoAdsVZ5irsVdirsVdirsVdirsVdirsVdirsVdirEfN3l99dtGi
gcrIBSg74Q5GDLwF8c+af+cdtS1+QlriVR24k48Lu8PaPC8M17/nBG71stIb65B/
1j/XInGS7PH2/wAPX7XlGqf8+8tRiJaK8uG69z/XIeEXNh7Sk8j9rxPzV/zhH5v0
NJJ7CSeTjUigJ6ZTOJi7XB2jHNylv73zTqvlTz95FuCssd2qoevEgbZVxlvJv+If
NMNN/PzzboJEMdzMko2IZ6ZA5Cv5XHPmyQf85Q+euFIrx6f8ZMrMyn+Q8EmN3v59
+ctUP+m3ctP9fImZUezOCXe8+1zzRrGttzku5eTdfjy2MzTOPYmLHtElIXtXEfK9
kZ29zXISk7DHoowHNNdJu0t42UD4O+Y0izmOEbPcvJ3m+CwjCr4ZTLdxTK2Z3/5l
TOpitifoOIi5OMvMNd1DUdXJnPPjvk6pcke5gttqE2nz/HWtcLSNno9p5h1KaIR2
xPEim2RbAWOajo+o3T1IY13whBgSnHl8yaHKrXYpv3wJiKfUXlvzvYmAWy8CXFDX
K5hwO1shjEcO7zv8y7zTLe3Zoipdh0rkoSdn2SBMDifHciuLk3NuTHvWq7dDXMmG
QufqtHA9X6Nf84p/85c3PlS4i0XzVKfqUPwAs3auZQyl887Y0cDYfqPD/wA5b+SL
mISRXaBiK7uMy4ZgebyMeypkoH/ob/yWsvoSXUY9+Yy6WSNbOTk7DyRjdFFH/nLz
yKDQ3if8GMq8Vwz2bPuPyT/Sv+cnvJeqmkV7GPm4weK0z0Ux0PyeuaP590LXIFvL
K+gKP0HqLXCMw6tBwyHQ/JkaalaSCsc8bD2YHLOIMDEjofkVX63D/OtPnhBYX+KW
pfW8renHIpbwByVMzAorAxdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirzn80fItp+YGhXGh6ggdWRu
NRXcjbITFhsxSo2/FC90/U/+cdfOMvlrWkc6bcuSlR8IB6ZiShbtMecgve4ZrV19
SBgY5k5KAe7Zizg7rBmKEit3tF9GTdq1zHMXaQna8GuRqmZFqgNdjgtpyYgASuKj
ETLgRzErSKZZGTkxNtR8vVUA0GXRmzOMFdqNq8lB8Dqex3y0ScXJpYlhevfl1oWt
pXUE9OQ9Ci98kJuLPQQYFdflTqmkuJNCvZAnVQHptkhldcdIFaEfmVpd3FFpF7IY
wy7Fz45fHK1nSh8q2Os+b9N/PDVbp5S2pvCA7Bt8n4rUNMLfWV9qf5q6o4W0vHSM
gdZCMgcrMaUIaHyR5u1ESP5l1CRj3/eVyk5S3R0oTDR/yq0PS5Pr2syNOx3IO4yq
WYso6YM+tzZW/wC68viOJB4/DgGUudiwAJffas0L/vm5OO4NRkDN2WPGAlM2uFxu
fxyB3bQEpl1EsTvlZDAoU3gI3O+TjKtliXR3NTtiZlujG04taykIdgdiciN2XA9C
gga2gSGwFWb7Ry6IcXKeFg/5l+b7fytYpZ2zc76cUIU71OZEIury6kh9Gf8AOF35
GXNtM/5leZkKzyHnb8l33Ncy8To9blMzu/TPLXCdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
8Q/+fpGsPbyWNjU0klC0+bZVl5M8fNQ/ICySHyxZRKKUoT92aHVF2WJ7f5mmY6Hq
dpZSJG7xUTkaZqCd7dnim+Evyw8hefoPMkWqXkscukq5LAb1Fe2bHHIU5WKZt6d/
zm9pms6xZaTeaGsi2ltGBLHHsTt4ZkY2zNkSv/nB7TvMckF19fV4tMJPMS/a3PbM
fLzahPZ9XeYF8t/lL5ij85ebp43jA+BC3xe2WQNtfEoX3/OSnlq51mDVtChaa4lK
xIUBIAbpXMiApsFU9kuNGnt9QHnHzXFCNFlgEhUqB1Fd8yPe2DIKqLxXzp+ffkvy
7EG8gWKzXyuQzQpWhHyyEotBs82fGSz/ADt8rafqer3UdtdRyBikjUIHXcHKJQap
YDdvI/O/kKb6zE2iajb/AFaAgzoHFGXwAzFiK5uyxackAh+ff5zea44Nfji8v6fK
s9q4pOkdFJ9jl8YszEgsm/JX84/M955qtfLupQzS2N2xE7SAtTttlnCxOU8mWa55
ah/Kbzpdec7OaS4iklLiGJqkV3oQMndur1Bos7Wfzn+dtb+XnZaMjfYf4WIyJoOp
ybliX5zflTpun+XWuLkFr2IEq3bYd8hhyeplkjUX2T/z6+/MJdS8q3XlK53uIZqq
R4CubrEXWT5v1fy5DsVdirsVdirsVaJC7k0GKoOTUrSL+9njX5sBiqEk8waXFtLe
W6/OVR/HFUDN500C3BafU7NQPGdP64qwnVvzy8l6QSJ9WtWp14yA4q851T/nL38u
9KqZdRjan8rjFWKaV/znT+Wmsa1Z+VLG853l7KIo6MKcj44q+zAQwDKag9DireKu
xV+SP51av5n8y/mjF5d01i0IkoAdxQHFWQebfL/m6LXNPtdKjSDgFEjFaVp1xVkv
/ORijyv5Wg8wWrNL5gRAG9M1oKb9MVUv+cZdLbzh5W1H8x9ZmZ57a3kYIxqQUQt/
DFWOf84seQrT87tXv/zU8wlpLKKeSGGEtuGQ0qcVZT/zmTPZfl5f+ULzy5xjujqK
LdhD8Xo1G5piqf6tKvnHXbvXfJ8TyCKFGVnFVJ470xV4Hp1xrfnDzvZ3D0jn0uQm
RY9qU8cVei/lT+WsX5wfmHq3mHW3c2+mTcXUn7R9sVZJ5j8v2Wj/AJiQ6J5cf0Im
JVuRoBiqXeYfy91b8utak87QOL6yJPqtH8QUHrirOPLPnDy55b8oX/mjy0TF9ado
5wxoeb7bffir470fTdU1XzVH+VUM0sVjfTi9ZmYgEMa0xV+lHnf8qfLegeRtRM0N
ZbXTpWEld/UVDSnzOKvzfbXb7VvyH8u2heVb/UNce0IYmoTnQV9sVfbOpfkd5c/L
n8tLqbUxzvYbT1Glr+2QNhirMP8AnEiCd/JcOqyOWtrhm9JSdwAcVfVGKuxV2Kux
V2KuxV2KuxV2KuxV2KuxVZJGsqmOQBlPUHpiq5VCgKooB0AxVvFXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYqsKk9DTDbAxJ6oKay9Uggj32wkuLk0sjyKoNPt6U
MSGvWqg5ScQLnQJjyJeeecvym0DzjbvbXtnCC4IJEYrvlZwdzl4dZKJ3Jfn5+Z//
AD7x0vWjJf6DxWZiSAAO/wBOVHEQ9Hpe2cUedvinzj/zgN530SRm0koYgTTYf1yq
UC7/AE/tHgj3vLrj/nFXz5a1jlgLEeCZUcZdvi9rdOByK2w/5xJ8933N4ozGV3+J
aV+WTAoOPLt3DllYeJ+b/JOs+SLs6b5kgkVgaciKA5WYlzsPaEJMa4saRxbRt1yi
QdjD18mb+XYY1YRyVytl+VIfRflbyZb3/GeSnH3wtEwIc3qU3kTTzATEoCgGu2RJ
ZYyJiw+YfPvl+DTLgvGBSp7YQ15IIjyjcJKUjHGgIrXwwpgH0npWl6VIommKUoK1
yDeIh45+a1nZ26GXTiKDwyQasgeD6PrV+rFLRiKV6nGQcfwpZNg3rc19crzumZvp
yLlY5eGN2EzyOy+n0yQRm1ImKCGdpYePElfddsujJ0+bQylyRz3lzbx8o7qUn+UO
a5kwKMWkOLnSpa22r6wKWy3jsT1Uk5ZTsDqY1VfYzKw/K7zTqKepAl4PmTkqLXLN
jPQfJFp5C88aK1YxefQTkqLjTyR6AfJP7Lzb+ZPltgkK3xiTcAM2TAcWUx3D5PbP
Kv8Azkv+Ythxtxb3pYd25HJBx8gEv4R8n0H5d/Oz83fMksVlaxyIkxpVgcsjI263
VaWIgTs+2/yi0P8AMKS5WfzLIDEDuK75c8iSAH2vCHVFEpq9N8iXXy57KuBDsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVfMn/ORn5DWX5s6TJcWsSjWYVJikIFdhtkTFshKn5NWmoar+WG
qN5Y89I5ZJCqSdFAGwzHnB2enzgPerfUE1RFuoGDowFGXcfLMScHe6fUBdU8uDKV
9z0zGMXYwyhzsIWAbfKyG6ZsIlTz36fPIU4EdOQpM29Bvkw3xxkKnDajbVyVtvJQ
FskJ9RWJb3OTEmuUwqNMz7TkcRkuNhxhQLxSIZ7djwXqCcqEt2Bwqdvrijhe2ynh
zC7/ADy4StqOEvhnTbu4h/PfWdU9M8HhG7DbLidnFGI8T7Eu/M854NsAQOmVGTkR
wlBSaizBnnc/H03ymU7bRhKTyaiVHGNqgeJyviT4KU3hguRV3ZX/AMk0w22CCChu
ZQptOQKHuTvlltgFIN71Q3p13G2KCpPOQaeOWNZKrByll9Hp/lHpmNlO7Allum6W
zuIyQa9+2MRbdGYDP7bRlgKLcD7R65lQgyllASLzd56svJEUkCMJJ2HwIp3r8syY
QdNqs4X/APOO35D67+cPmD/GHm+Nl0eJ+SpIOorXauXiDzmoy2X7O6TpVtolpFpe
nII7eFQqKOwzIiKcZMcKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+E3/P0+NzqGnOBsJx/x
LKs3Jsxc2S/kVKv+HLAdm4g/8DnOasuwgXq3nPyXJrtnPbWMlGlWmxzVCTm4yn/5
feWIvL+hGa+ljiOnqfUaSm+Z+DdzISpKvzI/MjytoGlprHmtY7yzZaqV3FMzBFtM
qYJ5X/MnSfPPl65i/J5EtrpnFABv1yiUaO7XOXp2YN+f3/OPeufmBZ2moatqAimS
AcyXoOQGSxZaLjgW8J/Kb8k/O3ly8W/s51u7OCRQCPi6HMsZAWwEh+wPlvRbn8w/
JMvl7zgpiuDCUDkUpUUyYnYpx5T4JW/LfzNpGlf84z3199cnS9MxkKivKlTjdu20
+MHcvkrXfzn13VJXn0ed4bWRiFVWKgb+AwEO3xaIHeikln+Y/mK2YtcXcjBd93bf
KeEOSdLXR9Dfk9+cWieY7ptF8+26Ba0WR16/TkTBp8MdQ+qfy78tWd1qF9faFbot
tCT6MnAbj2OAmnAzQrk861f8vNV8vfmTpb3KPcaXqJ9SckVVd+9cPibOkzxovs7U
rK1022aS7iWOFNo1RQtR9GU+I6+cd3zZ+d+nrqnlW7ngGwRyB9GV4Z+tOQel5b/z
6p1+WHzLf6NITxMjCn350uF1OTm/oCy9g7FXxN/zkJ/zm75U/wCce9SGieY4Hllr
8RU+9PDACpfHfmD/AJ+uaLLI/wDhyykMR+xWp/hhV5bqH/Pz/wA13QP6F09z4fCT
/DFXnuo/8/IPzquG46NpM0hPRVjJJ/DFUhl/5zk/5yL8wAwDRr6INt/dsMVSl/zN
/wCcjPNh5+jdxcvHkMVW/wCBP+ci/OB9U3dxEelOTDriqvH/AM4cf85A6+wku9Uu
EDb09Qjr9OKsv0z/AJ97/m5dhU1LVZTyNDWU/wBcVehaR/z7S8zhpItZvpXXjWvP
+3FXs35Yf8+yrTy5rGm+crq9Yz2kwl4lvDFX7AWdsLSCO2U1Eahan2FMVROKuxV8
Q/mv+UGv2HmVfPnk4h5S1fs1IOKoLS/Jf5j+b9VjudclSGJUrUrTFWZaP+RWqajq
k7+b5lnsWiaMA7ip2qBirxLWfJWt/wDOOdhqFnYXSHTdW9WFANgPU26fTirzf8k/
y7/ND8obWS58vyhrK9laZVpVavv0xV7Npv8Azj15g/NLUL/zD+Z83+kyRUt6j4Ub
sQO2KpJ5f8ifmj+Xd1J5e050ks4ieEnGvIdt8VUPIX5Fef8Ay9r2p+cNRkVv0qfs
0+zXFX1N+SP5Yah5BGqXmpOvr6g/MGnfxOKvMvMv/OP/AJg8wa5P5jju0SUMeB6Y
q83uvIf5p+XLG88pWswnsr16lnHKlffFV83/ADi35kg8ktoj3avey3KXDovYVqcV
Zf50/IDWmgsPNflyRY9Xs4I0IAo3wjFUk1Dy3+b3nq3g0TVZwlkXCTClOSd6/Riq
f6z/AM41ahLNpejWckY0uylW4VQBTmNyfvxV75+cfkq883+UJfLdixMpiCNTvRaH
FUw/JLye/kXyfp/lyYUkhUlh7k4q9XxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxVoEHpireKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KoOfT7e42
ljU/QMiYAsxMjklzeWtNbdreM/7Ef0yPhBn+ZmOqjN5W02cIvoIoQ9lG+A4h0ZQ1
cx1fGf8Azlz/AM44Wnn7y/JqPl+3RL23Xl8KrU0rlGXFTv8Asrted8BL+erVNMv9
DvrjR9THpy2zcaHr1zCyQfQ+z9UTzIZXpryRxxyoCT7ZQYvQiQIep2/n2XQoo/Vq
Btgp0+ukQNmWzfm8kqokDfCV33PXIkMNFk9O7yXzj5m/SoLr3riG+Zt59p+uXFk3
KIkAb5IhqBZR/wArE1GRAsLMKbdTgpl4irJrt1qkIW5JavicDK7Zl5Q8rSamG9JD
X5YlIkYcnoGp+RU0+yaa8WhptXKy1ynIvlXUIBFfsP8Addcmy0+ISO6jKRE3py9H
Pw/TlmMOylhxgbvrH/nHb/nFnUfzMvotRuEY2RIJqARSuZ+KFvL9raoYBxRIftL5
A/5xS8peVraL1rON51UV5IvX8cyDiPR4LVe0moJqBD1+3/J/yxbDjHZRD5Iv9Mtj
Ejq4Eu2dRLnJfJ+UXliT7dlEf9gv9MJie9I7Zzj+JRb8mvKbji+nwkf6i/0wcJ72
Q7c1A6qUf5KeUYm5pp0IP+ov9MeA97I9u6g9WS2P5f6Fp5V7WziVl6EIP6ZYCQ42
TtLLPmWXRwxw7RKF+QphtwSSVXAh2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVoiux6Yq+a/zt/5
x10b80LGVoYki1Eg0kAHfImNtsMpD8qPMOhecfyC1F9F1q1mufL8bkxyKNhvTc5T
PGHZ4dQR1epaB5vsfOFot1FcxSim0EZq6n3zEnjdpi1RPVPUKfaniYKPsgjp88xp
Qc/FqLNErXmRzQbVyHA7A0GyqwjmNzg4WJkEI92ZjXpTC0ymg5binfA0SkUue8IP
GuxxDUSbSu8u3huBBAfhI3pkHPQc+pTQcbaAVCnll8AxLGrnQ7KW/PmgqovZRxfb
fLGvhCtcXQkkVAemQISAEJd3beosIyimYUHl3K13GEQZ0hmUvuDh4UFRa1YfGDkm
PEthsTXmckAwMkfFpzzOKA5JgznSvLy3CLHdoTHXoOuUTjZaZyos5t7PT9JURXcT
cf2ZOy+5yzHja5ZqeWeefzVt/K8g0e2H6Yubk8LZbQ8jG/YtTM7HjcTNrCOr1H8j
/wDnFbWPzCv4/N/nvlGitzMcncHcbHMqMHUajUF+t3l/y/Z+WrKLStLiWOKNQPhU
Cv3ZYBTribTvCh2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+Ov/Pzry79asbfVEFTEeX3H
KNRybMfN5R/zjJqy6v5Zt1c0MZP4DOb1bmwL640ZHuJVVG2zVubjL5j/ADa/PDS9
Vub38ndOha31O7IjM1SAxr2zZ6aG1uXGXRAa15f8q+Y/LNp+VNxfxSa76fp05fEG
zNujbfsRSJ/5xk/5xd8zflLq8mq3V+G07lUW53LCtdso1EwQxlDhi+jP+cgbqS68
sT29pGyXjTBVbpQHMPEd3GsUzT8nfLlx+Xf5etc6in1i/kAmRONWPfMjitqnOtmb
+S/zks9W0K8Hm+P9GTgPHGJRxJ8Mv4mm7Oz8Nf8AnJSDULrzZcXk85m0tncq1TSh
OXQOz1XZmIyp4tF6bfu7Yj0hgJfQ9No5GApSCP6vKU/uR38cWnLpiENeSvfXEa24
MMaH7Y2BxdLqsRfen5T/AJma3d+RtXtfKqtJf6clI+NSXPtmPkq3SagGiyT/AJx4
/Nfzl5z1SPy958sJUlY/DNIv2KHxOU5aHJ0GQk7F9s69PLNdLBq/xwQgoqjv75i8
ThTju8N/MyRLTRLy1YfBIkhUe1MOnPrYZRs8n/59o6AIfOV7ex7D1Wb8TnVaY26f
K/e7Mtqdir5Y/OX/AJxI8j/nXd/pXzbamW4JqSCPGuQ4aUvNNI/597fldptB9Qqq
9AaHJBXp2m/84fflvpVPqumJt4qv9MKvS9I/JDyZojpNYaXAsidG4Kf4YqzNfJ2j
qeQs4K/8Yk/5pxVFJ5a0uPZbSH/kWv8ATFURFotjA3qRW8Sn2Rf6YqmIjUbBR92K
t8FrWgr8sVXe+KuxV2KuxV2KuxV2KuxV5v8AmZ+XNn+ZWnR6TqJ4+jKsqN7jFWYa
JpCaPYQaUKOsCBQaeGKpxirVAeuKt4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYqk2reYtM0JfU1i6itlArWRgNsVeTeYf+cjvy78
uxGW68wWJcGnESVOKvkD8wv+fmnkLyZctaWMZv1X9qMk139sVfIXmz/n6tqfnLUR
ov5aWb20znigIbc1xV+t3/OPWu+YfNHlu18wecOX1y4i5SA1+1tT+OKvoDFXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqoXNul1E1vKAVYUIIrgItlCXCbf
h/8A85v/APOLN3p+oHzz5cWlux5zhQAO53pmBkFPadla0SrvfBH5eyxT3w0+9AIB
pT6cw5PoWhz8W1PffNHkfTdXsy1sAGVTlJk5mp03GNnyzcWI0+7ayRq0anXF1kcf
Bsz/AEfyi2rqAorXA3iFs1h/KF3WoTqPbBbPwkh1n8vk0O3MhXcY2g46DzeK4jt5
Qkn2QcLVdPqbyDr2nafbLOACRu2IFpzQ4gKYh+a35lQ36fVbAgDptjwohiID5Tu7
oTVd2AY4QGU8vhjcPcPyZ/IvzB+a+q23pwv9UVl+PtQNmTidFre2oxHqBf0afkp+
VNr+WOiW+mxKvrCMBqKK1+ebXGNnzvtPtDx5bcntOWOoAbxS7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYqxjzV5P0vznZPo+vwLNbSAhgQOh+YwEWyjKn5l/
m3/zgpqHl65n83/kfffo+RayNbsa8t+gzHnByMeZ8wWn5ta/5Kuf0H+ZmlzROh4y
3UgIQgbVzFnBztPn9QeyaH5x8v8AmoV0SZJa9OBrlDvTqgmt3ZzxdAeOKjLaWSQP
4UyNNoKAmt5DjTbHGSlrWchNd64DFuGAqUWm3DXJqCTxwCDWTSjY6feidnaMkMeI
2y4C2syfL1h5x1O4/M/UvId3VYbaPmqmuW8LjDJ6qfRy+Wp6JcMDvlZDkQkqt5Zk
aRZSMqlFsBRLeUGkcu3fLYx2bbRcflId8BixJRi+VkXrTINZRqeWYBStMiSik8Gl
WWlwfWJlGw60yPEtMF1z80dA8s27XEdxFJfLUC0B+M09suxi3B1MqLBfL8X5jf8A
ORF4NE8rafcaLpTni08ykKynwOZuPG6rPmfpB+RH/OGXlv8AK1E1TW0W/wBZNGeZ
/iHIjegI8cyoxp1c8t8n2lBbRWq+nboqKKCigDp8sk0K+KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV8S/850+Rk81fl9d3FvDyuoUY8h1ptlWYWEg0/IP/AJw68wyab9b0
TVX5iNnCoe2arU4Yno5eCVv0R0a6aWVJ7Y8I1NWXNFmhR2dvhAfmZ/zlNoOoeTPN
0HnmBWHquGjl7JU5fp8vRyxAAvSdK8s6R5D0q1/PDXD9Z1SRPWReX2id9hmdinZo
u90umx1xSDyW9/5yu886nqo1uxumhtAapBQ7L4Zk5MUac/LpcUo7B9Tfll/zklbf
mRps/lHX0EmsOrPG5G4YdOuYZwgOmnowOjwKL/nJf8w/JfnSLQvME7yWP1hYooyD
ThWg9sn4Yp1GWABoh9xfn9+WvmX849BtNQ8uTNYM8CyFhtuR7ZXGQDIYYF4Pon5X
N5D8oXN5+aMB1r0kYqfcZPjs7O0wZDiHpL4Y0C3g/MnVbuHy7anTrWFmoh70OWS2
DlYO2NRxACWzpPy/1jULmXT9PRpRBvxXvlMch6u8nrpH+JdN+XXnaREt30K4W37P
TY5kwI6uJl1JlsS+3/ya0tP+cb/Kt/5s85f3l4peG3ehO/bI5Ixk6/LMRHNl35H/
APOSOm/mrq7w2Ok/VGDH97xp3zA1OLhGzo8uTifTOt3QuL0K7hgO+ajJKXR1uQl8
wf8AOQevCDSJLpHEdCYgnjUUzd6bCKBrdxJ5C+if+fcv5Xz6Lo8/nC/iKyTtVSe4
aubvBduHN+peZzS7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXjv5w/lRbfmhpEulPL9WnZGAlBIpXFX80H/OX3/ONA/Jq+l1G58w/XVkkakQ
kO1W9jir4Nli9JRcpKWBPQsTir9ZP+fdn/OLLeb9ci8/67GXsUbnGrdOg8Rir+ka
zs4bCFbSzRY4kFFVRQYqicVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVSPzB5c0/zRZyaTrcKz20o4srDqMhOAk3Yc8sZuJfmH+ef/OCEMjTa9+WrfVJ
d2Ea03oPlmHPDT0/Z3bmS6MqfmV508ifml+XcslvrFlcC1BIMxBoRTrlJxDue10X
anGN5W8NN5wued29Ziat12OYuaBB2cw6iF830d+XHmG1g4euRTbKDGTdHVQ73v0/
nnTLeHZ1Wg32yccZtmdbDvfOn5h+f7a/DW2nSLITUUGWxxHucTJrY9C8g07yH5q8
0P6uj2Es4J245eMXk4p1Hm9AsPyZ/Ncj0LHQrsR96VyQw+TjZu0YgfU9N8p/84Z+
fPPUqxalFLpxY7s+IxjucDL2mQNpvvT8qv8An27pugcLnztdDUVO5Xbx+WXjTDm8
7qfaHLdCT9GvJX5XeXPIFvHZeWrKOBUFAQBXL4aeIdJn7QyZdpF6Fl7hOxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVoiuxxpXnHnn8pPKv5jwPZe
btPjuo3FDUAH78gcYZxyEcnwP5+/59+vA0l7+UerfoZU3SHc179aZI4YHo5EdVLv
fK2p6L+bv5UzNa65pNzrdvGaeuoJFPHK5YI9zkx1Uh1Q+nfnxaRkwedbQ6PcE/Ck
wNTlEsURyczFqz3vQNK/MTyzrIH1HUIpXP7IzGnBzYavzZfD6N5SSMgL1B8crMXK
jqz3o94vU/0mP92QKE+IyvhknxR3qmmEXVykEU6rxYGnvXEcQR4g73wdZoJf+cht
bjnHxCAfF45ceLhccTjxvuVp2TjCsJdABTKak3+JFEqHnVwsJUgbY8MmXjDvQ0QC
/akDP3XJWQy8cd6Hv7+KxX1blfTQdScsiLaZ6jzYLqH5teULJWt7vUoY5x2Pjlsc
duHPVEdWBv8AnZfX8hsPKmgS6orfCs8QNN+hzJjhiebiT1sh1ZT5a/5x9/Nn817h
b6WeXSNPcg+k+1ActjpodzjHXZO99u/lr/zgx5T0RY9T88wDUdbQqTcluv0Uw+DE
cnFyaucjzfbeiaDY+XbVNM0mFYreMAKqgDp8skIgNE8hlzTjCwdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirFfO2gp5m0O+0OVQ4uIWQD3IyExsr+ZfXrC8/IH815tL
1VSllNcN16ULHMDLGw34C/SrT9Sju0t9S0xuVtOB0+WaPPDd3OKSbea9I0PWNJub
TzPYrqRdf3Ib9imYURR2c3HO3wB+dGv3HnbSP0TpGnmwsdCHpcADRwM2OGVF3GDL
Y5Pj6S8kKxC2gIRRR38MzuO3c6TJxmgn3lV7tNdtJvLSlLwyJyZa/ZrvkC2a7ARy
frbqI/KuI6Ze+czA+qrboWZuNRJ/t5jG+jyWuAB3ei/8rlt9Oht7OwcT2JdURQAQ
E7ZCnB4qeH/85J6T5z8/TWun/l5E50uQqZkTpxbrlkKHNzBLuVNP8m+S/K/lt/Ka
xx2vmuSPizbcuZG/44kkuXGgHxlon5feffKvnK3ETyTWTT1mk7cCf6ZKxTUNUb5P
s/8AP+x88X9tocX5c85IUK/WjGBsPemVRyjq3ZNYTyDwX8/vyf8APXnfTNHtjPJM
wUB49xT7sMNQO5xM+Uyeuf8AOP35FT/lXpTajrcfpzkV3OU5cnG4sjQe2atq9vPb
STAeiygnn8hlI019XGlu+M5NK1T/AJyM892nlXy2rNp1vInrFa0PE75vcWHhi6vJ
Ld+/HkHyna+S9CstAsECLBCitTuwG5zZYYUHEmbLMsuYuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpRreu2Pl20k1TWJ1gtolLMzmgoMVfjh/z
lp/z8fg0iWXyF+VB9e+kLRetGCTXp2OKvk/8q/8AnD38xf8AnJdrvz3+Z93LDpPA
zxiQkAk/FTfFXzB5c/5x3n8xfmvL+WunKZLK0kIdxWlAaeGKv6kPyP8Ayt038rPK
1h5e0uJVaKIcnAFSSBir2XFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FVkieoONaVyJFpiaYl5n8kaX5vh+p67EJ4SKFWA3/DHhDlYdZLGKi+Yv
Nv8Azhj5C1eQtp2lxxM4NXHY/dlObDxHZ2+j7a4R6xbwnVP+fcVleSmbTdYNopNQ
gB2/DKhpPNul7QD+atg/59zxQlfrGttOtfiBB3H3ZYNPXVA7diecXt3lL/nB/wAi
+Xyr39pHdOKVLeP3ZZDEBzaM3bfEKAp73o/5N+X/AC6Amg2cVuAKAr/tZkenucP+
U597MdL8vyWMpZpqx91AG/4ZGW7Tm1fGOTIhZwg8ggrlfhhxTlkeqJybW7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqoXNtHeRtb
3Cho2FCDikGnjPmn/nHX8vfOkouvMmiW9zMooHYbj7siYsxkIfN3nn/nAjyrrvNv
JrDRJP2Wiqe3yyk4S3jU+Twa9/59w+ckJl07z/PxXdYyrAbdumDwWcdWwrU/+cWv
zU8syBba+m1KNNqAn4qf1y38u2/nPJjtx+WH5uWt5H9S0GcgMtXFd98fy6fznk+M
4ND/ADCH54arZaXo0t3rKRAzQitVGPgMfzW90+x30D85HKoPLNxFsN98fy7L855I
y0/Kn849Z5lrOe2J7b4/l1Os8mQ2P/OH35leaAqy6tLpszfack7Ziyw7r+bZ9o3/
AD7n82JIsvmHz5PdRftRFWp8umWjC0nWPo7yv/zgv+XumBG8x2MepTLuZHJ3OSGI
tctRfR9I+WPyi8peTkWHy7pcFsi0oFHhloi0GZL0WOJIVCRgKo7DJMCVTFXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX5M/8/JPyCbzLoq/mB5dt+d/bkvK
VrXY1rtmPki243xv/wA4x/mmup6dH5c1WWl1bkqVbYim3fNTqcPk7DHPZ9v2lzBL
HJDM3wt0bwzVTxkORHLXVKfM/l/R9J8uXt49okkcg+Nv5qjrkIk27bTZx3viWx/I
Hyvrdhd+d5tba10uOQetHuArHtmXDKbp22n1EYeoyp7J/wAqItLXy5+nfJ6CS5Mf
7iYdWBGxyw5HKza+ExtK3xre/kH+Y2rSzPrULuTIWjck7DtlnGHTTxHJ5vor8ktO
m/Kcvc/mfL6oRP3cMhruOnXK5b8m/FoSBuH0H5d/NzW9dNxrXk63JjVSFhWlDTpk
SETxmIunzDr3msX/AJqtNU89g6ZfT3HAbHxyQHc6yeb1U9v/ADv/AD60n8vNGGla
Gq3d9NGqtNtyWo65LgtvyAgME/5w8/MLzPrl9qX6YuJJbOevpBugzD1Qrk0RJfft
xJHBE88kvOSLt4ZgxJJapzp53c3N1rAe/u7k/VYakoTQbZsMOMuHky+b5J8/eftR
/NDUR+Xv5c2ha79RY2ZAehNCajNvhweTjSzeb9SP+cX/APnHCy/JrSIr66UNrNyg
eZj1Vj1G+bKEKcCcrfW+XNbsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVcTTc4q+bvzt/5yW8p/kxbSnzFepFOI2K0IJ5AVA64q/Cb80P+cifzR/5y
/wBZk8r/AJbpPFpTTGIMikAo21dsVfoL/wA4pf8APufRPI8MHm/8zlGoaxJxkMct
TRqb1rir9Rx5etLbTG0DS0W2tjH6arGKAClMVfOf5X/843aV+X3m7UvOQhSaW8Bp
K3WpxV9UgBQFUUA6DFW8VdirsVQlrfQXvP6q6v6bcWoa0OKovFXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
X51+VPyS836P/wA5I6/+a5hZPL1/bBI5+xPh0ploIYmRfomBQAE1PjlTJvFXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUp1zRLTzFYza
PqsYktp14up8MEhaQafz1f8AOW3/ADjNr35Cea2/MnyJC50VpPUZUDEULb5i5MV7
OSJ9Xo35J/nhZ+dLNbZgv1yYUdHoOJG2avNp2XivpWGOytYntNUnMyy/7pO65rp4
3OwZ0q1TyFpHmHy/deUooUtYbuRXIXYGmVg0bc3UaisfJE+eLnUPy58mR6Z5ai9d
7eLgtN+gyUZ2XA0+sJ6PA/yh/MjzR5ps76XzLA8XpK5UkEdBmQaHJ6bs/MS/Pv8A
NHzVq/mbW7mW8uZeEcroENaUBzIiad0ST1fV3/OM35mR+U7Rba75NyoNx7ZVkcHV
ToPsy+/Lfy9+bMdt5huIEMsLiQEjcHrmMMhBeYnK8o9744/PD/nGzVfNOvC50qv1
OoG1aUBzKjm2d3mx2+nPyg/Lhfy40tI0UetT4j9GYs48bhZTws61zzRY2CG4vJgp
/aWo3w49MHV58r59vL/zP+eOpL5N8hQPBblgryopAIrQ7jNrgwAOtyZX6U/848/8
406R+UVil3fQpNrbAF5zuwNa9c2ePHTjmb6sy9g7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FUp1nW7PQbaS/1OVIo41LHkwGw+eKvya/5yd/5+K2f
liO48o+QU9fUHJjDx0Ygke1e+Kvg/wDK7/nGn8yP+cu9VXzJ5/lnXSnlWSkoYDjX
cYq/dr8lP+cZfKn5LW1umgWyi5jiVWenVh3xV9I4q7FXYq7FXYqk+s69YeX4GvdW
nSGJQTV2A/Xir8pf+coP+fiukeT7a68peUmV9Rc8I5lYEio7b4q9M/59tfmB5g/M
jyjqnmHzY0jO938BfuCTir9JsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVYn5y8l6X5606XQvMMKzW0
ooQwrTGkg0/C7/nIr/nC/wAz/kzqdx56/KhWlsWbmY0BPEVJOwzGywQZMM/K7/nJ
KEFNG88RvFqafDSVeO9ffNXmwt+Kb7GsfMtlr0CXcU6qf2QjD+Ga/Jjp2mAHJ6Ru
ycatJNJHZMi3EBG/M1ymnJlpJQ5hFXCWVvXTrK1iiSVSHKDx642yx5xj5l83eZf+
caNB1fVG1aN6RvVmABpU9cuGZzY66J6l6N5d/JTyvoNgGShkHiMjLInJqIyHN6hp
csei6cLTTNlb4RTKpHq6qY9VqJ1YW0Riu3Xl4lsqhlBLKeuj3vK9b8+6hBIdO0uI
y89gVFf1ZtdPC3ByasHqm3kv/nHTzB+bFyNR1pnt7RDVgaiu+bfHh8nCllvq/S38
uvys0P8ALmxisdHto1nVaNLx+In55lRhTTb0vJq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXg35z/n75d/KDTJb/AFS6iN0q1WPmta/KuKvwv/Ob
/nLbz/8A85Qauvlr8soZobKNhHI0S7Gvw9sVfVn/ADi1/wA+8DaXEXnb83V9e6ek
gjkBJO9e+Kv2B0Dy5pvli1TTNCt47a3QABUFMVTzFXYq7FXYq7FXyt+ff/OU/l78
k7V2uiZrxP8AddPnir+fr/nJT/nOvzX+bd09vocstpZ1oAhAFN8VfAd8L/zFdQve
O0968sdCdzuwGKv7Cf8AnEHyNaeSfy10aGxjEbXNsksoApVj44q+ocVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdiqGurOC+jNveRrLG3VXAIP34CL5oIfCf54/84JeTvzOMur6fGLK/PxD
0V47/QcoOmBZRNPzf8xf846/mf8AkxO9x5ZWW70+E0AcFjTrmPn0ceG3K0+rlilY
Q+g/nJ5u0KUL5wsJY1HUrGc135WJdhk7WyT5vRtP/wCcjNBglrJFdNK2xqh2rkfy
QcOWoMubL7T87NEZfThjuSH33Q98j+SCBmITNPzIsr+L6vZxTmvSqHD+UDYNXJEw
ah5r1ER2uh2btGT8JZDiNHEmkS1Uqei6J+QfmTznOreaPUgU9fTqMzY9iYouBxPr
7yD/AM45eXvJvGeVTczjf95vvmVDQxjyYnd9AW1nBZr6dpGsa+CimZgFIAROFLsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqCvdRtdNja4vpkijUVJdg
Kffir8wP+cpP+fhWkflqsvlnyUy3WqsOAMZDb1I2xV+a3kb8n/zN/wCct/MC+YPN
j3cemSvy4sDxpX+3FX7gfkP/AM4l+UvybsEjtrWOS8YfG5WhrWuKvrKONYlEcYoq
igAxVfirsVdirsVdirsVfKH5zf8AONnk7z7Fea75zkIjC8gTQAU8cVfzdfnJ5D0v
W/OUvkX8q4TPHFIUZo1r0r4YqwX8j/y2urr82NN8hanExIlUSKymtQw7Yq/r7/L/
AEIeW9AstGXYQRhQPAYqzPFXYq4mm5xV88fmL/zlB5C/K67Ol+bL8QzjqNv64qzz
8t/zb8tfmtaNqXk27FzEtC3Soriqv+Yf5p+XfyutE1PzjdLbQuaKT3xV57+XP/OU
P5f/AJpX50XynqSzXQNApoKn78VfQ2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV53+Yv
5p+XfyssRrHnG6FtbE0BNMVR/kT8wNG/MfTV8weVZvXsmNA/jirNcVdirsVdirsV
dirsVdirsVYv5v8AOOl+RtNl8weYphBaRAkscVYX+Wf52eV/zYiafynciXgxUjbt
8sVeuYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYCq0sQCQOmQzSMY2BZWO7lPIVODDMyjZFJK7LUOxV2KtV3pii28U
uxV2KuxV2KuxV2KuxV2KuxV2KuOCRobKtBJNCMpx5JE0RSSF2XodirsVdkQbV2SV
2KuxV2KuxV2KuxV2KtHbpkZkgbK3hCuwq7FXYq7FXYq7FXYq7FXYqsQsR8YofbIQ
JPNJrovyaHYq7FXYq1XADupdU7bZGUiDso3byauxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVDzWkFwCs8SOD1DKD+vARa
vPdd/Kbyz5hJa/sIDXwjXKjhZcTzyf8A5xc8jSyeutjGrf8AGMYnEkSTKD/nHHyb
DT/Q4yR34AY+EpmnNv8AkZ5VtWDw2iAj/JGPgrxvQ9L8saZpEYhs7aJQO/AZIYgE
GVp4sSJ9hQPkMsYr8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
diryX82Pzo8s/k9pMuvebLyKJUBIjLryNPbrir8IPzx/5zN86fn/AKxJ5S/KBJxY
3TmLnGTQCvXb2xV75/zjJ/z73bUbmPzN+b5kubhTzpIOVSaHvir9mfLXlHSfKNnF
pWgWsVvBEKLwQA/eMVZJirsVdirsVdirsVdirRIUVY0GKvx9/wCfg3/OUknl61fy
F5NuA1/LRCsT/FUkjpiqX/8APub/AJxeNpbTfmn+YlsZdQu6vEJk/m+eKvT2/wCc
RY/LX552P5n2ECi0lkMjhUFBvXFX6iAU2GKuxV2KtGgBLdO+Kv5aP+fn7XcnnyVL
GWT0+R+FWI74q9w/59Mfm5c6d5gufI2tzMUkXgvNu9NsVZN/z9l/NubUb+18h6HM
weDiG4N44q+TP+fZ9vOfzIjh1aaYIZBUcj1xV/Qh+e3/ADld5P8AyGjS11qX171x
RIkap+nFXzf5N/5+UeT9X1WHSfMEMlpDcEBJGFKVNBir7g86/nF5d8keU2/MrULh
ZNHCB1dGHxAiuKvhDWv+fmXlYzLL5csLi409WAklClgPHelMVfX35K/85MeTvzxt
3m8q3PGeJOcsUhAK+P3Yq8N/Of8A5z98kflZfv5etVkvr6Nirel8QFD7YqjfyX/5
zx8kfmpfR+XpWey1CVgqib4ak/PFXrX58f8AOS/lv8h7aK88yNVZaEEH4aHwOKvl
XzB/z838k6ZYw6tZ20ksEn2mFSMVfTv/ADjf/wA5SeWv+ckbK4vvKp4yWx+NCcVY
Z+ev/OcXkH8kZpdFv5jeauh4+hDuQfemKvN/y5/5+Qfl/wCa5I7DX1m066mcLGJB
QHkaDrTFXiH/AD9i1JLv8urPVNNnYwzcZEaJtip37Yq8h/5xK/5zc8v/AJO/lRBp
F7FJcXkZU8ia9t8VffX5T/8AOeHkv8ytPmniLLfQIXeMeAGKs1/Jv/nL/wAo/m/r
U/k7SWK6nASCvWtPbFVb87P+cuvKf5L6naeWdWYyaldSBBH0pU4qwLzt/wA55+S/
IK28uvhkE9PhrQ74q8q83f8APzbyZozWtzYQSGylI5O3h86Yqz7zB/z8R/L7TtAi
8w6YzXE8qBvTU144qy78hP8AnOHyP+eN5H5d06Q2+quP7tyACcVeh/nj/wA5SeTf
yJVYPNE/O9kUskKEVO2KvkXSP+fmnl2aWurWMkFs8gVJHBUUJ8aYqzP/AJy6/MDS
/wA1PyNu/M/lG5+CRSwCtuNsVfMH/PpS4e9068+tyM8iSSU5GvQHFX7dYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUs1DW9P
0kquqXcFsX+z60ipX5ciMVXafq9hq6mTSrqC5RTQmGRXAPvxJxVQv/MOl6U4h1O9
treQ9FmmRCfoYjFUba31tqEfrWE0c0Z/ajcMPvFcVRQFABireKuxV2KrJJEhUyys
FRRUsxoAPc4ql+n61p+rcxpd1BcmM0f0ZFfiffiTTFUzxV2KuxV2KuxV2KuxV2Ku
xV2KuxVLbvVrPTgX1G4ihWtPjcL+vFUZBcRXKiW3dZEO4ZSCPwxVWxV2KuxV2Kux
V2KuxV2KuxVTllSBDLMwRFFSzGgA9ycVQtjqdnqamTTp4p1U0JjcMAfoxVHYq4b7
4q7FXYq7FXYq7FXYq7FXYq7FXYq7FWiwXdtsVbxV2KuxVqvbFW8VdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVULi5itEM
9y6xxr1ZjQDFX5z/APOWH/OfXlr8lop/LPlmeO918oeJicMqnw2rv9OKvya8peQf
zZ/5zk186t5le5i0R5CaFjwKn4tq4q/bv/nHr/nDjyf+SVjCba1SXUAAXeRVJrTf
f54q+xIoI4BwhRUHgopiqrirsVdirsVdirsVdirsVfJv/OWf54235OeU7nU47qOO
84EqhajYq/F3/nFL8k9d/wCcqvzCb80/N3P9FRTGQLNuHANdq4q/pA0bSLTQbOLS
dLjWK2gUIiqKCg+WKpg0KOwkZQWXoSNxiqpirsVdirTAEEHocVfzLf8AOetrFq35
sxaMBzE0/Dx6tiryH61N/wA4s+brfzNbo0ay8G5DYb4qjoNQl/5yl82at5omDTLb
ry8aUGKs4/5wjhGh/mvdaXGtHWRgD/LTFXkv57fmBqXmv8+rrRdbEt9Z2l3wWCMl
iQPAYqy3/nIlW86WFpD5E8rajZXNnxBk9ErWnvTFX2X5T8l+dvzt/wCcZr/y8rzW
eoWpCKlwSGNPCuKvjL8p/OGpf84/6Td+RPzV8u3F7ayMw+sLCWAH+tTFX1t+TX5i
/lj5c8o6rrv5dma18zXEcnIO5AAIO1PHFXwJ+WXn+WTzhd6j5g0251ZpJ3oqKZDu
cVZN51j8wv8AmHpPmDypoWoWFu1whKiNkoK98VfVn/PxjU9Q8xfl75et7rnBcII+
fqGhbptir3P/AJxy/wCcUPLPm/8AIL9NeZYud99WdkkIB3A8cVfGP/OEfnLVfyh8
7+Y/L+gzEWqSSKFr23xVC/8AOOHlaD/nIP8A5yL1QecGeeFbxqpIeS7N4HFX6ufn
b/zgH5M84X9nq9ldwaQLcqVLERiqnFXzZ/z8W0KXyr+U1t5aa6jvIYAkSTKeQIA8
cVY9/wA4R/8AOKOifmJ+U9xr3mFQZTExjqAdwpP8MVfJ/wDzjzpq6B+cGseQbWvo
v6kKp9JA2xVP9D1K8/5xG/PWTXdQYpaXLhir9KE4qmvm7Vrn/nK//nInT7/S6zad
bTROyJuABQ9MVSf/AJ+IeU1sPzD0jypASsDvEnBdvDFX2J+c/wDzit5R0v8A5x1b
zZHARq1rZrIHoK1IxV8v/wDPsP8AILSvzw0fW9R85O0trp5KIjfFuRt1xV5tYeVk
/Kj/AJyDjtPLsrW9klxxCV41HLFX3t/zl5cflLFquj+Z/Oq3F7erCrNDGxJZvlir
4C/5yU8/aJ5z8uwjyRoF1penwlQHljKE06GtMVe6eQr68vf+cd7pmlLwqjDc17Yq
94/59GRIdJv5Qp5CWTf78VftrirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVfgp/z+R80azoV35Zh8vXs9pzVufpSFOXWnTFUw
/wCfQ/nrUrLT9Z0vzddTzG5k5wevIzmg605E4q+Wf+fmnn/zDqX5pW8eg39xBZwo
RSGVlUEU6ge2Kv1T/wCfX3mO88wflY93rM8txPHPxLyMWNBXucVffep/mL5W0SX6
rrGs2NrN/JNcIjfcSMVTzR9f0zzBF9a0K8gvIf54JFcfepOKoPU/N+h6NL9V1bUb
W3m/kllVT9xOKpQfzO8oiUWh1zT/AFjsE+sx1P0VxVKfzatJvMPkrVrLQ7pIJrq1
ZIrgMOKk96jFXwF/z7//ACV83/lNqmvT+avMkGtW9/IzrHHN6hTeviaYq/RjVfzI
8q6HM1nrGs2FtOpoUluEVgfkTirINJ1zT9eh+uaLdQ3UB/bhcOPvGKpLrf5geWfL
cws9f1eys5z0SedEb7icVTTRfMuk+Y4zc6De295EOrQSq4H3E4qoR+btEluTpseo
2rXQNDEJl5V+VcVXal5r0bRpEttWv7a3lk2VZZVUn5AnFUXqGu6dpVuNR1O7hgtW
6SySKqmvgSaYqx7TfzK8qaxcCw0rWrC4uWNBHFcRsxPyBxVm2KoS9vrfTYWvL+VI
YEFWeRgqj5k4qwq3/Nfybdzixtte06S4JoI1uULV+QOKvzN/5+Z+ZdV8oaHBqXl6
6eESOjVRyKjx2xV7B/zhZ+c3l+TyLaTecfMVompMiKY7i4UNuP8AKOKv0F0/UrTV
YVvdMnjuIH3V4mDKfpGKpHr3njy95XITzHqlpYsd6XEyIfxOKrNB8+eXPNLtD5b1
WzvpEFWW3nSQj6AcVTTV/MOmeX41uNcvILSNzRWmkVAT7EnFWK3v5s+S9O4C/wBf
02L1Psc7mMV+W+Ks2sNRtdVgW902aOe3cVWSNgykexGKpLrvnTQfLBC+YtStLEt0
FxMkdf8AgiMVb0LznoPmev8Ah3UrS+p1+rzJJ/xEnFU5v9QttLga91GVILdN2kkY
Ko+ZOKvi3/nLr829JT8uNTfybr9mb8RvQQXCsxIXp8J2xV8pf8+pvPuv+adG1K38
03Elw4mkIZ2LbAnxxV+w8rcUZvbFUj1jzRpPlq2S+8yXtvYwNsHuJFjBPzYjFUs0
H8xfK/miU2vl3WLG9mH7EE6O33A4qym8vbfToWvL+VIYEFWeRgqge5OKsKt/zV8m
3Uws7bXtNedjQIt1GWP0VxVm0t7bwQm9mlRbcDkZCwC08a9MVYm/5keVYkaaTWbB
UQ0Ym4joPnviqY6H5y0LzNX/AA9qVpe8ev1eZH/4iTiq/XPNmi+WgG8w6hbWQPT6
xKqf8SIxVD6R548veYA7aHqlndiMcn9GdHoPE0OKvzr/ADR/5+GeXfKn5nWv5S2F
xF6JmWKW55fADWhqemKv0Pfz75chs4NVn1WzW0uADHKZ0CtUV2NcVQtr+ZnlK9m+
p2mt6fJP/ItxGW+6uKptZebNE1O4OnWF/bTXKneJJVZh9AOKrr7zZoumTiw1HULa
C5Y0Eckqqx+gnFU0uNQtbS3OoXU0cdso5GVmASnjXpirB4vzc8lTz/Uodf05p604
C5jLV8KVxV5D/wA5Q/8AOSOjf849eVm80388RuH3ii5fEwp1AxVLv+cTv+cmNI/5
yI8rJ5hiu7cakZCrWwkUSAdvh6/hir6zxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV5z+ZH5peX/yt0yTXPNV3HBHGpYIzAM1
BXYYq/Cf/nJf/n4X5n/NbVpPy7/I2GR7OctA3pcuZ5bcqjFWaf8AOLX/AD7jv/M8
sXn/APOl5ZTMwmMM7cm+IVI3rir9t/JnkLRfy/06LQvKdpFa20QAAVRU0FNyKYqz
PFXYq7FXYq7FXYq7FXYq7FWH+evOdh5D0e58x6vIscMCFvi707Yq/mu/NTzt5h/5
zA/NT/D2m+rLoXrlDwY8QobuDtir+gj8h/yY038o/LllodnEglgj6hQDuB4Yq95x
V2KuxV2KuxVpjQE0r7Yq/nZ/5zA/LDzfrn5y2WreXdDu5rIXQLSqhKgcuuKvRv8A
nOz8gdW138vdJv8Ay1olxe6wI09T0UqQaYqiv+cBf+cYtX8ofl95g8y+YtPlt9Xu
IH9OGVfjJp0xV5L/AM4h/lj5y0v85LzUdf0G7t7Gad6zOhC0J61xVf8A85Z/84u+
bvyS/NSL88/y/spNTiuJvWaONOVDWpqMVX6p/wA5C/nT+a5tPK/lby29hcyMgd5L
YDatD2xV+h/5t/l7+Yeg/kskflKVV80+kkksUSUq5FaUHXFX5u6V+dn5jQ+Vrv8A
Lr82PJ9xfa1KjJDOtvvuKA1piqb/APOFP/OE/mfza2r63+YNvNp9pcLI1vDMOJBa
tNsVeYXvkT8yv+cSfOtzq1voc2qWHqsYikXIUrt2xV9E/lf57/OL89fOVnqd5oZ0
/R1kXkJLcDYfRirOf+foH5Z+Zdc8vaLb+W9In1KWPhzS1T7J71pir7N/5xx0TVdJ
/wCce4NJ1awliv1spR9VYUk6DamKvyv/AOcRvyT8yaj+cuoT+Y9HutP0WeaTm0y0
DAk4qxr8wvye/M3/AJxI/OnUfzJ8gafPfaRd3LSx+gpPwk17YqyTzB+YH57/APOV
3mSx0b9G3+k6aroXJDIKA74q+lf+c7PyV80J+UVh5X8v2dxqeoRiP1Y4wWckAVxV
9If8+/8AQte0H8nZdK80adNY3ywsoglWjE+mw6Yq/Nn8kfyv85Wn/OR915q1TQru
00xrluM8qEIRyxV6H/z9l/Li0t5o/O9lOi3ohX4FoGqPliqY/wDPor8nryM3n5s6
2hf11Kxs4qa0oCMVYx/z8C/Lzzf5x/NXR/MXlPRLueJLhC0ioSAA3U4q/RP89fLm
s3v/ADjdeaJDbSS6u9gtIFHxcqEUpir5Q/59C+RfMnkry15msfN+lXOnG4kDRG4Q
ry2oaVxV82ef/wAovON3+fB1jUdJuZLL1z6Eqr8NK7HFWPf85Zfkr+YegecNK87m
xudQ06FVYQIC1AN6EYqp/nT5+88/m/5Mt/K3lnyNfQeiio7rb0rQeNMVej/l35N8
32f5C3fkZvLt6mpvyNChruMVfR3/AD638gea/ItheWvmyxmtI2dyPVWnWuKv2LxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kv
wA/5/NxKmq+Ubi6+KLoAP9Y1xVK/+cXo2/Lbz55V0q5Pp2Gq6c89OgPw1xV86f8A
OSNjP52ufMnnxImmsdPvpYQ4FQKE98VfZ/8Azh5+biflL/zjPrHm+2+CdZZFjJPR
qGhxV8z/APOM8HkL/nJvVdX8wf8AORXmVbS+Yyi3D3RjAB6dTirI/wAlPzln/wCc
fPzgT8sfInmeDUvKs9wI+Jl9QFSaU6ntiqI/5+Na5eah+Z+i6f5XuZ7eO/kiDskj
BTyIr0OKoT/nMX/nGVPyg/L3QvzW0O+u/wBMuEklcTtQkgHxxV+g35QfmJd+ev8A
nF661G5nZ9SjsHVnqeQNBTf6MVfCn/PtrzV5jsbTz3q1hNPfapaGX6vDzZ2rv0GK
vkjyjLYfnn+Zmu+X/wA9dYm0TUZ7pvReedo1jNdgakDFX6yfkDoWrf8AOLHkzW9T
HnK08xaUpf6qIpfUKClRvU4q+Yf+cffyUf8A5ze81ax51/NHU55IYZZFt44ZmUKN
6bV7Yq+zPyM/5w//ADH/AOce9b1S70PzCJPKbQymO2lcu9ACR+GKvz9/JzzDql7/
AM5KzWupXk72YuCDGZG48uXhir0j/n5dq97ZfmR5dttKmuIFM0NQkjKDuPDFUr/5
zk/MjzvYeRPLOnXBuF0H9360kbMpK0FakYq87/JL8gtA81al5e/Mb8qPP9vpWqxz
LJcWdzdEs52JAUnFX9I/lpLqPTLZdUnW5ufTXnKn2WNOoxV+XP8Az858/wDnDyt5
Qn0vym7w2M4AndSQaHruPbFX5dfkx+S/lT819IsPM/kvzqmieabcxm4W7uj8bht6
AnFX2r/z8A03U9K/KnS9I1vUI9V1NIo41uojVSKeOKvnzyP/AM4d6BrX5Hv+aGqX
FzHr0KiSN0mKqKCvQHFX13/z7W/MvzPq+i6l5Pvbwy21oriGWRi3ArWhJOKvOPzX
/L3Rr/zLf+efz780x+Y9O5OsGkafORMCDsKA4q/Pn8sPzhf8svz1sv8AlVUF/o2g
393HbyWd9IxYoxpXfFX6Mf8AP4HzFqlv5Y8r/oe4mhgnKGsTshqfEimKsY/LL/nB
HTvzP/JBPOHnLUbqTzFJb87GdZ2AjelQW3xVv/nAX/nJfXfy2TzJ+U/5kXxv20bl
HZvzLEcem/0Yq+ffLHmzS/8AnKv83tT078+PMY07y7ZTskKNOYhxBoOpGKpjrXnr
Rv8AnEP80rO0/JDzRFqmgTSgSRLOZdienU4q+lv+c5f+cqtW846Po/kryPcG2j1W
OM3IUkMS/WlMVYj51/5wu0zy/wDkRJ57sLy4j1yaEzyGaUkEkVPU4q9C/wCfQbyH
Rb6K7IM0csi18aVxV+2F/cpZwPdTGkcY5NXwHXFX88n52ef9V/5yt/5yBf8AJLUL
mb/BmnyiiQOynY71pir6iu/+fcnmH8ufOGl+cP8AnHbzBJpdnDIr3cd1KziQdwBX
FXjn/Off/ORXnm61rQ/+cf8Ay7dGC4vXWDUZYiVEm9CRTFU0/MP/AJwF0X8vPyvi
/NDQtQvE81W0CzM7TtxLEV8fEYqifyG/5yf1/wA+/kz5h8see5zcX1hG0EMqE8wA
Nqnrir5V/wCcGPyfk/PnXNf0XzrqNzLp3qSssYmbkKVp3xVPv+cfNR1T8gf+ch5/
yq8sXVxLozO/FZZGcAg7DFUp/wCc6/P+t6z+clp5Z/M+ee08rTIqhkkaNAD3222x
V9E/84z/APOPdp5O83SeZ/y88+2t75dvbVVk036zzlHIb7VxV8ZfmB+Sug69/wA5
HP5RuBKdLllUyNy3JJ3IOKvff+fjvlYfln5a8r+RfINxc22nRugWQzMNztuQcVfW
v/OOv/OIvlHRvyui/NnWJrq68wtatcev67FagDt88VfI3/OBvmLUNW/PjXJNRu55
bdbhxGjSMVFD4HFWv+c2Ne1LSvz50qBrqdbea4UiNJGA6+AxV7x/zmR+fvmGfy1o
P5SeU7sWA1KGNZSxIkYHbrircH/PtKPzL5K03zZ5I1O6s/N7rFOZpJ24lhQ+OKsE
/wCc/fyV8weX/wAn7LVfzQ1L9IeYbIpDE8bbcVp1GKvcv+fVf5BeVtO8l2/5rrDN
/iCRuDMZDwpT+Xpir9icVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVUL
pikMjoeLBGIPgQMVfy9eef8AnMz/AJyC1L809b/Lr8r9ZcmO+khghRSdlPz9/DFW
V+Zvz2/5zD/K63Gu+bTdS2S/G7cWpQbnFX6Tf84E/wDOZepf85DwPpHmhD9fhWjM
Qa8h164q/S+81C209fUvpkiXxdgMVSmy826PqM5srK9hkmHVVYYqnss8cCGeZgsa
ipYnamKpUfMWmLCbxrqIQr1YsNsVU9I80aVrpK6RdxTkdQjb4qnFxcxWiGe5dY4x
1ZjQYqx+w85aLqUrWtnewtKppx5Df5YqybFXYqlX6c0/m0BuYvUXqOYqMVQtt5p0
i8mNnbXkLzDqobFVWfzHpdrILa4u4VlY0ClxXFU3SRJRyjYMviDXFUs1LXdP0cBt
UuI4K9ObUxVrTtf07VttOuYpj4Kwriqte6vZaayR388cLSfYDsBX5YqpXOvadZyJ
Bc3MaSSCqAt1xVVGr2TSCAXEfqEVC8hWmKrBrVg0v1VbiMy/yhgTiqGv/M+laXT6
/dwx18WGKozT9XstVBfTp45gOvBq4q1PrFjazrY3NxGk7/ZRmAJxVXvL+209BLfS
pEhNAXYAfjirrS+t79PVspUlQbVQ1GKoO01/T764k060uI5LmI0dAdxiqb4q7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
YqpzTJAjTTMFRQSSegAxV8Gf85I/853+T/ySsLmG0kF7qqhkSND0am3T3xV+NCj8
5/8AnPLzMHu3uE0B5BwlBZUSNtuPhir9pP8AnGX/AJwd8nfkbYwahfWsd55iAUvc
sA1CPoxV90IoRQiCigUA8AMVXYq7FXYq7FXYq7FXYq7FXYqpTzx20bXFwwSNBVmP
QDFX4N/8/C/+cnLvzbqy/k7+X8plMjmJmiJ3+KnbFX13/wA4B/8AOMEf5Y+XV8z+
Z7dZNTvF5AyAEjkAcVfpaBTYdMVbxV2KuxV2KuxV2KqL20Mp5yRozeJUE4qqcF48
KDj4U2xVakSRikahQfAUxVpIY4yWjRVJ6kADFVtxaw3a+ndRpIvg6hh+OKoC30HT
bWUXdraQRzDo6RqCPuGKpoyK4o4BHuK4qlVxoOnXdyuo3NrFJcIKB2QEj7xiqaoi
xjigCjwApiqEvdNtNSX09QgjmXwkQN+vFW7TT7WwX07KGOFfBFC/qxVEvGkm0ihh
7iuKrlUKOKigHYYqh/qVuH9YRR+p/NxFfvxV1xZ292At3FHKB0DqG/Xiq2DT7W1P
K1gijPiiKv6hiqIaNHNXUEjxFcVXAAbDYYqles2f1uzuEhVTcGJ/TYgEh6fCfvxV
+A35sf8AOJv5x/nf58Nl5tu5TozXDAFq8RGW2/DFX7N/84//AJMW/wCRnla38l2U
wlSJRUhab03xV7dJBFKQ0qKxHQsAaYq3JEkq+nKqsn8rAEfdirookhX04VVF8FAA
/DFVGWxt55FuJoo3lT7LMoJHyJxVbd6fa34AvYI5gOnqIGp9+Kr4LK3tU9K2ijjT
+VFCj7hiqqsSKpjVVCnqABTFWobeK3BWBFQHchQB+rFVXFXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/AX/n8i7DV/KkdzEZY
WdeNO3xb/firCv8AnLDU5/ym0H8vfzO0GFj6OlpEePbmtO2Ksbj0W/l/5xo8w/mB
dyCIajdGcxOPiPLf54q9Y/5xQ/L+X8zP+cVdb02KBp5hJIyIvUkVpTFXzP8A84a/
lr+Scdxqvlr/AJyctvqOsW0kjoZ5THyRewxV9S/k1H/zjrrH5lR6T+VfkS61KSCc
BL6NiyqQftVxV5d/z8BsDH+cvl2Gz/dWy3EPGA9VAI2xV9Uf8/HJLiD8idHljjLo
kEdR4bYqmP8Azi39Xtv+cUdS1a1Ws81k5KdwaYq+VP8An1prdz5bPnrzZp1s1zfW
7yMLYCpbckimKorWPPn/ADjd+e2p+Ybn81vLx8t+bbaRwZJW9MySUNCOnfFXlP8A
zhr+T3mHzkPNNnokk915UjlmFsnNmDIK0pXFXtf/ADg7+d/l/wD5xq8xa95G/Npf
0LcNcyvDJc7ckBOw+eKvv7yJ/wA50Wf5yeYb3yh5H0S4vNKEckYvUqVJIIrXFX5R
T3kf5Mf85E/4h85D6lplxPy9STZVJbviqp/z8B/NPTfzL/Mjy7b+TbyO5tY5YT9c
j3Q7jbFX2x+ef53eW/KvkDy55Y/NHyxLrGjSiNJLxV+ALQb1pir81f8AnJDyp+VE
2q+UdX/5xTLR61d3CetbQyElSTU7Dpir9rda/KT88fN/5feX7T8vPNg8t6zHApuf
VViTt8sVfPf5leYvM/8Azjx5RutL/wCcprd/zAjuxT14F2QHxxV+bP5+aZ+R/m7y
7Z67+QkDaN5lnaNjbrIQysT0IHvir3z88dG8x+W/yO0q386l5biRITHI9Ttt44q+
rfy/nkb/AJxtn08W7TlrYtyUdPhxV87f8+/jqVx5d806X5em9HVuFzSP9o7GgGKv
E/8AnFPWvIvkn8xtXvP+ckontr+3uZZIzdO3FiGPQHFXnP5xed9D89f85C6R508t
2yr5bkvYo4JkWiUDdajbbFX3Z/z96lR/IflGfT3DwD0qMNwdsVelfkl/zl55E8mf
84+wad5tuEtdRtrUqltIaNKSO2Kvmf8A5wm/IfVfzovPN/5kSadNp9pfs72DSbBw
a0pXxxV89/lZ+UXkXyl+cWo+W/8AnKC2a00ue4f07ieQxoRXxHjir6xuLD/nGDT/
ADzb+Svyn8nS+Yr2aQcL62cyIm/WpxVr/nPz8oJ/JUuh/mB5Y0yWPTbdYjInX0wK
Eg/LFWc/m3/zl55Q8x/848roOnMtzrKW4haBOqnjTpiqJ/58+zGfRr+WeMo7SyMP
lvir9r9ZtUvbOa0mNI3WjfLvir+cHzmzf84q/wDOS03n/X4G/wAJ6tNwS5b7C1PW
uKv0t84/8/G/J+na1pPlX8s7VvM01+yJJ9UJPpV8aeGKvzy/5zu8p+bfL3nXQfzv
g0W4ksDIs0y8a+iK1+LFX1h+bn/OaX5d+YPyWj0TTbyK58xXdqqfU1Pxo9Kb4q+a
P+ccvyH13y3+T3mf8yvNIayt7nlLFFJsXUjtiqd/8+tqX3mDXL+0t2jUGX94eh64
q8ZQTyf85VyehJ6JSZ3of26HoPnir6u/5yI/OH8q/N/nq38hf85AeU5ILdLcAahK
OKn3BxV8EeT/ACBp8/8AzkLaWP8Azi7PI/l7nG05jcsoQncfdir1389DB+VP/OTd
tq/mWZbbQ2SDnI/Tlty3+eKsp/5+bec9I85aV5XvfKVwl3pLyRjnHuB9OKv1g/5x
30pdS/Iix0my/fiWwdUA69Btir8WP+cX/MVh+Rv/ADkDqsX5iyLptrLcvwafYdTi
rHv+cqvzKsPPv5/aZdaGwvLIXC+lPHutK4q+kf8AnOH8qtUhj8pfm7pVnLd6fp0E
ZneP7K0oTXFX0/o//Px78vfI/wCX2nPZTJqOtwxxwmwhJ9QMdqUxV5v/AM5x+er/
APP78g1812mh3OmztKsiiUGvA9+mKvSv+fXX5oeWh+XNv+XlxqsD+YoHq9vWj0pi
r9XAa7jFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUPecTBKHFV4NUe1
MVfyCWv5kXX5U/8AOSGs+d9CsjePa6lN/o4FeW47fRir7R/5yD/5+FecPzJ8qT+V
ZvK8tjHNVWmaM0AIp3xV7b/z6u0byrpFhfea21WNtTcM72tRyBNa7Yq8t/5yx/5y
M86fm1+Zo/KD8uLqSwUyeksik+NK7YqxD82fyk/OX/nFawsfP+oeZJb5GKyypyJ+
E9Rir7EH/OU2q/mt+SsusaPMbfUrW3rI4rVioxV+d3/OPWo/nN/zkdc3vlnSdYmg
QM6ggt2JxVH/AJWfmN+Y3/OO/wCdFp+Wvm7V5LqN5+D8iTTfFX0p/wA5x/8AOZ2u
arqdl+W/kWc2TSkJLOlRuepxV8r+eNN/MD8m9Cs/zPsfOrahJRJJLZWJI7064q/b
L/nAj/nIy6/5yK8gDW9ZThf2TLC9erdd8VfWf5hX0um+XNSvbaX0ZY7dyr+Bpir+
Ze0/ND80vPX5mXnk3yzrEpaWd4l4k7AmgxVLfztv/wA4/wDnFrzJAuua1NdSXnEq
pLbcsVeh+bPJ/wCeer+TF/OqHXJ4bd4+aR1bbauKvuL/AJ97/wDOSXmnzv5Q1fQv
Mhe916wiYxyNWrMooMVfOuu+TPzv/OPzldp5u1uXy/o4kb05ZGIWlcVfNs35r+ff
+cfvzU0/y3Y+aG1uwSZVcqxIYE/PFX1F/wA/O/zt836JF5J17yxevYPd26yNGhI5
MRX9eKsZ/Jjy9+e/5/SaX5ua7uLXT7OAFmPIBwO+KvEP+ckPz9/MryX+Ydp5U8t6
lLJcIogZV5bsdvHFX0L5bvvza/KPRH/Nfz5fzXEc8BZIWJ2qMVeZ/k/5a/OH/nMD
Vb280bzDLp1nEXZRyIHyxVkP5bfnX+YP/OJ35q2/5e/mPfyahBcTLByckihNO+Ks
r/5zk/Mjzz5M/MHRfzA0PVHXQ7mSJhEtQoBocVZd/wA56f8AOT2s3f5W+U73yVet
Bqt2U9cx15MaCvQ4qnH/ADgb/wA5Ka9e/ln5v1jzlekX+hwMyiTqxpt1OKsX/wCf
eXnLzz+dn5n6r56u9Qk/QkE7M8JJoRyxV++mKuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVifm7ztpPkewm1rzLcLbW0Kl
iz96Cu2Kvw8/5yZ/5+J6n58uZvy9/JiFyS3pevGG+KopWoOKsa/5xo/5wF8wfnDq
cX5kfnFdObXkrtbyMfiNfA4q/dn8vvy30D8sdMj8veULRLW1QAEKN2I7k4qzvFXY
q7FXYq7FXYq7FXYq7FXYq7FX5+f85yf85QWH5QeUrnSNLb1dauw8QiH2h2r1xV+e
H/Pv7/nG+8/NXzDP+bP5hFiokaaJX33O464q/oKtLWOyhS0twFjjUKoHgMVRGKux
V2KuxV2KuxV2KuxV2KuxV86/85Df85I+Wv8AnHfSBrXmmRTPICYoa7tir8oda/5+
s+atXuG1Pyf5blfS4TvxRiGGKvsP/nFD/n4Xon/ORmpr5QubT6hrfQwmoYmtOhxV
7t+e3/OVmg/kfqtr5c1hQ91dceNT/Nir6G8meaLfzjpFtr9mQUnQPQdq4qynFXYq
7FWiwFKmlemKt4q7FXYqwb8xfzA0v8tNEuPNXmKQR20Ck7mlSBWmKvxm/MD/AJ+2
zW+rTaF5I0R75Y2NJI1J2HyxVkn5N/8AP2Sx8xatF5b8/wClPp0krqgaQEbk++Kv
2O8r+ZbLzdplv5g0dxJa3CBlI98VZBiq124KX8ATir8tdQ/5+LNafnHB+QSaGxDX
Ahe637mleuKpl/zkB/z8Jj/Jjz/Y/lvb6S13HcSIkkgrtyxV+jHlXzFD5p0e08xQ
DhFdRLLxP7NexxVP45ElHKJgw8Qa4qvxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvLfzE/Jfyd+az20vn3S4dQ
a0NYTIPs71xVS81fkf5J866Xb+WfMmkQXOnWqhYYmGygdAMVQl/+QvkjUtBHkW50
uL9BgAfVRshpirIPI/5W+W/y30hvKnkmyjsNNckmKMbVOKvI/Nn/ADh3+VHnm9bW
vNWgQ3V+9eUxJVjX5Yqzr8sfyB8ifk6Xf8vdJhsHkFGZNyR88Vd5x/IHyL591aHz
T5p0mK61OBgyTN1BGKsj84flb5Z8+aSnlXzTYx3WloAqwt0oMVUNA/K3yp5Y0VvI
eh6dFBo7oVa3UfCR4Yqlf5efkX5J/Kue6vfI2lQ2M16SZyg+1XrXFXlvnP8A5w1/
J/8AMTV5Ne8z+XIZr9n5yP8AZDHxNMVe2fl5+Vflf8q7I6N5E0+KwtD1SMdcVebf
mR/zif8AlZ+bV+Nc8+eX7e9vR0kNVP4YqzT8tvyS8m/lHEbT8v8ATItPhIoVjH8T
virG/wAxf+cZvy7/ADXuf0h560iK9m61bb9QxVisH/OGH5RW6QQxeXoQtuwePetC
Pnir1TzP+TXlHzhokXk3zBp0dxpMIokLDYAYq8t8o/8AOGP5QeRtTi8x+WvLdvBq
EDc45NzxPiK4q+ogKbDpirCPM/5f6R50hl0/zTbpeWUteUTioOKvBbD/AJwg/JnT
L4a1aeWbcXQYOGJNAQa9MVe2ecfym8qeftMh8ueatNhutOtwBFEw2UDoBiqnB+VP
l/TtGHlDSLVLfSqcTAo+Er4YqlHkn8j/ACP+X13LeeTtKisruUH1JIxu1etcVYB5
/wD+cSPym/MW9Op+dNAhu72WtZOh3+WKt6X/AM4c/lPpFrb6baaDD6Nq/OEHcq3j
WmKvzS/5/DaYuneU/LeiaFbEQQygDiCQoBoMVfR//OMP/OJf5ZfmT+VHlzVfPmhR
X16Yg5eQkb7dsVfo55W8q6V5L0yDy55ZtktNPtlCRxIKAAYq8n/M7/nGf8uPzimF
3+YeiQahMvRn2I+kYqo/ll/zjB+W35QXI1DyFokNlcDo4+Ij5VxV6z5s8naP5409
9C802sd3ZSVDRyCo3xV8/wBj/wA4XflBpyyR2vly3CyklgSTucVetfl9+T/lL8rY
mtvI2nRWMbdRH74q9GnhW4QwyfZbY4q8l/MP8h/I/wCallHpHnvSYdQtot0WQbg/
PFWBfld/ziN+Vf5Uag/mLyPoMVreMxIZviofauKvd/Mmg6T5vtJfLfmK2S6s5lo8
cgBBxV8323/ODX5K2d4NWt/LFstyG5BqnrWvTFX0VqXkfRNW0Q+TL60RtH9MRfV+
i8R2xVhPkj8nvJ/5Us0PkvTUs0nr6npjrXFUkuf+cf8A8u49db8wZNIjbXFPL1/2
q9cVVPPX5E+QfzsC3Pn3Ro7xol9Neex4/MYqrflf/wA42/l1+TdzJqP5d6JBp91I
vFpEqWp8ziqn+Y//ADjV+XX5szfXfPmiw309a836/fiqTT/84mflfdabb+XrjRIn
sLU1iiY1C/fir3Dyz5X0zyfp0Xl/y3bra2EApHGnQYq8V85/84p/lj+YV8dc836F
BeX5NTM2zV+jFUFp/wDziD+VGmXEV/aeXrcTwf3bncjFXt2peStF1fR38o6jaRy6
TInBoGFVIxV806f/AM4IfklpWo/p+x8sW6XvMScqkjkN60xV9H635C0PzDpA8par
aJJpKp6YgoOPEClMVeUeRP8AnFb8svy21ZvNPk3Q4bPU26yoTX7sVfQ4FNh0xV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVRuF5ROp7qw/DFX8ivljX9D8q/
85N6xqPnMgaYmqz+oGG32h44q/X781v+ckv+cfdR8pXmj2Vray3z27rGAgryI2xV
+cv/AD7d8r61rf5l60NIt5E0mVJnj2IWhJpTt0piqYahdt+TP/ORDeYPOcZW0E/2
mBoPi98VfaP/ADnj/wA5SeUvO3kaHy55Tdb28vI+AUCpVmGKvBPyn/L3Uvy//Im+
1PWFZTdQOwUg9GFcVex/8+ovq93cahcRCkqeryFMVfMX/OW/o2n/ADlBpzSr/e3V
HYD3xV4X/wA5NfltqXlz8z9O17WZHi0W7kVhKQaBTir6g85flz+XN15Tg1H/ABYs
/NV5WvXc+2Kv0x/5wI/KvRfIXlVrzyzfGeG5IcoNhvir7M/MiFJ/LGqLMKqLWRqf
JTir+dX/AJxEMN9/zkDdGNODpdkcaf5WKvTP+ft0hPnTQY1BqXhGw+WKvu3zXE8X
/OMUMSLRvqa02/ycVfnN/wA4MecrryZofmvU7GIvfxxSlGpvXfFWBfkZ+YPmn/nI
zztqXl/8xvM0ujadBIwVW+EUBxV4J/zkHoOieSvzOsNI8oakdTaKdA84qa/EO+Kv
qL/n51xfR/yxuHk5SG0i5Cntir9zv+carKLS/wAptBe1QJz00Smg6nif6Yq/n7/M
+CK//wCclbYFPUjN0pao2ryxV+x3/Obfke98y/lLHb+Xot4bVSQg6D0we2Kvgv8A
590/85BeWPyptb/yp52cWlyrMDIwoSR23xV83f8AOUnmdf8AnIX899LuvI6GWCK7
QlkB6Buu2Kv0W/5+C/k7+lfyc0m70+H/AHJadFGzsBvsoOKvx7/5xti1D/nIbzh5
c/LbXSzWum3P7zlWnEGmKu/5yS1PVP8AnHfz15x/LTQuSaZqhWNONaEHrir9t/8A
n2B+UI/L/wDLweYpR++1QBzXrvvir9O8VdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirwL/AJyB/Jn/AJXRoTeXDcGBWBBp
Xfr/AFxV8z/846f84B+V/wAn719a1aNL255VXnuOtcVfoXZ2UFhGLayjWKJeiqKD
FUVirsVdirsVdirsVdirsVdirsVdTviryL86/wA1LL8oPLNz5s1MgCNW4AnqwGKv
53NI0jzF/wA5sfm8dYXmdJinJZdwOINfcYq/pA/Lb8v9N/LnRLby/o8KxiKNAxA3
JCgHFXoGKuxV2KuxV2KuxV2KuxV2KuxV2Kvw8/5+9flx5h8zWOma7oVo93aWwBk4
1PEA+AxV4r/zi/8A85aflT+XflW18l/mHoEKXLxenNLIm9TtXcYq+hf+cef+cb/y
v138wn/On8rfMscF1Jzmjs42AoTvSlcVfmx/znxqXnfVfzEa485CS3ktrnhZ8if3
qg7EfPFX6yf84f8A5necfI3kdfM35mWb22hQ2o9OZ60ag264q+YfO/8Aznl+Z35l
eZLzSfyltpJdNtmf95HsKA+2KvZ/+cV/+c8NT1HzH/gT82JDBckhKSeOKoP/AJy7
/wCc8db/ACm85QeW/KMDXkU7KF496nFXz7+Y/wDzmX+cXk9bLzzrWnT2+jSEOgIN
KYqyu8/5z7/Mz80NCF1+Xmnys6L+8MYPb5Yq9b/5ws/5z813zx5rj/KL8xLVl1CR
ygZ+qmtMVftVir8Nv+fsf5p6rpUdt+XdpK0UV9xpTwYYq9c/591/84peT9L8hR+Z
/NNhBqep3ZVvUmHKgIqcVZX/AM5K/wDPuXy3+ampQeZvJMEWm3cTBikZ4io8MVev
W3mn/oUD8txb+b39ZrWM+jyNalR064q/LrWP+c2vzd/Mq+uPNvk3T5YtIt2Y/BWn
FT/TFX2V/wA4b/8AOdh/NvVJPIvnIejfJ8BLda0pir84/NRWD/nMuKKCWsK3qkke
BOKp9/znRGE/PLSRpq+t688VR92Kvu7/AJyh/wCc0Ln/AJxe8n+V/KumaX691qto
qs9fsbYq+XbT/nKT87/K1ta+cbPS5ZtKveMi71AU/Tir9gv+cafzivPzf8sx6vrt
ubXUFpzjIocVfR+KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KreA5c6fFSmKoW8uhbhRyA
JPfFVaEiRRLT4iN9sVVsVY7qHmzSNKuV0/UbuKK4fojNQ4qyBWDqHQ1UioI7g4qu
xV2KuxV2KuxV2KuxV2KuxVTkdIVaeQhVAqWPgMVSCx806Nq07Wlldwy3EfVAw5DF
V+p+atK0YV1K6ji/1mAxVgWv+V/I350xLba5BBqsNvuA1CBir0PRNE07yrp8Wj6N
ClrYW60SNNlUYqnCOsih0NVIqCMVXYq7FXYq7FXYq7FXYqhbUkhuX82KqfBfrPId
aYqjsVdirG5PNOjtfroT3URvW3WLkK4qnc1skitRRUjFUhmvItFY3WoyrBABvUgD
FU00nWbLXIBfaVMk8BJHJDUVGKpnirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVaIrsemKvzP87/8APsnyH528wX/nK8uZI7u/
maZuK9CcVSXTP+fWPkGwvEvpruWZEIPFgd6fTir7t/K78kfKv5SW4h8p2UcE3Dg0
qijEYq8v/PX/AJxE8nfnlJ9f1mP6vf8A+/UG5Pjir558l/8APtbyn5e1ePW9WvGv
YYnDLC4NBT54q+2vNH5M+XvM3l7/AATLCIrDh6YVR2pTFWC/kf8A84yeXPyKuLi8
8rM1bitQRQb4qwfzt/zhX5T89+dF/M/WZZGv1kEiqRWhrXxxV6J+bn/ONPlL83dE
i8u63bIr26BIpgvxCgpir5Q8t/8APs/yhpNyJ9RvXuIEYFYqHjsffFX6C+SPImkf
l/p0eh+XIFhgjUDYbmmKsj1TT4tWtJtNua+lOhRqeBGKvkvyF/zhp5S/L/zhJ+ZG
ku/16Ry5FKb1riqP/Pv/AJxI8t/n3qVpr3mKVkntGVloKj4cVeq6j+Tul6l5L/5V
jM7Cx9H0g46jamKvLfyh/wCcQ/KH5T2d5p9mDci9DCQuOzYq8G80/wDPtrynqmry
+ZfL2ozafPK3JlQUB39sVTK6/wCfcfka+msdTuZD9ftCC0oXdyPHFXo/51f84U+V
Pzrg0W016V1TRVVItq1C4q+qPLHlS18raDa+T7En6paW4t0PfjSmKvlrVf8AnC3y
pqPnCP8AMUNS7Rg5qNycVfW0+iWt5pp0G9QS2rReiysOq0pir88/Pn/PtvyX5svH
1PTbqSxkkkMjcBStT02xV6r+Sn/OE/k38ndR/wAQwj67fAAK8i9CO+Kvqbzl5RsP
O2j3XlnV41e2uYzGajpUdRir5N/JP/nB3yb+S2s3PmvRiWvp2LcgPsknFUL+dv8A
zgt5P/OnWbfzRrJ43UbBpCRu1Dir658j+T7HyFotp5V0VeNpaIEXFWWYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYqgNU1K30e1l1K+dY4YUZ2LGmwFcVfzp/85of
n/q//OQfnmP8ofJkjtp3r+kVQVHWnUVxV+tn/OHX/ONVl+RXlm3kmjA1a4jVpG7/
ABL7/PFX2firRIFK98VbxV2KuxV2KuxV2KuxV2KuxV2Kvzd/5zI/5ym0L8pry28s
ebbQT6ddEJIXWoAJp3xV4/P/AM40fkV+eugweZNPuba2mvIjIFDAUNK4q/KHyYdR
/Ir887fyh5Nv5JtMFwECoSVI5Yq+q/8An5pcpL5s8pazfJ8DRwtISO+2Kvrb85fM
E3mT8gLSHQZa2SWahlQg/s+2Kvy1/wCcTvLvmfV7u8t/KLGM829Sp47d+uKvadE/
5x0v7z8yodcmk5XEcqs4Vq7g79MVY/8A85P6SG/NrRrO9QARTRA/QRir9B/+c+dP
0+L8i9HjS3QIYE4vQV+yMVSf/n1t5R0mLydeNc20dxJOjULCvbFXwN+WdmLH/nMh
rK3QQqL9gqDpTkMVf1FYq/CX/n7R+WWp393YfmRwY6fYhASoJ6DFX0H/AM+8v+ci
/Kdx+Xkei63qUdteQMKJKQNumKob/nMr/nPK0/LCW10X8vLz17uR1U+iQak/LFXy
h/zlV5986/ml+Utr5n8028iWspB5kGtD3xV4B/zjD5X846v5du4fLDeppjIwclgK
Cm+KvUv+cbfyAu9K89S67YSf6YJCzqprviryy6iuIv8AnLOzF7HWQXaiU+1cVZp/
znORbfnloy2LUaSePjTt0xV9cf8AOX35beTfPnk/ywvmTUANdjgT0Vbs1BTFXw75
4sfzO/Ijy1Bql5M2o6EAphjZqgJ4AfLFX66/8++fzwsvzY8o8RZLZX0QHIAU5U64
q/RDFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqgtR1CDSraTUb5gkES8nY9hirEvKf5h+X/P
Ekg8tXiXLwVDhSNvuOKpJqf5j+VbnUx5Yk1CMamGp6QI5V+WKpv5q/MTy7+XtvFL
5qv47ZGHwlyKn6MVQPlD83/KXn2T6t5W1OG5lp9lWFfuxV+VP/OSvkLzXd/mtZXN
lrEkVsZlPpB6ClfCuKv1Pi83aN+XOh6ba+bNRRJPQjHORhVjTFUs1D/nIHyJphUX
WrQjn0oR/XFXpmgeYdP8z2aatoc63Fq/2XU1GKsF80/nT5Q8m3X6M1/UY4bjpxqD
T574qoWH56eSNTuoNMstXge5uDxjQMKk4q9bxVJta8waf5dgN7rE6QQjqzmmKvK7
D/nIr8v9SvhotrrMBu2PEKWG5+/FXrt3qtpY2p1S7mRLRV5mQkcaeNcVeOT/APOS
P5eW91+jpNag9flwoDtX54qz3zNrVtd+Wb3WNOlWWBrZ3R0NQdsVfgl/zjX+ZHmO
/wD+cgNTS/vpf0LC7Exk/DQHFWBf85n/AJ9ah5w/OmHyDpetTaZofqIkksZoNzvi
r9sv+cWvy20ryXoaahoetyawtzEpZ3NaEgYq+rH48T6lONN69KYq8R1z/nIr8vfL
F2+japrEEVzCeLRgg0+7FXoPlPz5oXniD655YvI7qP8AyDv92KpL5t/N3yn5Hf0f
MupQ2z9CrMK4qjvKn5l+W/Oy+p5a1CG5FK/CwxVJPNf52+TPJc/1LzDqkMM3hyB/
jirL/KvnLR/O1mNW8s3cd3bH9pCDirF/Of5yeUPIB4+aNSit2/lqCcVTTyZ+ZHl3
8wYDc+VL6O5XwUjl92KqF95/8v8AliZ7DWb+OGcHcSED9eKsKuf+cify/s70Ws+r
RLM2w3FP14qmXmH8/wDyL5XgivdW1aFYpgChUg1r9OKsv0Hzzo/nXSpdY8rXSXUP
puQUIr0xV/PTffmL5gh/5yIKarrM1rp8VyfhB24hsVfu35U/P3yPrxt9IsdXikvO
CqQxAJYCh7+OKvlf/n5P5h1XQPytm1bypdNBcGtHjPamKvMf+fan5nLZflCfMv5h
6ozubhgDMf64q/T/AMq+b9O84acuu6PKr2rV+IEECnuMVQWk/mHoOt6nN5e0y7jl
vYPtIpBxVmuKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxVgPnz8zfLv5aWyaj5xvFtIXNFLd8VT7yz5o03z
hp8Wu+X51uLKYVR174qyDFXYq7FVrusamSQ0VRUk9hirHLDzho+p3J06wu4pbgGh
RWqa4qxXzp+cXlT8v7qHTPNF+lvczkBE6mpxV6Fp2oW+q28eoWDiSCVQyMO4OKo3
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVE3ESuIWdRIei1FfuxVWxV2KuxV2KuxV
2KuxV2KuxV2KuOKuxVokKCx6DFX5Lf8APxX/AJyyg8k6I/5beT5fU1q8Jib0yGYc
hSlBvirz/wD592f84oywRL+cPnqD1b26YSoJgQw5b1AOKv2oVQgCKKACgGKrsVdi
rsVdirsVdirsVdirsVdirsVdir5F/wCcq/8AnFPQ/wDnJLSEs9TjRb6AH05KUJ8N
8VflFbf8+9PzR8lzvpXl7UbkWRNIuLNRVPhir6c/5xj/AOfdcvkPzKnn/wDMiX65
eI3MCQktWtcVe1f85o/84Zr/AM5EwW0+kkRT2yhVCkgig2pirGv+cef+cNNX8naD
L5S87Xkk9iUKCKUkrir5688/8+9vNWgeY5tc/LfUJrGzmLVW3Ygb/LFXv3/OOX/O
GvmDyLrA80ebtSluWNCRKxqfoxVLvz0/5wVvfzL/ADAtfP8AZzcYIJFcqCRWhxV9
Df8AOSP/ADjbL+cv5a2v5c20nC4tI1Vd6VIAGKqP/OHv/OOlz+Qflr/D+ptylIIr
XffFXy5of/OBWqab+fbfnikzfU47n1hUnepxV+uOKvM/zZ/LHS/zZ8vXPlPX4llh
lU8eXQEimKvxP84f8+w/NmkalPeeRLyS3s3YkJCxoBirIPyh/wCfYWsnzBb+ZfzK
uWuooXV+MxPY++Kv1l89/kH5e86eTz+XkkKpaLD6cY7AgUrir8oLv/nAXzz5Jupt
C8iarc29jcO20TNxoTir7Z/5xV/5xHvfyda51XzZfSXd5Ou3JqkE4q8Nvf8AnAfV
Ln88Y/zqNwTZRXAlA5H4gDXFU7/5yK/5wQvfzd/MjTPzJs5vThs5FcqD4Yq9H/5y
R/5w0k/NjRNLtNEuTDfadGq8lJBqB2xV8f6r/wA4KfmX5vitvLmv388umW1E4yMe
JAxV+ln/ADjT/wA45ad+Q2jrY2wX62y0Yr0xV9Q4q7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXgX/OT909p+WXmGWGQxSfVGCuvUHFX5Sf8APp/W9Vnu/MZ1e5eeJWl4uxrShOKv
nWx81avqH/OYtrpcl7K+nG9IMdfhpU9vuxVU/wCfjnnrzXp/5r2WlaxJcQ+WhIqj
gCQVNBir3n/nFr8ufL+hee9G82+QPMk10JrbnPZyvRQx7UOKvH/+c0/OusW/566N
bWWozRFriLlEh+GnIYq9e/5+havqsXlvypPoV5JDJJDbhyh6kgVxVhnm/wD5x3u9
T/Iq2/NJ9UmTUkiD9TU0GKvY/wDnBv8A5yA1DSvym1mLUpnmubCCUxs3YqDir51/
5xh8i6r/AM5geeNX1Pzhqc8dmHk4BSTShPhirwv8xvKWt/kf/wA5IaN5I0XUp7m3
hvYwgZjQiu4I+7FX9UOiTS3Gn2010KTNEhYe9MVfmP8A8/RNZ82aR5D9XycJFip+
8kiBJHWvTFX5Hfkr5T8u+ftIs9X1HzHdWOvwlC/IlDyDDxxV96/85nf85FXv5b/l
xpfkXRL95klhjje6VqtQjffFXzNovlf8ur78vf8AEd35hum8zNGLgLvXlStMVfVH
/OEX5/615p8q6x5K1UzXNvDDKkbyqa8QCBir5c/5xUSPUfz11nRLdyZ5XdeLbdSc
VeM/85K/lPBD/wA5GWvlPVZjE17cxqadqnb9eKv6Yvye/Lax/Kby9b6HbT80EafG
5p+yPHFVn546ytj5I1W6tbtbdjCQJUcVFe4OKv54b7ylp72up+ZYtTuNT1WTkwBq
2+/hiqJ/596/nx5ws/zAuvJru8kMjOBG37O/SmKpB/zkv5l1DWfzel0Pz/e3lnpc
krbqrcR9OKvq3/nGPyvZ+WpLy5/LPzDPqdyYJGWCV+m3YYq+Gr7Xp/N/5h6noP5u
6leWbGSUJ8J4j5HFX6c/84k3tj+TPlPWr7Tdck1KGO3lkiWR60IBpir4I/Jr8w/L
/wDzkN+Y2p3n56a3cWWkRTyLGinbY4qns/5y23/OPH512Mf5S6neah5SvZ0jowPE
CoBxV61/z808y6rqFx5Z8zeUbyW1TUGj9QIeJNfHFUH+eX/ONh0f8kbH82YtVnXV
zbrK1CetK4qx7/nFf8kb3/nIT8s7/wAx+c9UmE+mxsbYE/a4jFWX/wDOCvn3zL5V
87an+XIupLmzRpUCudgBXFXgXmfQH80/n9PpUzFZZLoggdgW3xV7t/zl9/zjzqH/
ADj7Fpf5veQtRnNqDH6y1IAbqRir0f8A5yD/ADPvPzF/5xng1jUSWuQgUnx2xVhP
/OOf5d3v5if84rXltpUjW91atNMHjryNB7YqiP8AnAX/AJyPv9F8i+a/y48zXTNf
aRBPIjSmjfCD44qm3/PskeYPzM/MLzH+YuvXc7WCvJ6StXifi2p2xV+9mKuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvjz80v+c1
vy9/LWS40e5vRNq8D8DBHRjUdehxVifkb/n4T+V/m29g8vXF1Ja6pMVVY5FoCT06
0xV9J/mh+dvlb8otHTzR5wuhFayqGjAoSwIrir5Kt/8An5F+W812kEhmS2duIkI2
+/FX1pYfnd5U1by6/njS7xZdPWPn1FemKvmmf/n4Z+WECSR/WHe6iJBRaHcYqivy
4/5z9/Ln8wNWi8rwTmC8lfgvMgCv04qwv/n4Xc+V38t6dD5vu2t47hgInQ7EV8cV
ZB+X350eRf8AnH38s9HlnvGmtpolZWZv44qnPm7/AJz7/LTyxZ2VzFd/WLm+CenG
hGxbxpir2bzX/wA5I+S/Inly085+b71LSC7hEscdRyNRXoTir5fi/wCflP5bxags
OotNFYyEKknHY16GuKvWPzG/5yu8pQ+SbvzJoM7TpNbt6bL2qPbFX4of847/APOZ
s+ifmebvVp55bO4uygU7gAnFX3D/AM5X655J83eY9G81anfyweo8ZWKtNzir9G9G
/MXyt+XHkbT/ADDrl8INMMS8HkIqdvA4q+VD/wA/JvIMGtzWF1z/AEQrUW5A2+eK
vtT8sfzh8r/m9YNrXke8W6tk+1SlR9AJxV876z/znh+W2heZLnyTqN0Uu7RzHJuK
8h7Yqwef/n47+XMOtJojSMIWcIHJAqSaYq+8vLPmSy826bBr+jSCS1uEDoQfHFU+
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvOfP35o6H+
XMcUuvy0aZuKom7fdirzrQ/+clPLWs6umgMJITMQsTuKAnFXpOr/AJk6PoOr23l7
VZRHLekCBj0JPviqG8wfmvoHly+j0e9m5TP14UIXFWDeYf8AnJTyjoF1HpxleaV/
5R0/Xiqc+U/z58sea5/0fBK0N12Rx1GKq3nP86tD8rVs4XNxqFKrEgrtiqh+Xn55
6D59uW0WJ/Q1RF5NC+2w774qlnmn/nI3yp5dvn0COcz6itQUQVAIxVf5M/5yD8ve
ab86BI5hvx2YbHFUJ5o/5yN8u6FqsvluyLXV7bDlcKo+wuKs88nfmnoPn+zub3QZ
2pbKTKGFCu2KvLPLnm7Qo73U/N2ragxisSWCFq/hiqtYf85ReV7qTlciWG1Y0SVl
2OKvWNV/M/y7o+kjzPeXiCxK8gw6n6MVeLXn/OWHlhQJLBXkiLBfUYUXf3xV9EeW
PMlp5r0+LWNNYNFIAevTFWQ4q7FXYq7FXYq7FXYq7FXzF/zlD/zkJpf5C+VLvW7y
RDfNG6xRlhWpXY0xV+IH/OKv5P65/wA5gfmRL+b3m5Hk0CK45r6qkr1xV/SFoGg2
flqxh0fSoxFbwIqKq9PhFMVTrFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq8N/5yP0WfzF+Xmt6LYLyuLi3ZEHvir8Nv8AnBD817D/AJxy1nzF
5U/M2C5hmmaVYyIzvWtMVeJ/lNrE3nH/AJy0tdd0m3m+oz3zFGkjI+HrWuKvuv8A
5zE/N3SND/Mm28u/m5oYl0UnitykPMgU2NaYq+LvJulweYfzv0uT8ipr5dHdeTqU
ZUAr0xVkn/OW9jfw/nR5etJbSWWRHiEkojJ35Cu+Kva/+flhuZdA8qR6PbzTUjt+
XFCabDFX0B5lgdv+cXYopFmW4+r/AN2FNa8fDFXhn/OBHku682/lj5o0W5tXjnmg
nSLkhDFiDTFXk3/OFv5tw/8AOIvnLWPLX5o2t0kU8sixMsZ7k064q8W/Nr8yE/Mz
/nKLRfN2koy2dxfR+kJBQ0qa/wAMVf1R6SS1lbluvpJX7sVfDn/Oc/5mS+S/Kz2H
6NF/bTAeoCnOgOKvwv8Azi8w+TPOXl+0f8t4Lqx8ylow8UERUcie9MVfQX5y/wDO
Mfna6/J3TvM19BJeSiGOQhlLOBTfbFV35R+cPyW0XyB9T/MGK6TzVCoiWERGhYDp
ir76/wCcQfLy6poGqeatL0uO308wSCL4OLMKEj6cVfnN/wA45yXjf85PX0i2cttB
9YIL8Co+144q3/zl5p7Q/wDOV2k3FvDcSo08Hx8CVBJ8cVfs5+f35PeaPzJ8v6dF
5I1Ka0ulij5hXK7cRir4Q/Pn8m/zF/Lb8q9YttQ1G5vrmeAhAHLkHFXy5/zh/wDn
t+Wn5beRr6x/NK1up/M6RuqpJCSCxqO/viryv/nDfVL6H/nIGTzdFps0Gm387y26
vEVUrWopXFX2d/zkf+e3kXVPOtzof5oaCYLZS6i5ityXrTY1pir5M/5xy0/zHc/m
TP5l/JmK5k0OMOQsyFVKDFXs35j/AJu/l9rF3qGlfmVo72nmBY5UE0MG5enWtMVe
f/8AOF35QebfzE/xBaeX5Lh9Glim9D1wRWtaDfFWDf8AOPXlLyf+Tn5iav5W/wCc
m7a4tbRHkeJ4oj8Rqe+Kvq/y7r3kX81/zG0/yj+Tmii50SynVmubiCjUr1rTFWL/
APPzTSBB5k8taRp8FwbKCWOoiQlRuPDFX1L/AM5HQTD/AJxns4LGN5ENovwlSW+z
4Yq80/594xCP8pdcN7HcQyJC/FGQiux6Yq+df+cNUv7f87tUury3mS0MstGZCPHF
XmX5geZr38vP+ci381W1nPNaLdFmIjJHHlvir6Q/5zd/5yltPz88taZ+VH5d2dw0
k0sX1gmM/C2wOKs4/PL8tW/LX/nGa00K5ill1GWIPwCkmtPDFXsP/PrzSHvPyaud
J1iJ4/XkZCkildj7HFX5A/8AOW3l7WPyA/NnWtO8pco7PV0eIqgoCHJrir99v+fd
/wCWtn5I/KbS9RWD09RvlMk7EUJrQ4q+9MVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdiqhchDDIsrcEKsGatKCm5rir+evz3oP5JeSf
zI1TzHrc99q2tvcsRDFWVASfDfFXw9/zk55jtD580bzD5LtH0+P14Qq8ODEch1xV
+jn/ADmP5D86/mD+V+heYfLTvL6drCzRtU1oB2xV8ZeS/O3lSLQo/Jv5v6VPZahD
1nEJUbDrWmKv0c8qQ+S4vyZ1C9/L29mndrd6qzVAFMVfBn/OC35G2n5s+c7uLzE3
qWZnfkDuaVxVmX/Ocv5G6f8A843earDzP5DLRqzowCih64qnX/ObnnrUfzG/Jbyt
qHmLlFOsSGF+jNSnU4qwr88pmn/IHy5CHYXK2ijkT3pir03/AJwO/wCcMbP86PL8
HnXz9O7G0K+iGqRsajFX1F/znD+Vv5VQfoqy8/alcwxWMSqltE/Xj0+EYq/PD89v
NXkvV/Kcfl3yDpM0KW6D07mWHiTxGx5UxV73/wA4VWMv5lfl1qeh+ZQskFvDIUru
dgcVeAf84tflnofmX8428v6jCvoQXpK1XwbFXrP/AD8WsLfy/wDmloHl7T+UVnDL
CVUbA7jFWK/85e/mxrXmbSvLn5Yq7waeTHGpQ0rsOuKvuryX/wA4QeUrv8l5rnWI
+epyWbSxzU3Bp44q+Qv+fb35iav+WH5maj+VM0jT6VLJIlGNaU6Yq+Z9R8jN+Yn/
ADlZq3lBGYC81JwoHTjUYq+q/wDnP3/nFPQPyV0Cx80eXWb64CrO4FByGKv0r/59
1+cLjzd+VNrd3rljAyxgnfscVfe+KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV+Qf5iX/nH8xvz41nyn5fQXOnaPEJRGw5Db2xVkPmPy1558
zX+nyWdta2EsMgoGAR2I8PHFWd/85ZXsfl7yfpF5JIT5vtFUqsZ3De+KpX/zjtYt
538k6l5488lpNTtEZt9yDTFUJ/zjH5OtvzW1vU/MerKsllYzmMKwqSa9MVRP/OSE
mm/lj550i+8vIsPKP96idB88VTO11KTXb9POHkS1a7ukhPqiZOSVpviryP8ALUa1
rvn/AFbzxeKtuttZzB44RTdR4DFWf/8AOJ35YRfmXqOofmt5iIltPrMsMcT7tyU9
8VTOfRbS6/OO50rymBC9soaUNsFUdz7Yqoa55M178r/PGo/mVHDDqWhalGI7plHM
Kneh8cVem+WfMPk+10DWNc8mOY/XiPqIdiDTfbFXxn5LttW8zeZYtDikYaZqclHq
diK4q/QT86fyz8vaF+XVwsluqSafCCska0YnFXwBfajqXmfS9P8AJxlYQ3PD0wTv
xrir67/Nv8t/L/5f/lPEHhVZV9DnNT4uTCvXFXvX/OPOky6d5VtZ3flBNErRivam
KvecVdirsVdirsVdirsVY/5o8yWHlPTLjXdamWC1gjZ2ZjToK0xV/M/+c3nzzD/z
mf8Amp/gjyc0s+jw3So5+0pStDir+g//AJx//JXRvyL8qWnlHy1F6a+lG8xIoTJx
+L8Tir3HFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXDbbFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
qlmqaf8ApCNYtqA1IPQ4q8X1n/nHDyXr2o/p7UNPgN3WpYRjc4qq6R/zjp5K0TWI
PNWn6dDFqFuapJGgU4qyP8wfyb8q/mZwfzXp8FzInR3jDN95xVL/ACP+RHk78vrg
aj5c06GK5UUEgQAjFVXXfyT8s+ZdbTzZrFnFLexmqMUBIxVP/Nn5Y+XPOkEFnr9j
DPHbkenyQGlMVRl/5B0W/wBIHleW1jFgF4iPiKU+WKsRsvy/0/8AK/Rb+48h2kaX
axO8caoAGemwpir8SYv+cqrRPzJvtM/5yQ8qFre2kb05La15EgHbcDFXkHlXynH/
AM5Nf85DWXmf8sdLuLLy3pNysi+pCU2BxV/TbZ2/1WCO3rXgoWvyGKpF5l8oaV5s
tpLHW7WK4RxT94obFXhmi/8AOJf5d6LffpiHS4Wn5cqFBSvtir6Gm0eyuLI6NLBG
1nw9P0ioK8aUpTFXzjef84hflxe37azLpkXrM3IjgONflir3vyz5R0vyhp40PQoF
htAKcFFAcVeexfkb5bsvMA856bZwQ3xbkzqgBJ+jFU58w/k/5W8yarH5p1LToH1S
IhkmZAWBHTfFXpcKlEVXpUADbpirHvNPlyHzNaHTrxI5Ij1WQVBxV4VN/wA4lfl1
dP8AWrnSbf1zuxEa0J+WKs9t/wAj/KFpe6fq9np0EFzpq8YjFGFqPemKtedvyL8l
+f5lu/MelW00w6v6a1Pz2xVM/JH5R+Vvy9Vk8r6fDbhhQ8UA2xVhHnD/AJxo8jeb
5mvr3TLf607Fmcxgk164q9C/L/8ALHQPyzszpnlS1S3jb7RUAE/dirEvOv8Azj75
K8/6l+nvMmmwzXRFCxQVPzOKpj5J/I/yh+X12+p+WNOgt53FKogB/DFU680flj5e
86yJN5nsYLpojWMsgJH0nFVTXvy30TzFpI8q6hAraYqhRDQUoMVVfLv5eaJ5R09d
A8vWUFvZU4uoQfEPfFUj0f8AJjyr5fv5dc0mwiivZSSXCjqcVSm5/IHydqN+2u6p
p0E949asyDviqVaZ/wA4zeQtKvjq9rpcPr8+YJQbGtcVek+bvIWlecrFNE1e3ils
0FAjrUAe2Ksan0ny9+TXlqWfT7Uxada/vHS3Tcgddhir+cT87vMd/wD85X/85A2M
fkLS7v8AQkF5GkrzwkAqG+Ikn2GKv6cPJvly28paLZeX9OQRw20KJxHiAK4qyfFX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqwH80NF
v/MHlfUtJ0KQx3s0DiNgaGtO2Kv5g/yy1jzB/wA48/mzqV3+Zmg3mrWjXLUZoTIO
vyOKpb/zlhr+sfm/570rzJ5N8s3lrYJNEwUW7BftDwGKv09/Oa6/NHSfy50XWPK1
r6ltbW0Jkg4VPwgVBGKvhn81vz2X85fKv+C9Z8oXUPmJFKevDald6dagYq9o/wCc
b/yn81flx+UWr6p5rjlj0+5t5BDHKCGWo2xV8Zf84u/mz5p/JfzPea/o1tLeQrPI
3CJS21T4Yq9b/MP8yfzB/wCcxvP2naS2i3VraCZV5SxEIAD7jFX01/z8s/K/V/LX
5YeU/KejWMt7cWyokv1WMtxI61AGKvE/z88s63d/kR5XsdO0e8a8S2jEkaxHkDt1
GKv1V/5926bc6V+WFna31nLZTcFLpMpVuXyOKvzG/wCfn3kTzsfzK07zTpFnd32j
QlHkWBSy7EE1HyriqQ/m1+esH5k+SbPyX5M8oXcOoQWgjllW1IJYLQ70xV7p/wA+
5vJXmRvLmraZf2M9nPLFIB6yFRuD44q+PkvvOf8Azj9+d/6QGjXk8L3lTJHExWnL
xApir0v/AJzVu/MH5peevLfm620S9ljM0PqGOIniNuuKvaP+cqP+cYPNfmnyZovn
7ydasZ7JI5WjCVfYYq860H/nPbz3oPkGb8p77y7fNqKQm3Wb0W2HTrTFXtH/AD7U
/wCcZfMkOtah+df5mxlPXZ3to2FG+LFXzN+WHljzKn/OYN75jXSrpLIalIVlaI8O
JIoa9PHFX6O/8/VNB1DWvyv46Hay3V0JAAsS8mH3Yqyr/n2JoWq+X/ykhs/MMD29
wZFYJIvE0oe2Kv0cxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KviHzz+Svnjyx57u/za/Jp7Q3upgR3aXIBHGvYHFUruPyi/Mz8wNZtvMXnK
6htptNcS2whPFGYeIHUYqzTQf+cftQ8z61e+YPzckS7LEfV0QgqMVeR+ZPy/80/k
xFrc9rdQDy5qDH046gEA9qYq87/I7yL+bflJb3VfIZh/RupuZfjA79xir16P/nGf
zP58trnVvzHuI21osTAa1A/piqC8q/l5+cf5fNP5b8umzaymVlEjKDsffFUo/L//
AJx6/M3yZfX+uarc207agroyRkGnqewxV9S/kD+T8n5S6TPZ3soe6uZWldUPwDka
9PHFXl9v+QPmM/mL5o/MnULmL6nrGnvaW0cR+JGIoD44q8z8vflr+c3kzQZPJCyw
XmlO7lnlo78WPicVTbSf+cZNc03RLwwyg3F8m8anpX2xVOdW/wCccfMGmaJo9x5H
lii16yFXL0G+KqGveTPzt84xweWPMs1qdMlAFwyUoaeOKpxbf84wXFrrWlai0iND
aKA5Xptir2D/AJyA/L+8/MDycfJmlCvOSIk07J0xV6F+W/lqTyh5dsfL9wayW8Sq
foGKs5xV2KuxV2KuxV2KrWYIC7kBQKknoBir8JP+fhv/ADlPc+ar4fkp+XczGaWQ
RSmJ96nY9MVfUP8Az71/5xNg/KTy7H5z8zwh9evAJFdlFQDvWuKv08xV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuIrscVee3/wCVHlDVL59a1HR7Oa8k+07xKSfwxVG+Wvy88veULmfUPLmn29pL
cfbMUar+rFWa4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYqo3FvFdRtbXKLJE4oysKgg+IOKsM0n8tPK2hXbarpGk2lvdsamRIlBr
irOcVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirE9T8i+X9XkNxqOm2ssxNS7RKWr86YqjP8JaJxWP9G2nFQAP3Ee1PoxVMW0u
zeD6i8ETW/T0ygK/diqQx+QvLcUpuY9KsxKereglf1Yq8y/5yE8j3Xm3yHqPlvy3
GkcjQtwRFAHTsBir82f+cE/+cZtb8oaxfzeeLEGJncgzRgjr74q/XvT/ACdommMs
tjp9rHKvR0hQH76Yqm99pdnqYCajbxXCruBLGrgfeDiqnLo1hPGtvPawPEn2UaJS
o+QIoMVRUVpDboIreNY0HRUAUD6BiqC1DRLHU4mgvraGZWFP3kat+vFUm0zyJ5f0
dGSx020UsasfRSp/DFU+sdJstMBTTreKAN1EaBa/cMVS+/8AKmj6kwlvLC2kkBry
aFC330riqK/QGmUCmztyB0rEh/hiqP8AqsJi+qmNPRpThxHGnhTpirFZvy98s3Bd
ptJs2Z/tH0Ur+rFWR6dplppMK2emwpBCuwVFAGKoePQdNiuTqUVnbrdncyiJQ/8A
wVK4qr6jpdnq8X1XVII7iE/sSKGH44q3p+mWmkxC00yFIIR0SNQo+4YqjsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeefmJ+XVj
+Y1kmlauzCBWqQO+Ksq8v6Ha+WtOt9D01eNvbIEQfLFU5xV2KuxV2KuxV2KuApsM
VdirsVdirsVdirsVdirsVdirsVaJAFTsBir4B/5zm/5yes/yb8p3GkaTMBrd4nGE
hiCOQPSmKvzl/wCcEf8AnGjUPzl19vzk/MBWkUSCQGWjVPLtXFX9B9jZRadbx2No
oSGJQqqNgAMVRWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KrVRU+wAPkKYq
uxV2KuxV2KuxVomgqemKqcU8c45wsGANKjAJArSrXCrsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirRUNQnsajFW8VdirsVdirsVdirsVdirsVcDXfFXkf50fmZpX5Y
eXLrXdclWMBDwU9SaHFX86+mWXmL/nNX80EvZ/Un8u2E4HAE04hqd8Vf0eflZ+Xe
mflpoNt5d0OAQxxoAwAA3+jFXpGKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV5/wCfvzH0L8vrNr7zLdRwrQ/Cx3IzHzZa2ZRjb520H/nM
P8up7w6dbX0FuGalCT1PfMeOUjkzMX1B5a84aT5rgW70S7iuEYA/uzmViycXNrIZ
TlyHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXn3nP8AM3QPIgjHmC7jheVuKqTvirLdG1e2120j1TTnD28oqrDviqaY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqhL++g0y3kv71xHBEpZ
2PQAYq/nW/5zc/PrU/z/APOUP5VeRJWkt4pRG3pkivxUPtir9Xv+cMv+cb7D8kPK
ltM0QGpXcQeYkAkEmvWmKvtbFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVOWZIFMkzBVHc4qvVgwDKag7g4q3irsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiq
xpFU8WYAnsTiq/FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWN+btdHlvSLrWCvM
wxOwA8QDkMkqCQ/GnQbfV/8AnKbzZeXvmG9ZNAtZ2jKkkLsfs5qs2YR5lvx4yXvl
3/zi35CvbZ9OttPSC+jQ8brl1I6HMcamPe2eEe54Z5A8yax+RXneLyrLcNNYyyhE
U1Ip0GZ+HIJcmicSH7SadcteWsN06lTJGrEH3Fc2AakbhV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KqFzcx2cTXNwwWNBUk+GK
vzj/AOcpf+c6tA/Ku3k0vyxdrPqyV/dKKmoPTY4q/K3y5pH5u/8AOYHm2HzTeST2
eivN8CnkAB1rir+iv8pPJlz5B8sWXli/uDcS26AFz8hir0rFXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FX5Mf8/C/wDnKf8Awbpf+APJ9xXUroBJEXrU
kjscVeYf8+9f+cT3aUfm553TleTEyor79SD3GKv21VQoCqAAOgGKt4q7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/PP
/nO//nIKT8n9DjttPl43cjoQB1od8VfQP/OMH5qp+bfkmy8wBw8qxosnjWmKvovF
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FWHa75Vk1e6W+iu3hKqF4AbbYqyTT7Z7OBbeaQyMopyOKo3FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq8Y/PvzRb+UfJ2oavqABtxDIhr4spplGeVBlE0X5rf8AOEFv
LP5L1+8nTjJPqjyx/wCoWNM5ntCW7sdPJ9m6ZEzSNNM1UVenvmt43J4nw7+dV3Dp
Xm2x8w6hGAiXCkMfY5v9DPZ1+cv1w/L3zHH5q0Gz1i3+w8agfQozfg2HCBZrhS7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqwLz9+Z
OhflxpkuveZruOCCJWO7DcgdOuKvw0/5yN/5z78x/m5qEn5cfk7bSIrM0QniBPIH
oajFU3/5xo/5996z511CPz7+cTNK0jCUrKW35CtN8Vftl5G/LXRPy+tE03y9brDE
iqoUAUFBTFWf4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWiQOuKvn
L/nJz87bD8lPKF1rV7IEu5Y2W3Fdy3yxV+Ff/OPP5baz/wA5ZfmC3m/zNGxsoZmb
mwNKBq4q/o/8qeWbTyjpsGhaaKQwKFG2KsjxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVQup1tYXuJDRUVmNfYVxV/
Kp/z8W/OyT81fzA/RGmyEWenSelIB0qo9sVfZP8Az62/PhLNv+VbXz0SSlCfmcVf
vOrBwHHQiuKrsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir8fP+cyv+ctPMf5Q+fLDyno8j
pDLOFYL0IJxV+nf5T+YrjzV5ZstdvSfUnRW3+QOKvSMVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir5E/wCc0LK81z8v
bvQdNjLvK6u1AT8Kj2zF1FqOb5c/5xl80WEflo+XrJAlzGyxyKPEdc5nWYzbscBf
Tl3aPZBPTaoJDMB4ZgCBbyXxZ/zlnq1h5gbTfLmioGv/AKwvKnXr7Zu9FAhwcr9M
vyF0afQfJWnadegrKsYJB91GdDj5OIHseTS7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYqpyypCpllYKoFSSaDFXwn/zkz/zm15X/Jizm03T
51udXKsqohVqEjbvir8cvW/Nf/nMjXDp9bmHy/NJz6MFo3yxV+uf/OL/APzhD5d/
Keyi1PXbZJ9VopLMDWo774q/QO2to7OJba3XjGgAAxVXxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxVjfmvzRY+UNNuNc1eVI4beMyHkQK0xV/N3/wA5
B/md5k/5y9/MhfJvl/nJolvOVUKKrQN/k4q/dr/nGv8AJTTPyd8rWmnWcCx3zxgz
PTckgYq+jsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdir5l/5y0/Na3/KH8utU80yShbqOMiGOoqxKkdMVfyD67qt
55wvtR823UbK17N6wJUjrir1j/nHfz9f/lh5v0/W4Y2WAzRKz8TShbffFX9g35fe
arLzloFhrulyiWOa3iJI7NxFQfpxVmmKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV/O3/z8
hWJvzd031QCRNHT7xir9t/8AnHqYy+R9NBFAsSgf8CMVe24q7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUg8zW9rNpt1
+kI1kjEMgow8VOV5QCGURu/IL8mbQaZ+YGo6bZAfVZJ3enhvmj1eIU5+IU+0wlzA
0twfjhKkAHqMwBiDa+Jha2835qwHWaNEJVKjrvXN1psQAcTLF+zNkEW3iEIonBeI
9qbZtA4iJwq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FW
Gec/PujeRLN9S8w3McCKpIDuFJoK98Vfif8A85L/APPwXUvPs8/kT8lI3kkVvReS
MVNSKbEYqwr/AJxz/wCcFfM/5vXsfnv83pJWDOsnCYNTrir9yPy5/KXQPy106HSt
BtIozEoHNRQmmKvUMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irTMEBZyAB1JxV+JH/Pxv/nKZr0n8kfIUnPV3YpN6RDbE07Yq9c/596/84tQeStC
h89+Zoi2q3NXIkUggsK98Vfq4BTYYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+A/+csfyB1H8+L+z0K7lePS
duapXi1PGmKvza/5zX/5x18ufkZ5csNM0WNRJxjUtQ1P34q9S/I7/nDfRPzk/LKL
X+Kw3y8GVlB5V+jFX6bf84y/l9qH5XeX/wDCF6zS28Rqkj1qPbfFX0zirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVfzsf8APyRAfzd0tv8Ai5P1jFX7g/kCQfI+l0FP3S/8RGKv
ZsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVY95g806b5atZL/AFW5hhSMEkPIqnb5nATSQLfn3+cX/Ob+jX0M3k78skmu
9YkrHy4VjqRTrmLmzxpyIY6eaf8AOO3kPzDZ38vnj8woxDLNV0VPfxzSanURczHA
vqSy1CO6u5JZ+S3LAoEOycfH55i+PFtp8W/mr5F86eS/Nv8AysnyTAl3BGfUdZBU
UB7Zs9NqY042SBfU/wCUH/OcPlzzVPF5Y86ctP1mojYMoWPkBvuad83EM0ZOJLG+
57LVbLUVV9PuIp1YVBjdWqOvY5a0phirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirTHiKmgHcnFXxr/zkp/zmX5R/ICyZZrmK61Vh8EKODua9Rir8RNZ
86/m1/znb5j/AEfpC3NnpbyDhxBVONae3bFX6xf840/8+/8Ay3+Ukdtq+vRrdaqq
gy81rVwa1xV+jdpZwWES21nGsUSigVRQDFUTirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdir4g/5zZ/5yasfyF8n3P1SdDrNyjRpEGHNa96Yq/K3
/nBj/nG/Uv8AnIPze/54fmMJTbxzmeFpVPxnqBXvir+ii1tYbONYLRFjjUABVFAA
BQbYqicVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVWlVJDEAkdDir8Zv8An67bNLpVnMpoEZMVfVn/AD73eRvy
wtVcfAAlD70OKvu4KF2UU+WKt4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX87f/PyT/wAm
5pn/ABmT9YxV+335Af8AKDaX/wAYl/4iMVezYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqpvIEZUINWJAoPDxxV8h/85M/85IW
n5D2yaXoafXPNGqGttCTyCk7AsO2AkBXwra/lH57/Oe6j8wfnjfz20N7+9hhtHKq
q+BA9so1GURgSCGzHE3yfSnk78nvLX5fWRg0y2jndSAJZUBf51znMmrkXYRg9RvW
/R9gj2QBYkDj4Zp8uokW+CpcoZYVGsKq2tAQ0f26/RmP48mdIZopJ4PTk4vpng27
EZsMGok0yDxX8wvyG8k+d4DLBG9rcvUepAvFgfGozc6bVHiA2cfJDZ4PdWH5r/8A
OMsUereRp21HQAalLhi8nH6a9s6Hjj3h19F+jn/OO/5/WP51aSJGpFrMC/6TB0Kk
e3bDa0+kMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVSXXvMWneWLOTVd
cuY7a2iUszSOF29qnfFX4u/85V/8/LBJLJ+Xv5Exvd6gT6c8sfxHrQ8aDFXzv/zj
z/zgx52/5yG1j/lYn5wzzrYl+fpXNa0qCKAnFX71flp+Svlb8q7CHTPLNjFGYhT1
AgDHFXrWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV53
+aXn60/Lby7eeatRliiS3jZ1MrBQSBWm+Kv5tbq68yf857/nIZ1WX/D9vOUeu8RR
T26Dtir+kn8q/wAudI/K3y3ZeUPLUIitbeNRsACTQVJxV6LirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
r8av+fqySNokLodhJGKYq+sf+ffq8fytsq9aJ+o4q+5MVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVfzt/wDPyT/ybmmf8Zk/WMVft9+QH/KDaX/xiX/iIxV7NirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqC1G/i0y2kv7
o8YolLMfliiRp+MX5fQy/nN+afmHzjrdZbXSboi3EvxLSvauajtKdDZt0r7fST1S
3rAKENIx0FPbOLs8XMu/NcLifHMm2ldTx3HhkgEtnfY7jwOSpC01ApXbw7ZAilWE
8RyAG2RNqrTBNQgWCdFkVtuLio+45LSEiXMplT4r/Ke/f8nfzhvbOdjFFr83CNK0
Xc9gM7HRSsODPZ+zS9BXNg4BbxQ7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWiQoq
xoBir5l/Pv8A5yl8n/kXo8uraxeRS3QB4wI/x1BpuMVfhF+Zf5/fmr/znBra+T/y
/iuYNHaQorxVCgVrU09sVfpN/wA4sf8APuzQ/wAqvqvmbzjGLvX1POdpVDqxIB74
q/Uq3tYbNBDaRpFGP2UUKPuGKojFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYqh7u6jsYJLy5YLFEjO7HsFFTir+dr/nPf/nJm8/5yB80R/kX
+WUs0umib0ZfRYhi+wJIHbFX6g/84Sf84yW35J+SLK31q3Q6vKFmaTiA+69z1xV9
2dNhirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVfjR/z9S/45EP+vH+rFX1Z/z73/8AJW2n+w/UcVfd
eKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kv52/8An5J/5NzTP+MyfrGKv2+/ID/lBtL/
AOMS/wDERir2bFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXg3/ADkx5lHlX8t9e1ZZAk6Wx9MVoSxPQYDKkSFvhP8A5xl0Yz+W
V1+NfTuNTT1JSepNc5/XztyNOKfUlyUnWL09mhHFvfOYjH1u3EtkPtmVwocdsBVq
uRtV2Tq1WkAgjAYq2z+j6Tr0BrjhFFBL4y/5yh019I82eUPPlkOMVpOJJ2G21e+d
Ho8tOHkfrR5F8zQ+btEtNdtGDJPGDUZuMcrDgzG7LssYuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KpNruv2Hlq0k1XWp0t7aNSzO5oNsVfkR/zlB/z8gtNAkm8qflXW6v25
RK8ZJ+Kvtir4z/J7/nEj8yf+ctfMC+d/zPuJ7TT2k9SVZmPF423ooOKv3r/J/wD5
x+8pfknp8Wm+SbKO3YKolcqpZ9qHelR9+KvccVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVcTTc4q/K7/n4l/zlpD+WOhSfl55Tmrrt8pT
nGx25CnHbvvirwz/AJ9qf84oPcO/58fmFDzvrpuccU4DGpqeW+Kv3CRQihEFFAoA
OwGKrsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdir8aP+fqX/HIh/14/wBWKvqz/n3v/wCSttP9h+o4
q+68VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVfzt/wDPyT/ybmmf8Zk/WMVft9+QH/KD
aX/xiX/iIxV7NirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdir8wv+c+fNdxd6h5e8g6VLyhvpON0ik9KnrmFnyhnGFvS/JmiR6No
+l6Lo6+kkEXGRu2aLNLicqEaYvqv5paWnm+z8h2zD63MPi9zmEMBG7kwnvT1JB6o
kJ+Exkih70wEOQttm+tIz/ZK9j3yiZQorLyXmRTelMrtVc7kLl8VQ2oTCztp7p/s
woWOXRjeylgvlX8xNM8z/wC46zZTPUqwHVfnkpYDHdxzJIv+chPKz6/5Kv7KFa3U
UX7mXwOXYcvCWqe70L/nBfzsNa8np5Unb1L3S14TNv1rnRaWVuLkGz7nzMaXYq7F
XYq7FXYq7FXYq7FXYq7FXE03OKvnz86P+ci/Kv5N6dNd65doLtEYrDX4iQMVfhR+
bf8Azk/+ZH/OV2rv5O/LeOddIeQx1j5AcW2rir7U/wCcVf8An3bp/l5IfNX5lf6V
fkrKVchiGI98VfrnpGkWuhWsemaZGsUEShVVQB0FO2KpnirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfPf/ADkd+d2nfkp5UvNfvJVF
36bCKM1qSVPTFX4Jf847flhrX/OZP5rv5084s40CG4EwjkNQaGvQ18MVf0p+XPLl
j5WsINH0iJYoIIkiUKKbKKdsVT7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX40f8/Uv+ORD/rx
/qxV9Wf8+9//ACVtp/sP1HFX3XirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir+dv/AJ+S
f+Tc0z/jMn6xir9vvyA/5QbS/wDjEv8AxEYq9mxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KrXdY1LuaKNyTgJpX4y65LL+Y/5zag
lyTJaWE/7uvQAHNJqJuZihb7Oe9g8vRyxXZC2vFqueg+HMCI4i3SFPxi0fXdal/N
a+/NW5Zv0JpF36KtvxILZn5MFQ5NWKXqfsrY6iur2Vnrtqaw3UYkqP8AKzTyjTsS
iSD9dWKL7BWpzDyIVHQNJxToMqVq4+FVkXMrGFYF+ausjRPLV5KTR5YSq/PM3DC5
BEuT8xf+cc9f1fy/5zvLjXWZbS+dlg5VpWvbNprMFR5OCJP16eaHW9PXQ7gchKvF
j9Gc+ZVJL5W/5xI1b/lV/wCY/mbypqLUi1Cc/VlPz7Z0/Z8uKmqUbfreDUVGbNxS
3gKuwq7FXYq7FXYq7FXYq7FUq1rW7Py/avqWqyrFBGCSzHwFcVfld/zlF/z8H0ry
vDN5U/L9hcai9UDpUmpG3T3xV8Bfl/8AkL+Zv/OXetx+cPPks0GlF12dmAKk0Oxx
V+5X5C/84weVfyN0+K30a2R74KvOYqK1A+WKvpgAAUGwxVvFXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqkPmXzDa+V9Mude1FuMFtGz
sT7CuKv5rv8AnIP80PMv/OYX5kL5J8rs/wCjYLlYyq1AKg0+WKv3d/5xs/InS/yZ
8r2Wn20Ki/MKeq9BWtPlir6SxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvxo/wCfqX/HIh/1
4/1Yq+rP+fe//krbT/YfqOKvuvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX87f/AD8k
/wDJuaZ/xmT9YxV+335Af8oNpf8AxiX/AIiMVezYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXn35rawfL/lLVtZQ0a3tmcHIZOTG
Rfln/wA44AazqGpeaLkVnvmZkP05z2o5u004Z5/zlP5vby/5Dv8ARbU01e6KCEjr
vttg0kd23MGHfmr+UFr5T/5xoTUrKOmq30VvcXEnfk2/z7Zu80fQ6/EfU9g/IfUm
1D8vNMinNZYbaNa5zWZ2werRSekouW+1TjmuyqqwRlCxbuCcpULE/fW6t/lZl4lf
Mf8AzlZrDaVpWlWimi3M3A/fm10cbmGOTkkH5w/lJHo35feXfPuhpxltGE05XuOu
+dB2hD0uuBfQP5P+ZYfNPluDXa/vZV2+YFM4jMam2h8q/mtHceTPzo8kzxVX9JSg
t7750fZJtBftNaSerCsg7jN5Pm4kxRVzlUzTBvJq7FXYq7FXYq7FXYq8F/OH/nIL
y1+UGnT6hrVwvrxDaOo3NPnir8Lvzo/5y287/wDOR+rf4U/LZpRaysF4xg0ofh7Y
q+n/APnGT/n3YZnh87fmmxe7qsnpOSSSDXvir9jvL3lrTvK9nFpWi26QW8ShQqCn
TFU+xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KvyD/AOfiP5p+eJ4o/wAv/wAu7WU29zRJXQNvUU7fPFWTf84Af84mt+XmmL55
84xldbuOMtGFTua9xir9VsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfjR/wA/Uv8AjkQ/
68f6sVfVn/Pvf/yVtp/sP1HFX3XirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir+dv/n5J
/wCTc0z/AIzJ+sYq/b78gP8AlBtL/wCMS/8AERir2bFXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+ev8AnKK9Fp+XOtqX487cjbvm
PqLrZlEPiT/nFHSUvPKAe6IhJVuEo6jfOU1PFxFyIyIYX/zl5o2pTXmheaNLiNzp
elBfrR3+OhrU5f2cTZtusnm9H/Oz86fLXnn/AJx7ubnQ7lfrFosMT2woCGG1KZ02
evDRjjUk/wDyBs5I/INheOOPqwRtTOWyuaHsyQ+rCEPUb5rsqSrrMJy3HstMoCAh
YP3VsA382ZmJL5P/AOcubCW8stCuIV5+jdBuPjvm10hqTGfJlf5q/n5otx+VsP5e
6CEu9fuYRDNbDf0tqVzb6uRIDrgN1n/ONflrU/L3luw0tVM8s3ITI1f3Vc5rLG5N
oYT/AM5Yx20fmTy7LNNw1GzZfQcbkb9s3nZwpjIv1M/LG6kvPLGm3FwxaVoFLser
Hxzd5A4s+bPcgwdirsVdirsVdiqEvb6302Fry+kWKFBVmc0AxV+YP/OUv/PxDQfy
3hn8seQmF9q7jgHj34k1G1Dir8yvIv5R/mr/AM5W66mseaXuP0XcvyKuGApX+hxV
+3H/ADjx/wA4keV/yctEkawibUV6SdT1rir7FVQoCqKAYq3irsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd16Yq7FXYq7FXYqxzUPKGi6rILn
ULKGWUGoZl3GKp/DCluiwwgKiigA7DFVTFXYq7FXdMVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir8m
f+fkfkDzL5+0y3tvL1iZSrJutTWnyxV9N/8AODflTWPJ/wCXNtpPmi2NtdDjRTXp
Q+OKvsvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX4R/858/kt5s86fmdpuveW7NriIX
C1ABoAD7Yq/YT8ldNv8ARvKdhpeswehcQxKCv+xGKvWMVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirzr80PI0Hn/QbvQLkkCaMjIT
jYZRL8irDU/Mn/ONGuv5e8wQOfL1w9IpOJICk++aTU6YHduBfaWm6voH5macselO
lxpsiH6yrEfDt4ZjYcfAW4F+ef5vf84sanbao8Xk6dz5dup0knhWvHY16ZtMue4N
kNy/Q7yppqeX9A0vy9EKLHbopA9s0Ezblsmkk9G7WJN0Kb5g5VQ8Q9F2HY5VS065
+GNUXxrmVjV4x+f2inWfKF5LHtLawtIrDqCO+Z+CXqDGfJ8l/wDOJP5VQ+aEk8za
1J61wrOSzdTTNxqTs68Pujzt+YWi/lXoct0zrDOU/dhCORNPDrmnOKyy4nyf+V/5
ceZf+co/MsPnLzJE9vpOmvWJ2BXmAc3OjhTCRfstoelR6HYwaVb/AN3AgQfRm0Jt
xibTXAh2KuxV2KuxV5d+Z35v+Wvym02TWvN15HAiioUsOR+iuKvwc/5yL/5zx83f
nvqcn5eflDbSiyLFFmiWvLfuRir2L/nF7/n3JcaxLB+YH5uOz3Tn1PTlB36HFX7V
+WfJ+k+UbSLTNCto4Iol4jgKYqyfFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq0SAKnYYq0jrIOaEMp7g1GKt17d8VbxV1e2KuxVokDc9MVb
BruMVWs6oOTkAeJNMVcpJFTT2oa7YqoXN3DZqJLpwik0BJ7nFVDU779H2sl6F58F
LAYq8+8jefLnzZd3EEtuI4Iq8XHfFXp6sG3Ug/LFV2KtcgNyeuKt4q7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUF
eadbagAt7EsoHTkK4qiYokgQRQqFRdgBiqpirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
qX3GlWd1ILi4hR5FNQxG4xVMMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirzX8yPyu0X8ytOfStbt43YiiSFd1+WVzhbOMqf
lR+Yv5Q+f/8AnGvUP0/+XqveeVSwa+rUlB1NBmvzY27ifRf5a/mj5a/NfTo7vQZm
NzCtLqGX4SH9hmq1EiBTdhNl6XGNm9bZ12Qe2YJLnKlkRxaS8/vP2cxpqh+bFeLj
4uW3yyFKrP8AEQzbKMvgrGvOUEOq6DqmluwpPbsg38cycUvUES5F+an5U/nXa/kp
d6h5O0oT3WuqX+qw8SyM5PQ50JHE6y305+Vn/ON/nH89dctvzL/O8PZRRP6kFkgP
pvTcBhkfBPQIJfrHoWgWHl21Sw0i2itolFOMSgDM/Fj4Q0yNp18stYuxV2KuxVZJ
IsSNLIaKoJJ9hir89P8AnJv/AJz88nfkzaXGjaTP9a16jKka0NGBp74q/IPRPLX5
xf8AOcvmBp9V+sweXppCPiBChCaimKv23/5xx/5wt8nfkXpkEQtYrvUkALTSJU8i
N9zir7QSNYlEcYCqNgAKAYqvxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KqNzOtrDJcy/YjUufkBXFXwp5u/OzzL561STQfyna3d45DG/qyK
tKGhxVW8h/nL5o8mecl/L78zxapp0yL6U8bqzeq3Y07VxVN/Mn58335Y/mXe6f8A
mAfQ8nT26myuAKlpD2xVS0388/MWraje3+mW4byxZIZkuH2Zh8/lirzHy9+cf5mf
mXrt5L5GtUk09SQhalNsVeneSPzs8x+WtXn8ufmfCqXUppAiGpJ+WKoDXfPn5o+a
L66i8nwWyWlu23rOENB88VUvIX/OQWuejeW+txxNcWJKTUYFeQ8DirCdF/OX8x/z
m1K6HkG1Q6TZlhI70HxL4Yq9A/J78/vMmpQ6n5c/MKBIdYshKYvToaqmKsG0P80/
zL/OfS7/AMw6NbWselabPIqKHUSM0Z2+HrvTFXuHlz83tWn/ACxn83edLdbbVgJY
FhIpUrsDTFXh+j/85Caknk+y0/yvbI/mS7umjdFoSFJ2JxVO9R/MD81fy7+q6p5n
s4hp7tWZgRspxVEfmf8A85PX0NjYQ+U4w13qVFhpTdvfFWJXv5jfm75atLfUPNNp
GlrIAag7kHFX3Z+XXmb/ABVoltqTgiVkHMe+Ks6xV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KtMwUVY0HvireKuxVqorSu+KrWkVaBiBXpU0
xVfiqjJcRRMscjhWboCeuKqte/bFVryLGOUjBR4k0xVcrBhyU1B7jFVnqpy9PkvL
wqK4qxPzj5gm8u2ovYVqg+0ep+VMVV/KWvv5hsBqcqcEY/CTtX5jFWTq6uKoQR7H
FV1cVWLIjkqjAkdQDiq/FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FWHecvNS+VLZLt1Lc24igqa/LFU50LUX1Wyj1CZOHqCoB22xVOK13GKr
VYN9kg022xVdirQIOw7Yq8t/MD80LDyLLBZ3ppLMRT6cVeh6XqCanaRahGCqSoGF
ffFUeCG3BqMVcSFFWNAMVaVg4DIQVPQjFXnvmn80/Lnk/VdP8sa5dCPUdSfhbxgV
qfffbFXomKurXpirAtc/Mvy95e1GLy/qV2q3832Y13P04qp6/wCdxot5BZekzicA
qQK1BxVnkUolRX+yWUNQ9d8VVcVaJCirGgxVvFXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYql2qaZaavbSWGpxLNbygh0YVBFO+U5oAjdIL8W9H8sN5Z/
O17fy8RBpRmb1IU+FTv4Zz2qFBysB9T7yuaGV6dORzVcTs1E5CSG1mCfARvkVUJ7
ZroFVNMndKwzXfKt3c2F2LWQiYxnhU7VyyE6IYy5Pzm/LrzJd/l3+Y80vmbSor4x
yksyxBzSvyzqMW4Dqi/R+0/5+HflhbaiPLer+vp90tF4yKFUffSmbOGPZgQ+vfLP
5o+V/NttDfaLqlrKswqqiVeX3VxkK5sGfKwcckIIPQjIg2reFXYq7FUv1Wy/SNlc
WAJUzROlR25CmKvymuv+fZekeZ/OT+dfN901xCZmlCP8XU1p1xV+mfkb8vtE/LzT
YdC8s2sUEEKhQUQAmgpucVZtirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVSvXCBp13y6fV5f+InFX5Efkb+TPlrzDqmsaj5v1e6066a
9lMYWUx9WNMVepaL+Uf5WTedn0zUtX1C612xX6ys7SFrfiu4HPpXFWCf85Gfpv8A
PmX9AeS4PU0/y8v1hrnjyDrH25d+mKvUW88afD+QlxqNiETVEtmSaNaCT4RQ1GKv
Rf8AnDXXPLtt+Wdl5mNzbw3k4cziWVVaoPSh3xV8sfmZ5/1VfzCXzp5Yg+sxWcvI
FhyiO/j0xV7Bqvl6LzT5b1L8zvzB1gae8g9SOGxnCnp0IBxV4j5Q0jTIfIWt655e
unkkaZeJmb42BP44q+7P+ccNE0/QfKL31hGYrmaBpJSV4gmlSfvxV8l/lF+YWh+S
dP8AMX5sfmzHK0R1SXTo/QQueEjFammKss1f8q9N8g20v5qfkRrakTo189lcXAEb
Bhy48CevtirG/Pv516h54/KvRPNXmK0FndX2qjT5IIl41HKhanviqL/JLyhp35e/
mne2/mKQR6bNbo9p9YIVRIy12rir3f8A5yj85WmoafF5S0SaKe7nNCI3DUr8sVfM
P5c+Vpr/AF3RdA1pAWspa1I6Yq+mf+cqdWOjnRNDtxVLg8aewNMVfTP5a6YmmeXr
JIwAXiDGmKs9xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KupX
Y4qxfzP5ptvLNtJc3darGzg022Hc4q+CY/zd/M/8ydTuR5Tn02DR4GbgXlRWJHQH
FWeflb+dHmee+v8Ay5+YD241OGBvqwt2BVnpsNutcVSq3/5yh1fysLrT/PsKRamA
31eJQBX+XamKoS//ADm812vlq5/MbVIxDJDGZIIX+EOR0AHfFUg8m6r+ev5y6Pbf
mBIllYwEGSxhRlVmof2xtir078qPz/17XNM8y2fnmJE1fy9WOUW4qeXToMVYA+q/
nB5ytZvMd7c6XZafHV7ACZEkMY3/AHg8fnirvJn/ADk5qeseQtc1bVBxvtFmNuZA
fhZh0oe4xVhHlT81Pzr/ADE0S4852cEEOh2zcQJKCRl8QOpxV6Lof/OQXmHSvJ0+
oPCJtQSRkq24BxViOj+Z/wA0Nb0qLz/oM0E07XFJLcOGYJX+XFXr/wCaX5y3+jeV
9K1R4h+lTMovIXFAF25GmKvOrX86fPP5mX7eXPyyhhSx4hXY0AA70xVVT8zPzI/J
jzRovk/z99Xk0vW7gQQShgWBPvviqA/OL/nIvzva+frf8q/y9t4ri5kkCCUAEIT/
ADntiqEm8+/mX+T/AJs0+Dz6YpLPUGrNwYEbn9nFX6PaXqCaraQ6jACI5kDgHwOK
o/FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+Uv+clfzEvv
Is2g/o+OOWOe6CyK9DQV60xV84+Vvz5/M783vPuseQfLUEMOjWCgF1oKCnY4qx/y
7/zkH+aHlDzxc/lJfW8V1cXMnCxd9wp/yjir0fS/zN8+/ld59tPLfngRy22rvynF
agH/AIr/ALMVb/N//nIDz9/ysTTfyz/K2KKW1v1+N2pyXFUZfedvzL/JydLrzf6V
xDcOK0IYUJxVLPzq8xN511HSdTtk3VY5Ci7++Ks317zt5z8yPDpOiPBp+lJbqpaR
hGSwFO+KsB8kfnj5x8p6rqflTWXgvLOxt2nEoYMdhXriqSeQfzz/ADW/Pa5lsvK1
tDFoySMonoATQ9zir0n8lfzS88XnnPXvyk8xCNrnT4i0T16GnXFXzH5b8tedfzT/
ADj1K01KRZLjyzNzFTULvt8sVfTvnDzn+Z3mDWE0HQntLOK0NJnlcJyp88VSz8vv
zt82WHnGL8sNVaC7ubvlxkRgyqR7jFXz3pvl7zrqn5z3C6gTNLDK5i7oADir3XUf
+ch9f8sazLp+qRW0s9tyjUGhII6Yqi7bzX+cn5haRN5u8vRwQ+izGNKgVVd9hirN
vyu/5yF1jWvLmp2vnNIofNGnwysAKBWKD9eKvDPyt/Nr86/z9tbyHT7e3tLGCaRE
nNFLBTQb7Yq92/5x6/OLX9V80ap+TvnmMHUtJj5+qu9fpxV9oYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7Bauwq0RXY4CFfjHYzyXv52XTW5rDDcMr/fmi7Th
UCXJ059Yfa9wf3r06cjnNAu1KytcsBQps3E9K4VXKxbYGmRJtXXFs09vLGH+0tOu
CB3CJci+WP8AnHb6m35r61pupwRz+iSaSqG/XnXaM2A6kvfvz8/5wN8j/nRLJr1v
F9S1OQAhogFFfopm7hlA2LUX50+YP+cDPzf/ACeuf01+XuryzwRmscfqlqd+lfbK
s1EbNZSfyj/znV+fv5Za7F5W/MzTGn0qFgjSCKrUr408Mwge5Ifqj+W3/ObPkPzv
HBazXH1O+ZRzS4cLQ/TmfjxcQbeF9S+W/O2kea0MmjXMc1P5WBr8srLBlmBXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqp
TQrcRtBKKo4KkexxV8xecv8AnFjy35qumvo5JrX1CS4hbjUnr0xVO/L/APzjZ5Y8
vaO/lq39R4pKhp2/viD1+Prir0Dyd+V+i+SNCfyho8Z+qSBuTOAXbl4nvir4i/O7
8ptP8oahpuheUobh49buPQvVoTEqMdyB0GKvTrb/AJwZ8iw20Vk89+kUe4SCUxpU
9dhir2zT/wAh/LOmaK3lW2hrasOJZwC5H+t1rirx+3/5wv8AKUxuYNWuLyW0lb4I
hMQoHy3xVl9r/wA4p+TbGKOws1mSzSlYg2zU8cVe92nlyxs9M/w9ZIYrNYzFRdjT
pirzex/IjyvY6NeeU1txJp97KZZEkUN8Z6nfv4Yq8Vn/AOcJPJ09wkZuL9dPjlE6
xLOQOY3p/q+2Kvatf/Iryx5jtdO07UIAIdNkSWFEAC8k6Gnj74ql/wCaX/OPXlj8
1WjutcWaK5hVQklu/A/D06YqxLyj/wA4n+UvLV0urSPdXN0pqPXk5D+OKvUrX8oN
AtNS/T0UZFxWoptTFVTzt+VOj+e7yz1LWQzPZmqDFXoen2EWmW6WVqKRRiig4qjM
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeR/nbZ3WoeVb2
000fvpInUNTpVcVfnF+SH5J+Sbfy3ey/mDq88OqG6kcJHcFT1PYHFXqf5caL5G0H
VbvW3lne4tIzJbSyPVHZegqeuKvB/wAxvL/mzzf5ltPzm8yQj9D+vRY4124qdqjF
Xpn/ADlx+Y2mXXl3yVcaUCbaW4QTxQ9AoABDgdsVfWHlf82/JnkbyhDq8FyjKsYL
W8bio26Be2KvgHy95q8y+QvM+v8Amezh/wBD86y+raNKP3aKT+3XFWc/nV5O8naH
5Gl82Xer3M2pycTcw2dwSA5/lAOwxVKNS0200D8oodA0iksWryQTlUoZtyPt964q
+6/MY/w9+V1nFp0aQUsogUAC7lN6jx8cVfJ35f8A5l+W/Kuhz6d+Y9lLLYXVx6fq
xrsCx61xVBeZbS3/ACh1Wz86/kzfrcaVeypztZJeVOR/lriqn+YGvan+bHmC/wBD
ijWGSKyD8SKKSRX4R44qzL/nGG80nyZDLFrUiWt9bFmm9YhSR7VxVJvz41Ufnf5x
8q33lNvUsNCvBPNIhqF33LHtirLv+cVdKivvzI89a3exCdvWT0JpAGAFQDwJ6fRi
qv8An21xqf5teTtD8wcJtNkb7MG5HxftDrir9ALW2js4ktbZeMUY4qo7AYqr4q7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX5lfnDqknmPzt5o0v
Uyz22i2v1iAVrRuu2KvYv+cNvKenR6DL+YFuhF/qZIlZh2B8cVeefkHYHzr+cvnT
WdchV00i4pZuRXq1Njiqp+dYbzJ+cHl27ko1lpPP1FQ1J6nfFXmP5L+f/Luq/mtq
+u6u/omwuHjjeU0CiuKvWv8AnInzZF+Yd/a+XfJki3hVeTGP4unyxV5Z5bk1W31h
La5UNJawE8GHQqPDFWV6Qmn/AJtWd/q/n7UFsbezVwkUMnByV9hir5h8t6vo2jXG
o3WiyyyQ3YktP3zVYjp3xV+lv/OMHli38j+RFljjEcbF5iSKEilTU4q8e/J6OeP8
x/OX5pXCiWKaE+lx6Hj2xVgH5I+crbyzrv5h/mjdsG1O6UusFd6qajbFUx8nQaV+
Zui6l52/NXVVtvWDPDDBNwlXwqAa4q81/wCce7DRk1TWPMGiPNJd2DuLR52qxHsT
ir3L8lPOlpanXvNnmB42v45XUVI57+HfFXzX5o8iT61qk/n6L1WtGuObdwATir70
8hfmh5T0bye1lb3kMdxFbuPTLDkXK7CnzxV+eWt23mE6K3mpAYnvdRaEkbcomb+m
Kv0z/LbS7T8vfy7d9IQRPBavcu1KVbhyriryX/nFvTD5m1HUvzdkUGTUmeJpPHie
xxV9tYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7BSuwq0TTc9MSr8R/wAg
JpPMH5oedNRvjz+qak6xnwHLNN2oLxly9NH1PvOZTI5eP7Nd85eAdlIqskHqgNan
p1y6MAw4ihWZXosLqXB+IZPgC8ShcoWkUW+y1HLKzEBNo4QxmdFirxJXKwN1PJ8d
/lU50j8+NcH2Y5iBnTaWRADqpP2EioUUr0oKfdm5BsNRXMiuKOAR7jChgHmP8rvL
Pmqp1jTreRiN29Na/fTKThF2inyN+ZX/ADgH+XvmPnrGhwT2moL8Q9J6AkfKmZEZ
kcmwSZh/zjl+R2p/lu7HUpnaCM8Yw7VNAciwfZWKuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpL5h1218tafPr
WpOEt7dC7EmmwxV+Vt3/AM/DdC83ef08h6Bp730cE3DnGpbjQ0r02xV+q+iakNXs
YdREbRiVA3BhQioxVNcVdTvirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVQl9ZQ6jA9ndLyicEEfPFXzzf8A
/OKnkLUbp9RntpxK7FiFloKn2pirKx+QvlEafFoa2zi2hbmtG+Kvuab4qzmXyPo0
2lr5amtlawUUCEDFXwtqf5I2+qedrzy1cQs3l6M/uUNG41PauKvd9O/5xI8haeRJ
HBOx7q0lV+7pir1HWfyh8sa9pK+WNRtA1mi8V40DAexptiryfQ/+cSPI+mJPbXME
09u7fCkknIAfSDirOdE/5x/8paGyvb27OE+wrmqrTwGKvSda8qadr9gNF1GMtaAc
QoNNsVYNe/kf5S1DRW8pXNmDYM/MjblX50xVhul/84seRNJkSe2t5mMbB1DycgCP
amKvQR+UPlsaiNeW2pdhQvIECoHjtirFvMv/ADjn5M81Xb6nqVtIs0go3pPwBHyA
xVNvJv5GeVPIlte6foFu6xX6FJubcjQ+BptirKvJ35eaJ5FV08vQekZPtsTUt8zi
qAl/Kvy/PrkfnOeFn1OE8kdmqFPsKYq9GxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV5re/lJ5Z1G/1DW7u05Xepx+lctX7S4qyPyr5Q0vyZ
pieXPL8Po2MdQqV8eu+KoHyx+X2ieULq81PQrf0rm+blO1a8j1xV5954/LLTbX6x
5s0aEjVjX4iajcYq+d/ya/5xk0HWU1jV/OdtIby8uCxKNw698VfTfkX8ivKf5eXX
6S8v2z/WOJXlK/OgPzGKsg/5VZ5cGpS+YRaD65KGDmu1G67Yq80u/wDnFnyNeXkm
oSQTKspLPEklFJPXFVWL/nFn8vYChh09lMbcl+Pv92KvcLfQLK2079AQx8bP0zFx
G3wkUxVIvLf5eaH5VglstIt+Mc1efI1JrirAtN/5x28maXqV3rttaP697X1lL/Ca
+1MVYzN/ziZ+X813LqH1a4VpjVkWYhPoFMVZv5c/Inyh5Vb1NHszGaUPxda+O2Ko
Cy/5x48mWFzcX1vayB7l+cg5/CT8qYqzmH8udAg0yTy7HaL9SlryU9d/fFXkJ/5x
N/L76x9eFrOH586Cbavypir1LUvyr8tarYQaHd2am0t2DRqNtx0JxVlU3l+xn0yT
y48f+gywtAyD+RhQ/hiqVeR/I+k/l3pMfljyvEYbCJmZVJqasanfFWX4q7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqlGvXf1HT7i66cInP/AApyE+TKPN+N
v/OHtoLnzD5+1Obq2pOQf9lmp7U/uy5en+p9yQyhYpFPWpzl8Zc8pLcX0uj6TdX8
n7KuR92Z0I21Evzz8qf85DXtz+YreWZnP1d5OAqTTc5knDs18T9JFga2AeQfbiDj
6RmDkDaCq2ZEccEz9TIP15jA+psPJ8ZXbfoP84ZdRTb6xIBXx3zptNyDqpc36/aT
L61pDIepQfqzcw5NMkxySHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq0zBQWbYDrir8Z/8An45/zlaN
Mtv+VP8Akaflq1yxjcRkhjU0ptirJv8An3V/ziZa+StN/wCVl+crQya3ffvKzAEr
yFa7798VfrkAFAVRQDYAYq3irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqXJpVrHctqKxj1
36tiqY4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVrosilJACp2IOKqcFvFbL6dugRetAKY
qrYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FWE/mE8iaHdeiCSY2Bp4cTleRlDm/KL/nFExw33m5LUhma
+POnY8s1Pan90XM0/wBT7Pu0SCNfTNWO5Gcxg3c+bz7829YGmeWJyfhUowr70zb6
eFlxZmn5YQeT5tPe1/My3jJrqCoXHhyzO4NqarfsDpGrLr9pbXNuecYtowWH+rmp
zRpyIFGoBKgAPwKaqfE5rr9TfLk+LvPlf+VgadJDvMbgcwOo3zqNNydTLm/X7y/X
9H29evBf1ZuYcmqSc5Ji7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXyJ/zmD/zkRp/5D+TLrUfrMa6p
NGyQxV+MmnYDFX46/wDOGv8Azj1rP/OUPnqT87/zBDx2UM5miEtSH7gAGuKv6ObC
yh06COztI1jjjVVCqAAABTtiqMxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2Kvz+/5zg/5yU1P8hNKiutDVmlkZQeIO1flir2//AJxZ/Nu5/OXyTbebNQjMczBQ
QRuSR74q+ksVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfk7/AM5b/wDOY2ufkr56tvKe
kK3ozyBDSu4rTFX6PflV5mm83+WbHzBd1EtxGGIPaoBxV6JirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVQl9Zpf28lnN9iRS
p+kUwSFpBp+LH/OJk4sPN/5h6O3VNVdU+XI5pu1v7oubpvqfc5HqvTuM5bTOfN87
/wDORWr+joq6VL0kkC0+edJpIuFkSHzH+Xp0H8m4LwilZhL/ABzOMWp6Z+QWrC/8
prOhqCfT+4ZpdYKcrEXsFjBX07U/suDTNJfqcmXJ8bWoPmT85rjSY9/qsgJ+/Or0
30h1En7BWEH1a3jh7qoH4ZuY8mkozJIdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVYX5988ab+X+j3PmLX
ZRDbwxSOGPQlRUDFX803nrzN5g/5zf8AzdWwt0eTQoLoxilQvEHr3HbFX9GP5L/l
bY/lN5btPLGmU4xxpXYfa474q9cxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV+NH/P1L/jkQ/68f6sVfVn/AD73/wDJW2n+w/UcVfdeKuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2Kv52/wDn5H/5NzTP+MyfrGKv2+/ID/lBtL/4xL/xEYq9mxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtM3EF
j0ArgKQH4r/l5Y/4Q/OPWrEfCmp3jSkeNTml7X/uS5unHqfcMgMM7ufs8jnK6Pm7
Cb44/wCcvr9bQ6bHEf7y6hH3kZ1+hjs63KX1v+c+jmL8mrWyUb/U0c/MoDmfwNV7
vn3/AJxWkJ8ofV5eq3DZoe0A5eF9KSTfV5GvBsoAOc0T6nNkNi+S/wDnHm1/TH54
eYNSkFUG4zr9P9IdPJ+vWbocmh2FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqh7u6jsoZLu4YLHGpdifACu
Kv5+/wDnP3/nJbUfze1pPyX/AC5LGIy+jIU3rWgPTFX39/zgb/zjRZfk75UhvNXt
1bWZ1SVpGFSOQ9xir9DumwxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2Kvxo/5+pf8ciH/AF4/1Yq+rP8An3v/AOSttP8AYfqOKvuvFXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FX87f/PyT/ybmmf8Zk/WMVft9+QH/KDaX/xiX/iIxV7NirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVWuAylT
0IOAjZIfjJBdjXfzqnmUemLOdk2775pe1/7kubpj6n2vd/vy0PReVS2cpoti52WT
4V/5yytzf6vpGnwMWhF3AS3uGGdhoZ7OsyyfpJ+bGni7/LaO2Arx0+Kn0RDNlKWz
jgviD/nG279LT5NMUf8AHw4Ptmi1wtzsMn07eReoJtKQ1jCVD+5zmzi9bsDL0vl/
/nGW6/R35ua7ppFTuOWdVp+QdNJ+twzdBpdhV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvzW/5z9/5ystvy
j8uzeT/LjibzBeKUCKQSAw8PpxV8df8APvv/AJxfk826ofzu888m1GWRZFtpAQKE
1rvir96LeBLaJLeIBURQoA9hiqtirhttirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdir8aP8An6l/xyIf9eP9WKvqz/n3v/5K20/2H6jir7rxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV/O3/wA/JP8Aybmmf8Zk/WMVft9+QH/KDaX/AMYl/wCIjFXs
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxVphyBXxwFIL8TPIBM35wa5H1KXrAffmm7VH7oubpvqfeDr+7lU9d85jRx3c3M+
JvNUR84/mXY+QQOcodJ6ddga9s67Rx2dXlfq95p0RbvyrNpripjsuAH+qlP4ZsSN
mh+Vn5A3p0/zbqeg3HwqjSEA7b1OaXWQNObhfZRP1a3S6fdpGpnPSgeN2J+l8j/k
W/8AyHHWwmwrnRafkHTyfsBm6DS7CrsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirxD8+vzh0v8AJ3yveeYtTnRJ
kjYRoWAJPE02OKv58/yg8ma7/wA5p/mu3m/zB6r6Nb3IKllPHiD4jFX9JHkryRpn
knTrfS9HhWIRQpHt7DFWZ4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq/Gj/n6l/wAciH/Xj/Vir6s/597/APkrbT/YfqOKvuvFXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FX87f/PyT/wAm5pn/ABmT9YxV+335Af8AKDaX/wAYl/4iMVezYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FVr
uI1Lt0AJP0YCr8TfyEprv5p+b9UXdbfUHFew3zUdp/3Zc7TfU+3Lq/ItLy9bYR8+
vsM5/SQ3c3MHy/8A84z2L+dvzml89upeG1ieINSqggGm+dZpY7Oryv1vvYvXt5YD
+2jL94pmY0Pxw852x/Ln8z5fS/di4cih2rU5rNVFzcL7KiJ1GK2tun2G39852cPU
7H+F8hflFJ+ivz41mJ/hUkbnYZutPyDqJP2KVgwDKag5uhyaG8KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVIfM2
v23lnTp9Yv3VIoUZqsQBsK98Vfzkf85U/m9rn/OVf5iW35a+UHkbT0lVJPT+JKdD
WmKv2m/5xR/5x/0r8lPKdrYWsCrfOitK/Eg8hir6vxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2Kvxo/5+pf8ciH/AF4/1Yq+rP8An3v/AOSttP8A
YfqOKvuvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX87f/PyP/ybmmf8Zk/WMVft7+QH
/KDaX/xiX/iIxV7PirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVSfzBqA0vTri+bpHGx/A5GZ2ZR5vxy/5xIhprnn2+bc3OpM
4PcfFmp7S/uy5mm+p9geaovrWlz2sPwlon6f6uaPRndzczyT/nBDVYtDvtW8n3Kq
buS4eUM32qVOdVpjYdXlfp+SFBY7AbnMpofjn/zlQi+ZPzWsv0cTxhkTkV7kEVzX
6o7OXiD7EUgfVeO1I4xt7DOdmd3Z/wAL451r/cX+acd2nwNczBeQ2J3zbabk6iT9
fdHDCzhDmp4L+rN1Dk0yTLJIdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVaZggLMaAbk4q/HH/n4n/zk5b6fDF+XHk26
aS9n/dyiJtwW26fTiq7/AJ96f84rz6HZH8wfOMPK5uiJkaVfj612OKv2KRFjURoK
KBQDFV+KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+NH/P1L
/jkQ/wCvH+rFX1Z/z73/APJW2n+w/UcVfdeKuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
v53P+fkSD/lbmmN/xcn6xir9uv8AnH3/AJQfTB/xWv8AxEYq9pxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpL5i079K6bc2
HeSJgPnTIzGzKPN+PH/OJE6jXfPemv8Abt9SZP8Ahs1Haf8AdlzNN9T7RmjDmRX+
z6T/AKs5/Ry3c7K+U/8AnGyV7X89LjT4NoGglYgdK0OdZpDs6rK/XG/JW2mYdRG/
6jma0Px11Zvr/wCZkpvNyJDSvzzWao7ObhfZ4T44o/Zc53JL1OxP0vjfzG36X/NO
zsIN3t5wWp883Om5Ook/YOwHG2iUdkX9WbqPJplzReSQ7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+R/wDnLf8A5yH0
78jPK09xLIP0jOhEShqEVBHbFX43f84l/ktqf/OTPnuT8yvNyySaeJvVHq/EKBvf
FX9GmiaPbaBYwaRp6KlvAgRQooKDFU1xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV+NH/AD9S/wCORD/rx/qxV9Wf8+9//JW2n+w/UcVfdeKu
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2Kv52P+fkhI/N3Sz29ZP1jFX7g/kAAPI2l0/wB9
L/xEYq9mxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KtE0BJxV+I/5ARSeUvzI87WF8anUNTeSNR4cs1naWEyxFy9NP1PufWr
ldPs5r6TdVRxT6M5TFLwzu5+aT5r/wCcVNMfWPzRuvOMW1uqvFTvU1GdngxGEQT1
dTlk/VrUImntpYo/tMhAzKLW/Hz80rNvKP5nIblgfUlGw9zmq7SHhR4i5eKT7Ogp
cTQ3P2Y+EZ3+Wc7jj4stnYmXpfGv5ZRN5n/PjWbSMfu7Yggnp1zqMeilEbunM7fs
NBH6MaxE14ilczwKDAquFDsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVYf5586af5C0i48xazIqQwIW3PXFX83XnzzTrv8A
zmL+abaDZNI2jJOAoDErxDeBxV+/v5A/kxp35N+XYND0+JUm4ASEKAT92KveMVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir8af+fqArpUKM
eNXjpX5Yq+rP+ffAp+V1oAa/Y/UcVfdWKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtE0FeuKv
mvzV/wA5MeXvJXmRfJfmL9xOzAcmOwBNMVfi5/z8H1qy8yfmlo+o6TMsttJcRgOv
QbjFX6q+Xf8AnIfyr+UPkjTbXVbqO4uhGoEcbbk8Rir6w8gebovPWh2vmi1UpFdL
yVT1A98VZnirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVfjt+ZGmf8q5/P/TLIjhb6sTK/gScxtYLxlv031h9R+cJAdA1G4U7
D1KfKmcZkh6h73YZ3mn/ADgRa/pWPVNdO5junSv0nO9EfRH3Oqyc36Y4GL8dP+cv
Q9l+adjNFsjOhP0kZru2o3iDkYn1l5g1BdM8rPrSmhgtVkJ+Qzn9BD1h2J+kvCv+
cNtJHmzzXqvn8Cpn5Dl8s7IulD9TsCXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqpTTpbo087BI0FWYnYDFX4Cf859f85M
ah5116T8ofy/nMxlYRExFt96Yq+2f+cE/wDnFS3/ACy8u2vmnzPCH1e4TmCwBIJo
fnir9J8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
fjX/AM/VZY7nQ7UGNg6snXY4q+qf+fexB/K204oUpw6/I4q+68VdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdir8f/APn5x+T94dIT81vLcrLeRNxdUNDsQa4q/AfWPzH1nXZop9Vk
aR7aT4WJJoVPvir6A/5x9sPM/wCfP5h6PpDTySafb3C+svI0CinY4q/rT8peWLby
hpsOh6fX0YlAH0ADFWS4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FX5g/wDOf3l9tBuNK/OGL4TpZWNm+ZyvMLjTbg+plH6W
/SvkG3vm63tiZvnVc5PNCpfF2GUoD/n3O9PL+txHr9fff6TnbcP7sOumH6S5S1vy
L/5zFKf8rG09D9oyRj9WYfa4/chyMT0L86tdbRfJraVX4ry1WMfSM03Z8PVbnSPp
eqf84Q+SX8seT47mYfvJixJPvnSuoD7exS7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX51f853f85SWv5QeV7nQNOl46he
xmMN3FTTtir4P/59+f8AOL99+YmryfnF57DSxu7SQtJuDvUda4q/f+3t47WJbeAB
Y0AAA8BiqtirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
Vdir8hv+fl3kzzN510uJ/LdhLNBC6BmXFX1J/wA4IaFq3l/8tbWw8yWz2tyOFEfq
RQ74q+1cVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdiry784PItn+YPlfUNB1Mclkt5FQHpzI
26++Kv46Pzx8k3n5X+bdR8mX6FHiklcV8C22Kv2q/wCfUX5I/o6xu/zE1OOq3afu
WNNjQdKjFX7fYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq+Z/+ct/y+H5mflvqXlgbO5WRW8OAJyvKdm3D9T4k/IbXX87
+TbzQ5Nm0KJ7L58RTOb1YqQc2ZZz/wA4C6vDpMms+U5/humu5JAp6kVOdhI/u4uF
N+nJIAqegzHan48/85VyjzN+athZaaamCWMuR7EZj9rjhwhyceyl/wA5Hao+r6no
flu2+EI8QceI2zWaAOTI+l+of5U6LHonlyztodh6amnhsM3brXpOKuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVxNOuKvHvzv8A
zh0n8lPLN15w15wBGh9JD+2w7Yq/nW8l+XvMn/Oef5vN5huRI/lqG4Jkt9wsaBq1
7jFX9LHkLyPpv5d6Nb+VfL8Yjs7ZQqigHYDFWZYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUFf6dbapCbPUI1lhYglWFRtiqvBBHa
xrb26hI0FFUdAMVVsVdirsVdirsVdirsVdiqQ6v5o0rQSqavdJAzdA1f4DFUzsr6
31GFbuxkWWFujL0OKovFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq0yhgVYVBxV/P9/z8J/5xo1DW/zM03zdpsBktdRuVjkp
XcFumwxV+yn/ADj9+XsH5b+TtP0C0T0lWJSUHYlRir27FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXzv/AM5T67deXfy5
1TU9NJE6hVFPcGuV5OTbh+p8O/8AONujpa+Vb2+sPt3hMs9P5j1zm9YfUHKmgPyD
f9Gfn19TsTS0ktX5gdOZBzq5z/dx+DjTfrbfv6dtK47I36sqkdragH4+aqon/N6a
e5+L4vu3zG7bleIORFb/AM5KxLoWvaJrSdLidFGa/QHZvkaD9V/y3laby9ZSP1Ma
/qGbt17OsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdiqX6rqUOj2c+q3pCwW8bSOSaUCjFX823/ADmZ+f8Aq/8Azlj50j/JjyCX
ewinMShASKhvEYq/Z/8A5w5/5x4svyC8j2ekvbCLW5kBu5O7EgGhxV9dYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYqk2p+XtN1og6rbRzlehcVxVMLSzgsIltbONY4l6KooBiqJxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xVjnmDyppvmb0Tq8IlNu/OMnscVZBGgiURp9lRQYqvxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV8Lf8AOfHneHRfy4vP
Ltg/LXLx4xbwd2G9T45XmNRZ4+bBvyH0F9A8hWkdP9LurVXlU9mI3zm8+MzlYc2b
yT8jGFp/zkMdMfflZyP8jQ50pmJQAHk4sy/W/Ujxs5ye0b/qyMgaag/H2wlSb82L
39JfCo5cCPGuYvap8TGBFyIMq/5yZ8vTazpmmalApZdPkEznwUd8wNF6DRb5DZ9w
/wDON3nm084+VLY2cnNolCncdgB2zfOvfQuKuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuJpucVfj3/z8i/5ywPk+xP5V+RLgtrly
DHIkRBrUjbbfFUt/59t/84it5btf+V0+e7dW1XUCXRJAaqWFa0PzxV+y2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV+V//ADnt5Y8w6VrGmfmtpVu1
5p2nBRJDxLA+OwynUC4s8RosQ0z/AJyy8rR6FBJqYmttQMNPRRKUJHSmazHDdypz
VP8AnFPTbjz9+azfmlHFIlkkDIrOpFag5sMUXEkbfrVq1ob6zmtFJBdCAR8svI2Y
l+M3n3W5fyi/MOe+1i3aSBmPx8CR18cwsgbYSTf8zf8AnJ3Q/MXl668taRE8l7fQ
GCMBK0Yj2zEjj9Qckz2fRf8AzgV5O1ryt5bKeYFZOdWAYEbNuM3Tgv0IxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV8o/wDOWP8A
zkHYfkZ5SutR9Zf0jLE6xJUcgadd8Vfip/zid+SWuf8AOWH5hyfml56Vn0+Gcyq0
oNCOtK4q/pG0bSbbQrKHStOjWO3gRUVV6bCmKpnirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVS/U9Ks9Zt2sNUgjuLdxRkkUMp+g5GUbFJBp8wah/zh
55D1XUjrl7aj1OXIIigKPozHhhI5s5Tt9CeU/JWkeSrRdN8v20cES7fCoBOZEY01
srySvKfPn5NeWvzCVhr1qrOw+2BvlcsdpBp5RoH/ADh95E0C7XUYrf1ZEbkOaigO
UDAQWZyPp/TtNttKgWzsI1jiQAAKKdMy2tHYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWH+ePOeneRdJuNe1uZYYYonYFjSpA6Yq/m
y/Nvz15n/wCcxfzTTyppIkl0WO64Hh8S8K+2Kv6DvyF/JnSfyX8sWnlvRY1WQRIZ
WC0Jbjvir2/FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FVKedLaNp5mCogLEnbYCuKvwe/5z//AOcl7/zjqH/KlvIs5kE03GQxtVt6
AjFX1x/zgN/zjRb/AJaaRH5y1KFTqF1EpJkQc6kdanFX6XYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXiv5lfnhon5YuI9c5U70y+GGxbVLJTG9B/wCcofJXmDj9VuCn
I0+MgZVKNGmYlb2bTvOuh6ogktL+3Ne3qKD+ORTbIIrqCfeCRHH+SwP6sU2iMVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeKf85Cfmqn5MeR9R8/
ScSbRfhDeJB/pir8t/8AnG//AJ+ey/mR5wTyd5jjUQXDhY2I8TTY4q/a6CZbiNJ0
+y6hh8iK4qvZ1QcnIA8SaYq+KP8AnL7/AJyhb/nH/S4LrTAss0zUY9aYq89g/wCc
tdb1r8tIvPOiW5a9dCS3GuKvcf8AnGL83dd/NPRU1DzFCVferkU6Yq+qajr4Yq0r
q4qhBHtiq7FVE3EQf0C6+of2aiv3YqrYq0SBudhirgQdx0xVvFVITxlvSDrz/lqK
/diqrirsVfDf5o/85oaB+XHna18h3FHMriN6HuTir1D8/vzf1DyF5AP5j+UITcAq
rgBeRow2xVJ/+cUfzl1r84fLb6v5ttXt7wNyXkpAKnFX1S8qR09RgtelTTFV+Kux
VpWDCqkEe2KuJA64q3irQIOw7Yq4kAVOwxVakiSf3bBvka4qvxV2KuxV2KuxV2Ku
xV2KuxV+eX/OdX/OT9l+T/lubRNNmH6ZuFKIFYg/Evtir4D/AOcFv+cZ9R/NrX2/
OXz+jsjSCVBKOVamvfFX79aZpsGk2sWn2ahYolCgAU6Yqj8VdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirRYDqaZEzA5p
pouo6kZE5YjmVpr1F8Rj4se9aXcgRUEUyQkCimlYOKqQR7YQbVdhV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V8Y/85D+R9P803SrqJO5od/fNnp4+lwch3fMd1/zjvaIDJps7RoenxUwz0xJtoOp
A2Ydd/kp5n01vX0TUpDToBIf65A6QpGpCPtPOP5q+R1/0R5JvT6dTXKjpyzGpBZV
pX/OXXn7SmA8x2blO/wH+mUy05bRqA988q/85paHdKsWvQvE/c9P4ZDwSy/Mh7/5
T/Pryh5sha5t9QhgoacJXAY4TjIZjOHp9l5g03UgHsLqKUH+RgchwsxlCcVr0wNl
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KvxB/5+0/nZdWNrYfk3o0nJtSdF
lRDvVtt6Yq/Mr80P+cdde/5xqHlj80rMtHHOLedz02NCemKv6cvyI/N/T/zC/Liw
89xSAxw2S+ua7co03++mKvyR/PT/AJzf84+f/PB/Lz8qmYRRTmMiOvY07Yq+Q/8A
nLHzv55ie28v/mHHKQ3EhnrTf54q+yNG8/Sflz/zj/b3hi9RXiO9K9sVerf849f8
5Aajbfk9fea9KXhJbwu4IHhir5Z/LX/nNb80/wA4by68teU2leZWZSV5HocVZDoX
/Oan5o/k151tPJ35mu0NjcyBT64NDU++Kv0K/wCcqP8AnNCy/JnyXZa5pDA6pqkK
vAf9YdvpxV+b9j+cv59eZNPP5q2xnSxA9UL8W6jfFX3r/wA4Y/8AObTfnNaXXl/z
aP8Ac3Yq3Ibg/B1rir5N/PX/AJzm836t57n/AC18mXyWkccjIDuNwaYqj/Jf/OSn
5z+S9dstP1v1dU02eRAzRgkUOKvqL/nKn/nN7/lWHl20g8vr6GvXoVWib7aFv1Yq
/Pa7/wCclPzb8rW0P5jXU0sto7eoyjl064q/YD/nEf8A5yYsv+chvLwvQ6/pO3Ue
ug6g++KvpLzt+kBol42hNwvBExQ/Rir+Sn/nJdvONv8AmpHNqsjrctcD0ySevLFX
6z+Y/PXnryH/AM49y6151/eWwVfSDitV6jFWV/8AOMH/ADlBLa/k3f8A5jXkaqto
CqLxp0G2KvkXSf8AnLb8zPz5vrvWfKupC3htJWCQVNSF6CmKvs7/AJxl/wCcm/zF
8x315pPniwnNtYwM/rup4HiPfFXzJ+Zv/OfHnXzv5vm/LnyLeJY8JDGTuOhpirI/
y5/5yT/OHyB5wsfKuvJLqunXUqq0qKWWhxV6/wD853f85aeYPyfGhNoxaAXTp6ii
opWla0xV9reRPzQ1HW/yfH5kXJP136k0ynuaAUOKvgH/AJxC/wCcx9d/MXz/AKl5
d8wys1nDI4KknoPnirG/+civ+c6/MOr+cLv8svyxcp9XlMTMldiNt6Yq8y8nf85l
+fPyb1y1tfzGleSzuHUMz147nFX7r/l554sfzD0K0806QwaG5jDbdiRirNsVdirs
VdirsVdirsVeQ/nV+ZNl+WXlq71+/uY7dkjbjzPU8T0xV/PD5e0zXP8AnNj81Fk1
ISNpFvcKRISeBAPvir+j/wDLnyFp/wCXmiWvl/SIliSCJEPEAVKjrtirPcVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVQN3
qVrYlVvJVjL/AGQxpX5ZGchEWWUYE8nn2r/mNZ2Upt1dRTvXrmqzdp4/5wDl49Ke
oeO+Zfzbv4LlUsFZoz3Fcoln24ifi5MdOQOSLP5q3cSoswPNhWm+YmXUSkbgbDkY
9LGtw3/ytW8rxCNy60oemUnWGP1GmZ0ke5Ql/Ny5aKRIweXEgdeuX49fE/xBplpR
0Ct5J/Ne4t4mGsg9TQGuZkNdEfxBoyaUno9R0b81NP1ScWrD0298yI9pY+sg40tJ
IdHpkF3DcisLhvkczsWeOT6TbjyxmPNE5cwdgBtXYVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfLH51Qj65HI2/wAXT6c2
2m+l1+XYvP1aKWII6mmbiGKJG7o8+SXFsrW6QW/9yu/vhlhgwGWTUjXcjh4mjCjx
UZTLDFsGWSBvNKtdQBXVYo5K/wAqDKTgiWwZpPO9Y/KPy1qZJW3ZWPcbZQcA7mfj
F5Zrn/ONkF0313QriS3K9F9QjfMXUYSD6Q5WHNfNJLfy3+Y3kL97oOos8adF5E9M
xzil3NwyBluj/wDOVP5h+V3WHzDby3EMRq9FNSB1yEsZ6hyI5R3vpfyJ/wA5v+Vf
NEiW2swSaY2ys1waCvftlRgW+OQF9b+XfOeiebIxceXb6G7Qiv7pgaYKbBIMnwJd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVSzWdTi0axuNUumCxQRs5J9hXFX8iv/ORXnPzF
+eH5zXU/lmKTUJrC6PoqlT9k7Yqz/wDPTU/zu/NDyrD5f816LdR6fYRhVLIRRUGK
vrb/AJ94fm7NrP5ea3+TfqFb2C2mPpknlVVO2KvH/wDnA/U9E0T86dTt/wAxFWC5
W7k9Np+leRp1xV9Ff8/TvM3lTUBYx2UsMl1RQGjp/DFXnPmiGWb/AJxyg9WUCEQn
iD8sVRn/ADjSxl/IDW4YGqFtpP1HFUm/59M6r5ds/NGt/pqaKK7SR+HqU3NffFUX
/wA/eNR0TzR5h8t2Hk0x3GrhgJmgpWpJ41I8NsVeN/8AOfum3ulaN+Viam7PClhb
+uu+xFK1+jFX7efl3508h/8AKlrST6zZi1TSCsi/DyD8DsR41xV+KH/ODaXF9+cO
u6voFf0c1zKrFfsmMk4q92/PL/nHryb5789y3X5ea1BZeYKFnj5DlzxV84aj+af5
h/8AOOfmnT/LHmu5+vW/roFPGu1dsVYh/wA5k+Y7/wA9eadH8yPG8KXTxjka8RWm
9MVfSmn/APOP3mTzd5SeXU/OlrZaOkAKxSU6U6Yq+q/+faP5KSflrf6xqVlqi6jZ
z1qyGqnFX7CkBhQ7g4q/mS/5zgktLf8APLTo9TmSGxW5Xcjb7WKv0X/5zfvbfVP+
cZY9Q8vzJc2UMESs0fQ/DT8MVeA/84I23l3VPyE1LSPPZVLKYk1Y7CuKvnpP+cab
2znvvNH5Ia/FDaI7yNGhB2GKp7/zi5/zlN5g0Xzrc/ll5znS7tipinYL26E1xVk/
5t/847+T/O3nBtX/ACg1qC11qX42jVhy5ManFXhEv5ufmB/zjn+YGl+VfPEn1y3F
wg5Fa1WtOuKvXf8An6Xr3+JvLvlLzikBjguijcqbbCuKv0D8lfmn5a07/nGiyf8A
ScHqrpnpmMOOXKnSmKvyX/5wmvzr/nbXNQ0LaRnlKkfTirxjyP5d1bXfzx1vRU1B
bC7lvW/eSHvX3xV9T/np/wA4ya1qE1rZ+Y/M8F3WRGUKQDscVft//wA4n+T28k/l
9p+jPcC44qKMDXamKvpbFXYq7FXYq7FXYqletapFotlNqd0wWOJCxJ9hir+db/nM
n8+tW/5yB85w/lf5VZpLMSrG6xkgeGKv1j/5w8/5xttPyb8sWs12gN9NGrmoBIPX
c0xV9tYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7AJb0
rsKrWHLMfLDi2SC2BQUy3HDhFKXEVybEi0PdXUdnG08xoqCpw0xMwNi8L85/mpEL
G5g0R+Vyq0Xj45pNZ7R49HIcUSXb6XsyWYWC8G1DWNa8zx2VzqMrCWEbCpGYur9q
MeqxGEY1btcfZEsQu0rn17S75msrudVvE23O9c5XB7Jy1ctp1bXPtEYtiLYFrnn0
+WopGC/WQleKr12z03tL2FyYdEJcd0Go9uA7cLyfQ/zq1jzjHNew6RNDbwyen65B
4jOP0OM6MeGd7Lj5O1h3IbzT+f11+W9xCNSjN6ZyqclB+EHOv1v/AAKc+tgJjJV7
/Nie3ox/hZZcfn/o+m+mWg5c1Ert/KDua/LJaT/gF6kbeKyj7URH8LI/K/5y+X/P
F06abcxtEF2ZegOZHbH/AAFtRo8XiHLYcuHtBGf8L0jTdXswWmsJBdXEY5OEPQZ5
Hruxzp8hgZcnPxZvF5Bn/lzzjeLXUkn9KMb+ia1b2zZ9mdpx0fmnUaXb1bvdPy+/
NK185mewZDBNB8PxH7Xyzr9LrRrInhFW8zqdPwGw9XjQhaHY9j1zK0un8EVduIZK
xFRQ5dOPEKQsX92KEk5jRIwijutW5YwGMg6nMzisJMtqVMDF2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvl/wDOb/etP9b+ObfRcnVa
nmXmw6DNmHVy5t4sXYUuxQ7FWyVC1YVOW4+TZFSt7iMtxZR92QmVpBanolpfgl1W
h2PwjMXIbSC8i8w/kX5e18s19DVD3U0/VmHONuRCbw3V/wAvvzA/Kq5/S35O30kd
kh5NGGLbZjyx05kJh9SfkX/zm3FqV3F5H/NCNrXVFPA3MlQGI27++Y+SFOXCb9G7
S7hv4Uu7ORZYZBVXU1BHtlDerqCCSTUE7DwwBK7Ch2KuxV2KuxV2KuxVgPnT8y/L
n5fRfWPNeoRWgb7AkO5xARKVC3zD5p/5zc8q6KCdFjOpHwhJyQ08u8NMNQD0efWX
/PwaxuJfSuPLt3En8xrT9WW+AW3jD23yT/zmB5G8ygprt5HpM1aKty1OWRlipgct
PpfRPMGn+Y4BfaJOlzbHdZIzVT8jlZDKM+JN2bjvQn5YLbAF2KHYq7FXYq7FXHbf
FUDJqVtEaSSqpHjg4gy4Shf0/Yc/SE68j74OILwFMYrmKf8AunDfLDbGlfCrsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVeS/nf5L1P8AMDyhqHlby7dG0vLlOKyDrQgjFXwn
/wA4h/8APvZfyG1+48/ebL8ajqU7lwjANQk13qMVfo15r8naf5r0q60K7ijC3ETx
8gg25ClemKvyo/JT/n21rf5Q/mFefmBp2ugafdyOWhBH2HJJFB88VQv/ADkD/wA+
07vzj5kX8xPy01g2l4TWRE+Elq7nbFXm+t/8+tvNf5gJDdecdfaSWChVXbc0xV9P
6t/zgne6v+WafloNVKSRxlQPHbxxV57e/wDOLsn/ADjb+SWsaZcah6s727gr7kYq
/L//AJwz/wCccdX/ADhvdTvvIWrtY6hbM/qlCQSa4q/Qz8tP+fZfmQeb4fPP5na+
16lvIHEbktWhr0OKv0E/P7/nFHyt+enlIeTL+JLe8giEdrecfijoKYq/LqL/AJ9m
fmV5eZvKOn+aJZ9BlPZjTj4Yq/Qj/nE7/nDTSf8AnHjTpxeMt1qVyCrv1pXqa4q+
c/zm/wCfeOqa35ol8/flzqjWV/M7NzVjVamvTFWD6V/z7L82a3rdl5p/MrzP+k2t
5VcxN4Dtir65/PL/AJwc8u/mr5eg0LTHWyvraNVjmp0YDr0xV8KW3/Ps78wrkt5W
1DzXIdMX/KNCuKv1j/5x7/IzTvyG8r2/lLTn9e4VR6056ucVe8Yq/Lr/AJzH/wCf
ekX/ADkfqtv5i0G+Gn3UZqzdN8VQOm/84F+bG/Ku7/JjWvMzSwzEcKkkUHvir0z8
h/8AnB63/LL8u738rfMuofXjdV4yD9ivTFXyh/0Tf8/+XtVurTyT5sez0u6Ltw5G
nE9sVe3f844/8+7bD8q9ZuvMvniddVu7lCrSEgmp74qw/wDM/wD59wapdeZpfPP5
W642lzkl1AY7GtemKsY8vf8APtLzR5l8xWPnj82PNB1RraQP6Lg7gdumKvsr/nKD
/nDzR/z/APJdp5EgkFodOQC2oNqgeOKvzi/Lz/n1955tVn8s69r8iaKtQiFjxp8s
VfS//OMf/Pvy4/5x980y+aVu/rNmGNYaj94Diqn/AM5G/wDPuWHz9r0v5j/lpqH6
G1aZ/UcJtuflirEPy5/59yecbLVbbXfzC81NqEcJVvSYk7A1pir9dPL2hW3lvT4N
G05AkMCBRTuQNziqdYq7FXYq7FXYq47bnFX5Hf8APwf/AJywHlLSpPI3kuXnfy0j
cJWtWqOxxV59/wA+7f8AnFaeZf8Albvn+Mtd3JE0Yk3Jq1e4xV+18aLEojjFFAoA
MVX4q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7BSuxJVr
IxCt5NUt1C/itEpK4U5ha3MIR5024sRlyeB/mH5+UW0mk6c9ZJBxJGcRl7ayifBG
fwdzpeyAfVKL5yabT/KkSXWp3S/WLjohOQ1HZ2q1W4iZO0GXHh2unlXmzzPrd5yb
QC3Mf3YXvno3s/7Jz8MHNiLoe0O1uYhJgXkv8uvMN1fPrnmJ3R3PKjE56j2d2Nos
MLMNw8jm1uSR5vcdJ/Lu6ec3s8ZuIF6r45z/APwQO2NPp+z5eoR7m7T5pfxF4v8A
mX/zkla/lF5gtvymi8un9G6gy+pccdg7e+fKWE6jWwOox5vp5D3OXLilyb/Ob8m7
i/ksE04GSO/jSZWH7HPp92dN7Mf8ErPfDnz7R2+THwZnmGUaT+Vf5f8AlLTV8mef
9bgXzBcx04u3xUYdOmYHtD/wRO2J6jj0OUyxAcxy+9idNLnTLfIP/OL+ieS7G91L
R6PZrG0yMG2O1c2PYf8AwUNVqiMeqz7dQVEMtWA+ZvPH5wS/lfHDceWNPa5nvpTC
4WpoAaZ7J2Jk7L1MgcpEiWWPXZY8pU9j/LL83bLWVVvNKixkt/iZH/azY+2XY3Z2
LEJaeIBLmaTtXJKVTk+i9N1OJblPMWiHhbTGoI6HPDcGo1Onzgg1F6WGMZRtu908
mfm015cNZawnowA0ErdM9Tw63T5sdxmOJ1et0UonaL36C4iu4xPbOHjYVDDpkQbd
byVqeOCUQVbySuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2Kvl/wDOb/etP9b+ObfRcnVanmXmw6DNmHVy5t4WLsVdirsVWs6j4HHX
EGmyPJcsEX2hscCS0yKSN9u+QMWKq8oP7qOPlB3bIeGkSbekcRg0uYEN9pAK5E4v
JuGR83fnH/zj7B+YtmJdEh+p6wm4mU0JPXtmJq8NAUHK0+W+q7/nFT/nJ3U/IOsH
8ivzZLiS3b0rOd61begoTmuMHPjkp+t0UqzIJYiGVhUEZSQ3g2qYpdirsVdirsVW
SSLEpkkNFUVJ8BiFfDH/ADkV/wA5d6f5Fjbyr+XyjV/MMvwGOGpMRr1OZOPF1Lj5
ctPjzSvyc82fm9JF5s/NS+e5Vjz+ouxBQdRmTiwXIbOFm1O3N7jov5KeV9BPK300
R/TXN3+Vh3Otx6iXeyW78iaHeJ6QtFp9GRlpo9zljUHvebeZf+cePK3mGFmvtPDS
j7EvKnHw6ZhZdN5KdQe95gsf5jfkJIlz5V1eS+8uKwL2a1ICjcjNVlxEN+LOD1fp
B+Q3/OQ2hfm/YpawSrFrESgS2x+1UdTmLRDsoSsPo/CzdiqQ+YPM+leVbc6j5huo
7S3HV5DQZGUqZRgTyfJ3n3/nNr8v/Lwe28s6lDqV9H1hjqanwyqWRuhgPUPlbXf+
c/vNPmZjo3lryzNbuTQT/Ea++RlkbY6cjo8h1L8x/wA7tZZ2g1ua2ik/3Vv8OVHL
5uZHS7ckqtbL82b2smoeZ5Er1qTj4rL8r5IhtJ/MSBvVh80PJMOiVO+Pir+V8kM9
r+cMTevZ+bZIKb8anHxEflPJkej/AJ5/nF5EYfpC9m1lV7AHemPiL+U8nuHk/wD5
z+1qxkjs/P8A5dls7WoDXbg0p3PXJRyHvcTUacg7B90eQP8AnIvyD+Y6Rp5a1q2n
u3ArADRwSOlP7cujl23cQ4yHuAIO46HLba28KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxVShhSBfThHFak0+eKquKuxVg/5ieRbH8xtCuvKmrj9xcoV5eGKvD/+cdP+cW/L
n/ON/wCkJPLjh3vzyldtiN64q+pUkSUcomDL4g1GKr8VdirsVdirQYMKqaj2xVa8
ix05sBXpU0xVfirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
r5l/5yg/P3T/AMiPK0+tXbA3joRFHtU1qOmKvwt/5xo/KnXP+csPzRP5heaFcaCZ
/UZGB40Dfdir+lTQNDtPLdhBomlII7W3QIigdhiqcYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq0RXImNq3klU5JFiUyOaACpyM5cItX
zT+YnmgXssttYy0413Hzzje1dbxHk9D2diD591LW7Ty1ayavrsgDkVi5EfGfDMLs
f2XjrswkZVu3avt84T4Yi/N/8wF8zfm55qt7zQr2SC1tpKtEtaAA+2e/9l+y5wgC
M7p5fWa/xeYfZP5VeSPMWqXMd5rPK1ttP6Mf93DOk7Q7Z/L4TCrIdOdOJPrC3RLq
QQRxiQeOee5PaI/zW2Gi82OeaNautGThpgIk5BfTHeueZf8ABMlHWaCRltTOWPhD
Etf8paGl/aa5570yO8iZFkMz78G6/hnzr2dqp4MZhA89nd9l4eKFs01T8xPK1zFH
baHKt3fxALDAB0A6LnO/6H52ZSNAlyZnhfL/AOZH5da3+YOvweb9V8sCK5t2V1lJ
NWVemel+zelGm0ZxQlYLjy1ZG1PYJfNnmHzFDHoEtm2i6XbKonkU7Mg2I+WcLLsm
Gimcl8ZJ2DTLIZ+nkHyZqv5x+RvzD87S/kta2kdrBph5JqYXd2rvvnsns+Mmh0g1
xjZG/CiHYozfxPYfO/8AziEPMHl29uvLeqvJeSw1tnWvxHr2zXZP+DnPWyGOWARr
YtWo7EGAcQlbC/yGv9U8kWB8h+bbh7rUrQFCj1+E1z2TF7OjtHRDUcVCQ5O+7J1f
higH0vJNDfQGKOalx/vrPNc+pHZGSgOJ6HMTmHc9k/KTzBPpUq6bqF2ZEforfs79
M7vsvtY6uINU8Tr8Awkm31QjB1Doaqdxm/Ea2caMuIWHV34028ckypdgQ7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXy/8AnN/vWn+t
/HNvouTqtTzLzYdBmzDq5c28LF2KuxV2KqiFR9panISSCsejdBTCytYq8djvkgGJ
NopHEcZhUfCcYhBKhbxR2zGSJaMe+W8LEyWyyXQSQwzFZXHwHwOY2qhs34J0XzJ/
zkP+UEfmzQF80aB8Hm7TVDxSL9t3Br2zWSxOwx5N30d/zhN/zkG35j6EPJHmM08w
6QvpXXLZiwNN8wskHNxzfe2UOS7FXYq7FWiQo5MaAd8Vfnr/AM5Z/wDOST6FEfy/
/L+YvrMpKTenvQVp2zKw4upYTlTwr8ofyXg0qJPzD8xqJNZuiWct9rffvmwhidTq
Mr6imEiRJd2b0MmzAdsyYw4d3WSneyELzH+9kLZlw1JKxxU4GhoOuZMZW2EbIhRJ
KPSlci3P2m8MjOFuPOdKcsVjPbS6OqCSKRSC/wAxmtzae+qceai+LNXsLj8gfMsX
mvypHwae4UOy1+yx3zXz0vm7jBnvZ+qtr+dHlu10CHzFrF9HFW3WRwxFeVNx18c1
Zk7mGM0/P/8ANH/nPrUNYuZvKv5S6Y15KSyC4UHbfrlZLlY9NfV8yz+VfzA/MeU6
j+YPmGdLeQkmwcmig70yqU3YYtJ5sw0L8l/KeiUuItOjkvBuZt6k5TKTnQ0g73rF
hpEUShbKARuOjAdMq4m78r5pnFYXKt8RLHucpMm0YqRZsZX2dajHiSMSGfSQvxxx
8JOzY8TLw0JJZyLvIeRx40+EgXDR/ZFDjxMvCSbUdIstcU2+vxi4tiKek3TJxm15
NHx9XiuvfkVFYXH6c/LSf9C3KnkDETWuWjI67PoK6vVvy3/5y787/k9dW+g+frWb
W9NLBJr5yR6KDbll0Mjp82nrq/V/8uvzU8v/AJo2n6V8oXK3NtQHkKdabilcyMeS
3CkKejVrlrG28UuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxVxNNzirD/M/nzQvKFo+p65ewxQpsfjWv3VxV
K/LH5r+VfN4H6D1OCRm6KXUN+vFWZ6nq1no1u1/qcyQ269XcgDFXm1r+d3lC71I6
JFqUHqU2YuOJPhir0oarZtbtqCTxtbKORkVgVp88VYVP+bHlS2ha7n1OBVStRzFd
vauKrfLX5t+U/Nsws9C1OCacmgTkOVfvxV8g/wDOffl/zZrXl2zb8v8AWJNJuVej
mN+JcV6Yq9Z/5x3uJPy//L/TJPzE1YS3skQLyTOPiPjir2bXfzX8reXreK91DUYA
s1PTAcVavTvirLf09ZR2Ca5dTJDaOgkDuwA4kV64q80tfz98jXl2dMh1WEzhuO7C
lfnXFU0/Mv8AMrSvIvlm681Xc6GEQuYyGBBNNsVfkF+QH/Oe2p6x+Y8mha/MRok0
5iSpFKE4q93/AOcuvK3nvWvNWjeYvy/8wywaPPLGxjSUAUJBpSuKv0X8hLdaN5ct
D5mug8yxKXlkYU6DvirHJvz78jQX50STVoPramhXkKV+dcVep6fqlpqsIvNOmjmh
O/JGBH4Yqw0/mn5XF82jHUYBdIaMpYCh998VSY/nl5KGofoMarAbuvHiGHX78Veq
W9xHdRrcWzh43FVZTUEYqrYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWOebfM1p
5P0m68x6q6pbWsZdixA6fPFX81H58fmFr/8Azmn+ZcHkjy0ZH0mOYJVQeNFanVcV
fv8Af848fklpn5I+VLPy3p8QW7WICd+5bFXvmKuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtEhQSegxV4N+busT/AFQQ6XcmMsSG
KnOY7S1froFzsWmJF0+Y9W1U6BYc0YXF3JUAMdyco0nZuXUn0i3JhnGPmafOH5q/
l7rv5o2Vk9rcPBLbvyliQ7AV9s9M9nNNiwyEcgovI63LOeYkGw9V/Kn8jLHyPbJe
6hcs9xe9a12zsddrhG4x2ptiNt30w9usIhTTnLQ24pIvZvnnnXauXLk5ElxNRmEe
rQb0w95F+7NdgMj2LocsgeMW4+HU2ebE9Zvv0HbT+YDF9akijdwh33UVzSf8EvDD
F2ZKMhRJD2nZmGM+Yt+c/kX/AJzm8y/mzruo/lnqWgKLSKd0WcpSigkdfozxbWey
eHRaeOcTsyANN2XOIy4QKfWFrrOl/lr5CvfzLtdOjudYgLlYyKmq9Ns4yHZufNqB
CW0D197SYk7sL/5xf/5zI1X877S8TznZHTlEjwowUig3A2zI9rvZ3J2Zkj4GQkbE
hxQJyPJm3nOTRPyXtW/MnzRr811p18xRbaX7Bqem+R0wPachgwRuceaOAh535Qn8
tecINY/MDT/Ldrb2PoM0V6g+JiBWu2ZWq1WTSyjpsmQ3e8VGsjDmafRfk3zbqOjf
lbdeedKU3U9tA8trCf2iO1M5/tjsyM9RCA9IJqUg7LQ545bI3p8vf844fnfqH56W
vmnzB588ux6NqelqzRSKhDSkfRvntXYmsxdh58OLJqDPHLoeTpdZqDCRrZhn5Sf8
5D6xc67quhec9KS0tPUK21zT4iK9c9u7S7K0/aMeLBjEu4uV2dryD6pPs/T9Sgmj
GpafJyI35DvnjwwZtLqTGXpAPJ6qeKGWHK31d+VvnGPXrP6tK9ZU23zttJr4ZNgb
ec1WjljPKg9bzZOE7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq+X/AM5v960/1v45t9FydVqeZebDoM2YdXLm3hYuxV2KuxVvrkJL
bqYAkFrJ2ypsHJcSCF1Rg42ohdIV4NT+8p8HzwfUsDSmjLYrHJOge5fqhyjJByoT
t+ffn/TNQ/5xq/M7Tfzc8tMx0e/lEuqxr9leR79s1+aDssM7ft75F842Xn3Q7PzX
pDBra8iEi0NaVzXTjRdhCVsuyLJ2KuxV8y/85KfnFD+WmgSx2r/6fOpVVFK75bji
4+bJWz4D/Jb8uo/NF9L+Z/mti97O5Ko9e+4zPxB1+XUeb60tUMkjJOvC2QfAPlmw
hFwMk7W28/J5Yh/dj7OXZB6S0AbqVDmtw8VuUJB3Qg5t8JNIlyVZHZ4Wth9hjucv
MqcOUCURcGyitBFaMPUAqx+WYebNBtw4JE8nxr/zk5+YenLpQ0ewpLqFaKBueXbp
mty6iNF3Ol00uIbPm/yP+WfmzzlEtz531CazttmS334svbOallFvbYtLsLD6Z8u+
WtE8r2os0tUtJR/x8p9pj45A5HPx6eujJIYZ7pQrfvLcH4Zz1OQMnLjiA6MnsNI5
gUGVksjQZtpmjEbcd8hbSckQyuPQAQG475Gmk5RfNX/QKqKlceFPiBDz6ErrQLhA
ZxyBjl55fCg7YRFsEww+80cqTQY0y4gkd3pIVDIdjhAb8eSIG6SRXLwH06VGC2Ew
Jcku1XS7PV43ttRhVreQUkr4YRJws2lvo8QjsvM//OO+rR+ffIN3LJoBbm1kleFO
4pmRjm6LUaQjo/Wv8gv+citH/O7TFvLYrb6io/ewEgEEDfqa5mRyd7qZwI5vpAb5
axDeKXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FVKfl6b+kKvxPEHuabYq/ns88/kx5486/mZql5+bHmGTTvJX
1liEim6LXbauKvjr8+ryL8jvzC0mD8m/M99eaWZ4Q/JiATyG2Kv0J/5zu/NLz5qv
5VaHJozz20EsEJmmgryNVFSaYq+NPIHlHy55y8rxLYeb76LzoQCY3Yr8RHucVfpZ
5Ls/O3kr8k77T/NF+ZZUgcxXKycnO22+Kvy+/wCcYPy685/n15svPL+o65drbNM6
7MaAVxVmv54flx5q/wCcO/OlnqOn6xdS2xkVt2NDU4q+g/8AnPf83tZ85/lL5X82
2N9LY3HpoztEaGQ7daYq8y/Ofzl5ii/ITQdbbUp0vGtVKMG3Y074qwH/AJxt/Iz8
3/8AnKGxsdavtQnj0ayZB6jMQSAcVfeX/OY/5T/mM9hofkjyrrklvp8Nskc7iXjU
AUPfFXwd+cn5a+Xvyx8mJqekearuXzYlC6KxPxD3xV7p/wA402+v/np+WN9p/nnV
J5I7eFynJiSaDFXyB/zjl+Qjea/zXHlue7kjtYrzZ1Jrs2Kvpb/nOu01r8sfP2g+
StB1+8W09SIBeRHWnvirNP8AnLb/AJyV1rSPIvl38svJmoznXpQiTODuajxxVT8v
f84G+ZPM35Zyfmjda7dL5k9AzBOTVJAriqe/8+z/AM/NdsPNGp/k5+Y17LcSlpEU
yGpBXpTFXxD57uPOXmr/AJyO1n8vPKOqXKifUXjjVWOy1H9cVeo/85bf841ecfyA
t9P89y6zc+sWR5SGPWtTU4q/bD/nBj8yJ/zJ/LKx1K9cyTQBY2dup2/sxV9l4q7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYqtZ1QF3ICjqTsMVfhR/z8Y/5ypudfvl/JH8up
WNw7enOYSG5VNN6Yq+kv+feX/OKkP5WaEPOXmW3D6tdgujOCGWtD3xV+o+KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2AmlarjE2g
mmG+e/MkflfSpdRlrShUU8chllUSXK0mITlRfFsusf4lJuryd1j9QkD6c4PW5D4r
0wwDhfC//OS3n3WfLmpW1n5PrO3qbL4mueq+xXZoy8yQ8n2hk4S+nfyBvfMV7p51
XzNb8Jpk+NT2FMzdVj8LV8HcebqeG930H6gSF5LtahR+6HhnQ6rAJ7D4pnJMrW9n
sI43jiVlmHxVzmtRpBE7ONPRRyc0PdXQkYrdDgrfy5tuyInhNNmHsiEd7U7aWHTk
a5u1Etoaqwfpv7Z5H/wa9VM9nygBe/Tfo7OHaMtOKiLYpL+Unk4epd+XdPgtdUui
ZOcYoTX3z5Ewe0OpAAyEmIrYufLVjUDjPNAf4F1fQ9Om0qzs4r+3kDExybg1zqcX
tacoAOyRnMejwnSvNNt+VV81v5k0Oy0+zZyfgABJ+Rzaz0v8oj6yUfnpdzKfzG0j
yn/zlzoafl9eM1lYxHmsiCm58PuyjTmfstL83g9cpbEFnPN4gAOz0D8svyr8v/k9
5Tk/LPy/dnUlgQmT1jXYj5nOY7S7Wy9pagazIOEk9GyHYmPLzKAs7bXtDsg0EEY8
sx1MyE0RU75m6jtGOoPCbEujPFoY9nHigbtkWm+d/KtldWGm6Lp8EdnqRIeSIAh9
j9ojLsfZU4EaicjKUOQLha6Ec4s7PyzuPzN0Tyn5285Wv5jxy2wiuqaSI4yUda+P
TPqT2a9uc+DT4/BiDY9Xk6OEfDPp3fWn5Kfmhp+vqlorVjmFUBp0rm97X9nsefEd
UZeo709p2TrZTqJ2fXfkrVU8s6onpH93Ia+25zh8P+Dn07uz7QwiY3L7PtJxcwpO
pBDAHbO1gbALxnkickrsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVfL/AOc3+9af638c2+i5Oq1PMvNh0GbMOrlzbwsXYq7FXYFVFG1c
BLCbR6YGUVmLeFo2yJkpCoBXfKzNrkFrwmV0dT8Smoy7THiLTPZUu50V+bitz+wO
1csyhsxF5f8AnH5GTzl5UvfLE6CS61Fa1O5QgV2zW5g7PBJAf8+9fzRlvLbU/wAr
dRf4tDk+rIJCFJoabA7nNbk3dnjfqHmO2uxVA6nerp1pNfOQBEjPv7DDEWiRoPx3
/MfzFJ+ennz9DqSba2lNR+zQH2zIg6nUTIfWFno2naPbR6ZZHi8SKeI6VAzNxOpl
kJVIrO5vKynaGPc79sz8ZUG1kV1DqLGGwFDF9s5lS3DbKNC1R08DmJiwi3FhlKiR
mfGFOQJ22rEVU/ZPXKtRKg2Rg8B/Ov8AMq18iWbW9k/K5lBACkE1Izn9TqCHbaTT
g975m/L7yDP5iuX87ec6taMeUYbxPTNJl1h5U9LpNELu30FZpIkVJei7Rj/J7Zgm
T0sIbJisYuYuF5GCvbDxt4FMh0jRSyD0WJj7L2GHiZy5PSNI0TgAWGJNuDlyU9B0
/ToowCRkbdbkzlOAkYNANhkgGAyLZFTCAzjkQE4QKSMNNkciSXMSupOGm4ZCxu6s
FfDwtgmxu/0pHJGQkaLRk1BiaphV5pYjJKCuVSLnafKZMZnWeJvUjjDcdwp6HBbt
BjsIZrWyty1/5hct9Z2W0O6D6MvhJwdTpBV28EurnWP+cf8AzNB+YmhKU025cOYI
/s0J7jMiJeY1emAL9sPyo/MSz/Mzy9aeZrJ19SdA0sYIJRvCgzLxmw6qcOF6XljB
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxVgn5l6zfaB5Z1HVtFj9S8hgcooFTWh3xV/MJ+XfmJvPX5p6ofzm1b
UbaxN0x9HkwTr4Yqwf8A5zBsvLlj560ceQRLPYLNF8RU7/EMVfqx+bv5oxeX/wAq
tF07VtOFzYtbwh2ZKkCgrir4G/NHyz+XOreV285+QLq4tdfKEmOEFaNT2xV7R/zi
9qnmrVfyo1aLznNczWQgkWJ56+G3XFXh/wDzhT+eUf5Qee7o3kZezM78np2rir0P
/nMT89Yv+ckvPNh5K8qWzywvIicwtab+2Ks6/wCfgH5fSfl3+TXlfy48cjziKMEB
SaVxV5Z+ej3Uf5A+WLH0JDW1jH2TUdMVfrL/AM+3rWKy/Ky0hRGSRlVmDCnjir81
P+fnv5hebrP8ydO0Yz3dnonJEd7fkBw2B3HtirBfzn8vflxZ+RbTVvKF7c6lrD2w
aZZKsQ5G+KvdP+fdgfV/JusWxSQTGGQKhUjscVfLn5UfmRcfk/8AnkV1iCRY3vSN
1NKcsVen/wDPwjzFH5y/Mny/5isIpDC0sO6rWm4xVD/85bflNqun6F5b/NDQbWSU
oY3eiEnYDrir6z8pf857aFo35SPol9G36cS2MQjp3Ip0xV88f8+2fy21T8wPzN1P
849ctpILSN5ZFqhANa0xV5d+V0df+c0rzUBE/wBX/ScrAlTShKj+GKv0g/5+x/H+
WSwRxs8rP8JUVPXFWZ/8+uY54fyiiiu4zG4kTZhQkUOKv0nxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV8F/8AOb//ADk/Y/kd5Yks7K4U6rdKVCKw5DemKvzK/wCcF/8A
nG3VPzy86XH52ef43NoshliMyn4t6injir+iG1tIbGJLW0QRxIAqqvQAYqiMVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVaJpkJF
IeI/nBqos7Ex3Ch4mqOJ3zQds5DwbF3PZEAZbvlNr6ys7OSeT4Ca0HTMbsHHxZo8
Qvcc3YdpzrHKu58LeanuNV84QS+iZYBNtVajrnvPa8Y44R8McOw5PmnZ8pSkeI2/
Sry4ixaZAqJw+FagfLOcJBNnn3ubLmmzANswqPDMmEihcCdlrsOgyEha22oBb94K
/PNVn4h9JpbKVa9btPAY4/s+Azn9VgGXbIBIdxRzYTqmqal5R8k32taQpuNWjdhG
pFSAPDPnH/gmdj4z2rjjwiGOt62dz2dtjKS/84/fmjqvmLy9caz5+D29yk9FU7VF
fDOE9pey4Y5jHpt9nYjIJB5t+dP5P6d+e+tW+u6td3FnY2zq3FKgNTxze+zfa57M
wHGQJSPejIBLm9P8xR6R+Wnk6a78uR8oo7fj6sa1f4RSuYnZGk1Gszk5NwTyPJxp
QeE/84++Ybv8yYbxfL8srXbc1Y3Hwn8c3vafZEsUxEgfBxpGfQsm/M/zBruueVdV
/JfQHKa1JCYnatKE+GXafS49FljnzRFA25OiEjYkbVfyF8leYfyr/L3/AA1+YkKy
6rHGRZSsKvU/PHtn2g0mqnLwtra9XEiNMv8ANf5S6P518nzSJp1pNrLKPWkkUGQN
mH7Ke1GLs7IY6iRo8nE7PjYNvC9P/I3VPyvjtfNNuimGJRyVRsK57N2Z7daTtKX5
fBIknoeSmRB2NPpS1vJtW0qPUUFJPhNR1GZOtmNLMQycyXpexOKWM8Rt9lflTqq3
ukpDJLymUCoJ3zt44JQhEnqHS5sZjI+96lkWl2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvl786P964/n/HNtouTrc/MvNlrQZnUXWy
5rsmGLYXkePjkwxKoIvT+1k4lg6tcnxBiQpMyqaSV+jKshFs4Bd6sB2qa5XbKljQ
hiGjOwxtVszxufjqPkMUoiH0AKIxr/lYNlpoRvKSRLEgHi4GAnuYkJXeataWPxXk
0JI7hxXKySsQx+bzz5fD1u7kEiv7Q8Mx5hzMb4fk82Wf5V/ndovm3RZRFpc7crhI
zRZCT1f3zCyQJc7HN+y+h/nf5X1m0F+t3HGCKhS4rlEsVOUMoR0P5yeVpiQL6EEe
LqMAxFmJAvnz/nI7/nIfy/onk+6/RV/EbuUMgVJFJpTLI4+HdZSD4J/IPz1oNpZz
+Y9WcC6eRm5Ajka5dFw8tPVrn/nIPRebTQeoxG1aZeDThTgCxfUf+cpVsgUs4J2X
wCVrl0ZtRxMRH/OW136noWmnTqX2JER3+e2GWQ0g4kXP/wA5M6uKUspf+RZ/plem
mW3T4wti/wCcmtYJA+oy/wDIs/0zZyyeljqce2yrff8AOUWqWdu95NZsiqCDySnb
5ZpNVlPe0aPEeJ4F5U1jU/zk15/NV+ha1gk48GHw9c0GeRfTOy8USBsH19ALbT7R
baaoQCgRR8NcwZc3M1UakKVbclqEn4T0+WTBdoSKZNp8fNgKVGLiZJPTtFgVOwpT
EuFMlnNmFUYWkgpwrgD4cmEcLU10qDrvi0nGbS83671OJLOOMpbcXy12OQJbRApb
LeAjrtkDJtpLJLkE1rkZSWkBcSBlr3y3Gdt0xixy6Fa5ElyIBiV8nElh2yBkHI3S
W9tVkWO6lHKh2r2xjJrmCWO+ZNJ/T9vxuVEsaD4UfcDLYypwskLYd/zi7+fQ/KLz
pc+S9cmb6nqEtERiAq79q5sdMbDoe0o0Q/bqxu4dRhjv7R+cUi1Ug7EZkOuRuKux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxVTmiSdGhmUNG4IZSKgg4q+OvOn/OD/wCXfnHU5PMEtuba6kfmxiUCpxVU
n/5wc/LO7MEl7ZGWSAqVZqVqMVe0a/8Akf5S8yeXl8kapYo+nooVagcgB74q+frT
/nAf8trF2a2ilEbEn0yARviqcfnV+V2leSfyn1Dyj5NtFTjC4TgnxE09sVfk9/zg
7/zjUnnfU9UsvOls8UheTi7JTucVfrJ+Wv8AzhT5B/LvUF8xQ24uNRVuQd1Gx9sV
eyfm1+SPlr85rCLR/OEHqRQmsdADx+jFWM+Yf+cZvJnmTy9Z+Sb+2H1CyQIg4itB
ir1HyJ5C0j8u9Li8veWoRFaxKAPemKsG/Nj/AJx/8n/nLEI/OVkksoFBKFHIYq8Q
8tf84Fflx5d9RTHJcxvUBJAKAH78Ve4flb+QflT8olmj8qWwQT15AgUofbFXn3nD
/nDn8vPOWtL5uvbP09QV/U5oB1rXFUy1z/nE/wAjeZJ7a71q29Z7QqY6gbUxV7Jq
P5deX9W0ZfKeo2Uc2nInBUZQaD2xV8hy/wDPvb8trjU5tWmjf05DUQgCg3rir62/
L/8ALXQPyz04aJ5TtEt4B9oqAC3zxV5PpH/OK3kjRfOUn5p2dtTWJJDITxHWteuK
vSvzP/KjQPzb0v8Aw/5ugEtvWo2qRiqN/Ln8udI/LDSU8teWY/TtENQKUxVn2Kux
V2KuxVoMDUA1p1xVvFWgwaoBBI64q3irsVdirsVdirzL82vzN0z8qfLt35p1qVYx
DGzIGIHIjFX83dva+Yv+c6fzba5PqvocVw1QfiQKGrir+lD8sPy+sPyy8u2flHR4
0SG2jCkooFTTcnFXoOKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxVZKSqMy9QDleTkkPjD8xPNF1e642lXq1txWgzmu1Tcad92
WKk+Qv8AnIPzVL5VtYvqINGbcDMz2ZxA5Yk969sZaiQzb8mLbT/M+mQazf24M4IN
SvtntvaxvHH4PnvZ4qZfS1V29IcUHQZy5O7sJc2syIliuU0IOWGKrm2NRmFlxgqv
qrijZqsunCEPbtFpNyL68VXsCOLIwqKn2OeV+3/spi1o8YiRkBtQdlosvCKeZ/mh
rFhpUijSYVjtv71lRaAnr0zwDRdmS4yJiQo1uHNGbdhnkn81dO/NHU73yY8LwLa2
rOrgUqwGS7V7NloxHLE2DKmQzXKkt8j+adRT6x5c1SBbrT2d0oRyNK+GdXOMdJEZ
MZokBtZ3o3kO1sLqO48nSwabxbnMrkRkg9ds5rWe0eaJMpAy7q3azi4uTLdc/Kax
uLlfO9lMHvYKPI0bVD09x1zW4vafNrT4WYUHIwYTj3JeJeevz0e20vU/N2tWzBfL
q84lVftfPOl7H9mMOfIMZO0mjWHiG7wj/nHr/nIy8/NvVn1ZI5Y9KuCzTChAWmbj
2r9jtPowIY9y4mjxjd6ZqP50alNpfmDQ7+KttHccbZmG/DOs/wCBT7JYMvaeISsA
jf5tJ+ohmn5ZeaP0pow3BIAFAc9a/wCCr7O4dBrIRxXR3er7BiPDL6c/Ja3uxqn1
6RiLUinE9KnBou1pZ4DGSNh0O7qNdGpF9bZkuvdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdir5f/ADo/3rj/ANb+ObXR8nW5+bzZPsjN
qIuqmd28JiwtsNxPLwwMmzIZN8AkoC9WCdcjxrwL/VZtolBTuaZCUmQjSGupLG3X
1L2RU8d6ZHiTTCNR/MHy9pQb1LgVUE/b8MeJPC8o1P8A5yN022DDSkMrgkCm+DxE
8Dzq+/PPzNr7ejpdnIqnYHgcHGkRSubQfzB86AfVZZIOG53IrgJKDQTKy/I7zpe/
8dC8cjv8WDhKOIMhi/5x11Iit1cOT88Bg2xmqah/zitpWoiO/wBVnkNzEPgNakZU
cTcMpCoP+ccrqEKbC+nEAHQMcidOG0ZmE65/zjXrd+zWlhqFwhatDzIwHAA2DOXz
75r/AOcPPOUT11C9uJ7avKhYsP15A4VOdSsPJo/L9I7DUI7gxKRyop7dcl4YDUcl
vbtC8+/lfpioNXSVZhTkGFMlQaqJet6b+cX5Uuqpp1vE7/5ag/wyYIRwWzWx/OHy
UCIE06y4ttyMa1/VhMtlOPZkH+PPJk5AS2s/+BXHTimOEUnNnrflW5IaO3sv+BXM
+ctlyi3zp/zk55m0i0sYtB0e3tvVuuO8ajv8s0Grk26DBulHkPRdN8n6RBarNBHL
dIsjDkAa5ospt9G7OFRZzJqKyusVo8Uq07EHMci3Kzi5Iy1U1qcjbkcezLtLYBwc
k0TL0ywnVFBGINuOQn0N8FyTHhXvqoXockF4Epuda61I+/IGTZ4ISttZWnUffg4l
8MJRc63TcN+OQMkcKXnWqjr+ORJWlh1UNuTkSVabUhw65bjOzZjjaAe+DV3wSk5M
IhJrqUOSD3yolyOAJNdz1McA+zXGJa5RAU55hb/uV3DZcDbhzD89vz5sP0F5s07X
7AkSqwb4fnXNjozsXnu140Q/WT/nDX/nIlfN1onlfW5gJkHFObb9czHUv0aBqKru
D4YquxV2KuxV2KuxV2KuxV2KuxV2KoK71K1sVMl5MkagVPJgMbSIkvE/NP8AzkX5
P8qcxf3asyV2VgdxlZyBsGIvnzVP+c6fLitImmKXK14+5+7KpZiA2DEGLaV/znBL
qdzHbG14q70rx7fdmHh1ErU4w+/PJvmJfNOlw6wg4+oKkfRmzjKw0SFMpyTF2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVCXtjb6jC1pexrJEwoVYVGK
sb0LyJoflqd73RLRIJXryKgDrirL8VdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdiqR+ZL2XTtNuL63IDRIXJ9h1p74q+M/yZ/Pu581+adW0mXk1tbE8VJPY4
q+mU87zcZjKq7D4Kdu+KvnL8gPzyu/zD84a95davp2M5RuR9+2KvtzFXYq7FXYqg
dS1GDSbWXUb5wkEKl3Y9gMVfzr/85tf85Dax+fvnZPyf/LySRrAymElGJU/Fir9W
v+cMP+cY7L8iPLEE17Ch1q5QNLJxAPxKO+KvtzFXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FUFqFz9Ut5Lg7hFJP3ZXLcJD
4r8y6mmsajNqlqlQvJaU3qM5fXm9nodBs/PX86fPsWoa9D5V1JeUnq0H351Pspgu
j5uo7cyiyH3f+WmkwaT5ct0tkCMVBqRQbjPSNfMnbo8noB6izhCWFSQx8R0znpHd
zZc2+m2XwkhrpmSCrbGuCUbVQ4NWtcoliVTvLc30Ytie4ObDQwjGJ4gD8GcZ0878
++W7jUnjNvQxqAGr4Z5d7Uex+XKJZYcIG/QN0Z0yLyD5J8uaYsl9YxCLUJYykjkU
2I3z5Y9qey9VgyVOQ4QbpyoEHfqzPyR5D07y5PJqFsFf1GJFaHc5yna/bIyxEL5e
bs9PRol+N/8Az8E8x/mX5Y86yf4Wmlh0q6PCH0SVoa96Z7X/AMDb8jqNIBlomO5t
hmyEGn6M/wDOJuoalYflha6n58mea6ij5Tb8mIpnIe1vsxPWaji0lCPToieSMQON
j3kvUNL/ADM1PzF5Y8w2v+4TUSVhXhvT3z0Lsj/gXa/FpoaiMhtuXXZsorZT8mfk
5Z/lmb/yn5VhSOK6akTFQKDOi0vsjq9WQSQa72OjzCio/mz5SttB8uSskYNwFpIV
HVqZ6b7F+z2Xs/Nx5a27nXzzjjLw7/nGu01yGaeTWG/0JnqiHrSuZv8AwSMZ1YuP
c9f7PZwcZfoh5L8xjTb5LcELbsQOPepzxT2P0WTHr7lKxXK3H10rL68if1UWTpyA
P356yQ65UwK7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq+X/zq+G6iZtgWpU/PNppOTrc/N58sIVAxdafPNyC6jIN0MXYmixsV/mA2wcmK
qYiRtvXsMgSzCjNd2WnoZL64jip2c0ymTYIvHvNn53+W/L3JTJ9YZe0TVykyZiJe
NX3/ADkRqWusY/ItpNHbdGMgPXBd8k8FJTHpX5i+d35yS+nEx6HbY40VsBmum/8A
OOtxeASeZLhmJ+1Rvvw8CON6Vov5G+VtBYSWsbM4/nFd8IggzelWek2dgBHb20PE
f5Arh4WNpwqW9KIgU/5Ipk4hEitpQ/ASBk2u16t/MThEbSJKbW0U8qvOT6Q6jJiK
8bXKeItHCf3Vdq+GSEU8as4WUgSbKBvTxwSgvGv+szE+m6q0PT4hXKjBeNINQ8sa
RrAYanbo1f8AIGQMF43zR+ZX/OMeh+Yo2n0pCl5ISBQUAqcplib4ZHybd/k3aflD
fo3nBJ7i3dtmi6Ae+VcNOXGVvq/QPyd8recrCHU/L8zMsg3UGrLt3w8LOXJND/zj
dADxs53qO5bLccHEMqSm+/IXVrCKS6tbsiOKpPxeAxmaDZj9RfN+kaYvnXzODK7S
2OmkxXAY8iW9s0WrmHoNFpin3mf8k9W1WV7q0u3SOp9FedKL2GaYzt6jTwIDLfy4
8hat5TFdXnMvhvXbDHcOdHGXtUEgzHvdqtkNhJRgcNpZtbahGq0YhaeOTCOBEDVV
J40KjxPTJBeFB3eqJFuG5fI5JBDEbzWuRJQMfYZExbwdkqbVmAqwZR74OFpnkCAl
1a1HxT3sMfs7gYOFxjlAURremjf9JWx9vUGDgYHKETHqttJtb3Ecv+o1cTAo8UK7
Xbso4KzEnoAclGNN8MlLo5WLNHQ1QVPyyMoOTDKEDLdLMnqQnkfAdcqMW/xQovKs
qxpQiWu5Pb54iLXPIFREijSa41KZIUhFQZDTn/q5cI04k8ofNflj8tLz/nIHzr+j
dKQm2tnIMzCqCnic2OkFB0HakrIYJ5q0rX/+cc/PNGDwWsEwBb7KuK1qviMy3Vv2
3/5xx/O3TPzb8vxz2Mn+kwqFcMaknFX0iDXFW8VdirsVdirsVdirsVQ11eQWMZuL
yRY41FSzkAZGUwOaREl8VfnP/wA5l+XfIpk0TQibvUt1UxGoBp7ZRLUxbo43wh5i
/Nn8xfzOdryKZreFz8K8iPhOYOXVxb4wSbS/yrv9UBn813Ekhbc0avXNfl1sW6OJ
l+m/lR5f09gwRmcdKiu+Y0tcG7w2UQ+WbSKeIwxICjVPwjBp8u7GeN+pX5Vqq+XL
QRig4/wGdLpJWHWZhu9FzManYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWM+cv+OHf
/wDGB/1Yq/LT/nGj/lNNf+bfrxV90/sS/I/qOKvi7/nDL/yZPnH/AJij+vFX6s4q
7FXYq0zBAXY0AFScVfk1/wA/Cf8AnKv/AAfoz+QvJNyr6ld8oW9NjWp2ptiryb/n
3p/zipcXR/5WX+Y0DSXMj+tGZACasKjc74q/byNFiVY0FFUAAewxVfirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVaJoK5CZoW
qReYHI024b/itv1ZDDLijay2L4QbUp7I3MtuKkyOG+Vc5nVbkvR6XYPmvVfy+0Tz
r5mXVCh+uK1fpz0P2Q048ESeV7dzHxSH2foUS2Niuj3/APcKgFBsaUzqdbVcQdVo
o+ooyGOGBPTs6iEdK5o5DdyJ813XJxKG6CmXxmrWWCSuwhV6qo/eHqM1HaWrz4pg
YRYa5ErjLDcfBIu+HTaiWoHBn5NsJFIb3T7hAzWB4g16Zou1P+B/2VqwZZBZcuEl
WK/1PSrGKSBgw5713zz7s7/gR9k6nIRkxyciGSurB/zF8jab+ZwtZdct1aSJgQSo
/jmy0v8AwPOz9Bn8PDGQiebOWoJNksn8teW4/Ltu2iW9BaSDjx7Uzp+1vYnRYwDi
iXF1mckBGWnk+w8tTfXLJQHbc0AzocOEw03hAbdzhyyEhO7yKEgX6/3gyrsfSeGd
wQy0kju84/NcW50YtcAFWFWr8s7PsrFCU6k6bJkPGXhX5cana398h0YD0IxxenSu
c/7c+DjyxxkgAh7T2ZmfCPvei6prE+l+bbO3jakTFSR9Ocrg7G0eA+Lh+pyNaKfp
TpMhlsreQ9WiU/hlsubrkwyKuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2Kvl/87po2ngguYmdOf7I9822k5Ouz8y87ltrEKBOTHEBsGO4+
ebLidTMbsA80/nBovkGEi41C2uY6f3CN8fywSyJGN8463+f2sebA8f5fWc1pK32H
kBplRmzEKSPTvy+8+/mAR/iy9oD14tTIbllxU9Y8u/8AONuj6Gy3Wrc7lxuRXlh4
E8b2fSfLWgadF6NhY+ko68kG+WQgGuRZDH9XgFLeHj9FMnwMbVvUL9emPArVMeFX
Ux4VdTwwiLGRXAeONMG6DJAK3k6RbsIoIt2N2gEuyJAZNUyJii1S1eC1Z5r/AOw4
olfHKpBtjJjGq+UdP82W9xpetQgiZeMTsBsT7nK+ByYZHxJb/pf/AJxy82R6ZI7S
aRqMnAtWqqCcrMaLlCdh95aDe29/E08Dhoph8DA+2SOziZzTzT85/Ma+R/LF7qDP
vSnXxGY2aezk6IWXyh+Rnlh7Gyu/MN7v+k29ZCfAnOf1cnvNDpRV09tuGL/Cp2Ga
cT3dhEUtUhFoeuZuOOzsMMbC5Ph3GYRLiEI+3uvTwgsoxTeOeK5Be4cKI/iG/XJg
s+FDDX5NVJtUHFF2rkwwISl7ya3l9CGrn78Ntdse80eaYfJMJ1LVZkQuKhGNCcyY
wsONk1Bjtbx621rz7+btx9S8iWU0Nsxp9YK/BTpWuHwnCyaonq9q0H/nDHzJqiqf
Odw807ipMbUAx4HDlqD3szH/ADgRb8eYkmD9qvhEPJiM3mwjXP8AnETzx5eJPk26
pTpyNckMI7mwZT3vO5vy1/PDyVK+p3lwlxAAQY1WpoMTiAZjUEdWMXX5w+YvKMVd
c0K9uJXJWVo0NKd8gcIbo6sjqitO/Pzy9qIFn5cspo9UTeZHqSPoyo4d28as96zW
v+cktA0mL9HTWUrarL8PFa1Y+CjEYWuesPe8G/M/zf5085WcD/oq9s9Ph3SRgVCj
/Ky6OIOHk1RPV9Uf84T/AJs235cXf+G/NCq8Gqn4rimybjq2ZWKNOv1OTifoF/zk
7+R+i/nf5dW909UlvooybaaMClAvc5a478a/yb/NTzH/AM42eeho+vl00SOdYpFJ
IqeXXbFX9E3kbznp/nnR7bXtFlWSOaMPQHpXxxVmEcnqCvTFVTFXYq7FXYq7FWD+
e/P2k+QNLuNc1ydI44FqVLUY7dBlOeRjEkMoRs0/JP8ANr/nJXzR+bt43l3yYzQa
XKacgSNjt1zUHUSPMuaMdcmKeVvyit9BZdR1xzdXslGJY8t/pzFy6g9GwYw9mttJ
htwPVRQf2QABtmvyZpN0Yo9kX7MY2zDyTk3Ri0loOp65QZSZgBBov+kj55n6U2xn
HZ+kn5Winly0/wBXOt0Q2dLn+p6Hmc0uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ks
a85f8cO//wCMD/qxV+Wf/ONH/Kaa/wDNv14q+6f2Jfkf1HFXxf8A84Zf+TJ84/8A
MUf14q/VjFXYq7FWPebIrmfR76DTTS5eB1jI/mI2xV+Dfk//AJw585fmL+bkuqef
/VOnwXDTr6hqCK174q/ejy1oFr5a0630fT41jihjRKKAOgp2xVPcVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVWOaKco1Rq
BKY80h1sc9NuAP5G/VlfZ8rx7Mcw3fCrJ6S3jA9WcD51zm8u5L0mAUA/PnW/zM1P
yN57Wynt5EjkloGNaUrnqnsmD+UHveM7cI8cv038tyDV9Lj16Y+oGjUlB16ZuNXK
xwuPowmUMyToJYUMaHop6jNTLm2z5qmRJpi3g4lcDTLIzVrrlomrvQLtyrRR1ynL
2xDSngkLJUL5GgOyfbGHN2RPN6gavdICHW7eJvTAqp2ODH2DMD6mxTvmlEYhtRyQ
Gu2Y0dVHs6RlPf3NZy0jQ3r2i8koy71yXhfmz40dgWmWfdfEFWFZWILHpmTkyjTg
XuwE+LZCEvM3GbcZm4p2BNyuDZuRQvwk/DlGftOMTybdLB4x+fl0NN8tTSSHjVfh
r8sPZWrGXOAHQTH7w+98x/8AOMepxaWbjSr81uLp/Ujqd6VziP8Agp9nyy6uButn
u/ZmF4jT6auNBm1LzXaTuDwBXf6c1PYmkOLmbc7tGFRfpDpcXo2cEX8saj8M38ju
6NH5FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXwN
/wA5b/mzP5G9IabZvdSo1fgFe+bbRmg67NuXxJDrX5hfm/IbjT2k0q3m+GklRtls
pbuHwgPRPLH/ADi/pGmSjU/OxfUL078w9RX5YjZiSX0HpvlXSNLVFs4FEafZ+EbZ
bGVtZZIEt0H7uP7hlwDArYzI70jbh88PCgomf1omCyETe6jplsQwlJsTjoy0OSpj
xLSOXTGltZxxpeJ3HGltsCmJitt4OFbdih2RMk01yyu1px6YwluoDQNMtIZLsS1l
U+pRagvp3bcUj+JSe5yNWgFRWZ76T6o44RRfZftiYtok8f8Azy8nw+ZPK2pyIolv
baGsDrSob55Gcdm/DPdh3/OMXmU6p5bj0TUnrqFipD161zGkWzXdGFf85U6n9Zs4
vJkrfvtQ48BmBqHM7L3KN8sWUmmeX9O0wiht4QhznNWX1LRYvQyK2X4eTZqoHdql
sUJJJ6snBc2+Eel2OjFwKIfYADNaebhmO6wVOwxbIhe9n9d4hm4qhq3yywFkQipr
hXAttIFSPtEYQ0TYV5486WvkexOoSEG4UVOSu3GkW/yK/wCcd9d/PTUV84fmcXm8
vTnnax1oOINc22OPpDzepy+ov148l+Q9H8g2C6J5cgWG1QUAAHT3oMsEacGc7Zes
aJ9hQK+AphpgvwqtKKx5MAT4kYptBy6bazsZJokZiKGoBxW2M3XkXRb31YbmziaO
VSGBRf6YDFkMj8eP+cjP+cdpvyM87L+b+hRGfy7dy1uoUAoqV3qBlZi2+MHpn5h/
84/+U/ze8k2/5y/k7Ev6UtYxKkaUJV1G9RgEUTzB7N+RHmzQvz68iTflZ5nWG38z
WsRhuw0ahmYbVG1cuEacWWW3wh+af5T3v5P6k/lm+ieOxmakNydlUVr1GEhGOVvp
D/nH7/nIC6/LUReUfP8AJ9Z026+G3umqURSadcDYn/8Azmh/zjPZfmP5ab8yfy+Q
POqet6USgM9B9ofdir5Q/wCcI/8AnJ25/L3WB+XvneVuIdYeDsSVNaUxV+9Npdx3
kMWoW5rFMisvyYVxVH4q7FXYq7FXn/5j/mHpn5b6RNrusyqnBSUVv2jir8X/AMw/
zD8wf85Ja+DA0iaFA1GVSQGA2yjWAjGW3T7zD1Tyl5Hs9ChFpbFY2UUq1K5y5Nu6
4GdW1mlu3GRDI3Zx0yEop4U5/RnIepKwbwp2yo40iK5LFBsMq8JKCu4DH9npkTiS
ElVP9Irl+lG6J8n6OflcP+dctP8AVzrdIKi6PP8AU9CzKaXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FWM+cv+OHf/APGB/wBWKJcn5bf840/8prr9PFv15VIlES+5z9mX
5H9Rx4iyfF3/ADhlX/lZPnH/AJim/XhBKv1ZyxXYq7FXYqoi3jEhuAg9Qiham9MV
VsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirRFdjkZRB2KpbqVr9Zt5IVNFKmv3ZAx4IERHRA3O74p8yQW0GryaRakBg
S1PfPPTkyxkePbd6fARKhHd85/mfaeUNPuotS87vGtwH2ZqZ7V7F6iEtMI31ed7b
0vr4q3fRPkO+sNY0iCTyrcLJa7fZ6UpmX7TyyYogw2ee086LKpVMbFB0GYuiuWMG
XNzDRWAnMnwwwpdXHwwxK7Y4OAIt1MNMbLdSBxHTKMumhkNyG7KKkIUBqBvmZ486
q2VlfxHfB40u9bK6MmIcY9gcxs2COX6xbEi1/quVMdfhPbJ44+GOGPJj4YUaIgCn
oOmQzR4+aRj7lArIzE/s5bh4gQDycviHD5tvMlOLjL9RiwndxxOQ5PLPzj1PSNJ8
vTr5uQTxuKxg9tts0elGTHl4oih3tOXFGrHN8n/kfBbajqzeYbWLnDCaR07DMrtG
OPUHj1O5A2cvsrNmxnhhyPN93+QLCbXdbS/f+5Q04/TnnPZ2aR1BiDtez6D2xGEd
MK+rvfbMKlI1Q9QoH3DOkLxwVMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVfM35w+XdNvpPVvIA7A1FaeObjSbh1GpkQdnk1tawwxLDE
gVF6AAZn+GC68zKLr8PDtj4YRxlYqBQQOhwjGEcRXqeIouSpbWlQ25xRasjFIjHD
s5wEkckEOtzsY7jeQ9MeIrS9I2tCXuTVD0GDiK0pi4RtgN8eIrSkwfqDth4itOV6
7d8MZFaXVOStadU4Fp1TgpXVxpXVOARpWsklcDXCUUslrJRG3AwikUrBiU9I/Y8M
NIUzZxTQvacapIKMPHGmzF9QfDn/ADi1cCb8xPPOjS7payERL/LvmszmrpzO0dqY
f/zkNPPqn5m+XLYNWOEgEZps+Ql33YGGMpCw+hJU9ILEPs5o9RIvfzJhtFROwoMw
wHHwnilRUFRUPNRvmRDIRs5pkYCorzvlxgGgE24CnTKJgW5EWmVpf3Sn7W2RBY5D
sse5h8t20+plgsVovqXBPZffMmEbdPqM0o8i87/5x5/Km+/5yX85X3mrWqr5OsX5
Rxn7FyAegzLhhHc6TLrJ979s9E0Sx8uWUOi6JAtvZW6hIok6KB2GZgFOBKRkbKa4
WLsVdirsVdirqdsVYz5t8qad5x0m48u63As9pcIUZGHY+GAhX5S6Jf6t/wA4Yefx
pWoBpvIeuzGNIWqVtlY9T2xpWRfnx+Wk35c67a/85EflDKH0mZlnuFhNVkB3OwyV
sTAPqDSdT8rf85ceSfRuUT9ImL4hSjRP/t4E0/N7XfIt15C1mX8o/wAxAXt7pq2F
43SJRuBXFL6A/Ib89bz8s9VH5WfmXJ6thcVis7ySpURE0A323GKvn/8A5zy/5xUk
8tEfnz+U9Vi5+u6REfEaV5bYq+iP+ffn/OXS/mdpEf5b+ZpDL5jtQq8d6hR418MV
fqTC5SMMG9Sp6jK8kiOSo0HJgq3hVjPm3zVY+TtNn1zV5FjhhUtuevtgJZRFvxO/
Nr80Nc/5yR8zHRrCRl0S3egAqBQHNVqtTKPIuXDEC9j8q+V7Xyjax6RpKAUFJWFD
U5oDrssjwk7OVjwgbsyh02ORuTrU4SW7iLJLe1CLwUUGCyniKIW2VRxUbY2vEVj2
6ruoxWyl08da1GRKiRYyYlW42waY+pcxoP0R/LEU8u2lP5c63RnZ0uXmz/Mtrdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVY15y/44d/8A8YH/AFYQr8tP+caP+U1175t+
vAYsDs+6T9mX5H9Rx4EW+Lf+cM//ACZHnH/mKb9ePCy4n6s4snYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FWiaA5GcuEWoUT+8Vl7EUwY58YtExT41/MnyRJpWvP5hjlPBgaD+Gc57QaPw8Xi
X1dt7P5uPNwU+P8A85vyptvzPSP9Lz/V1Vq8iaZs/YvtDhIx11dp21o+KJlfR6r+
Tmn2H5e2cHlfTrgSqSF5g+1M9c9oMHjYox5U+XCVEl9A3cAglMatzFAeWaDFHgjT
sMeSxahxy22Rktwq2DTAQpDfLBS8LYNcU03gV2KuxV2KqEy1oR2xDdpxZV+VUAB3
zJyDhxmTr8uWpkLY7USGsm2aEZRNysZePfm15Us/N2lzWeryiPjslT2pnTDTHwwR
3NOMcU6Yh+Tvlay8jaZNBEolDHY5517Sdq8M/Dp7bszsuhxW+n/yS026k1KTUHqL
bcge+aDsrF+847T2jruOPh18X1nnTOjdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirwT81F3r7/xzcaPk6bV8y8RApmyDri3hQ7FXYq7
FWz+7X1vDIlVGdqRm8HbfG1tKbLX01WT6rKaUNMFqn0lsq/3eG1tpGA+FsbVaYuH
xjvhBW3YVdirsVdirsVdhpWwaYaVuvemCldywjZVk16unxPfSmiRCpw22YvqD4i/
5xO055fzM87a/T/R7qVip8c1eo6uT2lLYMH86ONW/NJZDuLaag+/NJmel9nPqD6G
ml9RzTtmmzvdZ91hG2YgcbTj1KWWRczI7LJTagHZUS3DZUAYhooR+9ccU9jjEtWU
7Pn78z7nUPM+qaL+UmgsRcalcC31SReojJ6mmZ+EPP6ub9rfyg/K7Tfyg8sWXkjQ
wDDaJQyU3YnqTmxiHRTlZeoZJg7FXYq7FXYq7FXYq7FXkX5v/lPpH5t6Bd+XdaiR
p5IisUp6o3Y1xV+dn5Heer78kNZu/wAhvzwJuPLF25h06acVQKTTYnFVHzDoGsf8
4qedl88eV2abyVqkgkIQlkCMa4q+wvzK8meX/wDnJjyWNU0F4zqskQkt5lPxxkDp
ir857fRV1Qy/k1+aI+pa/Cf9B1GTY0ToAffFXt35H/mpdWVzN+UH5vj6zprI1tb+
qNmQ/CHqcVfn7/zkz+TfmD/nELz9F+bv5TO76PcTiaW5iqVEZNSm2Kv24/5xb/5y
F0X8/fKdtruiyIt/HCiT242PMLuae5wEWgvqC2Z3QPKOLeGIFKENqurWui2smpal
IIreIcmZuwyM58LIC34yf85Ffnpqv55eYZvIPkssNLtW4tKlaMAd+mYmXV7cnIxw
ZT5B8oWvlDTE02wiBv2FJJO9c0mozcTsMWN6pp1mlmPq7n1JpftHwzWiO9uRKFBk
EFlxNMutqCYrb8cU0v8ARHhiqEmTj1xQlE4G+A8lHNibr/pGQ031Jzcn6Ffll/yj
tp/q51uj5Omyc2f5mNbsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdiq3mvSo298U0s9ePpzX7xgteEquFDsVdirs
VdirsVYz5z20O/P/ABQ/6sVflt/zjRv5016ni368tAaZHd90spVJSelD+o4aS+LP
+cMiD+ZHnE9vrTfryBZU/VnIM3Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYqoTXUVv/AHzha+OLKMDLklNz5k0+0/vpgMW6OlmeihD5s0yfaOYH7sU/
lJ9ye291Fdr6luwZfbADbRKJHNXwsXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXHIyFhVnGmMBQp
ZbvB/wA6dClvtPE8chQI3Ko/VlHa2PxsHABZtyOyZeFl4js+UNctv8Raa9gi8Jog
d+5pnJY5S02QD6Tb2vFDLAnns+O7DzNq2k+Z49ACtwEtDJToK9c9r9ntfHVjhviI
fK+2tJLFvVB+jmkmllEzyeoeIJbv0yWujw5CA4unJ4AmagupdN1HXMVvCxB6oLR7
heuEMwtyTMLK4sgqIa5EsZL8CHYq7FXYqskIRGc9B1yrLKmUJiKlErQqlzc/DE/2
D45KGYT9F82nJiJ9SA8y6xFo9o2oytxt0FWbw2zYaTQ8wY7uOclPiaXzzJ+Z2unS
LK4ZLdHAqB1Fc1HbXbOPT4pQMqPc9H2LojOYJFvpc6avl23t9Lsm+sStxrnj+ozy
1M7ibe44o4gQdn2p+Wmmmw0qNpI/TdwCc7XT6cY4jajTwXGZTkTyt6LmQzdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirwr80h0J6Vzc
aLk6fV83hppXbNkHWlrCh2Kub4RVumKW1Bccl6YEKixmRCD/AHfc4atS1MqCEwDd
SMSEPCvNbXHl64W6sweBbcjwwFkC9M8qa6msqoVuRoK4QgskvgIWG+NIBV2POIOO
g64pCko5jkvTArgpYch0GKtYVdirYxVdtiqzCUriwQAvsDkTJIDnG4A6npkeJNPM
vzh16DQPKGrCeTheND+5XuxyJkzxj1Bgf/OK/l+bS/LR1+/j4Xd+rH3OYmp5Mu0Z
cnzLU3H5i3lf7xZjUfTmjyvV+zf1B9GOvFyO9c02Z7zMHMdsxA42AepZlgcnJzb2
7dciS1B1KZCRbkXZSUmRVFXZgAfA5ZjcbK8w/wCcbbL/ABP+emt6fdLzmsKOWPbN
liGzzmqO5fuEKKAv0ZsAHTEt4q7FXYq7FXYq7FXYq7FVMpQllG52OKvlT/nJ/wDI
Wy/NjRBdxgJqVivKCQVqCN9qYq+Xvyb/ADDh872z/wDOPv5urwuYAYbFpRT1abA1
OKpJ+XXmLV/+cTPPc3kbzZym0DUpv3Ex3WJSdgDir6w/Pn8j9H/PzQhrfleVINXC
+tBexn4wFGy7eOKvzingufOcEvkTXa2Hm7SWpBcGoeVIu9ffFX0j+UXm7SPz+8rX
f5C/mdEkOqwI8cXqUBemwNT44q/OTy/qHmb/AJ9//m1JbyxufLV3MV40JQITStTt
0OWYhZ3V/RD+Xv5h6X+Ynly1866NMrWU0YdmqKA8QTWmQyDhUPzP/wCcsf8AnIe7
87apJ+Vf5cyGVUPC5kj7Cu/TNLqcvW3IjFi/5Wfl9F5DsonSMTXk28sp675pc2oJ
6uZjg9sht2tZfUt4+Zl+0fDKYztzsYZBbaXHaMJlf1Hk3P8Ak5bEN2QbJyieGTpx
FQoewxpVhQqK0xpUvnBauCgqQ3CspJOMhsrGpP8AejbKNNzRm5P0I/LP/lHrSn8u
ddo/pdPk5s+zLa3Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqx/zB5gg0GD1pz8R6
DIylTdhw8ZeY/wDK37dAWkGwOQ43L/Jha/5y2XDlFQnDxo/KBSj/ADpsmWr0DeGD
jX8oO9Vg/OayZ6TAAY8a/lB3phF+blhK5C0K0wibGWlA6p/pf5iadqLcOQHyIwib
VLT9zMYNVtbgAxyrU9q5LiajiKN9RTuGH342wpcGB6GuFFN4qtDBvskHG1pzMF+0
QPnitIS51C3tF5TuB7V3yJmAzECWMXfnrTrVSWbceJGQOVtGBgeofmuilvqu6jwp
kPELbHTi3n99+c1zdP8AVIAeuPGXMGkixzUvzA1e0o9WAbHjU6UOt/P+pBPW5E16
48SRpQnmm/m1dwHi9a48aPykS9E0b83LeT4L40J8ckMjXPQg8noOmedbG/HxHiT0
IIocs4nAliplEV7BN/dSKfpw2GsxIRWFi7FWNecRXRL8H/fD/qwE0pfl1/zjWoXz
rr6Dxb9eWwOzRLZ9xMxKSqfA/qw8TOIt8Y/84aSRQ/mN5xDEV+tH9eVmTeI2/SPX
fOlporGMkMw6mu2QMm7Fp+Lmwu7/ADfsYRtQHI8bkDRjvYxdfnavqcIl+HxGQlkI
bo6KKva/nLEzAM3Xx3yIylB0cWdab+ZVlchfXYAt7gZaMjj5NJXJlA816eziNXrU
eI/rlgNtP5aSeRXkM391Ipr03xajjI5onFg7FXYqpSTxwisrBfmcBNJESXnvmL8w
rTSD6UTAv9GUyy9zkw0/e85ufzZljuPVeohpkRkLdj0wJpTi/Nya+fjASB7HJcZb
jpIsksfzat42FvekcvfJcbVPRhm1h56sL0hQevcH+GSE3Hlpj0ZlDPHcLzhYMvtk
3HlEjmq4odiqQal5itNPVquGdR0HSuR4m7HhMi+Z/M3nKXVL8tBOVUGhAIyJm7rB
pQGEeYLie4T4Lhq/PIHI50dMB1SvQRcryLztUCoweI2/lRXN6L5W/MO40ZhBdsdj
tkRKnTZdML3fRvljzbb6+gUMPV/Xl0J3zdbmwcPJmGWOO7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
HFBK2tRXEqDbHfMWkprdnJYzdCpI+eTgd6TKfCLfDGsabL5Z1aS3kB9JiR+Ocr7S
6UYsnEDezveydcZR4aeV+dvK9nYTHzJaxBpftZvv+Bv2rKOeYobBo9qtAJYwbS38
sfzkj1PWH0HUm9NVPEA0Gd5qc/iZDIvHxxcIp9VScopFe3PK3fuMqpkArTKEINuf
hb7QwpAWYWVtUxZBeopkSgldgQ7FXYq7FW1dXP6Ocb3Pwg+GY+ojYcfOaCSeZtbX
yzbG61QAW2litD0bMXSYuLKI8vN2UB+6t8geZv8AnJGy8xeZtO8nWsIey1Q/EKCi
9s7zGRgNDfzdVPDe71/yh5M0Ly9NcajDCiOGNKDPnf2w7SOXPKJHV9J7I04x4wQe
Yer+RdDl83amLpFPpRt1p4HMP2ZwDKbOzDtrVEHhfbFjaiygS2XfgKVzvibeYApF
4EuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV4Z+
afQfP+ObfR8nTarmXhIzZh18m8LFa5opI64pC9P3ifFgVQuZDDEfTxUMWtPMot5f
qFwacj3wxRJnNyIzAsqbg0yRDXbE/NmjR6jYO3U8TT54CEgvnPy7rs/lm/8Aq0tV
UuRkQGb6qsp49VtEuid6A5OmFolJlaF417DIyZRdZUaBqeGAsipW0nIMmABSGyKb
ZJDWKtjrhipX4yUKeMikNwqhk4zH4X2HscpJZgIeK5FvcS22okR2tsOYlPf6crMq
Z0+FvP2u335/ed4PJ3l8EaZpMtZ5ANnUHuR1yvist0RQt93eWNPt9Gih0K2H7q0F
B92R1fJwtbLk/ObUF9H8yr4xbF5/45osr2Xsz9QfQhY1JbrXNNmfQcsW2+zXMUOJ
iHqWDpljfk5rADkSGsBWAr1yBDYioaQ1b9s/Y+eTxmmjKNnhPk3zA35Pfmtaa3Me
E3mC4EMjexNNyc2OEvO6oU/eWF1ljWSM8lIBBrWubCJ2dLIbquFDsVdirsVdirsV
dirsVdiqmyqwMcgqp7HFXwv/AM5Nf849Nq9q/n3yAnpeYLOjxmOvLbc0pirxXyT5
gsPz38rXH5cefgF88Ww4wSS7PyX3xVW/Iv8ANzWPyT1R/wArPzI5LA0oSGZ+lK06
nFXuv/ORn/OP8H5i2Ceffy/Ig12JPWVodjIoFabeOKvzD1rX9YttYh8zvAdL8yaZ
IqSRoKeokfVjXxxV9yeavL3lj/nOz8s2sXMUXmmzhoW2D1UeI+WSjKlflV5J/wCc
gPOv/OOV/e/844300hteTxpJUEAdBucp1GSwziH2X+Vn5c22hW0XnC5f19QvjyZj
uTy3zndVO9nLxxfS0MLMAzLxPgM08obuZAJ9bQUHXJQFN8ZUmCRBd++ZcQylksIy
PbJU0qh2xpVF22xpUseSpODhVJb1uuMhsoYjIf8ASNsxtNzXNyfoZ+WX/KO2n+rn
W6Pk6bJzZ9mY1uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV4T+csrRLbtvwoa5j5
y7vsmNgvnm6v7Ge0ZVI55RxO28HyQflhLNy31ttvfHiQMHkhNQhtPrgWBvgr2xEl
8DyRnmK3tYbZDbN8e2PEpweSK0m3gawMjtSSmGJT+XvolOlPP67C2kNB0pk0flT3
I7/EmrWl2IVlYCvjga5aU9zOF8763YoHdiU7EnASWs6XyREH5o6q5+HfBu1HSnuR
tx+bWoyQmyQUmbpkoyaxo97pRj8/6xZIJZj95yziZ/lSejf/ACsLVr9ecPbwORtl
HSHuYRqPnLVb68EdxIyjpSuRJbo6U9ynrEzmD1TKa08cjbbHSnuSbQ9XiTks/wAX
zx4mUdKb5IOfV7a3vBLEoIr4ZDicnwfJfr2vDUgiRrQY8SDh8kws72OzteMlCWGP
EnwfJS0u8tXkJnoBjxL4Pkq6t9WmI+pvvUdMeJfA8k+mvZNPhjaKU14jvmRbhy0h
PRMdH826jGeYkYqMFtMtGe5nunfm1JYyenckkdKdcRKnDy6K+jMLX824ZXX1NlJ3
qBh8UuIdDSd6/wCctO1XQtREMoDLbt38Ricthp/KyBfm5/zi3IJ/O2vupqtW3+nL
4S2cHMKlT7ydl4zBfA/qxMmyEbfmd/zj3qlzp/nzzq9oSHF0aU+eVyLnYYPsOHW5
NSmK6nIeR61OQJdpixpPrTW0DAo1crMnOjg8lWxu9Pe3Kygep2yjJLdyBg8kphit
5bqnLiK48TE4PJNtYtTbon1aUgkilDl8ZNU8PkjbWO/tFFzJOxAFeuWAtMsTJtI8
7X8Z2ZmVcvEmg4fJ6d5b/N+KaVrG76p45IytwM+i7noU35iafGoYMtT4nBbRHQks
c1f804baMvb06HpkDNyIdmvFr78yL3U5yiOQp8DlE5Owx6ShyefazfyNdLLcOSDv
lJk5UNKe5M7/AFSzurNbUEc/HDGW7aNNXRrR9QsrNTUitMlxJ8DySf4NQ1AScqJX
CJNEsPkzi+caWou7aU0oO+SEmqWHyTHy7+at3A4iYkqD1yQlTi5NPfMPU4/zhhjA
Wc/H4UGT8VxZaAdEJqn5rma3cQbfKmJkUYtAQbp45F5kn1mWX1ZSAT45WS7XDpj3
PNtQLW940cUhYse2+Vym58cdLrqSaFA8pamUGay2RekSyXAJgLEgVyHHu1HIE20I
x3900WpHgR0rtmassW3JnnlbVWsNbSxsXLRkgbYh1Wpxvs2Fi6KzdSATmVE2HQEb
qmFDsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsUFoCm2JUCljJXCESFh4r+ZPkePUomvbZf3oBOartjEc
kLasObwpizs+Wr8wop03VF2BpvnGdn5zpJmRPD7n0DTYxqgKF+98p+ffysuNM1Rf
M3lmtJGqQoPjnsnZmYZsMckdwerw3a+LgzyjVPo7yV+aNjYafDpHmOUJdUpRiAc2
AdWQ9ljZLmOK7tG5RPuCMKEUB44liS3tgY8ThiyBbxZOxV2KuxVbIUiRrmTZ03Q+
+XYMXGaG6ODi5PiX88fzhm83pN5Y0oVe1+GfjuW+eXZdIcYM65Nfi8J4SUu/Kr8l
rG2Nl5w1hP8ASVHKIFemeedue0mPGa4yC9L2boJZdwLD6ihe21acadY7uzCoGcfh
0k9VPijvb0OTKMUaOz7H/LnyvH5d09RwAkfcnOp0GiOEUQAXnNVk45Xb0TNi4zsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirwz80+
g+f8c2+j5Om1XMvCRmzDr5N4WLqV2OKtyfu0+HAldBEJkPPAryDz/p7WU6avBtGn
WmSixLNPJWtJrtmELVK0ydsCGWyxCZPq43GKHzR+aegmzuRd260ANdsiQziWeflp
rxvbdbR26bfhhBUh6lfRraW8sqnfjgksEh8tar9aDwk5AMyGQKvpEnthVdWu+FDs
VbHXDFSvOWFAWDKpskJdXNnYRyXWqSiNePwVNN8pkW2IfIf5r/m9f+cox+W/lND9
ZJKPOgqSK+IzFlJuhHq9f/J38tIfJmlwiNf9zK/FdyHYtUdz3xhsUkvdNKjSCWSW
Y/HNWn3YdXyddrTdPzg87R/4e/NW1gn2F5JUe+aLK9t7L/VF73LX15fDltmnzvou
Vt/sjMOPNxMX1LV6Uy2PNlm5q8xVBtl8otQKA+tqp2O2USju5EeSIW4Ev7wdY/iA
yMWrKNnlP5x+TJPNlhb+brAUv9LPrRgdajM3EXRauD72/wCcRP8AnIa3/MHQI9A8
wyrHq9mvBwxHI0oOmZ8Juhyx6vt9WDgMpqD0OXNLeKuxV2KuxV2KuxV2KuxV2KrG
QPs246Edjir85f8AnI78h7zy5qS/mp+W6Ml/E3ORYgd+56YqxC2/Rf8Azk3o40DV
uFl5vtU+FvsuXX+3FVn5S/nfr/5I6n/yrj82A7IJBBbyNupStBucVek/85Sf847Q
/mHpP/Kw/JKhdTMXqMkW6NGQCTt3p1xV+R3lz879X/5x516+t7J2jS6ja14jaj9K
5VmNBMUw1b/nH/VPzN0CT80JGEusHlMXrVqNuMwJZW+MXrH/ADit+dSalJ/yq7zi
THeWTFY2k2qRt1OYWfHe4cnG/QtrX0X9MkHYbjcZgSxuSCjokCjfI8FIJVwR0wjm
iM96VVFMsbWnxVBTMeOJCpW7UqBjSpJeNUnBIbKxljW4zE031Lm5P0P/ACy/5R20
/wBXOt0fJ02Tmz7MxrdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirxz84IhJp3IAF
gDTMXUl23ZkzG6fHK+X5hBJdoTWvTMW3eRzEojRdDuLxGaQlSPDC3RmSgZoHspTG
tWkrQVwsrVrqG94CS8FEPTbAxMkTB9aMJEY/dEb4QaZRmVDTrptNctaAu561yXiF
l4pUrrUhPP6r1E3hjxlHEm91rM9/begwoUGDiYHdS8vX8dqHN+fljxKAp3V5zuP0
jDT0UPbHiYmDd35ik1JPQlHGPxHXDxlFKum6z+i1MUPxIetceMpSq9vWu7wNbfZP
X55HiZcZRl/HKkNWJ6Y3bLxSEV5b0gXysP2yNsBKRlKgmmwQ34sL+gYmmCl8Yq3m
2xg0MIYKENTGlOYozS9NS5tRcTH4WFceFPjFjVrZ/pKaa2jJBRqLTGkeMW9T0K60
SaMIxZXFTXGl8Yq86ahLF6swoo6ZeJMfFKN07zD9UhMUi/F0yEshDO7Qsepr6y3s
gqGahByPiFrliBZDr2rwC3A06nqUqclGVtE9OCgEp/h++unmYTyxEEV2y0QtpOmi
8L/5xGUweadaRjWvKp+nMqMdnldXGshD9AX4RtLXuD+rIS2YwnRfl9+SWqrp35ge
cmUVH1k9fnlUna6bd9N2ltc6/dvMtVSp6ZTKbvsOIVajfRmK5FmxJbpvlJyFyOIh
kEPlm4lT681AFHQYYx4hZT45Y63B7r6tESJq0pk/DDHximesaVeW0aTXrEJtxyQF
MZTJWmbUGgotTFTqcmJUwO7JPLOrxWsTxuAz++ETY8ASa0ntzfz3Mh4g+GJzEI8A
S5phq1/AyLJbStUe+Q8cp/LRCJTUoWsi5PKQDvgOUtkcYDFbSQtP6kdSciZMhs7U
GN1cLDOCMi2DIUy1Dy56UAuVY0pimWUoPSvLT3kH1lmNeVMWHiFDz2tza3TWdtvx
FQe9cPEwMi0zapLEY77aMdMPExO6d+WXjtgzyhSR0rhM2Jx2o3t89xM08gUBPs0p
jxsfBCvN5gjFtxCjmRvh8QtoxgIHRtLuroPcRminfAZtkdkkeuh3ZJ/eEmp5b5A7
p4ym2o+Y01KH0BGA3yyPAxO6P8qagulcnu1HTbI+EGvwggHguPMuos1n+7H+Tlwy
Hk5M40GYeUrKfQNZga4+J3cKa5fHd0+q5F94Q/3a/wCqP1Zkh5oqmFDsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVQ1xbJcqY5RVTkMkBMcJa5YhLm+Wfze/L+O1VtS0pSZaEgU71zS
z9nMOQ7k7u60XbeXSj0APEtJn9CFV1tAZWNAnh9GQh7Q5tBIaXGPRHkXKl2dDWDx
8n1F8j/nr+UmtPq1p5m013S0ZgzqldhXO37L1v5muMgfF5/WaMYvpBe26X+ctr5J
8ri41BiBaKA3M0J+/O0HZ+DhviHzedyZ8gNAF775Q866P550e38xaDcx+m6Bpgzj
Y5qsun4PPuYQ1EyaIZFeSBAt1ZujWtPjYGu+anLqZx5Au502lhP6ihzehiI4SGdt
xTfbI49TOXMOVk0OOPIop7qKMDlUnvTLY5ZHo48sER1XRv6nxkhYz0Lbb5bGRLjz
iAqACMcpnRj/AJBrmQI21EpZqusW2nW73LOqsorRjTLhhC2+YdY/Py5kvG0WOMNG
TxDChzQ9vdrZOzRGWEXfe7nsjSRzE8SW+UfytsptVl80uGLXJ5SBx8OaQ+2+qzRM
JAUXKzez+Hi4reyatq6acq2WlorkbBV3pXwGczqex8etlxZHN0+qlpRUHsP5L/lV
Itx/ibVwwZzzCkUHXN5oNBDTVwdHCz66eTm+vFUIAiCgHQZnE24a7ArsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirwf8ANRyPh9/4
5t9HydNq+ZeHDNmHXybwsXYq2TUcT0wK2rFV4DpjSpB5j0uLVtNl0+evFqmo69MK
l4b5C1S48vao2iR/7zFqVPXJBJi+kl/cOskW6sAcsjG2HCwb8w9NS/s3kcbhSdsm
cYUPGfywuHh1RrM7IGxhiBTIPpHU+Th7Y7xsoBOHLhAYA0848n3Ii1O5sgfhjO2Y
/AGwl6xKBI4jb7LYCKUFbLEB8NruF65ElKHW5ic+klfV98gZMhFyGQv6Tfa7YRNk
IAr2kWCrXbqijuxph8Qs/BDyvzl+bujeU1ZllWZ1rVY2DHbISmjwnzVrvmvzN+c0
4g0+OS30EtRWAIeuUndl9L6I/LX8orPyxCl0yCW66mSQfFWnjg8MMDmL2ZbYg1Bo
3enfCMY5sDnKh6ZnnWaQkGDoBgyx4ubWY+IaL89v+ch0MX5oeXNVlBWBT8bDpmp1
GAB6vsfKcBHD0e8Sss/+kQ7q+6nxGc9qhwvfYNXLLuUN++pSQbZr4z3ckQEd0RDw
bY5mQhe7iZsxJSzUbkxg8cs4mUQxZ7w13ORMbbhJMNKveUrGU7AVwcARI2yzT7tZ
i6NQxyChU9MldOFl04k8D1fQNT/KzV7jzp+XrP8AXpzyMXRK1ywZyHXS7NgX6S/8
4+/85Uad55sbfQ/NsiW2uoOMwZgBXM7HksOjz4uGRAfZ8M8Vwokt3V1PdSCPwy4F
x6VcKuxV2KuxV2KuxV2KtH264q6laE9cVUJ4VnUwzKrxsCGVhUb4ofm/+fX5DXXk
nVD+Y/5YmZL/AJeq8cYIWg3PTJiILCUiEo8v+Y/KP/ORGjyeXvzBUWfmS3QokhFH
9UCg369cBACiReJ6Z+f/AJt/5xNN9+W3nxxf6fMshspZW5MFIoo37UOY0shHJtAf
FXmb8sdS/OOwvfzGCJ+kGeSVIkFQATUUA75jZsxOxZGNJx/zij+dz6bfS/lT52eS
KbkYlWU8Qe3Q5jTh1Ddilb0X/nIv8mpvJkkHn7yQvG8BEshhHUHfrjEXs5XJ9Rf8
46fmvD+Y+jQabeSAatAKTh232GY2XHTE5C+k0sbm4laC14lY/tVzCmWUZmXNDpMp
kaLq6Gh8MrBbjjERxIoOT1yfGiGQnmsdh0OEyLfSEmApWuQ8QsJGkpl2rTEZSgFj
15JgllLkQxgsfBrOK5Vph6lz4xT9E/yy/wCUdtP9XOs0f0uhzDdn2ZjU7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXjX5wSmLT6jwOYep5u17OHN8kN5ieK1eKmYzuYo
TT/MtzbRF0XYnJORFa+rpPdpOw8CcWdJ55m8zQT2qQQLuMWJChaa9HHp3ohascUx
LvLF7ZJKzXn7XjiqzWY7P6z9ag+zWtBikI3WhZ29gl1asPVcbiuKAhNG8u/pezed
2oaYraS6XaNb3h066P8AoxO5xVlut6VY29vytGH0YopBaDYWs0ZN0wHzwKll4Lex
vuVuQYh3wqUy1LWLW5t/TFOQGKlItJ1a5sg8lsCeO4pigJf6l5rNz9foROD0xVFa
oLq6CpqtV49K4qURbXN6ypBbg+iu1cUhDxXbaVcExbyOa0xQi7jzHPqE6C9Wiril
O9S1yKe2EFsB0plhYonRtL0+5tGlumAfrvlc20MPe1El0bWPeHlsciyCc3WgG3Uu
x6jJwa5BDar5cuf0BdXUT0T0z3zJg0l4b/ziOzr5p1hH3I5VOZY5PI63+8L9ESiu
zhvA/qymbREbvy9/Jmygm/MLzhHIRT6yf15VN2+kD6o0nV10u9e0hFUqRXMYvRYe
Slq0kT3X1tft9aZTJnLkiLbzddRt9WdT6FKVyzFyYApDMEF8NRtzU1qRlipz5l8y
vqcMVuwoFIrhVkkOq2iacUanLjgZJN5V0cak8lwD8O+LFKRp/r6jPZRHptgLIBFa
roj6dCAx3ORSQmkGimPTjdk9RiqW6FcwW81bjpiod5g1O2a5Vrb7Q8MVtDzeYri4
X6iykIFrXFBKtoes3TWpihU7NigFA2mtvb6wxvRtTvihOPM+r2l1DGYDRm2NDgCS
t0/REliSWNz8XXfDa0l3mCxiszGsbnk3XfFaZBbaVZtY+tMw50riyY1B5iurEvb2
ykx9MUWq6AieYL4C+2Fd64pZL5u8uWWkqstmwLe2EhhE21oOjx6tBWc0oMDO6Yxe
arL5W1Mx2A5ClNsYt8zszfyxrT6zqdrJeDi3qDrmTB02rOxfecP92n+qP1ZlPMlU
xQ7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYql2oaZBqSelcqGHvigh8zfmJ+VdzaT/pry8vN
ialKVp9GabtHs6WbeD0PZ/a0McBCbwr9JR3c82neYlpPFsqN/TOU1XZueB2kR8Xb
R1GPKKAeS/mj+S1r54t0t2b0oZBuq7VzN7L7QOnP7yUj8XHz9mnJyAfLNv5H81/l
1DcaHoksws+QCbnpnqHY3tdpgKNl5nXdj5B3Pd7b8zdS8veTpdMu/Ue8NDWu+drj
7T0+oInGO48njtXocgPP7V35Sf8AOQcV3r0PlnWQ3N0G5OW5YjLsAPk1YYyxx3P2
vp3XvzM0DyZbPqepvyG5ArmHqIVzH2NsSZci+dPPn/OTFl5l0cReV+SyGQrUHMCW
uw4t6ciGjnLq8e8qfnL5w0PWI7bhJPaOwqTVtjmuye0mCHMOfj7Gyz5F9Q+cvU89
afDNbM8c7AcgDTMOftro4jkXY4vZjUS6hC+W/wArdP0qBNT1yjSLuK9c5rt7tzD2
lGMcHMc7dpoey8mhJOXryel6ffHzIf0BoERU/ZrTNPh05DkZcwL1z8tvyLu9F1Ea
l5hpKCagHfNthxkOtyzBfWcUSQKIoVCoOgAoMzHGVMVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirwT81ftfSc2+j5Om1fMvEV
zZh18m8LF2KuxV2KqkcXrEoehBwhjJ88+ZtObSNZW5jFFL42yBfQGlyi5sI5u/EZ
YJMLQ2q2ou7OVXFfhOW2r538sWxstcbiKfEcAluyL6Uli9VSx6kDHNkCIh4VoUc0
Ov3nUDlmJxbttPcrhiEjZeuEyRwqlgwug/6N/dyL9v1dgT7VyslkAshmti7LqLpb
yLWryfCu3vkbZAPDPPv596D5OmbTYeV3d7hXgPJa9txkBLdshF4bf6/+YP5qvw0v
9xpj+OzcTk6JbDQejeSf+cfdJsyt7rks02oGhIc8lrjwNcpvo3TvL9po8CwRwxoV
pQKoAw8LSSnMU8jDimwwcLWtVJUmV26A4gMCsjlEr3Tdh0yRgyxc3yJ/zlP5WV9I
i81Qj9/a8SCOuYOqxl6HQzCH8i6yPMGg2FzbmrxwgSfPOV1kHttBlBZNLcMT6TZp
xHd3l7KrRegnM5m4pbU4mSG7FtWlNDljbEbMLluuJNcLIBRj1H02Jr1xSYsj03Vj
GQQcDVKLMUvYb4ATAH54GrheV+bfy2SeT9K+TJJbfUDu5B4iuZMMlB0+fSEytnPk
L/nJHz9+UcQ0zzAy3VqNiWPJqVycco6OBl0kn2D5M/5zr8ma36dhrAlgvWG+3w5b
DM4h05fQ2h/np5R15eVrqEKf8ZJAuWeKGP5eSG8w/nx5U8uoZbm+gkA/33IDlgmG
yOlJeIa1/wA53fl9oMxtLgXEjqK/uxX+GQllAYy05BYhH/z8e/LeWb6sLa/BrSpj
oP1YRkDMaQvWPL3/ADmR+X3mKSG3huxA85Cr6zBaV8cPGGMtKQ+kLTzVo99Gs1nq
FrIpFfhmQ/hWuEG3GkCE7SVJFE0R5K24I3GSpAcJKH4+/TGklUoDvgQo3EEVwhiu
EV0YEEMK7HHipHC/MT/nL78orT8tYG/OHypKtq8TVaBDxLNSu3jlOSTOMX5qf4vi
/wCchvM6D8xC0bJCI4mY7VptmHkyAByYQeo6Mut/kRdLHfgXOguRx4fEOPbMUzEl
zRoMH/Pf8qLTzbDb/nd+WNIdQjb1JYUFG236ZZCXQscYfRn/ADjZ+b2lfnLpE/k7
zcQNXto+BSU1JKinQ4ygQ5IlbxLzX5W1f8gPNT+adOEiWN49WCiigE5CQtplzfoJ
5C88WvnPR4tQ0GUPeSLWVQ1TWmYOSDk4o2za3ljsCLadW+sTfaNOhzHMC7DJjPCm
LGmRcKEaQUreGGTYZoVn+Ag5BgSlU0g64gM4Bjd84JoMiXMgkCSVuAO2On+pc/J+
jf5Y7+XbP/Vzq9H9Lzub6mf5mNTsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVeFfn
LdGOOC2IPBxuewzD1XMO47MGxfOmtaRZ2mnG6Eicj2rmM7eAQvla2tLy2YXNF8C2
SciLFNYSCxvlhQ1jZqch0wtjJtX0SzgtI7n1Fq1Nq4GJTbT9DtjpzXLUqB0xQw7R
fL76zcukNQFJ6YpQurWkmmXYs5KkVxQo3Hl69EbXkjH0Oqg4qs0fXby1R7aIHj0r
ildFPPfSnT3BSaQ1UnqcUIyayvrUeldB+I2qemK0oxWtzP8AurYnfwxWli6bNb3I
0y6PxNvyOK0n2p+TfqsH1sSClK4oRvlNrSIMl0y7eOKaQU+pW2naoJ4qehXfwxUh
S89azFrixtpYrxpUpiil+m+ZbKwsBazsnr0pv1xSElsCLjWbeWcUhbep6YrTJfNy
2ZQx2bKJSwAA6nFNNz+XxptglxXkzrXbLS1sVh0y/vI2kg5BAcqm3Bq3vfqI9KXe
VTX32yKoy68xzagTGyMiAU5N0ycGEm9X1uf/AA/dWUMin92a0PTMmLTJ4z/ziCK+
ZdY5EMRyqwzLHJ5PWD94X6GSRM/qSJ9gA1bt0ymbRF+Vv5OwSz+fvOTWx50uTuvz
yubt9IH175Y0lGndr4hWqftZjHm9DiFBR1jS1gvQySAx17HKJNkhsy21ttOu7B4G
dFmoaV65PGdmsB5fbQGz1P6q7coy2TtNM3816ZbWtsk0RHJgMbWmPWejTXFqzb8Q
K42tILTNfutEZre3jdlO1Rjahu01CW1mn1GZSsj7qD1PyxUKs/mC51eKlxGyFenL
Am1GLzJfPbtp7wyCPpyI2xRaJ0+3OosEiUlgN6Yqh7zTjYXiG5BAr3xVl+rTWY0/
naKDPx7dcUlCeT9Utba1LXoCHl+1igBKp4ovMGuNHa04EfaHTFaTrV/JdraQl55R
VRXrio3Y7pOqmMNbwxSOidCN8VClLINSLtIrLIn2Q3XFW5bO9a3DfEq03rirLvKN
vbXEZhuQC/icUpT5jtf0FdqlgfifcBeuKEneW9uP3t/yCj+bFV6+YLi2Ho2atTpt
ikFEeXrmO81X/cwOBI/bwDm5E+T0B7e2h1iz/Rsin96tQpzKg6TVci+6LY1ijJ/l
H6synmpc1bFDsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVQEkZR2lQVJ8csiAebjZZyB2e
K+b/AMldP8y3J1q3Hp37GpPQVyv8rgmf3gc7Ta/LB4B5k8p6roDu2rQyTxwfYMQ2
zSdodj4Y74wXfYO1ZnmQwi21Cz8wkwXtqbULsWmWlfvzlpS1Gnl6IlzuKGb6ioXv
lLy9cxvCSkzGoolDm+7P9p9Zj57e9on2HpsnN59ZfkPpWmaiPMsUZM/7JUdBmbqf
bnXQlUCGI9l9IU38z/k9H5si+r3jsIyOlfHMeXtrrpjco/0M6SPJINE/5x80bRI/
qioWAPKpGUH2g1U+a/yNp48no+jeVND0xfRrAkg2q4Fcplqs2TmGyODHDkU4M1nY
N6NvbvcOfsmIVH4ZX+VlLmC3R1QhyIZz5Q/LTWfMtwbjWVZLBv7tCKEZm6DRiJ5E
OB2lrDMDcF9PeVvyy0ryyy3FtGPVHU0GbyGnAdJLMTs9JzJaHYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq8E/NX7X05t9
HydNq+ZeIjNmHXybwsXYq7FXYqrK/poZB18MWE3n/nfTBcKt0q1avhgREsl8uvXT
ljXcilRhBQnTjlbOF327ZZxJDxKwsmXWi5UgcuuASZ09z4nnElPhYgV7ZDPNOMMa
h8vpFqN1cKBU9NuuY/E3Ujb26trHh+lp0tY/5pTxGPEkC3gH5gf85G6FobHT7aF7
+5j+GJrMkj2rTISmzEHj7Wv5k/naA8spstFPSM/DJx6ZXZLLYPZfI35Bab5cVZNU
DXFKcjJ8Rr9OWYo7sTJ7tpuh2ekJxs41WPwApmTTAlMGFux/0dSsnicDElU9N2NJ
mBOBiV7n0R8GBgpeq7bnpkhzRTbxenGzL+31y7hCxYJ5/wDKq+btHfR56cHU9fYZ
j58dh2mjykF8LflJq0vlTUdS8pagGQpNwhVurLX9nOV1uIPX6DOX0ddcCFmX7XcZ
oZQovUYslhfJWaPi44tTocnjbCLYTrAIBA3y9Dz67YgnCGwJQ7Fj1pTAkhFwXxi2
riwIZFa6wUG9caaiKZTaeYrqML9bKtbnoB1yBkyOnBFlM5rbRNTX1Jo6setRXHjp
xZ6WLHbn8tvL+pgyWyGO47MNsnHIQ4c9HFjN3+S5lP8Ao13On+rIRlgzNJ0g7mrP
8mRCf9Kup5B/lSE4fHKRpQGS2H5WaTBJzmXm/i1DlGTUG0/lYptL5D0uY+gYIwvS
oQVy2GYt40o7nkXn78gdGvIpbuwadLsLWIxNQBvozIjNxtRpgGL/APOM3lfzXrGt
ap5Yg1K4W+tAfSEszEE9qAnMiJdHmx0+x7b8wP8AnIX8vpjZawkdxpFr04xguV+e
ZEd3Hp7F5Y/5z00WQppnmbRNRtbqP4ZpnQiOviCRkpRWT6m8sfnt5I81wrPaavaR
O3SOSZVb8aZUdkM71jzTp+lWEmsSXMQtUjZxJyqpoK9RtmPknTZGNvxc/N/8xtc/
5yR84NY6exTyvZSGKSKpo/HaoGYmXKXIhALfM35GaFq9hHceV4mttTiUKDTj8Q75
gTylyY4w82s/M195HuF8p/m7CbrTCeMcwFQPmcjjNnZr1Eaiu8xaJqnlC4HnjyxM
t75SuaB7aL4iFPXYZlBx4PBfNbWvk7VoPza/LrnE0r8prZTRhTrUDLwL2bCX6CeV
PN/l/wD5yV8qLpuqBDrLJx4dWBAymUaY3ZfLWi+brj/nFTzBNY6yXNtI9FViehPh
lcsfE5unG7688lf85LeWvPlwltK6w3NzvGzmgGY2TFQdyYAxp7xHMHHNGDp2cdDm
JTgzw8K40bdTU5EuCUDc7CgyCY7pFM/bC5cIseuzuTgLaCx9Hrc7ZHTfUufk/SP8
rjXy5Z1/lzrNH9Lz2b6noOZjU7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXhn57S
omiMEobk/YXuflmLqXa9m3u+Mry952ifXraVYQoDMa05Ziu8ijtJ8tarqtozpN6S
dYwdqr2yQciOyQzRzRN+jdRRmlRqg+NMW1XvrkzIq3MUirHQip8MaQQiovMGoeiZ
YY3a1ccRTpga3aRqOqWJaXT5QjN2OLGlBLy9a++t66wkWtTTFI2ZXrPmmO8s3tbQ
UQDbFVXyxe6etuBeFQwHfFIQWtX9tHrVpqkFPq8S0NOmKpnqPna21UG2CjjhTVJB
a+YoNGkqBVScCFmta9FrzKNNIS5OwbFJC6+tNc0+yD6jJ60J6BcVpJ7Hy1qOuwtd
aa5h4bkE9cKKX+WNIm1C8l07WSVHTfAik/8AMmjf4RiMennkknXvhSEZpHkHTtSt
4dRvqtLIKih6YFAYNDDf6trLaPZyBIYG4r44aWk41XQrjSZv0lehpWiNBTAmkQ3m
K8W35XELiM7ivhlp5NSfaF51gNs0LR/F8sqk3BIbe6sp75p72M8Cdq5FLIte1DTr
ixjtIo6EmlR1yzG1zQb+VbU6FfyKDVoT1zIg1EPDP+cQ1htPMmuaagPNwwqcyxye
T1g/eF+hksc2k2r2N1vFKu/jQjKZtEOb8u/yU1K08v8An7zZFaisclyeffvlU3b6
Tm+jn1G41a/K2UbenXtmOXo8PJdrrNYhUlRuZ8cok2TOy3T9AudStG1iLkpXbjXD
A7NQFoO1eNJKSIWuAdvHJ2mkxu72eZSmo28gQD4CegxtFKcOq39tYyqkqlOJ+7G0
0yryVqNk1hHJfFDJU9cbXhQ2o3NtreqRJEAqQt9BwhaZD5qtrURxuhUEU6DFAKn+
lrWbT/qrcAaUrTFS8ya9vtFnMulsGB8MUNR31/5iulTUWCnFWYan5VvrOD6zYSb8
T16YpSfyp5Ym8xwtFqUg2ftthpB2SXUln8ray2naW25FK4Eo2+1S5uEFhqUMjFd+
YrTFNFmXlTV7Oxj+r+n94xRTH/MWoKl/HNbRGleoG2KllF9r1o2nkTFQ9MUsM0QX
85eXTwSntixWxXckGqpPraElTtXFLMfNWs2moWwWzjqwHYYoApA+UbuyQEalHxI3
q2K8+TGNeQa/q3PSviRf5MQ3z5M8/LzTbaLXY1veXrAinI5kxdNq+RffkIAjQDpx
H6syg80earih2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KtEVxVorXplMoWqhNbxyoY5lD
KeoIrluM0xIYB5j/ACw0PzJAYrqAIT3QAfqzJGoPUD5N+PJwl5Qn/OOtnYFpNHl4
N25Guc/2h2bLPYBAdjj7RjHoWJan+SXm9pCNM1GKGD+Vhmvxezsx/Ezn2/CG3CUq
T8iPOrH95qkRzJj2FIdQ1S7fjLoWQWf5F+aUK/WNSiZa/EKdRmXj7PMOoa5doCfR
kQ/5x006+mW41IsadaGlT3zOhj4HGyZOJ7H5e/LvQ/LcaxWMAJXu1Dl51FdzjHHb
OI4kjHGJQo9hkRLiSI0qYUuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KvAvzV+2Pnm30XJ0+r5vFT1zZh10msLF2Kux
V2KqymNULP8Aa7YsJhL7i2kvkMajbI2iIX6PYHTCzOdqbjxwEsqR3rpcRslshgH+
XjbLhSGDSkWYyOylq9RgEmYiiNb1m28uQrPrl/DDC/8AdlzSmV5SzjGnzF52/wCc
nLXRpG0nynYy6tfnZZbarAHpvTKbbRBgdt+Xf5jfnGP0p51vvq+ltuLQnjIB4ZKM
SV4gH0B+X/5A6J5MVblAHcDpJRj+OTEGMslvYbeNFlEdsiqo/lUDJGDWSjp6qQpy
UI7oJUMupjbsaW3Y0gtg4OFDZYU3wGKqrn91UZPHkB2RPZDiL63A0J75OQ2Z48vC
Xwp/zkZ5N1Dy9fW/5haMlGsyqtwFKjvWmc/rcT0mh1AZt5P8xWXm2wttTst2EYM9
Oz5zeXG9dpNQCGQfWvr16HccYkXj7ZDw3aCdpLqlsGDEe+RZW811O23NBhZiTG5I
K7HC2BR9Mp0wKSrpcSIKAYtZTGK8YAcspI3cuEtk4tdQIIwcLGSfxasVFa4048os
gs9ZLChONMOBNkvDLsThtHAmARXT1T9rMbLzY8CgrrWjZPGXIEVwdUYNTkvcZn4y
4mqg+ZtV/MWL8mPzE03zDY2rsL+4AkVR1FfbM2DzGqFF+qWif85eeQNfk/R/mN4r
GQ0DG5pTp7jMqDrCmuvyflN+YsYgbXNJe0I+NInjDH6eoyRmjm+dvMX/ADh3+Vms
vJqnlnVPqhQFxJ654VAqOh8coySZxD87PzP86fmY+qv+UvlzWReaDE3GsTEkqvau
YkyHIiE6/Lz8w7zyB/o+raJdMyfC8vA0JHU1zCyBvgKfTnlP85vLXmCULczx2Epo
OEpoa5iSxlvE3omu+VfLvn6zez1IJqFsyHh6IFQT3rjhFFrzGxT5N1XyL5s/JGST
Wbdjf+TpiQunD4pFFc2FuONnner+WrPzpC3mvyO62jr8Vzpsm8pA6gL75bFjIvnO
1866x+V+tP5k8pyNp9wWq0UpO30YTG2IKD/Mn8xL386uF9r9yjXyU+JdhUYBGnba
YcTz/TNYn0KSKMiV5oiOEqE0G/tleWOzvsWInZ+tX/OO35zDzXZ2/l++erqvHete
vvmpyQbNXpzT64mCW8yxwGtRmPIPL54UUneQ1Yv1rkQFwC0mum61wudSRzHY1yMm
ky3Y/a/70j54NN9Tfm5P0q/LH/lHbP8A1c6zR/S87m+pn+ZbU7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXz7+e1m9pZx+amNbezHxp45i6iLt+zMoFx73yH5g/MyDzb
ozeXNLsik8jBw4HhmMHdAdWUeWPNdqltGNWkWMwRhKN3IwhyYi0lsNbGqaydTvY/
9HXZTTYjFspkPmrzBpt/AbSziAkIoCBhLGII5pdomvxaRpP6Ov4uW5IJGRYEIny1
JpN1K9zfzJGOtDii0Drt3p1/dfU9PZXANKjFU+vPK1rYaetxUc3HTCoNsR0HyVLr
/rPDJQJX8MCpVo1kJdWPl+9aqBqFjhUMn84eWLPRIPWs2BYeGFkN2/J/l2z1+2L3
rAN74FOwSjUvLUGg6gsiOBbA15V2xUM+1bzXpg01YbeRJnApQY2vDvbDtI85pZRu
7UjpUhT3wJY7Jrl1rk8t9p68JPAYq5NTvruB4dXryA2LYruuttX1mxhC2qM8Q6Ed
sK7oaw1KPTtSivHcLPJu4PWuK0yXzP50c31vaRR+pE9C1MCsp17zBZ3unJBFCA/G
h2y0tCVeW9BWW2e54+JyqTfFhTyPcan+jwhoGyKWR+aNPeyhgMSHlUZZja5sc1fU
tc+oXVlZxvRo6CmZEGkvHP8AnFDzbZ6T5z1XR9fpBeMSAz9zmUOTyus/vC/TKc82
P1tw9u4+A9umVTaYjd+YP5J6Na3v5g+creu5ujw+/K5u20g3fUNvqieU7xoGj5b0
rmOeb0mONxpA+bdRfV6XlvGaDfKJMpRoJRpf5hnSYDp11HudsY8msK9ldo8/6ZiW
oBrxwskTrfna415o9PhtGSIMA7U2A8cKKpN9TOhWOnSRwTozmPeh74GSX+TvKC6x
Zx3NrKOPI7A4WB2Qeu6Nc6PeqlsTVjhCCh9Rs9SnKxzMeJwoT+TyZdLY+uH7V64p
UtBubG0lEOoEMV2NcVVddutNW4WewZVpvtiqFuvOU18p0e2ajcD8XtioS7y9r7aL
CzytU898LIOsdWsNX1xrq6YBqd8VZv5w8x6ULBbKzlQXRFD44sQDe7EdG8g6nfWp
1SK9AB3pik7IKVZ7OCeC9nDyKNsUo3/Bk2p6WNQMnGgrTAwTbyP5hi0KN7OcBqbV
woItD6nbN55v+WmTLDxNCMCUNqflG/8ALShri7BB8cNIBtdY+StR8xxmS3uwikdv
fAk7MYt7xvyv1Job799Xr3wDm3zOz1f8utbs/NnmFbtV9NqigzKi6bVHYvvmIURR
7DMp5oqmKHYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7AVUyWPbbMMzydAyoLgKC
g2zMjdbsaaKV674JE9EGIPNrhgHEvCFwWmS3Wg3TxxS6gwGIKt5KldirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirw
L81ftj55t9FydPq+bxU9c2YddJrCxdirsVdiqokavu2RJQQskumQ+lBiWQiueykk
AleUBuoGRZAMP80efdF8oRtP5svI4WQVET7E0yEpNsYPl/zN/wA5MT+aJTof5c6H
PMzHiLqOpX55Sch6Nwx96E0b/nHvzt5/I1P8xdY56e3xJaFiGQHffEAnmiZEeT6Y
8jfk/wCXPIEYfy+ES6/ad6NU/TlojTTKVvRJGV29QlZbgd0AGTAYErEAqXn2J6jJ
iLG1SKSKIn0xucnwsSWnjd29Zj8OExpbaoMCuoMbVxAxtVmFVriqmnXIz5JCvbH4
OD5jaedndcq5QYalM2RqnE490h8w6RbeYrGbTNTQNA6tWoHWmanVwdvosxHV+Vs/
nOT8mPN8vkm1Uy2d5NzBFSFFc5zPjD12jzkPsyx1Ox8yWEUemMFnYBmp1yjgd/jy
lXmtlZeBO4FDmC5Akxm70P1ScNt8SkNx5bI3UYW0HZKptDZNyMVQbaey7ccWBK06
bId+OCmQyNpYyL2OPCnxLRsdu/cGmRpbTeGN0FQMFKmdrNKGpTHhUslsjI5AbYZj
5Ru1k7o+7thSqHfJYw5UXWcsVqjXF2RxTc1zNgHD1T45Tznb+ZPzIE+q6Y95pemS
8wANqA5mweW1Zfbd35q/5xz88TtD5y0T6nKaBnZ+PbMiBdRMpNN+Sf8AzjhrUgHk
TzHbaTIftB5zv+OSkUY93y7+flq/l2NfKH5d+aoryJ6LWGQn9RzHyFviGL+RP+cf
fNUel/pjSNcSPVJKMGY1NfpzDyScmAZnP+Rn5slK6x5phkhI+xxFaZjkgtu4eU+a
/wAktZ0wG8ksZ9RuV39SI0BP0YQLYksS0Pz/APmB5LmKIZdHs4Ny09aMB2w+GGHF
b3TyX/zmZb6zL+h/MNkZIx8JuiCUYjr1yQgtsp1zyb5d87zDzb+VmuQad5gHxz29
d5e/EDLhsGuZfIP5yMbn1bPzPpklpqQFHu3FFkp3GTAYjm+SNGuhodyyupuISftK
dskQ7rRB6/p90l0BJCQsJ3ZD1yjKNnruz8YkXqv5HeapdC81wJGxWIsKCp8c10xs
5OvwgdH7TaNP9big1FjWsdcwZvEauG6hPcCUsw8TkA14AkNzJWowufIbJPM1Qcrk
6+R9SUWv+9I+eOm+pzM/J+lX5Y/8o7Z/6udZo/pedzfUz/MtqdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirxn847ZtR039GzNxtZPt+GY+cW7Xs0Dcnm+TPMPliDRNGb
UdKi9OWMUDDuKZjCLu4y2S78udF03zFYzXuuRhpAT8B2qfHJCLcJXyY++gTanq58
s2Nz6ScuQbwHhg4G3xGSeYvIh0yBQLnjLGORbxph4aY+Lalp3k661iwOszz/ALhf
2flkJCmMstscsNOXUZ2s7S2MnA7kZDiYidpdqQi0mf6pZxendfjXDxMgU1uZ9b+q
o90GaMDf2xts4Su8p+cb7RjMlvAZVetSO2G0jDaQPJPPcTvYNz1CZ+SgdVwWsocO
6JkXW+Aj1yNgo7tjxMPGTK0WaGI/U7j0hjxJGVQgik1WYaZd3XqoTvjxJE2R+ZvI
cei2K3NjsxFag4bpIlaO8kaTpV9bMNao0vQV8cRJEr6IfSha6LrUqAD6tXr2pkg2
Vtst/MC/ttRAGigGlORGJQImt2XeU9U05dIAuHUSxKeSnvtiESvo8s8uWlnqevy3
Gpx0i5/AD4YFIZr5tsbVLyLTNGjDPKNpB+zhKBJKNY8pXGj2f1q4ut+tMTNr4FHQ
9Y1O3sn+roZI+lRkJG2yMUntJXs5/wBOs/qTct4e4wLSb6t5ubW/SYp6SxkEg+2S
iaU47ZjZ+dNPhtpJJVBYrSlMsjmpj4Hm+N/zY/LhvMcw84+RJ/qOqxHm4U0MprWm
2Zscli3Q6vs25GVvd/8AnHr/AJyLj87CP8tfOi/UdWsapzk6yECnfIzLgHScJ5vn
b8vFvoPzD83QaEpYpckeqvzyqRcvT+kvpPTrS7127GnanP6czftnKuG3fYs2yKv4
J9Cvk0VpvWR/2/DKjjcgm3oGh+UdMu7R5L9BNJQkSeHthhhtrkeEvN4dIuLjVzpu
nS+nbhvow+CjxGUeZdBk0uIR210A5HxDxHhkZYqZCVpBD5cjudOln+pn7JPKv45A
xTxIDy1rk+k28dpasYxyIwHZPNOl1CX66Ly6n9ehrw8MMSgxTnX/ADR9dRDaQ8Sn
tkrYkIR/P11d2v6NjhKtSnLHiYpEsbSSqsVmZpWG5Hjg4mPEh5rNoL6NL+2MSsR1
x4kgs/8AMVhpVvpvraYoW84/bHhko7put0o/L2x03UrNn1ihcPupyzgZcezHfNGn
WMGtCHR46RyEKHHbExSCm2sflzFp9v8ApCeT1JQvKtcHCy5pFpOq6nLELSxmKp0K
DtkbTzWvxBli1NuDD/dhyJK1aJu9duU076nY3PKOlOQxtfCR/kjysdZt5ZXuKvvk
huwlCmKpdy+QdTeZ5PVPLZPHDwsvBT3WfOc3nNQ0sRt1XxwiFoGKmrT8yH8vQNZW
cJkcKaMPEYfDT4do3yTFa+cH/Tvm1h6jPT0G6geOVxZZBsz69sbHyvrdjc+WVDLc
SqhVf2a98yY83R6mWz73tFZIY1kPJgoqcyQ89M2URhYuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVoGuQhPi3Cur2
w8W9K3kldirsVdirsVdirsVdgItXYVdirsVdiFdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfPn5
ry8ZApHf+ObfRnZ1GqFkvHKEjkBtm2ENnVyluuREb7TUwEMeNayEn07ceo56KO+Q
JXidztxWKaUJcj/dXeuAzZA2sbnF/vQvAHoT3yPiNgha2e4trSIz3MoVxuE8RlZz
0phTx/zZ+ePlnyoj+tcI10KgRdycfHDPwy+fb382vOf5iym38q6bLBA54pcKDRa9
GwmVtoiAyDy5/wA4z6n5juF1P809TOqA/FwZiKA9srMO9Tlp9Q+X/J+h+TIFsvKl
stsVABIAPtkTKtmPjp/SdzyeSp7++SxSthPLxL/q8LrstG75k8LAlJptTTS25KnE
g/ayQDFP+SX0K3CH4mFTk4hgWrR4qmJxRvHLAWJC2dpI5OINY8EisRbYavXIM+Fd
kbTwrScFppbg8RabU0NT0xvi9PeoFL5VIIkQ7HtjDQ8HVEzxL5boQqCVqTl8p8Ic
caa2MeedWj0XSJb6RgilT95Ga3U5bc7TYaL52/5x1/5x+tPz0h1bzP5pXhdRzMtt
K3UA7Cm2aTLHq9Hps3C89/MX8m/OX/OP+pS6no6SatYhySEqQqDr92Y0i7nFq/Jr
yx+bOjeYaRSXCw3A2dD1DdxmCcLsY6ryerWji7X1ITyjpXkMicVOTDU+TUcsMsjQ
KQXUdMg5WPNak8Jc7xVHjg4nIiLaFpbj+9QDIGbMae1BoLckqqjjkxlazpFM2cB6
DHxGX5anfUoW+HYe+DxEeHSqthCOjVyPGi6VYo4oTWlcPiMeJHOyOlYjxb+XKpji
NtOQ72h5J4tPiNxqMojUCu+X4sVsJa7g6Pn3zj+YNzrM7eT/ACpAZ7q//cRSJX4W
PfbNjj0zrdT2pY5Mk8k/84r/AJj/AJb2surXlvLqN1cDk0Y6/Fv4ZkDDTo82fiTb
6pqWiQyHzZ+Ul1qpP2pd9smI04UoW8a/MrzJ+XOkaaYpvID6RqlyP3ZZjVT9+Y+b
LwtmHG+bvJ2jeX3uH1S+1BbJyaorkmn35jSz30cgQp6/a+X9Uv2+t+XPOyRxqfhQ
eGVylfRnbP8ATf8AFVqAZ9cOoMvRR3pkOC1ORP7f83vzB8tn0oNEmu7cdWC1qMlG
FMDNFXf5rWvmuP6p+YHldjCeoYAb98ZDZjx8O7ybzfonkDXIGs9Kli0VTXjGeqk4
YRLIZLDwZ/Js3lDleeRb03up7lJkYnftmVGDVklTzPzb+YXmPVAmn/mLI13PF9pW
FCPDExppjqKYeujW2tcZtOnFrGOsfjlUp09L2aRkZra20NvEsEPxMooW8cx8maxT
3/Z+i4PVbKvI8JuNetfqoo4Za/fmIeTPtV+2flYPZaHavOat6YFM12ST53r8lFF3
FE3H7QrkAWnTZEkuG3OG3ZSFhKpTQGvXIScCeH1JTZyVuR88jppepyc/J+l/5Y/8
o7Z/6mdbo/pedzfUz/MxqdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirwv8+r30/L
8llan/TZP7sDrmPnkA7Ts3GSbD4wuL7XrbRSusI3oAAGuYwk7+MUm0yDVL+D655d
B9IbNxw23AUp2Fxd6RrIvrgH1QtCPfHiSYprqvmK91mVxdgonE0riZMDF2n+c7y2
099ChQmOh+KmQkbYiKYeQPN8HlqWRrsBnevXIr4ZSLW7lL3WP08Pscq0wNoi9Nv/
ADvp1xpL23ECVloNsNp4Dd2lnkW80+0sLo3wAdweNcIZG7eeeWeOm+YX1mY0gD7f
KuApycntXnPzLp1/p5MLAud+2BxoxpgXlbXtHhhePUEVm98WQixTXb22F8NR0MBV
B+yMLZSbaj53urmzW2vIyFpSpGBlVIPStIvdSQS6aTue2FK3RtMvb7WJdCvSVkO1
cbYGVbpz5l0j/lXlVuz6gm6V364kpjkBFphZ+S3n0h/MUD0R15Urja+IBskC2smp
vA+mCjRCjkeOC0EqV5LqPlqYXF0Czk1WvhjaDaM1zzDceYrEF1KheuFIKc+VPOVj
pWlvYzgFzUYrTHdHiS5vzqJP7iRqU+eLMM184aLY2WnrNaMC7DemFEZEpboHk6zu
dIk1C5kAfiTTEBkZVyS3yv5WNxcq9qeZLHguZUJbONnj1eI/n7+Qd1pFwPOvk+Ur
rw+Jo0O9fowSm6jNC9w8j/5w58z6jomreYH84RE3k0hMpcb1r75EyRghu+tXln1v
VzfaWDwVu2Ayd1ggv1OKdboS3NeY23yBLkmKJtBqZtXWCVkjJPTETpqlFL9Mc6TI
001yTMcTkYcKnPcPcSveahcEAAlQe+DiTTN9H8+CLQpreSKp4EVpkAUGNpV5FfS9
RiE+oEKSx64GQKT6xbW8mtpb6dJSJ2oxGITE2y3zFpEOkJEIZuXKlcKU/bRLC00r
9JiUGUrWmNNe98mB6Rqdx5fvBfSsWjfcYKUxUvMOvf4t1COGJuDYhhSL1/y7e6Pb
rePIXjK0pko82UQlvlvy7fXhkntSRGy9vE5bbOqY3eS3WlXcem3ALXKSV+jImTKm
f635ruxbiCaAlQoqadsgZJQX5b6hbi8uLq9jASQfBXImTGrUPPN5Bf3UcNpCDGp/
eUwcSbpkVtqWgx6W1qsKiWlMlaOLzYf5f1ybTGmFohCEmlMQkzb8oXVnq9/M3mNA
0nP4OXhXJCSibOvO1tp1tbhdMRRUdsJmiMu9C+RdK0p1MuqqpPXc4eNZSNbMM1qw
fUPNUsPl3a0WPYL0r9GBtIPDu9I/KixmufMP6P1j7UVGWvY5fB0OsD9CoV4xqta0
UCv0ZlB5081TCh2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KtDbK8caCS7vXDW9obyauxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV87/mx/fD5/wAc22j5Op1PMvHEmfn6X7GbbidZ
KKKkjiArXfISk1kKCS+ifUhPFx0bwyFrSneXtpwNxe26o463FRX55EllF4F56/5y
D0Xy+DpenzC/vOipStD9GVkuRGLw2OXz9+alwJ2tpNPsGNBMKiinbMXMd2+MXsvl
P/nHDQdKdNU8xyrrN3sxVz0OSgpt7PdajoPlKFbeJk01QKLGtDWnbMyBayETpXmH
9LrSFaA9D4jxyZFtRZFbWgHxSHfKZQ3a5FTYcH4joemOONFAUZq28ik9DmSzSDzr
Ztc2XqWo+OldsIYhgHlDzwsMg02+NDH8JrjEqQ9lWW1vAJ7VwSctairqpPXp44Cy
jzU5FA6ZEtlrVyNK5uuRIRa3IFbcBy2HfDA7raIU0Xie2Z0ixUYl+tkj+XMPKWcQ
+Vf+cktfkuIYfJWmMTd3Lx0UdaV3zWZpOdgi/SP8gfJMfkvyhp9sq8Z5YEaX/WzX
ZC7TCHreo6TZ6pG0GoQrKjgqwYdQeoykxciMiHxz+aP/ADhT5R87F7ny0iaJcuSx
eAEVY98pljbo6gh8S+cf+cXfzU/LaUx+Tnm1q1UkihPQZVwuXHUV1YFca35r8pIF
89aO+muNvVIJ5HK5Y3Jx6uuqrYfnXaIwgnJHzU5UcRcuGu82b2/n7Rb9fUnuAtfb
IHG5EdcP5yZp5s0TiCk6lckMXk2fnR/OX/4v0ToJlr9GPhMfzvmtl84aJGvN5loM
fCajrB3pTc/mTodqpdXDU9sHhNZ1g73n+r/n1pNkSEStP8k4fCa5a3zeIecv+cob
22kMXl3TWuF/nCNhGJpnrPNI/LX5gy/mXKIPOuovo8JO4KtmTjhTiZNTfV+gn5Mf
mD+Tn5SwJLd3MeraggDRzFDUNTqKjM2AcDJlvq+orT/nOPyHIGN9dCFuylTkiAGg
y7kl1f8A5zw8jW9rN6c6yPxPEEUrt75RKdMhb8kfNP5o6d+b/nObWPM5+r6fDJWB
SNmFcwdVNysEXpU+u/ldcNHpp0yGRqUMlMxBIt5ip31v+XsAC6bKloSOgByXGx4G
M3+iafffHpOum08GXJDIjhQUOoaj5fHAeapLhR+zTJcdsTFK73zzfIDKoOoHupGJ
kEGFvONX89eo/wDpPlRZ2/mIOWY5DvRw0ljeZ72ZQ2n6cdL91B2zJjMUz8Pi6PBN
bS61TVJnvyZWJ3c98EpBzNN2cZH6U206xtrbZgK5i5ZPadmdm8POKbTSrbjki0XM
O7exkIwhb6P/AOcaPIc2v60mpzKTErVr9OV5ZU8rrNQJdX6sSIPTjsofsxin3ZgS
LxWr3KEmnEnf7O2RY6eCSXDk4uxlySuV9jlci4E5+pLLL/ekfPBpvqcnPyfpn+WH
/KO2f+pnX6L6Xnc31M/zManYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+c/z1ia1
+q631jgG47HMLVDcO+7HIoh87+bvOEV55feG4RVV6U3HfMUF3Ij1a/LHVodM0aSy
tgrSSHlQkdMkJU2eDxG7Yh5i1K2m1uOb4RHUBtx174LbjGk1/Me6sntYF0fj6hpy
4kY21xG27ItD/REOgstwqG8C1JqK4QxANvOfKnlhdev5ppKCME0xba71HVLAxaqN
LT+6rTGlpnuoeQYYbE6lUcYhU740wMhdMO8saaPNskkVi1EhNGpikml0+kJfX48t
I/B2NC2KDunPmHyEvlyz9aecuo98WIFqXlPydBrcDXEQBpik0ObGb3RG0XXlEwpa
AioGBNPSvOY0jUNLRdPCiUAdPHJFjEHqkvkPWV0CM/WabHapwMjG0tnubq81yXXb
Cgpv1GRUY1DzNrY8zApq7Lyi6VIxphwAIiy/My207S20BnXhTiNxix4AUP5K83We
n3JsDxL3Jqu4wU2CCN8560uparbxEKY0oDQjCyGNmHmSbSLTR1S1CiRl3p44aagx
Dyl+X8WvWkl8WG1ThAUyA5sfltZbeZtEsj8ak0pi2Aq0mi6tp8BudZY+j2qcVtCW
mpXDwP6bsLYA1p0xZArvKnmm50W7aWAFzIf9HHi2WCdBMoWN1TW9b1q21AXupqzX
U52iPTIcTrcmKmXWf5UWMNlNrUcSx39+OcgHY5AzTjxJJ+X2uWmg3Vxpt5QyKxFc
mJOxjj2pFec9UgeT6zDTjy8RkbbSKCc23m+103ThYCJJJZACCSO+U5J0Wgx3ti0A
5Xi3l5CnoswPUZAZE0yL8x5NPlsbYadEoYsAxX+zLBktgI0yCzsNJstDke5C1MVf
wyyLE7MN8reSB5hthdaa5WNWJ2yVMTIBh11HBBqsulJIfrMRpsMNM4quptJaskep
zMSfs1wNifp5fvbi0+sPO31WladsU0gfKkA129bT7pyY4zxFcWJCtr+g2/lvV4po
5fhBr1xYSFJ95x/MbTZNPj0pZVaag2qMWMDul/lP8z7XSpP0U5WoUN1GPE3SHE60
u7XzJ5lbWnK+jSnUZElQKeo+abrTzpzxwRIzslAcBk1xiRuXiHlq2u9TlNlYxUaE
knK7Tab3ttdaNJKlzCGkn2QHGMt6YlTPlLU4bU6tcW4WMCpzIMaa6DI/Jeo6VPFK
L0KrJWtaDItgi8F8+fmtoXlnUXhtCGkBNOO/6sBRKnkOr/nXfaiPUtEcxjpVSMiU
IHTvzyvIw0UyuKDeinAsS+hfyP8Azy0Mykagw9cmhLAA/jmRHZvynijT6n8jatae
YfNr6hpZUxhQdiP4ZkRO7pdVHan2/CaxoSKfCNvozKDzcuapih2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kvnf8ANnaYH3/j
m40Q2dRqebxmRzTig3zNM3DMXGlrGbm6YBRvuRkSWEovGfOf59aN5biltbZVlvOi
IADU5WZsRjeEE+evzoYRQJJp+nt9plqNsQSWwAB7l5E/IbQ/I/G61OJNUvTuXl6g
5MMuK3qHmHzbpfkqzZNRdLSx4ljRl2pvSmYmqO7l4I2H5/8A5m/85tRrdt5U/LW1
F5M7FPWVQSCfllcJ9Gw42e/lF+WPmL8wPT80efbqRFJEqxPWm+9MzcQcbIa5Pt/S
dMtNNhCw0qihR9GZYDiSKwmaWT4Ps48FsLRUoNV8VyJFLF01LwADqMQyaotPQm3H
TJRYvnXz15DudOlk1SzqBIeQpjW6QWFaL5yvtEYR3LNxHiMNqQ938s/mFFrZWxX+
8IyYLCnoVvIZdjiQlEuvDIlVMGu+RKuysilVIvtjGA3VbAfXmkjXtmXkkoQr3P6M
guJz1Wv6s1+Wbkwjb5a/J3QJfzj/ADTi8wzgvYaXJwcdqg5rMkursccKfshBAltG
sEIoiCgHgMwSbdhEUKVcCWiK9cUKXBgeXI08MFLbFdc8j6H5kbn5hsor0dlmXkBk
eAJ43lfmP/nGjyLr9WTS4Ldz3jWmROJnHLTwvzB/zgb5b1mv1W+ktq9lG2R8Fmc7
zmT/AJ9taUxLDzJdqD2FaD8cl4bMZ/JQH/PtjSq/8pNd/wCf04PDXxvJMbH/AJ9w
aRayrcP5hu5VH7DA0P44+GxOZ6doP/ODfljSWDXdy9wAejDHwkeK9r0j/nGv8v8A
TIwlxottcMO8i1wjEwlkT2P8i/IEZ9OPy3YhPER/24fDDDiUpP8AnH/8u5G9STy5
YsfePb9eSEAEE2hrj/nHT8uLjif8O2SFTUcI6ZZxMDC0u1L8gvyz0mGXWL7QLMxw
ryPNdqDK5yoJjjfjh+c+neWPzT84N5V8gaXDaRQycWaIbbHxGa7JlcuOG3qul/k7
5W8u2UdittHeXcApOW/ZOazPnNudhwgBMk/LLyw4+tLZRI/gBmP4xbvCCMT8ptBR
f0hdWETp74fGLE43D8nvLkp9SyCmu/Hw9sl4xYeGiY/yk0GPae0jJ8ckMxQcat/y
pzQ5uqrbR9mXvhOYsseOyrj8oNGjosVJd++MM+7XlhRQWrfkxo86ASoqg5kwzls0
wuVPy3/NTSF8teab7TrSKtsh+FqHxzIGV7Ps/AwT4ZhzRfi+WUTm9NCfAGeeS/Jl
95rv4dO9JvSkIqaHxzGM6cXXa+QgRT9VPyn8gQeQrFY+IEhH8cxpZLeLy6m+j1WW
Q2lZn/a/jlJdVLdLHUpUn9rfAC5OCFBLZ3OAlsyHZLJDSuVEurl9SDsv96RktN9T
sM/J+mf5Yf8AKO2f+pnX6L6Xnc31M/zManYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq+Q/8AnLPU9Vj0NdI0CNXnnU0qd+/TMLVHcO67KAol+Ut7YfmNo1o9/q8DtbL0
DVpmM7eMks8ur+YPmNzqWmCWK3jFKJWmFvjNB3mtec4ZG067icXNTQkGuNJM27Xz
h5x8uuE1yJ2U/ZLg40xORksX5i+Y4GF7cwyfVT3Ck1xATDIjF/5yaudGmWztoWVi
aGi4QGw5QygfnotyVvp14ynfcAHFTkDOG/P+wubZNPvLll9YUYVGBBkE98k/m7oP
kd5XhmD+vU7kd8VJBFLpPzF0S/mm16O64T8uQoRigGkLrH5vaRqMItr69cgeJGKe
IITT/wDnIzRfKVu1nYyFyfAA40pmHnurf85GQ3E51KNDKzGgQjDTE5Ak1/8AnJqL
w/pCa3eKI9BwIGCmPiMesPOXnLzhID5Ytmkjr4HCUDJujtLtPzG1zVX8v8XgdvhP
EkYKbjkUvzC/Lvzn5AQNqdxKWm9z3w00ymEw0D8g/OPm7Sl1G1nk/erUMSdqYERI
eep5f86x3Uljp3qPNpzemzipNcNN0JWmkvmrzl5FlS51SF5pX3AcE9cNOSDT0ew/
PDU7eyr5jtOEb71K9BkacAz3el+Svzx0X6q0aXjxs23HYDfFYyB5s20XVbSaQeYY
pw6lu7CuLcCynzr5vi1/T1srZ9wKGhxSEZ5Sv9M03Rnhv1DOVNajFJSnyBJpJ1O5
ur1v3W5h5bBT7ZBsN8Oyd/mR5jsLm3EFoYjKoFJeQ5DIkuJKNMEuPzz0ny/paaZc
3XO5CkVqCa0yQCwkLfO2n/nddXcl7Ho9kLhnc0k41OTpy4ZGD6l5z80tFLyhbm7f
CrAimGmnLkURpX5mT2o1z0G9IUI69MoyDdx/EVI/OXnT0xbXCN6qn7OQEU+KzXTf
zi1zQIBF5mtD6f8AM69PffJRgnxGaad+f/l69gksb2eRVlXj9noTlwCRlD2v8ufz
c0PS7FNN0a59SUGtGIFa4oJBVtNmurHXZ/Meo20DRXp/dnkCRkiWQ25sm83Xkep6
dcR+jCJiBwaoqPlgbQRSWR+fYdF0OHTbj0zIqUNSMLMDq8Pv/wA29K8o+rdc6TvU
gJQ0wUgzDxS4/N7XfzGvjpehQs5c0VmFDvtiQ4k57ozzL+S3m3TLQa9q0siO+6ip
64hjE0Vbyj+SHnLX7M6lJI6zD7Bqakdhi3AsX1W/87eTdQ/w7cRslxCagL+1TAQv
iPSbb86tdhigt/MtqYRCQXPHqBkDFTkeg+Sf+cjvLmm6heXlxIUWRaCgFMjwp4gW
S6h+aGk+ZyNTsbnkib7kbZAQNsondW1z/nIHQbPTDZT3jGQLTjUUOZLeeEPlHX/P
uved2a08lxOsbHd0Xr92EBrkb5Mt/Jb8trOHVV1H8z25XQNVjk6HfviQwFDm+j/z
XtPKi6dTQ7W3iVR1SlceEqJgIf8AIvyr5P8AM9pLHqMUBkUHkWp074DjNsJZQB6e
bwb8zvyosJPNEz/l6T6ag/DGCRX6MkCiUrDKf+cZE83eTfPbQ6mHktpaJR60pT3z
Ji6nPLm/bi2ZmiRpNmKgn7syQ6GXPZXwsXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq+efzfAiZJ7ghIuXWtO+bjQ8nUarm+
R/On5yaB5YDwWkvq3ij7GxFcyZuOA+Y9R8xed/zYuPq9oj2unk05pUbZXuVoB7R5
E/5x806waO71aUXl11IlNd8armwJfQlk1tpp4WMYgW2+EonQ4DJYwYF+YX5j6f8A
lxol55j8xyiKSjGJSQK7bdch4lNsMZL8GPzp/wCciPMH5r6zJaWFxKto0vBEXoVb
btmLknxHZ2GKHCH3z/zh9/zjNDY2EfnrzTAsjPxYGQGvX3y7DjacuR+lkdrHYW6y
aeKQCihR0zYQdfkkrqABmTHk45LYPHphtWi2VzZALR8O42wBLjvudzkgwXzKmpp9
XmHILtviOasA1jyBaXLGsSCuTIQSlum/lomkzDVLZ6EbUBxjFQXptvb/AFeIFj8X
jliVdXjdfjOVkKVvpoUohyBCF0EHHcmoyClqaYRUIHTEc1CjBbGZZbt24U3FO+Sy
TZQNl4V+evnX/DXlueWJuN4aCNB1eu3TNZmm7HDC30f/AM4W/lhJ5J8pnzDfpS51
oi5JI+IA9t81mSTtMcX2flTa7FXYq7FXYq7FFNUxRTRUHFkGvTGK2uApireKuxV2
KuxV2KvzV/5zN/Pt7Mr+VnliYi8vD6UrRkErU5hZsgc3DifL/wCVvkYeWYTaXX/H
QkrW4P2yTv1zSajM7XDi8nqkXwPJbHd1NHfu/wA812TJfJtnCkSgHQDICTGkxErl
fSZiV/l7ZISY0iowsX90AvyyXEw4URzJ6muTEkcKqrF/hY1HhiZpjsmMD8KDpkeJ
ozRs7ImVwQOfxfPDHIw0wIL58/Mf8ktM83l74Iqzy9SK5kRz11ep0uqjEbl5T5e/
5xQtrWX17hiyg1oa4J6htz6+AG0i+nPK/wCX2jeWIgIIE9dehpvmLx2XR59fxbCR
ZsW5ChyduLx2h7h+Y4ua0yKYhL5HJ2rXAS5Ikl8zbZWSwnLZLpG2ORtw+H1KOmf7
0CuW6b6nOz8n6Z/ll/yjtp/q512i+l53N9TPszGp2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2Kvj3/nJXSiNR0vzJc3AisrQH1FLUDbk5iakW7bs6VAvnX81Pze8qaz5U
k07THjadNjRgT0zHEXZRyUxH8k/zk8t6R5dm0+7RDc861NK0w8LZGVm3n3nH80tD
1Tzjb39pEotEK86Db3x4Gw5WTfnj+Y3k/wAw2tpBo0aCVQvLiBjwtZnWzNvJnnry
QnlV7GWOB79I6kS08PfIyFMoZXnH5X+TPK35kazcPfrbRopPHcYCW4Tt5/8AmF+V
GmL5sXQ9LkH1fmB8B2642gy3Zpqf/OIGnQ2U3mC9unVYhyWlfDCCyABeZ/lx/wA4
8Q/mBPeR2VzKy2xIFa9sbZcIY1pv5PNL5hl8kJcyi4MnFQagdcbXgey/mB/zi1F5
P0UanPckygbgHFjEiXJMPyW/5x50jzZYSXt83J06chgJQTQ3Y5rn5aaR5Z80R6fL
GvBHBoR8NBjaLfR35nN5Wm8qRWNlDZJMEFaFa4LYy73zl5L/ADr078q4mt47VJqk
glRXCGByJTa/85A31/5gfW9AsZSa1H7s5dwNEtYUx/MnzT+ZX5pxpPYaYWWKhFUP
bBwhplq5Mp0X81vzc8p6DHpK6OqrGnGvA1wcIRHWSY5+VX5u/wCCr69ufzGspVl1
B+Z/dmgJOS4XJx6osm85fmT5b82+YrJ7JEFpQcvUoMPC58dUXov5gQ+Q/M+iJb2B
iW4CcTxp1zHPNru+byDyp/zi2nmSxm1HS5KAVYUw2x2HN4rfeTvOPlrU5NA0aRpS
pI4k1G2FItPBrXnbyLB9b1i1BXr8QxbLIR2mf85A+YbyBlXTwUAoSEr/AAxpPiFL
Lv8ANrzd57RfL/lmxWO4iNGKLQ5Aht8U1QYwvlHz1Jci38wySxhz4nGg4eQl7pon
/OJEWp6bL5g1q7mLgclG5yUVgN2VfktH5X/Lq6uLHUUiko1KzUHf3ywByb2pW/Pb
8wPK5RbrRkh+FgSIqH9WGrcbLkoInS/+ckvLUHl9NMvbeX1PTA2Q06ZXPFZcU6h4
75f/ADJ0CfzEmoXUci2fqAkOtBSuA41jle9/nZ5o8hedNP0+z0H0kmZ0V6UHzx4a
bI5OhRT/APOPPk+90ObUYJYBPHB6goRWtK5G2+IeD+Vf+cbtS14fpPRppFQuQONe
xydshB5/qeneeNB16by1p001z9XNKMSaYLa8hIVNauPzDsypukkWPvUHDsmEyuj8
hefPMEQvjz9JhUdemNuTEFmf5RflDpetasYPNM7NIpo6ydAa4krT1Lzl5a0n8r9a
hvdFNuIEIJ4sK7b5EG3FyypNfzU/5yL8sax5ci0iUzG5jof3Q5bj5YwG7R4tJd+W
v/OT+hWdikd8k8bIQFDKRWmTMEjOgtI8/aD+ZH5ivqetcIrYIOHMgAnGUWcJvfvz
d8n+Uta0OW5sjALkxUHAg5AhtiSeb4c8o/kvaebIp9JtlP1heQqF98FM4xtKNR/J
3U/JNzDoXqsDcniB0wtnBT0OX/nE25Gntr+oSMwUcqbn3xEkyk9e/JDVfKvk22uN
O1iOMSqCAzAA5IFrOV4X5989QXvmCSw8uK8ryMeBjHICvyy4QtxsmpLKPI3/ADjr
53/M4M160sVq5r8VRscujjcTJqjEWWU+Zf8AnF3zn+VOnS6h5dllcAEsFqTQYTia
o6wncJJ+Q35vad5L1F7X8xoHWdm4FpVpv9OYQ5udLJY3fUWiahYecfOUWoeUeDRK
Vdgprt17ZkQcDPK36KwEmJCevEfqzLDpJc1XCh2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVLNa1EaRYXOqMKi3ieSnjxFcVf
A/5Gf85vW35q+fL/APLa5gWM2zsiMvWoNMVex/8AOVH/ADkXD/zjv5e/xJMgdyKq
G6daYqnP/ONX57x/nx5WtvNoiEbTLWi9MVfR+KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV8D/APOa/wDzmQv/ADioNEjW2W4k1VyNxWig0/hir62/Knzo
35ieVNL86Mgj/SECzBR4HFXoWKuxV2KuxV2KuxV2KuxV2KvnL/nJb88JPyN8sS+Z
7O1a6uF3ChSRirG/+cTP+cip/wDnIny7N5hv7NrO4hcLxKlQR44q+scVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVccVL83P+cr9a8z3F/wDobSkYQk0BX55uNLsN
nU59y8M8h/kRHrcg1DzU7ev1PIZnDHbiGb6e0Xy/b6QP0PZxRrANuY2ORlGmJk+U
/wA5vP8Arv5Zait3o6vLZof3jAVAGYuTZsgLZV+XH/OU3lDzpaNpk8ypqbA8gWA3
GY/it0cb81f+c7fzybz5qsHk7R5uMMI4MEYUNBTKMmQuXix08o/5xR/J+5/MnzHa
t6Ba0gZA7FTSoPjlmnjxbrmlT+gSDR7fQ7G28n2n7tFjWvH2zYQi67JNN5UTTo10
xDy75kVThzna2mWg01cSm2AltiFuRJtsIdhCHZIMG1Bt/jXviOaoTUVnnjMkXUDL
CxLyi88z6hos5e75G3B74BzZBP8ASPzDtb8iOZgK+JyxXoEN1Y3aj05BU++BjZV2
tQN4mBX55CUVElBi8RyshbV41Eo+PBS21ERqjNBGeEUH2zWgynIWeJ8ZNFJ+eH5u
6V5UhRn0LTZeF2VFVND3zV5pu6wRftDpWmQaNZw6VYrxt4ECIvgo6ZgEueBSYYEu
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV5L+df5gW/wCXPlPUdfnkCTRwMYhUAlvb
Ksk62ZwG78WPy4tp/wAwtTuPzL83Fme8d/q3PsQds1OqykOfhk99toJrq4omzx98
0Goyu0wzR5IEjr+2D8RzGjK23IbVkamTakXXxwhiUWHpkxstqgemTBtCIjehqciW
mcqCKWWm4yIKcceNebgt1xbxhAXLcqRx3qMba8mUx2XJqJDemK0wtXiGavJcRFTy
+32yYh1R+WA3Qvq0FcLKMUHLN3wNvJBGTlvkJMJZKQkr5Aljx2gHfYjBTdHG3pn+
9Ay7TfU2Z+T9M/yy/wCUetP9XOu0X0vO5vqZ9mY1OxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV85fn/+R3/K5bOKy+syQemCPgalfnlOWBPJy9NmEAbfKum/8+89LtVC
TXsrqacwW/tyvwi5cdXAM6g/5wR8uabx/R80gFPiB8fvw+EWcddDraOP/ODXln0y
fUb1j3/zOPhFfz8L6oGy/wCcD/LJJkv5pGbt/nXHwiieuh0tKNY/5wB8vX/wQ3c8
UZ/kJH8cryYpJjrYeby3Wf8AnB7XPJXK5/La7lL/AOUT/XKvDPVt/Ow6Pn3U/wAl
vzf8u6kNTmj9WRWqGIrh8MpGuinOufmt+YMVk+geYrOX01HF/TQ4PCLkx7Rgw38u
v+cgrr8rJLhbfTrsm4J5VjPfJDEWX5+FUh1/Oi2utTl81yWN3HqDPyUiMj8cfBLL
8/Ctk817/nIb/FNt9R1WC9ZPAKTj4EmP5yCzyv8A85C6j5ZjOmeTbG6LtsOcZpj4
BYHWwTGXy5+bv5rz/pyG0SKCQ0qyUbfHwS1S10Xq3lT/AJwc8xebOM/nW+njB3Kq
xA3+nB4Mmo6/H5vp3yV/zhH5c8vcV1A/WAOvqDl+s5KOCRO7DLr4V6X0FoX5CeUd
AJa0sISSO8YzI8F1hzl6ZYeWNL02P0bW0hVfZBhGENZmS678saXelTc2sTBe3AU/
DE4QgTLznzR+RvljzWjJqFnAD+yVjAI/HAMLfHUkPl7zz/zgT5b8yo01jPJBOu6c
Ph7fPEYy5kNZHrb5T82f84g+efLUL/4YkaVYT8PLeoGUHTyc4a+DGdE/Nnz9+UVn
JoGvWUzdVLRoaYDpy2R10GN6J+a0UmrDzBeRSx3BesnrCi079cj4RbYayBe3fmN+
Z3lzzxoEcekNB6yj46sMj4Zb/wAxEsk/KbSfLTeV57+6a0MyIWIJFcBDYJghhv5M
at5a0/zPqF7dtbxpKSELEAYKXxohl359+fvKenW6z6TPFLfqAaQuG3+jHgcOeYPG
9B/5yb826tbweV/LGnStI6leTxnj4eGWjGwGrEWvK/8AzjR+ZH5l31xeeZh9Wimf
kPTFNq5aIMTr4dX1T5D/AOff+jWEZk8z3M081a0Y1HX55Pwi4ebWw6W+jrD/AJxa
8o2tqLCS1iZBtUoK5IYnFlrO5jnmP/nDzyhq8ZjtYhET3VQD+vInEeicetH8T578
3/8APvu0mja50G8kEqVdQT3+/InCXJGsg+cPNH5C/mz5Qt5P0FNJJbgFSrEmqjbI
nTSciOsij/y4/wCcjtW/Ki0by75z0+49VagOsZpXp1yP5WTf+cgefRf+X/5q6bJ5
ovfOGsmJbe4NeMrAGntXKsuIw5tnjDL9L178wvzY8t+cbCWz8tLCl0QOLMQBlYZ8
mMXn566V5T8uRaVOYpNQSPi3pEHemTECWf5mMRu+Z9K13zl55vpF8j2ksTzNs5Qg
b7dctGElx5a6L6Z8k/8AOFPmbzxw1L8x7uZWNDxDHx+eH8tJxMmsg+t/KX/OG/lb
QYxFcxC4KgbyLXf6cY6aQO7iZNZHoyXVv+cTfKGt23o3NtHDKpqpiQDLRhLWdbR2
5PA/OX/OBmn6kou9DuHgvFbYoSNvvwHCXJ/PY/N81/mD/wA4/wD5reRwi6S7XOnQ
mrVqxKjB4JbY9oQY1+XH53zflff3SebdOnWWQcUb0yBXp1yPglyoa+BT7XfOcP5h
3KeY0uoIZYDyiR5AD49MidPIt51cSGvMf/OTt9p+nf4agja5nYcT6XxDw7ZWNDMF
x56oMS8hfkz5+/OC8W8hha2spCCxZSppXLhppBw8mpD9Lfyj/wCcQ/Ln5dol5dqL
q+b4pGlHKjVrtvl0MR6uDk1I6PrWx0y10yMQWMSxoOygDLgKcSUzLmiZoI7hTFOi
uhFCGAI/HCxBp8ofnJ/zix5d/MaGS9jhWC+FWUxJTf6MwjpiDs7HHruknjf/ADjH
/wA46eZvyx8532ra6/qaK8ZWCvUECgy6OM9WvJqQeT9GMvcF2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KsR8/OU8uaoy9f
qktK/wCrir+aX/nH786fLv5P/nNq2reabeeaT13J+rpy/a9sVe1f8/Bv+czfIv5y
+WI/Knl+0v1uV/bniKDc4q+pv+cYPPdx+S3/ADjnJ51hWNrm1tuduu1Old8Ve1/8
4Nf85b61/wA5LaVqeoeZoIYprIt6fpAAHj40xV5F+X//ADnt5k81fnlN+QVzawC1
EzokoArRT40xVA/85Uf8/AfMv5Gef7b8stKsoJmuGCg8QTUmg7eOKvNvzd/5z6/O
T8mrvT77zPpVmNGvo0kDemtaNv1piqaeYv8AnOH85r/SYvzC8kaZaPoAjDSl0B7V
NNsVfYX/ADiH/wA5ep/zkFo11da5EsGpWSFpUQUrxG4AxV89/mv/AM5wefrjzJP5
X/KHSxEluxX1L6OiGhpWpGKsH/Kz/n4x5wg89Wv5b/nDBYA3MojD2nHv8hir6b/5
zj/5y11D/nGfTdI1/R0Wa21EjjTcmvj7UxV8q+ZP+c4/zqbyhB+aPlrS7V9D4CSV
zGKhfc0xV90/84Zf85SJ/wA5M+V5Nduljj1C1YJMEpSuKvsqWRYUMshoqipOKvzh
/wCclP8AnN9/IeojyF+VUSXvmV9lEigrXwpvir540b/nOj84PJeoWkP546PFZadc
OlJYogvwn3pir7I/Pn/nLa18g/l7D+ZvlHhOJlBo1DQ06Yq+KtB/5zy/N/8AMTyx
P5t8jaXatFahnkZo1+yv0Yqx78sv+fk35ifmpHP5U8s6bA/mWDkr/ACKjbwxVnf5
Mf8AOf3nQ+fovyn/ADqtYbfUJZfTi9EBaknatBiryf8A5/U3EBXyVM1DIruwHseR
/ViqvYf85Y/nL+T35YaBq+j6XDLoUVuio5jBPD50xV+iX5E/85YR/nB+Xdx55t4l
Gr2cLNNGOgYCvTFX59eW/wDn47+a/wCYvmvUPI/kLS7WWS0maMco1J2NPDFU+h/5
+E/mf5B84Wvkf82dOt4FupUTkEC05Gnhir7N/wCcnP8AnMG2/Jzyvp+t6SUk1C/W
NlUEGnMYqmvl3/nLW10P8s1/NL8ygIJGQtGq0HLbbFXxVF/zm9+eH5l2uo+Zvyi0
i2l8v2quyyPECxA8DTwxV9d/84df85laf+fNl/hPzMfq3nSy5C8hei7jwG2Kvlj8
2v8An4v5v8ofm/c/kj5Z0+Cb05hCjsqmpPhtXFUn13/n4H+Z/wCWfniw8v8A5p6b
b22iXcgCsiBSQT8sVfZX/OV/51aXZ/lO3my2t4rmG8iWRBKAwAIrirz7/nDL/nIP
Sr78tb3zPqlvb2ItKlRGoRWABpXFXhHmn/nOv83PNWoXSfkzpNvdabauweQxhjRf
A0xV9I/84l/85ia5+cV4/lb8wNKlstUiPBnERVOQ+jFX6K4q7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7GlfN/wCb0SSToXiRqNWpG/XN5oMJlGw6jVHd5RKPXHBQEUfy
7ZsJZRHYuuMxbaWycfTdm+ffKzISR4oY95j8rWGvaZcaHexJJDcKQzutWG3bMaeI
lsjmD8Rf+cifyC8wfkfq582eVDL9Tc8hxBpQiua/NhMXZYcok+HdT1GbXL1dW1N2
a8LAnevffMImnNiH7rf84IR6NaeSJtT0IRtfhwHB+3WubPs7cW4WtBt9wRyx3E4a
9DfXmG3hmxiHV5EQkRivDDdGsvGo+WX8FuJIqrbVwGBYAqRHbK5QNuTArAMEYFsJ
boct4WPE3xwgMbXODShw8K2saWSJCdiuSQWI36aVrzHSbr4ZGBPI9K4g7qHinmfy
DfaW7XWknlEK044WVsJsvNGpaZMILkuKGnXERKaeraD+ZSM/1a4cgqKksceAsCHr
nl/zLZeZCbe1cK6jcsdsjw2rJEUBzEpB4dSMhP0iykRt4l+dnnlPy88t315YkreT
qPTUGjOTt8I75rcmpiXKw4Te71r/AJwj/KiXQfL7/mDr8Sm+1oCdS6/GoJ75rc0+
53GCD7zzHcp2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuJpvgtX5Gf851fmWPM+t6
b+Wvl6VmkinAvkB/3Xy32zAyZOrkjSyLG9L0qz0i0TR7Qcbe3UNb0/mI3rmn1Erc
qGjmE6W6kjhD23+9J+1mkzxcyGKQVVAZQ5/vT9v55Xi2bgrJtl1pRAO2+ESQd0QG
pjxIpWDb5ITDExKqjCuEyvk1ZcRkNlYv4YgN+mjwc2i/hjTsJZ4lExT8B0FcSHWZ
cZkdlsdwwfm4FMlDZODHwndSuJGkkDr9nvlhyCna5dRCUOEDdxk75V4odZGNKLty
wHIFMUI7hT75DicaWGRQjyg7ZFlDERzQLtkuJz4zACI0xx9YUeJy/SwNuPmkKfpt
+WqFPL1oD14512jjUXQZj6meZltTsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVaIr1xIVCzWFvcbTRI3zUZAwCRKmOXXkXRLwlprKFietUBweGGwZS
xu5/JzyrdHlLp1uT/wAYlw8AZfmCk9z+Q/lSdTGLGAKf+KxjwMxqUotf+cd/K8Ev
P6lAV941w8LYdUKZZY/kz5V0+QTQafByH/Fa48LQc5Z9b6Dp9oAltbxoo6BVAH4Y
8AazkJTVUVBRAAPbDTBdhV2KuxV2KuxV2KqbxJICJFDA9ajFILFNX8iaFrSNHf2M
Dlu5jBOAhsGYh4D5r/5xL8n+bxJaajbiO2YEr6ICnkcr4G8aqnzfd/8APvXR7UyL
pc8ojavEFv7crlEuRDWMHX/nAzzVpzPb6RqPC1eo4mTt9+VmDaNejtM/5wEu7k/V
tYunUj7TRtSv01yPCs9Xtb2Lyh/z788j6LKt7qzXV1KDX43qPxOWDGerjy1fc+t/
Ln5Q+V/LEK22m2EIVRQEoOX35cMbjy1Ui9CtNPt7FeFrGqD2GWCNNMpmXNGYWDsV
dirsVQVxp1tdrwniVh7gYbZxmQ8+80flF5Z81wNbahYQfEKchGtfvw8TbHUnq+Nv
PP8AzgB5V12QXti80MimqhTQV96HMfUx4g5uDViLxi8/5wS195fqVjccbQbVBoaf
fmGIORLV3vb1zyJ/zgDoWkkT+YpJJ5a1NTUdfnmTHGXFlrH295Y/K7y95UgittMs
4l9JeIbgKnLxGnEnqSXoSIsY4oAB4DJNBNrsUOxV2KqUsEc4KTIrqezAHFbeVedP
yX8sedomh1KxhBYblY1B+/AXIx565vkPzB/z7s8k6rcHULea6ilBqFR6L9wOIDk/
mg9M/Lv/AJw18oeTWW5liNxKu4MoDfry0ljk1Q6PrTStCsdFiW302COJFFBxUDIE
uHLIZc02wMHYq7FXYqtVFQkqACdzQdcVXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWGfmJxPlnVfUBK/VJK069MVfz4
/wDOGnk/SvM/546wt/BHJbrM9FnUMT8Xvir6d/5+eflp5f0DyzHquhafbWsxUVKR
qtaHxGKpD5INrqP/ADijqSlXMi2h5N2FB2xVKP8AnzvdR3Gh+ZNOhIHEyCp9674q
+cfyPKL/AM5mTWkbBm+sSjn7g/24qq/85p2Yk/5yW0mK+4zf6QlO/wC1ir6h/wCf
omn2Y/Ljy7cIiLcelCoFN6bYqzn8uNLhX/nGCSSaFRKtvyBK7/ZxV81/8+4fNi+W
LvzD5s1ha2lqszKi9Dxr1xVH6J+YHnn/AJzJ/MK98reTTYWGgwyMkjooWTiDvuMV
fF/5w/lC35OfnppXlyxvhPcLdJ6jM9TUnfFX3b/z9ls2tPy68kyhuTOsXMsa9gds
VfS/ljRtPk/5xFeC3hWk2nN6jFe9OoOKvn3/AJ8yzRvp/mrSvipDcUXwpXFX7g+Y
I5X0y6S1/vfRfj86Yq/lZ/Mg+ej+e7vos0KaklwRAsxFCa7bYq+0/wA3vyj/AOcl
fzo0qx0zz/e6NpumKEMUjhY2I7bnFUq/5yA/LHzB+VX5HW+gecb6DUVD7SW7Bh+G
Kvc/+cINMsrj8i9cb0k5fVJDuor9k4q+Rv8An2XY2T/nFrtvcRKQJpKcgPE4qlf/
ADkZENN/5y40SOwUJE18nKg2pyxV6v8A8/mltkl8kyShq9z240NfwxV9t3dnpV5/
zjXo0twIGtBp4JYgED4cVfEX/ODEmrQeXvOCaS6yabzlpx3HHfFWLf8APt+K2m/O
jXfWiVpfrUtaqDvyOKvoX/n6D+TVxdRW/wCaulIiGzkXkVAB2oa4q/OK485Xv5+6
toHk2KUztbyW6MvLlSlO2Kvuj/n495dv/IX5TeXvL0Q9OyLxCbj8I40Fa4q+7f8A
nA/RdBg/JuzXQVgkt5o6SOQCCSu/I4q/I3yVeHQv+cs9T0vy3V4JLgrP9V2QCu/T
FVLU9NWb/nMWD1eEsIu022JH+tir3n/n7XbW9tr/AJckEKwqrR0kC0ruO+Ks4/PO
G41L/nHXT2v5VWAWq8CT1HHFXy5+Vx1Gb8hdWt9ILJGjCrrtUfPFX3H/AM+w77Sb
ny/eaW8KTXNT6juob51JxV+mmgr5Ksb+S28vNpqaiWJdYWj9SvyG+KvRcVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdir52/Nkfvh886Tss1F0+q5l5IvTHOLk60xb5ds
shFrMXfbPFtgctMEgML86eT9O/MCyk8s69CGjlUhHZa9qZiZsQLm4TT8Kv8AnKT/
AJxg1T8k9UfVdPiaXT5W5KVXYClc1GbBTtsU7TH/AJwp/Nq78l+b7fRLyYrplxxZ
0ZtuRPhlujnwbBhqY8QfvfZ6vHfyx6pGoMLpUMPfpmwjlLq8mMK7LzY30h+Img+W
ZUMhcKcN13KuTM2sQWE5WZEt8YtDHiplILq+2PiFjwur7Y+IV4WpWNBTHxCtLQwk
QqcfEKOFgXmPQZZ4WltCVlBqCOuGMyU8mDWnnqXRXGmauhaP7JJy8bMSySXytoXn
CP6zpzoLhh09zl0Qw4iEji/JddQka3kbhJD8bEbVGAhImyTyn5CX66yK7R20XVq0
BA98pJpsD0n0bXTHlaJ/9CA+ORjtT55j55+ktkBu+OPLdrf/APOUf5pQ6Sin/Dvl
Waj90lUH8c0NuzjGg/aDS9LttGtY9N09BHbxDiiDoB7ZjylbsYQ4RSYZFm7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FWM+cdfj8q6JfeYpzRLOB5jX/JFcpy7C2URZfhJ
5Xnm/NHz/rH5x3nx2F4XihU7gFT2zV5p1s7XDIvdFG+avLNzYyKLTY5gTjaeJEoa
ZWIUi1YHGkWqqfHpjS2rK9caRxFVDV748KRJWRxXJ447p4lX1Bl1BeJ3qDGgvEvE
gpjwheJv1BjwheJouKZGcRS8Siz+GUcK8SkXHjjwrxIeV99uuPCi0E5rhpPEh2bB
S2q6Yf8ASo/9bMnSy3Rmjs/UD8uv+OBaf6mddpDcXQZebOMymt2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2Ai1dTEBXYVdirsVdirsVdirsVdirsVapXGlbp3xpXYq7F
XYq7FXYq7FXYq7FXYq0BTYYq3irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVSPzNpsmsaTeaXbkCW4g
eNSelWFBir8vfyL/AOcGPN/5a/mLc/mZqWpQG1nmZ/SSlaE1ptir6H/5zW/5xu1b
/nI3yvH5e8uXKW1zFXd++9cVSv8AIT/nFvUfJn5YT/k957mjuLe6hMb8QO4pir4d
8j/84Efnd+RPmXU7z8ndctrfyzfSMTAWHPi3yxVkn5A/8+6vPv5f/nDB+evnHVra
4hLvLNEn94S9NuvtirLP+cg/+cEfNv5nfnRp35q+Vb2K30u2dZJRLSuxrir2H/nN
3/nEvXv+cg/K+j+W/KVwkOoWKxq8j/ZPGlTirNfL3/OOHmPRfyVf8nb28ik1hoPS
9ZfsjamKvFf+cPP+cE9d/JiHWrD8yb6G+sdTSRUjipUc8VfOd9/z7y/OP8s/OF/5
t/5x+1u30+xunZhHIwDbmvjiqU3/APz7L/NTzp5k0v8AMzzhrdu+twzLLdEsDy4m
u2+Kvq//AJzT/wCcMfN3/ORXlPy55Z0O/hSbRlUShqfFQU2rir3O2/5x716H8io/
yN0+6ig1Q2noPK/QVGKvKP8AnAL/AJw+8zf84sR6xD5svIbkahJyHp03367Yq/SZ
1DqUPQgj78Vflv8A85Rf84E3f5g6n/ysn8qrlLPzZE/qRu1AtRuK4q8Sl/5xP/5y
Z/Ni+sNH/OPzHbjQLIx1W3bgSq9tjir6v/5yF/5xKuPO/wCXtr+Vn5f3PoXUSLyl
uG5VNOtTiqe/843f84xax+UP5Y6l+XGtXMc2r3cDxLMtOILAgYq8L/5w3/5wW80/
kP551Tz551voLq3u3d4kipUVNRWmKpV+bX/OBXnPz7+e+mfnbY6jbJoFndLNJCx/
ecVNaDf+GKs3/wCfgP8Azhn5n/5ypn8vxeVruG3stLqJA9K0NQaffir5q86f84Z/
85DS+VLX8p9C8wW8fleNRE8bN8RXocVfdv8Azj3/AM4kQfkh+XNz5M051bXL6BhP
KaEGRhirwf8A5xD/AOcIPNf5H+ftU/MTzJexSW93O8ixilaMfbFX2B/zlro2jav+
XuqR+Zk5W6wSMPZgu2Kvww/59m/llYa5+YV/5meJprS3umWLuBRjTFX71f8AORH5
B6D/AM5A+VJfKHmWP4Qh9E7VViNuuKvzH8vf84g/85KflHo9x5B/JzzHaW/lqcuq
RzEF0Vvfttir6U/5xS/5wmT8h2ufzA/MCZNS87XtTc3IowJPgcVeSWv/ADgJ5tk/
Pb/oYODUoF0ia49Z7dqc+NegxV6h/wA54/8AOGvmz/nKe50o+WNRt7O108qSJOp7
nFU9/ND/AJxL1nzj+UWnfkzDcr+kbS3WIzA/CSBSuKt/841/84bXH5ZeQL38sPzH
mivo7wEKUptUYq+X5v8AnBz89fyxv9Qb/nHvzBaabpV27/upSA3FvDFX0h/ziF/z
hprX5WzTedvzg1KXUvNM0vMlZSY6k1O1cVfpHirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVfO/5sf3w+f8AHN5oJ1F0urG5ePDM0uFa8eOWY2BK4R+t+7O1cyKYcSjH
Ob4PZSKVaPZHOCUbbYZAxjXfJOnfmXplz5c85Ro/wssbsoPag3OYk8BLlRzAPwo/
5yL/ACC1z8j/ADF+m/L0b/o9Z1cSIKAKN+ozUanFwl2GLKJh+sH/ADip+blt+ZXk
2DTmPK+gVFY1qdsnh5ONmFPp70qirn4Bt9OZsIuDNUpl4gS0tUw8BSC4imVziy4m
shwrxOx4V4mivLHhXiWg+mceFeJEIiXJ9NqAZbgFSYZDYYX5r8n2mrRNGifvKH4g
MzyGkPBJPKGu+Upze6U7uAahQfDKzJlb2/yfr2pahZCTU42S7kHBq9aZEzpIgzz1
I3tV0OxQiX/dzDqAfHMTJkboQfJv/OQX5nXPpWn5Q/llym1K9Po3LRkkrU98wM2U
Vs5mHHu/QX/nGz8mLH8qfK1pzt6a5NFyu5SByZj75rDK9nbxh1fSYNQCdsrbW8Vd
irsVdirsVdirsVdirsVdirsVdirsVdiinwT/AM5//mbc+RPJFvpmkv8Av9WuDaSK
pNeDUHbMbUyoNkA+N/y38vr5P8s22lQAMzMZGp1HPfOZ1eoFuywwZko3rmtOYFz4
xRK9Rl2KTLhRAbwyeU0wMF4NMq4kcKoDjxLwuDk48S8KoG7DBxJ4VQSU2yUSjgb9
TLOJfDd6mPEvhrxKaYLXw2/VONr4bRlNMBkvhqfqHtldrwqJc/TjxJ4VoYnDxI4V
J98eNeBDMcBkoiiNMH+lRn3waU1Juzcn6gflx/xwbX/Vzr9AdnntR9TOs2DQ7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWiwX7Rp88VWNKiV5sop1qRiq5
HWQB4yGU9CDUYquxV2KuxV2KuxV2KuxV2KuxV2KuxVQF1CZPq4kX1R+zyFfuxVXx
V2KuxV2KuxV2KrWdU+2QK7bnFXM6oOTkAeJ2xVsEEVG4xVvFXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYqpTrzjZQKkjFVtujRxhJDVhiqvirsVdirsVdirsVaDA1oa02OKt4qoSW
6Susj9VxVXxV2KuxV2KqUsKTjjIKjriqoBQUHTFW8VfCX/OYP/OPP5lfn3aroHkH
zLFpGkOvGaJwatUUOKo7/nDX/nEKD/nGHQ3069uEvdTlbnJMo6t3OKvtx41kHFxU
YqvxVY8ayDi4BHviq4AAUGwGKt4q7FVrIrEFhUjpiq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq+d/zb+CQMT3/jmy0s6DqtTHcvHUIdeVRmeJuskCqADf4h
lsMlNcgV1ABswy4ZvNrouZy4AZhtk/FHekAhSkjWWnNht4ZAzZcUmE/mH5I0/wDM
bRp/KmoxLK8iMVPEE9PE5g6iIJc3BMgPgX8k/Jup/kP51k0x+S6ZJL9g9KVyGKAD
fklxB+ms/p6h6dxaHjasoYr7nM+MQ4Urb+HpyGX0A1EF3w/zDGwx3abivVgcpNFM
QVvNPEYOEMqLuaeIx4QtFcCvZhgoIorWRG+0ww0ForSiKKhxhFDdIiS2HAFOYyfj
eanGsBQHlVSfcDInIkYlZLYv/pCOu+2w+z7nKcuRtjieEfm/+b1v+X1o+leX5Fu9
cvgY6x9VOa/JlcnHielf84gf848Po5l/NTzyoudW1CrxiTcx13rvmFlm52LFZfoh
QdcxnNpvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqslkWJDK+yqKnFIFvxK/wCc
n/Ncv5l/mtJ5Jib1dL08esqf5YO58M1esyFy8UAym1IjhQWq8W4hWHsBnKanidni
gFUKR0GYMeJywA3Vh0zPwgp2XCRh1y3MCUbKqSN4ZTwlaCuJD4HGiuzqnHhK0G+T
DHhK0Fwdh1xorsu9Q+GHddneofDHddl4kNOmO67N+ofDHddlrSGnTGiuyj6h74KK
7Nc69saK7LGkYfZGPCUUEO0j9cPCU0FLk5YDxx4StBH6XGyahFG7gqW6Zbp4btOa
ez9R/wAvoxHolsq9OIp92dToQadDnO7Nc2DS7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FX4+/8/NvzY89+QU0+0/LvUm04zuicgSOtMVeX+Rv+cdP+cifP
XkiP8w4vzHPqywmUWw5fEAKkVxVmv/OIH/OXuvaJ5nl/JH82We5v4pDEtwa9RtXf
FX7NeovD1SRwpWvanjirA7v80vKljdfo261W2S4rTiW74qzi2uobyJbm1dZImFVZ
TUEYqkUHnDRrmeSyhvYTNFUOvIbUxVAwef8AQbmGe8gvY2ht34SMDsDiq1/zD8ux
WZ1aW/hW2BpyLd8VRmmec9G1e3N/ZXcTQD9rkKYqoWPn7y/qV2dLsdQgkuRtwDYq
yuWVIVMkzBVHUk0GKsG1P8zvLOkSrbX2owpI5oBy/Xiqerrlrq1jPd6FdRSlI2Id
CGAIFd8VfgJ+XX/ORn5gal/zk1P5Hl1B59P+tlOAJoByxV/Q388VU5ZUgRppmCoo
qWJoAMVefv8Amr5YW8GmJqELy1oeLAgHwxVntvdQ3aCa1dZEO4KmoxVj3mPzlpPl
SMT61cJEpNKEiuKq2g+bdI8zRifQ7uK4U/yNv92Kvx1/5+Rfnv8AmB+WPmXSLTyT
qDW1iZU5ItfH2xVjP/OZP59/mP5J/Jnyn5+0TWTHdanwEvGtd6Yq/RH/AJwd86a7
+YH5VaR5p83XX1m7nj3Y9e2KvsHFWCaz+Znlny/M1prGowQSqaFWbvirIdD8xad5
kg+vaHcJcQ1pyQ1GKoD/ABpoovf0Q93Gt1WnBjSpxVF6p5n0vRJUt9VuUgeQVXma
A4q+JP8AnOX/AJyfj/I7yP8Ap3ytOs+pO/wqh7dsVTP/AJwm/wCck7b87fy9tvM+
uzga28jLPFWrCnQ/LFX2BbecNHu5XtYbqP1IxVwT0+eKofRfPGjeYby40rR7lJ5r
b+9KGoH04qhta/MXy/oLiC/vYhITTiGBI+eKo/RPOmjeYW9LSbuOWQ78Qd8VZBdX
cNlGZ7uRY4xuWY0GKsIsfzQ8talfHR7S/ia4BpTkKVxVJPzg/Mu2/Lby3d+YXId0
idkANdwPbFX5mf8AOMn/ADntc/mr57n8recJPqlospSIvUd9qYqnf546p+a7fnJY
2nkrW2i8qPJGzqCeJUnFX6uw3cdhYRXGoTKFWJOcrHYniKn6cVYYPzb8pm7XS11K
EzseIAPfFXosciSqJYmDIwqCDUEYqxSy89aJf3dxpcF3GLi2NHVmAxVKrL80vLd9
fyaLFfRC5RuNCw3OKvQlYMAymoO4IxVvFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWH+cPPWjeRrYX/AJiuUgQkBQx3JOKs
j03UINWtYdSsWD286B0YdwcVRuKuxV2KuxV2KuxV2KuxV2KuxVoGu4xV5h+cHn9f
y18s3nmp15fVo2fj48RWmKvk3/nFT/nNu3/5yQOqWUGntaSaashMjA0bhirBfy+/
5+C2/mf80rr8lm0ySVopCn1ha0FDSuKv07U8gGHfFW8VWSMUUuoLEDoO+Kvhf/nM
b/nNLT/+cWbS2jexa/1S9A9GBetTirIv+cXP+chvNf59WEWu+YfLc+i2ckfNWlWn
IeIrir7FSJIq+mAORqcVVMVdirsVdirsVdirsVfIf/OVf/OUKf8AONuj/p+awa8T
YGnauKsp/wCcYPz+h/5yG8qr5zgtzbVYfAffFX0TetGkEks68kjUuR/qiuKvy/uf
+fhXqfm0v5Q2Glv6Cv6RYg7mtK4q/UC3m+t28dx9gyIrfLkK4qrxqUUK5qR3xVfi
rsVS3VtYs9Ctn1LVplgtoxVnc0AxVKfLHnHSfOMT3fl64W4hQ0LL0rirKMVdirsV
dirsVdirsVdiqVaxrlhoEBvdYuI7eEftOaYqhPL/AJn03zPE11ok6zxKaFl6YqyD
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXkn5h+U59bZZIRVT4Zl4Jjk4ueDzhfyxuwOhzJ8YOAdOV3/
ACrO698HjBh+WLh+Wd174/mQF/KnvVP+VaXPvh/NBfyp73f8q0uffD+ZC/lT3qo/
Li7sozqUAJmX4QMB1ALKOAgMcu/yIj80SfpXUI+NwDXoK5MaqI5sxhJ5Mii/Kq50
+AW614jYZeNbFEtMerX/ACrG498TrosTpiuH5Y3HvlEtcO5j+VK9fyxmPWuDFrR1
CY6Yrv8AlV82Xfnosvyp73f8qvmx/PRX8qe9d/yqe4O++P56Kfycnf8AKprj3x/P
RX8nJo/lNcHxyGTWxIpnDSEFYfykuffKRqg2/li3/wAqiuPfJfmYsfyxQV3+V19p
trfTRksZYSqD+VuxyMs4LIYSHgv5Jf8AOJL23mG585/mExu0Zi0EbGvE198w8k2+
OJ+iNnZw2EK2looSJBRVHQZSS5AFInAl2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxVLtXjeaxuYof7xonC/Mg0yMuSQafl1pn/OM+vx+ZrvzxeqxnuJHDV/lJzAzYOM
OXjyM1l/JPWYbl7iIMYXFFHvmqyaEnq5sM4DQ/JHXT+y2Ufyce9sOqDh+R2vH9ls
ujpCOrXLVhcfyN17+VsTpvNiNUGv+VIa/wCD4Pyvmy/Nhsfklr47Nj+V81/NBEj8
kNe8GwflT3r+bDv+VIa94Nj+VPev5sLW/JDXvBsfyp71/NhZ/wAqR1//ACsP5XzX
82Hf8qR1/wDysfyvmv5sNf8AKktfHZ8fyvmv5sO/5Unr/wDK+P5XzX82Gj+Sev8A
8r4/lfNfzQa/5Ulr/g2P5XzX80Hf8qS1/wAGx/K+a/mg0fyR189mx/K+a/mg1/yp
DXj2bH8r5r+aDX/Kj9eG5VqYnTea/mgmukfkdqhuo7iQNsa44MW7Tlyin3V5U0yT
SNNhspvtKP4Z0Onhwh10jZZHl7F2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KvxJ/5+xysg0Qx/FW4jBH3Yq/ST/nE9Vb8r9GVx8Jh3B91GKvxP/OyQeXP+
ck4bvR4eET3Y5ce/xe2KvuH/AJzo/wCcptR8g+SrXS/KEjW19cxIrOOv2aYq/LDQ
dE1vzl5TuPzA1HzU6avEpkEJY1J60xV9lf8AOB3/ADlT5j83abq35e+Yr5/rNusi
QSNWuwPSuKvgaz/M781vM/5tax+XHkm/nuL24vZIkCFqgA0P68VfZv5vflH+Z/5D
fk1qXmDXdZmS9uJucikmoY70xV41/wA40+QPzT/5yA8o3bNrM6adDG0vq8mpUDpi
rxryP5r/ADcPnCT8k9L1qd3FwYqgt0rSuKvRPz88s/ml/wA4w+Y9K1ibWp5ZJ5I3
kXkehxV+sHnX8wvPPnn8lLDW/J0jzazNEqyMuxHwjfFX50p+T3mHU/LV/wCbfPnn
drPXLZGkW0ZzUnrTrirKf+fcH59eZdQ8w615P8yXj3dtHzRCxJqBt3xV5X+VF2i/
85fTC2HAm9P/ABLFX9POKvyt/wCfj3/OROpflXpUXlry5cmDULsBURercx1/HFXx
h+V3/OJH5q+e/IE/5o2PmCeLVpv38VtyapFK4q+kv+cYPPn5rflV5X1SX8145pFt
hIqTS1/Z774q/P7Ufzn81/8AOQfni+0abXXstLWR1DVIA3+eKpZ5d/OjzX/zjt+Z
GmeWtM8wSalpU1yiu4JIAJ3xV7X/AM/FPMp80an5e1u1m9eOd4i/tWhOKph/znii
R/8AOPvkwVqnFOI99sVfp5/z7pZn/JfRSRReA4/dir1H/nLf82p/yb/LnVPN2my+
lfRIfSI69Dir+eL8vtf8wf8AOQwvvN3nHzE+nryZ15MRWn04q9k/5xg/5yT8z/lx
5+T8trnUpLjSZ39NZTUggmlcVe1/853+WvzA/LnV7H8z/JuoytYuq3DBSaeOKvln
yp+eH5lf85aecdN8tadfSxC3EUcjAkUpsTtir6G/5+Hf8466t+Xf5bW3mfVdZe94
8Ukjav2qAkb4q7/n3R+RGt3Xka+/M3TtXaCJom42oJopC9cVfGmpfnB+Z8/5n6t+
X/lXUpp7i6doECk7GtMVfrX/AM40/kT+Zn5S+TfMXmHzRdSz61fW5aNXY1BIr3xV
8RaB+W/nfzbrN/qH5n+aJNEjDMYg7HfrTvirzT8k/wA2vNn5dfnHD5atdcfUdOE3
FXqSGFcVfVv/ADnZ/wA5SeaLjVtK8heRZ3hu71VVgm27bdsVYzJ/zh3+cWleWLb8
ytA1y4m1aZFm+rBmr44q9Otfy9/M3z9+WN9afmJfTWl1bI55OTvQdMVfnJ/ziL+S
Op/mD+Z02kpqRils7ipYHrxPXFX0B+evnzzh+X3/ADkJovkODVnk031oI2XswrQj
FX09/wA/E/8AnKHWvL1vpf5W/l/K0GqTxRBwvUlgPDFXkMH/ADhh+ZS/lmn5y/4m
nXXfR+s/VCWr44q9g/5wI/5yr8zeZbXVPy9/MC7Z9Ss1dE59QQKYq+A7jzf+ZHnH
89tU8k+UtVmj9S6ZCFJoBXFWS/8AOQf5f/md/wA4361aeatW1yZlmkRnqx7kHFX7
8f8AOJ/n+5/MX8vtO1vUJPVm9NQXPeoxV9LYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/Pr/nNb/nLeP/nH+1gsNLX1dUmPwIOp
J7Yq+Ivy8/5z9/NHXfMOlWmu6JNb6bdftkGjDFXzH/z8F/On8wb7zdplgzTRWU5V
4YRWjmooMVfqZ/zjd/zkBrHkP8lH82/nbbtpLWUXGzM3+7Fp8NK4q+dvL3/Oav5x
fmTDqHmXyV5Znu9CtHZluVrxMa98VfXf/OIf/OY0P562l9pXmJBaa7YBuULdar1G
Kvknz3/z8Z81aB+Z0/5Y6Ppr3LBzHFGo6mtBirEvP3/PxD8x/wArfMMWkec9Clsl
uuIjDg/tdMVZD5v/AOc6/wA2/Lljb+a5vL86+X5AG+tUPGhxV+lP/OMH5+2v58eW
ItejNLoD4xir6XZggLtsAKnFX5Pf85B/85ya9pfnaL8s/wAmtPfVtRjYpLFFueX0
Yqln5T/85l/mDP8AmHY+R/za0SbSopxRhIp8cVes/wDOXv8AzmraflVbR+UvIP8A
p3me7p6UCdTXpTFXzZp3/Oa35sfl5p1prP5n+WZrCyuWQ+q4NOLd8VfZH5u/mbpf
5p/kvdeb9PCyxz2z8lHYld8Vfnb/AM+xLYabdeZZVHOKRJ6j51xV5B+R97Z6X/zk
5qkzqI4TM1T4fFir7A/5yP8A+fhmt+SPOUv5f/lxYtqEtuqj4O5xV6V/ziD/AM5j
ecPzY1m78uefdKktJ0aihgdsVfqcKkAnY4q/lt/5+eeYPNN7+aNm+s2ckcFtKos6
1pJQ7UxV95+Xf+cr/Pf5QfkpB5p8x6U0JtokW2BWnJadcVb/ACQ/5za/NP8AOlrf
VNI8vTPo6svrTAGgFdzir07/AJyW/wCc8pfIt9Z+SvIEBvPMcyrztkFW5nttiryG
y/5zt/M3yHrdk35weXZtK0u7KD1ZQacW774q+rP+ckf+czrX8uPIVv8AmF5KX65H
cIG9Rf2SR0xV8d2P/OeP5recfIz+e/Kfl+e5toVZ5JlB2Ud8VSn8vf8An4d+Y35u
6QNN8g6LLe69a19eJAagjFXqX/OO/wDznx5k1nzm35Yfm9Ytp2sSScI4JRvWvvir
9hoWZ0DSChO9MVflB/z9LWVPINzJKn+jggl/DbFXxL/zil+eH5hflr+Wct/5A0Ob
VrCIBmdAaADftir9Gv8AnFD/AJzQ/wChgNM1Hy/5jh+o+YIIpF+rts3QjFX5caEi
n/nJVnvG9KUXO3v8WKv1g/5yt/5yc1T8sNIs9C8jWTXutSLGeK7mlKDFXwr5k/5+
L/mD+XMWl3PnjR5bVJJh6rMP2MVfpJ5h/wCcqtLb8n3/ADos3Ecclt6kfu3GtBir
8z9G/wCfkH5oeY9FHmbQPL8tzp1uSWmANCAcVZP/AM5jf85Dec/NH5Q6d5q0aGW2
a/hDXIWo4fPFUn/59qfnJ540XR7q780WcknlqjPLfSV4oAa13xV7L52/5z681eZf
NE/lT8jdNfW/RcqfRB7fLFUf+UH/ADnt5jg84Q/l/wDnPpz6XeTsFEUoodzTvir6
J/5yz/5zBs/yVsbax8tUu9XvVDRRruTy6DFXxen/ADm3+cugTafqvmHy1cQ6PdTR
gzFWpwY9cVZ3/wA5F/8APwvW/wAs77QJ9K09hpt9LEkr0IHxUqMVfXH56/8AOWNn
+V/5Swfm/axc7i/twYI61o7L/nTFXgvkb/nPKaT8oD+Z/mq1MWoOjmHkPtHtir5V
0X/n4x+a2sRw6/Z6BNLo7MazAGnGuKqn/Odf5/8AnXzR+X2meYtHhks45Y1aUrUU
J+WKvUf+fWnnP8wNV0Wf/E9lNNpklSk713Fdjir9oBUgE7HwxVvFXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq6leuKCLdSnTFIDsVdirsVdgF9VdhV2KuxV2KuxV2KuxVxFd
j0xVoADYbDFW8VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVaIBFDuMFKo
i2jCiML8K9Bg4B3MuMqvBfDB4Y7kW7iPDB4Ue5Ft8R4Y+FHuW3cR4Y+FHuV3EeGP
gx7k27iPDHwo9yHcR4Y+FHuV3EeGPhR7lt3EeGPgx7k27iPDHwY9y27iPDHwY9y2
7iPDHwY9y27iPDHwY9y27iPDHwY9y27iPDHwY9y27iPDHwY9y27iPDHwY9y21xB2
Ix8GPctrUiVOgynFpYwPJJlapmUxdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVfh5/z9k1BLZtH9QFY0nRmYD5Yq+s/+cfv+cmvy/wDLf5U2X13Vokur
a3NYj9otxFMVfmh+Xel6l/zkH+fsfm3TI3l0aK75F6GnENXFXtf/AD9L/KbVIU0/
zD5fgaTTYQhcKCQKbHpir5u/Kl/ywXyWbzV9X9PVBGfUtSDsfDFX1H/zhx+VHlrz
Bb63568tkKbVZCCARXY4q+Sf+cGUhuv+cqNTvLgcXjvJeNR3LU/hir9Uv+fpsjr+
St6kYJLS9APAYq8i/wCfWL8vye1NZqqfSfYj/JOKvg78rpJLT/nJaSSNWFbynLif
5sVfS3/P2gS2+paHeRgvyMQIAr4Yqwf80PzS8z+SvyZ0keTJJLZplVZGQHYU64q8
8/K1vLPmfyHqms+fNbabWmgYqr9eVMVed/8APuK+s9J/MTWZrrk1tzfiSp3FTiqd
fldeLJ/zl5NfW8JML3vwmhp9rFX9QeKvwt/5+rflvq2panp3ne2haW2tCjVAJAC9
cVem/k3/AM59+WfK/wCWlvpyQ8tUsLf0/TApVgPDFWMeR/zl81/85U+V9a0OwsXh
jPrEMFI2OKvzJ/KjyHZeSfPN75d/MW8fTLdZ3dpiDvvuMVfVtx5S/K7zZ5y0my8s
XS3sguI+T098VQX/AD8W8vQeWtT8v6VowIgV4vsg+2Kpr/znXOjf84+eTbYKWcKn
Y7dMVfp3/wA+5nLfk1o8ZqAqAUI9sVRP/PwP8ur7z7+VOq2+iq0t0ke0YrvsfDFX
4X/84j6f5P0mwvvL35vagdOnjZgI2HevTFX1h+Rf5e/l/wCZ/wAyIdQ0W5FzZ2zV
V6GlFOKsv/5+IfnvD5ma3/JfyWTJdFPSXiPamKvgj8grvXf+cQvNlnq3m+2eL648
Z5FT0bvir9Xf+fivmWH81f8AnH2213y5/pLTskrKoNRsK7Yq8Z/592f85A6F5e/K
bUPy71NimrRxSUBFCTxIpir5Z/5xXto9T/5yGury5hLSi6ZlJU92rir95/8AnLzz
RqvlH8rde1jy2WS9jtm4ugqV2xV+A3/OKPmu1/NO31HUPzk1yQzQczHFL+rFXkug
tpj/AJ0W/wCiJGSwjn4rIAaUrir6A/5zH8j6x5L88eWvzEVHewQRv6lCaqCDir9B
fM//AD8P8taJ5BsrXyvyl1z6tHEy0rQgU2GKsr/KP81fMf5sfltq02s6cyiWGVlk
K0O4xV+XP/OGX5sab+Sf5yamfO6GI3E7xxllPc7dcVQ//OSGvQa7/wA5OaNrNkhk
tpLqF0PE03YHFXrn/PyP8vdY8reatC/OZLVjZ8YDUAkbAYq+tl/5zj8o3f5LrYrP
TW2s/R9KncDwxV8f/wDPvryBq3mnzF5g/Mm8tnW2rJIGIIqNzirz/wD5x6umH/OV
l9IikJJeHfif5sVfaP8Az9wVX0SxjClmJWoA98VfW3/Pu6b1fyosVKleAQUPyOKv
vHFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
5T/8/EPyO0H81o7O6+vC11u2oYxWhLDpir8ttZ88+c/+ceNS0Gw832P1yxJVYpWo
dq4qzP8A5+A+aB5r1j8v9asIfQ+sxwOSBSm4xV9T/wDPxZ9Ul/IHy1FpkZlsPqsH
rOm9DQdaYq8X/wCccP8AlbuoflILL8rbcrpbQhbh1YD4SN8VZp/zhX+RWseXPPuq
ebLuc8mgdp0Br+8pvirxjyuI9T/5yn5zQh2S4A39mxV6l/z9EiWfz1oK3KBI1aHf
7sVfRf8Azk7Csf8AzjRp01q3GL6stQB/k4qn3/PqhIG8imaBqt8VR9OKv1G81R3U
uk3cemCtyYmCD3pir+fD/nCpY7H/AJyN8x/40k9LVhev6Ak/1vfFX7eedbr8uW12
KLzQLR/MBQmAtQydO1MVfzc/85iPrFx/zkBYS6ZbtBIkii1O4BFdsVfVn5+/l7+c
f5j+XNNsPOYaHR/STg/IdKbYq+lPJfkOf8u/yBvbHUZzNH6D9d9+JxV4P/z7JZOP
maYPyAWc8fvxV4D+TAtLn/nI7U5L9qI0zCh7/Fir2j/nIn/nGifWPzAm87flRd+p
qyhXltgwFO+Kpd/zhf8A85Eahof5q3f5X+fdIWPVZZfTM9KsCDTrir+hCCAxMzNI
zhugPbFX8/H/AD9uMsfn/wAohR9t4/8AiWKvZv8AnNeVov8AnHDSvh3NvCK/7EYq
9h/59yabPZ/kjcwWCj1ZYWZZO/IodsVfnf8Ak2LHS/8AnJWYfmYge4M59FpfHlt1
xV94/wDP1ZNJl/LexvS6G99RRCgIqV2p0xV+dHnpr0/847afDqwaNWcgBq9Ke+Kv
0R/5w6s7W1/5xf1hIaFvqM3Lbp8Jpir5S/59AWccfnjzPcqeTM030bnFXmn5uRqP
+cztLYScg+oJ9G5xV/TN0xV+W3/P1Sdl/K6aBkrCxHI/fiqQf8+0r7Qo/wAk7363
NGluEYSqxA24nxxV8NfkPpFxqn586vP5HJTT1aYtInSlT4YqkkBt7n/nI9LeJvUu
IpAXr3IO+KvfP+cpfz0mX8y7L8vtH05f0k8UaJN3qemKvnj/AJz4/JTWPKvkTSfO
3mzVDJqNy6lrPkDxUkU6Yq+yfyG8j6N52/5xUtNM8x3QW2mhZYuR6GmKvhDTvJHn
v/nGfypqWv2YOpeUCGZVLArxJxV7H56/NmX82P8AnHybVLWwFrBDACABttir2j/n
GmS7vP8AnF/W4dHAM7W7VApXpirHf+fSUujwX2u22oBE14XDUZ6cgK79cVYh/wA/
CprPTPzTsLjQVW51kyKAV3INfbFXhP5z2+uR+f8Ayxf+fAyRuluYw9aVNKDfFX9C
tleeVIvJukL+YqWiW7QRemkxBBPEUIpir4Y/5+K/kbp/5l/lvFqP5eWsQOnVuVeE
dANxTFX5F+ZPzpn/ADc/Lnyf+Qk07SaxBf8AoSp3oDTfFX7B+bP+cfvLdn+Stn+X
XmyRbK5S2X02OxLFcVfmL5m0Dzz/AM42+W47uMHUPLA3QEggqTir1z86fzSH5pfk
jb3MFp9WUQrsBSlMVfpN/wA+2io/K+2iEokZQtR4Yq/RDFXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXzl+fn/ONXlv8A5yAtIrLzSCpiIowFcVfNZ/59s+SY4xa219cJCNitNv14q+s/
yc/IPyx+StkLDyvAPVIo0zD4jir0Tzj5M0nz3psugeZLdZ7WVSKMK0r3GKvhWf8A
59wfl6dROpWw4RO1Xj49d8VfXf5ffkt5Z/LTS5fL3li1WG3nUrJQU5VFMVeU+RP+
cP8AyT+X3nCX8zdDjK6nK5kb4RQsd8Vevfm9+VOk/nH5em8m+ZBW1lIatK0OKpP+
T35G6B+TOgv5R8tp/o0tQ5IpUEUxVgemf84l+TdL80Hz/BGfr5f1K071rirJvzf/
AOcdvLf5yy20/mdS5tivEEV6Yqt8wf8AONnk7zD5cTyTdWwFnGvFWAFcVfOem/8A
PunyLp0knGeU271+Cnj9OKvXfyu/5w+8i/lbdTX+kWiM8vcrQ4qu0T/nEnyjonnY
/mfbQot4H5qAN6++Kvq7FWG+efImkfmHpcvl7zJAs1tKCNwCRXwxV8Ow/wDPujyP
Y6mdQsGpaO3J4mGKvsz8u/yo8t/lhY/orypZxwIwo7KKFsVfP35r/wDOFPkj80bh
9Su4/RupGLMwHjiqp+Uv/OFXkT8rLlNWtrdbm9jYMrMNgRirNfzg/wCcYfKf5y3N
vf8AmJCktsQV4AU2xVA/mZ/zir5S/Mzyvp/kHVUK2WnU9NqVJpir138sfy40v8q9
AtvJ/l5aWluKA0oTirNb+wg1O3ksL1BJBKpVlPcHFXwT5t/593/l95n1SbXn5JLM
/Mrx2r9GKvbfyu/5xa8l/ldAY9HtEMzKV9QCh3xVic//ADhf5Ju/My+fLxWmv1kD
jmvTetOuKsz/ADd/5xf8mfnClsvmG1VJLUAIyKK0HTFU6tv+cfvLMHlr/AUsZm04
LxCuNh9GKvE/J3/OB/kLyZq02v6ZzBnJLRhfh3+nFWaeRv8AnEjyh5E83T/mHpkY
+tS7qtOhxV9G+aPLdl5v0q68uaygks7uMxyKRXY4q+EIf+fc3kGwvWv9KkkhjkJL
xhdt/pxVmGl/84JeQdI1GHWLWEGSMhixX4iQa4q99/Mj8kPLP5naJH5X8wWytDDH
6cT0qyilMVfJ+gf8+5PIGkXw1C4ZplVwwQrtscVfc2g+SdG8t6UPLWkWqRWITgUU
dR74q+PPO/8AzgF5A84+Y4vOzK0F3HMJiqrsSDXFWY+Yf+cM/JGu+YbHzm0XC7sf
T4/D14dMVe4fmX+Uvl/81tGHlbzXbrNaLThUVK0FP4Yq+KpP+favkEXiXdvPIIFb
kYiu368VfcHkT8sPL35c6T/hryxaJBasnCQqKF9qb4q8T8qf84ieTvKfnST80LGO
uoO5kAp3JrirPPzo/ITy9+dtnHY+Z0qYyOLUr0xVmf5bfl1pf5YaND5X8vJxtogP
pIxVn+KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KvhX/nL3/nGLVvzxFpfeVb57K7t9yYyQSRir4c0z/n335884+YNLT8y7yW40jT
2FHkYnYHFX0r/wA5bf8AOEp/NfR9G0jyXGEm0qJUjk6MOPTFU7/KT/nFnzB5g/LO
7/Kf87JnkQfBbMxqQANjir5rsv8AnEb84vyr0288l/llqFwNHuJio4sRSM4q+wf+
cW/+cUdS/J6zuL/zPq015qF8h9RZCTxZuuKvA9P/AOcD9Ysfzl/5WzbTstn63qE1
964q9E/5zJ/5wzvv+cg9Z0jXdNnK/UnjLgGlQtMVel/nD/zjXd+dvymtvypsHJmg
hCdfamKov/nDb/nG64/5x68tjRr1yZnryU9q4q+0sVfkv+f/APzgVqGp+fB+cf5X
XcsGpO5llRCRv9GKpd+Un/OGnnvVfPlr+ZH5qalccLM/BEzE8gDir2X/AJy9/wCc
KbT867mz86+WpTZa1p6qsZiqCadDtir5k1T/AJxN/OvzNd6foev61djRbcxqfjNO
I7Yq/RLzF+RAk/LKT8r7OZ5pjb8DI3UsRvir54/5w+/5w8vPyIt9XudUkJlvhIFQ
k/tYq8m8mf8AOBOowfmlN+aE8hhtHmL0qRXeuKpt+en/ADhx5+1PzRP5v/LTVZrd
Z1AZY2I6Yqh/+cTP+cHLvyR5zu/zI/MeZ7rVw/MNJUkn6cVfrRG0pkcSKBGKcSDu
cVfmd/zmp/zhlqX/ADkR5p0PzPpsziKwKlwCdqHFWcfn1/zixefmR+Vdr+WEEzm4
t44079hir1b/AJxS/IOb8h/Iq+Rr64aV3oTvuuxFPxxV81f85J/84GL571tPzK8h
3Lw65G3IAEg1+jFXkGnf84Oef/zR1e1X84L+Y6VZMrIjsSp44q+nv+cjP+cObX8w
fy+tfIHlNRG9oFFF2rQdRirK/wAiv+ccbn8ufylvfywvGP1u8t3ioT0qNsVeT/8A
OEX/ADh3qH/OOWua3rmqGqaizlN+nI4qwDzn/wA4GarrP556d+dFtMWsoLkTOa9K
GuKv1sAptir4+/5zD/5x8uf+chPKreU7KVkL1FB0xV+f/k3/AJwM8/8A5beW5/JO
hX8621yfi4Mab9emKvrL/nEP/nDE/kQbrXtcn+saldqwIckn4utcVeZX/wDzgZen
83D+bFjL6cDyczQ+Jriqz/nI7/nA2+/MLzLD5/8AK908eqQIoVlJrVcVfPPm7/nA
z80vzWim0f8AMHUbie3jjpbmRiaEdMVfZf5f/wDOHk/l/wDJaP8AJrVL+WC9RGWJ
lJ2JGKvjiL/nAf8ANiXTbjyBquq3F3oElVAkc04k4q+1LT/nCaxs/wAoJfyhiYJc
SwcKr40xV45/zjh/zhz50/KQS+TtTuZG8uXAZXBJpQ4qkur/APOBmueQ/M0/nD8n
r2WP6wzNIqEihOKov8mv+cFNdvvPS/mP+cNxJdSQvzVJSTuDXvir6J/5y3/5w10/
89rGDU9Fka21ewUC3CbfZ6Upir440L/nBz82vOE9np/n7XLqPTrGRDGC7U4L0GKv
011byFb+S/IGoaFf3Amgi09kLSmnRad8Vfzh/wDOHn5ZW/n7/nIC8NlD6sOmXbzx
gCqkhj9GKv6JP+ci/wAjz+dXl1dGE72N9HGPSaM78vDbFX5ma1/zgX+ZeuafF5R8
w6nPcaIho3JiaLXwxV9leaf+cKNLv/ylj/LLRKLfR24VX6cjTFWH/wDOI3/OOnn/
APIeOTR9QkdrE1ABY0pXCES5P01h5cF9X7dBX54lR5qmBLsVdirsVdirsVdirsVd
irsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsV
dirsVdirsVY35r826X5KsH1zzFOLe0Tq5xVJvJP5m+XPzDia48p3sd0q9QpFfwxV
MfNXnjRvJcH1zzHdJbx0r8RHTFUL5N/MPQvP0LXXli6W4jTrQj+BOKs2xV2KuxV2
KuxV2KuxV2KuxV2KuxV2KpD5l8yWHlLT5dd1yUQ2cIq7noMVSfyR+YegfmJaNqfl
K8S7gQ0YoQaH3pirNsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqyS
RYVMspCooqSewxV5fa/nJ5XvNW/w1BeKbyvGm3XFXqQNdx0xVvFXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FWgoFSBueuKt4q7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FVKSP1CpqRQ12PXFVQqGpyANNxireKuxVoioocVWxx
rEOCCgxVfirsVdir43/5y1/JjzJ+dOjjy95a1CfT4WBWRoGNWB8aZTLLRpWC/wDO
G/8AzhXpf/ONzXGvFzc6rdA85ZK8qnr1zIIpX376S8/WP2qUyKquKuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV+f8A/wA/JLyaz/KC+a0kaKQsaMvUbYq+HP8A
n035nMYuodd1FTVTQTSAb7+JxV9Df8/J/MsH+FDLoOox+uEZSIpFO/0HFXnP/Prj
zBLpvl2/v/Ml28iorOSxrQDfFX6J/l1/zlB5O/MvzDceSNAn5ahASCtQdxiqO/Nv
/nJDyn+T1xFp3mafjdS04rUDrirF/OX/ADl95E8kaZp2v6xc8bfUKFdwKD+OKvLP
Mv8Az8Q/LbRTb3FpOZ7SSnqSbfDXFWZX/wDznV+V1to6+YrXUPXDryEa0qPnQ4qi
Pyh/5zb/AC4/N26/Q+kXoiv+VBG5G/44q9l/M/8APHyj+Udh+mPON8sMJFQAQSfx
xV8kXX/Pyf8ALSPUY7G3aV7RyAZiNt/wxV9g+UPzl8reetFfzX5ZvFuLKOP1GpSo
FK4q+f8AVf8AnPD8s9ImlsLi7JuoWKsisDuMVY75X/5+Fflt5l1qHyxFOY5pn4KW
IG+Kvu2zvIb+FLy0cPDIAysO4OKvkH/nPeeW2/JPzLNayGKVYKqynfocVfA//Pn/
AMytp3kLzLrvmS9P1C2lLu0zV4BT7+2Kv0I8nf8AOYPlD8wNbm8reUWNzcRMVqNw
QOp2xVZ55/5zS/L3yBrC+WNduuN5Q81BHwkdsVeYv/z8c/LKPUUsJpmS3dwgkJHU
4q+3/LnnPSPNOkR+a9HuUk02RPU9UkAAUrvir47/ADI/5+C/ln+X2oNoclw91cox
VvTFQCPlir138nf+cpfI350FbTyxej6+esDUrirLPzd/Pfyh+Sll+kfPF6sBYVji
BBZvDbFXyt5V/wCfkX5ZeYdTj0SeSS3MrcUkcUXr74q++9I1e0120i1bSZVmtZ1D
I6GoIOKoq6uorKJrm5bjGgJJ+WKvkLXf+c4fy18ualPoOqXhS5hYqQCN6e2KsO0j
/n4X+Wmp62PL8lyYYmG0rkf1xVH+a/8An4J+VvlS4W3ubxpEJ+2tKYq+i/yo/O7y
n+c9j+lvI14LiMCrLtUYq81/Ov8A5y68ifkjKdN1+8EuojdoIyCQPf3xViP5R/8A
Odv5a/m3qKeXdNu2ttQkbiiS7An6cVeqfnZ/zkh5R/IdLSTzrP6ZuyBHQgDf3xV4
R5q/5+I/ld5ftIr62umnMlCQKUX6Rir2/wDLP/nIXyb+eOhXGoeV7sN+6YSISKjb
tir4D8m6Z5UP5rtJFqsjXqzE+iW26+GKvuT80P8AnLT8vvyiZdP8w31brjtElK7D
FXmXkf8A5+C/ln5x1BdEeeS1uJGCp6goDXp1xV9f67560Ty3ox836tdpHpYQSerU
UIPhir4h1D/n5P8AlVZ6q+kwzyzW8ZIadV+Go/DFX1X+Xv56eUfzQ0Sbzb5Ovkub
SCMySDkAygCu4rirBvyy/wCcr/I35q+YrryN5cuSdTtWKspINSDTFU+/Nj/nIzyl
+TtzBp/m6cxTTkBQSAN/niqbap+fPlHQvL0fnnWbxYNMlTmjVBqKV8cVfKsH/Pyb
8sWv2sZnmFtyokwX4aeJPTFX1/8Alf8AnF5X/OCxfWPIt2Lq3jNHOwIP3nFXqOKu
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2Di3pXYVdg4t6V2FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX
Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYKV2FXYq7FXYq7FXYq7FXYq7FXYq7
FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq
7FXYq7FXYq7FXYq7FXYq/P7/AJ+SylPyfv0C1DE1Phtir+ff/nFz8jvzB/Mtp/8A
lW15PBISf7tiP1YqzT/nIP8A5x4/Nr8vNBa48/X1xLEjsT6jk7DFX3n/AM+/7b1P
yt1jUWJ9UWrg09lxV5R/zgNJNJ+d2qXFpJzkM71Vj74qz/8A5+rWk48y6PceqEka
SOqoe1cVfL3/ADmbKY/y18mmF2DBU5ke9MVfXWmf84heV7v/AJxxb8xtRZjqb2H1
lDTpt/XFXyH/AM+9fyRt/wA6NavvLvmOZ3sImdVB3AAOKpf+d35fN/zjF+fGmeXv
KUrJbzzoNtti2Kv1F/5y78mfl/qnlfRNX/MnVZUSS1jkaGJ6sxKg/ZGKvzk/OLzP
+XumeSzpX5cabK86oQtxLCQemxrTFX0P/wA+9NX1Gf8AL/XU16Y+ibaXgoPTY4q+
Pf8AnGT8pIvzb/OjUNB1mWRtPa6frvsWOKvQ/wDnOD8h9J/5x2896PqPk93VWljb
pTqRir+gT/nGzX5fMn5f6TqVySZDEASe9AMVeQ/8/AGK/kxr9fsmEg/dir+Xb8qP
+cgvNH5b+VdQ8ieWxINM1Q0uXQGgqe5xV+/H/PvH8pfK2n+Tp/zH0yQXetvE7OKh
ipIJxV+Wf/OQOiSeavz9h0+7dglxchWUdgxp0xV9Pf8AOaH/ADh15f8Ay18mab5p
0J2W4dEmc0p8VAcVRHlr89NS8uf848y29rcypMoMXJWoaAYq+KfyJ81aDqtve6x5
rsbjUr13cgiIyGp+jFWR/kn568weSfzcs9a8m2NzDaXNyqGJ4ioAr4UxVM/+c2Pz
g1Pz3+b6aD5iaX0LYxE269PlxxVCfnhrPl/XPK9npXkjRbu11m2RazLbFanxrTFX
66/8+wfPXmbzP5IudF84+pXTyEjMta+HfFX6R+anEekXjMKj0X/Vir+W5/I8f5i/
nvNoN5Iwt5bqhHzamKvSP+fiX/OOmj/kP+iNR8nyMlxcKnIgU3OKvXPJH/OHOj+c
/wAkH/MzzNKx1FbcyLUV7YqwT/nALz5f+T5PMOhWEr+laQzcaHpxBpir5R0H8wo/
Of5q6lr3nL6xqVvFNJWLiZNlbwxVM/zq8xLa+YNK86flBpl3ZSwzKxAgZAaHvtir
6W/5+E+ctS86flD5D8x+YVaPVJiokJG5oMVe5/kd/wA4S6H50/Jv/HXmYk3U1qZY
ajwGKvmz/nCHX77yf5/1ryZBI31CCSROHTbcdMVTbyI1xb/85Gy3Qmb0nneiE+Jx
VJ/+cyPy0876P+Ydv56lhN5pKv6npBefw9emKoXT/On5T/mjrWk2HmeC40LVYWij
5JGYgWr3O2KvoD/nPX817jyF5T0n8nfK981xp96sarMr8jR6AVOKvef+cbP+cEvL
PmD8qY4fMUcb6nqEfqC4ZasOYrucVRf5Nf8AOIN9+QMPmo2usCXTvqkrCFJa0FD2
xV8U/wDPv6Rf+V46s1k1X9dweX+tir2L/n7RLM+r6Lb3biFWaMIync74qgPzS/Lr
zf5t/I/SIfK7tKEtxUE1J2xV8cflz550Xyzojflx+b+jPCZPga8EFCvvypir9lP+
cDLb8vvL9hLZ/lrfS3K3G7K5rQk4q/SnevtireKuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2Aq7EFXYVdirsVa75V/ElvLUNd8qH1Jby1DsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVfB
H/Pxqw1DUPyiv7fSLaS6Yt8SRKWbptQDFXxl/wA+nNDutMW7OqaddWkvFqGeMqOh
8cVfQn/PzHRtQ1TyZw0mzlumKNUQoWP4Yq8l/wCfaPlG9k8ha1o+tWVxatNBIqrM
hUkkHxxV+dEeuec/+cSfzf1HzVpGk3c9vLO7LxiYg/FiqS/85Jed/wAx/wA+Nf03
zvqmj3v1OeReEaxN8NPbFXp3/OYHlHXpfy+8nWUOl3c0kipzWOJmK9OoHTFX61aL
o17J/wA4rLosltKLpNJKejxPPbtTFXwr/wA+m/KWs6P5h1u51XT7m1VJHCGaMqCK
++KvOf8AnPXy15j1j/nIHR7y20y6ntxIv72KIlRv4jFUL/zmt5B836Tf+XvN0dve
3enwWsZkgVWZdgNiMVSLzl+eFn56/LE+T9B8qXMesRxcS4tSDWnjTFXqn/PvPQNa
t/KGvReYtPu4HNvMUR42WuxpQHFUF/zgP5X1uH86tRvdT0y5trYXDkSSRFVIqe5x
V6H/AM/UvL+p635h0ltG0+5u2R0q0MZYChHhir9Q/wDnEG3vbX8s9Jt9ViaGVU+w
4oRsOoxVin/Oe2n3Go/kr5jg0+GS4uPQ+GONSzHY9AMVfkh/zgN/zjFY/md+U3m2
x81aVLDrUgc2jzwlW26U5AHFWM/84leefPX/ADiZ59vfIuvadqF1o8rug/dsUoTt
iqE83aZrerf85Aaf51l0i7On3M6yAiI8VBbvir9MP+fiel32r/ljYw6NazXE3or8
EaFiPhGxAxV8lfkD+QGqfml+TV75bvbOa3vFDuqyxkEmngcVfLn5KfmJ5h/5w+1S
/wBC8weV21GMyOsZe25jrQdjir7Z/wCcWvMfmb/nIH8w/wDEmueXYtN0a3YSxcrf
h038MVeJ/wDOe3/ONvmryN+acf8AzkPolkL7THkR2hhj5/Y7EDFVLW/+c0NY/MnR
4PK3kjySIdWRVjZ3s6bjbc0xV+xP/OKXkW68qeTLXVNdgS31fUYxLcRovEA4q+gP
NTlNHvWVS5ED0UCpO2Kv5x/y98q69N/zkC2onTLuO2+tV9QxELTl44q+j/8An7jp
ep6rZ6FDoun3N3Knp19GMtTcdaYq+q/yq0jUIv8AnGhrHUraVbr6kaQ8Tzrx6UxV
+eX/AD778k6nqXm/zJpGraZc2sV6k8KPNGVWrVFanFXkWoeR/MP/ADg/+bWoa5qm
ivrGl3bvIvCD1E4sSffxxV7nY/8AOQXmn/nITzRpnlryn5Qjs9JkmVJpHtONFPXe
mKsp/wCfsHkbUtO8m+TvKvl7T5rn0WHL6tEWCt034++Kv0a/5x/07ULP8gNHsNQg
eO7XTqNEVo1KdCMVfjP/AM4yeXvMNv8Anrrd7qGlXcemC4kqzREBhU9DirJPJ/lT
XLv/AJyPm1K2027SxE7lXaIhOu2+Kvav+cg/zH/Mb8svOUWra/o7aj5cQ/YWIv8A
D8sVfFv/ADkJ5om/5yR1nTLT8rPLNzpt0JI/UkS2KUNd96DFX2D+eX/OFHmi8/KP
T/Mlp6l35os0jl4uCzDiOmKvNPy0/wCc8PzB/LDyZJ+WGpaFey+Ywhto3ELFVoOI
I22xV9If84R/lj+a3nU615o/NG4uEsNUicJFMx/b6ChxV+eWt6j5u/5xC/PC/wBX
0LSru4szMW5JExVgW8QMVQ3/ADld+ZH5gf8AOTmt6P5gvtFvE023dCqpC3QH5Yq/
RjX738wvLn5T6TeeQ7GR1tYB6sMiEsdulMVfIXmj/nIm286+T7ryV5v8o3C+Zp14
xzR2p2bp1pir6l/59V/k15z8nG/8w+ZopINOlcmNJwQwBPauKv29xV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV
2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux
V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku
xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K
uxVL9U+o/V2/TXo/VP2vrHHh9PLbFUt0P9BUP+G/qVO/1T0/x4YqjdX/AEb6P+57
6v8AV/8Al54cf+H2xVQ0T9DiM/4c+qel3+q+nx+nhirEPMlt5Cnnr5rOji4B/wCP
p4Fav+yIOKouJPJCwxLH+h/QH91vblf9icVTPUh5YMUY1f8ARvof7r9f0eP+x5bf
diqdJ+j/AKl+79D9H8e3H0uP/EaYql2hjQAX/wANfUeX7f1T0q/TwxVR1MeW/raH
Wf0f9e/Y9f0vU+jlvirevp5cktwvmb6j9WI2+tGMLT2LYqxDS7b8toa/ok6EfH03
t2/icVZjpA8uiNxoP1D0qHn9W9KlPfjirtKHl36w/wChPqH1v9v6v6XP6eO+Kqmt
DQC6/wCIfqPqfs/WvSr9HPFU5svq3or+j/T9D9n0qcfo47Yqpal9S+rP+mPR+qU+
P1+PCnvy2xVLvL40MRMPK31P0K/F9T9PjX34bYqlV0PKP1qt5+i/rtf92eh6lfp3
xVWb/C3rJz/Rn1j9ivo8vo74qnWp/o30B+mfq/1bt9Y4cP8AhtsVa0n9Geif0F9W
9Dv9W4cf+E2xVg/mK2/L+eYHzQdGE4O31mSBWr/siDirKPLy+X1Tj5V+o8Kb/UzG
dv8AYYqjdcGktbkeZPq31X/l64BP+H2xV57oVp+WsFzLJ5ebQjdMfjEEluzD6ATT
FXq8XDgvocfTp8PGlKe1MVXtSh50403r0pirFof8N/W62/6P+vV/Y9L1K/Rviqvr
40EhB5o+pcf2Prfp/hzxVMYf0f8AU/3HofUOP7PH0uP0fDTFUp0YeXRM3+H/AKh9
Y35fVvS5fTw3xVA+aYvKUtU85HTQSu/11olNPm5BpiqB8rQeSLdVi8oHSWofhNq8
DmvsVJOKsh8wjQSkf+KvqXCv7v656dK/5PqfwxVN7b6r9WX6n6X1Tj8Pp8fT4+1N
qYqx6xHln605039HfXK/H6Xo+pX3474qqwf4c+uH6t+j/r9d+HperX6PixVrzAvl
14yvmj6h6Z6/WzEB974qxjQ7f8vYZf8AnXjohnJ/3Q9uzV+gk4q9Il9D0T6/D0Kb
8qcae9dqYq8rmtfy0+vGac6D9fruGkt+dfkT/DFXp2nfUvRH6J9H0O3oceP0cdsV
YH5otvIU85/xgdHF13+tvAr/AE8iDiqtax+RY4ES0/Q3oD7HE25H0HFWV/7ifqv/
AB6/Uqf5Hp0/Virzya1/LNroSTHQfrddqyWwb7q4q9K0v9H+iP0L6H1ft9X48f8A
hdsVTLFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY
q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq/wD/2Qo=">
<p style="top:419.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Fig 1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Strategy for self-assembly for meniscus tissue engineering. Reprinted with permission.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:6.3pt;color:#0a7fac">13</span></sup></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">951</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">further work on point-of-care strategies such as BMAC</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is required, it may be that the next generation of</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">genetically manipulated MSCs may further enhance the</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regenerative process by promoting growth factor pro-</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">duction and directed cell differentiation.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">80,81</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">As another</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cell type for discussion, synoviocytes have often been</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">overlooked</span></p>
<p style="top:126.9pt;left:103.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:126.9pt;left:121.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus</span></p>
<p style="top:126.9pt;left:171.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regeneration</span></p>
<p style="top:126.9pt;left:236.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:126.9pt;left:262.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">82</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">This is despite the fact that meniscus</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair has been shown to be facilitated by</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">broblasts</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">from the surrounding synovium and joint capsule that</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">are believed to undergo</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brocartilaginous metaplasia at</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the repair site.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">83</span></sup></p>
<p style="top:198.6pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Cell chemotaxis, maintenance of cellular phenotype,</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and inducing matrix production are critical for the</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biological integration of a meniscus scaffold. The roles</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of biophysical and biochemical signaling are currently</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">under</span></p>
<p style="top:246.4pt;left:80.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">review</span></p>
<p style="top:246.4pt;left:120.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:246.4pt;left:138.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">this</span></p>
<p style="top:246.4pt;left:163.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regard.</span></p>
<p style="top:246.4pt;left:204.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Both</span></p>
<p style="top:246.4pt;left:235.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:246.4pt;left:258.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">micro-</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">architectural environment and biomechanical proper-</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ties of a scaffold material act as biophysical cues for</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">seeded and in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ltrated cells.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In addition, the effect of</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical loading on cellularized constructs, meniscus</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">explants, and scaffoldless-assembly meniscus tissue is</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">being investigated in an attempt to understand and use</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the resultant cellular responses; these may have a role</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the maintenance of cell phenotype, matrix produc-</span></p>
<p style="top:354.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion, and overall improved vital role of cell phenotype</span></p>
<p style="top:366.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">maintenance and differentiation. Fibroblastic growth</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor 2 has been shown to recover the monolayer</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">expansion of meniscus cells, whereas TGF-&#xdf;1 has</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">caused meniscus cells to take on a more chondrogenic</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">phenotype.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">As discussed, growth factor supplemen-</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tation has shown improved cellular migration, prolif-</span></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eration,</span></p>
<p style="top:437.7pt;left:89.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:437.7pt;left:116.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">matrix</span></p>
<p style="top:437.7pt;left:156.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">production,</span></p>
<p style="top:437.7pt;left:218.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">but</span></p>
<p style="top:437.7pt;left:244.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">important</span></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">translational considerations include mode of delivery,</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">localization of effect, and timing of growth factor</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">release. The use of innovative imaging markers in</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">future studies may prove ef</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cacious in tracking cell</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">migration and matrix production.</span></p>
<p style="top:509.5pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Regardless of the strategy applied, a key de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">nition to</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">be achieved in the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld is the target level of function-</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ality, which is required to support a superior clinical</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">outcome.</span></p>
<p style="top:545.3pt;left:93.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The</span></p>
<p style="top:545.3pt;left:118.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">unique</span></p>
<p style="top:545.3pt;left:157.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">anisotropic</span></p>
<p style="top:545.3pt;left:214.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">features</span></p>
<p style="top:545.3pt;left:257.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:545.3pt;left:273.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus may be nearly impossible to replicate or</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">generate.</span></p>
<p style="top:569.2pt;left:94.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although</span></p>
<p style="top:569.2pt;left:144.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ex</span></p>
<p style="top:569.2pt;left:163.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">vivo</span></p>
<p style="top:569.2pt;left:191.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">maturation</span></p>
<p style="top:569.2pt;left:249.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">is</span></p>
<p style="top:569.2pt;left:265.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">often</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mentioned, an increased level of maturation of engi-</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">neered meniscus grafts would require not only more</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">complex culture modalities but also likely longer cul-</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ture durations, which in view of clinical translation</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">would be re</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ected in higher manufacturing costs. The</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">role of in vivo mechanobiology and the rehabilitation</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">process is therefore likely to be of vital importance to</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">making progress. In the translational process, surgeons</span></p>
<p style="top:676.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">must be aware of the need to identify a match between</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the properties of a meniscus graft and a suitable</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regimen of postoperative rehabilitation. This process</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may be assisted by the use of bioreactors applying</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regimens of forces and</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">uid dynamics mimicking those</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at the site of implantation. This offers the opportunity to</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">investigate which structural and functional properties</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">are suf</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cient to tolerate certain loading regimens that</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">would be experienced by the graft on implantation or,</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">alternatively, to help de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ne which loading regimens are</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compatible for grafts of a de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ned functionality.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">84</span></sup></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">However, it is dif</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cult for scientists or engineers to</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">address this matter alone without clinical and rehabil-</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">itation input. If these areas of expertise can be matched</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">appropriately, the introduction of bioreactor systems in</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the manufacture of cellular grafts can be exploited, not</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">only to reach higher levels of tissue organization and</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical functionality but also to reduce operator</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">handling, automate processes, and ultimately stan-</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dardize the quality of the product.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">85</span></sup></p>
<p style="top:256.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Limitations</span></p>
<p style="top:268.4pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Limitations in this study relate to the relatively low</span></p>
<p style="top:280.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">number of articles evaluating the clinical and preclinical</span></p>
<p style="top:292.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(animal model) investigation of meniscus tissue engi-</span></p>
<p style="top:304.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">neering. In addition, there is as of yet no report in the</span></p>
<p style="top:316.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">literature of a tissue-engineered meniscus construct</span></p>
<p style="top:328.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used clinically. Neither does the literature provide</span></p>
<p style="top:340.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clarity on the optimal meniscus scaffold type or the</span></p>
<p style="top:352.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">biological augmentation with which meniscus repair or</span></p>
<p style="top:364.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">replacement would be best addressed in the future.</span></p>
<p style="top:376.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There needs to be an increased focus on this specialized</span></p>
<p style="top:387.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld of orthopaedic surgery, with an improved level of</span></p>
<p style="top:399.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">communication across the clinician-scientist interface</span></p>
<p style="top:411.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to ensure that we deliver improved treatment options</span></p>
<p style="top:423.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">going forward.</span></p>
<p style="top:457.5pt;left:392.9pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Conclusions</span></p>
<p style="top:471.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There appears to be signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant potential for biological</span></p>
<p style="top:483.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">augmentation and tissue engineering strategies in</span></p>
<p style="top:495.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">meniscus surgery to enhance options in repair and</span></p>
<p style="top:507.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">replacement. However, there are still relatively few</span></p>
<p style="top:518.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clinical studies being reported in this regard. There is a</span></p>
<p style="top:530.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strong need for improved translational activities and</span></p>
<p style="top:542.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">infrastructure to link the large amounts of in vitro and</span></p>
<p style="top:554.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">preclinical biological and tissue engineering data to</span></p>
<p style="top:566.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">clinical application.</span></p>
<p style="top:600.5pt;left:395.4pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">References</span></p>
<p style="top:614.9pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Verdonk PC, Forsyth RG, Wang J, et al. Characterisation</span></p>
<p style="top:625.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of human knee meniscus cell phenotype.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Osteoarthritis</span></p>
<p style="top:636.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Cartilage</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2005;13:548-560</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:647.7pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hutchinson MR. Are we wasting money on rehabilitation</span></p>
<p style="top:658.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">for patients receiving workers</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> compensation? Commen-</span></p>
<p style="top:669.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tary on an article by John Di Paola, MD:</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Disability,</span></p>
<p style="top:680.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">impairment,</span></p>
<p style="top:680.6pt;left:379.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and</span></p>
<p style="top:680.6pt;left:403.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">physical</span></p>
<p style="top:680.6pt;left:443.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">therapy</span></p>
<p style="top:680.6pt;left:482.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">utilization</span></p>
<p style="top:680.6pt;left:531.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">after</span></p>
<p style="top:691.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">arthroscopic partial meniscectomy in patients receiving</span></p>
<p style="top:702.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">workers</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> compensation.</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x201d;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;</span></p>
<p style="top:713.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">94:e38</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">952</span></p>
<p style="top:31.6pt;left:257.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">C. J. MORAN ET AL.</span></p>


<p style="top:55.2pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> King PJ, Bryant T, Minas T. Autologous chondrocyte</span></p>
<p style="top:66.2pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">implantation for chondral defects of the knee: indications</span></p>
<p style="top:77.2pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and technique.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Knee Surg</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2002;15:177-184</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:88.1pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Arnoczky SP, Warren RF. Microvasculature of the human</span></p>
<p style="top:99.1pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1982;10:90-95</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:110.0pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">5.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Maak TG, Fabricant PD, Wickiewicz TL. Indications for</span></p>
<p style="top:121.0pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus repair.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;31:1-14</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:132.0pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">6.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Papalia R, Franceschi F, Diaz Balzani L, D</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Adamio S,</span></p>
<p style="top:142.9pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Maffulli N, Denaro V. Scaffolds for partial meniscal</span></p>
<p style="top:153.9pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">replacement: an updated systematic review.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Br Med Bull</span></p>
<p style="top:164.8pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2013;107:19-40</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:175.8pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">7.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> McCormick F, Harris JD, Abrams GD, et al. Survival and</span></p>
<p style="top:186.8pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">reoperation rates after meniscal allograft transplantation:</span></p>
<p style="top:197.7pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">analysis of failures for 172 consecutive transplants at a</span></p>
<p style="top:208.7pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">minimum 2-year follow-up.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2014;42:</span></p>
<p style="top:219.7pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">892-897</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:230.6pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">8.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Noyes FR, Heckmann TP, Barber-Westin SD. Meniscus</span></p>
<p style="top:241.5pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">repair and transplantation: a comprehensive update.</span></p>
<p style="top:252.5pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J Orthop Sports Phys Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;42:274-290</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:49.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">9.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Arnoczky SP, Warren RF, Spivak JM. Meniscal repair</span></p>
<p style="top:274.4pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">using an exogenous</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin clot. An experimental study in</span></p>
<p style="top:285.4pt;left:60.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">dogs.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1988;70:1209-1217</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:296.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">10.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Kopf S, Birkenfeld F, Becker R, et al. Local treatment of</span></p>
<p style="top:307.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscal lesions with vascular endothelial growth factor.</span></p>
<p style="top:318.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;92:2682-2691</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:329.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">11.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Scotti</span></p>
<p style="top:329.2pt;left:90.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">C,</span></p>
<p style="top:329.2pt;left:107.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Hirschmann</span></p>
<p style="top:329.2pt;left:163.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">MT,</span></p>
<p style="top:329.2pt;left:187.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Antinol</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span></p>
<p style="top:329.2pt;left:231.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">P,</span></p>
<p style="top:329.2pt;left:247.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Martin</span></p>
<p style="top:340.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Peretti GM. Meniscus repair and regeneration: review on</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">I,</span></sup></p>
<p style="top:351.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">current methods and research potential.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Eur Cell Mater</span></p>
<p style="top:362.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2013;26:150-170</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:373.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">12.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Taylor SA, Rodeo SA. Augmentation techniques for iso-</span></p>
<p style="top:384.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">lated meniscal tears.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Curr Rev Musculoskelet Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;6:</span></p>
<p style="top:394.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">95-101</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:405.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">13.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Makris EA, Hadidi P, Athanasiou KA. The knee meniscus:</span></p>
<p style="top:416.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">structure-function, pathophysiology, current repair tech-</span></p>
<p style="top:427.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">niques,</span></p>
<p style="top:427.8pt;left:96.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and</span></p>
<p style="top:427.8pt;left:119.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">prospects</span></p>
<p style="top:427.8pt;left:163.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">for</span></p>
<p style="top:427.8pt;left:182.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">regeneration.</span></p>
<p style="top:427.8pt;left:243.2pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Biomaterials</span></p>
<p style="top:438.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2011;32:7411-7431</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:449.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">14.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Pereira H, Frias AM, Oliveira JM, Espregueira-Mendes J,</span></p>
<p style="top:460.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Reis RL. Tissue engineering and regenerative medicine</span></p>
<p style="top:471.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">strategies</span></p>
<p style="top:471.7pt;left:104.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">in</span></p>
<p style="top:471.7pt;left:120.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus</span></p>
<p style="top:471.7pt;left:165.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">lesions.</span></p>
<p style="top:471.7pt;left:202.8pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Arthroscopy</span></p>
<p style="top:471.7pt;left:253.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2011;27:</span></p>
<p style="top:482.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1706-1719</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:493.6pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">15.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Jang SH, Ha JK, Lee DW, Kim JG. Fibrin clot delivery</span></p>
<p style="top:504.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">system for meniscal repair.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee Surg Relat Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;23:</span></p>
<p style="top:515.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">180-183</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:526.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">16.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Henning CE, Lynch MA, Yearout KM, Vequist SW,</span></p>
<p style="top:537.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Stallbaumer RJ, Decker KA. Arthroscopic meniscal repair</span></p>
<p style="top:548.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">using an exogenous</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin clot.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Orthop Relat Res</span></p>
<p style="top:559.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1990;252:64-72</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:570.3pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">17.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> van</span></p>
<p style="top:570.3pt;left:86.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Trommel</span></p>
<p style="top:570.3pt;left:134.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">MF,</span></p>
<p style="top:570.3pt;left:162.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Simonian</span></p>
<p style="top:570.3pt;left:212.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">PT,</span></p>
<p style="top:570.3pt;left:237.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Potter</span></p>
<p style="top:570.3pt;left:272.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">HG,</span></p>
<p style="top:581.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Wickiewicz TL. Arthroscopic meniscal repair with</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin</span></p>
<p style="top:592.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">clot of complete radial tears of the lateral meniscus in the</span></p>
<p style="top:603.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">avascular zone.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Arthroscopy</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1998;14:360-365</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:614.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">18.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Vangsness CT Jr, Farr J II, Boyd J, Dellaero DT, Mills CR,</span></p>
<p style="top:625.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Leroux-Williams M. Adult human mesenchymal stem</span></p>
<p style="top:636.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">cells delivered via intra-articular injection to the knee</span></p>
<p style="top:647.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">following partial medial meniscectomy: a randomized,</span></p>
<p style="top:658.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">double-blind, controlled study.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span></p>
<p style="top:668.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2014;96:90-98</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:679.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">19.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Ra HJ, Ha JK, Jang SH, Lee DW, Kim JG. Arthroscopic</span></p>
<p style="top:690.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">inside-out repair of complete radial tears of the meniscus</span></p>
<p style="top:701.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">with a</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin clot.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee Surg Sports Traumatol Arthrosc</span></p>
<p style="top:712.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2013;21:2126-2130</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:55.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">20.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Riera KM, Rothfusz NE, Wilus R, Weinberg JB, Guilak F,</span></p>
<p style="top:66.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">McNulty A. Interleukin-1, tumor necrosis factor-alpha,</span></p>
<p style="top:77.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and transforming growth factor-beta 1 and integrative</span></p>
<p style="top:88.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscal repair: In</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">uences on meniscal cell proliferation</span></p>
<p style="top:99.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and migration.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Arthritis Res Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;13:R187</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:110.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">21.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Kon E, Filardo G, Tschon M, et al. Tissue engineering for</span></p>
<p style="top:121.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">total meniscal substitution: Animal study in sheep model</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt;color:#0a7fac">e</span></p>
<p style="top:131.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">results at 12 months.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;18:1573-1582</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:142.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">22.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gu Y, Zhu W, Hao Y, Lu L, Chen Y, Wang Y. Repair of</span></p>
<p style="top:153.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscal defect using an induced myoblast-loaded poly-</span></p>
<p style="top:164.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">glycolic acid mesh in a canine model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Exp Ther Med</span></p>
<p style="top:175.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2012;3:293-298</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:186.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">23.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moriguchi Y, Tateishi K, Ando W, et al. Repair of meniscal</span></p>
<p style="top:197.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">lesions using a scaffold-free tissue-engineered construct</span></p>
<p style="top:208.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">derived from allogenic synovial MSCs in a miniature</span></p>
<p style="top:219.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">swine model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biomaterials</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;34:2185-2193</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:230.6pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">24.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Esposito AR, Moda M, Cattani SM, et al. PLDLA/PCL-T</span></p>
<p style="top:241.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">scaffold for meniscus tissue engineering.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biores Open Access</span></p>
<p style="top:252.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2013;2:138-147</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">25.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hatsushika D, Muneta T, Nakamura T, et al. Repetitive</span></p>
<p style="top:274.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">allogeneic intraarticular injections of synovial mesen-</span></p>
<p style="top:285.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">chymal stem cells promote meniscus regeneration in a</span></p>
<p style="top:296.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">porcine massive meniscus defect model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Osteoarthritis</span></p>
<p style="top:307.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Cartilage</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2014;22:941-950</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:318.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">26.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> He W, Liu YJ, Wang ZG, Guo ZK, Wang MX, Wang N.</span></p>
<p style="top:329.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Enhancement of meniscal repair in the avascular zone</span></p>
<p style="top:340.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">using connective tissue growth factor in a rabbit model.</span></p>
<p style="top:351.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Chin Med J (Engl)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;124:3968-3975</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:362.1pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">27.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Scotti C, Pozzi A, Mangiavini L, et al. Healing of meniscal</span></p>
<p style="top:373.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tissue by cellular</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin glue: an in vivo study.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee Surg</span></p>
<p style="top:384.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Sports Traumatol Arthrosc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;17:645-651</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:394.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">28.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Horie M, Sekiya I, Muneta T, et al. Intra-articular injected</span></p>
<p style="top:405.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">synovial stem cells differentiate into meniscal cells directly</span></p>
<p style="top:416.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and promote meniscal regeneration without mobilization</span></p>
<p style="top:427.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">to distant organs in rat massive meniscal defect.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Stem Cells</span></p>
<p style="top:438.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2009;27:878-887</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:449.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">29.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Horie M, Driscoll MD, Sampson HW, et al. Implantation of</span></p>
<p style="top:460.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">allogenic synovial stem cells promotes meniscal regener-</span></p>
<p style="top:471.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ation in a rabbit meniscal defect model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg</span></p>
<p style="top:482.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;94:701-712</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:493.6pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">30.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Ferris D, Frisbie D, Kisiday J, McIlwraith CW. In vivo</span></p>
<p style="top:504.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing of meniscal lacerations using bone marrow-</span></p>
<p style="top:515.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">derived mesenchymal stem cells and</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brin glue.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Stem</span></p>
<p style="top:526.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Cells Int</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;2012:691605</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:537.4pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">31.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Desando G, Cavallo C, Sartoni F, et al. Intra-articular</span></p>
<p style="top:548.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">delivery of adipose derived stromal cells attenuates oste-</span></p>
<p style="top:559.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">oarthritis progression in an experimental rabbit model.</span></p>
<p style="top:570.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Arthritis Res Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;15:R22</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:581.3pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">32.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hong JH, Park JI, Kim KH, Kim YM, Joo YB, Jeon YS.</span></p>
<p style="top:592.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Repair of the complete radial tear of the anterior horn of</span></p>
<p style="top:603.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">the medial meniscus in rabbits: a comparison between</span></p>
<p style="top:614.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">simple pullout repair and pullout repair with human bone</span></p>
<p style="top:625.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">marrow stem cell implantation.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee Surg Relat Res</span></p>
<p style="top:636.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2011;23:164-170</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:647.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">33.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Zhang H, Leng P, Zhang J. Enhanced meniscal repair by</span></p>
<p style="top:658.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">overexpression of hIGF-1 in a full-thickness model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin</span></p>
<p style="top:668.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Orthop Relat Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;467:3165-3174</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:679.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">34.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> He W, Liu YJ, Wang ZG, Guo ZK, Wang MX, Wang N.</span></p>
<p style="top:690.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Enhancement of meniscal repair in the avascular zone</span></p>
<p style="top:701.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">using connective tissue growth factor in a rabbit model.</span></p>
<p style="top:712.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Chin Med J (Engl)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;124:3968-3975</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">953</span></p>


<p style="top:55.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">35.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Ionescu LC, Lee GC, Huang KL, Mauck RL. Growth factor</span></p>
<p style="top:66.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">supplementation</span></p>
<p style="top:66.2pt;left:137.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">improves</span></p>
<p style="top:66.2pt;left:183.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">native</span></p>
<p style="top:66.2pt;left:218.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and</span></p>
<p style="top:66.2pt;left:243.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">engineered</span></p>
<p style="top:77.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus repair in vitro.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Acta Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;8:3687-3694</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:88.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">36.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Zellner J, Hierl K, Mueller M, et al. Stem cell-based tissue-</span></p>
<p style="top:99.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">engineering for treatment of meniscal tears in the avas-</span></p>
<p style="top:110.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">cular zone.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res B Appl Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;101:</span></p>
<p style="top:121.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1133-1142</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:132.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">37.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moriguchi Y, Tateishi K, Ando W, et al. Repair of meniscal</span></p>
<p style="top:142.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">lesions using a scaffold-free tissue-engineered construct</span></p>
<p style="top:153.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">derived from allogenic synovial MSCs in a miniature</span></p>
<p style="top:164.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">swine model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biomaterials</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;34:2185-2193</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:175.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">38.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Esparza R, Gortazar AR, Forriol F. Cell study of the three</span></p>
<p style="top:186.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">areas of the meniscus: effect of growth factors in an experi-</span></p>
<p style="top:197.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mental model in sheep.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;30:1647-1651</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:208.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">39.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Haut Donahue TL, Hull ML, Rashid MM, Jacobs CR. How</span></p>
<p style="top:219.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">the stiffness of meniscal attachments and meniscal mate-</span></p>
<p style="top:230.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">rial</span></p>
<p style="top:230.6pt;left:81.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">properties</span></p>
<p style="top:230.6pt;left:128.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">affect</span></p>
<p style="top:230.6pt;left:158.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tibio-femoral</span></p>
<p style="top:230.6pt;left:218.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">contact</span></p>
<p style="top:230.6pt;left:254.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pressure</span></p>
<p style="top:241.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">computed using a validated</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">nite element model of the</span></p>
<p style="top:252.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">human knee joint.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomech</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2003;36:19-34</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">40.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Baker MI, Walsh SP, Schwartz Z, Boyan BD. A review of</span></p>
<p style="top:274.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">polyvinyl alcohol and its uses in cartilage and orthopedic</span></p>
<p style="top:285.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">applications.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res B Appl Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;100:</span></p>
<p style="top:296.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1451-1457</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:307.3pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">41.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Driscoll</span></p>
<p style="top:307.3pt;left:97.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">TP,</span></p>
<p style="top:307.3pt;left:117.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Nerurkar</span></p>
<p style="top:307.3pt;left:162.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">NL,</span></p>
<p style="top:307.3pt;left:184.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Jacobs</span></p>
<p style="top:307.3pt;left:217.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">NT,</span></p>
<p style="top:307.3pt;left:239.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Elliott</span></p>
<p style="top:307.3pt;left:270.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">DM,</span></p>
<p style="top:318.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Mauck RL. Fiber angle and aspect ratio in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">uence the</span></p>
<p style="top:329.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">shear mechanics of oriented electrospun nano</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brous</span></p>
<p style="top:340.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">scaffolds.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Mech Behav Biomed Mater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;4:1627-1636</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:351.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">42.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Fisher</span></p>
<p style="top:351.1pt;left:91.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">MB,</span></p>
<p style="top:351.1pt;left:115.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Henning</span></p>
<p style="top:351.1pt;left:156.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">EA, Soegaard</span></p>
<p style="top:351.1pt;left:221.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">N,</span></p>
<p style="top:351.1pt;left:237.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Esterhai JL,</span></p>
<p style="top:362.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Mauck RL. Organized nano</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brous scaffolds that mimic</span></p>
<p style="top:373.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">the macroscopic and microscopic architecture of the knee</span></p>
<p style="top:384.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Acta Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;9:4496-4504</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:394.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">43.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moutos FT, Estes BT, Guilak F. Multifunctional hybrid</span></p>
<p style="top:405.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">three-dimensionally woven scaffolds for cartilage tissue</span></p>
<p style="top:416.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">engineering.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Macromol Biosci</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;10:1355-1364</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:427.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">44.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moutos FT, Guilak F. Functional properties of cell-seeded</span></p>
<p style="top:438.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">three-dimensionally</span></p>
<p style="top:438.8pt;left:147.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">woven</span></p>
<p style="top:438.8pt;left:182.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">poly(epsilon-caprolactone)</span></p>
<p style="top:449.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">scaffolds for cartilage tissue engineering.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng Part</span></p>
<p style="top:460.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;16:1291-1301</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:471.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">45.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gunja NJ, Athanasiou KA. Effects of hydrostatic pressure</span></p>
<p style="top:482.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">on leporine meniscus cell-seeded PLLA scaffolds.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed</span></p>
<p style="top:493.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Mater Res A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;92:896-905</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:504.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">46.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gunja NJ, Huey DJ, James RA, Athanasiou KA. Effects of</span></p>
<p style="top:515.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">agarose mould compliance and surface roughness on self-</span></p>
<p style="top:526.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">assembled meniscus-shaped constructs.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Tissue Eng Regen</span></p>
<p style="top:537.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;3:521-530</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:548.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">47.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gunja NJ, Uthamanthil RK, Athanasiou KA. Effects of</span></p>
<p style="top:559.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">TGF-beta1 and hydrostatic pressure on meniscus cell-</span></p>
<p style="top:570.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">seeded scaffolds.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biomaterials</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;30:565-573</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:581.3pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">48.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gunja NJ, Athanasiou KA. Effects of co-cultures of</span></p>
<p style="top:592.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus cells and articular chondrocytes on PLLA scaf-</span></p>
<p style="top:603.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">folds.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biotechnol Bioeng</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;103:808-816</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:614.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">49.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Spilker RL, Donzelli PS, Mow VC. A transversely isotropic</span></p>
<p style="top:625.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">biphasic</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">nite element model of the meniscus.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomech</span></p>
<p style="top:636.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1992;25:1027-1045</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:647.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">50.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Balint E, Gatt CJ Jr, Dunn MG. Design and mechanical</span></p>
<p style="top:658.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">evaluation of a novel</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ber-reinforced scaffold for meniscus</span></p>
<p style="top:668.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">replacement.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;100:195-202</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:679.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">51.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Holloway JL, Lowman AM, Palmese GR. Mechanical</span></p>
<p style="top:690.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">evaluation of poly(vinyl alcohol)-based</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brous compos-</span></p>
<p style="top:701.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ites as biomaterials for meniscal tissue replacement.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Acta</span></p>
<p style="top:712.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;6:4716-4724</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:55.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">52.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gulotta</span></p>
<p style="top:55.2pt;left:358.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">LV,</span></p>
<p style="top:55.2pt;left:379.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Wiznia</span></p>
<p style="top:55.2pt;left:414.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">D,</span></p>
<p style="top:55.2pt;left:430.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Cunningham</span></p>
<p style="top:55.2pt;left:490.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">M,</span></p>
<p style="top:55.2pt;left:508.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Fortier</span></p>
<p style="top:55.2pt;left:542.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">L,</span></p>
<p style="top:66.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Maher S, Rodeo SA. What</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">s new in orthopaedic research.</span></p>
<p style="top:77.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;93:2136-2141</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:88.1pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">53.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Puetzer JL, Brown BN, Ballyns JJ, Bonassar LJ. The effect</span></p>
<p style="top:99.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of</span></p>
<p style="top:99.1pt;left:337.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">IGF-I</span></p>
<p style="top:99.1pt;left:366.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">on</span></p>
<p style="top:99.1pt;left:385.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">anatomically</span></p>
<p style="top:99.1pt;left:443.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">shaped</span></p>
<p style="top:99.1pt;left:479.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tissue-engineered</span></p>
<p style="top:110.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">menisci.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng Part A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;19:1443-1450</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:121.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">54.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Spencer SJ, Saithna A, Carmont MR, Dhillon MS,</span></p>
<p style="top:131.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Thompson P, Spalding T. Meniscal scaffolds: early expe-</span></p>
<p style="top:142.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">rience and review of the literature.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;19:760-765</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:153.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">55.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Wendt D, Riboldi SA, Ciof</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> M, Martin I. Potential and</span></p>
<p style="top:164.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bottlenecks of bioreactors in 3D cell culture and tissue</span></p>
<p style="top:175.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">manufacturing.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Adv Mater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;21:3352-3367</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:186.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">56.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Marsano A, Vunjak-Novakovic G, Martin I. Towards tis-</span></p>
<p style="top:197.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sue engineering of meniscus substitutes: selection of cell</span></p>
<p style="top:208.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">source and culture environment.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Conf Proc IEEE Eng Med</span></p>
<p style="top:219.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Biol Soc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;1:3656-3658</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:230.6pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">57.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Ballyns JJ, Wright TM, Bonassar LJ. Effect of media</span></p>
<p style="top:241.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mixing on ECM assembly and mechanical properties of</span></p>
<p style="top:252.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">anatomically-shaped tissue engineered meniscus.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Bio-</span></p>
<p style="top:263.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">materials</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;31:6756-6763</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:274.4pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">58.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Martinez H, Brackmann C, Enejder A, Gatenholm P.</span></p>
<p style="top:285.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Mechanical stimulation of</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">broblasts in micro-channeled</span></p>
<p style="top:296.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bacterial cellulose scaffolds enhances production of ori-</span></p>
<p style="top:307.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ented collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bers.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;100:</span></p>
<p style="top:318.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">948-957</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:329.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">59.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Connelly JT, Vanderploeg EJ, Mouw JK, Wilson CG,</span></p>
<p style="top:340.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Levenston ME. Tensile loading modulates bone marrow</span></p>
<p style="top:351.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stromal cell differentiation and the development of engi-</span></p>
<p style="top:362.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">neered</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brocartilage constructs.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng Part A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;16:</span></p>
<p style="top:373.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1913-1923</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:384.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">60.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Huey DJ, Athanasiou KA. Tension-compression loading</span></p>
<p style="top:394.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">with chemical stimulation results in additive increases to</span></p>
<p style="top:405.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">functional properties of anatomic meniscal constructs.</span></p>
<p style="top:416.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">PLoS One</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;6:e27857</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:427.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">61.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Petri M, Ufer K, Toma I, et al. Effects of perfusion and cyclic</span></p>
<p style="top:438.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">compression on in vitro tissue engineered meniscus im-</span></p>
<p style="top:449.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">plants.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee Surg Sports Traumatol Arthrosc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;20:223-231</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:460.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">62.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Huey DJ, Hu JC, Athanasiou KA. Unlike bone, cartilage</span></p>
<p style="top:471.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">regeneration remains elusive.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Science</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;338:917-921</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:482.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">63.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Huey DJ, Athanasiou KA. Maturational growth of self-</span></p>
<p style="top:493.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">assembled, functional menisci as a result of TGF-beta1</span></p>
<p style="top:504.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and</span></p>
<p style="top:504.5pt;left:344.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">enzymatic</span></p>
<p style="top:504.5pt;left:392.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">chondroitinase-ABC</span></p>
<p style="top:504.5pt;left:480.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stimulation.</span></p>
<p style="top:504.5pt;left:534.9pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Bio-</span></p>
<p style="top:515.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">materials</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;32:2052-2058</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:526.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">64.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Stewart</span></p>
<p style="top:526.5pt;left:361.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">K,</span></p>
<p style="top:526.5pt;left:379.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Pabbruwe</span></p>
<p style="top:526.5pt;left:428.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">M,</span></p>
<p style="top:526.5pt;left:448.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Dickinson</span></p>
<p style="top:526.5pt;left:497.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">S,</span></p>
<p style="top:526.5pt;left:514.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Sims</span></p>
<p style="top:526.5pt;left:542.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">T,</span></p>
<p style="top:537.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Hollander AP, Chaudhuri JB. The effect of growth factor</span></p>
<p style="top:548.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">treatment on meniscal chondrocyte proliferation and</span></p>
<p style="top:559.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">differentiation on polyglycolic acid scaffolds.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng</span></p>
<p style="top:570.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2007;13:271-280</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:581.3pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">65.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Tumia NS, Johnstone AJ. Platelet derived growth factor-</span></p>
<p style="top:592.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">AB enhances knee meniscal cell activity in vitro.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee</span></p>
<p style="top:603.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2009:1673-1676</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:614.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">66.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Pangborn CA, Athanasiou KA. Effects of growth factors</span></p>
<p style="top:625.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">on</span></p>
<p style="top:625.1pt;left:339.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscal</span></p>
<p style="top:625.1pt;left:382.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brochondrocytes.</span></p>
<p style="top:625.1pt;left:463.4pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Tissue</span></p>
<p style="top:625.1pt;left:492.9pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Eng</span></p>
<p style="top:625.1pt;left:515.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2005;11:</span></p>
<p style="top:636.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1141-1148</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:647.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">67.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Pangborn CA, Athanasiou KA. Growth factors and</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bro-</span></p>
<p style="top:658.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">chondrocytes</span></p>
<p style="top:658.0pt;left:383.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">in</span></p>
<p style="top:658.0pt;left:400.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">scaffolds.</span></p>
<p style="top:658.0pt;left:445.8pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J</span></p>
<p style="top:658.0pt;left:459.2pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Orthop</span></p>
<p style="top:658.0pt;left:493.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Res</span></p>
<p style="top:658.0pt;left:515.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2005;23:</span></p>
<p style="top:668.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1184-1190</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:679.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">68.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Elder</span></p>
<p style="top:679.9pt;left:349.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">SH,</span></p>
<p style="top:679.9pt;left:371.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Shim</span></p>
<p style="top:679.9pt;left:399.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">JW,</span></p>
<p style="top:679.9pt;left:422.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Borazjani</span></p>
<p style="top:679.9pt;left:467.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">A,</span></p>
<p style="top:679.9pt;left:484.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Robertson</span></p>
<p style="top:679.9pt;left:532.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">HM,</span></p>
<p style="top:690.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Smith KE, Warnock JN. In</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">uence of hydrostatic and</span></p>
<p style="top:701.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">distortional</span></p>
<p style="top:701.8pt;left:375.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stress</span></p>
<p style="top:701.8pt;left:405.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">on</span></p>
<p style="top:701.8pt;left:425.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">chondroinduction.</span></p>
<p style="top:701.8pt;left:507.8pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Biorheology</span></p>
<p style="top:712.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2008;45:479-486</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">954</span></p>
<p style="top:31.6pt;left:257.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">C. J. MORAN ET AL.</span></p>


<p style="top:55.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">69.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Elder BD, Athanasiou KA. Synergistic and additive effects</span></p>
<p style="top:66.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of hydrostatic pressure and growth factors on tissue for-</span></p>
<p style="top:77.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mation.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> PLoS One</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2008;3:e2341</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:88.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">70.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moran CJ, Barry FP, Maher SA, Shannon FJ, Rodeo SA.</span></p>
<p style="top:99.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Advancing regenerative surgery in orthopaedic sports</span></p>
<p style="top:110.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">medicine: the critical role of the surgeon.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span></p>
<p style="top:121.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2012;40:934-944</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:132.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">71.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Drolet BC, Lorenzi NM. Translational research: under-</span></p>
<p style="top:142.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">standing the continuum from bench to bedside.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Transl Res</span></p>
<p style="top:153.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2011;157:1-5</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:164.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">72.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Arnoczky SP, Cook JL, Carter T, Turner AS. Translational</span></p>
<p style="top:175.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">models for studying meniscal repair and replacement:</span></p>
<p style="top:186.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">what they can and cannot tell us.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng Part B Rev</span></p>
<p style="top:197.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2010;16:31-39</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:208.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">73.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Chu CR, Williams A, Tolliver D, Kwoh CK, Bruno S III,</span></p>
<p style="top:219.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Irrgang JJ. Clinical optical coherence tomography of early</span></p>
<p style="top:230.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">articular cartilage degeneration in patients with degener-</span></p>
<p style="top:241.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ative meniscal tears.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Arthritis Rheum</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;62:1412-1420</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:252.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">74.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Sah RL, Ratcliffe A. Translational models for musculo-</span></p>
<p style="top:263.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">skeletal tissue engineering and regenerative medicine.</span></p>
<p style="top:274.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Tissue Eng Part B Rev</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;16:1-3</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:285.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">75.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Klompmaker J, Jansen HW, Veth RP, Nielsen HK, de</span></p>
<p style="top:296.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Groot JH, Pennings AJ. Porous implants for knee joint</span></p>
<p style="top:307.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscus reconstruction: a preliminary study on the role</span></p>
<p style="top:318.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of pore sizes in ingrowth and differentiation of</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bro-</span></p>
<p style="top:329.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">cartilage.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Mater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1993;14:1-11</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:340.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">76.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gunja NJ, Athanasiou KA. Passage and reversal effects on</span></p>
<p style="top:351.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">gene expression of bovine meniscal</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brochondrocytes.</span></p>
<p style="top:362.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Arthritis Res Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2007;9:R93</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:55.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">77.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Weinand C, Peretti GM, Adams SB Jr, Bonassar LJ,</span></p>
<p style="top:66.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Randolph MA, Gill TJ. An allogenic cell-based implant for</span></p>
<p style="top:77.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">meniscal lesions.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;34:1779-1789</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:88.1pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">78.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Revell CM, Athanasiou KA. Success rates and immuno-</span></p>
<p style="top:99.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">logic responses of autogenic, allogenic, and xenogenic</span></p>
<p style="top:110.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">treatments to repair articular cartilage defects.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Tissue Eng</span></p>
<p style="top:121.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Part B Rev</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;15:1-15</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:131.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">79.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Caplan AI, Correa D. The MSC: an injury drugstore.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Cell</span></p>
<p style="top:142.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Stem Cell</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;9:11-15</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:153.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">80.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Steinert AF, Rackwitz L, Gilbert F, Noth U, Tuan RS.</span></p>
<p style="top:164.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Concise review: the clinical application of mesenchymal</span></p>
<p style="top:175.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stem cells for musculoskeletal regeneration: current status</span></p>
<p style="top:186.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and perspectives.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Stem Cells Trans Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;1:237-247</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:197.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">81.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Steinert AF, Palmer GD, Pilapil C, Noth U, Evans CH,</span></p>
<p style="top:208.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Ghivizzani SC. Enhanced in vitro chondrogenesis of pri-</span></p>
<p style="top:219.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mary mesenchymal stem cells by combined gene transfer.</span></p>
<p style="top:230.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Tissue Eng Part A</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;15:1127-1139</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:241.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">82.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Fox DB, Warnock JJ. Cell-based meniscal tissue engi-</span></p>
<p style="top:252.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">neering: a case for synoviocytes.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Orthop Relat Res</span></p>
<p style="top:263.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2011;469:2806-2816</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:274.4pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">83.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Arnoczky SP. Building a meniscus. Biologic consider-</span></p>
<p style="top:285.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ations.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Orthop Relat Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1999;(367 suppl):S244-S253</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:296.4pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">84.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Demarteau O, Jakob M, Schafer D, Heberer M, Martin I.</span></p>
<p style="top:307.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Development and validation of a bioreactor for physical</span></p>
<p style="top:318.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stimulation of engineered cartilage.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Biorheology</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2003;40:</span></p>
<p style="top:329.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">331-336</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:340.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">85.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Martin I, Smith T, Wendt D. Bioreactor-based roadmap</span></p>
<p style="top:351.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">for the translation of tissue engineering strategies into</span></p>
<p style="top:362.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">clinical products.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Trends Biotechnol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;27:495-502</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:31.6pt;left:244.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">MENISCUS ENGINEERING</span></p>
<p style="top:30.0pt;left:531.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">955</span></p>

</div>
